PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marten, R; McIntyre, D; Travassos, C; Shishkin, S; Longde, W; Reddy, S; Vega, J				Marten, Robert; McIntyre, Diane; Travassos, Claudia; Shishkin, Sergey; Longde, Wang; Reddy, Srinath; Vega, Jeanette			An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS)	LANCET			English	Article							DEVELOPMENT AGENDA; CARE	Brazil, Russia, India, China, and South Africa (BRICS) represent almost half the world's population, and all five national governments recently committed to work nationally, regionally, and globally to ensure that universal health coverage (UHC) is achieved. This analysis reviews national efforts to achieve UHC. With a broad range of health indicators, life expectancy (ranging from 53 years to 73 years), and mortality rate in children younger than 5 years (ranging from 10.3 to 44.6 deaths per 1000 livebirths), a review of progress in each of the BRICS countries shows that each has some way to go before achieving UHC. The BRICS countries show substantial, and often similar, challenges in moving towards UHC. On the basis of a review of each country, the most pressing problems are: raising insufficient public spending; stewarding mixed private and public health systems; ensuring equity; meeting the demands for more human resources; managing changing demographics and disease burdens; and addressing the social determinants of health. Increases in public funding can be used to show how BRICS health ministries could accelerate progress to achieve UHC. Although all the BRICS countries have devoted increased resources to health, the biggest increase has been in China, which was probably facilitated by China's rapid economic growth. However, the BRICS country with the second highest economic growth, India, has had the least improvement in public funding for health. Future research to understand such different levels of prioritisation of the health sector in these countries could be useful. Similarly, the role of strategic purchasing in working with powerful private sectors, the effect of federal structures, and the implications of investment in primary health care as a foundation for UHC could be explored. These issues could serve as the basis on which BRICS countries focus their efforts to share ideas and strategies.	[Marten, Robert; Vega, Jeanette] Rockefeller Fdn, New York, NY 10018 USA; [Marten, Robert] London Sch Hyg & Trop Med, London WC1, England; [McIntyre, Diane] Univ Cape Town, Hlth Econ Unit, ZA-7925 Cape Town, South Africa; [Travassos, Claudia] Fundacao Oswaldo Cruz, Inst Comunicacao & Informacao Cient & Tecnol, Rio De Janeiro, Brazil; [Shishkin, Sergey] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Longde, Wang] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Fundacao Oswaldo Cruz; HSE University (National Research University Higher School of Economics); Peking University; Public Health Foundation of India	Marten, R (corresponding author), Rockefeller Fdn, 420 Fifth Ave, New York, NY 10018 USA.	rmarten@rockfound.org		Reddy, K Srinath/0000-0003-3416-3548; McIntyre, Diane/0000-0001-6319-4111	Brazilian National Research Council (CNPq)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CT is partly supported by the Brazilian National Research Council (CNPq).	Abrucio LF, 2007, TRAJETORIA RECENTE G, P67; Alaba OA, 2012, DEV SO AFR, V29, P704, DOI 10.1080/0376835X.2012.730973; [Anonymous], 2012, LANCET, V379, P777; [Anonymous], 2012, LANCET, V380, P859; Ataguba JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-48; Ataguba JEO, 2013, HEALTH ECON POLICY L, V8, P21, DOI 10.1017/S1744133112000060; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Bahia L, 2012, POLITICAS SISTEMA SA, P427; Canfin P, 2013, LANCET, V381, P1885, DOI 10.1016/S0140-6736(13)60952-6; Cleary S, 2013, SOC SCI MED, V80, P37, DOI 10.1016/j.socscimed.2012.11.035; Das J., 2011, Economic and Political Weekly, V46, P87; De Costa A, 2008, QUAL HEALTH RES, V18, P756, DOI 10.1177/1049732308318504; Delhi Communique, 2013, 2 BRICS HLTH MIN DEC; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Fotaki M, 2009, J SOC POLICY, V38, P649, DOI 10.1017/S0047279409003274; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gordeev VS, 2014, HEALTH ECON POLICY L, V9, P25, DOI 10.1017/S1744133113000212; Instituto de Relaciones Internacionales, 2012, JOINT COMM BRICS MEM; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; McIntyre D, 2012, HLTH HLTH CARE S AFR; McIntyre D, 2012, HEALTH POLICY PLANN, V27, pi101, DOI 10.1093/heapol/czs003; Ministerstvo finansov Rossiyskoy Federatsii, OSN NAPR BYUDZH POL; Ministry of Finance, UN BUDG 2013 2014; Ministry of Health PRC, 2012, DEV CHIN NEW RUR COO; National Sample Survey Organization, 2005, NAT SAMPL SURV 60 RO; Planning Commission Government of India, 12 5 YEAR PLAN 2012; Popovich L, 2011, HLTH SYST TRANSIT, V13, pxiii; Popovich Larisa, 2011, Health Syst Transit, V13, P1; Rechel B, 2013, LANCET, V381, P1145, DOI 10.1016/S0140-6736(12)62084-4; Selvaraj S, 2012, EC POLIT WKLY, VXLVIL, P60; Sheikh M, 2013, LANCET, V381, P725, DOI 10.1016/S0140-6736(13)60580-2; Shepherd-Smith A, 2012, LANCET, V380, P874, DOI 10.1016/S0140-6736(12)61489-5; Shishkin S, 2007, EVIDENCE EQUITY RUSS; Shishkin SV, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2132; Silal SP, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-120; Tang SL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S8; The State Council of PRC, 2012, NOT ISS STAT COUNC P; The World Bank, LIF EXP BIRTH TOT YE; The World Bank, POP TOT; Uga MA, 2012, POLITICAS SISTEMA SA, P359; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, WHO DIR GEN ADDR 1 M; WHO, NAT HLTH ACC DAT; WHO, HLTH WORKF; *WHO, EUR HLTH ALL DAT HFA; WHO, MORT RISK PREM DEATH; World Bank, GNI PER CAP; World Bank, IND GINI; World Bank, 2012, HIV AIDS IND; World Bank, GDP GROWTH ANN; World Health Organization, UND 5 MORT; World Health Organization, DAT SIZ HIV AIDS EP; World Health Organization, MAT MORT; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	55	174	175	0	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2164	2171		10.1016/S0140-6736(14)60075-1	http://dx.doi.org/10.1016/S0140-6736(14)60075-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	24793339	Green Published, Bronze			2022-12-28	WOS:000346354300033
J	Truog, RD; Cohen, IG; Rockoff, MA				Truog, Robert D.; Cohen, I. Glenn; Rockoff, Mark A.			Physicians, Medical Ethics, and Execution by Lethal Injection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Truog, Robert D.] Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA 02115 USA; [Truog, Robert D.; Rockoff, Mark A.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Dept Med Eth Anaesthesia & Pediat, Boston, MA 02115 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Rockoff, Mark A.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Truog, RD (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, 300 Longwood Ave,Bader 621, Boston, MA 02115 USA.	robert.truog@childrens.harvard.edu						Alper T., 2009, J MED LICENSURE DISC, V95, P1; Alper T, 2012, HASTINGS CENT REP, V42, P6; American Board of Anesthesiology, AN CAP PUN; American Medical Association Code of Medical Ethics, OP 2 06 CAP PUN; Rubenstein LS, 2010, JAMA-J AM MED ASSOC, V304, P569, DOI 10.1001/jama.2010.1057; The Constitution Project, IRR ERR REC REF PREV	6	9	9	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2375	2376		10.1001/jama.2014.6425	http://dx.doi.org/10.1001/jama.2014.6425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24842282				2022-12-28	WOS:000337301500013
J	Mazur, PK; Reynoird, N; Khatri, P; Jansen, PWTC; Wilkinson, AW; Liu, SC; Barbash, O; Van Aller, GS; Huddleston, M; Dhanak, D; Tummino, PJ; Kruger, RG; Garcia, BA; Butte, AJ; Vermeulen, M; Sage, J; Gozani, O				Mazur, Pawel K.; Reynoird, Nicolas; Khatri, Purvesh; Jansen, Pascal W. T. C.; Wilkinson, Alex W.; Liu, Shichong; Barbash, Olena; Van Aller, Glenn S.; Huddleston, Michael; Dhanak, Dashyant; Tummino, Peter J.; Kruger, Ryan G.; Garcia, Benjamin A.; Butte, Atul J.; Vermeulen, Michiel; Sage, Julien; Gozani, Or			SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer	NATURE			English	Article							HISTONE METHYLTRANSFERASE; LUNG-CANCER; GROWTH-FACTOR; MOUSE MODEL; ACTIVATION; PROTEIN; PROGRESSION; KINASE; IDENTIFICATION; CHROMATIN	Deregulation of lysine methylation signalling has emerged as a common aetiological factor in cancer pathogenesis, with inhibitors of several histone lysine methyltransferases (KMTs) being developed as chemotherapeutics(1). The largely cytoplasmic KMT SMYD3 (SET and MYND domain containing protein 3) is overexpressed in numerous human tumours(2-4). However, the molecular mechanism by which SMYD3 regulates cancer pathways and its relationship to tumor-igenesisin vivo are largely unknown. Here we show that methylation of MAP3K2 by SMYD3 increases MAP kinase signalling and promotes the formation of Ras-driven carcinomas. Using mouse models for pancreatic ductal adenocarcinoma and lung adenocarcinoma, we found that abrogating SMYD3 catalytic activity inhibits tumour development in response to oncogenic Ras. We used protein array technology to identify the MAP3K2 kinase as a target of SMYD3. In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis. Finally, the PP2A phosphatase complex, a key negative regulator of the MAP kinase pathway, binds to MAP3K2 and this interaction is blocked by methylation. Together, our results elucidate a new role for lysine methylation in integrating cytoplasmic kinase-signalling cascades and establish a pivotal role for SMYD3 in the regulation of oncogenic Ras signalling.	[Mazur, Pawel K.; Butte, Atul J.; Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Mazur, Pawel K.; Butte, Atul J.; Sage, Julien] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Reynoird, Nicolas; Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, NL-3508 AB Utrecht, Netherlands; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 AB Utrecht, Netherlands; [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Epigenet Program, Philadelphia, PA 19104 USA; [Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barbash, Olena; Van Aller, Glenn S.; Huddleston, Michael; Dhanak, Dashyant; Tummino, Peter J.; Kruger, Ryan G.] GlaxoSmithKline, Oncol R&D, Canc Epigenet DPU, Collegeville, PA 19426 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline	Sage, J (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	julsage@stanford.edu; ogozani@stanford.edu	reynoird, nicolas/M-7568-2017; Vermeulen, Michiel/C-8883-2013; Reynoird, Nicolas/AAX-4043-2020; Mazur, Pawel K./AAU-6343-2021	reynoird, nicolas/0000-0003-1578-2781; Vermeulen, Michiel/0000-0003-0836-6894; Reynoird, Nicolas/0000-0003-1578-2781; Mazur, Pawel K./0000-0002-5820-8344; Gozani, Or/0000-0002-1365-4463; Khatri, Purvesh/0000-0002-4143-4708	NIH [RO1 CA172560]; NIH from the Office of the Director for B.A.G. [DP2 OD007447]; NWO-VIDI; Tobacco-Related Disease Research Program; Stanford University; Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Fondation pour la Recherche Medicale; NATIONAL CANCER INSTITUTE [R01CA172560, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Office of the Director for B.A.G.; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); Tobacco-Related Disease Research Program(University of California System); Stanford University(Stanford University); Child Health Research Institute; Lucile Packard Foundation for Children's Health at Stanford; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Gozani and Sage laboratories for critical reading of the manuscript, A. Smits for help with mass spectrometry data visualization and P.J. Utz and the Floren Family Trust for providing ProtoArrays. This work was supported in part by grants from the NIH to O.G. and J.S. (RO1 CA172560) and an NIH Innovator grant (DP2 OD007447) from the Office of the Director for B.A.G.; M. V. was supported by a grant from NWO-VIDI, P. K. M. was supported by the Tobacco-Related Disease Research Program, a Dean's Fellowship from Stanford University, and the Child Health Research Institute and Lucile Packard Foundation for Children's Health at Stanford. N.R. was supported by a grant from the Fondation pour la Recherche Medicale. J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; BRUNET A, 1994, ONCOGENE, V9, P3379; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Levy D, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-19; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Maruyama T, 2010, EMBO J, V29, P2501, DOI 10.1038/emboj.2010.141; Matitau AE, 2013, J BIOL CHEM, V288, P28293, DOI 10.1074/jbc.M113.511352; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	48	255	266	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					283	+		10.1038/nature13320	http://dx.doi.org/10.1038/nature13320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24847881	Green Accepted, Green Submitted			2022-12-28	WOS:000337032400053
J	Ludwig, DS; Friedman, MI				Ludwig, David S.; Friedman, Mark I.			Increasing Adiposity Consequence or Cause of Overeating?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WEIGHT-LOSS MAINTENANCE; ENERGY-EXPENDITURE; GLYCEMIC INDEX; OBESITY; FAT		[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Friedman, Mark I.] Nutr Sci Initiat, San Diego, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK082730, P30 DK040561] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1924, JAMA, V83, P1003; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; FRIEDMAN MI, 1976, PSYCHOL REV, V83, P409, DOI 10.1037/0033-295X.83.6.409; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Walsh CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058172	10	92	94	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2167	2168		10.1001/jama.2014.4133	http://dx.doi.org/10.1001/jama.2014.4133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24839118				2022-12-28	WOS:000336668400012
J	Gitlin, AD; Shulman, Z; Nussenzweig, MC				Gitlin, Alexander D.; Shulman, Ziv; Nussenzweig, Michel C.			Clonal selection in the germinal centre by regulated proliferation and hypermutation	NATURE			English	Article							DENDRITIC CELLS; AFFINITY MATURATION; IN-VIVO; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; DYNAMICS; RECEPTOR; CENTROBLASTS; ORGANIZATION; GENERATION	During immune responses, B lymphocytes clonally expand and undergo secondary diversification of their immunoglobulin genes in germinal centres (GCs)(1-4). High-affinity B cells are expanded through iterative interzonal cycles of division and hypermutation in the GC dark zone followed by migration to the GC light zone, where they are selected on the basis of affinity to return to the dark zone(5-10). Here we combine a transgenic strategy to measure cell division and a photoactivatable fluorescent reporter to examine whether the extent of clonal expansion and hypermutation are regulated during interzonal GC cycles. We find that both cell division and hypermutation are directly proportional to the amount of antigen captured and presented by GC B cells to follicular helper T cells in the light zone. Our data explain how GC B cells with the highest affinity for antigen are selectively expanded and diversified.	[Gitlin, Alexander D.; Shulman, Ziv; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019	Gitlin, Alexander/0000-0002-9229-0919	Empire State Stem Cell Fund through New York State Department of Health [C023046]; National Institutes of Health (NIH) [T32GM07739]; NIH [AI037526-19, AI072529-06]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526, UM1AI100663, R01AI072529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. W. Lowe and D. R. Fooksman for mice; D. Bosque and T. Eisenreich for help with mouse colony management; A. Abadir for protein production; K. Yao for technical help; K. Velinzon for help with cell sorting; D. Mucida and all members of the Nussenzweig laboratory for discussion. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health contract C023046. Supported by National Institutes of Health (NIH) Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A.D.G.); NIH grants AI037526-19 and AI072529-06 (M.C.N.); and the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N). Z.S. is a Human Frontiers of Science Fellow. M.C.N. is an HHMI investigator.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Oprea M, 1997, J IMMUNOL, V158, P5155; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wiesner SM, 2005, BLOOD, V106, P1054, DOI 10.1182/blood-2004-08-3306	30	358	361	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					637	+		10.1038/nature13300	http://dx.doi.org/10.1038/nature13300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24805232	Bronze, Green Accepted			2022-12-28	WOS:000336457100052
J	Chan, M				Chan, Margaret			Beyond expectations: 40 years of EPI	LANCET			English	Editorial Material							IMMUNIZATION		WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2013, Wkly Epidemiol Rec, V88, P482; Chan M, 2014, COMMUNICATION    MAR; Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; GAVI Alliance, 2014, GAVIS IMP; Mansoor OD, 2013, B WORLD HEALTH ORGAN, V91, P75, DOI 10.2471/BLT.12.110700; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; WHO, 2013, STRAT ADV GROUP EXP; WHO, 2013, SECR ANN REP 2013, V2013; WHO, 2014, DIS SURV BURD; WHO, 2012, WHO UNICEF COV EST 1; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2013, GLOB ACT PLAN PREV C	12	22	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1697	1698		10.1016/S0140-6736(14)60751-0	http://dx.doi.org/10.1016/S0140-6736(14)60751-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24835603				2022-12-28	WOS:000336267300005
J	Wells, JA; Kossiakoff, AA				Wells, James A.; Kossiakoff, Anthony A.			New Tricks for an Old Dimer	SCIENCE			English	Editorial Material							GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; DIMERIZATION; KINASE; JAK2; COMPLEX		[Wells, James A.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Kossiakoff, Anthony A.] Univ Chicago, Chicago, IL 60637 USA	University of California System; University of California San Francisco; University of Chicago	Wells, JA (corresponding author), Univ Calif San Francisco, 1700 4th St, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu; koss@bsd.uchicago.edu	Wells, Jim A/O-9854-2016					ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099	12	4	4	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					703	704		10.1126/science.1254799	http://dx.doi.org/10.1126/science.1254799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833381				2022-12-28	WOS:000335912900026
J	Liu, CY; Zhang, YF				Liu, Cai-Yue; Zhang, Ying-Fan			Pachydermoperiostosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Cai-Yue; Zhang, Ying-Fan] Second Mil Med Univ, Changzheng Hosp, Shanghai, Peoples R China	Naval Medical University	Liu, CY (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai, Peoples R China.	drzhangyf@126.com		zhang, ying fan/0000-0002-5002-6896					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1930	1930		10.1056/NEJMicm1309107	http://dx.doi.org/10.1056/NEJMicm1309107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827037				2022-12-28	WOS:000336123600009
J	Moulton, CA; Gu, CS; Law, CH; Tandan, VR; Hart, R; Quan, D; Smith, RJF; Jalink, DW; Husien, M; Serrano, PE; Hendler, AL; Haider, MA; Ruo, L; Gulenchyn, KY; Finch, T; Julian, JA; Levine, MN; Gallinger, S				Moulton, Carol-Anne; Gu, Chu-Shu; Law, Calvin H.; Tandan, Ved R.; Hart, Richard; Quan, Douglas; Smith, Robert J. Fairfull; Jalink, Diederick W.; Husien, Mohamed; Serrano, Pablo E.; Hendler, Aaron L.; Haider, Masoom A.; Ruo, Leyo; Gulenchyn, Karen Y.; Finch, Terri; Julian, Jim A.; Levine, Mark N.; Gallinger, Steven			Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEPATIC RESECTION; F-18-FDG PET; FDG-PET; CANCER; SURVIVAL; CHEMOTHERAPY; CARCINOMA; SELECTION; IMPACT	IMPORTANCE Patients with colorectal cancer with liver metastases undergo hepatic resection with curative intent. Positron emission tomography combined with computed tomography (PET-CT) could help avoid noncurative surgery by identifying patients with occult metastases. OBJECTIVES To determine the effect of preoperative PET-CT vs no PET-CT (control) on the surgical management of patients with resectable metastases and to investigate the effect of PET-CT on survival and the association between the standardized uptake value (ratio of tissue radioactivity to injected radioactivity adjusted by weight) and survival. DESIGN, SETTING, AND PARTICIPANTS A randomized trial of patients older than 18 years with colorectal cancer treated by surgery, with resectable metastases based on CT scans of the chest, abdomen, and pelvis within the previous 30 days, and with a clear colonoscopy within the previous 18 months was conducted between 2005 and 2013, involving 21 surgeons at 9 hospitals in Ontario, Canada, with PET-CT scanners at 5 academic institutions. INTERVENTIONS Patients were randomized using a 2 to 1 ratio to PET-CT or control. MAIN OUTCOMES AND MEASURES The primary outcomewas a change in surgical management defined as canceled hepatic surgery, more extensive hepatic surgery, or additional organ surgery based on the PET-CT. Survival was a secondary outcome. RESULTS Of the 263 patients who underwent PET-CT, 21 had a change in surgical management (8.0%; 95% CI, 5.0%-11.9%). Specifically, 7 patients (2.7%) did not undergo laparotomy, 4 (1.5%) had more extensive hepatic surgery, 9 (3.4%) had additional organ surgery (8 of whom had hepatic resection), and the abdominal cavity was opened in 1 patient but hepatic surgery was not performed and the cavity was closed. Liver resection was performed in 91% of patients in the PET-CT group and 92% of the control group. After a median follow-up of 36 months, the estimated mortality rate was 11.13 (95% CI, 8.95-13.68) events/1000 person-months for the PET-CT group and 12.71 (95% CI, 9.40-16.80) events/1000 person-months for the control group. Survival did not differ between the 2 groups (hazard ratio, 0.86[ 95% CI, 0.60-1.21]; P = .38). The standardized uptake value was associated with survival (hazard ratio, 1.11[ 90% CI, 1.07-1.15] per unit increase; P < .001). The C statistic for the model including the standardized uptake value was 0.62 (95% CI, 0.56-0.68) and without it was 0.50 (95% CI, 0.44-0.56). The difference in C statistics is 0.12 (95% CI, 0.04-0.21). The low C statistic suggests that the standard uptake value is not a strong predictor of overall survival. CONCLUSIONS AND RELEVANCE Among patients with potentially resectable hepatic metastases of colorectal adenocarcinoma, the use of PET-CT compared with CT alone did not result in frequent change in surgical management. These findings raise questions about the value of PET-CT scans in this setting.	[Moulton, Carol-Anne; Serrano, Pablo E.; Hendler, Aaron L.; Gallinger, Steven] Univ Hlth Network, Toronto, ON, Canada; [Gu, Chu-Shu; Tandan, Ved R.; Ruo, Leyo; Gulenchyn, Karen Y.; Finch, Terri; Julian, Jim A.; Levine, Mark N.] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada; [Law, Calvin H.; Haider, Masoom A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Law, Calvin H.; Haider, Masoom A.] Odette Canc Ctr, Toronto, ON, Canada; [Hart, Richard] St Josephs Hlth Ctr, Toronto, ON, Canada; [Quan, Douglas] London Hlth Sci Ctr, London, ON, Canada; [Smith, Robert J. Fairfull] Ottawa Hosp, Ottawa, ON, Canada; [Jalink, Diederick W.] Kingston Gen Hosp, Canc Ctr Southeastern Ontario, Kingston, ON K7L 2V7, Canada; [Husien, Mohamed] Grand River Reg Canc Ctr, Kitchener, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); London Health Sciences Centre; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Levine, MN (corresponding author), Juravinski Hosp & Canc Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	mlevine@mcmaster.ca	Serrano, Pablo/AAQ-7033-2021; Haider, Masoom/Q-1315-2017; Gallinger, Steven/E-4575-2013	Serrano, Pablo/0000-0002-3715-6880; 	Ontario Ministry of Health; Long-term Care	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-term Care(Ministry of Health and Long-Term Care, Ontario)	;This study was supported by a grant-in-aid from the Ontario Ministry of Health and Long-term Care to the Ontario Clinical Oncology Group (OCOG). The OCOG is an academic trials group, which designs and coordinates clinical trials and is based at McMaster University and Hamilton Health Sciences Hospital. The funding covered OCOG's data management and trial coordination, and stipends for the clinical sites for patient enrolment and data collection, for the nuclear medicine physicians for PET-CT reading, and for the fluorodeoxyglucose. In Canada, <SUP>18</SUP>fluorodeoxyglucose is considered an investigational agent and thus the OCOG was responsible for collecting adverse event reports.	Adam R, 2008, J CLIN ONCOL, V26, P3672, DOI 10.1200/JCO.2007.15.7297; Akhurst T, 2005, J CLIN ONCOL, V23, P8713, DOI 10.1200/JCO.2005.04.4222; Al Asfoor A, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006039.pub4, 10.1002/14651858.CD006039]; Arulampalam THA, 2004, EJSO-EUR J SURG ONC, V30, P286, DOI 10.1016/j.ejso.2003.10.023; Carpizo DR, 2009, ANN SURG ONCOL, V16, P2138, DOI 10.1245/s10434-009-0521-6; Charnsangavej C, 2006, ANN SURG ONCOL, V13, P1261, DOI 10.1245/s10434-006-9023-y; Desai DC, 2003, ANN SURG ONCOL, V10, P59, DOI 10.1245/ASO.2003.05.006; Evans WK, 2009, J CLIN ONCOL, V27, P5607, DOI 10.1200/JCO.2009.22.1614; Flamen P, 1999, J CLIN ONCOL, V17, P894, DOI 10.1200/JCO.1999.17.3.894; Hu YY, 2012, JNCI-J NATL CANCER I, V104, P1164, DOI 10.1093/jnci/djs286; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kantorova I, 2003, J NUCL MED, V44, P1784; Maziak DE, 2009, ANN INTERN MED, V151, P221, DOI 10.7326/0003-4819-151-4-200908180-00132; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nanji S, 2013, ANN SURG ONCOL, V20, P295, DOI 10.1245/s10434-012-2424-1; Pulitano C, 2011, ANN SURG ONCOL, V18, P1380, DOI 10.1245/s10434-010-1459-4; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Robertson DJ, 2009, CANCER-AM CANCER SOC, V115, P752, DOI 10.1002/cncr.24081; Rowan K, 2008, J NATL CANCER I, V100, P1665, DOI 10.1093/jnci/djn430; Ruers TJM, 2009, J NUCL MED, V50, P1036, DOI 10.2967/jnumed.109.063040; Shah SA, 2007, J AM COLL SURGEONS, V205, P676, DOI 10.1016/j.jamcollsurg.2007.06.283; Strasberg SM, 2001, ANN SURG, V233, P293, DOI 10.1097/00000658-200103000-00001; Valk PE, 1999, ARCH SURG-CHICAGO, V134, P503, DOI 10.1001/archsurg.134.5.503; Wiering B, 2005, CANCER-AM CANCER SOC, V104, P2658, DOI 10.1002/cncr.21569; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	25	110	114	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1863	1869		10.1001/jama.2014.3740	http://dx.doi.org/10.1001/jama.2014.3740			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825641	Bronze			2022-12-28	WOS:000335798100018
J	Amir, LH				Amir, Lisa H.			Managing common breastfeeding problems in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NIPPLE PAIN; MASTITIS; MILK; VASOSPASM; WOMEN		[Amir, Lisa H.] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic 3000, Australia; [Amir, Lisa H.] Royal Womens Hosp, Breastfeeding Serv, Parkville, Vic 3052, Australia	La Trobe University	Amir, LH (corresponding author), La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic 3000, Australia.	l.amir@latrobe.edu.au	Amir, Lisa/AAA-9786-2019	Amir, Lisa/0000-0002-2510-1399				Amir Lisa, 2004, Aust Fam Physician, V33, P44; Amir LH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002351; Amir LH, 2011, AUST FAM PHYSICIAN, V40, P684; Amir LH, 2008, BREASTFEED MED, V3, P177, DOI 10.1089/bfm.2008.9993; Amir Lisa Helen, 2003, Aust Fam Physician, V32, P141; Amir Lisa Helen, 2006, Aust Fam Physician, V35, P745; [Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Antibiotic Expert Group, 2010, THER GUID ANT; Buck ML, 2014, BREASTFEED MED, V9, P56, DOI 10.1089/bfm.2013.0106; Bunik M, 2011, BREASTFEED MED, V6, P41, DOI 10.1089/bfm.2011.9998; Carmichael AR, 2002, BREAST, V11, P88, DOI 10.1054/brst.2001.0313; Cataldo MA, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.11.2218; Colin W Binns, 2002, Breastfeed Rev, V10, P13; Fetherston CM, 2006, ACTA OBSTET GYN SCAN, V85, P20, DOI 10.1080/00016340500324514; Flammer J, 2001, PROG RETIN EYE RES, V20, P319, DOI 10.1016/S1350-9462(00)00028-8; Goundry B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e289; Hale T, 2012, MEDICATIONS MOTHERS; Hale TW, 2009, BREASTFEED MED, V4, P57, DOI 10.1089/bfm.2008.0144; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; INCH S, 1995, PRACTITIONER, V239, P472; Jahanfar S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005458.pub3; Kumar M, 2012, ACTA PAEDIATR, V101, P687, DOI 10.1111/j.1651-2227.2012.02661.x; Kvist LJ, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-6; Livingstone V, 1999, J Hum Lact, V15, P241, DOI 10.1177/089033449901500315; LIVINGSTONE VH, 1990, CAN FAM PHYSICIAN, V36, P1541; Mangesi L, 2010, COCHRANE DB SYST REV, V9; Mass S, 2004, CLIN OBSTET GYNECOL, V47, P676, DOI 10.1097/01.grf.0000135652.49154.75; Morino C, 2007, J HUM LACT, V23, P191, DOI 10.1177/0890334407300018; Morton J, 2009, J PERINATOL, V29, P757, DOI 10.1038/jp.2009.87; National Institute for Health and Care Excellence, 2005, NICE INT PROC GUID 1; Page SM, 2006, OBSTET GYNECOL, V108, P806, DOI 10.1097/01.AOG.0000214671.19023.68; Ramsay DT, 2005, J ANAT, V206, P525, DOI 10.1111/j.1469-7580.2005.00417.x; Reddy P, 2007, EMERG INFECT DIS, V13, P298, DOI 10.3201/eid1302.060989; Royal Women's Hospital, 2013, BREAST NIPPL THRUSH; Royal Women's Hospital, 2013, NIPPL VAS FACT SHEET; Royal Women's Hospital, 2012, CLIN GUID NIPPL BREA; Sachs HC, 2013, PEDIATRICS, V132, pE796, DOI 10.1542/peds.2013-1985; University of North Carolina Lactation Program, 2012, BREASTF ASS PAIN PRO; Vieira F, 2013, J NURS SCHOLARSHIP, V45, P116, DOI 10.1111/jnu.12010; Whitaker-Worth DL, 2000, J AM ACAD DERMATOL, V43, P733, DOI 10.1067/mjd.2000.109303; *WHO, 2000, WHOFCHCAH0013 DEP CH; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	42	28	30	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2014	348								g2954	10.1136/bmj.g2954	http://dx.doi.org/10.1136/bmj.g2954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5BW	24821712				2022-12-28	WOS:000336144400016
J	Gokhman, D; Lavi, E; Prufer, K; Fraga, MF; Riancho, JA; Kelso, J; Paabo, S; Meshorer, E; Carmel, L				Gokhman, David; Lavi, Eitan; Pruefer, Kay; Fraga, Mario F.; Riancho, Jose A.; Kelso, Janet; Paeaebo, Svante; Meshorer, Eran; Carmel, Liran			Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan	SCIENCE			English	Article							GENOME SEQUENCE; GENE; PLURIPOTENT	Ancient DNA sequencing has recently provided high-coverage archaic human genomes. However, the evolution of epigenetic regulation along the human lineage remains largely unexplored. We reconstructed the full DNA methylation maps of the Neandertal and the Denisovan by harnessing the natural degradation processes of methylated and unmethylated cytosines. Comparing these ancient methylation maps to those of present-day humans, we identified similar to 2000 differentially methylated regions (DMRs). Particularly, we found substantial methylation changes in the HOXD cluster that may explain anatomical differences between archaic and present-day humans. Additionally, we found that DMRs are significantly more likely to be associated with diseases. This study provides insight into the epigenetic landscape of our closest evolutionary relatives and opens a window to explore the epigenomes of extinct species.	[Gokhman, David; Lavi, Eitan; Meshorer, Eran; Carmel, Liran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Pruefer, Kay; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Fraga, Mario F.] Univ Oviedo, Univ Inst Oncol Asturias, Cajastur Social Program IUOPA, Canc Epigenet Lab, Oviedo, Spain; [Fraga, Mario F.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Riancho, Jose A.] Univ Cantabria, Dept Med, Hosp Univ Marques de Valdecilla, Inst Invest Marques de Valdecilla, E-39005 Santander, Spain; [Meshorer, Eran] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Max Planck Society; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hebrew University of Jerusalem	Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	meshorer@huji.ac.il; liran.carmel@huji.ac.il	Fraga, Mario F/H-7824-2017; Kelso, Janet/N-1812-2019	Fraga, Mario F/0000-0001-8450-2603; Kelso, Janet/0000-0002-3618-322X; Gokhman, David/0000-0002-3536-9006; Meshorer, Eran/0000-0003-4777-986X	Israel Science Foundation FIRST individual grant [ISF 1430/13]; Israel Science Foundation [ISF 1252/12, 657/12]; European Union Marie Curie Reintegration grant [IRG-248639]; Abisch-Frenkel Foundation; European Research Council [ERC-281781]; Presidential Innovation Fund of the Max Planck Society; Spanish Health Ministry [III-FIS PI09/539, PI12/615]	Israel Science Foundation FIRST individual grant; Israel Science Foundation(Israel Science Foundation); European Union Marie Curie Reintegration grant; Abisch-Frenkel Foundation; European Research Council(European Research Council (ERC)European Commission); Presidential Innovation Fund of the Max Planck Society; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government)	We thank S. Shifman, Y. Stelzer, M. Choder, O. Amster-Choder, U. Ben-David, M. Meyer, Y. Aaronson, and Y. N. Harari for critical comments. Supported by the Israel Science Foundation FIRST individual grant (ISF 1430/13 to L. C. and E. M.), the Israel Science Foundation (ISF 1252/12, 657/12 to E. M.), a European Union Marie Curie Reintegration grant (IRG-248639 to L. C.), the Abisch-Frenkel Foundation (to E. M.), the European Research Council (ERC-281781 to E. M.), the Presidential Innovation Fund of the Max Planck Society (to S. P.), and the Spanish Health Ministry (Instituto de Salud Carlos III-FIS PI09/539, PI12/615). Software (RoAM, after Reconstruction of Archaic Methylation) can be found at http://carmelab.huji.ac.il/software/RoAM/roam.html and data at http://carmelab.huji.ac.il/data.html. The authors declare no competing financial interests. Requests for data should be addressed to Liran Carmel (liran.carmel@huji.ac.il) and Eran Meshorer (meshorer@huji.ac.il).	Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; De Groote I, 2011, J HUM EVOL, V61, P396, DOI 10.1016/j.jhevol.2011.05.007; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; Dlugaszewska B, 2006, J MED GENET, V43, P111, DOI 10.1136/jmg.2005.033555; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fujimoto M, 1998, J HUM GENET, V43, P32, DOI 10.1007/s100380050033; Garcia-Ibarbia C, 2013, GENE, V532, P165, DOI 10.1016/j.gene.2013.09.080; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ohm JE, 2010, CANCER RES, V70, P7662, DOI 10.1158/0008-5472.CAN-10-1361; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; RIJLI FM, 1994, DEV DYNAM, V201, P366, DOI 10.1002/aja.1002010408; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; Weaver TD, 2003, P NATL ACAD SCI USA, V100, P6926, DOI 10.1073/pnas.1232340100; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	24	128	131	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					523	527		10.1126/science.1250368	http://dx.doi.org/10.1126/science.1250368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786081				2022-12-28	WOS:000335157700045
J	Gibson, CJ; Britton, KA; Miller, AL; Loscalzo, J				Gibson, Christopher J.; Britton, Kathryn A.; Miller, Amy Leigh; Loscalzo, Joseph			Out of the Blue	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; P-SELECTIN; PROGNOSIS; DOLENS	A 55-year-old man with a history of heart failure presented to the emergency department with pain and swelling in his right foot and leg. Three days before presentation, he noted a sudden onset of swelling in the right foot and calf, without any prior trauma. The swelling worsened progressively, extending to the upper leg, and was accompanied by pain in the foot and calf. He doubled his usual dose of torsemide, with no effect. On the day of presentation, he noted new dusky discoloration of the toes on his right foot.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					Ay C, 2008, BLOOD, V112, P2703, DOI 10.1182/blood-2008-02-142422; Chew HK, 2006, ARCH INTERN MED, V166, P458; Chinsakchai K, 2011, VASC ENDOVASC SURG, V45, P5, DOI 10.1177/1538574410388309; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Jones A, 2009, BRIT J CANCER, V101, P840, DOI 10.1038/sj.bjc.6605210; Kearon C, 2012, CHEST, V142, P1698; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Perkins JMT, 1996, BRIT J SURG, V83, P19, DOI 10.1002/bjs.1800830106; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Trousseau A., 1865, PHLEGMASIA ALBA DOLE, V3; Varki A, 2007, BLOOD, V110, P1723, DOI 10.1182/blood-2006-10-053736; WEAVER FA, 1988, SOUTH MED J, V81, P306, DOI 10.1097/00007611-198803000-00005; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	13	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1742	1748		10.1056/NEJMcps1213589	http://dx.doi.org/10.1056/NEJMcps1213589			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785210				2022-12-28	WOS:000335405200013
J	MacMillan, T; Benton, TG				MacMillan, Tom; Benton, Tim G.			Engage farmers in research	NATURE			English	Editorial Material							YIELD		[MacMillan, Tom] Soil Assoc, Bristol, Avon, England; [Benton, Tim G.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	MacMillan, T (corresponding author), Soil Assoc, Bristol, Avon, England.	tmacmillan@soilassociation.org; tim.benton@foodsecurity.ac.uk	Benton, Tim G/C-6493-2009	Benton, Tim G/0000-0002-7448-1973				Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fuglie K. O., 2011, RESEARCH INVESTMENTS; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Pollock C., 2013, FEEDING THE FUTURE; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Standing Committee on Agricultural Research, 2012, AGRICULTURAL KNOWLED; Vaarst M, 2007, J DAIRY SCI, V90, P2543, DOI 10.3168/jds.2006-607; Waddington H., 2014, FARMER FIELD SCHOOLS, V17	9	54	55	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					25	27		10.1038/509025a	http://dx.doi.org/10.1038/509025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784199	Bronze			2022-12-28	WOS:000335199100021
J	Kontis, V; Mathers, CD; Rehm, J; Stevens, GA; Shield, KD; Bonita, R; Riley, LM; Poznyak, V; Beaglehole, R; Ezzati, M				Kontis, Vasilis; Mathers, Colin D.; Rehm, Jurgen; Stevens, Gretchen A.; Shield, Kevin D.; Bonita, Ruth; Riley, Leanne M.; Poznyak, Vladimir; Beaglehole, Robert; Ezzati, Majid			Contribution of six risk factors to achieving the 25x25 non-communicable disease mortality reduction target: a modelling study	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; BODY-MASS INDEX; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; SMOKING PREVALENCE; SALT REDUCTION; GLOBAL TRENDS; WEIGHT-LOSS; HEALTH; METAANALYSIS	Background Countries have agreed to reduce premature mortality (defined as the probability of dying between the ages of 30 years and 70 years) from four main non-communicable diseases (NCDs)-cardiovascular diseases, chronic respiratory diseases, cancers, and diabetes-by 25% from 2010 levels by 2025 (referred to as 25x25 target). Targets for selected NCD risk factors have also been agreed on. We estimated the contribution of achieving six risk factor targets towards meeting the 25x25 mortality target. Methods We estimated the impact of achieving the targets for six risk factors (tobacco and alcohol use, salt intake, obesity, and raised blood pressure and glucose) on NCD mortality between 2010 and 2025. Our methods accounted for multi-causality of NCDs and for the fact that when risk factor exposure increases or decreases, the harmful or beneficial effects on NCDs accumulate gradually. We used data for risk factor and mortality trends from systematic analyses of available country data. Relative risks for the effects of individual and multiple risks, and for change in risk after decreases or increases in exposure, were from re-analyses and meta-analyses of epidemiological studies. Findings If risk factor targets are achieved, the probability of dying from the four main NCDs between the ages of 30 years and 70 years will decrease by 22% in men and by 19% in women between 2010 and 2025, compared with a decrease of 11% in men and 10% in women under the so-called business-as-usual trends (ie, projections based on current trends with no additional action). Achieving the risk factor targets will delay or prevent more than 37 million deaths (16 million in people aged 30-69 years and 21 million in people aged 70 years or older) from the main NCDs over these 15 years compared with a situation of rising or stagnating risk factor trends. Most of the benefits of achieving the risk factor targets, including 31 million of the delayed or prevented deaths, will be in low-income and middle-income countries, and will help to reduce the global inequality in premature NCD mortality. A more ambitious target on tobacco use (a 50% reduction) will almost reach the target in men (> 24% reduction in the probability of death), and enhance the benefits to a 20% reduction in women. Interpretation If the agreed risk factor targets are met, premature mortality from the four main NCDs will decrease to levels that are close to the 25x25 target, with most of these benefits seen in low-income and middle-income countries. On the basis of mortality benefits and feasibility, a more ambitious target than currently agreed should be adopted for tobacco use.	[Kontis, Vasilis; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE, Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Mathers, Colin D.; Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Riley, Leanne M.] WHO, Dept Prevent Noncommunicable Dis, CH-1211 Geneva, Switzerland; [Poznyak, Vladimir] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland; [Rehm, Jurgen; Shield, Kevin D.] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada; [Rehm, Jurgen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Rehm, Jurgen] Tech Univ Dresden, Klin Psychol & Psychotherapie, D-01062 Dresden, Germany; [Bonita, Ruth; Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand	Imperial College London; World Health Organization; World Health Organization; World Health Organization; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Technische Universitat Dresden; University of Auckland	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC PHE, Ctr Environm & Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Shield, Kevin/AAR-8220-2020	Kontis, Vasilis/0000-0002-0485-1561; Shield, Kevin/0000-0003-1871-8849; Mathers, Colin/0000-0002-0617-6731	UK MRC; MRC [G0801056, MR/K005901/1] Funding Source: UKRI; Medical Research Council [MR/K005901/1, G0801056] Funding Source: researchfish	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK MRC	Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Brand DA, 2007, PLOS MED, V4, P752, DOI 10.1371/journal.pmed.0040151; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; He F. J., 2013, BMJ, V346; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Holmes J, 2012, DRUG ALCOHOL DEPEN, V123, P7, DOI 10.1016/j.drugalcdep.2011.12.005; Huffman MD, 2013, CIRCULATION, V127, P2477, DOI 10.1161/CIRCULATIONAHA.112.000769; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Irving HM, 2009, J PANCREAS, V10, P387; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Keaver L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079827; Kehoe T, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-6; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laverty AA, 2011, J PUBLIC HEALTH-UK, V33, P302, DOI 10.1093/pubmed/fdq078; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Poznyak V, 2013, ALCOHOL RES-CURR REV, V35, P244; Preston S., 2000, DEMOGRAPHY MEASURING; Rehm J, 2014, ADDICTION, V109, P880, DOI 10.1111/add.12498; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Samokhvalov AV, 2010, EUR J CARDIOV PREV R, V17, P706, DOI 10.1097/HJR.0b013e32833a1947; Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x; Scholes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069935; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Thorolfsdottir RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085800; United Nations General Assembly, 2011, POL DECL HIGH LEV M; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, WHO METH DAT SOURC G; WHO, 2000, GLOB HLTH EST SUMM T; WHO, PROJ MORT CAUS DEATH; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Cancer Research Fund/American Institute for Cancer Research, 2012, CONT UPD PROJ REP FO; World Cancer Research Fund/American Institute for Cancer Research, 2013, CONT UPD PROJ REP FO; World Cancer Research Fund/American Institute for Cancer Research, 2010, CONT UPD PROJ REP FO; World Cancer Research Fund/American Institute for Cancer Research, 2014, CONT UPD PROJ REP FO; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ REP FO; World Health Organization, GLOB STRAT RED HARMF; Yach D, 2014, LANCET, V383, P1771, DOI 10.1016/S0140-6736(13)62155-8; YERUSHALMY J, 1959, J Chronic Dis, V10, P27, DOI 10.1016/0021-9681(59)90015-3; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	79	214	234	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					427	437		10.1016/S0140-6736(14)60616-4	http://dx.doi.org/10.1016/S0140-6736(14)60616-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24797573	Bronze			2022-12-28	WOS:000340195800026
J	Hoberman, A; Greenfield, SP; Mattoo, TK; Keren, R; Mathews, R; Pohl, HG; Kropp, BP; Skoog, SJ; Nelson, CP; Moxey-Mims, M; Chesney, RW; Carpenter, MA				Hoberman, Alejandro; Greenfield, Saul P.; Mattoo, Tej K.; Keren, Ron; Mathews, Ranjiv; Pohl, Hans G.; Kropp, Bradley P.; Skoog, Steven J.; Nelson, Caleb P.; Moxey-Mims, Marva; Chesney, Russell W.; Carpenter, Myra A.		RIVUR Trial Investigators	Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY-TRACT-INFECTION; ANTIBIOTIC-PROPHYLAXIS; TRIAL; PYELONEPHRITIS; MULTICENTER	Background Children with febrile urinary tract infection commonly have vesicoureteral reflux. Because trial results have been limited and inconsistent, the use of antimicrobial prophylaxis to prevent recurrences in children with reflux remains controversial. Methods In this 2-year, multisite, randomized, placebo-controlled trial involving 607 children with vesicoureteral reflux that was diagnosed after a first or second febrile or symptomatic urinary tract infection, we evaluated the efficacy of trimethoprimsulfamethoxazole prophylaxis in preventing recurrences (primary outcome). Secondary outcomes were renal scarring, treatment failure (a composite of recurrences and scarring), and antimicrobial resistance. Results Recurrent urinary tract infection developed in 39 of 302 children who received prophylaxis as compared with 72 of 305 children who received placebo (relative risk, 0.55; 95% confidence interval [CI], 0.38 to 0.78). Prophylaxis reduced the risk of recurrences by 50% (hazard ratio, 0.50; 95% CI, 0.34 to 0.74) and was particularly effective in children whose index infection was febrile (hazard ratio, 0.41; 95% CI, 0.26 to 0.64) and in those with baseline bladder and bowel dysfunction (hazard ratio, 0.21; 95% CI, 0.08 to 0.58). The occurrence of renal scarring did not differ significantly between the prophylaxis and placebo groups (11.9% and 10.2%, respectively). Among 87 children with a first recurrence caused by Escherichia coli, the proportion of isolates that were resistant to trimethoprim-sulfamethoxazole was 63% in the prophylaxis group and 19% in the placebo group. Conclusions Among children with vesicoureteral reflux after urinary tract infection, antimicrobial prophylaxis was associated with a substantially reduced risk of recurrence but not of renal scarring.	[Hoberman, Alejandro] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Greenfield, Saul P.] Women & Childrens Hosp Buffalo, Buffalo, NY USA; [Mattoo, Tej K.] Wayne State Univ, Sch Med, Detroit, MI USA; [Hoberman, Alejandro; Keren, Ron] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Mathews, Ranjiv] Johns Hopkins Sch Med, Baltimore, MD USA; [Pohl, Hans G.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Kropp, Bradley P.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Skoog, Steven J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Nelson, Caleb P.] Boston Childrens Hosp, Boston, MA USA; [Moxey-Mims, Marva] NIDDK, Bethesda, MD 20892 USA; [Chesney, Russell W.] Le Bonheur Childrens Hosp, Memphis, TN USA; [Carpenter, Myra A.] Univ N Carolina, Chapel Hill, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Women & Children's Hospital of Buffalo; Wayne State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Children's National Health System; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oregon Health & Science University; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill	Hoberman, A (corresponding author), Childrens Hosp Pittsburgh, 3414 Fifth Ave,CHOB 3rd Fl,Rm 321, Pittsburgh, PA 15213 USA.	hoberman@chp.edu	Montini, Giovanni/AAC-6612-2022; Mattoo, Tej K/CFB-5385-2022	Montini, Giovanni/0000-0002-7350-4475; Pohl, Hans/0000-0001-9679-0948; Moxey-Mims, Marva/0000-0001-8542-9313	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK074063, U01DK074082, U01DK074059, U01DK074062, K23DK088943, U01DK074053, U01DK074064] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; RIVUR ClinicalTrials.gov number, NCT00405704.	[Anonymous], 1987, Br Med J (Clin Res Ed), V295, P237; Benninga M, 2005, J PEDIATR GASTR NUTR, V40, P273, DOI 10.1097/01.MPG.0000158071.24327.88; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Brandstrom P, 2010, J UROLOGY, V184, P292, DOI 10.1016/j.juro.2010.01.060; Carpenter MA, 2013, PEDIATRICS, V132, pE34, DOI 10.1542/peds.2012-2301; Chesney Russell W, 2008, Pediatrics, V122 Suppl 5, pS233, DOI 10.1542/peds.2008-1285c; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUSC; Craig JC, 2010, NEW ENGL J MED, V362, P1250; Farhat W, 2000, J UROLOGY, V164, P1011, DOI 10.1016/S0022-5347(05)67239-4; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; Greenfield SP, 2012, J UROLOGY, V188, P1608, DOI 10.1016/j.juro.2012.06.032; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Hoberman A, 2009, NEW ENGL J MED, V361, P1804, DOI 10.1056/NEJMe0907623; Keren R, 2008, PEDIATRICS, V122, P1409, DOI 10.1542/peds.2008-1285d; LEVITT SB, 1981, PEDIATRICS, V67, P392; Montini G, 2008, PEDIATRICS, V122, P1064, DOI 10.1542/peds.2007-3770; Pennesi M, 2008, PEDIATRICS, V121, pE1489, DOI 10.1542/peds.2007-2652; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; Smellie JM, 2001, LANCET, V357, P1329, DOI 10.1016/S0140-6736(00)04520-7; WEISS R, 1992, J UROLOGY, V148, P1667, DOI 10.1016/S0022-5347(17)36998-7; Ziessman HA, 2009, J UROLOGY, V182, P272, DOI 10.1016/j.juro.2009.02.144	22	280	291	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2367	2376		10.1056/NEJMoa1401811	http://dx.doi.org/10.1056/NEJMoa1401811			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24795142	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000337353000005
J	Martinez, FJ; de Andrade, JA; Anstrom, KJ; King, TE; Raghu, G				Martinez, Fernando J.; de Andrade, Joao A.; Anstrom, Kevin J.; King, Talmadge E., Jr.; Raghu, Ganesh		Idiopathic Pulm Fibrosis Clinical	Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAMPLE-SIZE; DIAGNOSIS	BACKGROUND Acetylcysteine has been suggested as a beneficial treatment for idiopathic pulmonary fibrosis, although data from placebo-controlled studies are lacking. METHODS In our initial double-blind, placebo-controlled trial, we randomly assigned patients who had idiopathic pulmonary fibrosis with mild-to-moderate impairment in pulmonary function to receive a three-drug regimen of prednisone, azathioprine, and acetylcysteine; acetylcysteine alone; or placebo. The study was interrupted owing to safety concerns associated with the three-drug regimen. The trial continued as a two-group study (acetylcysteine vs. placebo) without other changes; 133 and 131 patients were enrolled in the acetylcysteine and placebo groups, respectively. The primary outcome was the change in forced vital capacity (FVC) over a 60-week period. RESULTS At 60 weeks, there was no significant difference in the change in FVC between the acetylcysteine group and the placebo group (-0.18 liters and -0.19 liters, respectively; P=0.77). In addition, there were no significant differences between the acetylcysteine group and the placebo group in the rates of death (4.9% vs. 2.5%, P=0.30 by the log-rank test) or acute exacerbation (2.3% in each group, P>0.99). CONCLUSIONS As compared with placebo, acetylcysteine offered no significant benefit with respect to the preservation of FVC in patients with idiopathic pulmonary fibrosis with mild-to-moderate impairment in lung function. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00650091.)	[Martinez, Fernando J.] Univ Michigan, Ann Arbor, MI 48109 USA; [Martinez, Fernando J.] Weill Cornell Med Coll, New York, NY USA; [de Andrade, Joao A.] Univ Alabama Birmingham, Birmingham, AL USA; [Anstrom, Kevin J.] Duke Clin Res Inst, Durham, NC USA; [King, Talmadge E., Jr.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Raghu, Ganesh] Univ Washington, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; Cornell University; University of Alabama System; University of Alabama Birmingham; Duke University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Raghu, G (corresponding author), Univ Washington, Box 356166, Seattle, WA 98195 USA.	graghu@uw.edu	De Andrade, Joao/X-5042-2019	De Andrade, Joao/0000-0002-3743-4561; Ryu, Jay/0000-0002-9576-2272; Moore, Bethany/0000-0003-3051-745X	NHLBI [U10HL080413, U10HL080274, U10HL080370, U10HL080371, U10HL080383, U10HL080411, U10HL080509, U10HL080510, U10HL080513, U10HL080543, U10HL080571, U10HL080685]; Cowlin Family Fund at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL080371, U10HL080370, U10HL080513, R01HL105479, U10HL080274, U10HL080510, U10HL080685, U10HL080383, U10HL080411, U10HL080571, U10HL080413, U10HL080509, U10HL080543] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cowlin Family Fund at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U10HL080413, to the data coordinating center; and U10HL080274, U10HL080370, U10HL080371, U10HL080383, U10HL080411, U10HL080509, U10HL080510, U10HL080513, U10HL080543, U10HL080571, and U10HL080685, to the clinical centers) from the NHLBI and by the Cowlin Family Fund at the Chicago Community Trust. Zambon provided the acetylcysteine and matching placebo that were used in the study.	American Thoracic Society European Respiratory Society. American Thoracic Society/ European Respiratory Society In- ternational Multidisciplinary Consensus Classification of the Idiopathic Intersti- tial Pneumonias: this joint statement of the American Thoracic Society ( ATS) and the European Respiratory Society ( ERS) was adopted by the ATS board of direc- tors June 2001 and by the ERS Executive Committee, 2001, AM J RESP CRIT CARE, V165, P277; American Thoracic Society European Respiratory Society. American Thoracic Society/ European Respiratory Society In- ternational Multidisciplinary Consensus Classification of the Idiopathic Intersti- tial Pneumonias: this joint statement of the American Thoracic Society ( ATS) and the European Respiratory Society ( ERS) was adopted by the ATS board of direc- tors June 2001 and by the ERS Executive Committee, 2001, AM J RESP CRIT CARE, V166, P426; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Peikert T, 2008, RESP MED, V102, P1342, DOI 10.1016/j.rmed.2008.03.018; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ries Andrew L, 2005, COPD, V2, P105; Rochon J, 1998, STAT MED, V17, P1643, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1643::AID-SIM869>3.0.CO;2-3; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053	13	312	328	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2093	2101		10.1056/NEJMoa1401739	http://dx.doi.org/10.1056/NEJMoa1401739			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24836309	Green Accepted			2022-12-28	WOS:000336434000007
J	Gal-Yam, A; Arcavi, I; Ofek, EO; Ben-Ami, S; Cenko, SB; Kasliwal, MM; Cao, Y; Yaron, O; Tal, D; Silverman, JM; Horesh, A; De Cia, A; Taddia, F; Sollerman, J; Perley, D; Vreeswijk, PM; Kulkarni, SR; Nugent, PE; Filippenko, AV; Wheeler, JC				Gal-Yam, Avishay; Arcavi, I.; Ofek, E. O.; Ben-Ami, S.; Cenko, S. B.; Kasliwal, M. M.; Cao, Y.; Yaron, O.; Tal, D.; Silverman, J. M.; Horesh, A.; De Cia, A.; Taddia, F.; Sollerman, J.; Perley, D.; Vreeswijk, P. M.; Kulkarni, S. R.; Nugent, P. E.; Filippenko, A. V.; Wheeler, J. C.			A Wolf-Rayet-like progenitor of SN 2013cu from spectral observations of a stellar wind	NATURE			English	Article							SUPERNOVA 2011DH; IIB SUPERNOVA; MASSIVE STARS; DISCOVERY; EVOLUTION; MODEL; IB/C	The explosive fate of massive Wolf-Rayet stars(1) (WRSs) is a key open question in stellar physics. An appealing option is that hydrogen-deficient WRSs are the progenitors of some hydrogen-poor supernova explosions of types IIb, Ib and Ic (ref. 2). A blue object, having luminosity and colours consistent with those of some WRSs, has recently been identified in pre-explosion images at the location of a supernova of type Ib (ref. 3), but has not yet been conclusively determined to have been the progenitor. Similar work has so far only resulted in non-detections(4). Comparison of early photometric observations of type Ic supernovae with theoretical models suggests that the progenitor stars had radii of less than 1012 centimetres, as expected for some WRSs(5). The signature of WRSs, their emission line spectra, cannot be probed by such studies. Here we report the detection of strong emission lines in a spectrum of type IIb supernova 2013cu (iPTF13ast) obtained approximately 15.5 hours after explosion (by 'flash spectroscopy', which captures the effects of the supernova explosion shock breakout flash on material surrounding the progenitor star). We identify Wolf-Rayet-like wind signatures, suggesting a progenitor of the WN(h) subclass (those WRSs with winds dominated by helium and nitrogen, with traces of hydrogen). The extent of this dense wind may indicate increased mass loss from the progenitor shortly before its explosion, consistent with recent theoretical predictions(6).	[Gal-Yam, Avishay; Arcavi, I.; Ofek, E. O.; Ben-Ami, S.; Yaron, O.; Tal, D.; De Cia, A.; Vreeswijk, P. M.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Cenko, S. B.] NASA, Astrophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kasliwal, M. M.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Cao, Y.; Horesh, A.; Perley, D.; Kulkarni, S. R.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Silverman, J. M.; Wheeler, J. C.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Taddia, F.; Sollerman, J.] Stockholm Univ, Oskar Klein Ctr, Dept Astron, AlbaNova, S-10691 Stockholm, Sweden; [Nugent, P. E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Phys, Berkeley, CA 94720 USA; [Filippenko, A. V.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94701 USA	Weizmann Institute of Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science; California Institute of Technology; University of Texas System; University of Texas Austin; Oskar Klein Centre; Stockholm University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel.	avishay.gal-yam@weizmann.ac.il	Nugent, Peter Edward/AGG-8472-2022; Horesh, Assaf/O-9873-2016	Horesh, Assaf/0000-0002-5936-1156; Kasliwal, Tamay/0000-0001-5634-7167; Sollerman, Jesper/0000-0003-1546-6615; De Cia, Annalisa/0000-0003-2082-1626; Taddia, Francesco/0000-0002-2387-6801; Nugent, Peter/0000-0002-3389-0586	I-CORE programme 'The Quantum Universe' of the Planning and Budgeting Committee; Israel Science Foundation; ISF; BSF; GIF; Minerva; FP7/ERC; Kimmel Investigator award; Hubble fellowship; Israeli MOST; NSF; TABASGO Foundation; Richard and Rhoda Goldman Fund; Christopher R. Redlich Fund; Swedish Research Council; W. M. Keck Foundation; Carnegie-Princeton fellowship; Direct For Mathematical & Physical Scien [1109801, 1211916] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1009987] Funding Source: National Science Foundation	I-CORE programme 'The Quantum Universe' of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); ISF(Israel Science Foundation); BSF(US-Israel Binational Science Foundation); GIF(German-Israeli Foundation for Scientific Research and Development); Minerva; FP7/ERC; Kimmel Investigator award; Hubble fellowship; Israeli MOST; NSF(National Science Foundation (NSF)); TABASGO Foundation; Richard and Rhoda Goldman Fund; Christopher R. Redlich Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); W. M. Keck Foundation(W.M. Keck Foundation); Carnegie-Princeton fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the I-CORE programme 'The Quantum Universe' of the Planning and Budgeting Committee and The Israel Science Foundation. A.G.-Y. acknowledges support by grants from the ISF, BSF, GIF, Minerva and FP7/ERC, and a Kimmel Investigator award. M. M. K. acknowledges support from Hubble and Carnegie-Princeton fellowships. E.O.O. acknowledges the Arye Dissentshik Career Development Chair and a grant from the Israeli MOST. J.C.W. is supported in part by the NSF. J.M.S. is supported by an NSF Postdoctoral Fellowship. A. V. F. acknowledges financial support from the TABASGO Foundation, the Richard and Rhoda Goldman Fund, the Christopher R. Redlich Fund and the NSF. The National Energy Research Scientific Computing Center, supported by the Office of Science of the US Department of Energy, provided staff, computational resources and data storage for this project. The Oskar Klein Centre is funded by the Swedish Research Council. We thank K. Clubb, O. Fox, P. Kelly, S. Tang and B. Sesar for their help with observations, and J. Groh, P. Crowther, M. Bersten, C. Fransson and E. Nakar for advice. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The observatory was made possible by the generous financial support of the W. M. Keck Foundation.	Arcavi I, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L18; Arcavi I, 2010, ASTROPHYS J, V721, P777, DOI 10.1088/0004-637X/721/1/777; Ben-Ami S, 2012, PROC SPIE, V8446, DOI 10.1117/12.926317; Ben-Ami S, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L33; Bersten MC, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/31; Cao Y, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L7; Chugai NN, 2009, MON NOT R ASTRON SOC, V400, P866, DOI 10.1111/j.1365-2966.2009.15506.x; Corsi A, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L5; Crockett RM, 2008, MON NOT R ASTRON SOC, V391, pL5, DOI 10.1111/j.1745-3933.2008.00540.x; Crowther PA, 2007, ANNU REV ASTRON ASTR, V45, P177, DOI 10.1146/annurev.astro.45.051806.110615; Denisenko D., 2013, CENTRAL BUR ELECT TE, V3540; Dessart L, 2011, MON NOT R ASTRON SOC, V414, P2985, DOI 10.1111/j.1365-2966.2011.18598.x; Eldridge JJ, 2013, MON NOT R ASTRON SOC, V436, P774, DOI 10.1093/mnras/stt1612; Ergon M, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201321850; Faber SM, 2003, P SOC PHOTO-OPT INS, V4841, P1657, DOI 10.1117/12.460346; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Gal-Yam A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/159; Grafener G, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117497; Groh JH, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321906; Hachinger S, 2012, MON NOT R ASTRON SOC, V422, P70, DOI 10.1111/j.1365-2966.2012.20464.x; Hamann WR, 2006, ASTRON ASTROPHYS, V457, P1015, DOI 10.1051/0004-6361:20065052; HILLIER DJ, 1987, ASTROPHYS J SUPPL S, V63, P965, DOI 10.1086/191188; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395, DOI 10.1086/648598; Leonard DC, 2000, ASTROPHYS J, V536, P239, DOI 10.1086/308910; Li WD, 2011, MON NOT R ASTRON SOC, V412, P1441, DOI 10.1111/j.1365-2966.2011.18160.x; Niedzielski A, 2002, ACTA ASTRONOM, V52, P81; NIEMELA VS, 1985, ASTROPHYS J, V289, P52, DOI 10.1086/162863; Ofek EO, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/47; Ofek EO, 2010, ASTROPHYS J, V724, P1396, DOI 10.1088/0004-637X/724/2/1396; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS, P47; PHILLIPS MM, 1990, PUBL ASTRON SOC PAC, V102, P299, DOI 10.1086/132634; Poole TS, 2008, MON NOT R ASTRON SOC, V383, P627, DOI 10.1111/j.1365-2966.2007.12563.x; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; Shiode JH, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/96; Van Dyk SD, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L32; Vink JS, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116614; WALBORN NR, 1989, ASTRON ASTROPHYS, V219, P229; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656; Yoon SC, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219790	40	197	197	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					471	+		10.1038/nature13304	http://dx.doi.org/10.1038/nature13304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848059	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000336126000034
J	Dandekar, P; Doherty, MF				Dandekar, Preshit; Doherty, Michael F.			Imaging Crystallization	SCIENCE			English	Editorial Material							ATOMIC FORCE MICROSCOPE; ORIENTED ATTACHMENT; CRYSTAL-GROWTH; SURFACE		[Dandekar, Preshit; Doherty, Michael F.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Dandekar, P (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	mfd@engineering.ucsb.edu		Doherty, Michael F./0000-0003-3309-3082	Div Of Chem, Bioeng, Env, & Transp Sys [1159746] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Cabrera N., 1958, GROWTH PERFECTION CR; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; Goniakowski J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016501; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Lupulescu AI, 2014, SCIENCE, V344, P729, DOI 10.1126/science.1250984; MANNE S, 1991, SCIENCE, V251, P183, DOI 10.1126/science.251.4990.183; MEYER G, 1990, APPL PHYS LETT, V56, P2100, DOI 10.1063/1.102985; Ohara M., 1973, MODELING CRYSTAL GRO; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968	12	13	13	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					705	706		10.1126/science.1254259	http://dx.doi.org/10.1126/science.1254259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833382				2022-12-28	WOS:000335912900027
J	Garcia, JM; Jones, GO; Virwani, K; McCloskey, BD; Boday, DJ; ter Huurne, GM; Horn, HW; Coady, DJ; Bintaleb, AM; Alabdulrahman, AMS; Alsewailem, F; Almegren, HAA; Hedrick, JL				Garcia, Jeannette M.; Jones, Gavin O.; Virwani, Kumar; McCloskey, Bryan D.; Boday, Dylan J.; ter Huurne, Gijs M.; Horn, Hans W.; Coady, Daniel J.; Bintaleb, Abdulmalik M.; Alabdulrahman, Abdullah M. S.; Alsewailem, Fares; Almegren, Hamid A. A.; Hedrick, James L.			Recyclable, Strong Thermosets and Organogels via Paraformaldehyde Condensation with Diamines	SCIENCE			English	Article							FORMALDEHYDE; COMPOSITES; DENSITY; POLYMER; SYSTEM	Nitrogen-based thermoset polymers have many industrial applications (for example, in composites), but are difficult to recycle or rework. We report a simple one-pot, low-temperature polycondensation between paraformaldehyde and 4,4'-oxydianiline (ODA) that forms hemiaminal dynamic covalent networks (HDCNs), which can further cyclize at high temperatures, producing poly(hexahydrotriazine)s (PHTs). Both materials are strong thermosetting polymers, and the PHTs exhibited very high Young's moduli (up to similar to 14.0 gigapascals and up to 20 gigapascals when reinforced with surface-treated carbon nanotubes), excellent solvent resistance, and resistance to environmental stress cracking. However, both HDCNs and PHTs could be digested at low pH (<2) to recover the bisaniline monomers. By simply using different diamine monomers, the HDCN- and PHT-forming reactions afford extremely versatile materials platforms. For example, when poly(ethylene glycol) (PEG) diamine monomers were used to form HDCNs, elastic organogels formed that exhibited self-healing properties.	[Garcia, Jeannette M.; Jones, Gavin O.; Virwani, Kumar; McCloskey, Bryan D.; Horn, Hans W.; Coady, Daniel J.; Hedrick, James L.] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [McCloskey, Bryan D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Boday, Dylan J.] IBM Tucson, Tucson, AZ 85744 USA; [ter Huurne, Gijs M.] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands; [Bintaleb, Abdulmalik M.; Alabdulrahman, Abdullah M. S.; Alsewailem, Fares; Almegren, Hamid A. A.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia	International Business Machines (IBM); University of California System; University of California Berkeley; International Business Machines (IBM); Eindhoven University of Technology; King Abdulaziz City for Science & Technology	Garcia, JM (corresponding author), IBM Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	jmgarcia@us.ibm.com; hedrick@us.ibm.com	Alsewailem, Fares/I-6804-2019; McCloskey, Bryan D/A-6556-2015	Alsewailem, Fares/0000-0002-5251-7330; McCloskey, Bryan D/0000-0001-6599-2336; Jones, Gavin/0000-0003-1528-6438				Barluenga J., 1988, J CHEM SOC P1, V1988, P1631; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brunovska Z, 1999, MACROMOL CHEM PHYSIC, V200, P1745, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1745::AID-MACP1745>3.0.CO;2-D; Chen JS, 2002, POLYMER, V43, P131, DOI 10.1016/S0032-3861(01)00605-X; Chernykh A, 2006, POLYMER, V47, P7664, DOI 10.1016/j.polymer.2006.08.041; CHOU S, 1992, COMPOS SCI TECHNOL, V45, P23, DOI 10.1016/0266-3538(92)90119-N; Dandia A, 2004, J FLUORINE CHEM, V125, P1273, DOI 10.1016/j.jfluchem.2004.03.002; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Ghandi M, 2006, MOLECULES, V11, P556, DOI 10.3390/11070556; GIUMANINI AG, 1985, J PRAKT CHEM, V327, P739, DOI 10.1002/prac.19853270506; Hiller M, 2002, MATER RES INNOV, V6, P179, DOI 10.1007/s10019-002-0185-3; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Ponzio EA, 2001, POLYM INT, V50, P1180, DOI 10.1002/pi.755; Schadler LS, 1998, APPL PHYS LETT, V73, P3842, DOI 10.1063/1.122911; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Singh A.K., 2011, J MAT ENV SCI, V2, P403; ULRICH H, 1961, J ORG CHEM, V26, P1637, DOI 10.1021/jo01064a606; Virwani KR, 2003, SMART MATER STRUCT, V12, P1028, DOI 10.1088/0964-1726/12/6/023	19	285	330	21	627	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					732	735		10.1126/science.1251484	http://dx.doi.org/10.1126/science.1251484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833389				2022-12-28	WOS:000335912900037
J	Nenoff, P; Schetschorke, C				Nenoff, Pietro; Schetschorke, Cornelia			Tinea Faciei	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nenoff, Pietro] Lab Med Mikrobiol, Molbis, Germany; [Schetschorke, Cornelia] Hautarztpraxis, Borna, Germany		Nenoff, P (corresponding author), Lab Med Mikrobiol, Molbis, Germany.	pietro.nenoff@gmx.de							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					E31	E31		10.1056/NEJMicm1311831	http://dx.doi.org/10.1056/NEJMicm1311831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827059				2022-12-28	WOS:000336123600030
J	Humphrey, JD; Milewicz, DM; Tellides, G; Schwartz, MA				Humphrey, Jay D.; Milewicz, Dianna M.; Tellides, George; Schwartz, Martin A.			Dysfunctional Mechanosensing in Aneurysms	SCIENCE			English	Editorial Material							SMOOTH-MUSCLE-CELLS; HOMEOSTASIS; COLLAGEN; FOCUS		[Humphrey, Jay D.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Tellides, George] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Schwartz, Martin A.] Yale Univ, Sch Med, Cardiovasc Res Ctr, New Haven, CT USA	Yale University; University of Texas System; University of Texas Health Science Center Houston; Yale University; Yale University	Humphrey, JD (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	martin.schwartz@yale.edu		schwartz, martin/0000-0002-2071-1243	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109942, R01HL075092, P01HL110869] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075092, P01 HL110869, R01 HL109942] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dajnowiec D, 2007, CLIN SCI, V113, P15, DOI 10.1042/CS20060337; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Kuang SQ, 2013, ARTERIOSCL THROM VAS, V33, P2172, DOI 10.1161/ATVBAHA.113.301624; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Li Q, 1998, J VASC RES, V35, P93, DOI 10.1159/000025570; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066	12	99	100	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					476	478		10.1126/science.1253026	http://dx.doi.org/10.1126/science.1253026			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786066	Green Accepted			2022-12-28	WOS:000335157700027
J	Scott, SH; Crevecoeur, F				Scott, Stephen H.; Crevecoeur, Frederic			NEUROSCIENCE Feedback throttled down for smooth moves	NATURE			English	Editorial Material							SHORT-RANGE STIFFNESS; MOTOR CONTROL		[Scott, Stephen H.; Crevecoeur, Frederic] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	steve.scott@queensu.ca		Crevecoeur, Frederic/0000-0002-1147-1153				Axelson HW, 2001, J PHYSIOL-LONDON, V535, P279, DOI 10.1111/j.1469-7793.2001.00279.x; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Jessell T. M., 2014, NATURE; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; Scott SH, 2012, TRENDS COGN SCI, V16, P541, DOI 10.1016/j.tics.2012.09.008; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; van Eesbeek S, 2010, J BIOMECH, V43, P2539, DOI 10.1016/j.jbiomech.2010.05.017; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	11	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					38	39		10.1038/509038a	http://dx.doi.org/10.1038/509038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784211				2022-12-28	WOS:000335199100033
J	Cooper, R; Strand, BH; Hardy, R; Patel, KV; Kuh, D				Cooper, Rachel; Strand, Bjorn Heine; Hardy, Rebecca; Patel, Kushang V.; Kuh, Diana			Physical capability in mid-life and survival over 13 years of follow-up: British birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FUNCTIONING OLDER-ADULTS; ALL-CAUSE MORTALITY; WALKING SPEED; GRIP STRENGTH; GAIT SPEED; PERFORMANCE-MEASURES; RISK-FACTORS; HEALTH; DEATH; CHILDHOOD	Objectives To examine associations between three commonly used objective measures of physical capability assessed at age 53 and a composite score of these measures and all cause mortality; to investigate whether being unable to perform these tests is associated with mortality. Design Cohort study. Setting MRC National Survey of Health and Development in England, Scotland, and Wales. Participants 1355 men and 1411 women with data on physical capability at age 53 who were linked to the National Health Service (NHS) central register for death notification. Main outcome measure All cause mortality between ages 53 (1999) and 66 (2012). Results For each of the three measures of physical capability (grip strength, chair rise speed, and standing balance time) those participants unable to perform the test and those in the lowest performing fifth were found to have higher mortality rates than those in the highest fifth. Adjustment for baseline covariates partially attenuated associations but in fully adjusted models the main associations remained. For example, the fully adjusted hazard ratio of all cause mortality for the lowest compared with the highest fifth of a composite score of physical capability was 3.68 (95% confidence interval 2.03 to 6.68). Those people who could not perform any of the tests had considerably higher rates of death compared with those people able to perform all three tests (8.40, 4.35 to 16.23). When a series of models including different combinations of the measures were compared by using likelihood ratio tests, all three measures of physical capability were found to improve model fit, and a model including all three measures produced the highest estimate of predictive ability (Harrell's C index 0.71, 95% confidence interval 0.65 to 0.77). There was some evidence that standing balance time was more strongly associated with mortality than the other two measures. Conclusions Lower levels of physical capability at age 53 and inability to perform capability tests are associated with higher rates of mortality. Even at this relatively young age these measures identify groups of people who are less likely than others to achieve a long and healthy life.	[Cooper, Rachel; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Strand, Bjorn Heine] Norwegian Inst Publ Hlth, N-0473 Oslo, Norway; [Patel, Kushang V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	University of London; University College London; Norwegian Institute of Public Health (NIPH); University of Washington; University of Washington Seattle	Cooper, R (corresponding author), UCL, MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	rachel.cooper@ucl.ac.uk	Cooper, Rachel/ABE-3768-2021; Hardy, Rebecca/AFR-1989-2022; Strand, Bjørn/AAV-7948-2021; Kuh, Diana/L-6019-2014	Cooper, Rachel/0000-0003-3370-5720; Strand, Bjørn/0000-0003-4385-8886; Kuh, Diana/0000-0001-7386-2857; Hardy, Rebecca/0000-0001-9949-0799	UK Medical Research Council [MC_UU_12019/4]; Norwegian Institute of Public Health; MRC [MC_UU_12019/4] Funding Source: UKRI; Medical Research Council [MC_UU_12019/4] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Norwegian Institute of Public Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by UK Medical Research Council (programme code MC_UU_12019/4) and the Norwegian Institute of Public Health. The funders of the study had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the article for publication.	Bassey EJ, 1998, AGE AGEING, V27, P12, DOI 10.1093/ageing/27.suppl_3.12; Bohannon RW, 2011, J STRENGTH COND RES, V25, P3205, DOI 10.1519/JSC.0b013e318234e59f; Bohannon RW, 2011, ISOKINET EXERC SCI, V19, P77, DOI 10.3233/IES-2011-0400; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; Curb JD, 2006, J AM GERIATR SOC, V54, P737, DOI 10.1111/j.1532-5415.2006.00700.x; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dumurgier J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4460; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Freiberger E, 2012, AGE AGEING, V41, P712, DOI 10.1093/ageing/afs099; Garcia-Pena C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069849; Grady D, 2011, ARCH INTERN MED, V171, P1701, DOI 10.1001/archinternmed.2011.482; Guralnik JM, 2006, J GERONTOL A-BIOL, V61, P694, DOI 10.1093/gerona/61.7.694; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hirsch CH, 2012, AGE AGEING, V41, P155, DOI 10.1093/ageing/afr151; Idland G, 2013, SCAND J PUBLIC HEALT, V41, P102, DOI 10.1177/1403494812466460; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; Kuh D, 2014, P NUTR SOC, P1; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kuh D, 2009, PSYCHOSOM MED, V71, P38, DOI 10.1097/PSY.0b013e31818a1620; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lusardi MM, 2012, TOP GERIATR REHABIL, V28, P67, DOI 10.1097/TGR.0b013e31824385a4; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; *MED RES COUNC, 1976, QUEST RESP SYMPT INS; Melzer D, 2006, RETIREMENT HLTH RELA; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rosero-Bixby L, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-11; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Sabia S, 2014, J GERONTOL A-BIOL, V69, P354, DOI 10.1093/gerona/glt114; Seino S, 2012, ARCH GERONTOL GERIAT, V55, P392, DOI 10.1016/j.archger.2011.11.011; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Strand BH, 2012, J EPIDEMIOL COMMUN H, V66, P225, DOI 10.1136/jech.2010.110155; Strand BH, 2011, EUR J EPIDEMIOL, V26, P475, DOI 10.1007/s10654-011-9562-9; Strand BH, 2011, J GERONTOL A-BIOL, V66, P142, DOI 10.1093/gerona/glq199; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; von Bonsdorff MB, 2013, INT J CARDIOL, V168, P2094, DOI 10.1016/j.ijcard.2013.01.067; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2; Walter Stefan, 2012, Am J Public Health, V102, pe3, DOI 10.2105/AJPH.2011.300596; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Xue QL, 2010, J AM GERIATR SOC, V58, P2076, DOI 10.1111/j.1532-5415.2010.03154.x; Yim-Chiplis P K, 2000, Biol Res Nurs, V1, P321	55	102	102	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2219	10.1136/bmj.g2219	http://dx.doi.org/10.1136/bmj.g2219			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG5RF	24787359	Green Published, hybrid			2022-12-28	WOS:000335475500002
J	New, K; Konstantopoulos, A; Arulkumaran, S; Day-Stirk, F				New, Karen; Konstantopoulos, Andreas; Arulkumaran, Sabaratnam; Day-Stirk, Frances			Every Newborn: the professional organisations' perspective	LANCET			English	Editorial Material									[New, Karen] Council Int Neonatal Nurses, Boston, MA 02131 USA; [Konstantopoulos, Andreas] Int Pediat Assoc, Elk Grove Village, IL USA; [Arulkumaran, Sabaratnam] Int Federat Gynecol & Obstet, London, England; [Day-Stirk, Frances] Int Confederat Midw, The Hague, Netherlands		New, K (corresponding author), Council Int Neonatal Nurses, Boston, MA 02131 USA.	karennew@coinnurses.org	New, Karen/E-7548-2011	New, Karen/0000-0002-6196-2452				Bhutta ZA, 2014, LANCET; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Lawn JE, 2014, LANCET; Mason E, 2014, LANCET; Save the Children, 2013, SURV 1 DAY STAT WORL; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	9	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E25	E26		10.1016/S0140-6736(14)60692-9	http://dx.doi.org/10.1016/S0140-6736(14)60692-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853602				2022-12-28	WOS:000338921500003
J	Masamha, CP; Xia, Z; Yang, JX; Albrecht, TR; Li, M; Shyu, AB; Li, W; Wagner, EJ				Masamha, Chioniso P.; Xia, Zheng; Yang, Jingxuan; Albrecht, Todd R.; Li, Min; Shyu, Ann-Bin; Li, Wei; Wagner, Eric J.			CFIm25 links alternative polyadenylation to glioblastoma tumour suppression	NATURE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; GLUTAMINE-METABOLISM; PROSTATE-CANCER; ANTISENSE RNA; C-MYC; GROWTH; WIDESPREAD; EXPRESSION; MICRORNAS	The global shortening of messenger RNAs through alternative polyadenylation (APA) that occurs during enhanced cellular proliferation represents an important, yet poorly understood mechanism of regulated gene expression(1,2). The 3' untranslated region (UTR) truncation of growth-promoting mRNA transcripts that relieves intrinsic microRNA-and AU-rich-element-mediated repression has been observed to correlate with cellular transformation(3); however, the importance to tumorigenicity of RNA 3'-end-processing factors that potentially govern APA is unknown. Here we identify CFIm25 as a broad repressor of proximal poly(A) site usage that, when depleted, increases cell proliferation. Applying a regression model on standard RNA-sequencing data for novel APA events, we identified at least 1,450 genes with shortened 3'UTRs after CFIm25knockdown, representing 11% of significantly expressed mRNAs in human cells. Marked increases in the expression of several known oncogenes, including cyclin D1, are observed as a consequence of CFIm25 depletion. Importantly, we identified a subset of CFIm25-regulated APA genes with shortened 39 UTRs in glioblastoma tumours that have reduced CFIm25 expression. Downregulation of CFIm25 expression in glioblastoma cells enhances their tumorigenic properties and increases tumour size, where as CFIm25 overexpression reduces these properties and inhibits tumour growth. These findings identify a pivotal role of CFIm25 in governing APA and reveal a previously unknown connection between CFIm25 and glioblastoma tumorigenicity.	[Masamha, Chioniso P.; Albrecht, Todd R.; Shyu, Ann-Bin; Wagner, Eric J.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yang, Jingxuan; Li, Min] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Wagner, EJ (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Ann-Bin.Shyu@uth.tmc.edu; WL1@bcm.edu; Eric.J.Wagner@uth.tmc.edu	Xia, Zheng/AAC-5360-2022; Xia, Zheng/F-6561-2014; Yang, Jingxuan/K-5047-2015	Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; Yang, Jingxuan/0000-0003-3265-161X; Li, Wei/0000-0001-9931-5990	CPRIT [RP100107, RP110471-C3]; Department of Defense [W81XWH-11-1-0304, W81XWH-10-1-0501]; National Institutes of Health (NIH) [GM046454, CA167752, CA166274]; Houston Endowment; NIH [R01HG007538]; Dr Marnie Rose Foundation; William and Ella Owens Medical Research Foundation; Department of Defense Postdoctoral Visionary Award [W81XWH-12-1-0218]; NATIONAL CANCER INSTITUTE [R01CA166274, R03CA167752] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454] Funding Source: NIH RePORTER	CPRIT; Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Marnie Rose Foundation; William and Ella Owens Medical Research Foundation; Department of Defense Postdoctoral Visionary Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of the E.J.W., A.-B.S. and W. L. laboratories for helpful discussions, P. Carpenter for reviewing the manuscript, and Q. Zhu and T. Shan of LC Sciences for their efforts on the RNA-seq. This work was supported by a CPRIT grant to E.J.W. and A.-B.S. (RP100107), and in part by a Department of Defense grant to E.J.W. (W81XWH-11-1-0304), National Institutes of Health (NIH) grants to A.-B.S. (GM046454) and E.J.W. (CA167752 and CA166274), and an endowment from Houston Endowment (to A.-B.S.). Work in the W. L. laboratory is funded by grants from the Department of Defense (W81XWH-10-1-0501), CPRIT (RP110471-C3) and NIH (R01HG007538). Work in the M. L. laboratory is funded by grants from the Dr Marnie Rose Foundation and the William and Ella Owens Medical Research Foundation. C. P. M. acknowledges a Department of Defense Postdoctoral Visionary Award (W81XWH-12-1-0218).	Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Braulke T, 1999, HORM METAB RES, V31, P235, DOI 10.1055/s-2007-978724; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Elkon R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r59; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gomez-Angelats M, 1999, MOL CARCINOGEN, V25, P157, DOI 10.1002/(SICI)1098-2744(199907)25:3<157::AID-MC1>3.0.CO;2-8; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kaplan PJ, 1999, CANCER RES, V59, P2203; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Ward A, 1998, J PATHOL, V185, P342, DOI 10.1002/(SICI)1096-9896(199808)185:4<342::AID-PATH136>3.0.CO;2-9; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	39	244	251	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					412	+		10.1038/nature13261	http://dx.doi.org/10.1038/nature13261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814343	Green Accepted			2022-12-28	WOS:000337350200038
J	Metcalfe, DB				Metcalfe, Daniel B.			A sink down under	NATURE			English	Editorial Material							CARBON; OCEANS; TREES; LAND		Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden	Lund University	Metcalfe, DB (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden.	dbmetcalfe@gmail.com						Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Serrano-Ortiz P, 2012, RECARBONIZATION BIOS, P347; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Zeng N, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002273	11	4	4	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					566	567		10.1038/nature13341	http://dx.doi.org/10.1038/nature13341			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847887				2022-12-28	WOS:000336457100032
J	Sommer, MOA				Sommer, Morten O. A.			Barriers to the spread of resistance	NATURE			English	Editorial Material							SOIL BACTERIA		[Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674	Novo Nordisk Fonden [NNF14OC0011335, NNF13SA0009311, NNF10CC1016517, NNF13SA0006019] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x	7	13	15	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					567	568		10.1038/nature13342	http://dx.doi.org/10.1038/nature13342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847882				2022-12-28	WOS:000336457100033
J	Pascoli, V; Terrier, J; Espallergues, J; Valjent, E; O'Connor, EC; Luscher, C				Pascoli, Vincent; Terrier, Jean; Espallergues, Julie; Valjent, Emmanuel; O'Connor, Eoin Cornelius; Luescher, Christian			Contrasting forms of cocaine-evoked plasticity control components of relapse	NATURE			English	Article							ACCUMBENS-PROJECTION NEURONS; LONG-TERM DEPRESSION; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; AMPA RECEPTORS; ADDICTION; MECHANISMS; DOPAMINE; INCUBATION; REWARD	Nucleus accumbens neurons serve to integrate information from cortical and limbic regions to direct behaviour. Addictive drugs are proposed to hijack this system, enabling drug-associated cues to trigger relapse to drug seeking. However, the connections affected and proof of causality remain to be established. Here we use a mouse model of delayed cue-associated cocaine seeking with ex vivo electrophysiology in optogenetically delineated circuits. We find that seeking correlates with rectifying AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor transmission and a reduced AMPA/NMDA (N-methyl-D-aspartate) ratio at medial prefrontal cortex (mPFC) to nucleus accumbens shell D1-receptor medium-sized spiny neurons (D1R-MSNs). In contrast, the AMPA/NMDA ratio increases at ventral hippocampus to D1R-MSNs. Optogenetic reversal of cocaine-evoked plasticity at both inputs abolishes seeking, whereas selective reversal at mPFC or ventral hippocampus synapses impairs response discrimination or reduces response vigour during seeking, respectively. Taken together, we describe how information integration in the nucleus accumbens is commandeered by cocaine at discrete synapses to allow relapse. Our approach holds promise for identifying synaptic causalities in other behavioural disorders.	[Pascoli, Vincent; Terrier, Jean; O'Connor, Eoin Cornelius; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Espallergues, Julie; Valjent, Emmanuel] CNRS, INSERM, U661, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] Univ Montpellier I, UMR 5203, F-34094 Montpellier, France; [Espallergues, Julie; Valjent, Emmanuel] Univ Montpellier 2, UMR 5203, F-34094 Montpellier, France; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Clin Neurol, CH-1211 Geneva, Switzerland	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011; Core, Vector/CAF-4832-2022	Lüscher, Christian/0000-0001-7917-4596; O'Connor, Eoin/0000-0002-7810-1915; Valjent, Emmanuel/0000-0002-1034-606X	Swiss National Science Foundation; National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation; European Research Council advanced grant (MeSSI); MD-PhD grant of the Swiss Confederation; Avenir grant (Inserm); Agence Nationale de la Recherche	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation; European Research Council advanced grant (MeSSI); MD-PhD grant of the Swiss Confederation; Avenir grant (Inserm); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank D. Huber and M. Brown as well the members of the Luscher laboratory for discussion and comments on the manuscript, and A. Hiver for assisting in animal surgery. This work was financed by a grant from the Swiss National Science Foundation, the National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation and a European Research Council advanced grant (MeSSI). J.T. is supported by an MD-PhD grant of the Swiss Confederation. The E. V. laboratory was supported by an Avenir grant (Inserm) and by the Agence Nationale de la Recherche.	Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Cerovic M, 2013, NEUROBIOL LEARN MEM, V105, P63, DOI 10.1016/j.nlm.2013.06.013; Chistyakov Vladimir S., 2006, Journal of Pharmacological and Toxicological Methods, V53, P117, DOI 10.1016/j.vascn.2005.03.009; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Counotte DS, 2014, PSYCHOPHARMACOLOGY, V231, P1675, DOI 10.1007/s00213-013-3294-3; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; French SJ, 2003, NEUROSCIENCE, V119, P19, DOI 10.1016/S0306-4522(03)00150-7; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; MacAskill AF, 2012, NAT NEUROSCI, V15, P1624, DOI 10.1038/nn.3254; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; Ortinski PI, 2012, NEUROPSYCHOPHARMACOL, V37, P1671, DOI 10.1038/npp.2012.12; OUIMET CC, 1984, J NEUROSCI, V4, P111; Papp E, 2012, BRAIN STRUCT FUNCT, V217, P37, DOI 10.1007/s00429-011-0331-z; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Saddoris Michael P, 2013, Front Biosci (Elite Ed), V5, P273; Schultz W, 2011, NEURON, V69, P603, DOI 10.1016/j.neuron.2011.02.014; Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026; Smith RJ, 2013, CURR OPIN NEUROBIOL, V23, P546, DOI 10.1016/j.conb.2013.01.026; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Thomsen M, 2007, BEHAV GENET, V37, P101, DOI 10.1007/s10519-006-9097-0	50	266	267	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					459	+		10.1038/nature13257	http://dx.doi.org/10.1038/nature13257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848058	Green Accepted			2022-12-28	WOS:000336126000032
J	Brooks, AJ; Dai, W; O'Mara, ML; Abankwa, D; Chhabra, Y; Pelekanos, RA; Gardon, O; Tunny, KA; Blucher, KM; Morton, CJ; Parker, MW; Sierecki, E; Gambin, Y; Gomez, GA; Alexandrov, K; Wilson, IA; Doxastakis, M; Mark, AE; Waters, MJ				Brooks, Andrew J.; Dai, Wei; O'Mara, Megan L.; Abankwa, Daniel; Chhabra, Yash; Pelekanos, Rebecca A.; Gardon, Olivier; Tunny, Kathryn A.; Blucher, Kristopher M.; Morton, Craig J.; Parker, Michael W.; Sierecki, Emma; Gambin, Yann; Gomez, Guillermo A.; Alexandrov, Kirill; Wilson, Ian A.; Doxastakis, Manolis; Mark, Alan E.; Waters, Michael J.			Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-ALPHA; ERYTHROPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTOR; GLYCOPHORIN-A; GH RECEPTOR; CONSTITUTIVE ACTIVATION; EXTRACELLULAR DOMAIN	Signaling from JAK (Janus kinase) protein kinases to STAT (signal transducers and activators of transcription) transcription factors is key to many aspects of biology and medicine, yet the mechanism by which cytokine receptors initiate signaling is enigmatic. We present a complete mechanistic model for activation of receptor-bound JAK2, based on an archetypal cytokine receptor, the growth hormone receptor. For this, we used fluorescence resonance energy transfer to monitor positioning of the JAK2 binding motif in the receptor dimer, substitution of the receptor extracellular domains with Jun zippers to control the position of its transmembrane (TM) helices, atomistic modeling of TM helix movements, and docking of the crystal structures of the JAK2 kinase and its inhibitory pseudokinase domain with an opposing kinase-pseudokinase domain pair. Activation of the receptor dimer induced a separation of its JAK2 binding motifs, driven by a ligand-induced transition from a parallel TM helix pair to a left-handed crossover arrangement. This separation leads to removal of the pseudokinase domain from the kinase domain of the partner JAK2 and pairing of the two kinase domains, facilitating trans-activation. This model may well generalize to other class I cytokine receptors.	[Brooks, Andrew J.; Abankwa, Daniel; Chhabra, Yash; Pelekanos, Rebecca A.; Gardon, Olivier; Tunny, Kathryn A.; Blucher, Kristopher M.; Sierecki, Emma; Gambin, Yann; Gomez, Guillermo A.; Alexandrov, Kirill; Mark, Alan E.; Waters, Michael J.] Univ Queensland, IMB, St Lucia, Qld 4072, Australia; [Dai, Wei; Doxastakis, Manolis] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA; [O'Mara, Megan L.; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Morton, Craig J.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Morton, Craig J.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fdn ACRF Rat Drug Discovery C, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Parker, Michael W.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Wilson, Ian A.] Scripps Res Inst, La Jolla, CA 92037 USA	University of Queensland; University of Houston System; University of Houston; University of Queensland; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Scripps Research Institute	Brooks, AJ (corresponding author), Univ Queensland, IMB, St Lucia, Qld 4072, Australia.	a.brooks@uq.edu.au; m.waters@uq.edu.au	Sierecki, Emma/I-2920-2019; Parker, Michael W/F-9069-2013; Mark, Alan E/A-8799-2011; GAMBIN, Yann/AAI-8501-2021; Pelekanos, Rebecca/C-8546-2011; SIERECKI, Emma/L-2556-2019; Sierecki, Emma/A-4810-2012; Morton, Craig/GON-8638-2022; Alexandrov, Kirill/A-5830-2013; Chhabra, Yash/C-8801-2018; Brooks, Andrew/A-9969-2011; waters, michael j/C-9582-2014; Gomez, Guillermo/J-2993-2014; GAMBIN, Yann/M-8799-2014; O'Mara, Megan/AAY-5934-2021; O'Mara, Megan/ABF-8913-2020; O'Mara, Megan L/A-4962-2011	Parker, Michael W/0000-0002-3101-1138; Mark, Alan E/0000-0001-5880-4798; Pelekanos, Rebecca/0000-0002-9463-7381; SIERECKI, Emma/0000-0001-9970-868X; Morton, Craig/0000-0001-5452-5193; Alexandrov, Kirill/0000-0002-0957-6511; Chhabra, Yash/0000-0003-2883-4675; Brooks, Andrew/0000-0002-2691-1668; Gomez, Guillermo/0000-0002-0494-2404; O'Mara, Megan/0000-0002-8764-1585; O'Mara, Megan L/0000-0002-8764-1585; GAMBIN, Yann/0000-0001-7378-8976; Doxastakis, Manolis/0000-0002-9175-9906; Abankwa, Daniel/0000-0003-2769-0745	National Health and Medical Research Council of Australia [511120, 1002893, 102082]; Australian Research Council; Victorian Government; NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division [1067356]; Kids Cancer Project of the Oncology Research Foundation; Directorate For Engineering [1067356] Funding Source: National Science Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division; Kids Cancer Project of the Oncology Research Foundation; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the National Health and Medical Research Council of Australia (511120, 1002893, and 102082) and the Australian Research Council to M.J.W., A.J.B, A.E.M., and M.W.P. Infrastructure funding from the Victorian Government to St Vincent's Institute is gratefully acknowledged. W.D. and M.D. acknowledge financial support by the NSF (USA) Chemical, Bioengineering, Environmental, and Transport Systems Division (grant number 1067356) and central processing unit time by the University of Houston Research Computing Center. G.A.G. acknowledges financial support by the Kids Cancer Project of the Oncology Research Foundation. We thank W.A. Johnston for optimizing the Leishmania-based cell-free lysate expression system used in the single-molecule and Alpha screen interaction studies. Confocal imaging was performed at the IMB/ACRF Cancer Biology Imaging Facility, established with the support of the Australian Cancer Research Foundation.	Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Behncken SN, 2000, J BIOL CHEM, V275, P17000, DOI 10.1074/jbc.275.22.17000; Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Biener-Ramanujan E, 2006, GROWTH HORM IGF RES, V16, P247, DOI 10.1016/j.ghir.2006.06.001; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chen CM, 1997, J BIOL CHEM, V272, P5133, DOI 10.1074/jbc.272.8.5133; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; ISHIZAKAIKEDA E, 1993, P NATL ACAD SCI USA, V90, P123, DOI 10.1073/pnas.90.1.123; Janosi L, 2010, BIOPHYS J, V99, P284, DOI 10.1016/j.bpj.2010.04.005; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Poger D, 2010, PROTEINS, V78, P1163, DOI 10.1002/prot.22636; Prakash A, 2011, BIOPHYS J, V101, P1949, DOI 10.1016/j.bpj.2011.09.017; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072	54	266	273	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					710	+	1249783	10.1126/science.1249783	http://dx.doi.org/10.1126/science.1249783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833397				2022-12-28	WOS:000335912900031
J	Kossin, JP; Emanuel, KA; Vecchi, GA				Kossin, James P.; Emanuel, Kerry A.; Vecchi, Gabriel A.			The poleward migration of the location of tropical cyclone maximum intensity	NATURE			English	Article							VERTICAL WIND SHEAR; CLUSTER-ANALYSIS; REANALYSIS; TRACKS; TRENDS	Temporally inconsistent and potentially unreliable global historical data hinder the detection of trends in tropical cyclone activity(1-3). This limits our confidence in evaluating proposed linkages between observed trends in tropical cyclones and in the environment(4,5). Here we mitigate this difficulty by focusing on a metric that is comparatively insensitive to past data uncertainty, and identify a pronounced poleward migration in the average latitude at which tropical cyclones have achieved their lifetime-maximum intensity over the past 30 years. The poleward trends are evident in the global historical data in both the Northern and the Southern hemispheres, with rates of 53 and 62 kilometres per decade, respectively, and are statistically significant. When considered together, the trends in each hemisphere depict a global-average migration of tropical cyclone activity away from the tropics at a rate of about one degree of latitude per decade, which lies within the range of estimates of the observed expansion of the tropics over the same period(6). The global migration remains evident and statistically significant under a formal data homogenization procedure(3), and is unlikely to be a data artefact. The migration away from the tropics is apparently linked to marked changes in the mean meridional structure of environmental vertical wind shear and potential intensity, and can plausibly be linked to tropical expansion, which is thought to have anthropogenic contributions(6).	[Kossin, James P.] Univ Wisconsin, NOAA Natl Climat Data Ctr, CIMSS, Madison, WI 53706 USA; [Emanuel, Kerry A.] MIT, Program Atmospheres Oceans & Climate, Cambridge, MA 02139 USA; [Vecchi, Gabriel A.] NOAA Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA	Kossin, JP (corresponding author), Univ Wisconsin, NOAA Natl Climat Data Ctr, CIMSS, 1225 W Dayton St, Madison, WI 53706 USA.	james.kossin@.noaa.gov	Kossin, James/C-2022-2016; Vecchi, Gabriel/A-2413-2008	Kossin, James/0000-0003-0461-9794; Vecchi, Gabriel/0000-0002-5085-224X				Barnston AG, 1997, ATMOS OCEAN, V35, P367; Bell GD, 2000, B AM METEOROL SOC, V81, pS1, DOI 10.1175/1520-0477(2000)81[s1:CAF]2.0.CO;2; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Camargo SJ, 2007, J CLIMATE, V20, P3654, DOI 10.1175/JCLI4203.1; Camargo SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001861; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel KA, 1999, NATURE, V401, P665, DOI 10.1038/44326; Emanuel K, 2013, J CLIMATE, V26, P2288, DOI 10.1175/JCLI-D-12-00242.1; Emanuel K, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.1; Frank WM, 2007, MON WEATHER REV, V135, P3587, DOI 10.1175/MWR3435.1; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Jiang HY, 2010, J CLIMATE, V23, P1526, DOI 10.1175/2009JCLI3303.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Knaff JA, 2004, MON WEATHER REV, V132, P2503, DOI 10.1175/1520-0493(2004)132<2503:OTIOVW>2.0.CO;2; Knapp KR, 2010, MON WEATHER REV, V138, P1459, DOI 10.1175/2009MWR3123.1; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kossin JP, 2013, J CLIMATE, V26, P9960, DOI 10.1175/JCLI-D-13-00262.1; Kossin JP, 2010, J CLIMATE, V23, P3057, DOI 10.1175/2010JCLI3497.1; Lam H, 2012, WEATHER, V67, P16, DOI 10.1002/wea.836; Landsea CW, 2010, J CLIMATE, V23, P2508, DOI 10.1175/2009JCLI3034.1; Lucas C, 2014, WIRES CLIM CHANGE, V5, P89, DOI 10.1002/wcc.251; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Ramsay HA, 2012, CLIM DYNAM, V39, P897, DOI 10.1007/s00382-011-1225-8; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Ross GJ, 2013, CPM SEQUENTIAL PARAM; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Vecchi GA, 2013, J CLIMATE, V26, P3877, DOI 10.1175/JCLI-D-12-00503.1; Vecchi GA, 2011, J CLIMATE, V24, P1736, DOI 10.1175/2010JCLI3810.1; Zhang FQ, 2013, J ATMOS SCI, V70, P975, DOI 10.1175/JAS-D-12-0133.1	32	347	354	7	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					349	+		10.1038/nature13278	http://dx.doi.org/10.1038/nature13278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828193	Green Submitted			2022-12-28	WOS:000336121200036
J	Smith, JM				Smith, Jeanette M.			The Pool, Medfield Dennis Miller Bunker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1838	1839		10.1001/jama.2013.279488	http://dx.doi.org/10.1001/jama.2013.279488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825626				2022-12-28	WOS:000335798100001
J	Boylan-Kolchin, M				Boylan-Kolchin, Michael			COSMOLOGY A virtual Universe	NATURE			English	Editorial Material							SIMULATIONS		Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Boylan-Kolchin, M (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	mbk@astro.umd.edu	Boylan-Kolchin, Michael/A-7200-2011	Boylan-Kolchin, Michael/0000-0002-9604-343X				Agertz O, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/25; Hopkins P. F., 2013, PREPRINT; Illingworth GD, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/6; Planck Collaboration, 2014, ASTRON ASTR IN PRESS; Springel V, 2010, MON NOT R ASTRON SOC, V401, P791, DOI 10.1111/j.1365-2966.2009.15715.x; Vogelsberger M, 2014, NATURE, V509, P177, DOI 10.1038/nature13316; Weinmann SM, 2012, MON NOT R ASTRON SOC, V426, P2797, DOI 10.1111/j.1365-2966.2012.21931.x	7	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					170	171		10.1038/509170a	http://dx.doi.org/10.1038/509170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805341				2022-12-28	WOS:000335454300025
J	Chung, S; Lee, EJ; Yun, S; Choe, HK; Park, SB; Son, HJ; Kim, KS; Dluzen, DE; Lee, I; Hwang, O; Son, GH; Kim, K				Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Park, Seong-Beom; Son, Hyo Jin; Kim, Kwang-Soo; Dluzen, Dean E.; Lee, Inah; Hwang, Onyou; Son, Gi Hoon; Kim, Kyungjin			Impact of Circadian Nuclear Receptor REV-ERB alpha on Midbrain Dopamine Production and Mood Regulation	CELL			English	Article							TYROSINE-HYDROXYLASE; CLOCK; GENE; TRANSCRIPTION; EXPRESSION; COMPONENT; BEHAVIOR; RHYTHM; IDENTIFICATION; DISRUPTION	The circadian nature of mood and its dysfunction in affective disorders is well recognized, but the underlying molecular mechanisms are still unclear. Here, we show that the circadian nuclear receptor REV-ERB alpha, which is associated with bipolar disorder, impacts midbrain dopamine production and mood-related behavior in mice. Genetic deletion of the Rev-erb alpha gene or pharmacological inhibition of REV-ERB alpha activity in the ventral midbrain induced mania-like behavior in association with a central hyperdopaminergic state. Also, REV-ERB alpha repressed tyrosine hydroxylase (TH) gene transcription via competition with nuclear receptor-related 1 protein (NURR1), another nuclear receptor crucial for dopa-minergic neuronal function, thereby driving circadian TH expression through a target-dependent antagonistic mechanism. In conclusion, we identified a molecular connection between the circadian timing system and mood regulation, suggesting that REVERBa could be targeting in the treatment of circadian rhythm-related affective disorders.	[Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Kim, Kyungjin] Seoul Natl Univ, Frontier Program Neurosci 21, Dept Biol Sci, Seoul 151742, South Korea; [Chung, Sooyoung; Lee, Eun Jeong; Yun, Seongsik; Choe, Han Kyoung; Kim, Kyungjin] Seoul Natl Univ, Frontier Program Neurosci 21, Brain Res Ctr, Seoul 151742, South Korea; [Park, Seong-Beom; Kim, Kyungjin] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Son, Hyo Jin; Hwang, Onyou] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst,Mol Neurobiol Lab, McLean Hosp,Dept Psychiat & Program Neurosci, Belmont, MA 02478 USA; [Dluzen, Dean E.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Son, Gi Hoon] Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Harvard University; McLean Hospital; Northeast Ohio Medical University (NEOMED); Korea University; Korea University Medicine (KU Medicine)	Son, GH (corresponding author), Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea.	songh@korea.ac.kr; kyungjin@snu.ac.kr	Choe, Han Kyoung/ABD-5083-2020; Core, Vector/CAF-4832-2022	Choe, Han Kyoung/0000-0001-7849-7094; Park, Seong-Beom/0000-0002-1346-4301; Son, Gi Hoon/0000-0001-9758-5903	Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program [2009K001287]; Neural Technology Development and Service for Neuroscience Research [2013056731]; National Research Foundation of Korea [2010-0025112, 2011-0019232, 2012M3A9C7050135]	Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Neural Technology Development and Service for Neuroscience Research; National Research Foundation of Korea(National Research Foundation of Korea)	We thank Dr. U. Schibler (University of Geneva) for providing Rev-erb alpha mutant mice, Dr. T. P. Burris (Scripps Institute) for providing SR8278, Dr. H. Kim (Korea University) for help with microarray experiments, Dr. T. Chun (Korea University) for assistance with FACS experiments, and S. Lee (Seoul National University) for constructing hyperdrives. This work was supported by the Brain Research Center of the 21<SUP>st</SUP> Century Frontier Research Program (2009K001287), the Neural Technology Development and Service for Neuroscience Research (2013056731), and the National Research Foundation of Korea (2010-0025112, 2011-0019232, 2012M3A9C7050135). BioScience Writers edited the manuscript.	Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chopin-Delannoy S, 2003, J MOL ENDOCRINOL, V30, P197, DOI 10.1677/jme.0.0300197; Chung S, 2005, ENDOCRINOLOGY, V146, P3202, DOI 10.1210/en.2004-1458; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Geldenhuys WJ, 2009, EUR J PHARMACOL, V619, P38, DOI 10.1016/j.ejphar.2009.08.012; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kondratova AA, 2010, AGING-US, V2, P285; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee EJ, 2011, J NEUROSCI, V31, P7131, DOI 10.1523/JNEUROSCI.4692-10.2011; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033292; McCarthy MJ, 2011, GENES BRAIN BEHAV, V10, P852, DOI 10.1111/j.1601-183X.2011.00725.x; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; Menet JS, 2011, CURR OPIN NEUROBIOL, V21, P849, DOI 10.1016/j.conb.2011.06.008; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Son GH, 2007, BIOCHEM BIOPH RES CO, V352, P823, DOI 10.1016/j.bbrc.2006.11.104; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Spencer S, 2012, J NEUROCHEM, V123, P124, DOI 10.1111/j.1471-4159.2012.07857.x; SURI C, 1993, J NEUROSCI, V13, P1280; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	51	185	189	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					858	868		10.1016/j.cell.2014.03.039	http://dx.doi.org/10.1016/j.cell.2014.03.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813609	Bronze			2022-12-28	WOS:000335765500014
J	Gagliani, N; Hu, B; Huber, S; Elinav, E; Flavell, RA				Gagliani, Nicola; Hu, Bo; Huber, Samuel; Elinav, Eran; Flavell, Richard A.			The Fire Within: Microbes Inflame Tumors	CELL			English	Review							INNATE LYMPHOID-CELLS; TOLL-LIKE RECEPTORS; COLORECTAL CARCINOGENESIS; INTESTINAL INFLAMMATION; COLON-CANCER; TH17 CELLS; TUMORIGENESIS; ACTIVATION; NLRP6; TRANSPLANTATION	The immune system and the microbiota mutually interact to maintain homeostasis in the intestine. However, components of the microbiota can alter this balance and promote chronic inflammation, promoting intestinal tumor development. We review recent advances in understanding the complex interactions between the microbiota and the innate and adaptive immune systems and discuss their potential to lead us in new directions for understanding cancer biology and treatment.	[Gagliani, Nicola; Hu, Bo; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 1, Hamburg, Germany; [Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Weizmann Institute of Science; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110; Huber, Samuel/0000-0001-9325-8227; Flavell, Richard/0000-0003-4461-0778; Gagliani, Nicola/0000-0001-8514-1395	Howard Hughes Medical Institute; U. S. Department of Defense [W81XWH-11-1-0745]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); U. S. Department of Defense(United States Department of Defense)	N.G. is supported by the Keith Landesman Memorial Fellowship of the Cancer Research Institute. S. H. is supported by the Stiftung Experimentelle Biomedizin, Ernst Jung-Stiftung, Werner-Otto Stiftung, Deutsche Forschungsgemeinschaft (SFB841, HU1714/3-1), and the European Research Council (ERC-2013-StG-337251). E.E. is supported by Yael and Rami Ungar, Israel, Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, Leona M. and Harry B. Helmsley Charitable Trust, Crown Endowment Fund for Immunological Research, Estate of Jack Gitlitz, Estate of Lydia Hershkovich, grants funded by the European Research Council, the Kenneth Rainin Foundation, the German-Israel Binational Foundation, the Israel Science Foundation, the Minerva Foundation, and the Alon Foundation scholar award. This work was supported, in part, by Howard Hughes Medical Institute (R.A.F. and B.H.) and the U. S. Department of Defense (W81XWH-11-1-0745) (R.A.F.).	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Anand PK, 2013, MICROBES INFECT, V15, P661, DOI 10.1016/j.micinf.2013.06.009; Anand VS, 2011, INT J DENT, V2011, DOI 10.1155/2011/214751; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, CANCER RES, V63, P6042; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gueimonde M, 2007, WORLD J GASTROENTERO, V13, P3985, DOI 10.3748/wjg.v13.i29.3985; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Jiang RQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-59; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; REDDY BS, 1975, CANCER RES, V35, P3421; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vannucci L, 2008, INT J ONCOL, V32, P609; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wu TY, 2013, CLIN IMMUNOL, V147, P38, DOI 10.1016/j.clim.2013.02.007; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	57	90	99	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					776	783		10.1016/j.cell.2014.03.006	http://dx.doi.org/10.1016/j.cell.2014.03.006			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813605	Bronze			2022-12-28	WOS:000335765500007
J	Matter, K; Balda, MS				Matter, Karl; Balda, Maria S.			SnapShot: Epithelial Tight Junctions	CELL			English	Editorial Material									[Matter, Karl; Balda, Maria S.] UCL, Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England	University of London; University College London	Matter, K (corresponding author), UCL, Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England.		Matter, Karl/C-4880-2008	Matter, Karl/0000-0001-8026-7220; /0000-0002-8427-6746	Biotechnology and Biological Sciences Research Council [BB/L007584/1, BB/H002294/1, BB/C514458/1] Funding Source: Medline; Medical Research Council [G0100200, G0400678, G0700743, G0900098] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/J015032/1] Funding Source: researchfish; Fight for Sight [1393/94] Funding Source: researchfish; BBSRC [BB/J015032/1, BB/H002294/1, BB/L007584/1] Funding Source: UKRI; MRC [G0100200, G0700743, G0400678, G0900098] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fight for Sight; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Gonzalez-Mariscal L, 2012, ANN NY ACAD SCI, V1257, P133, DOI 10.1111/j.1749-6632.2012.06537.x; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Steed E, 2014, J CELL BIOL, V204, P821, DOI 10.1083/jcb.201304115; Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zihni C, 2014, J CELL BIOL, V204, P111, DOI 10.1083/jcb.201304064	9	28	33	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4								10.1016/j.cell.2014.04.027	http://dx.doi.org/10.1016/j.cell.2014.04.027			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813618	Bronze			2022-12-28	WOS:000335765500024
J	Wen, L; Tang, FC				Wen, Lu; Tang, Fuchou			Reconstructing Complex Tissues from Single-Cell Analyses	CELL			English	Editorial Material							EMBRYOS	Techniques for profiling individual cells are rapidly advancing and are providing an unprecedented opportunity for studying the genetic regulation of development and disease. In this issue, Durruthy-Durruthy et al. analyze gene expression at the single-cell level for a simple but highly organized three-dimensional structure, the mouse otocyst.	[Wen, Lu; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Peking University	Tang, FC (corresponding author), Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn						Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	9	12	13	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					771	773		10.1016/j.cell.2014.04.024	http://dx.doi.org/10.1016/j.cell.2014.04.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813603	Bronze			2022-12-28	WOS:000335765500005
J	Watts, G				Watts, Geoff			John Victor Pickstone Obituary	LANCET			English	Biographical-Item																		PICKSTONE JV, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1542	1542		10.1016/S0140-6736(14)60738-8	http://dx.doi.org/10.1016/S0140-6736(14)60738-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24800299				2022-12-28	WOS:000335495400014
J	Aronson, L				Aronson, Louise			The art of medicine How do we tell the stories of medicine?	LANCET			English	Editorial Material									Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Aronson, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94118 USA.	aronsonl@medicine.ucsf.edu						Aronson L, 2013, NEW ENGL J MED, V369, P796, DOI 10.1056/NEJMp1303057; Chang J., 2010, THE NEW YORK TIMES; Meisel ZF, 2011, JAMA-J AM MED ASSOC, V306, P2022, DOI 10.1001/jama.2011.1648; Stewart J., 2003, ETHICS ROUNDS WINTER, V13, P9; Sudore RL, 2009, JAMA-J AM MED ASSOC, V302, P1629, DOI 10.1001/jama.2009.1422	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1456	1457		10.1016/S0140-6736(14)60707-8	http://dx.doi.org/10.1016/S0140-6736(14)60707-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24779054				2022-12-28	WOS:000335325800014
J	Dare, AJ; Grimes, CE; Gillies, R; Greenberg, SLM; Hagander, L; Meara, JG; Leather, AJM				Dare, Anna J.; Grimes, Caris E.; Gillies, Rowan; Greenberg, Sarah L. M.; Hagander, Lars; Meara, John G.; Leather, Andrew J. M.			Global surgery: defining an emerging global health field	LANCET			English	Editorial Material							COUNTRIES; CARE		[Dare, Anna J.; Grimes, Caris E.; Leather, Andrew J. M.] Kings Hlth Partners, Kings Ctr Global Hlth, London SE5 9RJ, England; [Dare, Anna J.; Grimes, Caris E.; Leather, Andrew J. M.] Kings Coll London, London SE5 9RJ, England; [Gillies, Rowan; Greenberg, Sarah L. M.; Meara, John G.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA USA; [Hagander, Lars] Lund Univ, Dept Clin Sci Int Paediat & Paediat, S-22100 Lund, Sweden	University of London; King's College London; University of London; King's College London; Harvard University; Harvard Medical School; Lund University	Dare, AJ (corresponding author), Kings Hlth Partners, Kings Ctr Global Hlth, London SE5 9RJ, England.	anna.dare@gmail.com	Grimes, Caris E/C-8252-2018	Grimes, Caris E/0000-0002-1662-5799; Leather, Andy/0000-0003-0500-5962; Gillies, Robert/0000-0002-8888-7747; Meara, John G./0000-0003-4369-3209				Abbud M, 2008, LANCET, V372, P5, DOI 10.1016/S0140-6736(08)60967-8; Boffa JD, 2008, MED J AUSTRALIA, V188, P560, DOI 10.5694/j.1326-5377.2008.tb01789.x; Bozorgmehr K, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-19; Campbell Ruth M, 2012, J Glob Health, V2, P010301, DOI 10.7189/jogh.02.010301; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horton R, 2009, INT HEALTH, V1, P26, DOI 10.1016/j.inhe.2009.06.003; Hoyler M, 2013, P 141 ANN M EXP AM P; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kim JY, 2014, LANCET COMMISSION GL; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Lynge DC, 2009, SURG CLIN N AM, V89, P1285, DOI 10.1016/j.suc.2009.07.003; Meara JG, 2014, LANCET, V383, P12, DOI 10.1016/S0140-6736(13)62345-4; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	21	84	86	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2245	2247		10.1016/S0140-6736(14)60237-3	http://dx.doi.org/10.1016/S0140-6736(14)60237-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	24853601				2022-12-28	WOS:000346655700028
J	Feldmann, H				Feldmann, Heinz			Ebola - A Growing Threat?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, Rocky Mt Labs, Virol Lab, Div Intramural Res, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Feldmann, H (corresponding author), NIAID, Rocky Mt Labs, Virol Lab, Div Intramural Res, Hamilton, MT 59840 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001188, ZIAAI001163] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Falzarano D, 2014, CELL RES; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Friedrich BM, 2012, VIRUSES-BASEL, V4, P1619, DOI 10.3390/v4091619; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536	5	61	70	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1375	1378		10.1056/NEJMp1405314	http://dx.doi.org/10.1056/NEJMp1405314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ3FJ	24805988				2022-12-28	WOS:000342674800005
J	Yoshida, S; Rudan, I; Lawn, JE; Wall, S; Souza, JP; Martines, J; Bahl, R				Yoshida, Sachiyo; Rudan, Igor; Lawn, Joy E.; Wall, Stephen; Souza, Joao Paulo; Martines, Jose; Bahl, Rajiv		Neonatal Hlth Res Priority Setting	Newborn health research priorities beyond 2015	LANCET			English	Editorial Material							REDUCE GLOBAL MORTALITY		[Yoshida, Sachiyo; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Edinburgh, Sch Med, Global Hlth Acad, Edinburgh, Midlothian, Scotland; [Lawn, Joy E.] London Sch Hyg & Trop Med, MARCH Maternal Reprod & Child Hlth, London WC1, England; [Lawn, Joy E.; Wall, Stephen] Save Children, Saving Newborn Lives, Washington, DC USA; [Souza, Joao Paulo] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Social Med, BR-05508 Sao Paulo, Brazil; [Martines, Jose] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth, N-5020 Bergen, Norway	World Health Organization; University of Edinburgh; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; Save the Children; Universidade de Sao Paulo; University of Bergen	Bahl, R (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland.	bahlr@who.int	Cecatti, Jose Guilherme/M-5945-2013; Lawn, Joy/ABE-6382-2020; smith, peter/ABH-9627-2020; Rudan, Igor/I-1467-2012; Hoque, Dewan/O-3606-2015; Olusanya, Bolajoko O./F-4504-2012; Souza, João Paulo/G-1982-2010; Hoque, Dewan Md. Emdadul/J-1999-2019; Lavender, Tina/B-1211-2011	Cecatti, Jose Guilherme/0000-0003-1285-8445; Lawn, Joy/0000-0002-4573-1443; smith, peter/0000-0003-0080-7560; Rudan, Igor/0000-0001-6993-6884; Hoque, Dewan/0000-0001-8219-9196; Olusanya, Bolajoko O./0000-0002-3826-0583; Souza, João Paulo/0000-0002-2288-4244; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; English, Michael/0000-0002-7427-0826; Lavender, Tina/0000-0003-1473-4956; Lackritz, Eve/0000-0002-5397-7291; Colbourn, Timothy/0000-0002-6917-6552; Blencowe, Hannah/0000-0003-1556-3159; McNamara, Patrick/0000-0001-7648-8872	MRC [MC_UP_A620_1016, MC_UU_12011/3] Funding Source: UKRI; Medical Research Council [MC_UU_12011/3, MC_UP_A620_1016] Funding Source: Medline; Wellcome Trust [100714, 203077, 091561] Funding Source: Medline; World Health Organization [001] Funding Source: Medline; Medical Research Council [U1475000003, MR/K012126/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); World Health Organization(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bahl R, 2009, PEDIATR INFECT DIS J, V28, pS43, DOI 10.1097/INF.0b013e31819588d7; Bahl Rajiv, 2012, J Glob Health, V2, P010403, DOI 10.7189/jogh.02.010403; Bhutta ZA, 2014, LANCET; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Lackritz EM, 2013, LANCET GLOB HEALTH, V1, pE328, DOI 10.1016/S2214-109X(13)70120-7; Lawn JE, 2014, LANCET; Lawn JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000389; Mason E, 2014, LANCET; Rudan I, 2012, PUBLIC HEALTH, V126, P237, DOI 10.1016/j.puhe.2011.12.001; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; You D., 2013, LEVEL TRENDS CHILD M	16	34	35	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E27	E29		10.1016/S0140-6736(14)60263-4	http://dx.doi.org/10.1016/S0140-6736(14)60263-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853596	Green Accepted			2022-12-28	WOS:000338921500004
J	Wartolowska, K; Judge, A; Hopewell, S; Collins, GS; Dean, BJF; Rombach, I; Brindley, D; Savulescu, J; Beard, DJ; Carr, AJ				Wartolowska, Karolina; Judge, Andrew; Hopewell, Sally; Collins, Gary S.; Dean, Benjamin J. F.; Rombach, Ines; Brindley, David; Savulescu, Julian; Beard, David J.; Carr, Andrew J.			Use of placebo controls in the evaluation of surgery: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; SHAM-CONTROLLED TRIAL; DOUBLE-BLIND; RANDOMIZED-TRIAL; LASER REVASCULARIZATION; PARKINSONS-DISEASE; ADVERSE EVENTS; SHORT-TERM; MULTICENTER; TRANSPLANTATION	Objective To investigate whether placebo controls should be used in the evaluation of surgical interventions. Design Systematic review. Data sources We searched Medline, Embase, and the Cochrane Controlled Trials Register from their inception to November 2013. Study selection Randomised clinical trials comparing any surgical intervention with placebo. Surgery was defined as any procedure that both changes the anatomy and requires a skin incision or use of endoscopic techniques. Data extraction Three reviewers (KW, BJFD, IR) independently identified the relevant trials and extracted data on study details, outcomes, and harms from included studies. Results In 39 out of 53 (74%) trials there was improvement in the placebo arm and in 27 (51%) trials the effect of placebo did not differ from that of surgery. In 26 (49%) trials, surgery was superior to placebo but the magnitude of the effect of the surgical intervention over that of the placebo was generally small. Serious adverse events were reported in the placebo arm in 18 trials (34%) and in the surgical arm in 22 trials (41.5%); in four trials authors did not specify in which arm the events occurred. However, in many studies adverse events were unrelated to the intervention or associated with the severity of the condition. The existing placebo controlled trials investigated only less invasive procedures that did not involve laparotomy, thoracotomy, craniotomy, or extensive tissue dissection. Conclusions Placebo controlled trial is a powerful, feasible way of showing the efficacy of surgical procedures. The risks of adverse effects associated with the placebo are small. In half of the studies, the results provide evidence against continued use of the investigated surgical procedures. Without well designed placebo controlled trials of surgery, ineffective treatment may continue unchallenged.	[Wartolowska, Karolina; Judge, Andrew; Dean, Benjamin J. F.; Rombach, Ines; Brindley, David; Beard, David J.; Carr, Andrew J.] Natl Inst Hlth Res, Musculoskeletal Biomed Res Unit, Oxford, England; [Wartolowska, Karolina; Judge, Andrew; Hopewell, Sally; Collins, Gary S.; Dean, Benjamin J. F.; Rombach, Ines; Brindley, David; Beard, David J.; Carr, Andrew J.] Univ Oxford, Botnar Inst Musculoskeletal Sci, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Judge, Andrew] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Hopewell, Sally; Collins, Gary S.] Univ Oxford, Ctr Stat Med, Oxford OX3 7LD, England; [Brindley, David] Univ Oxford, Oxford UCL Ctr Adv Sustainable Med Innovat, Oxford OX3 7LD, England; [Brindley, David] Harvard Stem Cell Inst, Holyoke Ctr, Cambridge, MA USA; [Savulescu, Julian] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX3 7LD, England; [Beard, David J.; Carr, Andrew J.] Botnar Inst Musculoskeletal Sci, RCS Surg Trials Unit, SITU, Oxford, England	University of Oxford; University of Southampton; University of Oxford; University of Oxford; Harvard University; University of Oxford	Wartolowska, K (corresponding author), Natl Inst Hlth Res, Musculoskeletal Biomed Res Unit, Oxford, England.	karolina.wartolowska@ndorms.ox.ac.uk	Wartolowska, Karolina/D-3968-2015; Collins, Gary Stephen/A-2258-2014; Dean, Benjamin/H-8437-2014	Collins, Gary Stephen/0000-0002-2772-2316; Dean, Benjamin/0000-0002-8969-8868; Wartolowska, Karolina A./0000-0003-4049-2364; Hopewell, Sally/0000-0002-6881-6984; Judge, Andrew/0000-0003-3015-0432	NIHR Oxford Musculoskeletal Biomedical Research Unit; National Institute for Health Research [NF-SI-0611-10216] Funding Source: researchfish	NIHR Oxford Musculoskeletal Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the NIHR Oxford Musculoskeletal Biomedical Research Unit. The funding source had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Abbott J, 2004, FERTIL STERIL, V82, P878, DOI 10.1016/j.fertnstert.2004.03.046; Arts J, 2012, AM J GASTROENTEROL, V107, P222, DOI 10.1038/ajg.2011.395; Back LJJ, 2009, LARYNGOSCOPE, V119, P1621, DOI 10.1002/lary.20562; Bajbouj M, 2009, GASTROENTEROLOGY, V137, P440, DOI 10.1053/j.gastro.2009.04.053; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Bradley JD, 2002, ARTHRITIS RHEUM-US, V46, P100, DOI 10.1002/1529-0131(200201)46:1<100::AID-ART10037>3.0.CO;2-V; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Calland JF, 2002, ANN SURG, V235, P690, DOI 10.1097/00000658-200205000-00011; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; COLCHER MD, 1994, HEPATOLOGY, V20, P618; Davys HJ, 2005, RHEUMATOLOGY, V44, P207, DOI 10.1093/rheumatology/keh435; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; de Craen AJM, 1999, J ROY SOC MED, V92, P511, DOI 10.1177/014107689909201005; Deviere J, 2005, GASTROENTEROLOGY, V128, P532, DOI 10.1053/j.gastro.2004.12.005; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Felson DT, 2002, NEW ENGL J MED, V347, P132, DOI 10.1056/NEJMe020055; Fischbach GD, 2001, NEW ENGL J MED, V344, P763, DOI 10.1056/NEJM200103083441011; FLEISCHER D, 1985, GASTROINTEST ENDOSC, V31, P4, DOI 10.1016/S0016-5107(85)71954-2; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman BJC, 2005, SPINE, V30, P2369, DOI 10.1097/01.brs.0000186587.43373.f2; Freeman TB, 1999, NEW ENGL J MED, V341, P988, DOI 10.1056/NEJM199909233411311; Friedman M, 2008, OTOLARYNG HEAD NECK, V138, P209, DOI 10.1016/j.otohns.2007.10.026; FULLARTON GM, 1989, BRIT J SURG, V76, P541, DOI 10.1002/bjs.1800760606; GEENEN JE, 1989, NEW ENGL J MED, V320, P82, DOI 10.1056/NEJM198901123200203; Gelijns AC, 2009, SURGERY, V145, P581, DOI 10.1016/j.surg.2009.04.003; Genco A, 2006, INT J OBESITY, V30, P129, DOI 10.1038/sj.ijo.0803094; Gillespie MB, 2011, OTOLARYNG HEAD NECK, V144, P230, DOI 10.1177/0194599810392173; Gottschalk A, 2011, DTSCH ARZTEBL INT, V108, P469, DOI 10.3238/arztebl.2011.0469; Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7; Grossman RG, 2001, NEUROSURGERY, V49, P580, DOI 10.1097/00006123-200109000-00008; Guyuron B, 2009, PLAST RECONSTR SURG, V124, P461, DOI 10.1097/PRS.0b013e3181adcf6a; Haidich AB, 2011, J CLIN EPIDEMIOL, V64, P124, DOI 10.1016/j.jclinepi.2010.03.005; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HOGAN RB, 1989, GASTROINTEST ENDOSC, V35, P381, DOI 10.1016/S0016-5107(89)72839-X; Horng S, 2003, CRIT CARE MED, V31, pS126, DOI 10.1097/01.CCM.0000054906.49187.67; Howes N, 1997, BRIT J SURG, V84, P1220; Hull SC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3757; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jarrell J, 2005, J OBSTET GYNAECOL CA, V27, P477, DOI 10.1016/S1701-2163(16)30531-X; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; LAINE L, 1987, NEW ENGL J MED, V316, P1613, DOI 10.1056/NEJM198706253162601; Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037; Li G, 2009, ANESTHESIOLOGY, V110, P759, DOI 10.1097/ALN.0b013e31819b5bdc; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; London AJ, 2002, STAT METHODS MED RES, V11, P413, DOI 10.1191/0962280202sm300ra; Macklin R, 1999, NEW ENGL J MED, V341, P992, DOI 10.1056/NEJM199909233411312; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Miller FG, 2003, AM J BIOETHICS, V3, P41, DOI 10.1162/152651603322614580; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Montgomery M, 2006, SCAND J GASTROENTERO, V41, P1382, DOI 10.1080/00365520600735738; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Pauza Kevin J, 2004, Spine J, V4, P27, DOI 10.1016/j.spinee.2003.07.001; Rothstein R, 2006, GASTROENTEROLOGY, V131, P704, DOI 10.1053/j.gastro.2006.07.004; Salem M, 2004, AM J CARDIOL, V93, P1086, DOI 10.1016/j.amjcard.2004.01.032; Savulescu J, 2001, J MED ETHICS, V27, P148, DOI 10.1136/jme.27.3.148; Savulescu J, 1998, BRIT MED J, V316, P891; Savulescu J, 2010, ROUTLEDGE COMPANION, P781; Savulescu J., 1998, BMJ-BRIT MED J, V316, P3; Schwartz MP, 2007, GUT, V56, P20, DOI 10.1136/gut.2006.096842; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Silverberg GD, 2008, NEUROLOGY, V71, P202, DOI 10.1212/01.wnl.0000316197.04157.6f; Steward DL, 2008, OTOLARYNG HEAD NECK, V139, P506, DOI 10.1016/j.otohns.2008.07.021; Stone GW, 2002, J AM COLL CARDIOL, V39, P1581, DOI 10.1016/S0735-1097(02)01829-6; Stuck BA, 2005, SLEEP, V28, P847, DOI 10.1093/sleep/28.7.847; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Swank DJ, 2003, LANCET, V361, P1247, DOI 10.1016/S0140-6736(03)12979-0; Tenery R, 2002, ANN SURG, V235, P303, DOI 10.1097/00000658-200202000-00021; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; Thompson CC, 2013, GASTROENTEROLOGY, V145, P129, DOI 10.1053/j.gastro.2013.04.002; van Schie CHM, 2000, DIABETES CARE, V23, P634, DOI 10.2337/diacare.23.5.634; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weinstein JN, 2009, NEW ENGL J MED, V361, P619, DOI 10.1056/NEJMe0905889; Wenner DM, 2012, J AM COLL SURGEONS, V215, P722, DOI 10.1016/j.jamcollsurg.2012.06.018; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zegers M, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-13	87	158	156	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2014	348								g3253	10.1136/bmj.g3253	http://dx.doi.org/10.1136/bmj.g3253			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZX	24850821	Green Published, hybrid			2022-12-28	WOS:000336429200002
J	Keramati, AR; Fathzadeh, M; Go, GW; Singh, R; Choi, M; Faramarzi, S; Mane, S; Kasaei, M; Sarajzadeh-Fard, K; Hwa, J; Kidd, KK; Bigi, MAB; Malekzadeh, R; Hosseinian, A; Babaei, M; Lifton, RP; Mani, A				Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Choi, Murim; Faramarzi, Saeed; Mane, Shrikant; Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Hwa, John; Kidd, Kenneth K.; Bigi, Mohammad A. Babaee; Malekzadeh, Reza; Hosseinian, Adallat; Babaei, Masoud; Lifton, Richard P.; Mani, Arya			A Form of the Metabolic Syndrome Associated with Mutations in DYRK1B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOTIC CLONAL EXPANSION; PROTEIN-KINASE; FAMILIAL HYPERCHOLESTEROLEMIA; BINDING PROTEIN; RISK-FACTORS; GENE; PREVALENCE; EXPRESSION; OBESITY; INHIBITION	BACKGROUND Genetic analysis has been successful in identifying causative mutations for individual cardiovascular risk factors. Success has been more limited in mapping susceptibility genes for clusters of cardiovascular risk traits, such as those in the metabolic syndrome. METHODS We identified three large families with coinheritance of early-onset coronary artery disease, central obesity, hypertension, and diabetes. We used linkage analysis and whole-exome sequencing to identify the disease-causing gene. RESULTS A founder mutation was identified in DYRK1B, substituting cysteine for arginine at position 102 in the highly conserved kinase-like domain. The mutation precisely cosegregated with the clinical syndrome in all the affected family members and was absent in unaffected family members and unrelated controls. Functional characterization of the disease gene revealed that nonmutant protein encoded by DYRK1B inhibits the SHH (sonic hedgehog) and Wnt signaling pathways and consequently enhances adipogenesis. Furthermore, DYRK1B promoted the expression of the key gluconeogenic enzyme glucose-6-phosphatase. The R102C allele showed gain-of-function activities by potentiating these effects. A second mutation, substituting proline for histidine 90, was found to cosegregate with a similar clinical syndrome in an ethnically distinct family. CONCLUSIONS These findings indicate a role for DYRK1B in adipogenesis and glucose homeostasis and associate its altered function with an inherited form of the metabolic syndrome.	[Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Faramarzi, Saeed; Hwa, John; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Choi, Murim; Mane, Shrikant; Lifton, Richard P.; Mani, Arya] Yale Univ, Sch Med, Yale Ctr Mendelian Genom, New Haven, CT USA; [Kidd, Kenneth K.; Lifton, Richard P.; Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Fathzadeh, Mohsen; Sarajzadeh-Fard, Kazem; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Fathzadeh, Mohsen] Univ Tehran Med Sci, Dept Med Genet, Tehran, Iran; [Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Bigi, Mohammad A. Babaee] Shiraz Univ Med Sci, Cardiovasc Res Ctr, Shiraz, Iran; [Hosseinian, Adallat; Babaei, Masoud] Ardabil Univ Med Sci, Ardebil, Iran	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shiraz University of Medical Science; Ardabil University of Medical Sciences	Mani, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA.	arya.mani@yale.edu	Wang, Guilin/G-8794-2018; kasaei, mohammad/ABB-5658-2020; Fathzadeh, Mohsen/AAJ-5249-2020; Kasaei, Mohammad Mehdi/AAR-3903-2021; Malekzadeh, Reza/U-1382-2017; SINGH, RAJVIR/C-8191-2012; Choi, Murim/AAP-9120-2021; Kasaei, Mohammad/AAN-2386-2020; Hosseinian, Adalat/V-6083-2017	Fathzadeh, Mohsen/0000-0002-7962-9148; Kasaei, Mohammad Mehdi/0000-0001-9478-9783; Malekzadeh, Reza/0000-0002-9820-6335; Kasaei, Mohammad/0000-0001-6574-7568; Hosseinian, Adalat/0000-0003-1328-8413; Keramati, Ali/0000-0002-8728-1508; Malekzadeh, Reza/0000-0003-1043-3814	National Institutes of Health (NIH) [R01HL094784-01, R01HL094574-03]; NIH Centers for Mendelian Genomics [5U54HG006504]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115247, R01HL094574, R01HL122830, R01HL094784] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (NIH) (R01HL094784-01 and R01HL094574-03, to Dr. Mani) and by a grant from the NIH Centers for Mendelian Genomics (5U54HG006504).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Akyurek LM, 2010, BIOCHEM BIOPH RES CO, V396, P359, DOI 10.1016/j.bbrc.2010.04.097; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Barak T, 2011, NAT GENET, V43, P590, DOI 10.1038/ng.836; BEAGLEHOLE R, 1990, EPIDEMIOL REV, V12, P1; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Borycki AG, 2000, DEVELOPMENT, V127, P2075; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Ewton DZ, 2003, INT J CANCER, V103, P21, DOI 10.1002/ijc.10743; Friedman E, 2013, INT J MOL SCI, V14, P5560, DOI 10.3390/ijms14035560; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Katakura M, 2003, DIABETES CARE, V26, P638, DOI 10.2337/diacare.26.3.638; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Leder S, 2003, BIOCHEM J, V372, P881, DOI 10.1042/BJ20030182; Lee K, 2000, CANCER RES, V60, P3631; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719; Mani A, 2013, SCIENCE, V341, P959; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Naaz A, 2004, FASEB J, V18, P1925; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pishdad GR, 1996, INT J OBESITY, V20, P963; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SEGAL HL, 1959, J BIOL CHEM, V234, P1937; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	52	82	86	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1909	1919		10.1056/NEJMoa1301824	http://dx.doi.org/10.1056/NEJMoa1301824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827035	Green Accepted			2022-12-28	WOS:000336123600007
J	Weinreb, RN; Aung, T; Medeiros, FA				Weinreb, Robert N.; Aung, Tin; Medeiros, Felipe A.			The Pathophysiology and Treatment of Glaucoma A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OPEN-ANGLE GLAUCOMA; LONG-TERM EFFICACY; ARGON-LASER TRABECULOPLASTY; OPTIC-NERVE DAMAGE; INTRAOCULAR-PRESSURE; COHERENCE TOMOGRAPHY; CLOSURE GLAUCOMA; PREVALENCE; ONSET; TRABECULECTOMY	IMPORTANCE Glaucoma is a worldwide leading cause of irreversible vision loss. Because it may be asymptomatic until a relatively late stage, diagnosis is frequently delayed. A general understanding of the disease pathophysiology, diagnosis, and treatment may assist primary care physicians in referring high-risk patients for comprehensive ophthalmologic examination and in more actively participating in the care of patients affected by this condition. OBJECTIVE To describe current evidence regarding the pathophysiology and treatment of open-angle glaucoma and angle-closure glaucoma. EVIDENCE REVIEW A literature search was conducted using MEDLINE, the Cochrane Library, and manuscript references for studies published in English between January 2000 and September 2013 on the topics open-angle glaucoma and angle-closure glaucoma. From the 4334 abstracts screened, 210 articles were selected that contained information on pathophysiology and treatment with relevance to primary care physicians. FINDINGS The glaucomas are a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and resulting changes in the optic nerve head. Loss of ganglion cells is related to the level of intraocular pressure, but other factors may also play a role. Reduction of intraocular pressure is the only provenmethod to treat the disease. Although treatment is usually initiated with ocular hypotensive drops, laser trabeculoplasty and surgerymay also be used to slow disease progression. CONCLUSIONS AND RELEVANCE Primary care physicians can play an important role in the diagnosis of glaucoma by referring patients with positive family history or with suspicious optic nerve head findings for complete ophthalmologic examination. They can improve treatment outcomes by reinforcing the importance of medication adherence and persistence and by recognizing adverse reactions from glaucoma medications and surgeries.	[Weinreb, Robert N.; Medeiros, Felipe A.] Univ Calif San Diego, Shiley Eye Ctr, Glaucoma Ctr, La Jolla, CA 92093 USA; [Weinreb, Robert N.; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Aung, Tin] Singapore Natl Eye Ctr, Singapore, Singapore; [Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; Singapore National Eye Center; National University of Singapore	Weinreb, RN (corresponding author), Univ Calif San Diego, Shiley Eye Ctr, 9500 Gilman Dr,MC 0946, La Jolla, CA 92093 USA.	rweinreb@ucsd.edu			National Institutes of Health/National Eye Institute [EY019692, EY021818]; Research to Prevent Blindness; National Medical Research Council, Singapore; National Research Foundation, Singapore; NATIONAL EYE INSTITUTE [R01EY019692, R01EY021818, P30EY022589] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation, Singapore(National Research Foundation, Singapore); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by grants EY019692 (Weinreb), EY021818 (Medeiros), from the National Institutes of Health/National Eye Institute; and an unrestricted grant from Research to Prevent Blindness. Dr Aung is supported by grants from the National Medical Research Council, Singapore, and the National Research Foundation, Singapore.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Amerasinghe N, 2011, OPHTHALMOLOGY, V118, P480, DOI 10.1016/j.ophtha.2010.06.043; American Academy of Ophthalmology Preferred Practice Patterns Committee GP, 2010, OPHTALMOLOGY; Aung T, 2001, AM J OPHTHALMOL, V131, P7, DOI 10.1016/S0002-9394(00)00621-8; Ayyala RS, 2011, OPHTHALMOLOGY, V118, P2427, DOI 10.1016/j.ophtha.2011.05.021; Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Budenz DL, 2013, JAMA OPHTHALMOL, V131, P651, DOI 10.1001/jamaophthalmol.2013.1686; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gaton DD, 2001, ARCH OPHTHALMOL-CHIC, V119, P1165, DOI 10.1001/archopht.119.8.1165; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hennis A, 2007, OPHTHALMOLOGY, V114, P1816, DOI 10.1016/j.ophtha.2007.06.013; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Jampel HD, 2009, AM J OPHTHALMOL, V147, P39, DOI 10.1016/j.ajo.2008.07.023; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kersey JP, 2006, EYE, V20, P407, DOI 10.1038/sj.eye.6701895; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; Leite MT, 2011, ARQ BRAS OFTALMOL, V74, P83, DOI 10.1590/S0004-27492011000200001; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liu JHK, 2004, AM J OPHTHALMOL, V138, P389, DOI 10.1016/j.ajo.2004.04.022; Mansouri K, 2013, GRAEF ARCH CLIN EXP, V251, P2609, DOI 10.1007/s00417-013-2464-7; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P1340, DOI 10.1016/j.ophtha.2007.11.008; Medeiros FA, 2012, AM J OPHTHALMOL, V154, P814, DOI 10.1016/j.ajo.2012.04.022; Medeiros FA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1250, DOI 10.1001/archophthalmol.2009.276; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Odberg T, 1999, ACTA OPHTHALMOL SCAN, V77, P176, DOI 10.1034/j.1600-0420.1999.770212.x; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rotchford AP, 2003, OPHTHALMOLOGY, V110, P376, DOI 10.1016/S0161-6420(02)01568-3; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Sakai H, 2005, OPHTHALMOLOGY, V112, P413, DOI 10.1016/j.ophtha.2004.08.026; Sakata LM, 2008, OPHTHALMOLOGY, V115, P769, DOI 10.1016/j.ophtha.2007.06.030; Sathyamangalam RV, 2009, INDIAN J OPHTHALMOL, V57, P355, DOI 10.4103/0301-4738.55073; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SHINGLETON BJ, 1993, OPHTHALMOLOGY, V100, P1324; SHINGLETON BJ, 1987, OPHTHALMOLOGY, V94, P1513; Stewart WC, 2008, OPHTHALMOLOGY, V115; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P3737, DOI 10.1167/iovs.08-2844; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang N, 2012, OPHTHALMOLOGY, V119; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2011, INVEST OPHTH VIS SCI, V52, P7842, DOI 10.1167/iovs.11-7895; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wong HT, 2009, ARCH OPHTHALMOL-CHIC, V127, P256, DOI 10.1001/archophthalmol.2009.22	63	1689	1733	22	248	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1901	1911		10.1001/jama.2014.3192	http://dx.doi.org/10.1001/jama.2014.3192			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825645	Bronze, Green Accepted			2022-12-28	WOS:000335798100022
J	Gornall, J				Gornall, Jonathan			Is the billion unit pledge just window dressing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathangornall@mac.com						[Anonymous], 2008, JUST DRINKS     0626; [Anonymous], 2009, DRUM            0419; Cave A, 2012, SUNDAY TELEGRAP 1216; Department of Health, PUBL HLTH RESP DEAL; Department of Health, 2014, LIV WELL LONG NAT SU; Department of Health, 2012, ALC NETW GROUP M 19; Dinkovski N, 2012, MORNING ADVERTI 0408; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646; Jones L., 2012, CAN PROMOTION LOWER; Joseph S., 2012, MARKETING WEEK; Public Health Responsibility Deal Alcohol Network, PLEDG A8 ALC UN RED; Responsibility Deal Alcohol Network, 2014, PLEDG REM 1 BILL UN; Wilson S, 2013, 12 PLEN M EUR ALCH H	13	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2014	348								g3190	10.1136/bmj.g3190	http://dx.doi.org/10.1136/bmj.g3190			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5BW	24821683				2022-12-28	WOS:000336144400006
J	Chen, GX; Zhao, Y; Fu, G; Duchesne, PN; Gu, L; Zheng, YP; Weng, XF; Chen, MS; Zhang, P; Pao, CW; Lee, JF; Zheng, NF				Chen, Guangxu; Zhao, Yun; Fu, Gang; Duchesne, Paul N.; Gu, Lin; Zheng, Yanping; Weng, Xuefei; Chen, Mingshu; Zhang, Peng; Pao, Chih-Wen; Lee, Jyh-Fu; Zheng, Nanfeng			Interfacial Effects in Iron-Nickel Hydroxide-Platinum Nanoparticles Enhance Catalytic Oxidation	SCIENCE			English	Article							WATER; OXIDE; SURFACES; TRENDS; GOLD; CO	Hybrid metal nanoparticles can allow separate reaction steps to occur in close proximity at different metal sites and accelerate catalysis. We synthesized iron-nickel hydroxide-platinum (transition metal-OH-Pt) nanoparticles with diameters below 5 nanometers and showed that they are highly efficient for carbon monoxide (CO) oxidation catalysis at room temperature. We characterized the composition and structure of the transition metal-OH-Pt interface and showed that Ni2+ plays a key role in stabilizing the interface against dehydration. Density functional theory and isotope-labeling experiments revealed that the OH groups at the Fe3+-OH-Pt interfaces readily react with CO adsorbed nearby to directly yield carbon dioxide (CO2) and simultaneously produce coordinatively unsaturated Fe sites for O-2 activation. The oxide-supported PtFeNi nanocatalyst rapidly and fully removed CO from humid air without decay in activity for 1 month.	[Chen, Guangxu; Zhao, Yun; Fu, Gang; Zheng, Yanping; Weng, Xuefei; Chen, Mingshu; Zheng, Nanfeng] Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Collaborat Innovat Ctr Chem Energy Mat, Natl Engn Lab Green Chem Prod Alcohols Ethers & E, Xiamen 361005, Peoples R China; [Chen, Guangxu; Zhao, Yun; Fu, Gang; Zheng, Yanping; Weng, Xuefei; Chen, Mingshu; Zheng, Nanfeng] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Gu, Lin] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Duchesne, Paul N.; Zhang, Peng] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4R2, Canada; [Pao, Chih-Wen; Lee, Jyh-Fu] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan	Xiamen University; Xiamen University; Chinese Academy of Sciences; Institute of Physics, CAS; Dalhousie University; National Synchrotron Radiation Research Center	Fu, G (corresponding author), Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Collaborat Innovat Ctr Chem Energy Mat, Natl Engn Lab Green Chem Prod Alcohols Ethers & E, Xiamen 361005, Peoples R China.	gfu@xmu.edu.cn; l.gu@iphy.ac.cn; nfzheng@xmu.edu.cn	Zhang, Peng/K-5174-2012; Zheng, Nanfeng/G-4613-2010; Gu, Lin/D-9631-2011; China, iChEM/F-2855-2015; yang, zheng/HGC-7753-2022; Chen, Mingshu/G-4590-2010	Zhang, Peng/0000-0003-3603-0175; Zheng, Nanfeng/0000-0001-9879-4790; Gu, Lin/0000-0002-7504-031X; Chen, Mingshu/0000-0002-4923-9632	Ministry of Science and Technology of China [2011CB932403]; National Nature Science Foundation of China [21131005, 20925103, 21373167, 21033006, 21333008]; Natural Sciences and Engineering Research Council of Canada	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We appreciate the financial support from the Ministry of Science and Technology of China (2011CB932403) and the National Nature Science Foundation of China (21131005, 20925103, 21373167, 21033006, and 21333008). P.Z. appreciates the funding from Natural Sciences and Engineering Research Council of Canada. We also thank L. S. Zheng, Z. Q. Tian, X. Lu, Y. Wang, and S. C. Lin for helpful discussions, and Shanghai Supercomputer Center (SSC) for providing computational resources. X-ray absorption spectroscopy studies were carried out at the beamline 17C1 of the National Synchrotron Radiation Research Center (NSRRC) in Taiwan.	Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Cargnello M, 2012, SCIENCE, V337, P713, DOI [10.1126/science.1222887, 10.1126/science.1223488]; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Fu Q, 2013, ACCOUNTS CHEM RES, V46, P1692, DOI 10.1021/ar300249b; Fu Q, 2010, SCIENCE, V328, P1141, DOI 10.1126/science.1188267; Gong M, 2013, J AM CHEM SOC, V135, P8452, DOI 10.1021/ja4027715; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; Han YF, 2008, CHEM MATER, V20, P360, DOI 10.1021/cm7023789; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Merte LR, 2012, SCIENCE, V336, P889, DOI 10.1126/science.1219468; Park JB, 2009, P NATL ACAD SCI USA, V106, P4975, DOI 10.1073/pnas.0812604106; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Somorjai GA, 2006, P NATL ACAD SCI USA, V103, P10577, DOI 10.1073/pnas.0507691103; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Subbaraman R, 2012, NAT MATER, V11, P550, DOI [10.1038/NMAT3313, 10.1038/nmat3313]; Subbaraman R, 2011, SCIENCE, V334, P1256, DOI 10.1126/science.1211934; TAN BJ, 1990, CHEM MATER, V2, P186, DOI 10.1021/cm00008a021; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Wu BH, 2013, NANO TODAY, V8, P168, DOI 10.1016/j.nantod.2013.02.006; Yamada Y, 2011, NAT CHEM, V3, P372, DOI [10.1038/NCHEM.1018, 10.1038/nchem.1018]; Zhang HJ, 2012, NAT MATER, V11, P49, DOI [10.1038/NMAT3143, 10.1038/nmat3143]; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569	26	502	512	49	1751	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					495	499		10.1126/science.1252553	http://dx.doi.org/10.1126/science.1252553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786074				2022-12-28	WOS:000335157700037
J	Juern, J; Verhaalen, A				Juern, Jeremy; Verhaalen, Amy			Gastrostomy-Tube Exchange	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MODEL		[Juern, Jeremy; Verhaalen, Amy] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Juern, J (corresponding author), Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, Milwaukee, WI 53226 USA.	jjuern@mcw.edu						Maxwell CI, 2011, JPEN-PARENTER ENTER, V35, P630, DOI 10.1177/0148607111413596; MELLINGER JD, 1991, SURG ENDOSC-ULTRAS, V5, P189, DOI 10.1007/BF02653261; Michaud L, 2004, J PEDIATR GASTR NUTR, V38, P426, DOI 10.1097/00005176-200404000-00011	3	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18								10.1056/NEJMvcm1207131	http://dx.doi.org/10.1056/NEJMvcm1207131			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785226				2022-12-28	WOS:000335405200002
J	Wright, G				Wright, Gerard			PERSPECTIVE Synthetic biology revives antibiotics	NATURE			English	Editorial Material									McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Wright, G (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.		Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131				Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Thaker MN, 2013, NAT BIOTECHNOL, V31, P922, DOI 10.1038/nbt.2685	2	20	20	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S13	S13		10.1038/509S13a	http://dx.doi.org/10.1038/509S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784423	Bronze			2022-12-28	WOS:000335199100007
J	Stirling, P; Shalhoub, J; Sengupta, N; Brown, KRL				Stirling, Paul; Shalhoub, Joseph; Sengupta, Neel; Brown, Katherine R. L.			Colonic marbling in Clostridium difficile pancolitis	LANCET			English	Editorial Material									[Stirling, Paul; Shalhoub, Joseph; Sengupta, Neel; Brown, Katherine R. L.] Luton & Dunstable Univ Hosp, Dept Surg, Luton LU4 0DZ, Beds, England		Brown, KRL (corresponding author), Luton & Dunstable Univ Hosp, Lewsey Rd, Luton LU4 0DZ, Beds, England.	katherine.brown@ldh.nhs.uk	Shalhoub, Joseph/P-2171-2014	Shalhoub, Joseph/0000-0003-1011-7440; Stirling, Paul/0000-0003-3857-8628					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2014	384	9948					1128	1128		10.1016/S0140-6736(13)62332-6	http://dx.doi.org/10.1016/S0140-6736(13)62332-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ2PU	24814091	Bronze			2022-12-28	WOS:000342630600033
J	Pouchelon, G; Gambino, F; Bellone, C; Telley, L; Vitali, I; Luscher, C; Holtmaat, A; Jabaudon, D				Pouchelon, Gabrielle; Gambino, Frederic; Bellone, Camilla; Telley, Ludovic; Vitali, Ilaria; Luescher, Christian; Holtmaat, Anthony; Jabaudon, Denis			Modality-specific thalamocortical inputs instruct the identity of postsynaptic L4 neurons	NATURE			English	Article							NEURITE GROWTH-INHIBITORS; SOMATOSENSORY CORTEX; FUNCTIONAL RECOVERY; BARREL CORTEX; CONNECTIVITY; EXPRESSION; PLASTICITY; PROJECTION; CORTICES; PATHWAYS	During development, thalamocortical (TC) input has a critical role in the spatial delineation and patterning of cortical areas(1-6), yet the underlying cellular and molecular mechanisms that drive cortical neuron differentiation are poorly understood. In the primary (S1) and secondary (S2) somatosensory cortex, layer 4 (L4) neurons receive mutually exclusive input originating from two thalamic nuclei(7,8): the ventrobasalis (VB), which conveys tactile input(9,10), and the posterior nucleus (Po), which conveys modulatory and nociceptive input(11-14). Recently, we have shown that L4 neuron identity is not fully committed postnatally(15), implying a capacity for TC input to influence differentiation during cortical circuit assembly. Here we investigate whether the cell-type-specific molecular and functional identity of L4 neurons is instructed by the origin of their TC input. Genetic ablation of the VB at birth resulted in an anatomical and functional rewiring of Po projections onto L4 neurons in S1. This induced acquisition of Po input led to a respecification of postsynaptic L4 neurons, which developed functional molecular features of Po-target neurons while repressing VB-target traits. Respecified L4 neurons were able to respond both to touch and to noxious stimuli, in sharp contrast to the normal segregation of these sensory modalities in distinct cortical circuits. These findings reveal a behaviourally relevant TC-input-type-specific control over the molecular and functional differentiation of postsynaptic L4 neurons and cognate intracortical circuits, which instructs the development of modality-specific neuronal and circuit properties during corticogenesis.	[Pouchelon, Gabrielle; Gambino, Frederic; Bellone, Camilla; Telley, Ludovic; Vitali, Ilaria; Luescher, Christian; Holtmaat, Anthony; Jabaudon, Denis] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Hosp Geneva, Clin Neurol, Dept Clin Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Geneva, Inst Genet & Genom Geneva IGE3, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Jabaudon, D (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	denis.jabaudon@unige.ch	Lüscher, Christian/A-2496-2011; Jabaudon, Denis/B-8802-2014	Lüscher, Christian/0000-0001-7917-4596; Jabaudon, Denis/0000-0003-2438-4769; Holtmaat, Anthony/0000-0002-7577-0769; Vitali, Ilaria/0000-0001-9536-0292; bellone, camilla/0000-0002-6774-6275; Telley, Ludovic/0000-0002-5041-1997; gambino, frederic/0000-0002-2981-5030	Swiss National Science Foundation (SNF) [PP00P3_123447]; Leenaards Foundation; Synapsis Foundation; NARSAD Foundation; Ambizione grant from the SNF; Gertrude von Meissner Foundation; SNF; Simons Foundation Autism Research Initiative (SFARI); SNF [31003A-135631]; EMBO; International Foundation for Research in Paraplegia; Hans Wilsdorf Foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Leenaards Foundation; Synapsis Foundation; NARSAD Foundation(NARSAD); Ambizione grant from the SNF; Gertrude von Meissner Foundation; SNF; Simons Foundation Autism Research Initiative (SFARI); SNF; EMBO(European Molecular Biology Organization (EMBO)); International Foundation for Research in Paraplegia; Hans Wilsdorf Foundation	We thank S. Endo for the gift of the G-substrate antibody, N. Aagaard Jensen for the gift of the miR-Zbtb20 construct, F. Ango for the gift of the Sema3a-Tomato construct, and A. Goffinet for the gift of Dlx5/6::Cre/Celsr3<SUP>flox</SUP> tissue. We are thankful to A. Benoit and F. Smets for technical assistance, to B. Golding for help with the in situ hybridizations, to O. Schaad, C. Barraclough and M. Docquier of the Genomics Platform of the University of Geneva for help with the microarray experiments. We thank E. Azim and F. Rijli for their comments on the manuscript. Work in the Jabaudon laboratory is supported by the Swiss National Science Foundation (SNF) (PP00P3_123447), the Leenaards Foundation, the Synapsis Foundation and the NARSAD Foundation. C.B. was supported by an Ambizione grant from the SNF and by the Gertrude von Meissner Foundation, C.L. by the SNF and the Simons Foundation Autism Research Initiative (SFARI), and F.C. and A.H. by the SNF (grant 31003A-135631), EMBO, the International Foundation for Research in Paraplegia, and the Hans Wilsdorf Foundation.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Cioni JM, 2013, CURR BIOL, V23, P850, DOI 10.1016/j.cub.2013.04.007; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; Endo S, 2012, PROG MOL BIOL TRANSL, V106, P381, DOI 10.1016/B978-0-12-396456-4.00004-3; Frangeul L., 2014, EUR J NEUROSCI; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Gauriau C, 2004, J NEUROSCI, V24, P752, DOI 10.1523/JNEUROSCI.3272-03.2004; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kichula EA, 2008, J COMP NEUROL, V509, P239, DOI 10.1002/cne.21690; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Le Bars D, 2001, PHARMACOL REV, V53, P597; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Li H, 2013, NEURON, V79, P970, DOI 10.1016/j.neuron.2013.06.043; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Nicolelis MAL, 2005, J PHYSIOL-LONDON, V566, P37, DOI 10.1113/jphysiol.2005.083709; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Wagener RJ, 2010, J NEUROSCI, V30, P15700, DOI 10.1523/JNEUROSCI.3707-10.2010; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Yun J, 2013, J BIOL CHEM, V288, P2655, DOI 10.1074/jbc.M112.413310; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	46	82	83	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					471	+		10.1038/nature13390	http://dx.doi.org/10.1038/nature13390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24828045				2022-12-28	WOS:000339335700047
J	Truwit, JD; Bernard, GR; Steingrub, J; Matthay, MA; Liu, KD; Albertson, TE; Brower, RG; Shanholtz, C; Rock, P; Douglas, IS; Deboisblanc, BP; Hough, CL; Hite, RD; Thompson, BT				Truwit, Jonathon D.; Bernard, Gordon R.; Steingrub, Jay; Matthay, Michael A.; Liu, Kathleen D.; Albertson, Timothy E.; Brower, Roy G.; Shanholtz, Carl; Rock, Peter; Douglas, Ivor S.; deBoisblanc, Bennett P.; Hough, Catherine L.; Hite, R. Duncan; Thompson, B. Taylor		Natl Heart Lung Blood Inst ARDS	Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; STATIN THERAPY; CLINICAL-TRIAL; MORTALITY; ATORVASTATIN; INFECTION; PHARMACOKINETICS; INFLAMMATION; DEFINITIONS; SIMVASTATIN	BACKGROUND In the acute respiratory distress syndrome (ARDS), inflammation in the lungs and other organs can cause life-threatening organ failure. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) can modulate inflammatory responses. Previous observational studies suggested that statins improved clinical outcomes in patients with sepsis. We hypothesized that rosuvastatin therapy would improve clinical outcomes in critically ill patients with sepsis-associated ARDS. METHODS We conducted a multicenter trial in which patients with sepsis-associated ARDS were randomly assigned to receive either enteral rosuvastatin or placebo in a double-blind manner. The primary outcome was mortality before hospital discharge home or until study day 60 if the patient was still in a health care facility. Secondary outcomes included the number of ventilator-free days (days that patients were alive and breathing spontaneously) to day 28 and organ-failure-free days to day 14. RESULTS The study was stopped because of futility after 745 of an estimated 1000 patients had been enrolled. There was no significant difference between study groups in 60-day in-hospital mortality (28.5% with rosuvastatin and 24.9% with placebo, P = 0.21) or in mean (+/-SD) ventilator-free days (15.1+/-10.8 with rosuvastatin and 15.1+/-11.0 with placebo, P = 0.96). The groups were well matched with respect to demographic and key physiological variables. Rosuvastatin therapy, as compared with placebo, was associated with fewer days free of renal failure to day 14 (10.1+/-5.3 vs. 11.0+/-4.7, P = 0.01) and fewer days free of hepatic failure to day 14 (10.8+/-5.0 vs. 11.8+/-4.3, P = 0.003). Rosuvastatin was not associated with an increased incidence of serum creatine kinase levels that were more than 10 times the upper limit of the normal range. Conclusions Rosuvastatin therapy did not improve clinical outcomes in patients with sepsis-associated ARDS and may have contributed to hepatic and renal organ dysfunction. (Funded by the National Heart, Lung, and Blood Institute and the Investigator-Sponsored Study Program of AstraZeneca; ClinicalTrials.gov number, NCT00979121.)	[Truwit, Jonathon D.] Froedtert & Med Coll Wisconsin, Milwaukee, WI USA; [Bernard, Gordon R.] Vanderbilt Univ, Nashville, TN 37235 USA; [Steingrub, Jay] Baystate Med Ctr, Springfield, MA USA; [Steingrub, Jay] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Matthay, Michael A.; Liu, Kathleen D.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Albertson, Timothy E.] Univ Calif Davis, Sacramento, CA 95817 USA; [Brower, Roy G.] Johns Hopkins Univ, Baltimore, MD USA; [Shanholtz, Carl; Rock, Peter] Univ Maryland, Baltimore, MD 21201 USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA; [Douglas, Ivor S.] Univ Colorado, Denver, CO 80202 USA; [deBoisblanc, Bennett P.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Hough, Catherine L.] Univ Washington, Seattle, WA 98195 USA; [Hite, R. Duncan] Cleveland Clin, Cleveland, OH 44106 USA; [Thompson, B. Taylor] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Thompson, B. Taylor] Harvard Univ, Sch Med, Boston, MA USA	Vanderbilt University; Baystate Medical Center; Tufts University; University of California System; University of California San Francisco; University of California System; University of California Davis; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Denver Health Medical Center; University of Colorado System; University of Colorado Denver; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Truwit, JD (corresponding author), Med Coll Wisconsin, Ctr Clin Canc, Suite C4000,9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jtruwit@mcw.edu	Shanholtz, Carl/P-1190-2019; Douglas, Ivor S/AAC-6245-2021	Shanholtz, Carl/0000-0003-3938-178X; Douglas, Ivor S/0000-0002-4541-1431; Liu, Kathleen/0000-0003-4891-8649; Lanspa, Michael/0000-0003-0968-4755; Hite, Robert Duncan/0000-0002-2625-8750; truwit, jonathon/0000-0001-7129-9300	National Heart, Lung, and Blood Institute; AstraZeneca	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca)	Funded by the National Heart, Lung, and Blood Institute and the Investigator-Sponsored Study Program of AstraZeneca; ClinicalTrials.gov number, NCT00979121.	Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Arnaud Claire, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P127, DOI 10.2174/1568006043586198; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bernard GR, 1995, AM J RESP CRIT CARE, V151, pA323; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; Chalmers JD, 2008, AM J MED, V121; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Gao F, 2008, BRIT J ANAESTH, V100, P288, DOI 10.1093/bja/aem406; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Janda S, 2010, J CRIT CARE, V25; Khan AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052929; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kor DJ, 2009, INTENS CARE MED, V35, P1039, DOI 10.1007/s00134-009-1421-8; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kruger PS, 2008, BRIT J ANAESTH, V100, P862, DOI 10.1093/bja/aen114; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051548; Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe; Masadeh M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-13; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082775; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Smith ME, 2004, DRUG CLASS REV HMG C; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tleyjeh, 2010, ARCH INTERN MED, V170, P42; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	46	342	351	4	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2191	2200		10.1056/NEJMoa1401520	http://dx.doi.org/10.1056/NEJMoa1401520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24835849	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000336729900007
J	Rowe, BH				Rowe, Brian H.			Review: Prehospital noninvasive ventilation for severe respiratory distress reduces hospital mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Alberta, Edmonton, AB, Canada	University of Alberta	Rowe, BH (corresponding author), Univ Alberta, Edmonton, AB, Canada.							Hess DR, 2009, RESP CARE, V54, P1306; Lim WJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004360.pub4; Ram FS., 2004, COCHRANE DB SYST REV, V3, DOI [DOI 10.1002/14651858.CD004104.PUB3, 10.1002/14651858.cd004104.pub3]; Vital FMR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005351.pub2	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC2	10.7326/0003-4819-160-10-201405200-02002	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842436				2022-12-28	WOS:000337347100001
J	Wu, Z; Autry, AE; Bergan, JF; Watabe-Uchida, M; Dulac, CG				Wu, Zheng; Autry, Anita E.; Bergan, Joseph F.; Watabe-Uchida, Mitsuko; Dulac, Catherine G.			Galanin neurons in the medial preoptic area govern parental behaviour	NATURE			English	Article							MATERNAL-BEHAVIOR; SEXUAL-BEHAVIOR; MALE-AGGRESSION; MALE-MICE; VOMERONASAL; NUCLEUS; INFANTICIDE; EXPRESSION; ORGANIZATION; RECEPTOR	Mice display robust, stereotyped behaviours towards pups: virgin males typically attack pups, whereas virgin females and sexually experienced males and females display parental care. Here we show that virgin males genetically impaired in vomeronasal sensing do not attack pups and are parental. Furthermore, we uncover a subset of galanin-expressing neurons in the medial preoptic area (MPOA) that are specifically activated during male and female parenting, and a different subpopulation that is activated during mating. Genetic ablation of MPOA galanin neurons results in marked impairment of parental responses in males and females and affects male mating. Optogenetic activation of these neurons in virgin males suppresses inter-male and pup-directed aggression and induces pup grooming. Thus, MPOA galanin neurons emerge as an essential regulatory node of male and female parenting behaviour and other social responses. These results provide an entry point to a circuit-level dissection of parental behaviour and its modulation by social experience.	[Wu, Zheng; Autry, Anita E.; Bergan, Joseph F.; Dulac, Catherine G.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Watabe-Uchida, Mitsuko] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Dulac, CG (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Core, Vector/CAF-4832-2022; Autry, Anita/ABF-9006-2021	Dulac, Catherine/0000-0001-5024-5418	Howard Hughes Medical Institute; National Institute of Health (NIDCD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903, F32DC010089, R01DC013087, R01DC009019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Deisseroth for the Cre-dependent AAV-ChR2:EYFP construct; E. Boyden for the Cre-dependent AAV-GFP construct; N. Shah for the AAV-Flex-taCasp3-TEVp virus; S. Sullivan for behaviour annotation and scoring; R. Hellmiss for figure artwork; E. Soucy and J. Greenwood for technical assistance. We also thank members of the Dulac and Uchida laboratories and V. Murthy, A. Schier and M. Meister for advice on experiments and statistical analysis and comments on the manuscript, and the anonymous reviewers for their helpful suggestions and comments. This work was supported by the Howard Hughes Medical Institute and the National Institute of Health (NIDCD).	ARENDASH GW, 1983, BRAIN RES BULL, V10, P147, DOI 10.1016/0361-9230(83)90086-2; Bakker J, 2002, J NEUROENDOCRINOL, V14, P116, DOI 10.1046/j.0007-1331.2001.00751.x; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; BROOKS RJ, 1983, BEHAV NEURAL BIOL, V37, P149, DOI 10.1016/S0163-1047(83)91159-7; BROWN RE, 1993, BEHAV PROCESS, V30, P1, DOI 10.1016/0376-6357(93)90009-G; CALAMANDREI G, 1994, BEHAV NEUROSCI, V108, P113, DOI 10.1037/0735-7044.108.1.113; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2003, ENDOCRINOLOGY, V144, P4720, DOI 10.1210/en.2003-0564; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; ELWOOD RW, 1985, J COMP PSYCHOL, V99, P457, DOI 10.1037/0735-7036.99.4.457; FLEMING A, 1979, SCIENCE, V203, P372, DOI 10.1126/science.760196; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; JENNES L, 1994, FRONT NEUROENDOCRIN, V15, P51, DOI 10.1006/frne.1994.1003; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; LABOV JB, 1980, BEHAV ECOL SOCIOBIOL, V6, P297, DOI 10.1007/BF00292772; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; Mechenthaler I, 2008, CELL MOL LIFE SCI, V65, P1826, DOI 10.1007/s00018-008-8157-4; MENNELLA JA, 1988, PHYSIOL BEHAV, V42, P303, DOI 10.1016/0031-9384(88)90087-X; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; NUMAN M, 1974, J COMP PHYSIOL PSYCH, V87, P746, DOI 10.1037/h0036974; Numan M., 2003, HORM BR BEHAV; Numan M, 2010, BEHAV BRAIN RES, V214, P368, DOI 10.1016/j.bbr.2010.06.006; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; POWERS B, 1972, SCIENCE, V175, P1003, DOI 10.1126/science.175.4025.1003; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Schneider JS, 2003, P NATL ACAD SCI USA, V100, P2951, DOI 10.1073/pnas.0130100100; SEGOVIA S, 1993, BRAIN RES REV, V18, P51, DOI 10.1016/0165-0173(93)90007-M; SIMERLY RB, 1986, J COMP NEUROL, V246, P343, DOI 10.1002/cne.902460305; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; Soriano P, 1997, DEVELOPMENT, V124, P2691; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SVARE B, 1981, PHYSIOL BEHAV, V27, P921, DOI 10.1016/0031-9384(81)90062-7; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; TERKEL J, 1968, J COMP PHYSIOL PSYCH, V65, P479, DOI 10.1037/h0025817; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; VOMSAAL FS, 1982, SCIENCE, V215, P1271; Wynick D, 1998, P NATL ACAD SCI USA, V95, P12671, DOI 10.1073/pnas.95.21.12671; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	55	307	311	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					325	+		10.1038/nature13307	http://dx.doi.org/10.1038/nature13307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828191	Green Accepted, Green Submitted			2022-12-28	WOS:000336121200031
J	Fujita, K; Kim, CK; Lee, I; Lee, J; Hamidian, MH; Firmo, IA; Mukhopadhyay, S; Eisaki, H; Uchida, S; Lawler, MJ; Kim, EA; Davis, JC				Fujita, K.; Kim, Chung Koo; Lee, Inhee; Lee, Jinho; Hamidian, M. H.; Firmo, I. A.; Mukhopadhyay, S.; Eisaki, H.; Uchida, S.; Lawler, M. J.; Kim, E. -A.; Davis, J. C.			Simultaneous Transitions in Cuprate Momentum-Space Topology and Electronic Symmetry Breaking	SCIENCE			English	Article							HIGH-T-C; COPPER-OXIDE SUPERCONDUCTORS; PHASE-TRANSITIONS; MOTT INSULATOR; PSEUDOGAP; ORDER; BI2SR2CACU2O8+DELTA; NEMATICITY; DIAGRAM; STATE	The existence of electronic symmetry breaking in the underdoped cuprates and its disappearance with increased hole density p are now widely reported. However, the relation between this transition and the momentum-space ((k) over right arrow -space) electronic structure underpinning the superconductivity has not yet been established. Here, we visualize the (Q) over right arrow =0 (intra-unit-cell) and (Q) over right arrow not equal 0 (density-wave) broken-symmetry states, simultaneously with the coherent. (k) over right arrow -space topology, for Bi2Sr2CaCu2O8+delta samples spanning the phase diagram 0.06 <= p <= 0.23. We show that the electronic symmetry-breaking tendencies weaken with increasing p and disappear close to a critical doping p(c) = 0.19. Concomitantly, the coherent. (k) over right arrow -space topology undergoes an abrupt transition, from arcs to closed contours, at the same p(c). These data reveal that the (k) over right arrow -space topology transformation in cuprates is linked intimately with the disappearance of the electronic symmetry breaking at a concealed critical point.	[Fujita, K.; Kim, Chung Koo; Lee, Inhee; Lee, Jinho; Hamidian, M. H.; Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Fujita, K.; Hamidian, M. H.; Firmo, I. A.; Mukhopadhyay, S.; Lawler, M. J.; Kim, E. -A.; Davis, J. C.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Fujita, K.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Lee, Jinho] Inst for Basic Sci, Seoul 151747, South Korea; [Lee, Jinho] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Mukhopadhyay, S.] Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA; [Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Lawler, M. J.] SUNY Binghamton, Dept Phys & Astron, Binghamton, NY 13902 USA; [Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Davis, J. C.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Cornell University; University of Tokyo; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Cornell University; National Institute of Advanced Industrial Science & Technology (AIST); State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of St Andrews; Cornell University	Davis, JC (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	jcseamusdavis@gmail.com	Eisaki, Hiroshi/F-6317-2018; Lawler, Michael/K-6770-2012	Eisaki, Hiroshi/0000-0002-8299-6416; Lawler, Michael/0000-0002-2319-2274; KIM, CHUNG KOO/0000-0002-2463-197X	U.S. Department of Energy [DE-2009-BNL-PM015]; Ministry of Science and Education (Japan); Global Centers of Excellence Program for Japan Society for the Promotion of Science; FlucTeam program at BNL [DE-AC02-98CH10886]; Institute for Basic Science, Korea; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/60952/2009]; NSF [DMR-1120296, DMR-0955822]; Direct For Mathematical & Physical Scien [0955822] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish; EPSRC [EP/I031014/1] Funding Source: UKRI	U.S. Department of Energy(United States Department of Energy (DOE)); Ministry of Science and Education (Japan); Global Centers of Excellence Program for Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FlucTeam program at BNL; Institute for Basic Science, Korea; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are particularly grateful to S. Billinge, J. E. Hoffman, S. A. Kivelson, D.-H. Lee, and A. P. Mackenzie for key scientific advice. We thank K. Efetov, E. Fradkin, P. D. Johnson, J. W. Orenstein, C. Pepin, S. Sachdev, and K. M. Shen for helpful discussions and communications. Experimental studies were supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center, headquartered at Brookhaven National Laboratory (BNL) and funded by the U.S. Department of Energy under grant DE-2009-BNL-PM015, as well as by a Grant-in-Aid for Scientific Research from the Ministry of Science and Education (Japan) and the Global Centers of Excellence Program for Japan Society for the Promotion of Science. C. K. K. acknowledges support from the FlucTeam program at BNL under contract DE-AC02-98CH10886. J.L. acknowledges support from the Institute for Basic Science, Korea. I.A.F. acknowledges support from Fundacao para a Ciencia e a Tecnologia, Portugal, under fellowship number SFRH/BD/60952/2009. S.M. acknowledges support from NSF grant DMR-1120296 to the Cornell Center for Materials Research. Theoretical studies at Cornell University were supported by NSF grant DMR-1120296 to Cornell Center for Materials Research and by NSF grant DMR-0955822. The original data are archived by Davis Group, BNL, and Cornell University.	Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Chatterjee U, 2011, P NATL ACAD SCI USA, V108, P9346, DOI 10.1073/pnas.1101008108; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; De Almeida-Didry S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.020504; Fujita K, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011005; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; He RH, 2011, SCIENCE, V331, P1579, DOI 10.1126/science.1198415; He Y, 2014, SCIENCE, V344, P608, DOI 10.1126/science.1248221; Hinton JP, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060508; Hucker M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104506; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kim EA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.132501; Kim YJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064520; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; Li Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224508; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Mesaros A, 2011, SCIENCE, V333, P426, DOI 10.1126/science.1201082; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; Mook HA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020506; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Plate M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077001; Shekhter A, 2013, NATURE, V498, P75, DOI 10.1038/nature12165; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Torchinsky DH, 2013, NAT MATER, V12, P387, DOI [10.1038/NMAT3571, 10.1038/nmat3571]; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323	39	181	181	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					612	616		10.1126/science.1248783	http://dx.doi.org/10.1126/science.1248783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812397	Green Submitted			2022-12-28	WOS:000335537400038
J	Geleoc, GSG; Holt, JR				Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.			Sound Strategies for Hearing Restoration	SCIENCE			English	Review							EMBRYONIC STEM-CELLS; MOUSE INNER-EAR; MEDIATED GENE-THERAPY; AUDITORY HAIR-CELLS; IN-VITRO; NEURONAL DIFFERENTIATION; COCHLEAR IMPLANT; SUPPORTING CELLS; HUMAN DEAFNESS; EXPRESSION	Hearing loss is the most common sensory deficit in humans, with some estimates suggesting up to 300 million affected individuals worldwide. Both environmental and genetic factors contribute to hearing loss and can cause death of sensory cells and neurons. Because these cells do not regenerate, the damage tends to accumulate, leading to profound deafness. Several biological strategies to restore auditory function are currently under investigation. Owing to the success of cochlear implants, which offer partial recovery of auditory function for some profoundly deaf patients, potential biological therapies must extend hearing restoration to include greater auditory acuity and larger patient populations. Here, we review the latest gene, stem-cell, and molecular strategies for restoring auditory function in animal models and the prospects for translating these approaches into viable clinical therapies.	[Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Otolaryngol,FM Kirby Neurobiol Ctr, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Holt, JR (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Otolaryngol,FM Kirby Neurobiol Ctr, Boston, MA 02114 USA.	jeffrey.holt@childrens.harvard.edu		Geleoc, Gwenaelle/0000-0002-2825-6521	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [RO1DC008853, R01DC005439]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008853, R01DC005439] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Inner-ear gene-therapy research in the Holt/Geleoc lab is supported by the Bertarelli Foundation Program in Translational Neuroscience and Neuroengineering. This review was support by grants from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders: RO1DC008853 (G.S.G.G) and R01DC005439 (J.R.H). We thank A. Cheng, D. Corey, and A. Edge for critical comments on the manuscript.	Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; [Anonymous], 2011, 29 YEARS OLD HEARING; Atkinson PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052338; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; Di Domenico M, 2011, J CELL PHYSIOL, V226, P2494, DOI 10.1002/jcp.22617; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Eshraghi AA, 2012, ANAT REC, V295, P1967, DOI 10.1002/ar.22580; Fukui H, 2013, HEARING RES, V297, P99, DOI 10.1016/j.heares.2012.11.017; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Geschwind MD, 1996, HUM GENE THER, V7, P173, DOI 10.1089/hum.1996.7.2-173; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Gunewardene N, 2012, STEM CELL REV REP, V8, P741, DOI 10.1007/s12015-011-9320-0; HARRIS JP, 1995, OTOLARYNG HEAD NECK, V112, P639, DOI 10.1016/S0194-5998(95)70170-2; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hernandez VH, 2014, J CLIN INVEST, V124, P1114, DOI 10.1172/JCI69050; Holt JR, 2014, HEARING RES, V311, P17, DOI 10.1016/j.heares.2014.01.001; Holt JR, 2012, MOL THER, V20, P1836, DOI 10.1038/mt.2012.196; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kesser BW, 2007, GENE THER, V14, P1121, DOI 10.1038/sj.gt.3302980; Kilpatrick LA, 2011, GENE THER, V18, P569, DOI 10.1038/gt.2010.175; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Korrapati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073276; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Lentz JJ, 2010, DEV NEUROBIOL, V70, P253, DOI 10.1002/dneu.20771; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Maeda Y, 2009, ADV OTO-RHINO-LARYNG, V66, P13, DOI 10.1159/000218205; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin DM, 2012, NEURON, V75, P188, DOI 10.1016/j.neuron.2012.06.008; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; Nelson Y., 1984, HDB PHYSL NERVOUS SY, V3, P639; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Park YH, 2014, MOL THER, V22, P873, DOI 10.1038/mt.2013.292; Pfingst BE, 2011, HEARING RES, V281, P65, DOI 10.1016/j.heares.2011.05.002; Pinyon JL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008177; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; Reisinger E, 2011, J NEUROSCI, V31, P4886, DOI 10.1523/JNEUROSCI.5122-10.2011; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Rivera T, 2012, CURR DRUG DELIV, V9, P231, DOI 10.2174/156720112800389098; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rubel EW, 2013, HEARING RES, V297, P42, DOI 10.1016/j.heares.2012.12.014; Sacheli R, 2013, GENE THER, V20, P237, DOI 10.1038/gt.2012.51; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Sheffield AM, 2011, HEARING RES, V277, P28, DOI 10.1016/j.heares.2011.03.016; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Shi FX, 2013, HEARING RES, V297, P106, DOI 10.1016/j.heares.2013.01.017; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Sugawara M, 2007, J COMP NEUROL, V501, P30, DOI 10.1002/cne.21227; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wei DG, 2008, P NATL ACAD SCI USA, V105, P21000, DOI 10.1073/pnas.0808044105; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Xia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043218; Yang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046355; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Yu Q, 2014, GENE THER, V21, P71, DOI 10.1038/gt.2013.59; Zhan WH, 2010, AM J EPIDEMIOL, V171, P260, DOI 10.1093/aje/kwp370; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	83	142	150	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					596	+	1241062	10.1126/science.1241062	http://dx.doi.org/10.1126/science.1241062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812404	Green Accepted			2022-12-28	WOS:000335537400033
J	Yamaguchi, N; Winter, CM; Wu, MF; Kanno, Y; Yamaguchi, A; Seo, M; Wagner, D				Yamaguchi, Nobutoshi; Winter, Cara M.; Wu, Miin-Feng; Kanno, Yuri; Yamaguchi, Ayako; Seo, Mitsunori; Wagner, Doris			Gibberellin Acts Positively Then Negatively to Control Onset of Flower Formation in Arabidopsis	SCIENCE			English	Article							TRANSCRIPTION FACTORS; FLORAL INDUCTION; THALIANA; EXPRESSION; PLANTS; GENES; INITIATION; PATHWAYS; CYP714A1; IDENTITY	The switch to reproductive development is biphasic in many plants, a feature important for optimal pollination and yield. We show that dual opposite roles of the phytohormone gibberellin underpin this phenomenon in Arabidopsis. Although gibberellin promotes termination of vegetative development, it inhibits flower formation. To overcome this effect, the transcription factor LEAFY induces expression of a gibberellin catabolism gene; consequently, increased LEAFY activity causes reduced gibberellin levels. This allows accumulation of gibberellin-sensitive DELLA proteins. The DELLA proteins are recruited by SQUAMOSA PROMOTER BINDING PROTEIN-LIKE transcription factors to regulatory regions of the floral commitment gene APETALA1 and promote APETALA1 up-regulation and floral fate synergistically with LEAFY. The two opposing functions of gibberellin may facilitate evolutionary and environmental modulation of plant inflorescence architecture.	[Yamaguchi, Nobutoshi; Winter, Cara M.; Wu, Miin-Feng; Yamaguchi, Ayako; Wagner, Doris] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kanno, Yuri; Seo, Mitsunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	University of Pennsylvania; RIKEN	Wagner, D (corresponding author), Univ Penn, Dept Biol, 415 South Univ Ave, Philadelphia, PA 19104 USA.	wagnerdo@sas.upenn.edu	Yamaguchi, Nobutoshi/AAU-6928-2020; Seo, Mitsunori/N-9603-2015; kanno, yuri/C-9211-2017	Yamaguchi, Nobutoshi/0000-0003-3738-6157; Wagner, Doris/0000-0003-4656-2490; Seo, Mitsunori/0000-0001-8325-7984	NSF [IOS 0849298, 1257111];  [T32-HD007516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Wagner laboratory members and K. Gallagher, R. S. Poethig, and J. D. Wagner for critical comments. We thank R. Austin for the LFY binding motif functional depth analyses, T. Sun for pRGA: RGA-GFP and GA pathway mutant seeds, X. Chen for 35S: AlcR pAlcA: MIR156f and pRGA: RGA-HA seeds, M. Schmid for RGL1 and rgl1delta17 constructs, S. Poethig for pSPL9: rSPL9-FLAG and 35S: SPL9-GR seeds, H. Yu for ga1-3 rgl2-1 rga-2 35S: RGA-GR seeds, G. Angenent for pAP1: AP1-GFP seeds, and the Arabidopsis Biological Resource Center for insertion mutant seeds and the F6A4 bacterial artificial chromosome clone. This work was supported by NSF grants IOS 0849298 and 1257111 to D. W. and training grant T32-HD007516 (Developmental Biology) support to C.M.W.	Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Galvao VC, 2012, DEVELOPMENT, V139, P4072, DOI 10.1242/dev.080879; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hirano K, 2012, PLANT J, V71, P443, DOI 10.1111/j.1365-313X.2012.05000.x; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Nomura T, 2013, PLANT CELL PHYSIOL, V54, P1837, DOI 10.1093/pcp/pct125; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Porri A, 2012, DEVELOPMENT, V139, P2198, DOI 10.1242/dev.077164; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Steeves TA, 1989, PATTERN PLANT DEV; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang YY, 2011, PLANT J, V67, P342, DOI 10.1111/j.1365-313X.2011.04596.x	30	166	191	18	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					638	641		10.1126/science.1250498	http://dx.doi.org/10.1126/science.1250498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812402				2022-12-28	WOS:000335537400045
J	Colli, A; Petranzan, E				Colli, Andrea; Petranzan, Enrico			Traumatic Tension Pneumothorax Causing Heart Rotation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 48-year-old man was referred to the emergency department for chest trauma related to a motorcycle accident. The findings on cardiac auscultation and electrocardiography were consistent with possible dextrocardia. A 48-year-old man was referred to the emergency department for chest trauma related to a motorcycle accident. The findings on cardiac auscultation and electrocardiography were consistent with possible dextrocardia. A chest radiograph and computed tomographic (CT) scan showed a 90-degree rightward rotation of the cardiac silhouette (Panel A, arrow) and great vessels (Panel C, arrows), with left tension pneumothorax and multiple rib fractures (Fig. 5 in the Supplementary Appendix), bilateral pulmonary contusion (Fig. 1 and Fig. 3 in the Supplementary Appendix), and ruptured spleen. A total-body CT scan showed rightward rotation of the pulmonary artery and aorta (Panel C), rotation of both ...	[Colli, Andrea; Petranzan, Enrico] Univ Padua, Padua, Italy	University of Padua	Colli, A (corresponding author), Univ Padua, Padua, Italy.			Colli, Andrea/0000-0003-2724-3961					0	4	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19								10.1056/NEJMicm1310017	http://dx.doi.org/10.1056/NEJMicm1310017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806189	Green Published			2022-12-28	WOS:000335997900001
J	Larrieu, D; Britton, S; Demir, M; Rodriguez, R; Jackson, SP				Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Rodriguez, Raphael; Jackson, Stephen P.			Chemical Inhibition of NAT10 Corrects Defects of Laminopathic Cells	SCIENCE			English	Article							HUTCHINSON-GILFORD PROGERIA; A-TYPE LAMINS; NUCLEAR MORPHOLOGY; NUCLEOLAR PROTEIN; HELA-CELLS; ACETYLTRANSFERASE; FARNESYLATION; FIBROBLASTS; EXPRESSION; MUTATIONS	Down-regulation and mutations of the nuclear-architecture proteins lamin A and C cause misshapen nuclei and altered chromatin organization associated with cancer and laminopathies, including the premature-aging disease Hutchinson-Gilford progeria syndrome (HGPS). Here, we identified the small molecule "Remodelin" that improved nuclear architecture, chromatin organization, and fitness of both human lamin A/C-depleted cells and HGPS-derived patient cells and decreased markers of DNA damage in these cells. Using a combination of chemical, cellular, and genetic approaches, we identified the acetyl-transferase protein NAT10 as the target of Remodelin that mediated nuclear shape rescue in laminopathic cells via microtubule reorganization. These findings provide insights into how NAT10 affects nuclear architecture and suggest alternative strategies for treating laminopathies and aging.	[Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust Canc Res UK CRUK Gurdon Inst, Cambridge CB2 1QN, England; [Larrieu, Delphine; Britton, Sebastien; Demir, Mukerrem; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Rodriguez, Raphael] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Wellcome Trust Sanger Institute	Rodriguez, R (corresponding author), CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France.	raphael.rodriguez@cnrs.fr; s.jackson@gurdon.cam.ac.uk	Britton, Sébastien/AAL-1862-2020; Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Britton, Sébastien/0000-0002-7008-5316; Jackson, Stephen Philip/0000-0001-9317-7937; Rodriguez, Raphael/0000-0001-7668-446X; Larrieu, Delphine/0000-0002-2335-9361	Cancer Research UK [C6/A11224]; European Research Council; European Community [HEALTH-F2-2010-259893]; CRUK [C6946/A14492]; Wellcome Trust [WT092096]; University of Cambridge, UK; European Molecular Biology Organization (EMBO) long-term fellowship [ALTF 834-2011]; Medical Research Council, UK [MR/L019116/1]; EMBO [ALTF 93-2010]; CRUK; CNRS; European Research Council grant DDREAM; Cancer Research UK [11224] Funding Source: researchfish; Medical Research Council [MR/L019116/1] Funding Source: researchfish; MRC [MR/L019116/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); CRUK(Cancer Research UK); Wellcome Trust(Wellcome Trust); University of Cambridge, UK(University of Cambridge); European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO)); CRUK(Cancer Research UK); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council grant DDREAM; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the Jackson laboratory for help and support, J. Forment for discussions, and K. Dry and J. Travers for discussions and critical reading of the manuscript. We thank R. Belotserkovskaya for the GFP-H2B U2OS cell line and S. Heidorn and M. Garnett (Wellcome Trust Sanger Institute) for providing us with the cancer cells used in the lamin A/C expression screen. We thank Imagif and Institut de Chimie des Substances Naturelles, Centre National de la Recherche Scientifique (CNRS) de Gif-sur-Yvette, France, for proteomic analysis. Research in the Jackson laboratory is funded by Cancer Research UK program grant C6/A11224, the European Research Council, and the European Community Seventh Framework Programme grant agreement HEALTH-F2-2010-259893 (DDR). Core funding is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S. P. J. receives his salary from the University of Cambridge, UK, supplemented by CRUK. D. L is funded by a European Molecular Biology Organization (EMBO) long-term fellowship ALTF 834-2011 and by a Project Grant from the Medical Research Council, UK MR/L019116/1. S. B. was funded by a EMBO long-term fellowship ALTF 93-2010 and CRUK. R. R. is supported by CNRS. M. D. is supported by the European Research Council grant DDREAM. A patent (application number 1405991.9) on the small molecule Remodelin and structural analogs for the treatment of disease has been filed by the University of Cambridge and CNRS. The data presented in this paper are included in the main paper and the supplementary materials. D. L. conceptualized the study and carried out all the experiments unless stated otherwise. S. B. cloned NAT10 expression constructs, performed the NAT10 structure analysis, produced high-resolution microscopy images, and contributed to live-cell imaging. R. R. designed and synthesized the small molecules and performed circular dichroism spectroscopy experiment. M. D. provided assistance with IF, fluorescence-activated cell sorting, and western blotting experiments. D. L. designed the experiments and analyzed the data. D. L. and S. P. J wrote the paper, with contributions from R. R., and S.B.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Amin MA, 2007, BIOCHEM BIOPH RES CO, V360, P320, DOI 10.1016/j.bbrc.2007.06.092; BROERS JLV, 1993, AM J PATHOL, V143, P211; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimenti F, 2009, J MED CHEM, V52, P530, DOI 10.1021/jm800885d; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Li X, 2012, J AM CHEM SOC, V134, P1982, DOI 10.1021/ja210528v; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P10499, DOI 10.1073/pnas.95.18.10499; Tamiello C, 2013, NUCLEUS-AUSTIN, V4, P61, DOI 10.4161/nucl.23388; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Verstraeten VLRM, 2011, P NATL ACAD SCI USA, V108, P4997, DOI 10.1073/pnas.1019532108; Wang GX, 2010, J BIOL CHEM, V285, P19060, DOI 10.1074/jbc.M110.100396; Wang YX, 2012, NUCLEUS-AUSTIN, V3, P452, DOI 10.4161/nucl.21675; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	26	183	186	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					527	532		10.1126/science.1252651	http://dx.doi.org/10.1126/science.1252651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786082	Green Submitted, Green Accepted			2022-12-28	WOS:000335157700046
J	Cully, M				Cully, Megan			PUBLIC HEALTH The politics of antibiotics	NATURE			English	Editorial Material														Cully, Megan/0000-0003-4726-134X				Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; European Medicines Agency, 2013, SAL VET ANT AG 25 EU; Hollis A, 2013, NEW ENGL J MED, V369, P2474, DOI 10.1056/NEJMp1311479; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	4	75	77	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S16	S17		10.1038/509S16a	http://dx.doi.org/10.1038/509S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784425	Bronze			2022-12-28	WOS:000335199100009
J	Heneghan, CJ; Onakpoya, I; Thompson, M; Spencer, EA; Jones, M; Jefferson, T				Heneghan, Carl J.; Onakpoya, Igho; Thompson, Matthew; Spencer, Elizabeth A.; Jones, Mark; Jefferson, Tom			Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAMINIDASE INHIBITORS	Objectives To describe the potential benefits and harms of zanamivir. Design Systematic review of clinical study reports of randomised placebo controlled trials and regulatory information Data sources Clinical study reports, trial registries, electronic databases, regulatory archives, and correspondence with manufacturers. Eligibility criteria for selecting studies Randomised placebo controlled trials in adults and children who had confirmed or suspected exposure to natural influenza. Main outcome measures Time to first alleviation of symptoms, influenza outcomes and complications, admissions to hospital, and adverse events in the intention to treat (ITT) population. Results We included 28 trials in stage 1 (judgment of appropriate study design) and 26 in stage 2 (formal analysis). For treatment of adults, zanamivir reduced the time to first alleviation of symptoms of influenza-like illness by 0.60 days (95% confidence interval 0.39 to 0.81, P<0.001, I-2=9%), which equates to an average 14.4 hours' reduction, or a 10% reduction in mean duration of symptoms from 6.6 days to 6.0 days. Time to first alleviation of symptoms was shorter in all participants when any relief drugs were allowed compared with no use. Zanamivir did not reduce the risk of self reported investigator mediated pneumonia risk difference 0.17%, -0.73% to 0.70%) or radiologically confirmed pneumonia (-0.06%, -6.56% to 2.11%) in adults. The effect on pneumonia in children was also not significant (0.56%, -1.64% to 1.04%). There was no significant effect on otitis media or sinusitis in both adults and children, with only a small effect noted for bronchitis in adults (1.80%, 0.65% to 2.80%), but not in children. There were no data to assess effects on admissions in adults and children. Zanamivir tended to be well tolerated. In zanamivir prophylaxis studies, symptomatic influenza in individuals was significantly reduced (1.98%, (0.98% to 2.54%); reducing event rates from 3.26% to 1.27%, which means 51 people need to be treated to prevent one influenza case (95% confidence interval, 40 to 103). In contrast, the prophylaxis effect on asymptomatic influenza cases was not significant in individuals (risk difference 0.14%, -1.10% to 1.10%) or in households (1.32%, -2.20% to 3.84%). In households treated prophylactically there was an effect on symptomatic influenza (14.84%, 12.18% to 16.55%), but this was based on only two small studies including 824 participants. Prophylaxis in adults reduced unverified pneumonia (0.32%, 0.09% to 0.41%; NNTB (number needed to treat to benefit) 311, 244 to 1086) but had no effect on pneumonia in children or on bronchitis or sinusitis in adults or children (risk difference 0.32%, 0.09% to 0.41%; NNTB 311, 244 to 1086). Conclusions Based on a full assessment of all trials conducted, zanamivir reduces the time to symptomatic improvement in adults (but not in children) with influenza-like illness by just over half a day, although this effect might be attenuated by symptom relief medication. Zanamivir also reduces the proportion of patients with laboratory confirmed symptomatic influenza. We found no evidence that zanamivir reduces the risk of complications of influenza, particularly pneumonia, or the risk of hospital admission or death. Its harmful effects were minor (except for bronchospasm), perhaps because of low bioavailability.	[Heneghan, Carl J.; Onakpoya, Igho; Spencer, Elizabeth A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Jefferson, Tom] Cochrane Acute Resp Infect Grp, I-00187 Rome, Italy	University of Oxford; University of Washington; University of Washington Seattle; University of Queensland	Heneghan, CJ (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	carl.heneghan@phc.ox.ac.uk	Jones, Mark/I-2720-2016	Jones, Mark/0000-0001-6858-9710; Spencer, Elizabeth/0000-0002-9079-8006	NIHR Health Technology Assessment programme; National Institute for Health Research [10/80/01] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment programme and will be published in full in the Health Technology Assessment journal series (see www.nets.nihr.ac.uk/projects/hta/108001 for more details). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The study sponsor had no role in study design, the collection, analysis and interpretation of data, the writing of the article and the decision to submit it for publication. All the authors have no ties to the manufacturer or the sponsor (apart from those disclosed) and had access to all parts of the anonymised clinical study report from the zanamivir evidence programme.	[Anonymous], COCHRANE DATABASE SY; Cao B, 2012, CHINESE MED J-PEKING, V125, P3002, DOI 10.3760/cma.j.issn.0366-6999.2012.17.007; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Del Mar C, 2009, BMJ-BRIT MED J, V339, pb5106; Department of Health and Human Services, LETT; Department of Health and Human services/FDA, REL ZAN INH; Higgins JPT, 2001, COCHRANE HDB SYSTEMA; Jefferson T, 2010, COCHRANE DB SYST REV; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; MATHESON NJ, 2007, COCHRANE DB SYST REV, V1; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen-Van-am JS, 1999, BRIT MED J, V319, P655, DOI 10.1136/bmj.319.7211.655; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Wang K, 2012, COCHRANE DB SYST REV, V4; Williamson JC, 2000, NEW ENGL J MED, V342, P661, DOI 10.1056/NEJM200003023420914	18	63	68	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2547	10.1136/bmj.g2547	http://dx.doi.org/10.1136/bmj.g2547			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811412	hybrid, Green Published			2022-12-28	WOS:000334348700013
J	Valdiserri, RO; Koh, HK				Valdiserri, Ronald O.; Koh, Howard K.			Breaking the Silence on Viral Hepatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES		[Valdiserri, Ronald O.; Koh, Howard K.] US Dept HHS, Washington, DC 20201 USA		Valdiserri, RO (corresponding author), US Dept HHS, 200 Independence Ave SW,HHH Bldg,Room 443-H, Washington, DC 20201 USA.	ron.valdiserri@hhs.gov						Berg CL, 2009, AM J TRANSPLANT, V9, P907, DOI 10.1111/j.1600-6143.2009.02567.x; Centers for Disease Control and Prevention, 2011, VIR HEP STAT SURV SU; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; U.S. Department of Health and Human Services, ACT PLAN PREV CAR TR; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; Valdiserri RO, 2014, AM J PUBLIC HEALTH, pe1	10	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					147	+		10.7326/M14-0404	http://dx.doi.org/10.7326/M14-0404			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	24781348				2022-12-28	WOS:000339764600025
J	Liu, V; Escobar, GJ; Greene, JD; Soule, J; Whippy, A; Angus, DC; Iwashyna, TJ				Liu, Vincent; Escobar, Gabriel J.; Greene, John D.; Soule, Jay; Whippy, Alan; Angus, Derek C.; Iwashyna, Theodore J.			Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MORTALITY		[Liu, Vincent; Escobar, Gabriel J.; Greene, John D.] Kaiser Permanente, Div Res, Oakland, CA USA; [Soule, Jay; Whippy, Alan] Permanente Med Grp Inc, Oakland, CA USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Iwashyna, Theodore J.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Kaiser Permanente; Permanente Medical Groups; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Liu, V (corresponding author), 2000 Broadway, Oakland, CA 94612 USA.	vincent.x.liu@kp.org	Angus, Derek C/E-9671-2012	Iwashyna, Theodore/0000-0002-4226-9310				Agency for Healthcare Research and Quality HCUP, INTR HCUP NAT INP SA; Escobar GJ, 2013, MED CARE, V51, P446, DOI 10.1097/MLR.0b013e3182881c8e; Gordon NP, SIMILARITY ADULT KAI; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu Vincent, 2013, Ann Am Thorac Soc, V10, P466, DOI 10.1513/AnnalsATS.201304-099OC	6	506	540	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					90	92		10.1001/jama.2014.5804	http://dx.doi.org/10.1001/jama.2014.5804			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24838355	Bronze			2022-12-28	WOS:000338131100026
J	Yang, Y; Lisberger, SG				Yang, Yan; Lisberger, Stephen G.			Purkinje-cell plasticity and cerebellar motor learning are graded by complex-spike duration	NATURE			English	Article							PARALLEL FIBERS; CLIMBING FIBERS; OSCILLATIONS; DENDRITES; MODEL	Behavioural learning is mediated by cellular plasticity, such as changes in the strength of synapses at specific sites in neural circuits. The theory of cerebellar motor learning(1-3) relies on movement errors signalled by climbing-fibre inputs to cause long-term depression of synapses from parallel fibres to Purkinje cells(4,5). However, a recent review(6) has called into question the widely held view that the climbing-fibre input is an 'all-or-none' event. In anaesthetized animals, there is wide variation in the duration of the complex spike (CS) caused in Purkinje cells by a climbing-fibre input(7). Furthermore, the amount of plasticity in Purkinje cells is graded according to the duration of electrically controlled bursts in climbing fibres(8,9). The duration of bursts depends on the 'state' of the inferior olive and therefore may be correlated across climbing fibres(8,10). Here we provide a potential functional context for these mechanisms during motor learning in behaving monkeys. The magnitudes of both plasticity and motor learning depend on the duration of the CS responses. Furthermore, the duration of CS responses seems to be a meaningful signal that is correlated across the Purkinje-cell population during motor learning. We suggest that during learning, longer bursts in climbing fibres lead to longer-duration CS responses in Purkinje cells, more calcium entry into Purkinje cells, larger synaptic depression, and stronger learning. The same graded impact of instructive signals for plasticity and learning might occur throughout the nervous system.	[Yang, Yan; Lisberger, Stephen G.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Lisberger, Stephen G.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Lisberger, SG (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	yanyang@neuro.duke.edu; lisberger@neuro.duke.edu	Yang, Yan/A-8505-2016	Yang, Yan/0000-0002-9139-5532	Howard Hughes Medical Institute; National Eye Institute of the National Institutes of Health [R01-EY003878]; NATIONAL EYE INSTITUTE [R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. Hull, L. Glickfeld and R. Mooney for helpful comments, and M. Joshua and J. Lee for 'blind' tests of our measurements of complex-spike duration. Research supported by the Howard Hughes Medical Institute and by the National Eye Institute of the National Institutes of Health under Award Number R01-EY003878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bazzigaluppi P, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00091; Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; GILBERT PFC, 1974, BRAIN RES, V70, P1, DOI 10.1016/0006-8993(74)90208-X; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HIGHSTEIN SM, 1973, EXP BRAIN RES, V17, P301; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; Lisberger S. G., 2014, J NEUROSCI IN PRESS; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Maruta J, 2007, J NEUROSCI, V27, P11263, DOI 10.1523/JNEUROSCI.2559-07.2007; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Miall RC, 1998, NAT NEUROSCI, V1, P13, DOI 10.1038/212; Najafi F, 2014, CELL REP, V6, P792, DOI 10.1016/j.celrep.2014.02.001; Najafi F, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00115; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Rasmussen A, 2013, J NEUROSCI, V33, P13436, DOI 10.1523/JNEUROSCI.1527-13.2013; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Yang Y, 2013, ELIFE, V2, DOI 10.7554/eLife.01574; Yang Y, 2010, J NEUROPHYSIOL, V104, P2850, DOI 10.1152/jn.00761.2010; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	29	119	120	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					529	+		10.1038/nature13282	http://dx.doi.org/10.1038/nature13282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24814344	Green Submitted, Green Accepted			2022-12-28	WOS:000337806300045
J	Suh, J; Weinstein, AJ; Lei, CU; Wollman, EE; Steinke, SK; Meystre, P; Clerk, AA; Schwab, KC				Suh, J.; Weinstein, A. J.; Lei, C. U.; Wollman, E. E.; Steinke, S. K.; Meystre, P.; Clerk, A. A.; Schwab, K. C.			QUANTUM MECHANICS Mechanically detecting and avoiding the quantum fluctuations of a microwave field	SCIENCE			English	Article							BACK-ACTION; NANOMECHANICAL MOTION; GROUND-STATE; OSCILLATOR; RESONATOR; NOISE	Quantum fluctuations of the light field used for continuous position detection produce stochastic back-action forces and ultimately limit the sensitivity. To overcome this limit, the back-action forces can be avoided by giving up complete knowledge of the motion, and these types of measurements are called "back-action evading" or "quantum nondemolition" detection. We present continuous two-tone back-action evading measurements with a superconducting electromechanical device, realizing three long-standing goals: detection of back-action forces due to the quantum noise of a microwave field, reduction of this quantum back-action noise by 8.5 +/- 0.4 decibels (dB), and measurement imprecision of a single quadrature of motion 2.4 +/- 0.7 dB below the mechanical zero-point fluctuations. Measurements of this type will find utility in ultrasensitive measurements of weak forces and nonclassical states of motion.	[Suh, J.; Weinstein, A. J.; Lei, C. U.; Wollman, E. E.; Steinke, S. K.; Schwab, K. C.] CALTECH, Pasadena, CA 91125 USA; [Suh, J.; Weinstein, A. J.; Lei, C. U.; Wollman, E. E.; Schwab, K. C.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Steinke, S. K.; Meystre, P.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Clerk, A. A.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	California Institute of Technology; California Institute of Technology; University of Arizona; McGill University	Schwab, KC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	schwab@caltech.edu	Clerk, Aashish/A-4008-2008	Clerk, Aashish/0000-0001-7297-9068; Suh, Junho/0000-0002-0112-0499; Wollman, Emma/0000-0002-5474-3745	Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation [NSF-IQIM 1125565]; Defense Advanced Research Projects Agency [DARPA-QUANTUM HR0011-10-1-0066]; NSF [NSF-DMR 1052647, NSF-EEC 0832819]; Direct For Mathematical & Physical Scien [1205374] Funding Source: National Science Foundation	Institute for Quantum Information and Matter, an NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We would like to acknowledge J. Hertzberg, T. Rocheleau, T. Ndukum, and M. Shaw for work on earlier experiments that led to these results. This work is supported by funding provided by the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation (NSF-IQIM 1125565), by the Defense Advanced Research Projects Agency (DARPA-QUANTUM HR0011-10-1-0066), and by NSF (NSF-DMR 1052647 and NSF-EEC 0832819).	Anetsberger G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.061804; Bertotti B., 1976, P INT M EXP GRAV PAV; Bocko MF, 1996, REV MOD PHYS, V68, P755, DOI 10.1103/RevModPhys.68.755; Braginskii V. B., 1975, Soviet Physics - Uspekhi, V17, P644, DOI 10.1070/PU1975v017n05ABEH004362; Braginsky V. B., 1992, QUANTUM MEASUREMENT; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Clerk AA, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095010; Fragner A, 2008, SCIENCE, V322, P1357, DOI 10.1126/science.1164482; Hertzberg JB, 2010, NAT PHYS, V6, P213, DOI 10.1038/NPHYS1479; HU BL, 1993, MOD PHYS LETT A, V8, P3575, DOI 10.1142/S0217732393002312; KOCH RH, 1982, PHYS REV B, V26, P74, DOI 10.1103/PhysRevB.26.74; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Mutus JY, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821136; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Ruskov R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235407; Schreppler S., 2013, ARXIV13124896; Suh J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816428; Suh J, 2012, NANO LETT, V12, P6260, DOI 10.1021/nl303353r; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; THORNE KS, 1978, PHYS REV LETT, V40, P667, DOI 10.1103/PhysRevLett.40.667	25	107	108	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1262	1265		10.1126/science.1253258	http://dx.doi.org/10.1126/science.1253258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24831528	Green Accepted, Green Submitted			2022-12-28	WOS:000337077500035
J	Betsholtz, C				Betsholtz, Christer			Double function at the blood-brain barrier	NATURE			English	Editorial Material							SYNCYTIN-2; PERICYTES; MEMBRANE; RECEPTOR; MFSD2A		[Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Betsholtz, C (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	christer.betsholtz@igp.uu.se						Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; DRAGSTEN PR, 1981, NATURE, V294, P718, DOI 10.1038/294718a0; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kidd PM, 2007, ALTERN MED REV, V12, P207; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x	14	38	42	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					432	433		10.1038/nature13339	http://dx.doi.org/10.1038/nature13339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828036				2022-12-28	WOS:000336126000025
J	Petrou, P; Patwary, S; Banerjee, PJ; Kirkby, GR				Petrou, Petros; Patwary, Showrob; Banerjee, Philip J.; Kirkby, Graham R.			Bilateral macular hole from a handheld laser pointer	LANCET			English	Editorial Material							INJURIES		[Petrou, Petros; Patwary, Showrob; Kirkby, Graham R.] City Hosp NHS Trust, Birmingham & Midlands Eye Ctr, Birmingham, W Midlands, England; [Petrou, Petros; Banerjee, Philip J.] Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Petrou, P (corresponding author), Moorfields Eye Hosp, 162 City Rd, London EC1V 2PD, England.	petros.petrou@moorfields.nhs.uk						Alsulaiman SM, 2014, OPHTHALMOLOGY, V121, P566, DOI 10.1016/j.ophtha.2013.09.006; Ciulla TA, 1997, ARCH OPHTHALMOL-CHIC, V115, P929; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Mainster MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1210, DOI 10.1001/archopht.122.8.1210; Wyrsch S, 2010, NEW ENGL J MED, V363, P1089, DOI 10.1056/NEJMc1005818	5	19	24	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1780	1780		10.1016/S0140-6736(14)60757-1	http://dx.doi.org/10.1016/S0140-6736(14)60757-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24835614				2022-12-28	WOS:000336267300032
J	Zhang, YJ; Oka, T; Suzuki, R; Ye, JT; Iwasa, Y				Zhang, Y. J.; Oka, T.; Suzuki, R.; Ye, J. T.; Iwasa, Y.			Electrically Switchable Chiral Light-Emitting Transistor	SCIENCE			English	Article							VALLEY POLARIZATION; MONOLAYER; MOS2; ELECTROLUMINESCENCE; DIODES	Tungsten diselenide (WSe2) and related transition metal dichalcogenides exhibit interesting optoelectronic properties owing to their peculiar band structures originating from the valley degree of freedom. Although the optical generation and detection of valley polarization has been demonstrated, it has been difficult to realize active valley-dependent functions suitable for device applications. We report an electrically switchable, circularly polarized light source based on the material's valley degree of freedom. Our WSe2-based ambipolar transistors emit circularly polarized electroluminescence from p-i-n junctions electrostatically formed in transistor channels. This phenomenon can be explained qualitatively by the electron-hole overlap controlled by the in-plane electric field. Our device demonstrates a route to exploit the valley degree of freedom and the possibility to develop a valley-optoelectronics technology.	[Zhang, Y. J.; Oka, T.; Suzuki, R.; Ye, J. T.; Iwasa, Y.] Univ Tokyo, QPEC, Tokyo 1138656, Japan; [Zhang, Y. J.; Oka, T.; Suzuki, R.; Ye, J. T.; Iwasa, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Ye, J. T.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Ye, J. T.; Iwasa, Y.] RIKEN, CEMS, Wako, Saitama 3510198, Japan	University of Tokyo; University of Tokyo; University of Groningen; RIKEN	Zhang, YJ (corresponding author), Univ Tokyo, QPEC, Tokyo 1138656, Japan.	yzhang@mp.t.u-tokyo.ac.jp; iwasa@ap.t.u-tokyo.ac.jp	Zhang, Yijin/T-2403-2019; Ye, Jianting/K-8194-2012; Oka, Takashi/C-4350-2011; Ishida, Mari/AAU-3379-2020; Iwasa, Yoshihiro/C-1719-2009; Institute, Zernike/W-7033-2019	Oka, Takashi/0000-0002-2235-6775; Zhang, Yijin/0000-0003-1127-1124	Japan Society for the Promotion of Science (JSPS); Strategic International Collaborative Research Program (SICORP-LEMSUPAR) of the Japan Science and Technology Agency [25000003]; "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic International Collaborative Research Program (SICORP-LEMSUPAR) of the Japan Science and Technology Agency; "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from JSPS	We thank Y. Saito, H. Shioya, Y. Kasahara, T. Hatano, and Y. Segawa for experimental help and R. Akashi, R. Arita, T. Takenobu, H. Aoki, and B. P. Zhang for discussions. Y.J.Z. is supported by the Japan Society for the Promotion of Science (JSPS) through a research fellowship for young scientists. This research was supported by the Strategic International Collaborative Research Program (SICORP-LEMSUPAR) of the Japan Science and Technology Agency, Grant-in-Aid for Specially Promoted Research (25000003), and the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from JSPS.	ASHCROFT NW, 1976, SOLID STATE PHYS, pCH12; Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Bisri SZ, 2011, ADV MATER, V23, P2753, DOI 10.1002/adma.201004572; Braga D, 2012, NANO LETT, V12, P5218, DOI 10.1021/nl302389d; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Konishi K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057402; Kormanyos A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045416; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Podzorov V, 2004, APPL PHYS LETT, V84, P3301, DOI 10.1063/1.1723695; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; Ross JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2498; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Song Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.026601; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Sundaram RS, 2013, NANO LETT, V13, P1416, DOI 10.1021/nl400516a; Sze S. M, 1981, PHYSICS SEMICONDUCTO; Wang YH, 2013, SCIENCE, V342, P453, DOI 10.1126/science.1239834; Wu SF, 2013, NAT PHYS, V9, P149, DOI 10.1038/nphys2524; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Yang Y, 2013, ADV MATER, V25, P2624, DOI 10.1002/adma.201204961; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Yuan HT, 2013, NAT PHYS, V9, P563, DOI [10.1038/NPHYS2691, 10.1038/nphys2691]; Zaumseil J, 2006, NAT MATER, V5, P69, DOI 10.1038/nmat1537; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YJ, 2013, NANO LETT, V13, P3023, DOI 10.1021/nl400902v; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Zhu ZY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.153402; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	33	581	589	19	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					725	728		10.1126/science.1251329	http://dx.doi.org/10.1126/science.1251329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24790028				2022-12-28	WOS:000335912900035
J	Engels, S; Schneider, NL; Lefeldt, N; Hein, CM; Zapka, M; Michalik, A; Elbers, D; Kittel, A; Hore, PJ; Mouritsen, H				Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Kittel, Achim; Hore, P. J.; Mouritsen, Henrik			Anthropogenic electromagnetic noise disrupts magnetic compass orientation in a migratory bird	NATURE			English	Article							MAGNETORECEPTION; MECHANISM; MODEL; CUES	Electromagnetic noise is emitted everywhere humans use electronic devices. For decades, it has been hotly debated whether man-made electric and magnetic fields affect biological processes, including human health(1-5). So far, no putative effect of anthropogenic electromagnetic noise at intensities below the guidelines adopted by the World Health Organization(1,2) has withstood the test of independent replication under truly blinded experimental conditions. No effect has therefore been widely accepted as scientifically proven(1-6). Here we show that migratory birds are unable to use their magnetic compass in the presence of urban electromagnetic noise. When European robins, Erithacus rubecula, were exposed to the background electromagnetic noise present in unscreened wooden huts at the University of Oldenburg campus, they could not orient using their magnetic compass. Their magnetic orientation capabilities reappeared inelectrically grounded, aluminium-screened huts, which attenuated electromagnetic noise in the frequency range from 50 kHz to 5 MHz by approximately two orders of magnitude. When the grounding was removed or when broadband electromagnetic noise was deliberately generated inside the screened and grounded huts, the birds again lost their magnetic orientation capabilities. The disruptive effect of radiofrequency electromagnetic fields is not confined to a narrow frequency band and birds tested far from sources of electromagnetic noise required no screening to orient with their magnetic compass. These fully double-blinded tests document a reproducible effect of anthropogenic electromagnetic noise on the behaviour of an intact vertebrate.	[Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Engels, Svenja; Schneider, Nils-Lasse; Lefeldt, Nele; Hein, Christine Maira; Zapka, Manuela; Michalik, Andreas; Elbers, Dana; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Kittel, Achim] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26111 Oldenburg, Germany; [Hore, P. J.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Oxford	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Mouritsen, Henrik/A-5401-2010; Hore, Peter/R-1923-2017	Mouritsen, Henrik/0000-0001-7082-4839; Hore, Peter/0000-0002-8863-570X	Defense Advanced Research Projects Agency [QuBE: N66001-10-1-4061]; VW-Stiftung; DFG [FOR 701, MO 1408/2-2]; Heinz Neumuller Stiftung; BMBF; European Research Council; EMF Biological Research Trust	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); VW-Stiftung; DFG(German Research Foundation (DFG)); Heinz Neumuller Stiftung; BMBF(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Wuschek, Rohde & Schwarz, Bundesnetzagentur, and ETS Lindgren for help with measuring the electromagnetic fields, the workshops at the University of Oldenburg, especially T. Geiger, for building equipment, etc, and a large number of Bachelors, Masters and PhD students for help in conducting the experiments. We are grateful to the following for financial support: Defense Advanced Research Projects Agency (QuBE: N66001-10-1-4061 to P.J.H. and H. M.), VW-Stiftung (Lichtenberg professorship to H. M.), DFG (FOR 701 and MO 1408/2-2 to H. M.), Heinz Neumuller Stiftung (to C. M. H. and S. E.), BMBF (to H. M.), the European Research Council (to P.J.H.) and the EMF Biological Research Trust (to P.J.H.).	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Batschelet E., 1981, CIRCULAR STAT BIOL; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Chernetsov N, 2011, J EXP BIOL, V214, P2540, DOI 10.1242/jeb.057729; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Engels S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043271; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Health Protection Agency, 2012, HLTH EFF RAD EL FIEL; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2011, J ORNITHOL, V152, P27, DOI 10.1007/s10336-010-0540-x; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MERKEL FRIEDRICH WILHELM, 1965, VOGELWARTE, V23, P71; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03845; Swanson J, 2006, RADIAT RES, V165, P470, DOI 10.1667/RR3522.1; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R., 1995, TIEROSYCHOL; World Health Organization, 2007, ENV HLTH CRIT MON, V238; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528; Ziegelberger G, 2009, HEALTH PHYS, V97, P257, DOI 10.1097/HP.0b013e3181aff9db	36	221	223	7	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					353	+		10.1038/nature13290	http://dx.doi.org/10.1038/nature13290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805233	Green Submitted			2022-12-28	WOS:000336121200037
J	Mongiat, LA; Schinder, AF				Mongiat, Lucas A.; Schinder, Alejandro F.			A Price to Pay for Adult Neurogenesis	SCIENCE			English	Editorial Material							SPATIAL-PATTERN SEPARATION; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; NEURONS BORN; MEMORIES; CELLS		[Mongiat, Lucas A.] Consejo Nacl Invest Cient & Tecn, INI BIOMA, Res Inst Biodivers & Environm, San Carlos De Bariloche, Rio Negro, Argentina; [Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, IIBBA, Leloir Inst, Lab Neuronal Plast, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Mongiat, LA (corresponding author), Consejo Nacl Invest Cient & Tecn, INI BIOMA, Res Inst Biodivers & Environm, San Carlos De Bariloche, Rio Negro, Argentina.	aschinder@leloir.org.ar	Mongiat, Lucas/GXG-5680-2022	Mongiat, Lucas/0000-0003-2643-8062; Schinder, Alejandro/0000-0003-4863-8348				Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Weisz VI, 2012, COGNITION, V125, P13, DOI 10.1016/j.cognition.2012.07.002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	11	12	12	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					594	595		10.1126/science.1254236	http://dx.doi.org/10.1126/science.1254236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812393				2022-12-28	WOS:000335537400032
J	Talhelm, T; Zhang, X; Oishi, S; Shimin, C; Duan, D; Lan, X; Kitayama, S				Talhelm, T.; Zhang, X.; Oishi, S.; Shimin, C.; Duan, D.; Lan, X.; Kitayama, S.			Large-Scale Psychological Differences Within China Explained by Rice Versus Wheat Agriculture	SCIENCE			English	Article							CULTURE; INDEPENDENCE; SOCIETIES; COGNITION; VALUES	Cross-cultural psychologists have mostly contrasted East Asia with the West. However, this study shows that there are major psychological differences within China. We propose that a history of farming rice makes cultures more interdependent, whereas farming wheat makes cultures more independent, and these agricultural legacies continue to affect people in the modern world. We tested 1162 Han Chinese participants in six sites and found that rice-growing southern China is more interdependent and holistic-thinking than the wheat-growing north. To control for confounds like climate, we tested people from neighboring counties along the rice-wheat border and found differences that were just as large. We also find that modernization and pathogen prevalence theories do not fit the data.	[Talhelm, T.; Oishi, S.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; [Zhang, X.; Duan, D.] Beijing Normal Univ, Dept Psychol, Beijing 100875, Peoples R China; [Zhang, X.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shimin, C.] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Lan, X.; Kitayama, S.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Virginia; Beijing Normal University; Beijing Normal University; South China Normal University; University of Michigan System; University of Michigan	Talhelm, T (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	tat8dc@virginia.edu			Fulbright Scholarship; NSF Graduate Research Fellowship; NSF East Asian and Pacific Summer Institute Fellowship	Fulbright Scholarship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF East Asian and Pacific Summer Institute Fellowship	We thank Z. Xia, N. Qingyun, Y. Wu, Y. Wang, Y. Ma, and A Jiao for collecting data; A. Leung and C. Wang for making the loyalty/nepotism task available; L. Jun Ji for the Chinese version of the triad task; M. Hunter for statistical guidance; and J. P. Seder, A. Putnam, Y. Wang, T. Wilson, and E. Gilbert for comments on earlier versions of this paper. The data are available at the Inter-University Consortium for Political and Social Research (ICPSR no. 35027) or by request to the first author. This research was supported by a Fulbright Scholarship, a NSF Graduate Research Fellowship, and a NSF East Asian and Pacific Summer Institute Fellowship. The Beijing Key Lab of Applied Experimental Psychology supplied laboratory space for the study.	Aoki M., 2001, COMP I ANAL; BERRY JW, 1967, J PERS SOC PSYCHOL, V7, P415, DOI 10.1037/h0025231; Bray F., 1986, RICE EC TECHNOLOGY D, DOI 10.1525/9780520914933; Buck J. L., 1935, LAND UTILIZATION CHI; Cohen D., 1997, CULTURE HONOR; FAO & IIASA, 2010, GLOB AGR ZON GAEZ V3; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Greenfield PM, 2009, DEV PSYCHOL, V45, P401, DOI 10.1037/a0014726; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Harris M., 1977, CANNIBALS AND KINGS; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; Ji LJ, 2004, J PERS SOC PSYCHOL, V87, P57, DOI 10.1037/0022-3514.87.1.57; Junshi C., 1990, DIET LIFE STYLE MORT; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; LESTER D, 1995, PSYCHOL REP, V76, P258, DOI 10.2466/pr0.1995.76.1.258; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Peng KP, 1997, PSYCHOL METHODS, V2, P329, DOI 10.1037/1082-989X.2.4.329; Rose, 1982, CHINESE AGR EC, P13; SHANE SA, 1992, J BUS VENTURING, V7, P29, DOI 10.1016/0883-9026(92)90033-N; State Statistical Bureau of the People's Republic of China, 2005, CHIN STAT YB; State Statistical Bureau of the People's Republic of China, 1996, CHIN STAT YB; Triandis H.C, 1995, INDIVIDUALISM COLLEC; Wang CS, 2011, J EXP SOC PSYCHOL, V47, P1295, DOI 10.1016/j.jesp.2011.04.011; WITKIN HA, 1977, REV EDUC RES, V47, P1; Xiaotong F., 1945, EARTHBOUND CHINA STU	27	515	549	57	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					603	608		10.1126/science.1246850	http://dx.doi.org/10.1126/science.1246850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6OD	24812395				2022-12-28	WOS:000335537400036
J	Kazatchkine, M				Kazatchkine, Michel			PERSONAL VIEW Russia's ban on methadone for drug users in Crimea will worsen the HIV/AIDS epidemic and risk public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UN Secretary Gen Special Envoy HIV AIDS Eastern E, Int AIDS Soc, CH-1202 Geneva, Switzerland		Kazatchkine, M (corresponding author), UN Secretary Gen Special Envoy HIV AIDS Eastern E, Int AIDS Soc, Ave France 23, CH-1202 Geneva, Switzerland.							Andrey Rylkov Foundation for Health and Social Justice, 2011, ACT IR TEPL WHO REC; Andrey Rylkov Foundation for Health and Social Justice, 2012, IV AN COMPL UN SPEC; [Anonymous], 2004, 2004 REP GLOB AIDS E; [Anonymous], 2014, 24 WORLD        0420; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Drug Reporter, 2014, DRUG REPORTER   0402; European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; Federal Service of the Russian Federation for Narcotics Control, 2014, ORG ANT ACT CRIM FED; Federal Service of the Russian Federation for Narcotics Control, 2014, DECR SIGN EST REG AN; Russian Federation, FED LAW DRUGS PSYCH; Stebenkova Lyudmila, 2014, MEMBERS MOSCOW CITY; Subata E., 2013, OPIOID SUBSTITUTION; Ukrainian Center for Socially Dangerous Disease Control of the Ministry of Health, INF QUANT QUAL CHAR; UNAIDS, 2010, REP GLOB AIDS EP 201; WHO UNODC UNAIDS, 2012, WHO UNODC UNAIDS TEC; World Health Organization, 2009, GUID PSYCH ASS PHARM	16	20	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g3118	10.1136/bmj.g3118	http://dx.doi.org/10.1136/bmj.g3118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812004	Bronze			2022-12-28	WOS:000335819700013
J	ter Meulen, V				ter Meulen, Volker			Time to settle the synthetic controversy	NATURE			English	Editorial Material									[ter Meulen, Volker] German Acad Sci Leopoldina, Halle, Germany			volker.termeulen@mail.uni-wuerzburg.de							0	8	8	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					135	135		10.1038/509135a	http://dx.doi.org/10.1038/509135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805310	Bronze			2022-12-28	WOS:000335454300004
J	Benjamin, DK; Hudak, ML; Duara, S; Randolph, DA; Bidegain, M; Mundakel, GT; Natarajan, G; Burchfield, DJ; White, RD; Shattuck, KE; Neu, N; Bendel, CM; Kim, MR; Finer, NN; Stewart, DL; Arrieta, AC; Wade, KC; Kaufman, DA; Manzoni, P; Prather, KO; Testoni, D; Berezny, KY; Smith, PB				Benjamin, Daniel K., Jr.; Hudak, Mark L.; Duara, Shahnaz; Randolph, David A.; Bidegain, Margarita; Mundakel, Gratias T.; Natarajan, Girija; Burchfield, David J.; White, Robert D.; Shattuck, Karen E.; Neu, Natalie; Bendel, Catherine M.; Kim, M. Roger; Finer, Neil N.; Stewart, Dan L.; Arrieta, Antonio C.; Wade, Kelly C.; Kaufman, David A.; Manzoni, Paolo; Prather, Kristi O.; Testoni, Daniela; Berezny, Katherine Y.; Smith, P. Brian		Fluconazole Prophylaxis Study Team	Effect of Fluconazole Prophylaxis on Candidiasis and Mortality in Premature Infants A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; ANTIFUNGAL PROPHYLAXIS; FUNGAL COLONIZATION; NEONATAL CANDIDIASIS; SURGICAL-PATIENTS; INFECTION; RATES	IMPORTANCE Invasive candidiasis in premature infants causes death and neurodevelopmental impairment. Fluconazole prophylaxis reduces candidiasis, but its effect on mortality and the safety of fluconazole are unknown. OBJECTIVE To evaluate the efficacy and safety of fluconazole in preventing death or invasive candidiasis in extremely low-birth-weight infants. DESIGN, SETTING, AND PATIENTS This study was a randomized, blinded, placebo-controlled trial of fluconazole in premature infants. Infants weighing less than 750 g at birth (N = 361) from 32 neonatal intensive care units (NICUs) in the United States were randomly assigned to receive either fluconazole or placebo twice weekly for 42 days. Surviving infants were evaluated at 18 to 22 months corrected age for neurodevelopmental outcomes. The study was conducted between November 2008 and February 2013. INTERVENTIONS Fluconazole (6 mg/kg of body weight) or placebo. MAIN OUTCOMES AND MEASURES The primary end point was a composite of death or definite or probable invasive candidiasis prior to study day 49 (1 week after completion of study drug). Secondary and safety outcomes included invasive candidiasis, liver function, bacterial infection, length of stay, intracranial hemorrhage, periventricular leukomalacia, chronic lung disease, patent ductus arteriosus requiring surgery, retinopathy of prematurity requiring surgery, necrotizing enterocolitis, spontaneous intestinal perforation, and neurodevelopmental outcomes-defined as a Bayley-III cognition composite score of less than 70, blindness, deafness, or cerebral palsy at 18 to 22 months corrected age. RESULTS Among infants receiving fluconazole, the composite primary end point of death or invasive candidiasis was 16%(95% CI, 11%-22%) vs 21% in the placebo group (95% CI, 15%-28%; odds ratio, 0.73 [95% CI, 0.43-1.23]; P = .24; treatment difference, -5%[95% CI, -13% to 3%]). Invasive candidiasis occurred less frequently in the fluconazole group (3% [95% CI, 1%-6%]) vs the placebo group (9% [95% CI, 5%-14%]; P = .02; treatment difference, -6%[95% CI, -11% to -1%]). The cumulative incidences of other secondary outcomes were not statistically different between groups. Neurodevelopmental impairment did not differ between the groups (fluconazole, 31% [95% CI, 21%-41%] vs placebo, 27% [95% CI, 18%-37%]; P = .60; treatment difference, 4%[95% CI, -10% to 17%]). CONCLUSIONS AND RELEVANCE Among infants with a birth weight of less than 750 g, 42 days of fluconazole prophylaxis compared with placebo did not result in a lower incidence of the composite of death or invasive candidiasis. These findings do not support the universal use of prophylactic fluconazole in extremely low-birth-weight infants.	[Benjamin, Daniel K., Jr.; Prather, Kristi O.; Testoni, Daniela; Berezny, Katherine Y.; Smith, P. Brian] Duke Clin Res Inst, Durham, NC USA; [Hudak, Mark L.] Univ Florida, Coll Med Jacksonville, Jacksonville, FL USA; [Hudak, Mark L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Randolph, David A.] Univ Alabama Birmingham, Birmingham, AL USA; [Bidegain, Margarita] Duke Univ, Med Ctr, Durham, NC USA; [Mundakel, Gratias T.] Kings Cty Hosp, Brooklyn, NY USA; [Natarajan, Girija] Wayne State Univ, Detroit, MI USA; [Burchfield, David J.] Univ Florida, Hlth Shands Hosp, Gainesville, FL USA; [White, Robert D.] Mem Hosp South Bend, South Bend, IN USA; [Shattuck, Karen E.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Neu, Natalie] Columbia Univ, New York, NY USA; [Bendel, Catherine M.] Univ Minnesota, Amplatz Childrens Hosp, Minneapolis, MN USA; [Kim, M. Roger] Brookdale Univ Hosp, Brooklyn, NY USA; [Finer, Neil N.] Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA; [Stewart, Dan L.] Univ Louisville, Louisville, KY 40292 USA; [Arrieta, Antonio C.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Wade, Kelly C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kaufman, David A.] Univ Virginia, Charlottesville, VA USA; [Manzoni, Paolo] St Anna Hosp, Turin, Italy	Duke University; State University System of Florida; University of Florida; University of Miami; University of Alabama System; University of Alabama Birmingham; Duke University; Wayne State University; State University System of Florida; University of Florida; University of Texas System; University of Texas Medical Branch Galveston; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of Louisville; Childrens Hospital of Orange County; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Virginia; A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna	Benjamin, DK (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	danny.benjamin@duke.edu	Smith, Phillip B/I-5565-2014; NOBRE, DANIELA TESTONI COSTA/D-6657-2017; Natarajan, Girija/AAJ-3308-2021; Ranu, Sukhvinder/AAI-2753-2020; Stewart, Dan/R-7130-2019; Dhanireddy, Ramasubbareddy/I-3699-2016	NOBRE, DANIELA TESTONI COSTA/0000-0001-7629-4904; Ranu, Sukhvinder/0000-0001-9077-076X; Dhanireddy, Ramasubbareddy/0000-0002-8787-6499; Bendel, Catherine/0000-0001-6093-5930; Ezeanolue, Echezona/0000-0002-6294-9479	NIH [5R01HD057956-05]; USFDA [5R01FD003519-04]; Thrasher Research Fund; Best Pharmaceuticals for Children Act under NICHD [HHSN2752010000031]; National Center for Advancing Translational Sciences of the NIH [UL1TR001117]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057956] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [R01FD003519] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER; FDA [5R01FD003519-04] Funding Source: Federal RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USFDA; Thrasher Research Fund; Best Pharmaceuticals for Children Act under NICHD; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FDA(United States Department of Health & Human Services)	This work was funded by grants from NIH (5R01HD057956-05), the USFDA (5R01FD003519-04), the Thrasher Research Fund, and the Best Pharmaceuticals for Children Act under the guidance of the NICHD (HHSN2752010000031) for the Pediatric Trials Network. Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the NIH (UL1TR001117).	Adams-Chapman I, 2013, J PEDIAT, V163, pe3; Adams-Chapman I, 2013, J PEDIATR-US, V163, P961, DOI 10.1016/j.jpeds.2013.04.034; Aliaga S, 2014, PEDIATRICS, V133, P236, DOI 10.1542/peds.2013-0671; Bayley N, 2006, MANUAL BAYLEY SCALES; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; BERENGUER J, 1993, DIAGN MICR INFEC DIS, V17, P103, DOI 10.1016/0732-8893(93)90020-8; Burwell LA, 2006, PEDIATRICS, V118, pE1019, DOI 10.1542/peds.2006-0446; Castagnola E, 2004, CLIN MICROBIOL INFEC, V10, P86, DOI 10.1111/j.1470-9465.2004.00847.x; Clerihew L, 2008, ARCH DIS CHILD-FETAL, V93, pF238, DOI 10.1136/adc.2007.121830; Gordon PV, 2009, PEDIATR RES, V65, P138, DOI 10.1203/PDR.0b013e31818c7920; Gotzsche PC., 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858, 10.1002/14651858.CD000026/full, DOI 10.1002/14651858.CD000026/FULL]; Ho KM, 2005, CRIT CARE, V9, pR710, DOI 10.1186/cc3883; Kaufman D, 2001, NEW ENGL J MED, V345, P1660, DOI 10.1056/NEJMoa010494; Kaufman DA, 2011, J PEDIATR-US, V158, P759, DOI 10.1016/j.jpeds.2010.11.002; Kicklighter SD, 2001, PEDIATRICS, V107, P293, DOI 10.1542/peds.107.2.293; Laverdiere M, 2000, J ANTIMICROB CHEMOTH, V46, P1001, DOI 10.1093/jac/46.6.1001; Manzoni P, 2007, NEW ENGL J MED, V356, P2483, DOI 10.1056/NEJMoa065733; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Parikh TB, 2007, INDIAN PEDIATR, V44, P830; Playford EG, 2006, J ANTIMICROB CHEMOTH, V57, P628, DOI 10.1093/jac/dki491; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; WaggonerFountain LA, 1996, CLIN INFECT DIS, V22, P803, DOI 10.1093/clinids/22.5.803	23	71	73	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1742	1749		10.1001/jama.2014.2624	http://dx.doi.org/10.1001/jama.2014.2624			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794367	Bronze, Green Accepted			2022-12-28	WOS:000335382300019
J	Makrides, M; Gould, JF; Gawlik, NR; Yelland, LN; Smithers, LG; Anderson, PJ; Gibson, RA				Makrides, Maria; Gould, Jacqueline F.; Gawlik, Nicola R.; Yelland, Lisa N.; Smithers, Lisa G.; Anderson, Peter J.; Gibson, Robert A.			Four-Year Follow-up of Children Born to Women in a Randomized Trial of Prenatal DHA Supplementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VISUAL DEVELOPMENT; PREGNANCY		[Makrides, Maria] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Gould, Jacqueline F.] Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia; [Gawlik, Nicola R.] Univ Adelaide, Sch Pediat & Reprod Hlth, Adelaide, SA, Australia; [Yelland, Lisa N.; Smithers, Lisa G.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia; [Anderson, Peter J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gibson, Robert A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Murdoch Children's Research Institute; University of Adelaide	Makrides, M (corresponding author), Womens & Childrens Hlth Res Inst, 72 King William Rd, Adelaide, SA 5006, Australia.	maria.makrides@health.sa.gov.au	Anderson, Peter J/B-6839-2015; Gibson, Robert Alan/E-7546-2012; Smithers, Lisa/D-1605-2009; Makrides, Maria/B-6392-2014; Yelland, Lisa N/GPP-4533-2022; Anderson, Peter John/O-5302-2019	Anderson, Peter J/0000-0001-7430-868X; Gibson, Robert Alan/0000-0002-8750-525X; Smithers, Lisa/0000-0002-6585-7836; Makrides, Maria/0000-0003-3832-541X; Yelland, Lisa N/0000-0003-3803-8728; Anderson, Peter John/0000-0001-7430-868X				Gould JF, 2013, AM J CLIN NUTR, V97, P531, DOI 10.3945/ajcn.112.045781; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Smithers LG, 2011, AM J CLIN NUTR, V93, P1293, DOI 10.3945/ajcn.110.009647	4	55	55	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1802	1804		10.1001/jama.2014.2194	http://dx.doi.org/10.1001/jama.2014.2194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794375				2022-12-28	WOS:000335382300027
J	McGavin, CL				McGavin, Colleen L.			More Than "A Case of Fragile X"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	McGavin, CL (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.	cmcgavin@med.umich.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1735	1735		10.1001/jama.2014.3071	http://dx.doi.org/10.1001/jama.2014.3071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794363				2022-12-28	WOS:000335382300015
J	[Anonymous]				[Anonymous]			Physiology for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1887, JAMA, V8, P548	1	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1811	1811		10.1001/jama.2013.279481	http://dx.doi.org/10.1001/jama.2013.279481			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794384				2022-12-28	WOS:000335382300035
J	Masoudi, FA; Mi, XJ; Curtis, LH; Peterson, PN; Curtis, JP; Fonarow, GC; Hammill, SC; Heidenreich, PA; Al-Khatib, SM; Piccini, JP; Qualls, LG; Hernandez, AF				Masoudi, Frederick A.; Mi, Xiaojuan; Curtis, Lesley H.; Peterson, Pamela N.; Curtis, Jeptha P.; Fonarow, Gregg C.; Hammill, Stephen C.; Heidenreich, Paul A.; Al-Khatib, Sana M.; Piccini, Jonathan P.; Qualls, Laura G.; Hernandez, Adrian F.			Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL EVENT REDUCTION; BRANCH BLOCK MORPHOLOGY; PRIMARY PREVENTION; QRS DURATION; METAANALYSIS; MORTALITY; TRIALS	Background: Trials comparing implantable cardioverter-defibrillator (ICD) therapy with cardiac resynchronization therapy with a defibrillator (CRT-D) are limited to selected patients treated at centers with extensive experience. Objective: To compare outcomes after CRT-D versus ICD therapy in contemporary practice. Design: Retrospective cohort study using the National Cardiovascular Data Registry's ICD Registry linked with Medicare claims. Setting: 780 U. S. hospitals implanting both CRT-D and ICD devices. Patients: 7090 propensity-matched patients older than 65 years with reduced left ventricular ejection fraction (<0.35) and prolonged QRS duration on electrocardiography (>= 120 ms) having CRT-D or ICD implantation between 1 April 2006 and 31 December 2009. Measurements: Risks for death, readmission, and device-related complications over 3 years. Results: Compared with ICD therapy, CRT-D was associated with lower risks for mortality (cumulative incidence, 25.7% vs. 29.8%; adjusted hazard ratio [HR], 0.82 [99% CI, 0.73 to 0.93]), all-cause readmission (cumulative incidence, 68.6% vs. 72.8%; adjusted HR, 0.86 [CI, 0.81 to 0.93]), cardiovascular readmission (cumulative incidence, 45.0% vs. 52.4%; adjusted HR, 0.80 [CI, 0.73 to 0.88]), and heart failure readmission (cumulative incidence, 24.3% vs. 29.4%; adjusted HR, 0.78 [CI, 0.69 to 0.88]). It was also associated with greater risks for device-related infection (cumulative incidence, 1.9% vs. 1.0%; adjusted HR, 1.90 [CI, 1.07 to 3.37]). The lower risks for heart failure readmission associated with CRT-D compared with ICD therapy were most pronounced among patients with left bundle branch block or a QRS duration at least 150 ms and in women. Limitations: Patients were not randomly assigned to treatment groups, and few patients could be propensity-matched. The findings may not extend to younger patients or those outside of fee-for-service Medicare. Conclusion: In older patients with reduced left ventricular ejection fraction and prolonged QRS duration, CRT-D was associated with lower risks for death and readmission than ICD therapy alone.	Univ Colorado, Aurora, CO 80045 USA; Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; Denver Hlth Med Ctr, Denver, CO 80204 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA; Ahmanson Univ Calif, Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Mayo Clin, Rochester, MN 55905 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Denver Health Medical Center; Yale University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Masoudi, FA (corresponding author), Univ Colorado, Div Cardiol, Anschutz Med Campus,Box B132,Room 522, Aurora, CO 80045 USA.	fred.masoudi@ucdenver.edu	Masoudi, Frederick/Q-7467-2019; Fonarow, Gregg C/D-5988-2014; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016	Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Adelstein EC, 2009, AM J CARDIOL, V103, P238, DOI 10.1016/j.amjcard.2008.08.069; Al-Khatib SM, 2013, JAMA-J AM MED ASSOC, V309, P55, DOI 10.1001/jama.2012.157182; Al-Majed NS, 2011, ANN INTERN MED, V154, P401, DOI 10.7326/0003-4819-154-6-201103150-00313; Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061; Austin PC, 2009, COMMUN STAT SIML COM, V38, P6; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bilchick KC, 2010, CIRCULATION, V122, P2022, DOI 10.1161/CIRCULATIONAHA.110.956011; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gross CP, 2002, ANN INTERN MED, V137, P10, DOI 10.7326/0003-4819-137-1-200207020-00007; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Masoudi FA, 2012, CIRC-CARDIOVASC QUAL, V5, pE78, DOI 10.1161/CIRCOUTCOMES.112.965368; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Peterson PN, 2013, JAMA-J AM MED ASSOC, V310, P617, DOI 10.1001/jama.2013.8641; Rickard J, 2010, PACE, V33, P590, DOI 10.1111/j.1540-8159.2009.02649.x; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Sipahi I, 2012, AM HEART J, V163, P260, DOI 10.1016/j.ahj.2011.11.014; Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Tracy CM, 2012, J AM COLL CARDIOL, V60, P1297, DOI 10.1016/j.jacc.2012.07.009; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278	29	22	24	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					603	U148		10.7326/M13-1879	http://dx.doi.org/10.7326/M13-1879			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI0GO	24798523				2022-12-28	WOS:000336524400003
J	Sommers, BD; Long, SK; Baicker, K				Sommers, Benjamin D.; Long, Sharon K.; Baicker, Katherine			Changes in Mortality After Massachusetts Health Care Reform A Quasi-experimental Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNIVERSAL COVERAGE; INSURANCE-COVERAGE; ACCESS; MEDICAID; DISPARITIES; SERVICES; IMPACTS; NATIONS; REMAINS; ADULTS	Background: The Massachusetts 2006 health care reform has been called a model for the Affordable Care Act. The law attained near-universal insurance coverage and increased access to care. Its effect on population health is less clear. Objective: To determine whether the Massachusetts reform was associated with changes in all-cause mortality and mortality from causes amenable to health care. Design: Comparison of mortality rates before and after reform in Massachusetts versus a control group with similar demographics and economic conditions. Setting: Changes in mortality rates for adults in Massachusetts counties from 2001 to 2005 (prereform) and 2007 to 2010 (post-reform) were compared with changes in a propensity score-defined control group of counties in other states. Participants: Adults aged 20 to 64 years in Massachusetts and control group counties. Measurements: Annual county-level all-cause mortality in age-, sex-, and race-specific cells (n = 146 825) from the Centers for Disease Control and Prevention's Compressed Mortality File. Secondary outcomes were deaths from causes amenable to health care, insurance coverage, access to care, and self-reported health. Results: Reform in Massachusetts was associated with a significant decrease in all-cause mortality compared with the control group (-2.9%; P = 0.003, or an absolute decrease of 8.2 deaths per 100 000 adults). Deaths from causes amenable to health care also significantly decreased (-4.5%; P < 0.001). Changes were larger in counties with lower household incomes and higher prereform uninsured rates. Secondary analyses showed significant gains in coverage, access to care, and self-reported health. The number needed to treat was approximately 830 adults gaining health insurance to prevent 1 death per year. Limitations: Nonrandomized design subject to unmeasured con-founders. Massachusetts results may not generalize to other states. Conclusion: Health reform in Massachusetts was associated with significant reductions in all-cause mortality and deaths from causes amenable to health care.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Urban Inst, Washington, DC 20037 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Urban Institute	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Kresge Bldg,Room 406,677 Huntington Ave, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu						Abadie A, 2012, COMP POLITICS SYNTHE; Afendulis CC, 2011, HEALTH SERV RES, V46, P1022, DOI 10.1111/j.1475-6773.2011.01244.x; [Anonymous], 2011, KEY IND Q ENR UPD; [Anonymous], 2012, CD ROM SER, V20; [Anonymous], 2012, AR HLTH RES FIL AHRF; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Besley T, 2004, Q J ECON, V119, P91, DOI 10.1162/003355304772839533; CHARLTON JRH, 1986, BRIT MED J, V292, P295, DOI 10.1136/bmj.292.6516.295; Clark CR, 2011, HEALTH AFFAIR, V30, P247, DOI 10.1377/hlthaff.2010.0319; Cooper AL, 2012, NEW ENGL J MED, V366, P150, DOI 10.1056/NEJMsa1104273; Cotet AM, 2013, HEALTH ECON, V22, P393, DOI 10.1002/hec.2807; Courtemanche CJ, 2014, J POLICY ANAL MANAG, V33, P36, DOI 10.1002/pam.21737; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DeLeire T, 2013, HEALTH AFFAIR, V32, P1037, DOI 10.1377/hlthaff.2012.1026; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Eisenberg JM, 2000, JAMA-J AM MED ASSOC, V284, P2100, DOI 10.1001/jama.284.16.2100; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Gray BH, 2006, INQUIRY-J HEALTH CAR, V43, P211, DOI 10.5034/inquiryjrnl_43.3.211; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; Keating NL, 2013, CANCER-AM CANCER SOC, V119, P250, DOI 10.1002/cncr.27757; Kolstad JT, 2012, J PUBLIC ECON, V96, P909, DOI 10.1016/j.jpubeco.2012.07.003; Kronick R, 2009, HEALTH SERV RES, V44, P1211, DOI 10.1111/j.1475-6773.2009.00973.x; Lien DS, 2005, J HUM RESOUR, V40, P373; Long SK, 2008, HEALTH AFFAIR, V27, pW270, DOI 10.1377/hlthaff.27.4.w270; Long SK, 2012, HEALTH AFFAIR, V31, P444, DOI 10.1377/hlthaff.2011.0653; Long SK, 2009, HEALTH AFFAIR, V28, pW578, DOI 10.1377/hlthaff.28.4.w578; MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106; McDonough JE, 2006, HEALTH AFFAIR, V25, pW420, DOI 10.1377/hlthaff.25.w420; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Miller S, 2012, INQUIRY-J HEALTH CAR, V49, P317, DOI 10.5034/inquiryjrnl_49.04.05; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; Pande AH, 2011, AM J PREV MED, V41, P1, DOI 10.1016/j.amepre.2011.03.010; Singer J.D., 2003, APPL LONGITUDINAL DA; Sommers BD, 2014, HEALTH AFFAIR, V33, P78, DOI 10.1377/hlthaff.2013.1087; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; U.S. Census Bureau, 2005, MOD BAS SMALL AR HLT; U.S. Census Bureau, 2007, STAT RANK STAT ABSTR; Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029; Weathers RR, 2012, J HEALTH ECON, V31, P863, DOI 10.1016/j.jhealeco.2012.08.004; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	46	145	147	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					585	U118		10.7326/M13-2275	http://dx.doi.org/10.7326/M13-2275			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI0GO	24798521	Green Submitted			2022-12-28	WOS:000336524400001
J	Weinberg, DS; Schoen, RE				Weinberg, David S.; Schoen, Robert E.			Screening for Colorectal Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; CT-COLONOGRAPHY; COST-EFFECTIVENESS; CLINICAL-TRIAL; DATA SYSTEM; COLONOSCOPY; RISK; MORTALITY; POPULATION											Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Coups EJ, 2007, CANCER EPIDEM BIOMAR, V16, P510, DOI 10.1158/1055-9965.EPI-06-0143; Day Lukejohn W, 2013, Curr Gastroenterol Rep, V15, P357, DOI 10.1007/s11894-013-0357-x; de Haan MC, 2011, EUR RADIOL, V21, P1747, DOI 10.1007/s00330-011-2104-8; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Edwards JT, 2001, AM J GASTROENTEROL, V96, P3009; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; FERLITSCH M, 2011, SEX SPECIFIC PREVALE, V306, P1352; Guittet L, 2007, GUT, V56, P210, DOI 10.1136/gut.2006.101428; Gupta S, 2013, JAMA INTERN MED, V173, P1725, DOI 10.1001/jamainternmed.2013.9294; Heigh RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085659; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Howard K, 2011, VALUE HEALTH, V14, P1146, DOI 10.1016/j.jval.2011.07.012; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kim DH, 2010, RADIOLOGY, V254, P493, DOI 10.1148/radiol.09091478; Ko CW, 2007, GASTROINTEST ENDOSC, V65, P648, DOI 10.1016/j.gie.2006.06.020; Ko CW, 2010, CLIN GASTROENTEROL H, V8, P166, DOI 10.1016/j.cgh.2009.10.007; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Leung K, 2010, GASTROINTEST ENDOSC, V71, P111, DOI 10.1016/j.gie.2009.05.010; Lidgard GP, 2013, CLIN GASTROENTEROL H, V11, P1313, DOI 10.1016/j.cgh.2013.04.023; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Lieberman D, 2014, JAMA INTERN MED, V174, P10, DOI 10.1001/jamainternmed.2013.11499; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Losi L, 2005, AM J GASTROENTEROL, V100, P2280, DOI 10.1111/j.1572-0241.2005.00223.x; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rothwell Peter M, 2013, Recent Results Cancer Res, V191, P121, DOI 10.1007/978-3-642-30331-9_7; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Skally M, 2013, APPL HEALTH ECON HEA, V11, P181, DOI 10.1007/s40258-013-0010-8; Smith RA, 2012, CA CANC J CLIN; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; STEELE CB, 2010, MMWR SURVEILL SUM S3, V62, P53; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; Theuer CP, 2001, GASTROENTEROLOGY, V120, P848, DOI 10.1053/gast.2001.22535; Towler BP, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Vart G, 2012, PREV MED, V55, P87, DOI 10.1016/j.ypmed.2012.05.006; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926; Zalis ME, 2012, ANN INTERN MED, V156, P692, DOI 10.7326/0003-4819-156-10-201205150-00005	67	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9							ITC5	10.7326/0003-4819-160-9-201405060-01005	http://dx.doi.org/10.7326/0003-4819-160-9-201405060-01005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QS	24798544				2022-12-28	WOS:000364907400001
J	Chae, L; Kim, T; Nilo-Poyanco, R; Rhee, SY				Chae, Lee; Kim, Taehyong; Nilo-Poyanco, Ricardo; Rhee, Seung Y.			Genomic Signatures of Specialized Metabolism in Plants	SCIENCE			English	Article							EVOLUTION; CHEMODIVERSITY; BIOLOGY; VIEW	All plants synthesize basic metabolites needed for survival (primary metabolism), but different taxa produce distinct metabolites that are specialized for specific environmental interactions (specialized metabolism). Because evolutionary pressures on primary and specialized metabolism differ, we investigated differences in the emergence and maintenance of these processes across 16 species encompassing major plant lineages from algae to angiosperms. We found that, relative to their primary metabolic counterparts, genes coding for specialized metabolic functions have proliferated to a much greater degree and by different mechanisms and display lineage-specific patterns of physical clustering within the genome and coexpression. These properties illustrate the differential evolution of specialized metabolism in plants, and collectively they provide unique signatures for the potential discovery of novel specialized metabolic processes.	[Chae, Lee; Kim, Taehyong; Nilo-Poyanco, Ricardo; Rhee, Seung Y.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Rhee, SY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	srhee@carnegiescience.edu	Poyanco, Ricardo Nilo/AAJ-8006-2021	Poyanco, Ricardo Nilo/0000-0003-3041-7539	Becas Chile-Conicyt; NSF [DBI-0640769, IOS-1026003]; Direct For Biological Sciences [1026003] Funding Source: National Science Foundation	Becas Chile-Conicyt; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Osbourn, E. Sattely, and K. Dreher for comments. Supported by a Becas Chile-Conicyt postdoctoral fellowship (R.N.-P.) and by NSF grants DBI-0640769 and IOS-1026003. Data are available as supplementary data files S1 to S5. The enzyme annotation program is available for download at https://dpb.carnegiescience.edu/labs/rhee-lab/software.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Kliebenstein DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001838; Mishler BD, 2000, TAXON, V49, P661, DOI 10.2307/1223970; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Weng JK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00119; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Wink M., 2010, BIOCH PLANT SECONDAR, V2nd; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yonekura-Sakakibara K, 2009, NAT PROD REP, V26, P1466, DOI 10.1039/b817077k	16	171	176	7	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					510	513		10.1126/science.1252076	http://dx.doi.org/10.1126/science.1252076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786077				2022-12-28	WOS:000335157700041
J	Kirby, T				Kirby, Tony			Profile: Australia's Baker IDI Heart and Diabetes Institute	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1452	1452		10.1016/S0140-6736(14)60704-2	http://dx.doi.org/10.1016/S0140-6736(14)60704-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24779053				2022-12-28	WOS:000335325800012
J	Poulter, B; Frank, D; Ciais, P; Myneni, RB; Andela, N; Bi, J; Broquet, G; Canadell, JG; Chevallier, F; Liu, YY; Running, SW; Sitch, S; van der Werf, GR				Poulter, Benjamin; Frank, David; Ciais, Philippe; Myneni, Ranga B.; Andela, Niels; Bi, Jian; Broquet, Gregoire; Canadell, Josep G.; Chevallier, Frederic; Liu, Yi Y.; Running, Steven W.; Sitch, Stephen; van der Werf, Guido R.			Contribution of semi-arid ecosystems to interannual variability of the global carbon cycle	NATURE			English	Article							BIOMASS BURNING EMISSIONS; ATMOSPHERIC CO2 GROWTH; TERRESTRIAL CARBON; VEGETATION INDEX; DYNAMICS; COVER; AUSTRALIA; RESPONSES; LAND	The land and ocean act as a sink for fossil-fuel emissions, thereby slowing the rise of atmospheric carbon dioxide concentrations(1). Although the uptake of carbon by oceanic and terrestrial processes has kept pace with accelerating carbon dioxide emissions until now, atmospheric carbon dioxide concentrations exhibit a large variability on interannual timescales(2), considered to be driven primarily by terrestrial ecosystem processes dominated by tropical rainforests(3). We use a terrestrial biogeochemical model, atmospheric carbon dioxide inversion and global carbon budget accounting methods to investigate the evolution of the terrestrial carbon sink over the past 30 years, with a focus on the underlying mechanisms responsible for the exceptionally large land carbon sink reported in 2011 (ref. 2). Here we show that our three terrestrial carbon sink estimates are in good agreement and support the finding of a 2011 record land carbon sink. Surprisingly, we find that the global carbon sink anomaly was driven by growth of semi-arid vegetation in the Southern Hemisphere, with almost 60 per cent of carbon uptake attributed to Australian ecosystems, where prevalent La Nina conditions caused up to six consecutive seasons of increased precipitation. In addition, since 1981, a six per cent expansion of vegetation cover over Australia was associated with a fourfold increase in the sensitivity of continental net carbon uptake to precipitation. Our findings suggest that the higher turnover rates of carbon pools in semi-arid biomes are an increasingly important driver of global carbon cycle inter-annual variability and that tropical rainforests may become less relevant drivers in the future. More research is needed to identify to what extent the carbon stocks accumulated during wet years are vulnerable to rapid decomposition or loss through fire in subsequent years.	[Poulter, Benjamin] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Poulter, Benjamin] Dept Ecol, Bozeman, MT 59717 USA; [Poulter, Benjamin; Ciais, Philippe; Broquet, Gregoire; Chevallier, Frederic] CEA CNRS UVSQ, LSCE, F-91191 Gif Sur Yvette, France; [Frank, David] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Myneni, Ranga B.; Bi, Jian] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Andela, Niels; van der Werf, Guido R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Canadell, Josep G.] CSIRO, Global Carbon Project, Marine & Atmospher Res, Canberra, ACT 2601, Australia; [Liu, Yi Y.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Liu, Yi Y.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Running, Steven W.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Sitch, Stephen] Univ Exeter, Coll Engn Comp & Math, Exeter EX4 4QF, Devon, England	Montana State University System; Montana State University Bozeman; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Boston University; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; University of Montana System; University of Montana; University of Exeter	Poulter, B (corresponding author), Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA.	benjamin.poulter@montana.edu	Poulter, Ben/ABB-5886-2021; Sitch, Stephen A/F-8034-2015; Liu, Yi/H-9226-2013; Ciais, Philippe/A-6840-2011; Chevallier, Frederic JM/E-9608-2016; van der Werf, Guido/M-8260-2016; Liu, Yi/M-7169-2015; Myneni, Ranga B/F-5129-2012; Myneni, Ranga B./AAU-6088-2021; Canadell, Pep/E-9419-2010; Frank, David/C-7764-2013	Poulter, Ben/0000-0002-9493-8600; Sitch, Stephen A/0000-0003-1821-8561; Ciais, Philippe/0000-0001-8560-4943; Chevallier, Frederic JM/0000-0002-4327-3813; van der Werf, Guido/0000-0001-9042-8630; Liu, Yi/0000-0001-9059-8269; Myneni, Ranga B/0000-0002-0234-6393; Canadell, Pep/0000-0002-8788-3218; Frank, David/0000-0001-5463-5640; Broquet, Gregoire/0000-0001-7447-6907; Bi, Jian/0000-0002-0890-9839	EU FP7 GEOCARBON programme [283080]; Australian Climate Change Science Program; NASA Earth Science Division; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	EU FP7 GEOCARBON programme; Australian Climate Change Science Program; NASA Earth Science Division; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	We acknowledge support from the EU FP7 GEOCARBON programme (283080), and thank the researchers involved with collecting and maintaining the climate data at the Climate Research Unit, University of East Anglia, UK, and the National Center for Atmospheric Research, USA. We also acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP. We thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also thank M. Jung for providing the 'upscaled' NEE data used in our analysis. J.G.C. acknowledges the support of the Australian Climate Change Science Program. R. B. M. and S. W. R. were funded by the NASA Earth Science Division. C. Le Quere and L. Cernusak provide dcomments and suggestions that improved the manuscript. This paper is a contribution to the Global Carbon Budget activity of the Global Carbon Project.	Andela N, 2013, BIOGEOSCIENCES, V10, P6657, DOI 10.5194/bg-10-6657-2013; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Chevallier F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013887; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Donohue RJ, 2009, GLOBAL CHANGE BIOL, V15, P1025, DOI 10.1111/j.1365-2486.2008.01746.x; Francey RJ, 2013, NAT CLIM CHANGE, V3, P520, DOI [10.1038/nclimate1817, 10.1038/NCLIMATE1817]; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Haverd V, 2013, BIOGEOSCIENCES, V10, P2011, DOI 10.5194/bg-10-2011-2013; Haverd V, 2013, BIOGEOSCIENCES, V10, P851, DOI 10.5194/bg-10-851-2013; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Kang SM, 2013, GEOPHYS RES LETT, V40, P4054, DOI 10.1002/grl.50769; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Le Quere C., 2013, EARTH SYST SCI DATA, V5, P1107; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Poulter B, 2011, BIOGEOSCIENCES, V8, P2027, DOI 10.5194/bg-8-2027-2011; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Sitch S., 2013, BIOGEOSCI DISCUSS, V10, P20113, DOI [10.5194/bgd-10-20113-2013, DOI 10.5194/BGD-10-20113-2013]; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Van der Werf G. R., 2010, ATMOS CHEM PHYS DISC, V10, P16153, DOI DOI 10.5194/ACPD-10-16153-2010; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110; Wolter K, 1993, PROC 17 CLIMATE DIAG, V52; Woodward FI, 2008, PHILOS T R SOC B, V363, P2779, DOI 10.1098/rstb.2008.0017; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	40	818	843	44	696	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					600	+		10.1038/nature13376	http://dx.doi.org/10.1038/nature13376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847888	Green Accepted			2022-12-28	WOS:000336457100045
J	Ramogola-Masire, D; Russell, AH; Dryden-Peterson, S; Efstathiou, JA; Kayembe, MKA; Wilbur, DC				Ramogola-Masire, Doreen; Russell, Anthony H.; Dryden-Peterson, Scott; Efstathiou, Jason A.; Kayembe, Mukendi K. A.; Wilbur, David C.			Case 16-2014: A 46-Year-Old Woman in Botswana with Postcoital Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ANTIRETROVIRAL THERAPY; PARTICLE VACCINE; VAGINAL-CANCER; YOUNG-WOMEN; HIV; PREVENTION; HPV; VIRUS; CHEMORADIATION		[Ramogola-Masire, Doreen] Botswana UPenn Partnership, Philadelphia, PA 19104 USA; [Ramogola-Masire, Doreen] Botswana UPenn Partnership, Gaborone, Botswana; [Ramogola-Masire, Doreen] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Russell, Anthony H.; Efstathiou, Jason A.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Wilbur, David C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dryden-Peterson, Scott] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Russell, Anthony H.; Efstathiou, Jason A.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Dryden-Peterson, Scott] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wilbur, David C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kayembe, Mukendi K. A.] Univ Botswana, Dept Anat Pathol, Natl Hlth Lab, Gaborone, Botswana; [Kayembe, Mukendi K. A.] Univ Botswana, Dept Pathol, Gaborone, Botswana	University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Botswana; University of Botswana	Ramogola-Masire, D (corresponding author), Botswana UPenn Partnership, Philadelphia, PA 19104 USA.		Ramogola-Masire, Doreen/AAP-2754-2020	Ramogola-Masire, Doreen/0000-0001-9624-8366; Dryden-Peterson, Scott/0000-0002-8487-9731	Harvard University Center for AIDS Research [NIH 2P30 AI060354-06]; McCord Hospital (Durban); University of KwaZulu-Natal; South African HIV Clinicians Society; Department of Health, KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; McCord Hospital (Durban); University of KwaZulu-Natal; South African HIV Clinicians Society; Department of Health, KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sponsored by the Harvard University Center for AIDS Research (NIH 2P30 AI060354-06), McCord Hospital (Durban), the University of KwaZulu-Natal, the South African HIV Clinicians Society, and the Department of Health, KwaZulu-Natal.	Alfa-Wali M, 2012, ANN ONCOL, V23, P141, DOI 10.1093/annonc/mdr050; Antoniou T, 2005, CLIN PHARMACOKINET, V44, P111, DOI 10.2165/00003088-200544020-00001; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Brown DR, 2005, J INFECT DIS, V191, P182, DOI 10.1086/426867; Chabner BA, 2013, ONCOLOGIST, V18, P777, DOI 10.1634/theoncologist.2013-0218; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Dalrymple JL, 2004, INT J GYNECOL CANCER, V14, P110, DOI 10.1111/j.1048-891x.2004.014066.x; de Jongh FE, 2003, BRIT J CANCER, V88, P1199, DOI 10.1038/sj.bjc.6600884; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Dryden-Peterson S, 2012, 19 C RETR OPP INF SE; Dryden-Peterson S, 2013, 20 C RETR OPP INF AT; Efstathiou JA, INT J RAD O IN PRESS; Fraunholz I, 2011, RADIOTHER ONCOL, V98, P99, DOI 10.1016/j.radonc.2010.11.011; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Heard I, 2004, ANTIVIR THER, V9, P13; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Samant R, 2007, INT J RADIAT ONCOL, V69, P746, DOI 10.1016/j.ijrobp.2007.04.015; Seo Y, 2009, INT J RADIAT ONCOL, V75, P143, DOI 10.1016/j.ijrobp.2008.10.046; Shapley M, 2006, BRIT J GEN PRACT, V56, P453; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Torres HA, 2014, CLIN MICROBIOL INFEC; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	34	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					2032	2041		10.1056/NEJMcpc1400839	http://dx.doi.org/10.1056/NEJMcpc1400839			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24849087				2022-12-28	WOS:000336125500012
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Suicide Risk in Adolescents, Adults, and Older Adults in Primary Care: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							DELIBERATE SELF-HARM; IDEATION; BEHAVIOR; THERAPY; HEALTH; REDUCE; TRIAL	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for suicide risk. Methods: The USPSTF reviewed the evidence on the accuracy and reliability of instruments used to screen for increased suicide risk, benefits and harms of screening for increased suicide risk, and benefits and harms of treatments to prevent suicide. Population: This recommendation applies to adolescents, adults, and older adults in the general population who do not have an identified psychiatric disorder. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in adolescents, adults, and older adults in a primary care setting. (I statement)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Almeida OP, 2012, ANN FAM MED, V10, P347, DOI 10.1370/afm.1368; *AM MED ASS, 1997, GUID AD PREV SERV; American Academy of Family Physicians, 2014, CLIN REC SUIC SCREEN; American College of Obstetricians and Gynecologists, 2011, GUID AD HLTH CAR; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Centers for Disease Control and Prevention, 2014, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; Crawford MJ, 2011, BRIT J PSYCHIAT, V198, P379, DOI 10.1192/bjp.bp.110.083592; Donaldson D, 2005, J AM ACAD CHILD PSY, V44, P113, DOI 10.1097/00004583-200502000-00003; Feldman MD, 2007, ANN FAM MED, V5, P412, DOI 10.1370/afm.719; Fitzpatrick KK, 2005, BEHAV THER, V36, P323, DOI 10.1016/S0005-7894(05)80114-5; Gould MS, 2005, JAMA-J AM MED ASSOC, V293, P1635, DOI 10.1001/jama.293.13.1635; Greenfield B, 2002, PSYCHIATR SERV, V53, P1574, DOI 10.1176/appi.ps.53.12.1574; Hazell PL, 2009, J AM ACAD CHILD PSY, V48, P662, DOI [10.1097/CHI.0b013e3181aOacec, 10.1097/CHI.0b013e3181a0acec]; Heisel MJ, 2010, J AM BOARD FAM MED, V23, P260, DOI 10.3122/jabfm.2010.02.080163; Holi MM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-97; Kovac SH, 2002, SUICIDE LIFE-THREAT, V32, P428, DOI 10.1521/suli.32.4.428.22335; Lauterbach E, 2008, ACTA PSYCHIAT SCAND, V118, P469, DOI 10.1111/j.1600-0447.2008.01266.x; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McCarty CA, 2011, ACAD PEDIATR, V11, P422, DOI 10.1016/j.acap.2011.01.004; McNamee JE, 1994, CANADIAN TASK FORCE; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; O'Connor E, 2013, AHRQ PUBLICATION; Olfson M, 1996, J GEN INTERN MED, V11, P447, DOI 10.1007/BF02599038; Olfson M, 2014, JAMA-J AM MED ASSOC, V311, P1107, DOI 10.1001/jama.2014.501; Robinson J, 2012, EARLY INTERV PSYCHIA, V6, P145, DOI 10.1111/j.1751-7893.2011.00334.x; Robinson J, 2011, CRISIS, V32, P254, DOI 10.1027/0227-5910/a000087; Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550; Shaffer D, 2001, J AM ACAD CHILD PSY, V40, p24S, DOI 10.1097/00004583-200107001-00003; Shain BN, 2007, PEDIATRICS, V120, P669, DOI 10.1542/peds.2007-1908; Substance Abuse and Mental Health Services Administration, 2012, HHS PUBL, V(SMA) 12-4681; Thompson EA, 1999, J AM ACAD CHILD PSY, V38, P1506, DOI 10.1097/00004583-199912000-00011; Vannoy SD, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000198	35	99	100	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					719	+		10.7326/M14-0589	http://dx.doi.org/10.7326/M14-0589			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842417				2022-12-28	WOS:000337347100018
J	Long, TE				Long, Timothy E.			Toward Recyclable Thermosets	SCIENCE			English	Editorial Material							POLYMERS		Virginia Tech, Dept Chem, Macromol & Interfaces Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Long, TE (corresponding author), Virginia Tech, Dept Chem, Macromol & Interfaces Inst, Blacksburg, VA 24061 USA.	telong@vt.edu						Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Breneman CM, 2013, ADV FUNCT MATER, V23, P5746, DOI 10.1002/adfm.201301744; Bucknall DG, 2003, SCIENCE, V302, P1904, DOI 10.1126/science.1091064; Chen D, 2010, J MATER CHEM, V20, P3610, DOI 10.1039/b925163d; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Garcia JM, 2014, SCIENCE, V344, P732, DOI 10.1126/science.1251484; Hedrick JL, 1999, ADV POLYM SCI, V147, P61; Kaur G, 2014, POLYM CHEM-UK, V5, P2171, DOI 10.1039/c3py01234d; Kingsbury CM, 2011, J MATER CHEM, V21, P8381, DOI 10.1039/c0jm04015k; Kumpfer JR, 2012, MACROMOLECULES, V45, P473, DOI 10.1021/ma201659d; McGrath JE, 1999, ADV POLYM SCI, V140, P61; Sanders DE, 2013, POLYMER, V54, P4729, DOI 10.1016/j.polymer.2013.05.075; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601	13	44	44	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					706	707		10.1126/science.1254401	http://dx.doi.org/10.1126/science.1254401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833383				2022-12-28	WOS:000335912900028
J	Sheridan, RL; Shumaker, PR; King, DR; Wright, CD; Itani, KMF; Cancio, LC				Sheridan, Robert L.; Shumaker, Peter R.; King, David R.; Wright, Cameron D.; Itani, Kamal M. F.; Cancio, Leopoldo C.			Case 15-2014: A Man in the Military Who Was Injured by an Improvised Explosive Device in Afghanistan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEIVING MASSIVE TRANSFUSIONS; DAMAGE CONTROL RESUSCITATION; COMBAT; TRAUMA; SURVIVAL; BLOOD; MORTALITY; LANDSTUHL; PRODUCTS; SURGEONS		[Sheridan, Robert L.] Massachusetts Gen Hosp, Dept Surg, Div Burns, Boston, MA 02114 USA; [King, David R.] Massachusetts Gen Hosp, Dept Surg, Div Trauma Acute Care Surg & Surg Crit Care, Boston, MA 02114 USA; [Wright, Cameron D.] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Sheridan, Robert L.] Shriners Hosp Children, Surg Serv, Boston, MA USA; [Sheridan, Robert L.; King, David R.; Wright, Cameron D.; Itani, Kamal M. F.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Itani, Kamal M. F.] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA; [Sheridan, Robert L.; Itani, Kamal M. F.] Vet Affairs Boston Healthcare Syst, Dept Surg, West Roxbury, MA USA; [Shumaker, Peter R.] Naval Med Ctr San Diego, Dept Dermatol, San Diego, CA USA; [Cancio, Leopoldo C.] Army Inst Surg Res, Dept Surg, Ft Sam Houston, TX USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Sheridan, RL (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Burns, Boston, MA 02114 USA.			King, David/0000-0003-1028-1478				Anderson RR, 2014, JAMA DERMATOL, V150, P187, DOI 10.1001/jamadermatol.2013.7761; [Anonymous], 2012, VHA HDB, V1172.03; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Borgman M, J TRAUMA ACUTE CAR S, V73, pS509; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bush RL, 2009, J VASC SURG, V49, P226, DOI 10.1016/j.jvs.2008.09.015; Cancio LC, 2004, INT J DISASTER MED, V2, P114; Cannon JW, 2010, ANN SURG, V251, P566, DOI 10.1097/SLA.0b013e3181d12d3f; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Harvey Zach T, 2012, J Surg Orthop Adv, V21, P50; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Kang DG, 2012, SPINE J, V12, P849, DOI 10.1016/j.spinee.2011.11.014; Krueger CA, J TRAUMA ACUTE CAR S, V73, pS438; Lairet JR, 2012, J TRAUMA ACUTE CARE, V73, pS38, DOI 10.1097/TA.0b013e3182606022; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; Military Health System and Defense Health Agency, TACT COMB CAS CAR; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Ozog DM, 2013, JAMA DERMATOL, V149, P50, DOI 10.1001/2013.jamadermatol.668; Resnik L, 2012, J AM ACAD ORTHOP SUR, V20, pS31, DOI 10.5435/JAAOS-20-08-S31; Schoenfeld AJ, 2012, AM J SURG, V204, P377, DOI 10.1016/j.amjsurg.2011.09.028; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Shumaker PR, J TRAUMA ACUTE CAR S, V73, pS116; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Steele NM, 2010, NURS CLIN N AM, V45, P205, DOI 10.1016/j.cnur.2010.02.004; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Tenuta Joachim J, 2006, J Am Acad Orthop Surg, V14, pS45; United States Army Institute of Surgical Research, CLIN PRACT GUID; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833	30	8	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1931	1940		10.1056/NEJMcpc1310008	http://dx.doi.org/10.1056/NEJMcpc1310008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827038				2022-12-28	WOS:000336123600010
J	Channa, R; Kiely, A; Woreta, FA				Channa, Roomasa; Kiely, Amanda; Woreta, Fasika A.			Eye Mass	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURFACE SQUAMOUS NEOPLASIA; CONJUNCTIVAL; CORNEAL		[Channa, Roomasa; Kiely, Amanda; Woreta, Fasika A.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Channa, R (corresponding author), 600 N Wolfe St,Wilmer B-20, Baltimore, MD 21287 USA.	rchanna3@jhmi.edu	C, Roomasa/AAK-5176-2020					ERIE JC, 1986, OPHTHALMOLOGY, V93, P176; Holland EJ, 2013, OCULAR SURFACE DISEA; Nanji AA, 2013, CURR OPIN OPHTHALMOL, V24, P336, DOI 10.1097/ICU.0b013e3283622a13; Stone DU, 2005, CORNEA, V24, P297, DOI 10.1097/01.ico.0000138834.42489.ba; Tabin G, 1997, OPHTHALMOLOGY, V104, P485, DOI 10.1016/S0161-6420(97)30287-5	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1914	1915		10.1001/jama.2014.1894	http://dx.doi.org/10.1001/jama.2014.1894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825647				2022-12-28	WOS:000335798100024
J	Steinhoff, MC; MacDonald, N; Pfeifer, D; Muglia, LJ				Steinhoff, Mark C.; MacDonald, Noni; Pfeifer, Dina; Muglia, Louis J.			Influenza vaccine in pregnancy: policy and research strategies	LANCET			English	Editorial Material							NEONATAL OUTCOMES; PRETERM BIRTH; H1N1 INFLUENZA; IMMUNIZATION		[Steinhoff, Mark C.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Global Child Hlth Ctr, Cincinnati, OH 45229 USA; [MacDonald, Noni] Dalhousie Univ, IWK Hlth Ctr, Halifax, NS, Canada; [Pfeifer, Dina] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Muglia, Louis J.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Dalhousie University; World Health Organization; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Steinhoff, MC (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Global Child Hlth Ctr, Cincinnati, OH 45229 USA.	mark.steinhoff@cchmc.org			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Dodds L, 2012, J OBSTET GYNAECOL CA, V34, P714, DOI 10.1016/S1701-2163(16)35336-1; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Legge A, 2014, CAN MED ASSOC J, V186, pE157, DOI 10.1503/cmaj.130499; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Rasmussen SA, 2012, AM J OBSTET GYNECO S, V207, P3; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	14	27	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1611	1613		10.1016/S0140-6736(14)60583-3	http://dx.doi.org/10.1016/S0140-6736(14)60583-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24814446				2022-12-28	WOS:000335670800004
J	Agarwal, G; Stevenson, IH; Berenyi, A; Mizuseki, K; Buzsaki, G; Sommer, FT				Agarwal, Gautam; Stevenson, Ian H.; Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy; Sommer, Friedrich T.			Spatially Distributed Local Fields in the Hippocampus Encode Rat Position	SCIENCE			English	Article							PLACE CELLS; COMPONENT ANALYSIS; THETA-RHYTHM; EEG; RECONSTRUCTION; ENSEMBLE; ORIGIN; CORTEX; MEMORY	Although neuronal spikes can be readily detected from extracellular recordings, synaptic and subthreshold activity remains undifferentiated within the local field potential (LFP). In the hippocampus, neurons discharge selectively when the rat is at certain locations, while LFPs at single anatomical sites exhibit no such place-tuning. Nonetheless, because the representation of position is sparse and distributed, we hypothesized that spatial information can be recovered from multiple-site LFP recordings. Using high-density sampling of LFP and computational methods, we show that the spatiotemporal structure of the theta rhythm can encode position as robustly as neuronal spiking populations. Because our approach exploits the rhythmicity and sparse structure of neural activity, features found in many brain regions, it is useful as a general tool for discovering distributed LFP codes.	[Agarwal, Gautam; Stevenson, Ian H.; Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy] NYU, Sch Med, Ctr Neural Sci, Inst Neurosci, New York, NY 10016 USA; [Berenyi, Antal; Mizuseki, Kenji; Buzsaki, Gyoergy] Univ Szeged, Magyar Tudomanyos Akad Szegedi Tudomanyegyetem MT, Momentum Oscillatory Neuronal Networks Res Grp, Dept Physiol, H-6720 Szeged, Hungary	University of California System; University of California Berkeley; New York University; Szeged University	Buzsaki, G (corresponding author), NYU, Sch Med, Ctr Neural Sci, Inst Neurosci, New York, NY 10016 USA.	gyorgy.buzsaki@nyumc.org; fsommer@berkeley.edu	Berényi, Antal/A-9174-2013; Mizuseki, Kenji/A-9214-2011	Berényi, Antal/0000-0003-0084-8530; Mizuseki, Kenji/0000-0002-1456-2149; Stevenson, Ian/0000-0002-1428-5946; Buzsaki, Gyorgy/0000-0002-3100-4800; Agarwal, Gautam/0000-0001-7300-7586	NIH National Research Service Award [1F32MH093048]; NSF CIF-D-018 [0937060, 0855272, 1219212]; Marie Curie FP7-PEOPLE-2009-IOF grant [254780]; EU-FP7-ERC-2013-Starting grant [337075]; Lendulet program of the Hungarian Academy of Sciences; Japan Society for the Promotion of Science's Research Fellowship for Research Abroad; NIH [NS-034994, MH-54671, NS074015]; NSF SBE [0542013]; J. D. McDonnell Foundation; Division Of Computer and Network Systems [0855272] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH093048, R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS074015] Funding Source: NIH RePORTER	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CIF-D-018; Marie Curie FP7-PEOPLE-2009-IOF grant; EU-FP7-ERC-2013-Starting grant; Lendulet program of the Hungarian Academy of Sciences; Japan Society for the Promotion of Science's Research Fellowship for Research Abroad; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF SBE; J. D. McDonnell Foundation; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH National Research Service Award fellowship no. 1F32MH093048 (G.A.); NSF CIF-D-018 no. 0937060 (I. H. S.); Marie Curie FP7-PEOPLE-2009-IOF grant no. 254780, EU-FP7-ERC-2013-Starting grant no. 337075, and the Lendulet program of the Hungarian Academy of Sciences (A. B.); Japan Society for the Promotion of Science's Research Fellowship for Research Abroad (K. M.); NIH nos. NS-034994, MH-54671, and NS074015, NSF SBE no. 0542013, and the J. D. McDonnell Foundation (G. B.); NSF nos. 0855272 and 1219212 (F. S.). We thank D. Kaufman and J. Wolfe for advice on movies; C. Thanapirom for suggesting the Kuramoto model for rendering; K. D. Harris for suggestions about modeling; A. Khosrowshahi, J. Culpepper, C. Cadieu, and B. Olshausen for convolutional sparse coding; Walter Freeman for feedback; and members of the Buzsaki laboratory and the Redwood Center for discussions. All data collected from 32- to 64-electrode arrays is available in the hc-3 data set at crcns. org (26).	Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; de Cheveigne A, 2013, J NEUROPHYSIOL, V109, P261, DOI 10.1152/jn.00040.2012; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P393, DOI 10.1037/0735-7044.101.3.393; Freeman WJ, 2004, CLIN NEUROPHYSIOL, V115, P2077, DOI 10.1016/j.clinph.2004.02.029; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Hillar C., 2011, CAN DICT LEARNING UN; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; JOHN ER, 1972, SCIENCE, V177, P850, DOI 10.1126/science.177.4052.850; Khosrowshahi A., 2010, EXPLORING STAT STRUC; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Mizuseki K., 2013, Multiple single unit recordings from different rat hippocampal and entorhinal regions while the animals were performing multiple behavioral tasks; Novey Mike, 2006, Proceedings of the 2006 IEEE Signal Processing Society Workshop, P79, DOI 10.1109/MLSP.2006.275526; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	26	89	89	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					626	630		10.1126/science.1250444	http://dx.doi.org/10.1126/science.1250444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812401	Green Accepted			2022-12-28	WOS:000335537400042
J	Ding, QH; Wallace, JM; Battisti, DS; Steig, EJ; Gallant, AJE; Kim, HJ; Geng, L				Ding, Qinghua; Wallace, John M.; Battisti, David S.; Steig, Eric J.; Gallant, Ailie J. E.; Kim, Hyung-Jin; Geng, Lei			Tropical forcing of the recent rapid Arctic warming in northeastern Canada and Greenland	NATURE			English	Article							SEA-ICE; SURFACE-TEMPERATURE	Rapid Arctic warming and sea-ice reduction in the Arctic Ocean are widely attributed to anthropogenic climate change(1-3). The Arctic warming exceeds the global average warming because of feedbacks that include sea-ice reduction(4,5) and other dynamical and radiative feedbacks(6-13). We find that the most prominent annual mean surface and tropospheric warming in the Arctic since 1979 has occurred in northeastern Canada and Greenland. In this region, much of the year-to-year temperature variability is associated with the leading mode of large-scale circulation variability in the North Atlantic, namely, the North Atlantic Oscillation(14,15). Here we show that the recent warming in this region is strongly associated with a negative trend in the North Atlantic Oscillation, which is a response to anomalous Rossby wave-train activity originating in the tropical Pacific. Atmospheric model experiments forced by prescribed tropical sea surface temperatures simulate the observed circulation changes and associated tropospheric and surface warming over northeastern Canada and Greenland. Experiments from the Coupled Model Intercomparison Project Phase 5 (ref. 16) models with prescribed anthropogenic forcing show no similar circulation changes related to the North Atlantic Oscillation or associated tropospheric warming. This suggests that a substantial portion of recent warming in the northeastern Canada and Greenland sector of the Arctic arises from unforced natural variability.	[Ding, Qinghua; Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Ding, Qinghua; Steig, Eric J.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Wallace, John M.; Battisti, David S.; Geng, Lei] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Gallant, Ailie J. E.] Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; [Kim, Hyung-Jin] APEC Climate Ctr, Climate Res Dept, Pusan 612020, South Korea	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Monash University	Ding, QH (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	qinghua@uw.edu	Steig, Eric J/G-9088-2015; geng, lei/O-6804-2014; ding, qinghua/G-1186-2011; Battisti, David S/A-3340-2013; Geng, Lei/M-3418-2018	Steig, Eric J/0000-0002-8191-5549; Battisti, David S/0000-0003-4871-1293; Geng, Lei/0000-0003-2175-2538; Gallant, Ailie/0000-0002-7917-1069	US National Science Foundation [OPP 1043092, ATM 1122989]; University of Washington's Quaternary Research Center; National Basic Research Program of China (973 Program) [2013CB430203]; APEC Climate Center	US National Science Foundation(National Science Foundation (NSF)); University of Washington's Quaternary Research Center; National Basic Research Program of China (973 Program)(National Basic Research Program of China); APEC Climate Center	We thank the Max Planck Institute for Meteorology model developer for making ECHAM4.6 available and C. Bitz, Q. Fu, D. L. Hartmann, D. Frierson and W.-J. Li for discussion. This work was supported by the US National Science Foundation (OPP 1043092 and ATM 1122989). Q. D. acknowledges support from the University of Washington's Quaternary Research Center and the National Basic Research Program of China (973 Program-2013CB430203). H.-J.K. acknowledges support from the APEC Climate Center.	Abbot DS, 2009, J CLIMATE, V22, P5719, DOI 10.1175/2009JCLI2854.1; [Anonymous], 2006, EOS T AM GEOPHYS UN, DOI DOI 10.1029/2006EO460001; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bromwich DH, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007859; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Graf HF, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016493; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Guilyardi E, 2012, B AM METEOROL SOC, V93, P235, DOI 10.1175/BAMS-D-11-00106.1; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Lee S, 2012, J CLIMATE, V25, P4015, DOI 10.1175/JCLI-D-12-00055.1; PLUMB RA, 1985, J ATMOS SCI, V42, P217, DOI 10.1175/1520-0469(1985)042<0217:OTTDPO>2.0.CO;2; Polyakov IV, 2012, B AM METEOROL SOC, V93, P145, DOI 10.1175/BAMS-D-11-00070.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Roeckner E., 1996, ATMOSPHERIC GEN CIRC; Screen JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051598; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shindell D, 2009, NAT GEOSCI, V2, P294, DOI 10.1038/NGEO473; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; WILLMOTT CJ, 1995, J APPL METEOROL, V34, P2577, DOI 10.1175/1520-0450(1995)034<2577:SIOAAA>2.0.CO;2; Yoo C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049881	32	241	252	6	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					209	+		10.1038/nature13260	http://dx.doi.org/10.1038/nature13260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805345				2022-12-28	WOS:000335454300035
J	Lobell, DB; Roberts, MJ; Schlenker, W; Braun, N; Little, BB; Rejesus, RM; Hammer, GL				Lobell, David B.; Roberts, Michael J.; Schlenker, Wolfram; Braun, Noah; Little, Bertis B.; Rejesus, Roderick M.; Hammer, Graeme L.			Greater Sensitivity to Drought Accompanies Maize Yield Increase in the US Midwest	SCIENCE			English	Article							STRESS TOLERANCE; ENVIRONMENTS; SIMULATION; TRENDS; TRAIT; BELT; HEAT	A key question for climate change adaptation is whether existing cropping systems can become less sensitive to climate variations. We use a field-level data set on maize and soybean yields in the central United States for 1995 through 2012 to examine changes in drought sensitivity. Although yields have increased in absolute value under all levels of stress for both crops, the sensitivity of maize yields to drought stress associated with high vapor pressure deficits has increased. The greater sensitivity has occurred despite cultivar improvements and increased carbon dioxide and reflects the agronomic trend toward higher sowing densities. The results suggest that agronomic changes tend to translate improved drought tolerance of plants to higher average yields but not to decreasing drought sensitivity of yields at the field scale.	[Lobell, David B.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, David B.] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Roberts, Michael J.] Univ Hawaii Manoa, Dept Econ, Honolulu, HI 96822 USA; [Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Braun, Noah; Rejesus, Roderick M.] N Carolina State Univ, Dept Agr & Resource Econ, Raleigh, NC 27695 USA; [Little, Bertis B.] Tarleton State Univ, Dept Math, Off Provost, Stephenville, TX USA; [Little, Bertis B.] Tarleton State Univ, Div Acad Affairs, Stephenville, TX USA; [Hammer, Graeme L.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Stanford University; Stanford University; University of Hawaii System; University of Hawaii Manoa; Columbia University; University of North Carolina; North Carolina State University; Texas A&M University System; Tarleton State University; Texas A&M University System; Tarleton State University; University of Queensland	Lobell, DB (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	dlobell@stanford.edu	Hammer, Graeme L/A-3785-2008	Hammer, Graeme L/0000-0002-1180-7374; Braun, Noah/0000-0002-9710-0686; Lobell, David/0000-0002-5969-3476	NSF [SES-0962625]; National Oceanic and Atmospheric Administration [NA11OAR4310095]; USDA's Risk Management Agency; Australian Research Council [LP100100495]	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); USDA's Risk Management Agency; Australian Research Council(Australian Research Council)	We thank G. McLean for assistance with APSIM simulations and acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison, and the Working Group on Coupled Modelling of the World Climate Research Programme (WCRP) for their roles in making available the WCRP CMIP5 multimodel data set. This work was supported by NSF grant SES-0962625 and National Oceanic and Atmospheric Administration grant NA11OAR4310095. B.B.L. was supported by a Research Services Agreement from USDA's Risk Management Agency, and G.L.H. by grant LP100100495 from the Australian Research Council. Data used in this study are available as supplementary materials on Science Online.	Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Chenu K, 2013, NEW PHYTOL, V198, P801, DOI 10.1111/nph.12192; Connor D.J., 2011, CROP ECOLOGY PRODUCT; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Fonseca AE, 2005, FIELD CROP RES, V94, P114, DOI 10.1016/j.fcr.2004.12.001; Food and Agriculture Organization of the United Nations (FAO), 2013, FAO STATISTICAL DATA; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Lyon DJ, 2003, AGRON J, V95, P884, DOI 10.2134/agronj2003.0884; McGrath JM, 2011, GLOBAL CHANGE BIOL, V17, P2689, DOI 10.1111/j.1365-2486.2011.02406.x; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; National Agriculture Statistics Service, 2007, CORN OBJECTIVE YIELD; National Agriculture Statistics Service, 2013, 2013 ILLINOIS ANNUAL; National Agriculture Statistics Service, 2007, SOYBEAN OBJECTIVE YI; National Research Council (NRC), 2010, THE IMPACT OF GENETI; Ray JD, 2002, PLANT SOIL, V239, P113, DOI 10.1023/A:1014947422468; Roberts M. J., 2011, THE ECONOMICS OF CLI, P225; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Woli P, 2012, AGRON J, V104, P287, DOI 10.2134/agronj2011.0286	26	601	629	22	468	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					516	519		10.1126/science.1251423	http://dx.doi.org/10.1126/science.1251423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786079				2022-12-28	WOS:000335157700043
J	Yuan, J				Yuan, Jun			APPLIED PHYSICS Bright electron twisters	NATURE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM; VORTEX BEAMS		Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England	University of York - UK	Yuan, J (corresponding author), Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England.	jun.yuan@york.ac.uk	Yuan, Jun/J-2577-2012	Yuan, Jun/0000-0001-5833-4570	EPSRC [EP/J022098/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J022098/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bliokh KY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190404; Clark L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.064801; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Gnanavel T., 2012, P EUR MICR C; Grillo V, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863564; Idrobo JC, 2011, J ELECTRON MICROSC, V60, P295, DOI 10.1093/jmicro/dfr069; Lloyd SM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.254801; McMorran BJ, 2011, SCIENCE, V331, P192, DOI 10.1126/science.1198804; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366	12	4	4	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					37	38		10.1038/509037a	http://dx.doi.org/10.1038/509037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784210				2022-12-28	WOS:000335199100032
J	He, HH; Kise, Y; Izadifar, A; Urwyler, O; Ayaz, D; Parthasarthy, A; Yan, B; Erfurth, ML; Dascenco, D; Schmucker, D				He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Parthasarthy, Akhila; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar			Cell-intrinsic requirement of Dscam1 isoform diversity for axon collateral formation	SCIENCE			English	Article							DENDRITIC SELF-AVOIDANCE; MOLECULAR DIVERSITY; DROSOPHILA-DSCAM; RECOGNITION; PROTOCADHERINS; ORGANIZATION; SPECIFICITY; ADHESION; GUIDANCE	The isoform diversity of the Drosophila Dscam1 receptor is important for neuronal self-recognition and self-avoidance. A canonical model suggests that homophilic binding of identical Dscam1 receptor isoforms on sister dendrites ensures self-avoidance even when only a single isoform is expressed. We detected a cell-intrinsic function of Dscam1 that requires the coexpression of multiple isoforms. Manipulation of the Dscam1 isoform pool in single neurons caused severe disruption of collateral formation of mechanosensory axons. Changes in isoform abundance led to dominant dosage-sensitive inhibition of branching. We propose that the ratio of matching to nonmatching isoforms within a cell influences the Dscam1-mediated signaling strength, which in turn controls axon growth and growth cone sprouting. Cell-intrinsic use of surface receptor diversity may be of general importance in regulating axonal branching during brain wiring.	[He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar] Vlaams Inst Biotechnol VIB Vesalius Res Ctr, Neuronal Wiring Lab, B-3000 Louvain, Belgium; [He, Haihuai; Kise, Yoshiaki; Izadifar, Azadeh; Urwyler, Olivier; Ayaz, Derya; Yan, Bing; Erfurth, Maria-Luise; Dascenco, Dan; Schmucker, Dietmar] Univ Louvain, Sch Med, Dept Oncol, B-3000 Louvain, Belgium; [He, Haihuai; Parthasarthy, Akhila] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Erfurth, Maria-Luise] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	Flanders Institute for Biotechnology (VIB); Harvard University; Dana-Farber Cancer Institute; University of Kiel	Schmucker, D (corresponding author), Vlaams Inst Biotechnol VIB Vesalius Res Ctr, Neuronal Wiring Lab, B-3000 Louvain, Belgium.	schmucker@vib-kuleuven.be		Urwyler, Olivier/0000-0001-8334-8667; Dascenco, Dan/0000-0002-4629-8266	NIH [2RO1NS046747-05A1]; Fonds Wetenschappelijk Onderzoek (FWO) [G059611N, G078913N, G077013N]; BELSPO IUAP VII-20 "WIBRAIN project"; VIB; JSPS postdoctoral fellowship; Human Frontier Science Program long-term fellowship; FWO Ph.D. fellowship; Swiss National Science Foundation postdoctoral fellowship; Boehringer Ingelheim Fonds Ph.D. fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); BELSPO IUAP VII-20 "WIBRAIN project"; VIB; JSPS postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); FWO Ph.D. fellowship; Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Boehringer Ingelheim Fonds Ph.D. fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant 2RO1NS046747-05A1 (D. S.); Fonds Wetenschappelijk Onderzoek (FWO) grants G059611N, G078913N, and G077013N (D. S.); BELSPO IUAP VII-20 "WIBRAIN project" (D. S.); VIB funding; a JSPS postdoctoral fellowship and a Human Frontier Science Program long-term fellowship (Y.K.); an FWO Ph.D. fellowship (D. D.); a Swiss National Science Foundation postdoctoral fellowship (O.U.); and a Boehringer Ingelheim Fonds Ph.D. fellowship (M.-L. E.). We thank members of the lab and especially B. Hassan (VIB, Center for the Biology of Disease) for critical reading of the manuscript, discussions, and insightful comments.	Celotto AM, 2001, GENETICS, V159, P599; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kise Y, 2013, CURR OPIN NEUROBIOL, V23, P983, DOI 10.1016/j.conb.2013.09.011; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2007, NAT REV NEUROSCI, V8, P915, DOI 10.1038/nrn2256; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu W, 2012, NEURON, V74, P261, DOI 10.1016/j.neuron.2012.02.029; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	20	45	45	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1182	1186		10.1126/science.1251852	http://dx.doi.org/10.1126/science.1251852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24831526				2022-12-28	WOS:000336791200053
J	Marec, F				Marec, Frantisek			Female silkworms have the sex factor	NATURE			English	Editorial Material							BOMBYX-MORI; CHROMOSOME		Biol Ctr ASCR, Inst Entomol, Ceske Budejovice 37005, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Marec, F (corresponding author), Biol Ctr ASCR, Inst Entomol, Ceske Budejovice 37005, Czech Republic.	marec@entu.cas.cz	Marec, Frantisek/G-7943-2014	Marec, Frantisek/0000-0002-6745-5603				Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; HASIMOTO HARUO, 1933, JAP JOUR GENETICS, V8, P245; Kageyama D, 2004, P ROY SOC B-BIOL SCI, V271, P251, DOI 10.1098/rspb.2003.2604; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Suzuki MG, 2010, J GENET, V89, P357, DOI 10.1007/s12041-010-0047-5; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Tazima Y, 1964, GENETICS SILKWORM; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Walters JR, 2011, GENOME BIOL EVOL, V3, P491, DOI 10.1093/gbe/evr036	10	2	2	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					570	571		10.1038/nature13336	http://dx.doi.org/10.1038/nature13336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24828037				2022-12-28	WOS:000336457100035
J	Amos, CB; Audet, P; Hammond, WC; Burgmann, R; Johanson, IA; Blewitt, G				Amos, Colin B.; Audet, Pascal; Hammond, William C.; Buergmann, Roland; Johanson, Ingrid A.; Blewitt, Geoffrey			Uplift and seismicity driven by groundwater depletion in central California	NATURE			English	Article							SIERRA-NEVADA; SEASONAL-VARIATION; ROCK UPLIFT; GPS; SUBSIDENCE; PARKFIELD; STRAIN; REGION; MODEL; FAULT	Groundwater use in California's San Joaquin Valley exceeds replenishment of the aquifer, leading to substantial diminution of this resource(1-4) and rapid subsidence of the valley floor(5). The volume of groundwater lost over the past century and a half also represents a substantial reduction in mass and a large-scale unburdening of the lithosphere, with significant but unexplored potential impacts on crustal deformation and seismicity. Here we use vertical global positioning system measurements to show that a broad zone of rock uplift of up to 1-3 mm per year surrounds the southern San Joaquin Valley. The observed uplift matches well with predicted flexure from a simple elastic model of current rates of water-storage loss, most of which is caused by groundwater depletion(3). The height of the adjacent central Coast Ranges and the Sierra Nevada is strongly seasonal and peaks during the dry late summer and autumn, out of phase with uplift of the valley floor during wetter months. Our results suggest that long-term and late-summer flexural uplift of the Coast Ranges reduce the effective normal stress resolved on the San Andreas Fault. This process brings the fault closer to failure, thereby providing a viable mechanism for observed seasonality in microseismicity at Parkfield(6) and potentially affecting long-term seismicity rates for fault systems adjacent to the valley. We also infer that the observed contemporary uplift of the southern Sierra Nevada previously attributed to tectonic or mantle-derived forces(7-10) is partly a consequence of human-caused groundwater depletion.	[Amos, Colin B.] Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA; [Audet, Pascal] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Hammond, William C.; Blewitt, Geoffrey] Univ Nevada, Nevada Geodet Lab, Nevada Bur Mines & Geol, Reno, NV 89557 USA; [Hammond, William C.; Blewitt, Geoffrey] Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA; [Buergmann, Roland; Johanson, Ingrid A.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Western Washington University; University of Ottawa; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Amos, CB (corresponding author), Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA.	colin.amos@wwu.edu	Amos, Colin/B-2397-2008; Burgmann, Roland/AAE-5138-2022	Amos, Colin/0000-0002-3862-9344; Audet, Pascal/0000-0003-2364-9454; Burgmann, Roland/0000-0002-3560-044X; Johanson, Ingrid/0000-0002-6049-2225	NSF Earth Scope award [EAR-1252210]; Directorate For Geosciences [1252210] Funding Source: National Science Foundation; Division Of Earth Sciences [0951430] Funding Source: National Science Foundation	NSF Earth Scope award(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this work comes from NSF Earth Scope award number EAR-1252210 to G. B. and W. C. H. GPS data were collected using the EarthScope Plate Boundary Observatory, SCIGN, BARGEN, BARD, CORS and IGS networks. We are particularly grateful to UNAVCO for operating the vast majority of GPS stations used in this project. GPS data were processed using the GIPSY OASIS II software and data products from the Jet Propulsion Laboratory.	Altamimi Z, 2011, J GEODESY, V85, P457, DOI 10.1007/s00190-011-0444-4; Argus DF, 2014, GEOPHYS RES LETT, V41, P1971, DOI 10.1002/2014GL059570; Bar-Sever YE, 1998, J GEOPHYS RES-SOL EA, V103, P5019, DOI 10.1029/97JB03534; Ben-Zion Y, 2013, EARTH PLANET SC LETT, V379, P120, DOI 10.1016/j.epsl.2013.08.024; Bennett RA, 2009, EARTH PLANET SC LETT, V287, P255, DOI 10.1016/j.epsl.2009.08.011; Bertiger W, 2010, J GEODESY, V84, P327, DOI 10.1007/s00190-010-0371-9; Bettinelli P, 2008, EARTH PLANET SC LETT, V266, P332, DOI 10.1016/j.epsl.2007.11.021; BLEWITT G, 1989, J GEOPHYS RES-SOLID, V94, P10187, DOI 10.1029/JB094iB08p10187; Blewitt G, 2013, J GEODYN, V72, P11, DOI 10.1016/j.jog.2013.08.004; Boehm J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025546; California Department of Water Resources, 2005, DEP WAT RES B, V1, P160; CHRISTENSEN MN, 1966, GEOL SOC AM BULL, V77, P163, DOI 10.1130/0016-7606(1966)77[163:LCCMIT]2.0.CO;2; Christiansen LB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028634; DETTINGER MD, 1995, J CLIMATE, V8, P606, DOI 10.1175/1520-0442(1995)008<0606:LSAFOR>2.0.CO;2; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Faunt C.C., 2009, GROUNDWATER AVAILABI, P225; Fay NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034949; Fu YN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008925; Gonzalez PJ, 2012, NAT GEOSCI, V5, P821, DOI [10.1038/ngeo1610, 10.1038/NGEO1610]; Hammond WC, 2012, GEOLOGY, V40, P667, DOI 10.1130/G32968.1; Harris RA, 1998, J GEOPHYS RES-SOL EA, V103, P24347, DOI 10.1029/98JB01576; Heki K, 2003, EARTH PLANET SC LETT, V207, P159, DOI 10.1016/S0012-821X(02)01148-2; HOLZER TL, 1979, J GEOPHYS RES, V84, P4689, DOI 10.1029/JB084iB09p04689; Jeager J.C., 2007, FUNDAMENTALS ROCK ME; Jiang Y, 2010, NAT GEOSCI, V3, P404, DOI 10.1038/NGEO845; Le Pourhiet L, 2013, GEOLOGY, V41, P999, DOI 10.1130/G34244.1; Luttrell K, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004752; Nof RN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008961; Poland JF, 1975, 437H US GEOL SURV, P78; Rebischung P, 2012, GPS SOLUT, V16, P483, DOI 10.1007/s10291-011-0248-2; Saleeby J, 2013, GEOSPHERE, V9, P394, DOI 10.1130/GES00816.1; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; SCHERNECK HG, 1991, GEOPHYS J INT, V106, P677, DOI 10.1111/j.1365-246X.1991.tb06339.x; Schmidt DA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002267; SMALL EE, 1995, SCIENCE, V270, P277, DOI 10.1126/science.270.5234.277; STEIN RS, 1992, J GEOPHYS RES-SOL EA, V97, P4865, DOI 10.1029/91JB02847; Toda S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000172; van Dam T, 2001, GEOPHYS RES LETT, V28, P651, DOI 10.1029/2000GL012120; Williamson A, 1989, 1401D US GEOL SURV, DOI 10.3133/pp1401D; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	40	155	156	10	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					483	+		10.1038/nature13275	http://dx.doi.org/10.1038/nature13275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828048				2022-12-28	WOS:000336126000037
J	Khazeni, N; Hutton, DW; Collins, CIF; Garber, AM; Owens, DK				Khazeni, Nayer; Hutton, David W.; Collins, Cassandra I. F.; Garber, Alan M.; Owens, Douglas K.			Health and Economic Benefits of Early Vaccination and Nonpharmaceutical Interventions for a Human Influenza A (H7N9) Pandemic	ANNALS OF INTERNAL MEDICINE			English	Article							COST-EFFECTIVENESS; AVIAN INFLUENZA; H1N1 VIRUS; HAND HYGIENE; TRANSMISSION; INFECTION; ILLNESS; H5N1; RECOMMENDATIONS; HOUSEHOLDS	Background: Vaccination for the 2009 pandemic did not occur until late in the outbreak, which limited its benefits. Influenza A (H7N9) is causing increasing morbidity and mortality in China, and researchers have modified the A (H5N1) virus to transmit via aerosol, which again heightens concerns about pandemic influenza preparedness. Objective: To determine how quickly vaccination should be completed to reduce infections, deaths, and health care costs in a pandemic with characteristics similar to influenza A (H7N9) and A (H5N1). Design: Dynamic transmission model to estimate health and economic consequences of a severe influenza pandemic in a large metropolitan city. Data Sources: Literature and expert opinion. Target Population: Residents of a U. S. metropolitan city with characteristics similar to New York City. Time Horizon: Lifetime. Perspective: Societal. Intervention: Vaccination of 30% of the population at 4 or 6 months. Outcome Measures: Infections and deaths averted and cost-effectiveness. Results of Base-Case Analysis: In 12 months, 48 254 persons would die. Vaccinating at 9 months would avert 2365 of these deaths. Vaccinating at 6 months would save 5775 additional lives and $51 million at a city level. Accelerating delivery to 4 months would save an additional 5633 lives and $50 million. Results of Sensitivity Analysis: If vaccination were delayed for 9 months, reducing contacts by 8% through nonpharmaceutical interventions would yield a similar reduction in infections and deaths as vaccination at 4 months. Limitation: The model is not designed to evaluate programs targeting specific populations, such as children or persons with comorbid conditions. Conclusion: Vaccination in an influenza A (H7N9) pandemic would need to be completed much faster than in 2009 to substantially reduce morbidity, mortality, and health care costs. Maximizing nonpharmaceutical interventions can substantially mitigate the pandemic until a matched vaccine becomes available.	Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, Stanford, CA USA; Univ Michigan, Ann Arbor, MI 48109 USA; Harvard Univ, Cambridge, MA 02138 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; University of Michigan System; University of Michigan; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khazeni, N (corresponding author), Stanford Univ, Div Pulm & Crit Care Med, Med Ctr, 300 Pasteur Dr,Room H3143, Stanford, CA 94305 USA.	nayer@stanford.edu			Agency for Healthcare Research and Quality [5 K08 HS 019816]; National Institutes of Health [5 R01 DA015612-12]; Veterans Affairs Palo Alto Health Care System; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Palo Alto Health Care System(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	In part by Agency for Healthcare Research and Quality (grant 5 K08 HS 019816; Dr. Khazeni), National Institutes of Health (grant 5 R01 DA015612-12; Dr. Owens), and Veterans Affairs Palo Alto Health Care System (Dr. Owens).	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Centers for Disease Control and Prevention, SEAS INFL FLU BAS; Centers for Disease Control and Prevention, SES INFL SEL VIR; Centers for Disease Control and Prevention, VACC CHILD VFC CDC V; Centers for Disease Control and Prevention, SEAS INFL FLU KEY CF; Centers for Disease Control and Prevention, 2009, 2009 H1N1 VACC DOS; Centers for Disease Control and Prevention, SEAS INFL CLEL DF; Centers for Disease Control and Prevention, 2009, CDC EST 2009 H1N1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Centers for Medicare Medicaid Services, NAT HLTH EXP DAT; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Choo AY, 2010, IDRUGS, V13, P707; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; European Medicines Agency, 2011, ASS ERP APNA; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fielding JE, 2011, MODERATE INFLUENC, P17; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GlaxoSmithKline Canada, AR H1N1; Glezen WP, 2011, LANCET, V377, P698, DOI 10.1016/S0140-6736(11)60174-8; Green C, 2000, PHARMACOECONOMICS, V17, P151, DOI 10.2165/00019053-200017020-00004; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jegerlehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078947; Ke YH, 2013, ANN INTERN MED, V159, P159, DOI [10.7326/0003-4819-159-2-201307160-00669, 10.7326/0003-4819-159-2-201307160-00022]; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MENDELL JR, 2001, DIAGNOSIS MANAGEMENT; MetLife, 2012 METLIFE MARK SU; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Neustadt RE, 2008, SEWINE FLUAFF; New York City Department of Health and Mental Hygiene, 2009, HLTH A L; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Orwin R.G., 1994, HDB RES SYNTHESIS; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rambhia KJ, 2010, BIOSECUR BIOTERROR, V8, P321, DOI 10.1089/bsp.2010.0043; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Schnirring L, 2012, DEB H5N1 DEATH RAT; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2005, ARCH VIROL, P101; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thorpe LE, 2004, EMERG INFECT DIS, V10, P917; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U.S. Census Bureau, 2012, STAT ABSTR US; U.S. Census Bureau, STQAT OCUNT QUICKF; U.S. Department of Commerce Bureau of Economic Analysis, NAT DAT NAT INC PROD; U.S. Department of Health and Human Services, HLTH HUM SERV PAND; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; *WHO, 2005, WHO GLOB INF PREP PL; World Health Organization, 2009, PAND INFL VACC MAN; World Health Organization, CUM NUMB CONF HUM F; World Health Organization, 2009, GLOB AL REPS GAR	71	13	13	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					684	+		10.7326/M13-2071	http://dx.doi.org/10.7326/M13-2071			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842415	Green Accepted			2022-12-28	WOS:000337347100015
J	Jonas, DE; Amick, HR; Feltner, C; Bobashev, G; Thomas, K; Wines, R; Kim, MM; Shanahan, E; Gass, CE; Rowe, CJ; Garbutt, JC				Jonas, Daniel E.; Amick, Halle R.; Feltner, Cynthia; Bobashev, Georgiy; Thomas, Kathleen; Wines, Roberta; Kim, Mimi M.; Shanahan, Ellen; Gass, C. Elizabeth; Rowe, Cassandra J.; Garbutt, James C.			Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; COPING SKILLS THERAPY; QUALITY-OF-LIFE; DOUBLE-BLIND; PRIMARY-CARE; UNITED-STATES; RELAPSE PREVENTION; BEHAVIORAL-THERAPY; SUBSTANCE USE	IMPORTANCE Alcohol use disorders cause substantial morbidity and early mortality yet remain greatly undertreated. Medications are considerably underused. OBJECTIVE To conduct a systematic review and meta-analysis of the benefits and harms of medications (US FDA-approved and others) for adults with alcohol use disorders. DATA SOURCES PubMed, Cochrane Library, PsycINFO, CINAHL, EMBASE, FDA website, and clinical trials registries (January 1, 1970, to March 1, 2014). STUDY SELECTION Two reviewers selected randomized clinical trials (RCTs) with at least 12 weeks' duration that reported eligible outcomes and head-to-head prospective cohort studies reporting health outcomes or harms. DATA EXTRACTION AND SYNTHESIS We conducted meta-analyses using random-effects models and calculated numbers needed to treat for benefit (NNTs) or harm (NNHs). MAIN OUTCOMES AND MEASURES Alcohol consumption, motor vehicle crashes, injuries, quality of life, function, mortality, and harms. RESULTS We included 122 RCTs and 1 cohort study (total 22 803 participants). Most assessed acamprosate (27 studies, n = 7519), naltrexone (53 studies, n = 9140), or both. The NNT to prevent return to any drinking for acamprosate was 12 (95% CI, 8 to 26; risk difference [RD], -0.09; 95% CI, -0.14 to -0.04) and was 20 (95% CI, 11 to 500; RD, -0.05; 95% CI, -0.10 to -0.002) for oral naltrexone (50 mg/d). The NNT to prevent return to heavy drinking was 12 (95% CI, 8 to 26; RD -0.09; 95% CI, -0.13 to -0.04) for oral naltrexone (50 mg/d). Meta-analyses of trials comparing acamprosate to naltrexone found no statistically significant difference between them for return to any drinking (RD, 0.02; 95% CI, -0.03 to 0.08) or heavy drinking (RD, 0.01; 95% CI, -0.05 to 0.06). For injectable naltrexone, meta-analyses found no association with return to any drinking (RD, -0.04; 95% CI, -0.10 to 0.03) or heavy drinking (RD, -0.01; 95% CI, -0.14 to 0.13) but found an association with reduction in heavy drinking days (weighted mean difference [WMD], -4.6%; 95% CI, -8.5% to -0.56%). Among medications used off-label, moderate evidence supports an association with improvement in some consumption outcomes for nalmefene (heavy drinking days per month: WMD, -2.0; 95% CI, -3.0 to -1.0; drinks per drinking day: WMD, -1.02; 95% CI, -1.77 to -0.28) and topiramate (% heavy drinking days: WMD, -9.0%; 95% CI, -15.3% to -2.7%; drinks per drinking day: WMD, -1.0; 95% CI, -1.6 to -0.48). For naltrexone and nalmefene, NNHs for withdrawal from trials due to adverse events were 48 (95% CI, 30 to 112) and 12 (95% CI, 7 to 50), respectively; risk was not significantly increased for acamprosate or topiramate. CONCLUSIONS AND RELEVANCE Both acamprosate and oral naltrexone were associated with reduction in return to drinking. When directly compared with one another, no significant differences were found between acamprosate and naltrexone for controlling alcohol consumption. Factors such as dosing frequency, potential adverse events, and availability of treatments may guide medication choice.	[Jonas, Daniel E.; Feltner, Cynthia; Gass, C. Elizabeth] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Jonas, Daniel E.; Amick, Halle R.; Feltner, Cynthia; Thomas, Kathleen; Wines, Roberta; Shanahan, Ellen] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Bobashev, Georgiy] Res Triangle Inst Int, Res Triangle Pk, NC USA; [Kim, Mimi M.] Univ N Carolina, North Carolina Translat & Clin Sci Inst, Chapel Hill, NC 27599 USA; [Kim, Mimi M.] Duke Univ, Ctr Biobehav Hlth Dispar Res, Durham, NC USA; [Rowe, Cassandra J.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Garbutt, James C.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Garbutt, James C.] Univ N Carolina, Bowles Ctr Alcohol Studies, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jonas, DE (corresponding author), Univ N Carolina, Dept Med, 5034 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.	daniel_jonas@med.unc.edu			Agency for Healthcare Research and Quality (AHRQ), US Dept of Health and Human Services [HHSA290201200008I_HHSA29032002T]	Agency for Healthcare Research and Quality (AHRQ), US Dept of Health and Human Services	This project was funded by the Agency for Healthcare Research and Quality (AHRQ), US Dept of Health and Human Services (contract HHSA290201200008I_HHSA29032002T).	Agency for Healthcare Research and Quality, METH GUID EFF COMP E; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2011, ALK21O14; [Anonymous], 2009, REV NALTR HYDR; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Anton RF, 2005, J CLIN PSYCHOPHARM, V25, P349, DOI 10.1097/01.jcp.0000172071.81258.04; Anton RF, 2004, J CLIN PSYCHOPHARM, V24, P421, DOI 10.1097/01.jcp.0000130555.63254.73; Anton RF, 1999, AM J PSYCHIAT, V156, P1758; Balldin J, 2003, ALCOHOL CLIN EXP RES, V27, P1142, DOI 10.1097/01.ALC.0000075548.83053.A9; Baltieri DA, 2004, J STUD ALCOHOL, V65, P136, DOI 10.15288/jsa.2004.65.136; Barrias J, 1997, PSIQUIATRIA CLIN, V18, P149; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berger L, 2013, ALCOHOL CLIN EXP RES, V37, P668, DOI 10.1111/acer.12010; Besson J, 1998, ALCOHOL CLIN EXP RES, V22, P573, DOI 10.1111/j.1530-0277.1998.tb04295.x; Bondy SJ, 1999, CAN J PUBLIC HEALTH, V90, P264, DOI 10.1007/BF03404129; Brady KT, 2002, DRUG ALCOHOL DEPEN, V67, P323, DOI 10.1016/S0376-8716(02)00105-9; Castro Luís André, 2009, J. bras. psiquiatr., V58, P79; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Cherpitel CJ, 2008, J STUD ALCOHOL DRUGS, V69, P535, DOI 10.15288/jsad.2008.69.535; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P587, DOI 10.1093/alcalc/35.6.587; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P176, DOI 10.1093/alcalc/35.2.176; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; FULLER RK, 1979, ANN INTERN MED, V90, P901, DOI 10.7326/0003-4819-90-6-901; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Gastpar M, 2002, J CLIN PSYCHOPHARM, V22, P592, DOI 10.1097/00004714-200212000-00009; Geerlings P, 1995, T ALC DRUGS, V21, P129; Geerlings PJ, 1997, EUR ADDICT RES, V3, P129, DOI 10.1159/000259166; Gual A, 2001, ALCOHOL ALCOHOLISM, V36, P413, DOI 10.1093/alcalc/36.5.413; Gual A, 2013, EUR NEUROPSYCHOPHARM, V23, P1432, DOI 10.1016/j.euroneuro.2013.02.006; Guardia J, 2002, ALCOHOL CLIN EXP RES, V26, P1381, DOI 10.1097/01.ALC.0000030561.15921.A9; Harris AHS, 2012, PSYCHIAT SERV, V63, P679, DOI 10.1176/appi.ps.201000553; Harris AHS, 2010, PSYCHIAT SERV, V61, P392, DOI 10.1176/ps.2010.61.4.392; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; [黄雄 Huang Xiong], 2002, [中国心理卫生杂志, Chinese Mental Health Journal], V16, P302; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jonas DE, 2014, AHRQ PUBLICATION, V14-EHC029-EF; Jonas DE, AHRQ PUBLICATION, V12-EHC055-EF; Kampman KM, 2013, DRUG ALCOHOL DEPEN, V133, P94, DOI 10.1016/j.drugalcdep.2013.05.026; Karhuvaara S, 2007, ALCOHOL CLIN EXP RES, V31, P1179, DOI 10.1111/j.1530-0277.2007.00401.x; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Kiefer F, 2003, SUCHT, V49, P342; Killeen TK, 2004, ALCOHOL CLIN EXP RES, V28, P1710, DOI 10.1097/01.ALC.0000145688.30448.2C; Kiritze-Topor P, 2004, ALCOHOL ALCOHOLISM, V39, P520, DOI 10.1093/alcalc/agh088; Kissin B, 1968, Psychiatr Res Rep Am Psychiatr Assoc, V24, P44; Kranzler HR, 2004, ALCOHOL CLIN EXP RES, V28, P1051, DOI 10.1097/01.ALC.0000130804.08397.29; Kranzler HR, 2003, J CLIN PSYCHOPHARM, V23, P294, DOI 10.1097/00004714-200306000-00010; Krupitskii E. M., 1994, Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova, V94, P57; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Ladewig D, 1993, Ther Umsch, V50, P182; Latt NC, 2002, MED J AUSTRALIA, V176, P530, DOI 10.5694/j.1326-5377.2002.tb04550.x; LoCastro JS, 2009, J STUD ALCOHOL DRUGS, V70, P186, DOI 10.15288/jsad.2009.70.186; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mann K, 2005, ADDICTION, V100, P797, DOI 10.1111/j.1360-0443.2005.01065.x; Mann K, 2013, ADDICT BIOL, V18, P937, DOI 10.1111/adb.12012; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; Mason BJ, 2006, J PSYCHIATR RES, V40, P383, DOI 10.1016/j.jpsychires.2006.02.002; Mason BJ, 1999, ARCH GEN PSYCHIAT, V56, P719, DOI 10.1001/archpsyc.56.8.719; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Monti PM, 2001, ALCOHOL CLIN EXP RES, V25, P1634, DOI 10.1111/j.1530-0277.2001.tb02170.x; Morgenstern J, 2012, J CONSULT CLIN PSYCH, V80, P863, DOI 10.1037/a0028615; Morley KC, 2006, ADDICTION, V101, P1451, DOI 10.1111/j.1360-0443.2006.01555.x; Morris PLP, 2001, ADDICTION, V96, P1565, DOI 10.1046/j.1360-0443.2001.961115654.x; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; Narayana P L, 2008, Med J Armed Forces India, V64, P320, DOI 10.1016/S0377-1237(08)80009-3; National Collaborating Centre for Mental Health (UK), 2011, ALC US DIS DIAGN ASS; Norstrom T, 2004, ADDICTION, V99, P1274, DOI [10.1111/j.1360-0443.2004.00849.x, 10.1111/j.1360-0443.2004.00894.x]; O'Connor PG, 2013, JAMA-J AM MED ASSOC, V310, P1132, DOI 10.1001/jama.2013.277610; O'Malley SS, 2003, ARCH INTERN MED, V163, P1695, DOI 10.1001/archinte.163.14.1695; O'Malley SS, 2008, ALCOHOL CLIN EXP RES, V32, P1271, DOI 10.1111/j.1530-0277.2008.00682.x; O'Malley SS, 2007, ALCOHOL CLIN EXP RES, V31, P625, DOI 10.1111/j.1530-0277.2007.00347.x; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oslin D, 1997, AM J GERIAT PSYCHIAT, V5, P324, DOI 10.1097/00019442-199700540-00007; Oslin DW, 2008, ALCOHOL CLIN EXP RES, V32, P1299, DOI 10.1111/j.1530-0277.2008.00698.x; Oslin DW, 2014, J GEN INTERN MED, V29, P162, DOI 10.1007/s11606-013-2625-8; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; PAILLE FM, 1995, ALCOHOL ALCOHOLISM, V30, P239; Pelc I, 1997, BRIT J PSYCHIAT, V171, P73, DOI 10.1192/bjp.171.1.73; Petrakis IL, 2005, BIOL PSYCHIAT, V57, P1128, DOI 10.1016/j.biopsych.2005.02.016; Pettinati H. M., 2004, COMBINE MONOGRAPH SE, V2; Pettinati HM, 2010, AM J PSYCHIAT, V167, P668, DOI 10.1176/appi.ajp.2009.08060852; Pettinati HM, 2009, ALCOHOL CLIN EXP RES, V33, P350, DOI 10.1111/j.1530-0277.2008.00843.x; Poldrugo F, 1997, ADDICTION, V92, P1537; Polich JM, 1981, STABILITY CHANGE DRI, P159; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rivara FP, 2004, J STUD ALCOHOL, V65, P530, DOI 10.15288/jsa.2004.65.530; Roussaux J P, 1996, J Pharm Belg, V51, P65; Saitz R, 2013, JAMA-J AM MED ASSOC, V310, P1156, DOI 10.1001/jama.2013.277609; Salloum IM, 2005, ARCH GEN PSYCHIAT, V62, P37, DOI 10.1001/archpsyc.62.1.37; Sass H, 1996, ARCH GEN PSYCHIAT, V53, P673; Sass H, 1996, SUCHT, V42, P316; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Shalala DE, 10 US C ALC HLTH HIG; Sutton A.J., 2000, METHODS METAANALYSIS; Teesson M, 2006, DRUG ALCOHOL DEPEN, V81, P149, DOI 10.1016/j.drugalcdep.2005.06.007; Tempesta E, 2000, ALCOHOL ALCOHOLISM, V35, P202, DOI 10.1093/alcalc/35.2.202; Viswanathan M, ASSESSING RISK BIAS; Volpicelli JR, 1997, ARCH GEN PSYCHIAT, V54, P737; Whitworth AB, 1996, LANCET, V347, P1438, DOI 10.1016/S0140-6736(96)91682-7; Wolwer W, 2011, DRUG ALCOHOL DEPEN, V118, P417, DOI 10.1016/j.drugalcdep.2011.05.001; Zarkin GA, 2010, MED CARE, V48, P396, DOI 10.1097/MLR.0b013e3181d68859	108	497	501	2	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1889	1900		10.1001/jama.2014.3628	http://dx.doi.org/10.1001/jama.2014.3628			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825644	Green Published, Bronze			2022-12-28	WOS:000335798100021
J	He, Y; Yin, Y; Zech, M; Soumyanarayanan, A; Yee, MM; Williams, T; Boyer, MC; Chatterjee, K; Wise, WD; Zeljkovic, I; Kondo, T; Takeuchi, T; Ikuta, H; Mistark, P; Markiewicz, RS; Bansil, A; Sachdev, S; Hudson, EW; Hoffman, JE				He, Yang; Yin, Yi; Zech, M.; Soumyanarayanan, Anjan; Yee, Michael M.; Williams, Tess; Boyer, M. C.; Chatterjee, Kamalesh; Wise, W. D.; Zeljkovic, I.; Kondo, Takeshi; Takeuchi, T.; Ikuta, H.; Mistark, Peter; Markiewicz, Robert S.; Bansil, Arun; Sachdev, Subir; Hudson, E. W.; Hoffman, J. E.			Fermi Surface and Pseudogap Evolution in a Cuprate Superconductor	SCIENCE			English	Article							QUASI-PARTICLE STATES; HIGH-TEMPERATURE SUPERCONDUCTOR; QUANTUM OSCILLATIONS; EXCITATION SPECTRUM; CRITICAL-POINT; DENSITY; COMPETITION; INTERFERENCE; SIGNATURE; INSULATOR	The unclear relationship between cuprate superconductivity and the pseudogap state remains an impediment to understanding the high transition temperature (T-c) superconducting mechanism. Here, we used magnetic field-dependent scanning tunneling microscopy to provide phase-sensitive proof that d-wave superconductivity coexists with the pseudogap on the antinodal Fermi surface of an overdoped cuprate. Furthermore, by tracking the hole-doping (p) dependence of the quasi-particle interference pattern within a single bismuth-based cuprate family, we observed a Fermi surface reconstruction slightly below optimal doping, indicating a zero-field quantum phase transition in notable proximity to the maximum superconducting T-c. Surprisingly, this major reorganization of the system's underlying electronic structure has no effect on the smoothly evolving pseudogap.	[He, Yang; Yin, Yi; Zech, M.; Soumyanarayanan, Anjan; Yee, Michael M.; Williams, Tess; Zeljkovic, I.; Sachdev, Subir; Hoffman, J. E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Boyer, M. C.; Chatterjee, Kamalesh; Wise, W. D.; Hudson, E. W.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Kondo, Takeshi; Takeuchi, T.; Ikuta, H.] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan; [Mistark, Peter; Markiewicz, Robert S.; Bansil, Arun] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Nagoya University; Northeastern University	Hudson, EW (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	ehudson@psu.edu; jhoffman@physics.harvard.edu	Soumyanarayanan, Anjan/C-9023-2013; He, Yang/E-7772-2015; Zeljkovic, Ilija/N-9439-2013; Sachdev, Subir/A-8781-2013; Hoffman, Jennifer E/H-4334-2011; Hudson, Eric/C-4170-2017; Hudson, Eric/C-2746-2008; Kondo, Takeshi/H-2680-2016; Sachdev, Subir/Y-3037-2019	Soumyanarayanan, Anjan/0000-0003-2680-6005; Sachdev, Subir/0000-0002-2432-7070; Hoffman, Jennifer E/0000-0003-2752-5379; Hudson, Eric/0000-0001-7064-0351; Hudson, Eric/0000-0001-7064-0351; Sachdev, Subir/0000-0002-2432-7070; Zeljkovic, Ilija/0000-0001-9966-2140	Air Force Office of Scientific Research [FA9550-06-1-0531]; NSF [DMR-0847433, DMR-1103860]; New York Community Trust-George Merck Fund; Cottrell Scholarship; Research Corporation; NSF; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-FG02-07ER46352]; DOE [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1341286] Funding Source: National Science Foundation; Division Of Materials Research [0847433] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); New York Community Trust-George Merck Fund; Cottrell Scholarship; Research Corporation(Research Corporation for Science Advancement); NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H.-I. Ha for her role in the Harvard STM system construction and E. Dalla Torre, E. Demler, S. Kivelson, L. Taillefer, P. Phillips, F. Zhang, R. He, J. C. Davis, P. Coleman, I. Mazin, L. Benfatto, C. Varma, T. Honma, M. Randeria, and N. Trivedi for helpful discussion. Work at Harvard University was supported by the Air Force Office of Scientific Research under grant FA9550-06-1-0531, the NSF under grants DMR-0847433 and DMR-1103860, and the New York Community Trust-George Merck Fund. Work at MIT was supported by a Cottrell Scholarship awarded by the Research Corporation and by the Materials Research Science and Engineering Center and Early Career Development (CAREER) programs of the NSF. Work at Northeastern University was supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences contract number DE-FG02-07ER46352, and benefited from Northeastern University's Advanced Scientific Computation Center, theory support at the Advanced Light Source, Berkeley and the allocation of time at the National Energy Research Scientific Computing supercomputing center through DOE grant number DE-AC02-05CH11231. T. K., T. T., and H. I. synthesized and characterized the samples. M. B., K. C., and D. W. performed the STM measurements on UD25K, UD32K, and OPT35K samples; Y. Y., T. W., and M. Z. performed the magnetic field-dependent STM measurements on OD15K samples. Y. H. analyzed the data and wrote the manuscript, with input from A. S., M. M. Y., and S. S. P. M. and R. S. M. performed theoretical simulations, with advice from A. B. E. W. H. and J. E. H. advised the experiments and analysis, and shaped the manuscript. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to J. E. H. (jhoffman@physics.harvard.edu) and E. W. H. (ehudson@psu.edu).	Alldredge JW, 2008, NAT PHYS, V4, P319, DOI 10.1038/nphys917; Ando Y, 2000, PHYS REV B, V61, P14956, DOI 10.1103/PhysRevB.61.R14956; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Boyer MC, 2007, NAT PHYS, V3, P802, DOI 10.1038/nphys725; Chatterjee U, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107006; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; Harrison N., 2014, RELATIONSHIP CHARGE; He RH, 2011, SCIENCE, V331, P1579, DOI 10.1126/science.1198415; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Jia X, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134503; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Kondo T, 2009, NATURE, V457, P296, DOI 10.1038/nature07644; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Ma JH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.207002; McElroy K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067005; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; Nie L., 2013, QUENCHED DISORDER VE; Norman Michael R., 2010, Physics, V3, DOI 10.1103/Physics.3.86; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Pereg-Barnea T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020509; Punk M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195123; Sacepe B, 2011, NAT PHYS, V7, P239, DOI 10.1038/NPHYS1892; Sachdev S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027202; Sebastian SE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102501; Sebastian SE, 2010, P NATL ACAD SCI USA, V107, P6175, DOI 10.1073/pnas.0913711107; Tallon JL, 1999, PHYS STATUS SOLIDI B, V215, P531, DOI 10.1002/(SICI)1521-3951(199909)215:1<531::AID-PSSB531>3.0.CO;2-W; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Vishik IM, 2012, P NATL ACAD SCI USA, V109, P18332, DOI 10.1073/pnas.1209471109; Vishik IM, 2009, NAT PHYS, V5, P718, DOI 10.1038/NPHYS1375; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Yang HB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.047003; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501; Zeljkovic I, 2012, NAT MATER, V11, P585, DOI [10.1038/NMAT3315, 10.1038/nmat3315]; Zheng GQ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047006	44	109	111	1	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					608	611		10.1126/science.1248221	http://dx.doi.org/10.1126/science.1248221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812396	Green Submitted			2022-12-28	WOS:000335537400037
J	Zhao, ZZ; Arruda, EM				Zhao, Zhouzhou; Arruda, Ellen M.			An Internal Cure for Damaged Polymers	SCIENCE			English	Editorial Material							SELF-HEALING POLYMERS; COMPOSITE; FIBERS		[Zhao, Zhouzhou; Arruda, Ellen M.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhao, ZZ (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	arruda@umich.edu						Baginska M, 2012, ADV ENERGY MATER, V2, P583, DOI 10.1002/aenm.201100683; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; Hayes SA, 2007, COMPOS PART A-APPL S, V38, P1116, DOI 10.1016/j.compositesa.2006.06.008; Imato K, 2012, ANGEW CHEM INT EDIT, V51, P1138, DOI 10.1002/anie.201104069; Kirkby EL, 2008, ADV FUNCT MATER, V18, P2253, DOI 10.1002/adfm.200701208; Speck T, 2013, SELF-HEALING POLYMERS: FROM PRINCIPLES TO APPLICATIONS, P61; Tee BCK, 2012, NAT NANOTECHNOL, V7, P825, DOI [10.1038/nnano.2012.192, 10.1038/NNANO.2012.192]; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Trask RS, 2006, SMART MATER STRUCT, V15, P704, DOI 10.1088/0964-1726/15/3/005; White SR, 2014, SCIENCE, V344, P620, DOI 10.1126/science.1251135; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Zhao Y, 2012, SMALL, V8, P2954, DOI 10.1002/smll.201200530	15	13	13	1	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					591	592		10.1126/science.1254317	http://dx.doi.org/10.1126/science.1254317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812391				2022-12-28	WOS:000335537400030
J	Brownell, KD; Pomeranz, JL				Brownell, Kelly D.; Pomeranz, Jennifer L.			The Trans-Fat Ban-Food Regulation and Long-Term Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The FDA proposes to declare partially hydrogenated oils unsafe and to allow only a small amount of artificial trans fats in foods. The move portends future government actions regarding the food supply that will affect human health much more broadly. Trans fats naturally exist in small amounts in the fat in meat and milk, but most trans fats in the food supply have been added by food manufacturers. Since 1911, when Procter and Gamble introduced Crisco, companies have used artificial trans fats because of their commercially favorable properties, such as long shelf life, stability during deep frying, and palatability. These fats have therefore been incorporated into a great many foods, including snack and deep-fried foods, baked goods, margarines, and crackers (see graph). The primary dietary source of artificial trans fat is partially hydrogenated oils, created by adding hydrogen to vegetable ...	[Brownell, Kelly D.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Pomeranz, Jennifer L.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Pomeranz, Jennifer L.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA	Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Brownell, KD (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.							Dietz WH, 2012, JAMA-J AM MED ASSOC, V308, P143, DOI 10.1001/jama.2012.7379; Food and Drug Administration (FDA), 2013, FED REGISTER, V78, P67169; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035	3	43	44	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1773	1775		10.1056/NEJMp1314072	http://dx.doi.org/10.1056/NEJMp1314072			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806156				2022-12-28	WOS:000335997900002
J	Fang, EF; Scheibye-Knudsen, M; Brace, LE; Kassahun, H; SenGupta, T; Nilsen, H; Mitchell, JR; Croteau, DL; Bohr, VA				Fang, Evandro Fei; Scheibye-Knudsen, Morten; Brace, Lear E.; Kassahun, Henok; SenGupta, Tanima; Nilsen, Hilde; Mitchell, James R.; Croteau, Deborah L.; Bohr, Vilhelm A.			Defective Mitophagy in XPA via PARP-1 Hyperactivation and NAD(+)/SIRT1 Reduction	CELL			English	Article							PIGMENTOSUM GROUP-A; DNA-REPAIR; UNCOUPLING PROTEIN-2; MOUSE MODEL; DAMAGE; MITOCHONDRIA; METABOLISM; EXPRESSION; PROTECTS; DISEASE	Mitochondrial dysfunction is a common feature in neurodegeneration and aging. We identify mitochondrial dysfunction in xeroderma pigmentosum group A (XPA), a nucleotide excision DNA repair disorder with severe neurodegeneration, in silico and in vivo. XPA-deficient cells show defective mitophagy with excessive cleavage of PINK1 and increased mitochondrial membrane potential. The mitochondrial abnormalities appear to be caused by decreased activation of the NAD(+)-SIRT1-PGC-1 alpha axis triggered by hyperactivation of the DNA damage sensor PARP1. This phenotype is rescued by PARP-1 inhibition or by supplementation with NAD(+) precursors that also rescue the lifespan defect in xpa-1 nematodes. Importantly, this pathogenesis appears common to ataxia-telangiectasia and Cockayne syndrome, two other DNA repair disorders with neurodegeneration, but absent in XPC, a DNA repair disorder without neurodegeneration. Our findings reveal a nuclear-mitochondrial crosstalk that is critical for the maintenance of mitochondrial health.	[Fang, Evandro Fei; Scheibye-Knudsen, Morten; Croteau, Deborah L.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Brace, Lear E.; Mitchell, James R.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Kassahun, Henok; SenGupta, Tanima; Nilsen, Hilde] Univ Oslo, Ctr Biotechnol, N-0317 Oslo, Norway; [Bohr, Vilhelm A.] Univ Copenhagen, Danish Ctr Hlth Aging, DK-2200 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard Medical School; University of Oslo; University of Copenhagen	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Fang, Evandro Fei/AAV-4653-2020; Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020; Fang, Evandro Fei/AAC-5511-2019	Brace, Lear/0000-0001-6961-9758; Croteau, Deborah/0000-0002-6094-4084; Scheibye-Knudsen, Morten/0000-0002-6637-1280; Fang, Evandro Fei/0000-0003-0355-7202	Intramural Research Program of the NIH, National Institute on Aging; research council of Norway; Luke O'Brien Foundation; National Science Foundation Graduate Research Fellowship Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000733, ZIAAG000722, ZIAAG000723] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); research council of Norway(Research Council of Norway); Luke O'Brien Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Kevin Becker, Yongqing Zhang, and Elin Lehrmann for their help in performing microarray and data analysis, and Dr. Magdalena Misiak for preparing rat neurons. We thank Drs. Mark Mattson and Peter Sykora for reading this manuscript. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging. H.N. was supported by a grant from the research council of Norway. J.R.M. and L.E.B. were supported by the Luke O'Brien Foundation, and L.E.B. was supported by the National Science Foundation Graduate Research Fellowship Program.	Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arczewska KD, 2013, NUCLEIC ACIDS RES, V41, P5368, DOI 10.1093/nar/gkt225; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Berra CM, 2013, FREE RADICAL BIO MED, V61, P343, DOI 10.1016/j.freeradbiomed.2013.03.026; Brace LE, 2013, AGING CELL, V12, P1144, DOI 10.1111/acel.12142; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Ding J, 2001, INT J BIOCHEM CELL B, V33, P603, DOI 10.1016/S1357-2725(01)00037-1; Fensgard O, 2010, AGING-US, V2, P133, DOI 10.18632/aging.100127; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hayashi M, 2005, BRAIN DEV-JPN, V27, P34, DOI 10.1016/j.braindev.2004.04.001; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Islam R, 2012, NEUROBIOL DIS, V46, P137, DOI 10.1016/j.nbd.2011.12.055; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Scheibye-Knudsen M, 2013, AGING-US, V5, P192, DOI 10.18632/aging.100546; Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	29	428	436	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					882	896		10.1016/j.cell.2014.03.026	http://dx.doi.org/10.1016/j.cell.2014.03.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813611	Bronze, Green Accepted			2022-12-28	WOS:000335765500016
J	Fink, AJP; Croce, KR; Huang, ZJ; Abbott, LF; Jessell, TM; Azim, E				Fink, Andrew J. P.; Croce, Katherine R.; Huang, Z. Josh; Abbott, L. F.; Jessell, Thomas M.; Azim, Eiman			Presynaptic inhibition of spinal sensory feedback ensures smooth movement	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CORD; NEURONS; AFFERENT; CELLS; MUSCLE; CORTEX; DEPOLARIZATION; TRANSMISSION; CIRCUITS	The precision of skilled movement depends on sensory feedback and its refinement by local inhibitory microcircuits. One specialized set of spinal GABAergic interneurons forms axo-axonic contacts with the central terminals of sensory afferents, exerting presynaptic inhibitory control over sensory-motor transmission. The inability to achieve selective access to the GABAergic neurons responsible for this unorthodox inhibitory mechanism has left unresolved the contribution of presynaptic inhibition to motor behaviour. We used Gad2 as a genetic entry point to manipulate the interneurons that contact sensory terminals, and show that activation of these interneurons in mice elicits the defining physiological characteristics of presynaptic inhibition. Selective genetic ablation of Gad2-expressing interneurons severely perturbs goal-directed reaching movements, uncovering a pronounced and stereotypic forelimb motor oscillation, the core features of which are captured by modelling the consequences of sensory feedback at high gain. Our findings define the neural substrate of a genetically hardwired gain control system crucial for the smooth execution of movement.	[Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Neurosci, New York, NY 10032 USA; [Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Biochem, New York, NY 10032 USA; [Fink, Andrew J. P.; Croce, Katherine R.; Jessell, Thomas M.; Azim, Eiman] Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Mol Biophys, New York, NY 10032 USA; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Abbott, L. F.] Columbia Univ, Ctr Theoret Neurosci, Dept Physiol, New York, NY 10032 USA; [Abbott, L. F.] Columbia Univ, Ctr Theoret Neurosci, Dept Neurosci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Columbia University; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Mortimer B Zuckerman Mind Brain Behav Inst, Kavli Inst Brain Sci,Dept Neurosci, New York, NY 10032 USA.	af2243@columbia.edu; tmj1@columbia.edu		Huang, Z. Josh/0000-0003-0592-028X; Azim, Eiman/0000-0002-1015-1772	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093338, U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033245, R01NS033245, R01NS080932] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [T32 HD007430] Funding Source: Medline; NIMH NIH HHS [MH078844, U01 MH078844, R01 MH093338, MH093338] Funding Source: Medline; NINDS NIH HHS [R37 NS033245, R01 NS080932, R01 NS033245, NS033245] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Akay T., 2013, LOCOMOTOR PATTERN DE; Akay T, 2008, J NEUROSCI METH, V171, P39, DOI 10.1016/j.jneumeth.2008.02.001; [Anonymous], 1977, HDB PHYSL NERVOUS SY; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; BARKER JL, 1972, SCIENCE, V176, P1043, DOI 10.1126/science.176.4038.1043; BAWA P, 1976, J NEUROPHYSIOL, V39, P788, DOI 10.1152/jn.1976.39.4.788; BEHAR T, 1993, DEV BRAIN RES, V72, P203, DOI 10.1016/0165-3806(93)90185-D; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; Capaday C, 2002, EXP BRAIN RES, V143, P67, DOI 10.1007/s00221-001-0970-z; CAPADAY C, 1987, J NEUROSCI METH, V21, P91, DOI 10.1016/0165-0270(87)90107-5; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; CLEMENTS JD, 1987, J PHYSIOL-LONDON, V383, P153; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; CONRADI S, 1969, ACTA PHYSIOL SCAND, P85; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P237, DOI 10.1113/jphysiol.1962.sp006884; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; EVANS CM, 1983, J PHYSIOL-LONDON, V344, P483, DOI 10.1113/jphysiol.1983.sp014953; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Frank K, 1957, FED PROC, V16, P49; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KUNO M, 1964, J PHYSIOL-LONDON, V175, P100, DOI 10.1113/jphysiol.1964.sp007505; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Li Y, 2001, J NEUROPHYSIOL, V85, P2047, DOI 10.1152/jn.2001.85.5.2047; Llinas RR, 2009, NEUROSCIENCE, V162, P797, DOI 10.1016/j.neuroscience.2009.04.045; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; LUNDBERG A., 1964, PROGR BRAIN RES, V12, P197, DOI 10.1016/S0079-6123(08)60624-X; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; Prochazka A, 1999, PROG BRAIN RES, V123, P133, DOI 10.1016/S0079-6123(08)62850-2; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUDOMIN P, 1983, J NEUROPHYSIOL, V50, P743, DOI 10.1152/jn.1983.50.4.743; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Shneider NA, 2009, J NEUROSCI, V29, P4719, DOI 10.1523/JNEUROSCI.5790-08.2009; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Sonner PM, 2013, J NEUROPHYSIOL, V109, P2118, DOI 10.1152/jn.00783.2012; STEIN RB, 1976, BIOL CYBERN, V22, P147, DOI 10.1007/BF00365525; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Varela JA, 1997, J NEUROSCI, V17, P7926; Whishaw IQ, 1996, BEHAV BRAIN RES, V78, P101, DOI 10.1016/0166-4328(95)00236-7; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	57	130	131	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					43	+		10.1038/nature13276	http://dx.doi.org/10.1038/nature13276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784215	Green Accepted			2022-12-28	WOS:000335199100036
J	Hodgins, S				Hodgins, Sheilagh			Antipsychotics, mood stabilisers, and reductions in violence	LANCET			English	Editorial Material							SCHIZOPHRENIA; PATHWAYS; BEHAVIOR; DISORDER		[Hodgins, Sheilagh] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Hodgins, Sheilagh] Karolinska Inst, Stockholm, Sweden	Universite de Montreal; Karolinska Institutet	Hodgins, S (corresponding author), Univ Montreal, Dept Psychiat, CP 6128 Succ Ctr Ville Pavillon 3050, Montreal, PQ H3C 3J7, Canada.	s.hodgins@umontreal.ca		Hodgins, Sheilagh/0000-0002-3436-7121				Coid JW, 2013, JAMA PSYCHIAT, V70, P465, DOI 10.1001/jamapsychiatry.2013.12; Fazel S, 2014, LANCET; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Hodgins S, 2011, EUR PSYCHIAT, V26, P518, DOI 10.1016/j.eurpsy.2010.09.006; Hodgins Sheilagh, 2014, Curr Top Behav Neurosci, V17, P329, DOI 10.1007/7854_2013_259; Mojtabai R, 2006, SOC PSYCH PSYCH EPID, V41, P183, DOI 10.1007/s00127-005-0020-4; Monahan J., 2001, RETHINKING RISK ASSE; Schiffer B, 2013, SCHIZOPHRENIA BULL, V39, P1115, DOI 10.1093/schbul/sbs115; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; Volavka J, 2011, SCHIZOPHRENIA BULL, V37, P921, DOI 10.1093/schbul/sbr041; Wallace C, 2004, AM J PSYCHIAT, V161, P716, DOI 10.1176/appi.ajp.161.4.716; Winsper C, 2013, JAMA PSYCHIAT, V70, P1287, DOI 10.1001/jamapsychiatry.2013.2445; Witt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055942	13	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1167	1168		10.1016/S0140-6736(14)60694-2	http://dx.doi.org/10.1016/S0140-6736(14)60694-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24816047	hybrid			2022-12-28	WOS:000343002600007
J	Wang, HD; Liddell, CA; Coates, MM; Mooney, MD; Levitz, CE; Schumacher, AE; Apfel, H; Iannarone, M; Phillips, B; Lofgren, KT; Sandar, L; Dorrington, RE; Rakovac, I; Jacobs, TA; Liang, XF; Zhou, MG; Zhu, J; Yang, GH; Wang, YP; Liu, SW; Li, YC; Ozgoren, AA; Abera, SF; Abubakar, I; Achoki, T; Adelekan, A; Ademi, Z; Alemu, ZA; Allen, PJ; AlMazroa, MA; Alvarez, E; Amankwaa, AA; Amare, AT; Ammar, W; Anwari, P; Cunningham, SA; Asad, MM; Assadi, R; Banerjee, A; Basu, S; Bedi, N; Bekele, T; Bell, ML; Bhutta, ZQ; Blore, JD; Basara, BB; Boufous, S; Breitborde, N; Bruce, NG; Bui, LN; Carapetis, JR; Cardenas, R; Carpenter, DO; Caso, V; Castro, RE; Catala-Lopez, F; Cavlin, A; Che, X; Chiang, PPC; Chowdhury, R; Christophi, CA; Chuang, TW; Cirillo, M; Leite, ID; Courville, KJ; Dandona, L; Dandona, R; Davis, A; Dayama, A; Deribe, K; Dharmaratne, SD; Dherani, MK; Dilmen, U; Ding, EL; Edmond, KM; Ermakov, SP; Farzadfar, F; Fereshtehnejad, SM; Fijabi, DO; Foigt, N; Forouzanfar, MH; Garcia, AC; Geleijnse, JM; Gessner, BD; Goginashvili, K; Gona, P; Goto, A; Gouda, HN; Green, MA; Greenwell, KF; Gugnani, HC; Gupta, R; Hamadeh, RR; Hammami, M; Harb, HL; Hay, S; Hedayati, MT; Hosgood, HD; Hoy, DG; Idrisov, BT; Islami, F; Ismayilova, S; Jha, V; Jiang, GH; Jonas, JB; Juel, K; Kabagambe, EK; Kazi, DS; Kengne, AP; Kereselidze, M; Khader, YS; Khalifa, SEAH; Khang, YH; Kim, D; Kinfu, Y; Kinge, JM; Kokubo, Y; Kosen, S; Defo, BK; Kumar, GA; Kumar, K; Kumar, RB; Lai, T; Lan, Q; Larsson, A; Lee, JT; Leinsalu, M; Lim, SS; Lipshultz, SE; Logroscino, G; Lotufo, PA; Lunevicius, R; Lyons, RA; Ma, S; Mahdi, AA; Marzan, MB; Mashal, MTQ; Mazorodze, TT; McGrath, JJ; Memish, ZA; Mendoza, W; Mensah, GA; Meretoja, A; Miller, TR; Mills, EJ; Mohammad, KA; Mokdad, AH; Monasta, L; Montico, M; Moore, AR; Moschandreas, J; Msemburi, WT; Mueller, UO; Muszynska, MM; Naghavi, M; Naidoo, KS; Narayan, KMV; Nejjari, C; Ng, M; Ngirabega, JD; Nieuwenhuijsen, MJ; Nyakarahuka, L; Ohkubo, T; Omer, SB; Caicedo, AJP; Pillay-van Wyk, V; Pope, D; Pourmalek, F; Prabhakaran, D; Rahman, SUR; Rana, SM; Reilly, RQ; Rojas-Rueda, D; Ronfani, L; Rushton, L; Saeedi, MY; Salomon, JA; Sampson, U; Santos, IS; Sawhney, M; Schmidt, JC; Shakh-Nazarova, M; She, J; Sheikhbahaei, S; Shibuya, K; Shin, HH; Shishani, K; Shiue, I; Sigfusdottir, ID; Singh, JA; Skirbekk, V; Sliwa, K; Soshnikov, SS; Sposato, LA; Stathopoulou, VK; Stroumpoulis, K; Tabb, KM; Talongwa, RT; Teixeira, CM; Terkawi, AS; Thomson, AJ; Thorne-Lyman, AL; Toyoshima, H; Dimbuene, ZT; Uwaliraye, P; Uzun, SB; Vasankari, TJ; Vasconcelos, AMN; Vlassov, VV; Vollset, SE; Waller, S; Wan, X; Weichenthal, S; Weiderpass, E; Weintraub, RG; Westerman, R; Wilkinson, JD; Williams, HC; Yang, YC; Yentur, GK; Yip, P; Yonemoto, N; Younis, M; Yu, C; Jin, KY; Zaki, ME; Zhu, SK; Vos, T; Lopez, AD; Murray, CJL				Wang, Haidong; Liddell, Chelsea A.; Coates, Matthew M.; Mooney, Meghan D.; Levitz, Carly E.; Schumacher, Austin E.; Apfel, Henry; Iannarone, Marissa; Phillips, Bryan; Lofgren, Katherine T.; Sandar, Logan; Dorrington, Rob E.; Rakovac, Ivo; Jacobs, Troy A.; Liang, Xiaofeng; Zhou, Maigeng; Zhu, Jun; Yang, Gonghuan; Wang, Yanping; Liu, Shiwei; Li, Yichong; Ozgoren, Ayse Abbasoglu; Abera, Semaw Ferede; Abubakar, Ibrahim; Achoki, Tom; Adelekan, Ademola; Ademi, Zanfina; Alemu, Zewdie Aderaw; Allen, Peter J.; AlMazroa, Mohammad AbdulAziz; Alvarez, Elena; Amankwaa, Adansi A.; Amare, Azmeraw T.; Ammar, Walid; Anwari, Palwasha; Cunningham, Solveig Argeseanu; Asad, Majed Masoud; Assadi, Reza; Banerjee, Amitava; Basu, Sanjay; Bedi, Neeraj; Bekele, Tolesa; Bell, Michelle L.; Bhutta, Zulfi Qar; Blore, Jed D.; Basara, Berrak Bora; Boufous, Soufiane; Breitborde, Nicholas; Bruce, Nigel G.; Linh Ngoc Bui; Carapetis, Jonathan R.; Cardenas, Rosario; Carpenter, David O.; Caso, Valeria; Estanislao Castro, Ruben; Catala-Lopez, Ferran; Cavlin, Alanur; Che, Xuan; Chiang, Peggy Pei-Chia; Chowdhury, Rajiv; Christophi, Costas A.; Chuang, Ting-Wu; Cirillo, Massimo; Leite, Iuri da Costa; Courville, Karen J.; Dandona, Lalit; Dandona, Rakhi; Davis, Adrian; Dayama, Anand; Deribe, Kebede; Dharmaratne, Samath D.; Dherani, Mukesh K.; Dilmen, Ugur; Ding, Eric L.; Edmond, Karen M.; Ermakov, Sergei Petrovich; Farzadfar, Farshad; Fereshtehnejad, Seyed-Mohammad; Fijabi, Daniel Obadare; Foigt, Nataliya; Forouzanfar, Mohammad H.; Garcia, Ana C.; Geleijnse, Johanna M.; Gessner, Bradford D.; Goginashvili, Ketevan; Gona, Philimon; Goto, Atsushi; Gouda, Hebe N.; Green, Mark A.; Greenwell, Karen Fern; Gugnani, Harish Chander; Gupta, Rahul; Hamadeh, Randah Ribhi; Hammami, Mouhanad; Harb, Hilda L.; Hay, Simon; Hedayati, Mohammad T.; Hosgood, H. Dean; Hoy, Damian G.; Idrisov, Bulat T.; Islami, Farhad; Ismayilova, Samaya; Jha, Vivekanand; Jiang, Guohong; Jonas, Jost B.; Juel, Knud; Kabagambe, Edmond Kato; Kazi, Dhruv S.; Kengne, Andre Pascal; Kereselidze, Maia; Khader, Yousef Saleh; Khalifa, Shams Eldin Ali Hassan; Khang, Young-Ho; Kim, Daniel; Kinfu, Yohannes; Kinge, Jonas M.; Kokubo, Yoshihiro; Kosen, Soewarta; Defo, Barthelemy Kuate; Kumar, G. Anil; Kumar, Kaushalendra; Kumar, Ravi B.; Lai, Taavi; Lan, Qing; Larsson, Anders; Lee, Jong-Tae; Leinsalu, Mall; Lim, Stephen S.; Lipshultz, Steven E.; Logroscino, Giancarlo; Lotufo, Paulo A.; Lunevicius, Raimundas; Lyons, Ronan Anthony; Ma, Stefan; Mahdi, Abbas Ali; Marzan, Melvin Barrientos; Mashal, Mohammad Taufi Q.; Mazorodze, Tasara T.; McGrath, John J.; Memish, Ziad A.; Mendoza, Walter; Mensah, George A.; Meretoja, Atte; Miller, Ted R.; Mills, Edward J.; Mohammad, Karzan Abdulmuhsin; Mokdad, Ali H.; Monasta, Lorenzo; Montico, Marcella; Moore, Ami R.; Moschandreas, Joanna; Msemburi, William T.; Mueller, Ulrich O.; Muszynska, Magdalena M.; Naghavi, Mohsen; Naidoo, Kovin S.; Narayan, K. M. Venkat; Nejjari, Chakib; Ng, Marie; de Dieu Ngirabega, Jean; Nieuwenhuijsen, Mark J.; Nyakarahuka, Luke; Ohkubo, Takayoshi; Omer, Saad B.; Paternina Caicedo, Angel J.; Pillay-van Wyk, Victoria; Pope, Dan; Pourmalek, Farshad; Prabhakaran, Dorairaj; Rahman, Sajjad U. R.; Rana, Saleem M.; Reilly, Robert Quentin; Rojas-Rueda, David; Ronfani, Luca; Rushton, Lesley; Saeedi, Mohammad Yahya; Salomon, Joshua A.; Sampson, Uchechukwu; Santos, Itamar S.; Sawhney, Monika; Schmidt, Juergen C.; Shakh-Nazarova, Marina; She, Jun; Sheikhbahaei, Sara; Shibuya, Kenji; Shin, Hwashin Hyun; Shishani, Kawkab; Shiue, Ivy; Sigfusdottir, Inga Dora; Singh, Jasvinder A.; Skirbekk, Vegard; Sliwa, Karen; Soshnikov, Sergey S.; Sposato, Luciano A.; Stathopoulou, Vasiliki Kalliopi; Stroumpoulis, Konstantinos; Tabb, Karen M.; Talongwa, Roberto Tchio; Teixeira, Carolina Maria; Terkawi, Abdullah Sulieman; Thomson, Alan J.; Thorne-Lyman, Andrew L.; Toyoshima, Hideaki; Dimbuene, Zacharie Tsala; Uwaliraye, Parfait; Uzun, Selen Beguem; Vasankari, Tommi J.; Nogales Vasconcelos, Ana Maria; Vlassov, Vasiliy Victorovich; Vollset, Stein Emil; Waller, Stephen; Wan, Xia; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Westerman, Ronny; Wilkinson, James D.; Williams, Hywel C.; Yang, Yang C.; Yentur, Gokalp Kadri; Yip, Paul; Yonemoto, Naohiro; Younis, Mustafa; Yu, Chuanhua; Jin, Kim Yun; Zaki, Maysaa El Sayed; Zhu, Shankuan; Vos, Theo; Lopez, Alan D.; Murray, Christopher J. L.			Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							MILLENNIUM DEVELOPMENT GOALS; CHILD-MORTALITY; MATERNAL EDUCATION; 187 COUNTRIES; HEALTH; DEMOCRACY; COVERAGE; TRENDS; SURVIVAL; NEWBORN	Background Remarkable financial and political efforts have been focused on the reduction of child mortality during the past few decades. Timely measurements of levels and trends in under-5 mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4) target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of success. Methods We generated updated estimates of child mortality in early neonatal (age 0-6 days), late neonatal (7-28 days), postneonatal (29-364 days), childhood (1-4 years), and under-5 (0-4 years) age groups for 188 countries from 1970 to 2013, with more than 29 000 survey, census, vital registration, and sample registration datapoints. We used Gaussian process regression with adjustments for bias and non-sampling error to synthesise the data for under-5 mortality for each country, and a separate model to estimate mortality for more detailed age groups. We used explanatory mixed effects regression models to assess the association between under-5 mortality and income per person, maternal education, HIV child death rates, secular shifts, and other factors. To quantify the contribution of these different factors and birth numbers to the change in numbers of deaths in under-5 age groups from 1990 to 2013, we used Shapley decomposition. We used estimated rates of change between 2000 and 2013 to construct under-5 mortality rate scenarios out to 2030. Findings We estimated that 6.3 million (95% UI 6.0-6.6) children under-5 died in 2013, a 64% reduction from 17.6 million (17.1-18.1) in 1970. In 2013, child mortality rates ranged from 152.5 per 1000 livebirths (130.6-177.4) in Guinea-Bissau to 2.3 (1.8-2.9) per 1000 in Singapore. The annualised rates of change from 1990 to 2013 ranged from 6.8% to 0.1%. 99 of 188 countries, including 43 of 48 countries in sub-Saharan Africa, had faster decreases in child mortality during 2000-13 than during 1990-2000. In 2013, neonatal deaths accounted for 41.6% of under-5 deaths compared with 37.4% in 1990. Compared with 1990, in 2013, rising numbers of births, especially in sub-Saharan Africa, led to 1.4 million more child deaths, and rising income per person and maternal education led to 0.9 million and 2.2 million fewer deaths, respectively. Changes in secular trends led to 4.2 million fewer deaths. Unexplained factors accounted for only -1% of the change in child deaths. In 30 developing countries, decreases since 2000 have been faster than predicted attributable to income, education, and secular shift alone. Interpretation Only 27 developing countries are expected to achieve MDG 4. Decreases since 2000 in under-5 mortality rates are accelerating in many developing countries, especially in sub-Saharan Africa. The Millennium Declaration and increased development assistance for health might have been a factor in faster decreases in some developing countries. Without further accelerated progress, many countries in west and central Africa will still have high levels of under-5 mortality in 2030.	[Wang, Haidong; Liddell, Chelsea A.; Coates, Matthew M.; Mooney, Meghan D.; Levitz, Carly E.; Schumacher, Austin E.; Apfel, Henry; Iannarone, Marissa; Phillips, Bryan; Lofgren, Katherine T.; Sandar, Logan; Achoki, Tom; Dandona, Lalit; Forouzanfar, Mohammad H.; Lim, Stephen S.; Mokdad, Ali H.; Naghavi, Mohsen; Vos, Theo; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa; [Dorrington, Rob E.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Rakovac, Ivo] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Jacobs, Troy A.] USAID, HIDN, MCH Div, Global Hlth Bur, Washington, DC USA; [Liang, Xiaofeng; Zhou, Maigeng; Liu, Shiwei] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Zhu, Jun; Wang, Yanping] Natl Off Maternal & Childs Hlth Surveillance, Chengdu, Peoples R China; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Yang, Gonghuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ozgoren, Ayse Abbasoglu; Cavlin, Alanur] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Abera, Semaw Ferede] Mekelle Univ, Tigray, Ethiopia; [Abubakar, Ibrahim] UCL, London, England; [Achoki, Tom] Minist Hlth, Gaborone, Botswana; [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogpb, Nigeria; [Chiang, Peggy Pei-Chia] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Ademi, Zanfina; Blore, Jed D.; Meretoja, Atte; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Alemu, Zewdie Aderaw] Markos Univ, Debre Markos, Ethiopia; [Allen, Peter J.] Minist Hlth, Belmopan, Cayo, Belize; [AlMazroa, Mohammad AbdulAziz; Memish, Ziad A.; Saeedi, Mohammad Yahya] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Anwari, Palwasha] UNFPA, Kabul, Afghanistan; [Dayama, Anand] Emory Univ, Sch Med, Atlanta, GA USA; [Cunningham, Solveig Argeseanu; Narayan, K. M. Venkat; Omer, Saad B.] Emory Univ, Atlanta, GA USA; [Asad, Majed Masoud] Minist Hlth, Amman, Jordan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Khorasan, Iran; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Bekele, Tolesa] Madawalabu Univ, Bale Goba, Oromia, Ethiopia; [Bell, Michelle L.] Yale Univ, New Haven, CT USA; [Bhutta, Zulfi Qar] Aga Khan Univ, Med Ctr, Karachi, Pakistan; [Basara, Berrak Bora; Dilmen, Ugur; Uzun, Selen Beguem; Yentur, Gokalp Kadri] Minist Hlth, Gen Directorate Hlth Res, Ankara, Turkey; [Boufous, Soufiane] Univ New S Wales, Sydney, NSW, Australia; [Breitborde, Nicholas] Univ Arizona, Tucson, AZ USA; [Bruce, Nigel G.; Dherani, Mukesh K.; Pope, Dan] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Linh Ngoc Bui] Hanoi Sch Publ Hlth, Hanoi, Vietnam; [Carapetis, Jonathan R.] Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Carpenter, David O.] Univ Albany, Rensselaer, NY USA; [Caso, Valeria] Univ Perugia, Stroke Unit, I-06100 Perugia, Italy; [Estanislao Castro, Ruben] Univ Diego Port, Santiago, Chile; [Catala-Lopez, Ferran] Minist Hlth, Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacol & Pharmacovigilance, Madrid, Spain; [Mensah, George A.] NHLBI, CTRIS, Bethesda, MD 20892 USA; [Lan, Qing] NCI, Bethesda, MD 20892 USA; [Che, Xuan] NIH, Bethesda, MD 20892 USA; [Chowdhury, Rajiv] Univ Cambridge, Cambridge, England; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Chuang, Ting-Wu] Taipei Med Univ, Taipei, Taiwan; [Cirillo, Massimo] Univ Salerno, I-84081 Baronissi, SA, Italy; [Leite, Iuri da Costa] Fiocruz MS, ENSP, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Courville, Karen J.] Hosp Dr Gustavo N Collado, Chitre, Herrera, Panama; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil; Kumar, Ravi B.] Publ Hlth Fdn India, New Delhi, India; [Davis, Adrian; Schmidt, Juergen C.] Publ Hlth England, London, England; [Deribe, Kebede] Univ Addis Ababa, Addis Ababa, Ethiopia; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Ding, Eric L.; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Edmond, Karen M.] Univ Western Australia, Perth, WA 6009, Australia; [Ermakov, Sergei Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Forouzanfar, Mohammad H.; Sheikhbahaei, Sara] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrine & Metab Res Inst, Tehran, Iran; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Stockholm, Sweden; [Idrisov, Bulat T.] Brandeis Univ, Heller Grad Sch, Waltham, MA USA; [Foigt, Nataliya] Ukraine Acad Med Sci, Inst Gerontol, UA-252655 Kiev, Ukraine; [Garcia, Ana C.] Primary Hlth Care Grp Almada Seixal Reg Lisbon, Publ Hlth Unit, Almada, Portugal; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Goginashvili, Ketevan] Minist Labour Hlth & Social Aff airs, Tbilisi, Georgia; [Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA USA; [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gouda, Hebe N.; McGrath, John J.] Univ Queensland, Brisbane, Qld, Australia; [Green, Mark A.] Univ Sheffield, Sheffield, S Yorkshire, England; [Greenwell, Karen Fern] Stattis LLC, Kishinev, Moldova; [Gugnani, Harish Chander] St James Sch Med, Kralendijk, Kralendijk, Bonaire, Netherlands; [Gupta, Rahul] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Hay, Simon] Univ Oxford, Oxford, England; [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Islami, Farhad] Amer Canc Soc, New York, NY USA; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh, India; [Jonas, Jost B.] Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [Kabagambe, Edmond Kato] Vanderbilt Univ, Nashville, TN 37235 USA; [Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kengne, Andre Pascal; Msemburi, William T.; Pillay-van Wyk, Victoria] South African Med Res Council, Cape Town, Western Cape, South Africa; [Kereselidze, Maia; Shakh-Nazarova, Marina] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, AlRamtha, Irbid, Jordan; [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia; [Kinge, Jonas M.; Skirbekk, Vegard; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Oslo, Norway; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kosen, Soewarta] NIHRD, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Kumar, Kaushalendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Lee, Jong-Tae] Korea Univ, Seoul, South Korea; [Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia; [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA; [Logroscino, Giancarlo] Univ Bari, Bari, Italy; [Lotufo, Paulo A.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Lyons, Ronan Anthony] Swansea Univ, Swansea, W Glam, Wales; [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore; [Mahdi, Abbas Ali] King Georges Med Univ, Lucknow, Uttar Pradesh, India; [Mashal, Mohammad Taufi Q.] Minist Publ Hlth, Kabul, Afghanistan; [Marzan, Melvin Barrientos] Univ East Ramon Magsaysay, Med Ctr, Quezon City, Metro Manila, Philippines; [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, Eastern Cape, South Africa; [Mendoza, Walter] UNFPA, Lima, Peru; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Mohammad, Karzan Abdulmuhsin] Univ Salahaddin, Erbil, Iraq; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Moschandreas, Joanna] Univ Crete, Iraklion, Greece; [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany; [Muszynska, Magdalena M.] Warsaw Sch Econ, Warsaw, Poland; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, KwaZulu Natal, South Africa; [Nejjari, Chakib] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Dept Epidemiol & Publ Hlth, Fes, Morocco; [de Dieu Ngirabega, Jean] Rwanda Biomed Ctr, Kigali, Rwanda; [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena, Bolivar, Colombia; [Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Rahman, Sajjad U. R.] Hamad Med Corp, Doha, Qatar; [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Punjab, Pakistan; [Rushton, Lesley] Univ London Imperial Coll Sci Technol & Med, London, England; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Shin, Hwashin Hyun; Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Shishani, Kawkab] Washington State Univ, Spokane, WA USA; [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland; [Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Soshnikov, Sergey S.] Fed Res Inst Hlth Org, Moscow, Russia; [Soshnikov, Sergey S.] Informat Minist Hlth Russian Federat, Moscow, Russia; [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Ctr Dis Control, KEELPNO, Athens, Greece; [Tabb, Karen M.] Univ Illinois, Champaign, IL 61820 USA; [Talongwa, Roberto Tchio] Minist Hlth, Yaounde, Cameroon; [Teixeira, Carolina Maria] ARS Norte, Oporto, Portugal; [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thorne-Lyman, Andrew L.] Columbia Univ, New York, NY USA; [Thorne-Lyman, Andrew L.] Earth Inst, New York, NY USA; [Toyoshima, Hideaki] Hlth Care Ctr Anjo Kosei Hosp, Anjo, Aichi, Japan; [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, DEM REP CONGO; [Uwaliraye, Parfait] Minist Hlth, Kigali City, Rwanda; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Nogales Vasconcelos, Ana Maria] Univ Brasilia, Brasilia, DF, Brazil; [Vlassov, Vasiliy Victorovich] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Waller, Stephen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Wilkinson, James D.] Univ Miami, Miami, FL USA; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Yang, Gonghuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Yang C.] Univ N Carolina, Chapel Hill, NC USA; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodira, Tokyo, Japan; [Younis, Mustafa] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Hubei, Peoples R China; [Jin, Kim Yun] TCM MED TK SDN BHD, Nusajaya, Johor Bahru, Malaysia; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; World Health Organization; United States Agency for International Development (USAID); Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hacettepe University; Mekelle University; University of London; University College London; University of Melbourne; University of Melbourne; University System of Georgia; Albany State University; University of Groningen; Bahir Dar University; Emory University; Emory University; Mashhad University Medical Science; University of Birmingham; Stanford University; Yale University; Aga Khan University; Ministry of Health - Turkey; University of New South Wales Sydney; University of Arizona; University of Liverpool; Hanoi University of Public Health; Telethon Kids Institute; University of Western Australia; Universidad Autonoma Metropolitana - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Perugia; University Diego Portales; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of Cambridge; Cyprus University of Technology; Taipei Medical University; University of Salerno; Fundacao Oswaldo Cruz; Public Health Foundation of India; Public Health England; Addis Ababa University; University of Peradeniya; Harvard University; Harvard T.H. Chan School of Public Health; University of Western Australia; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska Institutet; Brandeis University; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; Wageningen University & Research; Agence de Medecine Preventive; University of Massachusetts System; University of Massachusetts Worcester; National Center for Global Health & Medicine - Japan; University of Queensland; University of Queensland; University of Sheffield; Arabian Gulf University; University of Oxford; Mazandaran University Medical Sciences; Yeshiva University; Albert Einstein College of Medicine; American Cancer Society; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Ruprecht Karls University Heidelberg; Vanderbilt University; University of California System; University of California San Francisco; South African Medical Research Council; National Center for Disease Control & Public Health - Georgia; Jordan University of Science & Technology; Seoul National University (SNU); Northeastern University; University of Canberra; Norwegian Institute of Public Health (NIPH); National Cerebral & Cardiovascular Center - Japan; National Institute of Health Research & Development (NIHRD); Universite de Montreal; International Institute for Population Sciences; Uppsala University; Korea University; National Institute for Health Development - Estonia; Universita degli Studi di Bari Aldo Moro; Universidade de Sao Paulo; Aintree University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Swansea University; Ministry of Health-Singapore; King George's Medical University; UERM Memorial Medical Center; Pacific Institute for Research & Evaluation (PIRE); University of Ottawa; Salahaddin University; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; University of Crete; Philipps University Marburg; Warsaw School of Economics; University of Kwazulu Natal; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Rwanda Biomedical Center; Makerere University; Teikyo University; Universidad de Cartagena; University of British Columbia; Hamad Medical Corporation; University of Punjab; Imperial College London; Marshall University; Fudan University; University of Tokyo; Health Canada; Washington State University; Heriot Watt University; Reykjavik University; University of Alabama System; University of Alabama Birmingham; Ministry of Health of the Russian Federation; Western University (University of Western Ontario); Alexandra Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; King Fahad Medical City; Columbia University; Universite de Kinshasa; UKK Institute; Universidade de Brasilia; HSE University (National Research University Higher School of Economics); Uniformed Services University of the Health Sciences - USA; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Miami; University of Nottingham; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Zhejiang University	Wang, HD (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	haidong@uw.edu	Bedi, Neeraj/H-2838-2019; Nyakarahuka, Luke/W-8164-2019; Hamadeh, Randah R./AAE-9720-2020; Idrisov, Bulat/A-8271-2018; Paternina-Caicedo, Angel/N-4496-2015; Zaki, Maysaa El Sayed/C-1522-2013; Montico, Marcella/B-5290-2013; Terkawi, Abdullah Suleiman/AAC-1113-2019; Khader, Yousef/AAE-9620-2019; Rakovac, Ivo/A-7678-2013; Lopez, Alan D/F-1487-2010; Wyk, Victoria Pillay-van/D-3567-2018; Ermakov, Sergey/G-1709-2016; Alvarez, Elena/S-1068-2019; Hankey, Graeme J/H-4968-2014; Dimbuene, Zacharie Tsala/H-3029-2019; Gona, Philimon/K-1477-2019; Hedayati, Mohammad T./E-2304-2017; Mokdad, Ali H./AAD-1232-2022; Ding, Eric L./K-1118-2019; Naohiro, Yonemoto/Y-3761-2019; Vasconcelos, Ana Maria Nogales/AAL-9776-2020; Zaki, Maysaa El Sayed/H-3049-2019; Soshnikov, Sergey/R-7352-2016; LOGROSCINO, GIANCARLO/K-5148-2016; Memish, Ziad Ahmed/AEJ-9424-2022; Chowdhury, Rajiv/AHB-1253-2022; Santos, Itamar/M-2208-2019; Lotufo, Paulo/A-9843-2008; wang, YA XING/K-9671-2016; Meretoja, Atte/G-7381-2014; Carapetis, Jonathan R/H-8933-2014; Castro, Ruben E/J-1948-2015; Monasta, Lorenzo/B-1388-2012; Hay, Simon Iain/F-8967-2015; McGrath, John Joseph/G-5493-2010; Amare, Azmeraw T./B-9487-2018; Weiderpass, Elisabete/M-4029-2016; Pourmalek, Farshad/A-8188-2010; Geleijnse, Johanna Marianna M/B-5749-2012; Ronfani, Luca/B-6668-2013; assadi, reza/AAT-6629-2020; Cunningham, Solveig A/K-6760-2012; Lee, Jong-Tae/AAF-5746-2020; Rojas-Rueda, David/AAK-2184-2020; SHIN, HS/AAE-5381-2022; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Lunevicius, Raimundas/B-2528-2018; ABBASOGLU OZGOREN, AYSE/I-8707-2013; Deribe, Kebede/K-7055-2019; Davis, Adrian C/E-6022-2015; Vasconcelos, Ana Maria Nogales/E-1935-2019; Sposato, Luciano A/D-7782-2012; Kinfu, Yohannes/AAC-8054-2020; Meretoja, Atte/H-6531-2019; Catalá-López, Ferrán/N-6018-2018; Banerjee, Amitava/D-4381-2014; assadi, reza/AAI-1124-2021; Waller, Stephen/AAI-1787-2020; Juel, Knud/C-8916-2013; Zhou, Maigeng/HCH-7703-2022; Lopez, Alan/AAA-2734-2022; Bell, Michelle/Y-4608-2018; Salomon, Joshua A/D-3898-2009; Soshnikov, Sergey/AAG-9739-2020; Courville, Karen/AAW-1462-2021; Li, Yichong/A-3559-2019; Deribe, Kebede/I-5422-2019; Bedi, Neeraj/AGR-0606-2022; Marzan, Melvin/AAP-8443-2020; Santos, Itamar S/K-7055-2012; Soshnikov, Sergey/AAV-8566-2020; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Salomon, Joshua/S-1929-2019; Foigt, Nataliya/AAU-5229-2020; Narayan, K.M. Venkat/J-9819-2012; Naidoo, Kovin Shunmugam/AAF-5914-2020; CASO, VALERIA/AAC-5156-2022; Nieuwenhuijsen, Mark J/C-3914-2017; Singh, Jasvinder/R-6172-2019; Leinsalu, Mall/I-3768-2018; Rana, Saleem M/Y-9791-2018; Cunningham, Solveig/W-2672-2019; Prabhakaran, Dorairaj/B-4147-2011; Weiderpass, Elisabete/AAP-2747-2021; Nyakarahuka, Luke/AGH-2432-2022; Vasconcelos, Ana/AAK-4526-2020; Kengne, Andre Pascal/ABB-3696-2020; Vlassov, Vasiliy/B-4036-2014; Kuate Defo, Barthelemy/I-4818-2017; Cirillo, Massimo/G-5480-2018	Bedi, Neeraj/0000-0003-4709-8423; Nyakarahuka, Luke/0000-0002-2944-9157; Hamadeh, Randah R./0000-0002-4205-1354; Paternina-Caicedo, Angel/0000-0002-6332-5174; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Montico, Marcella/0000-0003-0377-8232; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Khader, Yousef/0000-0002-7830-6857; Rakovac, Ivo/0000-0003-3462-2636; Lopez, Alan D/0000-0001-5818-6512; Wyk, Victoria Pillay-van/0000-0001-8772-7197; Ermakov, Sergey/0000-0003-1072-1162; Alvarez, Elena/0000-0002-9679-2721; Hankey, Graeme J/0000-0002-6044-7328; Dimbuene, Zacharie Tsala/0000-0002-7977-1689; Hedayati, Mohammad T./0000-0001-6415-4648; Mokdad, Ali H./0000-0002-4994-3339; Ding, Eric L./0000-0002-5881-8097; Vasconcelos, Ana Maria Nogales/0000-0001-7589-107X; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Soshnikov, Sergey/0000-0002-6983-7066; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Memish, Ziad Ahmed/0000-0002-5099-0714; Santos, Itamar/0000-0003-3212-8466; Lotufo, Paulo/0000-0002-4856-8450; wang, YA XING/0000-0003-2749-7793; Meretoja, Atte/0000-0001-6433-1931; Carapetis, Jonathan R/0000-0002-1182-9792; Castro, Ruben E/0000-0002-7289-9081; Monasta, Lorenzo/0000-0001-7774-548X; Hay, Simon Iain/0000-0002-0611-7272; McGrath, John Joseph/0000-0002-4792-6068; Amare, Azmeraw T./0000-0002-7940-0335; Weiderpass, Elisabete/0000-0003-2237-0128; Pourmalek, Farshad/0000-0002-2134-0771; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Ronfani, Luca/0000-0001-5710-3914; Cunningham, Solveig A/0000-0002-2354-1526; Lee, Jong-Tae/0000-0002-8510-3054; Rojas-Rueda, David/0000-0001-5854-2484; SHIN, HS/0000-0002-7263-6257; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Lunevicius, Raimundas/0000-0003-3295-0142; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; Davis, Adrian C/0000-0001-7134-7528; Sposato, Luciano A/0000-0001-6425-9343; Kinfu, Yohannes/0000-0001-9607-6891; Meretoja, Atte/0000-0001-6433-1931; Catalá-López, Ferrán/0000-0002-3833-9312; Banerjee, Amitava/0000-0001-8741-3411; Bell, Michelle/0000-0002-3965-1359; Salomon, Joshua A/0000-0003-3929-5515; Soshnikov, Sergey/0000-0002-6983-7066; Courville, Karen/0000-0002-4182-6736; Li, Yichong/0000-0003-3842-475X; Deribe, Kebede/0000-0002-8526-6996; Bedi, Neeraj/0000-0003-4709-8423; Marzan, Melvin/0000-0003-2696-7335; Santos, Itamar S/0000-0003-3212-8466; Salomon, Joshua/0000-0003-3929-5515; Foigt, Nataliya/0000-0002-3613-5965; Narayan, K.M. Venkat/0000-0001-8621-5405; CASO, VALERIA/0000-0002-2020-8891; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Singh, Jasvinder/0000-0003-3485-0006; Leinsalu, Mall/0000-0003-4453-4760; Rana, Saleem M/0000-0001-6479-9235; Prabhakaran, Dorairaj/0000-0002-3172-834X; Weiderpass, Elisabete/0000-0003-2237-0128; Nyakarahuka, Luke/0000-0002-2944-9157; Ohkubo, Takayoshi/0000-0002-3283-8196; Islami, Farhad/0000-0002-7357-5994; Mahdi, Abbas Ali/0000-0002-8580-9911; Farzadfar, Farshad/0000-0001-8288-4046; Goto, Atsushi/0000-0003-0669-654X; Shiue, Ivy/0000-0003-1788-3009; Vlassov, Vasiliy/0000-0001-5203-549X; Rakovac, Ivo/0000-0002-6815-5274; Abubakar, Ibrahim/0000-0002-0370-1430; Pope, Daniel/0000-0003-2694-5478; Kim, Daniel/0000-0001-8907-6420; Juel, Knud/0000-0002-4134-1173; williams, hywel/0000-0002-5646-3093; Khang, Young-Ho/0000-0002-9585-8266; Kuate Defo, Barthelemy/0000-0002-6589-0564; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Kengne, Andre Pascal/0000-0002-5183-131X; Cavlin, Alanur/0000-0001-9714-9984; Levitz, Carly/0000-0003-3094-411X; Boufous, Soufiane/0000-0002-5686-1729; Coates, Matthew/0000-0002-8474-4992; Green, Mark/0000-0002-0942-6628; Gouda, Hebe/0000-0002-5709-4509; Cirillo, Massimo/0000-0002-6409-3504; Shibuya, Kenji/0000-0003-2528-7530; Muszynska-Spielauer, Magdalena/0000-0002-1591-6893; Dandona, Rakhi/0000-0003-0926-788X; Jha, Vivekanand/0000-0002-8015-9470; Idrisov, Bulat/0000-0002-1971-2572; Che, Xuan/0000-0001-7981-6456; Miller, Ted/0000-0002-0958-2639; Achoki, Tom/0000-0001-6309-8904; WILKINSON, JAMES/0000-0003-1945-5622; Lyons, Ronan/0000-0001-5225-000X; Assadi, Reza/0000-0002-5016-2994; Christophi, Christopher/0000-0002-1349-0884; Dherani, Mukesh/0000-0002-3055-9636; Tabb Dina, Karen/0000-0002-4722-9502	Bill & Melinda Gates Foundation; US Agency for International Development; MRC [MR/K023233/1, MR/L003120/1, MR/K006525/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/K006525/1, MR/K023233/1, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, CL-2010-09-002] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the countless individuals who have contributed to the Global Burden of Disease Study 2013 in various capacities. We would also like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank:; Michael F MacIntyre, Peter Speyer, and Summer Lockett Ohno for their management of the Global Burden of Disease Study 2013; Rafael Lozano for his expert input on results; Peter Speyer, James Bullard, Serkan Yalcin, Edgar Sioson, Andrew Ernst, and Bill Britt for their tireless support of the computational infrastructure required to produce the results;; Linda Ettinger for her expert administrative support; Peter Speyer, Abigail McLain, Eden Stork, Brent Bell, Noelle Nightingale, Jamie Hancock, Lyla E Medeiros, Rachel Woodbrook, Natalie Stephens, Elissa Thomas, Erica Leigh Nelson, Stephanie R Atkinson, and Matthew Israelson for their persistent and invaluable work to gain access to and catalogue as much data as possible to inform the estimates; Timothy M Wolock, Ryan M Barber, Emily A Dansereau, D Allen Roberts, Katrina Ortblad, Herbert C Duber, Megan S Coggeshall, Elizabeth K Johnson, and Jonathan C Brown for their extensive efforts to develop and improve the HIV modeling process;; Madeline L Moyer, Katya A Shackelford, Maggie Lind, and Lavanya Singh for their work extracting essential data; Erin C Mullany and Gillian Hansen for their systematic efforts organising correspondence with co-authors; and Katya A Shackelford, Madeline L Moyer, Megan S Coggeshall, Gillian Hansen, Farah Daoud, and Christopher Margono for their work fact-checking and proofing the final report. No individuals acknowledged received additional compensation for their efforts. This study was funded by the Bill & Melinda Gates Foundation and the US Agency for International Development.	Adamson P, 2001, J GRANT UNICEF VISIO; Alkema L, 2013, GLOBAL ESTIMATION CH; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; [Anonymous], LEV TRENDS CHILD MOR; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bell A, 2013, EXPLAINING FIXED EFF; Bill and Melinda Gates Foundation, 2012, FAM PLANN STRAT OV FAM PLANN STRAT OV; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; Bulatao R., 1998, VALUE FAMILY PLANNIN; Buor D, 2003, HEALTH POLICY, V64, P297, DOI 10.1016/S0168-8510(02)00178-1; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cutler D.M., 2006, DETERMINANTS MORTALI; Dacuycuy L, 2012, APPL ECON LETT, V19, P1279, DOI 10.1080/13504851.2011.619486; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Doces JA, 2007, DEMOCRACY CHILD MORT; Elo IT, 1982, SOC SCI MED, V1996, P47; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; Fukuda-Parr S, 2004, GLOBAL GOV, V10, P395, DOI 10.1163/19426720-01004001; Futures Institute, SPECTR MAN SPECTR SY; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; GAVI Alliance, 2010, INV IMM GAVI ALL; Girard F, 2010, SCIENCE, V329, P147, DOI 10.1126/science.1193294; Guillot M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001299; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Hill K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P15; Horiuchi S, 2008, DEMOGRAPHY, V45, P785; Institute for Health Metrics and Evaluation, 2013, GBD 2013 GLOB BURD D; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; Lazarova EA, 2006, ANN PUBLIC COOP ECON, V77, P385, DOI 10.1111/j.1467-8292.2006.00311.x; LENA HF, 1993, INT J HEALTH SERV, V23, P585, DOI 10.2190/EQUY-ACG8-X59F-AE99; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lutz, 2010, VIENNA YEARB POPUL R, V8, P175, DOI DOI 10.1553/populationyearbook2010s175; Lynch S, 2012, SCIENCE, V337, P298, DOI 10.1126/science.1225702; Madden D, 2012, J R STAT SOC A STAT, V175, P893, DOI 10.1111/j.1467-985X.2011.01020.x; Mahler H., 1981, MEANING HLTH ALL YEA; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2013, LANCET UNPUB; Navia P, 2003, J DEMOCR, V14, P90, DOI 10.1353/jod.2003.0059; Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872; O'Hare B, 2013, J ROY SOC MED, V106, P408, DOI 10.1177/0141076813489680; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Partnership for Maternal Newborn & Child Health, 2013, PMNCH 2013 REP AN PR; Patel MM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001330; Pena R, 2000, AM J PUBLIC HEALTH, V90, P64, DOI 10.2105/AJPH.90.1.64; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Saith A, 2006, DEV CHANGE, V37, P1167, DOI 10.1111/j.1467-7660.2006.00518.x; Secretary-General UN, 2004, INT COORD IMPL FOLL; Shandra JM, 2004, SOC SCI MED, V59, P321, DOI 10.1016/j.socscimed.2003.10.022; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The Partnership for Maternal Newborn and Child Health, 2013, REACH EV WOM EV CHIL; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF, 2011, LEV TRENDS CHILD MOR; United Nations Department of International Economic and Social Affairs, 1985, SOC EC DIFF CHILD MO; United Nations Department of International Economic and Social Affairs, 1988, MORT CHILDR AG 5 WOR; United Nations Population Division, 2013, UN WORLD POP PROSP 1; USAID, 2012, CHILD SURV CALL ACT; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, 2011, IMCI INS TRAIN; World Health Organization, WORLD HLTH REP 2000; You D., 2010, LEVELS TRENDS CHILD; Zweifel TD, 2000, J DEMOCR, V11, P99	86	426	443	3	252	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					957	979		10.1016/S0140-6736(14)60497-9	http://dx.doi.org/10.1016/S0140-6736(14)60497-9			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	24797572	Green Accepted, Green Submitted			2022-12-28	WOS:000341679700030
J	Atun, R				Atun, Rifat			Decisive action to end apathy and achieve 25x25 NCD targets	LANCET			English	Editorial Material							NONCOMMUNICABLE DISEASES; HEALTH		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				[Anonymous], 2014, LANCET; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Bloom DE, 2011, GLOBAL EC BURDEN NON; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Institute for Health Metrics and Evaluation, 2013, FIN GLOB HLTH 2013 T; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; United Nations, 2011, REPORT SPECIAL RAPPO; World Health Organization, 2010, PACK ESS NONC PEN DI	14	12	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					384	385		10.1016/S0140-6736(14)60728-5	http://dx.doi.org/10.1016/S0140-6736(14)60728-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24797574				2022-12-28	WOS:000340195800007
J	Bhutta, ZA; Das, JK; Bahl, R; Lawn, JE; Salam, RA; Paul, VK; Sankar, MJ; Blencowe, H; Rizvi, A; Chou, VB; Walker, N				Bhutta, Zulfiqar A.; Das, Jai K.; Bahl, Rajiv; Lawn, Joy E.; Salam, Rehana A.; Paul, Vinod K.; Sankar, M. Jeeva; Blencowe, Hannah; Rizvi, Arjumand; Chou, Victoria B.; Walker, Neff		Lancet Newborn Interventions; Lancet Every Newborn Study Grp	Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CONTRACEPTIVE SERVICE INTERVENTIONS; NEONATAL DEATHS; CHILD HEALTH; INTEGRATED MANAGEMENT; NARRATIVE SYNTHESIS; DELPHI ESTIMATION; PRETERM BIRTH; YOUNG-PEOPLE; PREGNANCY	Progress in newborn survival has been slow, and even more so for reductions in stillbirths. To meet Every Newborn targets of ten or fewer neonatal deaths and ten or fewer stillbirths per 1000 births in every country by 2035 will necessitate accelerated scale-up of the most effective care targeting major causes of newborn deaths. We have systematically reviewed interventions across the continuum of care and various delivery platforms, and then modelled the effect and cost of scale-up in the 75 high-burden Countdown countries. Closure of the quality gap through the provision of effective care for all women and newborn babies delivering in facilities could prevent an estimated 113 000 maternal deaths, 531 000 stillbirths, and 1.325 million neonatal deaths annually by 2020 at an estimated running cost of US$4.5 billion per year (US$0.9 per person). Increased coverage and quality of preconception, antenatal, intrapartum, and postnatal interventions by 2025 could avert 71% of neonatal deaths (1.9 million [range 1.6-2.1 million]), 33% of stillbirths (0.82 million [0.60-0.93 million]), and 54% of maternal deaths (0.16 million [0.14-0.17 million]) per year. These reductions can be achieved at an annual incremental running cost of US$5.65 billion (US$1.15 per person), which amounts to US$ 1928 for each life saved, including stillbirths, neonatal, and maternal deaths. Most (82%) of this effect is attributable to facility-based care which, although more expensive than community-based strategies, improves the likelihood of survival. Most of the running costs are also for facility-based care (US$3.66 billion or 64%), even without the cost of new hospitals and country-specific capital inputs being factored in. The maximum effect on neonatal deaths is through interventions delivered during labour and birth, including for obstetric complications (41%), followed by care of small and ill newborn babies (30%). To meet the unmet need for family planning with modern contraceptives would be synergistic, and would contribute to around a halving of births and therefore deaths. Our analysis also indicates that available interventions can reduce the three most common cause of neonatal mortality-preterm, intrapartum, and infection-related deaths-by 58%, 79%, and 84%, respectively.	[Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.; Das, Jai K.; Salam, Rehana A.; Rizvi, Arjumand] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bahl, Rajiv] WHO, CH-1211 Geneva, Switzerland; [Lawn, Joy E.; Blencowe, Hannah] London Sch Hyg & Trop Med, Maternal Adolescent Reprod & Child Hlth MARCH Ctr, London WC1, England; [Lawn, Joy E.] Save Children, Saving Newborn Lives, Washington, DC USA; [Lawn, Joy E.] UK AID, Res & Evidence Div, London, England; [Paul, Vinod K.; Sankar, M. Jeeva] All India Inst Med Sci, New Delhi, India; [Chou, Victoria B.; Walker, Neff] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Save the Children; All India Institute of Medical Sciences (AIIMS) New Delhi; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bhutta, ZA (corresponding author), Peter Gilgan Ctr Res & Learning, Ctr Global Child Hlth, 686 Bay St, Toronto, ON M5G 0A4, Canada.	zulfiqar.bhutta@sickkids.ca	Sankar, Jeeva/Q-1007-2019; Lawn, Joy/ABE-6382-2020	Sankar, Jeeva/0000-0003-1474-1451; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159; Rizvi, Arjumand/0000-0003-4553-8130; McDougall, Lori/0000-0002-1885-5344; Das, Jai/0000-0002-2966-7162; Abdus Salam, Rehana/0000-0001-5423-7343	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	RB's views are his own and do not represent the official position of WHO. The systematic reviews and the consultative meetings were supported by unrestricted support to various review group members from the Aga Khan University, WHO, Mother and Child Care Trust, Save the Children (USA), and grants from Bill & Melinda Gates Foundation to the US Fund for UNICEF. None of the funding bodies had any influence on the content and scope of the paper. We thank Smisha Agarwal and Alain Labrique (USAID) for information about mHealth interventions for newborn survival and Ingrid Friberg (JHU) for her support towards the LiST analyses. We thank Akber Ali for his assistance in the logistics around communications and the preparation of this report.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Amudhan S, 2013, INT J EPIDEMIOL, V42, P769, DOI 10.1093/ije/dyt071; Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; Arrowsmith ME, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008896.pub2; Balas EA, 1997, JAMA-J AM MED ASSOC, V278, P152, DOI 10.1001/jama.278.2.152; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, BRIT MED J, V329, P1151, DOI 10.1136/bmj.329.7475.1151; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blank L, 2012, HEALTH EDUC RES, V27, P1102, DOI 10.1093/her/cys056; Blank L, 2010, J PEDIATR ADOL GYNEC, V23, P341, DOI 10.1016/j.jpag.2010.03.007; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Cheung NW, 2005, AUST NZ J OBSTET GYN, V45, P479, DOI 10.1111/j.1479-828X.2005.00480.x; Chowdhary N, 2014, BEST PRACT RES CL OB, V28, P113, DOI 10.1016/j.bpobgyn.2013.08.013; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Cousens S, 2010, INT J EPIDEMIOL, V39, P134, DOI 10.1093/ije/dyq030; Crawley H., 2001, COCHRANE DB SYST REV, V2; Crowther C., 2000, COCHRANE DB SYST REV, V1997, DOI DOI 10.1002/14651858.CD000021; Crowther CA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000020.pub2; Darlow BA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000501.pub2; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Darmstadt GL, 2011, ARCH DIS CHILD, V96, P1140, DOI 10.1136/archdischild-2011-300591; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Dean SV, 2013, NESTLE NUTR WORKS SE, V74, P63, DOI 10.1159/000348402; Debes AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S19; Devane D., 2012, COCHRANE DB SYST REV, V2; Di Mario S, 2013, COCHRANE DB SYST REV, V2; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001240.pub2; FEDRICK J, 1973, BMJ-BRIT MED J, V4, P753, DOI 10.1136/bmj.4.5895.753; Fisk N.M., 2001, TURNBULLS OBSTET, V3rd Edition, P197; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; GULMEZOGLU AM, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004945.PUB2; Guttmacher Institute, FACTS INV FAM PLANN; Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2; Haldre K, 2007, EUR J OBSTET GYN R B, V131, P45, DOI 10.1016/j.ejogrb.2006.05.002; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Ho J J, 2002, Cochrane Database Syst Rev, pCD002271; Hodnett ED, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub3; Hodnett ED, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000198.pub2; Hollier LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004946.pub2; Homer CSE, LANCET IN PRESS; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Imdad A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008635.pub2; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jabeen M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S6; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Karanth L, 2013, COCHRANE DB SYST REV, V3; Kawaza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086327; Kumar P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007969.pub2; Lassi Z.S., 2013, EXPERT REV OBSTET GY, V8, P639, DOI [10.1586/17474108.2013.841453, DOI 10.1586/17474108.2013.841453]; Lassi ZS, 2010, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD007754.PUB2; Lavender T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub2; Lawn J, 2005, PRICE TAG NEWBORN CH; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006964.pub3; Lopez LM, 2012, COCHRANE DB SYST REV, V15; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mason E, 2014, LANCET; McCarthy FP, 2011, COCHRANE DB SYST REV, V3; Mehra Sunil, 2004, Indian Pediatr, V41, P137; Mittal K, 2014, INDIAN J PEDIATR, V81, P797, DOI 10.1007/s12098-013-1225-2; Moore ER, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub2; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Newell ML, 2013, CURR OPIN HIV AIDS, V8, P504, DOI 10.1097/COH.0b013e3283632b88; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007467.pub3; Opiyo N, 2010, COCHRANE DB SYST REV, V4; ORINGANJE C, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005215.PUB2; Osborn DA, 2010, COCHRANE DB SYST REV; Osborn DA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002059.pub3; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Pauliah SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058834; Peyron F, 2000, COCHRANE DB SYST REV, V3; Piper AJ, 2008, THORAX, V63, P395, DOI 10.1136/thx.2007.081315; PLoS Medicine Editors, 2010, PLOS MED, V7; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Puckett RM., 2000, COCHRANE DB SYST REV; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Renfrew Mary J, 2012, Cochrane Database Syst Rev, pCD001141, DOI 10.1002/14651858.CD001141.pub4; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S31; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Singh S, 2009, ADDING IT COSTS BENE; Smaill F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub2; Soll RF, 1997, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000511; Spector JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035151; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Swadpanich U, 2008, COCHRANE DB SYST REV, V2; Tan K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006818.pub2; Taskforce for innovative international financing for health systems, 2009, MOR MON HLTH MOR HLT; UNICEF, 2011, CHILD HLTH DAYS 1999; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Wagaarachchi PT, 2002, EUR J OBSTET GYN R B, V101, P36, DOI 10.1016/S0301-2115(01)00510-3; WHO, OPT DUR EXCL BREASTF; WHO, 2009, WHO IMM SURV ASS MON; WHO Commission on Macroeconomics and Health, 2002, IMPR HLTH OUTC POOR; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Health Organization, 2012, DAIL IR FOL AC SUPPL; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization (WHO), 2007, WHO DISC PAP AD; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S7; Zaidi AKM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S13; Zaidi S, RES BAS FIN MECH IMP	141	693	707	7	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					347	370		10.1016/S0140-6736(14)60792-3	http://dx.doi.org/10.1016/S0140-6736(14)60792-3			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24853604				2022-12-28	WOS:000339722400032
J	Roman, BR; Asch, DA				Roman, Benjamin R.; Asch, David A.			Faded Promises: The Challenge of Deadopting Low-Value Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Robert Wood Johnson Fdn Clin Scholars Program, Ctr Hlth Equity Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Equity Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Head & Neck Serv, New York, NY 10021 USA	Robert Wood Johnson Foundation (RWJF); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Memorial Sloan Kettering Cancer Center	Asch, DA (corresponding author), Blockley Hall 1123,423 Guardian Dr, Philadelphia, PA 19104 USA.	asch@wharton.upenn.edu		Asch, David/0000-0002-7970-286X				Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Pollack A, 2014, NY TIMES, pB1; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; SIEGLER M, 1975, NEW ENGL J MED, V293, P853, DOI 10.1056/NEJM197510232931705; Squiers LB, 2013, AM J PREV MED, V45, P182, DOI 10.1016/j.amepre.2013.04.005; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806	8	47	47	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					149	+		10.7326/M14-0212	http://dx.doi.org/10.7326/M14-0212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM3PJ	24781317				2022-12-28	WOS:000339764600026
J	Sklansky, M; Nadkarni, N; Ramirez-Avila, L				Sklansky, Mark; Nadkarni, Nikhil; Ramirez-Avila, Lynn			Banning the Handshake From the Health Care Setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSMISSION		[Sklansky, Mark] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Cardiol,Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Nadkarni, Nikhil] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ramirez-Avila, Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis,Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Ramirez-Avila, Lynn] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Sklansky, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, 200 Med Plaza,Ste 330, Los Angeles, CA 90095 USA.	msklansky@mednet.ucla.edu						Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Doring G, 1996, PEDIATR PULM, V21, P90, DOI 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO;2-T; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Ghareeb PA, 2013, J HOSP INFECT, V85, P321, DOI 10.1016/j.jhin.2013.08.010; HAMBURGER M, 1947, AM J MED, V2, P23, DOI 10.1016/0002-9343(47)90003-X; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; KINGERY F A, 1964, JAMA, V189, P850	7	18	18	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2477	2478		10.1001/jama.2014.4675	http://dx.doi.org/10.1001/jama.2014.4675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24833502				2022-12-28	WOS:000337757000016
J	Myers, SS; Zanobetti, A; Kloog, I; Huybers, P; Leakey, ADB; Bloom, AJ; Carlisle, E; Dietterich, LH; Fitzgerald, G; Hasegawa, T; Holbrook, NM; Nelson, RL; Ottman, MJ; Raboy, V; Sakai, H; Sartor, KA; Schwartz, J; Seneweera, S; Tausz, M; Usui, Y				Myers, Samuel S.; Zanobetti, Antonella; Kloog, Itai; Huybers, Peter; Leakey, Andrew D. B.; Bloom, Arnold J.; Carlisle, Eli; Dietterich, Lee H.; Fitzgerald, Glenn; Hasegawa, Toshihiro; Holbrook, N. Michele; Nelson, Randall L.; Ottman, Michael J.; Raboy, Victor; Sakai, Hidemitsu; Sartor, Karla A.; Schwartz, Joel; Seneweera, Saman; Tausz, Michael; Usui, Yasuhiro			Increasing CO2 threatens human nutrition	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATION; ELEVATED CO2; ENRICHMENT FACE; SPRING WHEAT; GRAIN-YIELD; NITROGEN; QUALITY; PROTEIN; CEREALS; GROWTH	Dietary deficiencies of zinc and iron are a substantial global public health problem. An estimated two billion people suffer these deficiencies(1), causing a loss of 63 million life-years annually(2,3). Most of these people depend on C-3 grains and legumes as their primary dietary source of zinc and iron. Here we report that C-3 grains and legumes have lower concentrations of zinc and iron when grown under field conditions at the elevated atmospheric CO2 concentration predicted for the middle of this century. C-3 crops other than legumes also have lower concentrations of protein, whereas C-4 crops seem to be less affected. Differences between cultivars of a single crop suggest that breeding for decreased sensitivity to atmospheric CO2 concentration could partly address these new challenges to global health.	[Myers, Samuel S.; Zanobetti, Antonella; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Myers, Samuel S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Kloog, Itai] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Huybers, Peter] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Leakey, Andrew D. B.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Leakey, Andrew D. B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Bloom, Arnold J.; Carlisle, Eli] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Dietterich, Lee H.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Fitzgerald, Glenn] Dept Environm & Primary Ind, Horsham, Vic 3001, Australia; [Hasegawa, Toshihiro; Sakai, Hidemitsu; Usui, Yasuhiro] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Holbrook, N. Michele] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Nelson, Randall L.] Univ Illinois, USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Dept Crop Sci, Urbana, IL 61801 USA; [Ottman, Michael J.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Raboy, Victor] USDA ARS, Aberdeen, ID 83210 USA; [Sartor, Karla A.] Nature Conservancy, Santa Fe, NM 87544 USA; [Seneweera, Saman] Univ Melbourne, Dept Agr & Food Syst, Melbourne Sch Land & Environm, Creswick, Vic 3363, Australia; [Tausz, Michael] Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne Sch Land & Environm, Creswick, Vic 3363, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Ben Gurion University; Harvard University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; University of Pennsylvania; National Institute for Agro-Environmental Sciences (NIAES) Japan; Harvard University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Arizona; United States Department of Agriculture (USDA); Nature Conservancy; University of Melbourne; University of Melbourne	Myers, SS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.	smyers@hsph.harvard.edu	Hasegawa, Toshihiro/H-8211-2019; Seneweera, Saman/H-3770-2012; Usui, Yasuhiro/AAD-7621-2020; Tausz, Michael/C-1990-2013; Seneweera, Saman/AAX-9011-2021; Tausz, Michael/AHC-9128-2022; Leakey, Andrew DB/Q-9889-2016	Hasegawa, Toshihiro/0000-0001-8501-5612; Seneweera, Saman/0000-0001-5147-9988; Usui, Yasuhiro/0000-0003-3239-0907; Tausz, Michael/0000-0001-8205-8561; Tausz, Michael/0000-0001-8205-8561; Leakey, Andrew DB/0000-0001-6251-024X; Sakai, Hidemitsu/0000-0003-4790-1933; Huybers, Peter/0000-0002-3734-8145	Bill & Melinda Gates Foundation; Winslow Foundation; Commonwealth Department of Agriculture (Australia); International Plant Nutrition Institute, (Australia); Grains Research and Development Corporation (Australia); Ministry of Agriculture, Forestry and Fisheries (Japan); National Science Foundation (NSF) [IOS-08-18435]; USDA NIFA [2008-35100-044459]; US Department of Agriculture Agricultural Research Service; Illinois Council for Food and Agricultural Research (CFAR); Department of Energy's Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University [DEFC02- 06ER64158]; National Research Initiative of Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2010-65114-20343]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [8UL1TR000170-05]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Winslow Foundation; Commonwealth Department of Agriculture (Australia); International Plant Nutrition Institute, (Australia); Grains Research and Development Corporation (Australia)(Grains R&D Corp); Ministry of Agriculture, Forestry and Fisheries (Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); National Science Foundation (NSF)(National Science Foundation (NSF)); USDA NIFA(United States Department of Agriculture (USDA)); US Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Illinois Council for Food and Agricultural Research (CFAR); Department of Energy's Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University(United States Department of Energy (DOE)); National Research Initiative of Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. S. De la Puente, M. Erbs, A. Fangmeier, P. Hogy, M. Lieffering, R. Manderscheid, H. Pleijel and S. Prior for sharing data from their groups with us; H. Nakamura, T. Tokida, C. Zhu and S. Yoshinaga for contributions to the rice FACE project; and M. Hambidge, W. Willett, D. Schrag, K. Brown, R. Wessells, N. Fernando, J. Peerson and B. Kimball for reviews of earlier drafts or conceptual contributions to this project. V. R. thanks A. L. Harvey for her efforts in producing the phytate data included here. The National Agriculture and Food Research Organization (Japan) provided the grain samples of some rice cultivars. We thank the following for financial support of this work: the Bill & Melinda Gates Foundation; the Winslow Foundation; the Commonwealth Department of Agriculture (Australia), the International Plant Nutrition Institute, (Australia), the Grains Research and Development Corporation (Australia), the Ministry of Agriculture, Forestry and Fisheries (Japan); the National Science Foundation (NSF IOS-08-18435); USDA NIFA 2008-35100-044459; research at SoyFACE was supported by the US Department of Agriculture Agricultural Research Service; Illinois Council for Food and Agricultural Research (CFAR); Department of Energy's Office of Science (BER) Midwestern Regional Center of the National Institute for Climatic Change Research at Michigan Technological University, under Award Number DEFC02- 06ER64158; and the National Research Initiative of Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65114-20343 from the USDA National Institute of Food and Agriculture. Early stages of this work received support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05).	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bloom AJ, 2012, ECOLOGY, V93, P355, DOI 10.1890/11-0485.1; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; De la Puente LS, 2000, AGROCHIMICA, V44, P221; Duval BD, 2012, PLANT ECOL, V213, P505, DOI 10.1007/s11258-011-9998-8; Erbs M, 2010, AGR ECOSYST ENVIRON, V136, P59, DOI 10.1016/j.agee.2009.11.009; Ezzati M, 2004, COMP QUANTIFICATION, V1; Fangmeier A, 1997, ENVIRON POLLUT, V96, P43, DOI 10.1016/S0269-7491(97)00013-4; Fisher B, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P169; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Gillespie KM, 2012, PLANT CELL ENVIRON, V35, P169, DOI 10.1111/j.1365-3040.2011.02427.x; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; Hogy P, 2009, EUR J AGRON, V30, P85, DOI 10.1016/j.eja.2008.07.006; Hogy P, 2009, PLANT BIOLOGY, V11, P60, DOI 10.1111/j.1438-8677.2009.00230.x; Horwitz W, 2006, OFFICIAL METHODS ANA, P5; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Lieffering M, 2004, FIELD CROP RES, V88, P279, DOI 10.1016/j.fcr.2004.01.004; MANDERSCHEID R, 1995, AGR ECOSYST ENVIRON, V54, P175, DOI 10.1016/0167-8809(95)00602-O; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; McGrath JM, 2013, PLANT CELL ENVIRON, V36, P697, DOI 10.1111/pce.12007; Miller LV, 2007, J NUTR, V137, P135, DOI 10.1093/jn/137.1.135; Millward DJ, 2012, BRIT J NUTR, V108, pS3, DOI 10.1017/S0007114512002450; Mollah M, 2009, CROP PASTURE SCI, V60, P697, DOI 10.1071/CP08354; Monasterio Ivan, 2000, Food and Nutrition Bulletin, V21, P392; MOSSE J, 1990, J AGR FOOD CHEM, V38, P18, DOI 10.1021/jf00091a004; Mullany L., 2004, COMP QUANTIFICATION, V1; Ottman MJ, 2001, NEW PHYTOL, V150, P261, DOI 10.1046/j.1469-8137.2001.00110.x; Pleijel H, 2000, PHYSIOL PLANTARUM, V108, P61, DOI 10.1034/j.1399-3054.2000.108001061.x; Prior SA, 2008, J PLANT NUTR, V31, P758, DOI 10.1080/01904160801928364; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; SAH RN, 1992, ANAL CHEM, V64, P230, DOI 10.1021/ac00026a026; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Searle SR., 1992, VARIANCE COMPONENTS; Seneweera SP, 1997, SOIL SCI PLANT NUTR, V43, P1131; Swaminathan S, 2012, BRIT J NUTR, V108, pS50, DOI 10.1017/S0007114512002413; Tulchinsky TH, 2010, PUBLIC HEALTH REV, V32, P243, DOI 10.1007/BF03391600; Wuehler SE, 2005, PUBLIC HEALTH NUTR, V8, P812, DOI 10.1079/PHN2005724	41	677	715	21	541	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					139	+		10.1038/nature13179	http://dx.doi.org/10.1038/nature13179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24805231	Green Accepted			2022-12-28	WOS:000336768900044
J	King, TE; Bradford, WZ; Castro-Bernardini, S; Fagan, EA; Glaspole, I; Glassberg, MK; Gorina, E; Hopkins, PM; Kardatzke, D; Lancaster, L; Lederer, DJ; Nathan, SD; Pereira, CA; Sahn, SA; Sussman, R; Swigris, JJ; Noble, PW				King, Talmadge E., Jr.; Bradford, Williamson Z.; Castro-Bernardini, Socorro; Fagan, Elizabeth A.; Glaspole, Ian; Glassberg, Marilyn K.; Gorina, Eduard; Hopkins, Peter M.; Kardatzke, David; Lancaster, Lisa; Lederer, David J.; Nathan, Steven D.; Pereira, Carlos A.; Sahn, Steven A.; Sussman, Robert; Swigris, Jeffrey J.; Noble, Paul W.		ASCEND Study Grp	A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FORCED VITAL CAPACITY; INTERSTITIAL PNEUMONIA; HISTOLOGIC PATTERN; MORTALITY; PREDICTOR; SURVIVAL; DISTANCE	BACKGROUND In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by the decline in forced vital capacity (FVC) or vital capacity, in patients with idiopathic pulmonary fibrosis; in the third trial, this end point was not achieved. We sought to confirm the beneficial effect of pirfenidone on disease progression in such patients. METHODS In this phase 3 study, we randomly assigned 555 patients with idiopathic pulmonary fibrosis to receive either oral pirfenidone (2403 mg per day) or placebo for 52 weeks. The primary end point was the change in FVC or death at week 52. Secondary end points were the 6-minute walk distance, progression-free survival, dyspnea, and death from any cause or from idiopathic pulmonary fibrosis. RESULTS In the pirfenidone group, as compared with the placebo group, there was a relative reduction of 47.9% in the proportion of patients who had an absolute decline of 10 percentage points or more in the percentage of the predicted FVC or who died; there was also a relative increase of 132.5% in the proportion of patients with no decline in FVC (P<0.001). Pirfenidone reduced the decline in the 6-minute walk distance (P=0.04) and improved progression-free survival (P<0.001). There was no significant between-group difference in dyspnea scores (P=0.16) or in rates of death from any cause (P=0.10) or from idiopathic pulmonary fibrosis (P=0.23). However, in a prespecified pooled analysis incorporating results from two previous phase 3 trials, the between-group difference favoring pirfenidone was significant for death from any cause (P=0.01) and from idiopathic pulmonary fibrosis (P=0.006). Gastrointestinal and skin-related adverse events were more common in the pirfenidone group than in the placebo group but rarely led to treatment discontinuation. CONCLUSIONS Pirfenidone, as compared with placebo, reduced disease progression, as reflected by lung function, exercise tolerance, and progression-free survival, in patients with idiopathic pulmonary fibrosis. Treatment was associated with an acceptable side-effect profile and fewer deaths. (Funded by InterMune; ASCEND ClinicalTrials.gov number, NCT01366209.)	[King, Talmadge E., Jr.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bradford, Williamson Z.; Fagan, Elizabeth A.; Gorina, Eduard; Kardatzke, David] InterMune, Brisbane, CA USA; [Noble, Paul W.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Castro-Bernardini, Socorro] Neumocare, Clin San Borja, Lima, Peru; [Glaspole, Ian] Alfred Hosp, Melbourne, Vic, Australia; [Hopkins, Peter M.] Prince Charles Hosp, Brisbane, Qld 4032, Australia; [Glassberg, Marilyn K.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lancaster, Lisa] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Lederer, David J.] Columbia Univ, Med Ctr, New York, NY USA; [Nathan, Steven D.] Inova Fairfax Hosp, Falls Church, VA USA; [Pereira, Carlos A.] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil; [Sahn, Steven A.] Med Univ S Carolina, Charleston, SC USA; [Sussman, Robert] Atlantic Hlth Syst, Overlook Med Ctr, Summit, NJ USA; [Swigris, Jeffrey J.] Natl Jewish Hlth, Denver, CO USA	University of California System; University of California San Francisco; Cedars Sinai Medical Center; Florey Institute of Neuroscience & Mental Health; Prince Charles Hospital; University of Miami; Vanderbilt University; Columbia University; Inova Fairfax Hospital; Universidade Federal de Sao Paulo (UNIFESP); Medical University of South Carolina; Atlantic Health System; National Jewish Health	King, TE (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave,Box 0120, San Francisco, CA 94143 USA.	tking@medicine.ucsf.edu	Nambiar, Anoop M./P-5319-2017; Lederer, David/W-7957-2018; Carvalho, Carlos Roberto R/N-9827-2018; Hopkins, Peter/B-1329-2011	Nambiar, Anoop M./0000-0003-2778-0433; Lederer, David/0000-0001-5258-0228; Carvalho, Carlos Roberto R/0000-0002-1618-8509; Ryu, Jay/0000-0002-9576-2272; Glaspole, Ian/0000-0002-5118-2890	InterMune	InterMune	Supported by InterMune.	Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Caminati A, 2009, RESP MED, V103, P117, DOI 10.1016/j.rmed.2008.07.022; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; du Bois RM, 2014, EUR RESPIR J, V43, P1421, DOI 10.1183/09031936.00131813; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; du Bois RM, 2011, AM J RESP CRIT CARE, V183, P1231, DOI [10.1164/rccm.201007.1179OC, 10.1164/rccm.201007-1179OC]; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holland AE, 2009, RESP MED, V103, P1430, DOI 10.1016/j.rmed.2009.04.024; Jegal Y, 2005, AM J RESP CRIT CARE, V171, P639, DOI 10.1164/rccm.200403-331OC; King TE, 2014, AM J RESP CRIT CARE, V189, P825, DOI 10.1164/rccm.201311-1951OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213, DOI 10.1164/ajrccm.162.6.2003049; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2012, THORAX, V67, P407, DOI 10.1136/thoraxjnl-2011-201184; Seer.cancer.gov, SEER CANC STAT REV 2; Swigris JJ, 2010, THORAX, V65, P173, DOI 10.1136/thx.2009.113498; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Valeyre D, RESPIROLOGY IN PRESS; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108	27	2212	2271	8	177	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2083	2092		10.1056/NEJMoa1402582	http://dx.doi.org/10.1056/NEJMoa1402582			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24836312				2022-12-28	WOS:000336434000006
J	Barrangou, R				Barrangou, Rodolphe			Cas9 Targeting and the CRISPR Revolution	SCIENCE			English	Editorial Material							RNA; ENDONUCLEASE; COMPLEX		N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Barrangou, R (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu	Barrangou, Rodolphe/I-2878-2014	Barrangou, Rodolphe/0000-0002-0648-3504				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011	13	61	75	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					707	708		10.1126/science.1252964	http://dx.doi.org/10.1126/science.1252964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833384				2022-12-28	WOS:000335912900029
J	Brodsky, EE; Lay, T				Brodsky, Emily E.; Lay, Thorne			Recognizing Foreshocks from the 1 April 2014 Chile Earthquake	SCIENCE			English	Editorial Material							TOHOKU-OKI EARTHQUAKE		[Brodsky, Emily E.; Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Brodsky, EE (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	brodsky@pmc.ucsc.edu; tlay@ucsc.edu	Lay, Thorne/ABE-6272-2021	Brodsky, Emily/0000-0002-6855-6860	Directorate For Geosciences [1245717] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Abercrombie RE, 1996, NATURE, V381, P303, DOI 10.1038/381303a0; Barnes CR, 2013, IEEE J OCEANIC ENG, V38, P144, DOI 10.1109/JOE.2012.2212751; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Burgmann R., 2014, ANN REV EARTH PLANET, V42; Felzer KR, 2004, B SEISMOL SOC AM, V94, P88, DOI 10.1785/0120030069; Helmstetter A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002409; Hino R, 2014, MAR GEOPHYS RES, V35, P181, DOI 10.1007/s11001-013-9208-2; Holtkamp SG, 2011, GEOPHYS J INT, V187, P128, DOI 10.1111/j.1365-246X.2011.05137.x; Ito Y, 2013, TECTONOPHYSICS, V600, P14, DOI 10.1016/j.tecto.2012.08.022; JONES L, 1976, NATURE, V262, P677, DOI 10.1038/262677a0; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Marsan D, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009039; Monastersky R, 2012, NATURE, V483, P144, DOI 10.1038/483144a; Smith A., 2014, NBC NEWS        0325; Vigny C, 2009, PHYS EARTH PLANET IN, V175, P86, DOI 10.1016/j.pepi.2008.02.013	15	73	78	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					700	702		10.1126/science.1255202	http://dx.doi.org/10.1126/science.1255202			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833379	Green Published			2022-12-28	WOS:000335912900024
J	Riccobono, F; Schobesberger, S; Scott, CE; Dommen, J; Ortega, IK; Rondo, L; Almeida, J; Amorim, A; Bianchi, F; Breitenlechner, M; David, A; Downard, A; Dunne, EM; Duplissy, J; Ehrhart, S; Flagan, RC; Franchin, A; Hansel, A; Junninen, H; Kajos, M; Keskinen, H; Kupc, A; Kurten, A; Kvashin, AN; Laaksonen, A; Lehtipalo, K; Makhmutov, V; Mathot, S; Nieminen, T; Onnela, A; Petaja, T; Praplan, AP; Santos, FD; Schallhart, S; Seinfeld, JH; Sipila, M; Spracklen, DV; Stozhkov, Y; Stratmann, F; Tome, A; Tsagkogeorgas, G; Vaattovaara, P; Viisanen, Y; Vrtala, A; Wagner, PE; Weingartner, E; Wex, H; Wimmer, D; Carslaw, KS; Curtius, J; Donahue, NM; Kirkby, J; Kulmala, M; Worsnop, DR; Baltensperger, U				Riccobono, Francesco; Schobesberger, Siegfried; Scott, Catherine E.; Dommen, Josef; Ortega, Ismael K.; Rondo, Linda; Almeida, Joao; Amorim, Antonio; Bianchi, Federico; Breitenlechner, Martin; David, Andre; Downard, Andrew; Dunne, Eimear M.; Duplissy, Jonathan; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Hansel, Armin; Junninen, Heikki; Kajos, Maija; Keskinen, Helmi; Kupc, Agnieszka; Kuerten, Andreas; Kvashin, Alexander N.; Laaksonen, Ari; Lehtipalo, Katrianne; Makhmutov, Vladimir; Mathot, Serge; Nieminen, Tuomo; Onnela, Antti; Petaja, Tuukka; Praplan, Arnaud P.; Santos, Filipe D.; Schallhart, Simon; Seinfeld, John H.; Sipila, Mikko; Spracklen, Dominick V.; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Tsagkogeorgas, Georgios; Vaattovaara, Petri; Viisanen, Yrjo; Vrtala, Aron; Wagner, Paul E.; Weingartner, Ernest; Wex, Heike; Wimmer, Daniela; Carslaw, Kenneth S.; Curtius, Joachim; Donahue, Neil M.; Kirkby, Jasper; Kulmala, Markku; Worsnop, Douglas R.; Baltensperger, Urs			Oxidation Products of Biogenic Emissions Contribute to Nucleation of Atmospheric Particles	SCIENCE			English	Article							SULFURIC-ACID; AEROSOL MICROPHYSICS; ORGANIC-COMPOUNDS; GROWTH-RATES; GLOBAL-MODEL; H2SO4; SIZE; NANOPARTICLES; UNCERTAINTY; MAGNITUDE	Atmospheric new-particle formation affects climate and is one of the least understood atmospheric aerosol processes. The complexity and variability of the atmosphere has hindered elucidation of the fundamental mechanism of new-particle formation from gaseous precursors. We show, in experiments performed with the CLOUD (Cosmics Leaving Outdoor Droplets) chamber at CERN, that sulfuric acid and oxidized organic vapors at atmospheric concentrations reproduce particle nucleation rates observed in the lower atmosphere. The experiments reveal a nucleation mechanism involving the formation of clusters containing sulfuric acid and oxidized organic molecules from the very first step. Inclusion of this mechanism in a global aerosol model yields a photochemically and biologically driven seasonal cycle of particle concentrations in the continental boundary layer, in good agreement with observations.	[Riccobono, Francesco; Dommen, Josef; Bianchi, Federico; Praplan, Arnaud P.; Weingartner, Ernest; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland; [Schobesberger, Siegfried; Ortega, Ismael K.; Duplissy, Jonathan; Franchin, Alessandro; Junninen, Heikki; Kajos, Maija; Lehtipalo, Katrianne; Nieminen, Tuomo; Petaja, Tuukka; Schallhart, Simon; Sipila, Mikko; Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Scott, Catherine E.; Dunne, Eimear M.; Spracklen, Dominick V.; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Rondo, Linda; Almeida, Joao; Ehrhart, Sebastian; Kuerten, Andreas; Wimmer, Daniela; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60054 Frankfurt, Germany; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Lisbon, Lab Syst Instrumentat & Modeling Sci & Technol Sp, P-1699 Lisbon, Portugal; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Beira Interior, Lisbon, Portugal; [Breitenlechner, Martin; Hansel, Armin] Ionicon Analyt GmbH, Innsbruck, Austria; [Breitenlechner, Martin; Hansel, Armin] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [David, Andre; Mathot, Serge; Onnela, Antti; Kirkby, Jasper] CERN European Org Nucl Res, Geneva, Switzerland; [Downard, Andrew; Flagan, Richard C.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Keskinen, Helmi; Laaksonen, Ari; Vaattovaara, Petri] Univ Eastern Finland, Kuopio, Finland; [Kupc, Agnieszka; Vrtala, Aron; Wagner, Paul E.] Univ Vienna, Fac Phys, Vienna, Austria; [Kvashin, Alexander N.; Makhmutov, Vladimir; Stozhkov, Yuri] PN Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 117924, Russia; [Duplissy, Jonathan; Nieminen, Tuomo; Sipila, Mikko; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, Helsinki, Finland; [Stratmann, Frank; Tsagkogeorgas, Georgios; Wex, Heike] Leibniz Inst Tropospher Res, Leipzig, Germany; [Viisanen, Yrjo] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Helsinki; University of Leeds; Goethe University Frankfurt; Universidade de Lisboa; Universidade da Beira Interior; University of Innsbruck; European Organization for Nuclear Research (CERN); California Institute of Technology; University of Eastern Finland; University of Vienna; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Helsinki Institute of Physics; University of Helsinki; Leibniz Institut fur Tropospharenforschung (TROPOS); Finnish Meteorological Institute; Carnegie Mellon University; Aerodyne Research	Baltensperger, U (corresponding author), Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland.	urs.baltensperger@psi.ch	Amorim, Antonio/C-8460-2013; Wex, Heike/X-5882-2018; Kirkby, Jasper/A-4973-2012; Duplissy, Jonathan/A-1723-2010; Santos, Filipe/M-7709-2013; Franchin, Alessandro/AAH-3069-2019; Sipilä, Mikko/G-3024-2010; Breitenlechner, Martin/AAA-3402-2021; Viisanen, Yrjö/CAG-3818-2022; Laaksonen, Ari/B-5094-2011; Praplan, Arnaud P./F-8357-2011; Dunne, Eimear M/H-1567-2014; Kulmala, Markku T/I-7671-2016; Hansel, Armin/F-3915-2010; Franchin, Alessandro/GVR-8219-2022; Schobesberger, Siegfried/L-4454-2014; Makhmutov, Vladimir/N-2086-2015; Spracklen, Dominick/AAA-6257-2019; Nieminen, Tuomo J/D-1618-2011; Yuri, Stozhkov/ABG-7096-2021; Tinoco Mendes, Andre David/D-4314-2011; Stozhkov, Yuri/M-7433-2015; Scott, Catherine E/K-8758-2013; Tome, Antonio R/A-5681-2013; Weingartner, Ernest/B-6793-2009; Donahue, Neil M/A-2329-2008; Nieminen, Tuomo/AAB-8686-2020; Spracklen, Dominick V/B-4890-2014; Curtius, Joachim/A-2681-2011; Bianchi, Federico/G-8428-2012; Kürten, Andreas/O-3851-2019; Carslaw, Ken S/C-8514-2009; Petäjä, Tuukka/A-8009-2008; Worsnop, Douglas R/D-2817-2009; Ortega Colomer, Ismael Kenneth/A-7930-2008; Junninen, Heikki/C-2157-2014	Amorim, Antonio/0000-0003-0638-2321; Wex, Heike/0000-0003-2129-9323; Kirkby, Jasper/0000-0003-2341-9069; Duplissy, Jonathan/0000-0001-8819-0264; Santos, Filipe/0000-0001-7316-1479; Sipilä, Mikko/0000-0002-8594-7003; Viisanen, Yrjö/0000-0002-9660-3281; Laaksonen, Ari/0000-0002-1657-2383; Praplan, Arnaud P./0000-0002-9944-3084; Dunne, Eimear M/0000-0001-7085-8473; Kulmala, Markku T/0000-0003-3464-7825; Hansel, Armin/0000-0002-1062-2394; Schobesberger, Siegfried/0000-0002-5777-4897; Makhmutov, Vladimir/0000-0002-2242-1055; Tinoco Mendes, Andre David/0000-0001-5854-7699; Stozhkov, Yuri/0000-0003-1917-0328; Scott, Catherine E/0000-0002-0187-969X; Tome, Antonio R/0000-0001-9144-7120; Weingartner, Ernest/0000-0002-2427-4634; Donahue, Neil M/0000-0003-3054-2364; Nieminen, Tuomo/0000-0002-2713-715X; Curtius, Joachim/0000-0003-3153-4630; Bianchi, Federico/0000-0003-2996-3604; Kürten, Andreas/0000-0002-8955-4450; Carslaw, Ken S/0000-0002-6800-154X; Petäjä, Tuukka/0000-0002-1881-9044; Worsnop, Douglas R/0000-0002-8928-8017; Kupc/Straus, Agnieszka/0000-0002-7996-2506; Ehrhart, Sebastian/0000-0002-6517-5341; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Breitenlechner, Martin/0000-0002-2382-6660; Junninen, Heikki/0000-0001-7178-9430; Keskinen, Helmi/0000-0003-3614-0542; Dommen, Josef/0000-0002-0006-0009; Lehtipalo, Katrianne/0000-0002-1660-2706	CERN; European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN") [215072]; European Research Council [227463]; Academy of Finland via the Centre of Excellence program [1118615, 1133872]; German Federal Ministry of Education and Research [01LK0902A]; Swiss National Science Foundation [206621_125025, 206620_130527]; Austrian Science Fund [P19546, L593]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Russian Foundation for Basic Research [N08-02-91006-CERN]; Davidow Foundation; Royal Society Wolfson Award; NSF [AGS1136479, CHE1012293]; Direct For Mathematical & Physical Scien [1012293] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1136479] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [L 593] Funding Source: researchfish; Natural Environment Research Council [NE/G015015/1] Funding Source: researchfish	CERN; European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN"); European Research Council(European Research Council (ERC)European Commission); Academy of Finland via the Centre of Excellence program; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Davidow Foundation; Royal Society Wolfson Award(Royal Society of London); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank CERN for supporting CLOUD with important technical and financial resources and providing a particle beam from the CERN PS; J.-L. Agostini, P. Carrie, L.-P. De Menezes, F. Josa, I. Krasin, R. Kristic, O. S. Maksumov, S. V. Mizin, R. Sitals, A. Wasem, and M. Wilhelmsson for their important contributions to the experiment; and C. Kuang and V.-M. Kerminen for providing the observational data sets used in Fig. 1A and the authors that contributed to them. This research was funded by the European Commission Seventh Framework Programme (Marie Curie Initial Training Network "CLOUD-ITN," grant no. 215072), the European Research Council Advanced Grant "ATMNUCLE" (no. 227463), the Academy of Finland via the Centre of Excellence program (project no. 1118615) and grant no. 1133872, the German Federal Ministry of Education and Research (project no. 01LK0902A), the Swiss National Science Foundation (project no. 206621_125025 and 206620_130527), the Austrian Science Fund (project no. P19546 and L593), the Portuguese Foundation for Science and Technology (project no. CERN/FP/116387/2010), the Russian Foundation for Basic Research (grant N08-02-91006-CERN), the Davidow Foundation, the Royal Society Wolfson Award, and the NSF (grants AGS1136479 and CHE1012293). The data reported in this paper are available online as .txt files in the supplementary materials).	Almeida J, 2013, NATURE, V502, P359, DOI 10.1038/nature12663; Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Carslaw KS, 2013, FARADAY DISCUSS, V165, P495, DOI 10.1039/c3fd00043e; Chen M, 2012, P NATL ACAD SCI USA, V109, P18713, DOI 10.1073/pnas.1210285109; Ehn M, 2010, ATMOS CHEM PHYS, V10, P8513, DOI 10.5194/acp-10-8513-2010; Ehrhart S, 2013, ATMOS CHEM PHYS, V13, P11465, DOI 10.5194/acp-13-11465-2013; Eisele FL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006568; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hakola H, 2012, ATMOS CHEM PHYS, V12, P11665, DOI 10.5194/acp-12-11665-2012; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P7255, DOI 10.5194/acp-8-7255-2008; Lee LA, 2013, ATMOS CHEM PHYS, V13, P8879, DOI 10.5194/acp-13-8879-2013; Mann GW, 2010, GEOSCI MODEL DEV, V3, P519, DOI 10.5194/gmd-3-519-2010; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Nadykto AB, 2007, CHEM PHYS LETT, V435, P14, DOI 10.1016/j.cplett.2006.12.050; OXTOBY DW, 1994, J CHEM PHYS, V100, P7665, DOI 10.1063/1.466859; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Riccobono F, 2012, ATMOS CHEM PHYS, V12, P9427, DOI 10.5194/acp-12-9427-2012; Riipinen I, 2007, ATMOS CHEM PHYS, V7, P1899, DOI 10.5194/acp-7-1899-2007; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Sihto SL, 2006, ATMOS CHEM PHYS, V6, P4079, DOI 10.5194/acp-6-4079-2006; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Solomon S., 2007, PHYS SCI BASIS WORKI; Sorokin A, 2007, ATMOS ENVIRON, V41, P3740, DOI 10.1016/j.atmosenv.2007.01.017; Spracklen DV, 2010, ATMOS CHEM PHYS, V10, P4775, DOI 10.5194/acp-10-4775-2010; Spracklen DV, 2005, ATMOS CHEM PHYS, V5, P2227, DOI 10.5194/acp-5-2227-2005; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; Weber RJ, 1997, J GEOPHYS RES-ATMOS, V102, P4375, DOI 10.1029/96JD03656; Weber RJ, 1998, J GEOPHYS RES-ATMOS, V103, P16385, DOI 10.1029/97JD02465; Young LH, 2008, ATMOS CHEM PHYS, V8, P4997, DOI 10.5194/acp-8-4997-2008; Yu F, 2009, ATMOS CHEM PHYS, V9, P7691, DOI 10.5194/acp-9-7691-2009; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Zhang RY, 2009, P NATL ACAD SCI USA, V106, P17650, DOI 10.1073/pnas.0910125106; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139	39	357	361	21	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					717	721		10.1126/science.1243527	http://dx.doi.org/10.1126/science.1243527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833386	Green Accepted, Green Submitted			2022-12-28	WOS:000335912900033
J	Boston, R; Schnepp, Z; Nemoto, Y; Sakka, Y; Hall, SR				Boston, Rebecca; Schnepp, Zoe; Nemoto, Yoshihiro; Sakka, Yoshio; Hall, Simon R.			In Situ TEM Observation of a Microcrucible Mechanism of Nanowire Growth	SCIENCE			English	Article							SUPERCONDUCTOR NANOWIRES; WHISKERS; ARRAYS; WALL; GELS	The growth of metal oxide nanowires can proceed via a number of mechanisms such as screw dislocation, vapor-liquid-solid process, or seeded growth. Transmission electron microscopy (TEM) can resolve nanowires but invariably lacks the facility for direct observation of how nanowires form. We used a transmission electron microscope equipped with an in situ heating stage to follow the growth of quaternary metal oxide nanowires. Video-rate imaging revealed barium carbonate nanoparticles diffusing through a porous matrix containing copper and yttrium oxides to subsequently act as catalytic sites for the outgrowth of Y2BaCuO5 nanowires on reaching the surface. The results suggest that sites on the rough surface of the porous matrix act as microcrucibles and thus provide insights into the mechanisms that drive metal oxide nanowire growth at high temperatures.	[Boston, Rebecca; Hall, Simon R.] Univ Bristol, Sch Chem, Complex Funct Mat Grp, Bristol BS8 1TS, Avon, England; [Boston, Rebecca] Ctr Nanosci & Quantum Informat, Bristol Ctr Funct Nanomat, Bristol BS8 1FD, Avon, England; [Schnepp, Zoe] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Nemoto, Yoshihiro; Sakka, Yoshio] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	University of Bristol; University of Birmingham; National Institute for Materials Science	Hall, SR (corresponding author), Univ Bristol, Sch Chem, Complex Funct Mat Grp, Cantocks Close, Bristol BS8 1TS, Avon, England.	simon.hall@bristol.ac.uk	Hall, Simon/AAV-7132-2020; Sakka, Yoshio/H-2536-2011	Hall, Simon/0000-0002-2816-0191; Sakka, Yoshio/0000-0001-8357-5843; Schnepp, Zoe/0000-0003-2171-067X	Engineering and Physical Sciences Research Council (EPSRC), UK [EP/G036780/1]; Bristol Centre for Functional Nanomaterials; EPSRC under their "Building Global Engagements in Research" scheme [EP/K004581/1]; Electron and Scanning Probe Microscopy Facility and Electron Microscopy Group in the Schools of Chemistry and Physics, University of Bristol; National Institute for Materials Science (NIMS) in Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; EPSRC [EP/K004581/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K004581/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC), UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bristol Centre for Functional Nanomaterials; EPSRC under their "Building Global Engagements in Research" scheme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Electron and Scanning Probe Microscopy Facility and Electron Microscopy Group in the Schools of Chemistry and Physics, University of Bristol; National Institute for Materials Science (NIMS) in Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	S. R. H. and R. B. acknowledge the Engineering and Physical Sciences Research Council (EPSRC), UK (grant EP/G036780/1), and the Bristol Centre for Functional Nanomaterials for project funding. S. R. H. and R. B. also acknowledge the support of the EPSRC under their "Building Global Engagements in Research" scheme (grant EP/K004581/1) and the Electron and Scanning Probe Microscopy Facility and Electron Microscopy Group in the Schools of Chemistry and Physics, University of Bristol, respectively. Z.S. would like to thank the National Institute for Materials Science (NIMS) in Japan for the award of an International Center for Young Scientists Postdoctoral Fellowship. All authors would like to thank M. Takeguchi for his help with all aspects of TEM operation at NIMS. A part of this work was supported by the NIMS microstructural characterization platform as a program of the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Badica P, 2006, SUPERCOND SCI TECH, V19, pR81, DOI 10.1088/0953-2048/19/10/R01; Badica P, 2005, J MATER RES, V20, P3358, DOI 10.1557/JMR.2005.0413; Badica P, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/10/105003; Berrigan JD, 2011, ADV FUNCT MATER, V21, P1693, DOI 10.1002/adfm.201002676; Cagliero S, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/12/125002; Cao YL, 2012, NANO LETT, V12, P3783, DOI 10.1021/nl3016957; CHICK LA, 1990, MATER LETT, V10, P6, DOI 10.1016/0167-577X(90)90003-5; Gorbunov A, 2002, CARBON, V40, P113, DOI 10.1016/S0008-6223(01)00080-X; Hall SR, 2006, ADV MATER, V18, P487, DOI 10.1002/adma.200501971; MATSUBARA I, 1994, J CRYST GROWTH, V141, P131, DOI 10.1016/0022-0248(94)90103-1; Nagashima K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978347; Ozin G.A., 2015, NANOCHEMISTRY CHEM A; Schnepp Z, 2010, CHEM COMMUN, V46, P4887, DOI 10.1039/c0cc00516a; Schnepp Z, 2010, CRYSTENGCOMM, V12, P1410, DOI 10.1039/b923543b; Schnepp ZAC, 2008, ADV MATER, V20, P1782, DOI 10.1002/adma.200702679; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Xu K, 2008, NANO LETT, V8, P3845, DOI 10.1021/nl802264x; Yang C, 2005, SCIENCE, V310, P1304, DOI 10.1126/science.1118798; Zeng HC, 1996, CHEM MATER, V8, P2667, DOI 10.1021/cm960197n	19	43	43	6	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					623	626		10.1126/science.1251594	http://dx.doi.org/10.1126/science.1251594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812400	Green Submitted			2022-12-28	WOS:000335537400041
J	Bader, J				Bader, Juergen			CLIMATE SCIENCE The origin of regional Arctic warming	NATURE			English	Editorial Material									[Bader, Juergen] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Bader, Juergen] Uni Res, Uni Climate, Bergen, Norway; [Bader, Juergen] Bjerknes Ctr Climate Res, Bergen, Norway	Max Planck Society; Bjerknes Centre for Climate Research	Bader, J (corresponding author), Max Planck Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany.	juergen.bader@mpimet.mpg.de						Ding QH, 2014, NATURE, V509, P209, DOI 10.1038/nature13260; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Shindell D, 2009, NAT GEOSCI, V2, P294, DOI 10.1038/NGEO473	6	10	10	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					167	168		10.1038/509167a	http://dx.doi.org/10.1038/509167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805339				2022-12-28	WOS:000335454300023
J	Krishnamoorthy, KS; Eichler, F; Rapalino, O; Frosch, MP				Krishnamoorthy, Kalpathy S.; Eichler, Florian; Rapalino, Otto; Frosch, Matthew P.			Case 14-2014: An 11-Month-Old Girl with Developmental Delay	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-STANDARDS-SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; CEREBRAL-PALSY; PRACTICE PARAMETER; PRACTICE-COMMITTEE; PLANTAR REFLEX; CHILD; DISEASE; YIELD	An 11-month-old girl was seen in the neurology clinic because of developmental delay. Development to 6 months was normal; by 11 months, she had difficulty sitting and had stopped reaching for objects and feeding herself. An examination and diagnostic tests were performed. Presentation of CaseDr. Jenny Linnoila (Neurology): An 11-month-old girl was seen in the outpatient neurology clinic because of developmental delay. The patient was born at another hospital by vaginal delivery after induction of labor at 38 weeks' gestation because of oligohydramnios. The mother had received prenatal care, including obstetrical ultrasonographic testing, the results of which were reportedly normal. Serologic screening tests during pregnancy were reportedly negative. The prenatal course was uncomplicated. The mother took ondansetron for nausea and levothyroxine for hypothyroidism and reported that there had been less fetal movement in utero as compared with her previous pregnancy. No ...	[Krishnamoorthy, Kalpathy S.; Eichler, Florian] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Krishnamoorthy, Kalpathy S.; Eichler, Florian] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Krishnamoorthy, KS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Rapalino, Otto/0000-0002-5038-4183	Shire/UBC; Alexion	Shire/UBC; Alexion	Dr. Eichler reports receiving consulting fees from Shire/UBC and Alexion. No other potential conflict of interest relevant to this article was reported.	Accardo J, 2004, J PEDIATR-US, V145, pS19, DOI 10.1016/j.jpeds.2004.05.018; American Academy of Pediatrics National Center of Medical Home Initiatives for Children with Special Need Carepoints, 2008, CAM ARC CREAT FULL L; Ashwal S., 2004, Neurology, V62, P851; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bley AE, 2011, PEDIATRICS, V128, pE1233, DOI 10.1542/peds.2011-0078; Engbers HM, 2008, ANN NEUROL, V64, P212, DOI 10.1002/ana.21435; GORDON N, 1993, DEV MED CHILD NEUROL, V35, P1015; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; HOGAN GR, 1971, NEW ENGL J MED, V285, P502, DOI 10.1056/NEJM197108262850907; Imamura A, 2008, NEUROPEDIATRICS, V39, P259, DOI 10.1055/s-0029-1202285; JONES CJP, 1990, PLACENTA, V11, P395, DOI 10.1016/S0143-4004(05)80215-2; JONES CJP, 1991, PLACENTA, V12, P183; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; Kinnala A, 1999, PEDIATRICS, V103, P724, DOI 10.1542/peds.103.4.724; Kolodny E, 2002, CURRENT MANAGEMENT C, P245; PURPURA DP, 1976, BRAIN RES, V116, P1, DOI 10.1016/0006-8993(76)90245-6; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; RICH E, 1973, NEW ENGL J MED, V289, P1043; ROBERTS D J, 1991, Pediatric Pathology, V11, P647; Russman Barry S, 2004, Semin Pediatr Neurol, V11, P47, DOI 10.1016/j.spen.2004.01.007; Sachs B, 1887, J NERV MENT DIS, V14, P541, DOI [10.1097/00005053-188714090-00001, DOI 10.1097/00005053-188709000-00001]; SCHNECK L, 1964, J PEDIATR-US, V65, P749, DOI 10.1016/S0022-3476(64)80161-X; Schneider A, 2009, AM J MED GENET A, V149A, P2444, DOI 10.1002/ajmg.a.33085; Sharma S, 2008, ARCH NEUROL-CHICAGO, V65, P1669, DOI 10.1001/archneur.65.12.1669; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Shen WC, 1998, J FORMOS MED ASSOC, V97, P296; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Shevell MI, 2001, BRAIN DEV-JPN, V23, P228, DOI 10.1016/S0387-7604(01)00212-1; Srour M, 2006, PEDIATRICS, V118, P139, DOI 10.1542/peds.2005-2702; Steenweg ME, 2013, BRAIN, V136, P2923, DOI 10.1093/brain/aws156; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Swaiman KF, 2006, PEDIAT NEUROLOGY PRI, P491; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Walkley SU, 1995, NEUROCHEM RES, V20, P1287, DOI 10.1007/BF00992503; Zhao CL, 2011, EUR J RADIOL, V79, P447, DOI 10.1016/j.ejrad.2010.09.015	35	1	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1830	1841		10.1056/NEJMcpc1305987	http://dx.doi.org/10.1056/NEJMcpc1305987			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806163				2022-12-28	WOS:000335997900011
J	Munoz, FM; Bond, NH; Maccato, M; Pinell, P; Hammill, HA; Swamy, GK; Walter, EB; Jackson, LA; Englund, JA; Edwards, MS; Healy, CM; Petrie, CR; Ferreira, J; Goll, JB; Baker, CJ				Munoz, Flor M.; Bond, Nanette H.; Maccato, Maurizio; Pinell, Phillip; Hammill, Hunter A.; Swamy, Geeta K.; Walter, Emmanuel B.; Jackson, Lisa A.; Englund, Janet A.; Edwards, Morven S.; Healy, C. Mary; Petrie, Carey R.; Ferreira, Jennifer; Goll, Johannes B.; Baker, Carol J.			Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVISORY-COMMITTEE; PRACTICES ACIP; PREVENTING TETANUS; POSTPARTUM WOMEN; YOUNG INFANTS; VACCINE; ANTIBODIES; RECOMMENDATIONS; PROTECTION; INFECTION	IMPORTANCE Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine could prevent infant pertussis. OBJECTIVE To evaluate the safety and immunogenicity of Tdap immunization during pregnancy and its effect on infant responses to diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine. DESIGN, SETTING, AND PARTICIPANTS Phase 1-2, randomized, double-blind, placebo-controlled, clinical trial conducted from 2008 to 2012. Forty-eight pregnant women aged 18 to 45 years received Tdap (n = 33) or placebo (n = 15) at 30 to 32 weeks' gestation, with crossover immunization postpartum. INTERVENTIONS Tdap vaccination at 30 to 32 weeks' gestation or postpartum. MAIN OUTCOMES AND MEASURES Primary outcomes were maternal and infant adverse events, pertussis illness, and infant growth and development until age 13 months. Secondary outcomes were antibody concentrations in pregnant women before and 4 weeks after Tdap immunization or placebo, at delivery and 2 months' postpartum, and in infants at birth, at 2 months, and after the third and fourth doses of DTaP. RESULTS No Tdap-associated serious adverse events occurred in women or infants. Injection site reactions after Tdap immunization were reported in 26 (78.8% [95% CI, 61.1%-91.0%]) and 12 (80% [95% CI, 51.9%-95.7%]) pregnant and postpartum women, respectively (P >.99). Systemic symptoms were reported in 12 (36.4%[95% CI, 20.4%-54.9%]) and 11 (73.3%[95% CI, 44.9%-92.2%]) pregnant and postpartum women, respectively (P = .03). Growth and development were similar in both infant groups. No cases of pertussis occurred. Significantly higher concentrations of pertussis antibodies were measured at delivery in women who received Tdap during pregnancy vs postpartum (eg, pertussis toxin antibodies: 51.0 EU/mL [95% CI, 37.1-70.1] and 9.1 EU/mL [95% CI, 4.6-17.8], respectively; P < .001) and in their infants at birth (68.8 EU/mL [95% CI, 52.1-90.8] and 14.0 EU/mL [95% CI, 7.3-26.9], respectively; P < .001) and at age 2 months (20.6 EU/mL [95% CI, 14.4-29.6] and 5.3 EU/mL [95% CI, 3.0-9.4], respectively; P < .001). Antibody responses in infants born to women receiving Tdap during pregnancy were not different following the fourth dose of DTaP. CONCLUSIONS AND RELEVANCE This preliminary assessment did not find an increased risk of adverse events among women who received Tdap vaccine during pregnancy or their infants. For secondary outcomes, maternal immunization with Tdap resulted in high concentrations of pertussis antibodies in infants during the first 2 months of life and did not substantially alter infant responses to DTaP. Further research is needed to provide definitive evidence of the safety and efficacy of Tdap immunization during pregnancy.	[Munoz, Flor M.; Maccato, Maurizio; Pinell, Phillip; Edwards, Morven S.; Healy, C. Mary; Baker, Carol J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Munoz, Flor M.; Bond, Nanette H.; Baker, Carol J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Maccato, Maurizio; Pinell, Phillip] Womans OB GYN Specialists, Houston, TX USA; [Swamy, Geeta K.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Walter, Emmanuel B.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Jackson, Lisa A.] Grp Hlth Res Inst, Seattle, WA USA; [Englund, Janet A.] Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Petrie, Carey R.; Ferreira, Jennifer; Goll, Johannes B.] EMMES Corp, Rockville, MD USA	Baylor College of Medicine; Baylor College of Medicine; Duke University; Duke University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Emmes Corporation	Munoz, FM (corresponding author), Baylor Coll Med, Dept Pediat, One Baylor Plaza,Ste 221-D,BCM 280, Houston, TX 77030 USA.	florm@bcm.edu			Division of Microbiology and Infectious Diseases [N01AI80002C, HHSN272200800004C, HHSN272200800057C]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1RR025014]; National Institute for Allergy and Infectious Diseases-Division of Microbiology and Infectious Diseases(DMID) [HHSN272200800013C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080002] Funding Source: NIH RePORTER	Division of Microbiology and Infectious Diseases; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute for Allergy and Infectious Diseases-Division of Microbiology and Infectious Diseases(DMID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Division of Microbiology and Infectious Diseases Contracts N01AI80002C (Baylor College of Medicine, Houston, Texas), HHSN272200800004C (Group Health Research Institute, Seattle, Washington), and HHSN272200800057C (Duke University School of Medicine, Durham, North Carolina). Dr Englund was also supported in Seattle by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1RR025014. Ms Petrie, Ms Ferreira, and Mr Goll performed this work supported by National Institute for Allergy and Infectious Diseases-Division of Microbiology and Infectious Diseases(DMID) contract (Clinical Research in Infectious Disease [CRID], HHSN272200800013C).	Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424; [Anonymous], 2011, PHARMACOEPIDEM DR S, V20, pS1; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Castagnini LA, 2012, CLIN INFECT DIS, V54, P78, DOI 10.1093/cid/cir765; Centers for Disease Control and Prevention, PERT SURV REP; ENGLUND JA, 1995, PEDIATRICS, V96, P580; Gall SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.024; Glezen WP, 2003, VACCINE, V21, P3389, DOI 10.1016/S0264-410X(03)00339-6; Gonik Bernard, 2005, Infect Dis Obstet Gynecol, V13, P59, DOI 10.1080/10647440500068289; Halperin BA, 2011, CLIN INFECT DIS, V53, P885, DOI 10.1093/cid/cir538; Hardy-Fairbanks AJ, 2013, PEDIATR INFECT DIS J, V32, P1257, DOI 10.1097/INF.0b013e3182a09b6a; Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033; Heininger U, 2013, PEDIATR INFECT DIS J, V32, P695, DOI 10.1097/INF.0b013e318288b610; Kapasi A, 2012, CLIN VACCINE IMMUNOL, V19, P64, DOI 10.1128/CVI.05460-11; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; VANSAVAGE J, 1990, J INFECT DIS, V161, P487, DOI 10.1093/infdis/161.3.487; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Zheteyeva YA, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.006	24	334	347	3	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1760	1769		10.1001/jama.2014.3633	http://dx.doi.org/10.1001/jama.2014.3633			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794369	Green Accepted			2022-12-28	WOS:000335382300021
J	Vinci, SR; Rifas-Shiman, SL; Cheng, JK; Mannix, RC; Gillman, MW; de Ferranti, SD				Vinci, Samuel R.; Rifas-Shiman, Sheryl L.; Cheng, Jennifer K.; Mannix, Rebekah C.; Gillman, Matthew W.; de Ferranti, Sarah D.			Cholesterol Testing Among Children and Adolescents During Health Visits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Vinci, Samuel R.; Cheng, Jennifer K.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Rifas-Shiman, Sheryl L.; Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [de Ferranti, Sarah D.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	de Ferranti, SD (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	sarah.deferranti@cardio.chboston.org	Mannix, Rebekah/AAD-8702-2020	Mannix, Rebekah/0000-0003-3608-2792				Centers for Disease Control and Prevention, ABOUT THE AMBULATORY; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Gillman MW, 2012, JAMA-J AM MED ASSOC, V307, P259, DOI 10.1001/jama.2011.2012; Haney EM, 2007, PEDIATRICS, V120, pE189, DOI 10.1542/peds.2006-1801; Kimm SYS, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e50; Kit BK, 2012, JAMA-J AM MED ASSOC, V308, P591, DOI 10.1001/jama.2012.9136	6	38	38	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1804	1807		10.1001/jama.2014.2410	http://dx.doi.org/10.1001/jama.2014.2410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794376	Bronze			2022-12-28	WOS:000335382300028
J	Gibson, R				Gibson, Rosemary			FEATURE The human cost of overuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hastings Ctr, Garrison, NY 10524 USA		Gibson, R (corresponding author), Hastings Ctr, 21 Malcolm Gordon Rd, Garrison, NY 10524 USA.	gibsonr@thehastingscenter.org							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2014	348								g2975	10.1136/bmj.g2975	http://dx.doi.org/10.1136/bmj.g2975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OG	24803401				2022-12-28	WOS:000335819000002
J	Butterworth, A				Butterworth, Andy			The moral problem with commercial seal hunting	NATURE			English	Editorial Material									Univ Bristol, Bristol BS8 1TH, Avon, England	University of Bristol	Butterworth, A (corresponding author), Univ Bristol, Bristol BS8 1TH, Avon, England.	andy.butterworth@bristol.ac.uk		Butterworth, Andrew/0000-0002-5904-8397				Butterworth A, 2013, MAR POLICY, V38, P457, DOI 10.1016/j.marpol.2012.07.006	1	4	4	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					9	9		10.1038/509009a	http://dx.doi.org/10.1038/509009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784181	Bronze			2022-12-28	WOS:000335199100013
J	Matsuzaki, S; Uchiyama, J; Takemura-Uchiyama, I; Daibata, M				Matsuzaki, Shigenobu; Uchiyama, Jumpei; Takemura-Uchiyama, Iyo; Daibata, Masanori			PERSPECTIVE The age of the phage	NATURE			English	Editorial Material							INFECTION MODEL		[Matsuzaki, Shigenobu; Uchiyama, Jumpei; Takemura-Uchiyama, Iyo; Daibata, Masanori] Kochi Univ, Sch Med, Kochi, Japan	Kochi University	Matsuzaki, S (corresponding author), Kochi Univ, Sch Med, Kochi, Japan.		Uchiyama, Jumpei/GWC-4189-2022; Uchiyama, Jumpei/GNP-6661-2022	Uchiyama, Jumpei/0000-0003-0846-0100	Grants-in-Aid for Scientific Research [26461504, 24791025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2012, YAKUGAKU ZASSHI, V132, P79, DOI 10.1248/yakushi.132.79; Takemura-Uchiyama I, 2013, FEMS MICROBIOL LETT, V347, P52, DOI 10.1111/1574-6968.12220	3	38	40	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S9	S9		10.1038/509S9a	http://dx.doi.org/10.1038/509S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784429				2022-12-28	WOS:000335199100005
J	Snellen, IAG; Brandl, BR; de Kok, RJ; Brogi, M; Birkby, J; Schwarz, H				Snellen, Ignas A. G.; Brandl, Bernhard R.; de Kok, Remco J.; Brogi, Matteo; Birkby, Jayne; Schwarz, Henriette			Fast spin of the young extrasolar planet beta Pictoris b	NATURE			English	Article							COLLISION-INDUCED ABSORPTION; WATER-ABSORPTION; CARBON-MONOXIDE; DOPPLER IMAGES; ROTATING STARS; C/O RATIO; H-2 PAIRS; SPECTROSCOPY; VELOCITIES; ATMOSPHERE	The spin of a planet arises from the accretion of angular momentum during its formation(1-3), but the details of this process are still unclear. In the Solar System, the equatorial rotation velocities and, consequently, spin angular momenta of most of the planets increase with planetary mass(4); the exceptions to this trend are Mercury and Venus, which, since formation, have significantly spun down because of tidal interactions(5,6). Here we report near-infrared spectroscopic observations, at a resolving power of 100,000, of the young extrasolar gas giant planet beta Pictoris b (refs 7, 8). The absorption signal from carbon monoxide in the planet's thermal spectrum is found to be blueshifted with respect to that from the parent star by approximately 15 kilometres per second, consistent with a circular orbit(9). The combined line profile exhibits a rotational broadening of about 25 kilometres per second, meaning that beta Pictoris b spins significantly faster than any planet in the Solar System, in line with the extrapolation of the known trend in spin velocity with planet mass.	[Snellen, Ignas A. G.; Brandl, Bernhard R.; de Kok, Remco J.; Brogi, Matteo; Birkby, Jayne; Schwarz, Henriette] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [de Kok, Remco J.] Netherlands Inst Space Res SRON, NL-3584 CA Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC	Snellen, IAG (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	snellen@strw.leidenuniv.nl	de Kok, Remco/U-5637-2019; Brogi, Matteo/GWM-8542-2022	Snellen, Ignas/0000-0003-1624-3667; de Kok, Remco/0000-0001-6906-2662	NWO VICI	NWO VICI(Netherlands Organization for Scientific Research (NWO))	We thank T. de Zeeuw for granting Director's Discretionary Time on the VLT to perform these observations (292.C-5017(A)). I.A.G.S. acknowledges support from an NWO VICI grant. R.J.d.K. acknowledges the NWO PEPSci programme.	Arsenault R, 2003, P SOC PHOTO-OPT INS, V4839, P174, DOI 10.1117/12.458836; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Barnes JR, 2000, MON NOT R ASTRON SOC, V314, P162, DOI 10.1046/j.1365-8711.2000.03237.x; Binks AS, 2014, MON NOT R ASTRON SOC, V438, pL11, DOI 10.1093/mnrasl/slt141; Bonnefoy M, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201220838; Borysow A, 2001, J QUANT SPECTROSC RA, V68, P235, DOI 10.1016/S0022-4073(00)00023-6; Borysow A, 2002, ASTRON ASTROPHYS, V390, P779, DOI 10.1051/0004-6361:20020555; Brandl BR, 2012, PROC SPIE, V8446, DOI 10.1117/12.926057; Brogi M, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/27; Brogi M, 2012, NATURE, V486, P502, DOI 10.1038/nature11161; Chauvin G, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219446; Correia ACM, 2001, NATURE, V411, P767, DOI 10.1038/35081000; Crossfield IJM, 2014, NATURE, V505, P654, DOI 10.1038/nature12955; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Currie T, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/15; de Kok RJ, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321381; desEtangs AL, 1997, ASTRON ASTROPHYS, V328, P311; DESETANGS AL, 1995, ASTRON ASTROPHYS, V299, P557; DONES L, 1993, ICARUS, V103, P67, DOI 10.1006/icar.1993.1059; European. Southern Observatory, 2011, CRIRES DAT RED PIP; Gontcharov GA, 2006, ASTRON LETT+, V32, P759, DOI 10.1134/S1063773706110065; Hughes DW, 2003, PLANET SPACE SCI, V51, P517, DOI 10.1016/S0032-0633(03)00035-7; Johansen A, 2010, MON NOT R ASTRON SOC, V404, P475, DOI 10.1111/j.1365-2966.2010.16309.x; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Konopacky QM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/79; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; Lee S, 2010, PROC SPIE, V7735, DOI 10.1117/12.857630; LISSAUER JJ, 1991, ICARUS, V94, P126, DOI 10.1016/0019-1035(91)90145-J; Madhusudhan N, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/36; Maiolino R., 2013, PREPRINT; PETTENGI.GH, 1965, NATURE, V206, P1240, DOI 10.1038/2061240a0; Rothman LS, 2010, J QUANT SPECTROSC RA, V111, P2139, DOI 10.1016/j.jqsrt.2010.05.001; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Rucinski S, 1999, ASTR SOC P, V185, P82; Sparks WB, 2002, ASTROPHYS J, V578, P543, DOI 10.1086/342401; Vogt SS, 1999, ASTROPHYS J SUPPL S, V121, P547, DOI 10.1086/313195; VOGT SS, 1987, ASTROPHYS J, V321, P496, DOI 10.1086/165647; VOGT SS, 1983, PUBL ASTRON SOC PAC, V95, P565, DOI 10.1086/131208	42	234	234	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					63	+		10.1038/nature13253	http://dx.doi.org/10.1038/nature13253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784216	Green Submitted			2022-12-28	WOS:000335199100039
J	Dunlop, DD; Song, J; Semanik, PA; Sharma, L; Bathon, JM; Eaton, CB; Hochberg, MC; Jackson, RD; Kwoh, CK; Mysiw, WJ; Nevitt, MC; Chang, RW				Dunlop, Dorothy D.; Song, Jing; Semanik, Pamela A.; Sharma, Leena; Bathon, Joan M.; Eaton, Charles B.; Hochberg, Marc C.; Jackson, Rebecca D.; Kwoh, C. Kent; Mysiw, W. Jerry; Nevitt, Michael C.; Chang, Rowland W.			Relation of physical activity time to incident disability in community dwelling adults with or at risk of knee arthritis: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; OBESE ADULTS; OSTEOARTHRITIS; EXERCISE; HEALTH; FITNESS; LIFE; OUTCOMES; DISEASE; ARTHROPLASTY	Objective To investigate whether objectively measured time spent in light intensity physical activity is related to incident disability and to disability progression. Design Prospective multisite cohort study from September 2008 to December 2012. Setting Baltimore, Maryland; Columbus, Ohio; Pittsburgh, Pennsylvania; and Pawtucket, Rhode Island, USA. Participants Disability onset cohort of 1680 community dwelling adults aged 49 years or older with knee osteoarthritis or risk factors for knee osteoarthritis; the disability progression cohort included 1814 adults. Main outcome measures Physical activity was measured by accelerometer monitoring. Disability was ascertained from limitations in instrumental and basic activities of daily living at baseline and two years. The primary outcome was incident disability. The secondary outcome was progression of disability defined by a more severe level (no limitations, limitations to instrumental activities only, 1-2 basic activities, or >= 3 basic activities) at two years compared with baseline. Results Greater time spent in light intensity activities had a significant inverse association with incident disability. Less incident disability and less disability progression were each significantly related to increasing quartile categories of daily time spent in light intensity physical activities (hazard ratios for disability onset 1.00, 0.62, 0.47, and 0.58, P for trend=0.007; hazard ratios for progression 1.00, 0.59, 0.50, and 0.53, P for trend=0.003) with control for socioeconomic factors (age, sex, race/ethnicity, education, income) and health factors (comorbidities, depressive symptoms, obesity, smoking, lower extremity pain and function, and knee assessments: osteoarthritis severity, pain, symptoms, prior injury). This finding was independent of time spent in moderate-vigorous activities. Conclusion These prospective data showed an association between greater daily time spent in light intensity physical activities and reduced risk of onset and progression of disability in adults with osteoarthritis of the knee or risk factors for knee osteoarthritis. An increase in daily physical activity time may reduce the risk of disability, even if the intensity of that additional activity is not increased.	[Dunlop, Dorothy D.; Song, Jing; Sharma, Leena; Chang, Rowland W.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, Chicago, IL 60611 USA; [Dunlop, Dorothy D.; Song, Jing; Sharma, Leena; Chang, Rowland W.] Northwestern Univ, Feinberg Sch Med, Med Ctr Healthcare Studies, Chicago, IL 60611 USA; [Semanik, Pamela A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Bathon, Joan M.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Eaton, Charles B.] Brown Univ, Pawtucket, RI USA; [Hochberg, Marc C.] Univ Maryland, Baltimore, MD 21201 USA; [Jackson, Rebecca D.; Mysiw, W. Jerry] Ohio State Univ, Columbus, OH 43210 USA; [Kwoh, C. Kent; Nevitt, Michael C.] Univ Arizona, Coll Med, Tucson, AZ USA; [Nevitt, Michael C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Rush University; Columbia University; Brown University; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; University of Arizona; University of California System; University of California San Francisco	Dunlop, DD (corresponding author), Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth, 750 Lakeshore Dr, Chicago, IL 60611 USA.	ddunlop@northwestern.edu	Mysiw, Walter/E-3724-2011	Eaton, Charles/0000-0002-7723-9461	National Institute for Arthritis and Musculoskeletal Diseases [R01-AR054155, R21-AR059412, P60-AR064464]; Falk Medical Trust; National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer; Foundation for the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022258, P60AR064464, N01AR022262, R01AR054155, R21AR059412, N01AR022261, N01AR022260, N01AR022259] Funding Source: NIH RePORTER	National Institute for Arthritis and Musculoskeletal Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Falk Medical Trust; National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is funded in part by National Institute for Arthritis and Musculoskeletal Diseases (grant No R01-AR054155, R21-AR059412, and P60-AR064464) and by the Falk Medical Trust. The publicly released Osteoarthritis Initiative (OAI) data were funded through a public-private partnership comprising five contracts (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262) awarded by the National Institutes of Health, a branch of the Department of Health and Human Services. Private funding partners include Merck Research Laboratories, Novartis Pharmaceuticals Corporation, GlaxoSmithKline, and Pfizer. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. The funders had no role in the collection, management, analysis, and interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the private funding partners, or the Osteoarthritis Initiative.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Anderson WL, 2010, PUBLIC HEALTH REP, V125, P44, DOI 10.1177/003335491012500107; [Anonymous], 2013, DATA NEWS; Bates JH, 2001, JAMA-J AM MED ASSOC, V285, P2973, DOI 10.1001/jama.285.23.2973; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Brault M.W., 2012, AM DISABILITIES 2010, P1; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2012, ANN INTERN MED, V156, P131, DOI 10.7326/0003-4819-156-2-201201170-00009; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Miller ME, 2000, J AM GERIATR SOC, V48, P1264, DOI 10.1111/j.1532-5415.2000.tb02600.x; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Pandya R, 2005, PSYCHOSOMATICS, V46, P131, DOI 10.1176/appi.psy.46.2.131; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Peterfy C, 2003, SKELETAL RADIOL, V32, P128, DOI 10.1007/s00256-002-0603-z; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Voelker R, 2011, JAMA-J AM MED ASSOC, V306, P1428, DOI 10.1001/jama.2011.1388; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295	46	73	74	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2472	10.1136/bmj.g2472	http://dx.doi.org/10.1136/bmj.g2472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24782514	Green Published, hybrid			2022-12-28	WOS:000335475500003
J	Darmstadt, GL; Kinney, MV; Chopra, M; Cousens, S; Kak, L; Paul, VK; Martines, J; Bhutta, ZA; Lawn, JE				Darmstadt, Gary L.; Kinney, Mary V.; Chopra, Mickey; Cousens, Simon; Kak, Lily; Paul, Vinod K.; Martines, Jose; Bhutta, Zulfiqar A.; Lawn, Joy E.		Lancet Every Newborn Study Grp	Who has been caring for the baby?	LANCET			English	Article							NEWBORN SURVIVAL; NEONATAL SURVIVAL; CHILD HEALTH; SYSTEMATIC ANALYSIS; POLITICAL PRIORITY; GLOBAL HEALTH; DECADE; CARE; MORTALITY; STILLBIRTHS	Nearly a decade ago, The Lancet published the Neonatal Survival Series, with an ambitious call for integration of newborn care across the continuum of reproductive, maternal, newborn, and child health and nutrition (RMNCH). In this first of five papers in the Every Newborn Series, we consider what has changed during this decade, assessing progress on the basis of a systematic policy heuristic including agenda-setting, policy formulation and adoption, leadership and partnership, implementation, and evaluation of effect. Substantial progress has been made in agenda setting and policy formulation for newborn health, as witnessed by the shift from maternal and child health to maternal, newborn, and child health as a standard. However, investment and large-scale implementation have been disappointingly small, especially in view of the size of the burden and potential for rapid change and synergies throughout the RMNCH continuum. Moreover, stillbirths remain invisible on the global health agenda. Hence that progress in improvement of newborn survival and reduction of stillbirths lags behind that of maternal mortality and deaths for children aged 1-59 months is not surprising. Faster progress is possible, but with several requirements: clear communication of the interventions with the greatest effect and how to overcome bottlenecks for scale-up; national leadership, and technical capacity to integrate and implement these interventions; global coordination of partners, especially within countries, in provision of technical assistance and increased funding; increased domestic investment in newborn health, and access to specific commodities and equipment where needed; better data to monitor progress, with local data used for programme improvement; and accountability for results at all levels, including demand from communities and mortality targets in the post-2015 framework. Who will step up during the next decade to ensure decision making in countries leads to implementation of stillbirth and newborn health interventions within RMNCH programmes?	[Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Global Dev Div, Seattle, WA 98102 USA; [Kinney, Mary V.; Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Chopra, Mickey] UNICEF, New York, NY USA; [Cousens, Simon; Lawn, Joy E.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Cousens, Simon; Lawn, Joy E.] London Sch Hyg & Trop Med, Ctr Maternal Reprod & Child Hlth, London WC1, England; [Kak, Lily] US Agcy Int Dev, Washington, DC 20523 USA; [Paul, Vinod K.] All India Inst Med Sci, New Delhi, India; [Martines, Jose] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Martines, Jose] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Lawn, Joy E.] Dept Int Dev, Res & Evidence Div, London, England	Bill & Melinda Gates Foundation; Save the Children; UNICEF; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; United States Agency for International Development (USAID); All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization; University of Bergen; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Global Dev Div, POB 23350, Seattle, WA 98102 USA.	Gary.Darmstadt@GatesFoundation.org	Kinney, Mary V/M-6952-2013; Lawn, Joy/ABE-6382-2020; Darmstadt, Gary/AAU-7488-2020	Kinney, Mary V/0000-0002-2903-0161; Lawn, Joy/0000-0002-4573-1443; Darmstadt, Gary/0000-0002-7522-5824; McDougall, Lori/0000-0002-1885-5344	Children's Investment Fund Foundation; USAID; Bill & Melinda Gates Foundation	Children's Investment Fund Foundation; USAID(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	No specific funding was received for the work in this paper, but the Every Newborn Action Plan and the Every Newborn Lancet Series process and products are funded through a grant from the Bill & Melinda Gates Foundation to the US Fund for UNICEF and from USAID; the epidemiological and official development assistance analyses were funded by a grant to the London School of Hygiene & Tropical Medicine from the Children's Investment Fund Foundation and by a grant to the Aga Khan University from USAID. The time of JEL and MVK was funded by Saving Newborn Lives, Save the Children, through a grant from the Bill & Melinda Gates Foundation. We thank John Grove for inputs towards the policy change assessment method, Sarah Henry for her assistance in development of timeline (figure 3) and global architecture figures (appendix), and Hannah Blencowe and Marek Lalli for assistance with compiling of the data in the table and figure 5. We acknowledge the work of Igor Rudan to compile data on newborn and stillbirth publications, and thank Marek Lalli for updating this analysis. We acknowledge the Countdown to 2015 economist team at the London School of Hygiene & Tropical Medicine for sharing previous official development assistance analyses, particularly Catherine Pitt and Justine Hsu, and we are especially grateful to Marek Lalli for the official development assistance analyses. We also thank Al Bartlett, David Oot, and the Saving Newborn Lives team at Save the Children, and the 150 policy and programme experts who were authors from the five countries on the Decade of Change for Newborn Survival analyses published in Health Policy and Planning, who informed our synthesis of learning on implementation. We acknowledge Kim Dickson and colleagues at UNICEF for provision of data on countries with national plans and mortality reduction targets. Jim Larson, Gabriel Sedman, and Joel Segre contributed to the figure on adoption of global health innovations (appendix). We are grateful to Jeremy Shiffman, Ann Starrs, and Bob Black for their reviews and critical insights, and to Hannah Blencowe, Mariam Claeson, Kate Kerber, Elizabeth Mason, and Lori McDougal for helpful critiques of the paper.	African Union, 2013, INT C MAT NEWB CHILD; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; [Anonymous], BORN TOO SOON GLOB A; [Anonymous], 2006, INT WORKSH STRENGTH; Ban Ki-moon., 2010, GLOBAL STRATEGY WOME; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhattacharyya S, 2012, HLTH SYSTEMS POLICY, V1, P2; Bhutta ZA, 2014, LANCET; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blencowe H, 2013, 15 MILLION BABIES BO; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Brewer G. D., 1983, FDN POLICY ANAL; Bryce J, 2012, COUNTDOWN 2015 MATER; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Bustreo F, 2012, INT J GYNECOL OBS S1, V119, P6; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Commission on Information and Accountability, 2011, KEEP PROM MEAS RES C; Darmstadt GL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-216; Darmstadt GL, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czs054; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Darmstadt GL, GLOB PUBLIC IN PRESS; Dean SV, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S3; Dickson KE, 2014, LANCET; Engmann C, 2013, LANCET, V382, pE26, DOI 10.1016/S0140-6736(13)62293-X; Every Woman Every Child, 2013, COMM APPR COORD REPR; EWEC, 2013, COMM EV WOM EV CHILD; Family Care International Global Health Vision, 2012, MAPP GLOB ARCH NEWB; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Graft-Johnson J, 2006, CONTINUUM CARE MATER; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hofmeyr GJ, 2009, INT J GYNECOL OBS S1, V107, P44; Howlett M, 2003, STUDYING PUBLIC POLI; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; IGME, 2013, LEV TRENDS CHILD MOR; Independent Expert Review Group on Information and Accountability, 2013, EV WOM EV CHILD STRE; Johns Hopkins Bloomberg School of Public Health, 2010, LIST LIV SAV TOOL EV; Khan A, 2012, HEALTH POLICY PLANN, V27, P72, DOI 10.1093/heapol/czs047; Kinney MV, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-28; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Kumar V, 2012, INT J GYNECOL OBSTET, V117, P48, DOI 10.1016/j.ijgo.2011.10.031; Lackritz EM, 2013, LANCET GLOB HEALTH, V1, pE328, DOI 10.1016/S2214-109X(13)70120-7; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lawn JE, 2009, INT J GYNECOL OBS S1, V107, P19; Lawn JE, 2014, LANCET; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lawn JE, 2013, PEDIATR RES, V74, P1, DOI 10.1038/pr.2013.202; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Levine Ruth, 2004, MILLIONS SAVED PROVE; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Malaria RB, 2011, ROLL BACK MALARIA PR; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mason E, 2014, LANCET; Mbonye AK, 2012, HEALTH POLICY PLANN, V27, P104, DOI 10.1093/heapol/czs045; Metcalfe R, 2013, INT HEALTH, V5, P96, DOI 10.1093/inthealth/ihs001; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; Moran AC, 2012, HEALTH POLICY PLANN, V27, P29, DOI 10.1093/heapol/czs046; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; OECD, AID EFF PAR DECL ACC; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Partnership for Maternal Newborn & Child Health, 2013, PMNCH 2013 REP AN PR; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Requejo JH, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-42; Requejo JH, 2012, ACCOUNTABILIY MATERN; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; Scott J, 2011, LANCET, V377, P1386, DOI 10.1016/S0140-6736(11)60107-4; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2013, AM J PUBLIC HEALTH, V103, P623, DOI 10.2105/AJPH.2012.300919; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Smith SL, 2014, HEALTH POLICY PLANN, V29, P951, DOI 10.1093/heapol/czt076; Smith SL, 2011, SOC SCI MED, V72, P568, DOI 10.1016/j.socscimed.2010.11.022; Stenberg K, 2013, LANCET; The Global Fund to Fight AIDS TaM, 2012, GLOB FUND STRAT 2012; The Partnership for Maternal Newborn Child Health, 2013, GLOB INV FRAM WOM CH; The Partnership for Maternal Newborn Child Health, 2013, POLICY PRACTICE; The World Bank, 2013, RES BAS FIN HLTH HLT; UN Foundation, 2012, EV WOM EV CHILD; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF, 2013, STATE WORLDS CHILDRE; UNICEF/WHO, 2013, EV NEWB ACT PLAN END; United Nations, 2012, UN COMM LIF SAV COMM; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO, 2009, WHO UNICEF JOINT STA; WHO, 2014, IMM SURV ASS MON MAT; WHO Regional Office for South-East Asia, 2008, STENGTH MAT NEWB HLT; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization,, 2012, INF M PROV HOM BAS C; Zimba E, 2012, HEALTH POLICY PLANN, V27, P88, DOI 10.1093/heapol/czs043	113	106	107	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					174	188		10.1016/S0140-6736(14)60458-X	http://dx.doi.org/10.1016/S0140-6736(14)60458-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24853603				2022-12-28	WOS:000338921500037
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			The world we want for every newborn child	LANCET			English	Editorial Material									[Samarasekera, Udani; Horton, Richard] The Lancet, London NW1 7BY, England		Samarasekera, U (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2014, LANCET; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Lawn JE, 2014, LANCET; Mason E, 2014, LANCET; World Health Organization, 2014, EV NEWB ACT PLAN END; You D, 2013, LEVELS TRENDS CHILD	8	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					107	109		10.1016/S0140-6736(14)60837-0	http://dx.doi.org/10.1016/S0140-6736(14)60837-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853598				2022-12-28	WOS:000338921500009
J	Franklin, RA; Liao, W; Sarkar, A; Kim, MV; Bivona, MR; Liu, K; Pamer, EG; Li, MO				Franklin, Ruth A.; Liao, Will; Sarkar, Abira; Kim, Myoungjoo V.; Bivona, Michael R.; Liu, Kang; Pamer, Eric G.; Li, Ming O.			The cellular and molecular origin of tumor-associated macrophages	SCIENCE			English	Article							DENDRITIC CELLS; SIGNALING CONTROLS; MAMMARY-TUMORS; MONOCYTES; DIFFERENTIATION; RECRUITMENT; HOMEOSTASIS; EXPRESSION; INFECTION; IMMUNITY	Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being rediscovered as regulators of several diseases, including cancer. Here we show that in mice, mammary tumor growth induces the accumulation of tumor-associated macrophages (TAMs) that are phenotypically and functionally distinct from mammary tissue macrophages (MTMs). TAMs express the adhesion molecule Vcam1 and proliferate upon their differentiation from inflammatory monocytes, but do not exhibit an "alternatively activated" phenotype. TAM terminal differentiation depends on the transcriptional regulator of Notch signaling, RBPJ; and TAM, but not MTM, depletion restores tumor-infiltrating cytotoxic T cell responses and suppresses tumor growth. These findings reveal the ontogeny of TAMs and a discrete tumor-elicited inflammatory response, which may provide new opportunities for cancer immunotherapy.	[Franklin, Ruth A.; Sarkar, Abira; Kim, Myoungjoo V.; Bivona, Michael R.; Pamer, Eric G.; Li, Ming O.] Mem Sloan Kettering Canc Ctr MSKCC, Immunol Program, New York, NY 10065 USA; [Franklin, Ruth A.; Kim, Myoungjoo V.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Liao, Will] New York Genome Ctr, New York, NY 10022 USA; [Liu, Kang] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr MSKCC, Immunol Program, New York, NY 10065 USA.	lim@mskcc.org	Franklin, Ruth/AFK-5723-2022; Franklin, Ruth/AAG-4161-2022	li, ming/0000-0002-1383-0535	Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant; NIH grant [AI101251]; Cancer Research Institute Clinic and Laboratory Integration Program Grant; American Cancer Society Research Scholar Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031, R01AI101251] Funding Source: NIH RePORTER	Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Clinic and Laboratory Integration Program Grant; American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Honjo for the Rbpj <SUP>fl/fl</SUP> mouse strain and B. Reizis for the CD11c<SUP>cre</SUP> mouse strain. We also thank J. Joyce and the M. Li lab for their insightful discussions. The data presented in this paper are tabulated in the manuscript and in the supplementary materials (Gene Expression Omnibus accession no. GSE56755). MSKCC has filed a provisional patent application with the U.S. Patent and Trademark Office (application no. 61/935,318). The application is directed toward methods and compositions for targeted cancer therapy and to identify potential responders to targeted therapy based on the presence of specific tumor-associated macrophages. R.A.F and M.O.L are listed as inventors on this patent application. This work was supported by the Cancer Research Institute Tumor Immunology Predoctoral Fellowship Training Grant (R.A.F), NIH grant AI101251 (K.L.), Cancer Research Institute Clinic and Laboratory Integration Program Grant (M.O.L.), and the American Cancer Society Research Scholar Award (M.O.L.).	Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	30	810	842	15	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					921	925		10.1126/science.1252510	http://dx.doi.org/10.1126/science.1252510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24812208	Green Accepted			2022-12-28	WOS:000336233800053
J	Ben-Zvi, A; Lacoste, B; Kur, E; Andreone, BJ; Mayshar, Y; Yan, H; Gu, CH				Ben-Zvi, Ayal; Lacoste, Baptiste; Kur, Esther; Andreone, Benjamin J.; Mayshar, Yoav; Yan, Han; Gu, Chenghua			Mfsd2a is critical for the formation and function of the blood-brain barrier	NATURE			English	Article							CNS; INTEGRITY; RECEPTOR; DIFFERENTIATION; TRANSPORTER; MECHANISMS; EXPRESSION; PERICYTES; MOUSE	The central nervous system(CNS) requires a tightly controlled environment free of toxins and pathogens to provide the proper chemical composition for neural function. This environment is maintained by the 'blood-brain barrier' (BBB), which is composed of blood vessels whose endothelial cells display specialized tight junctions and extremely low rates of transcellular vesicular transport (transcytosis)(1-3). In concert with pericytes and astrocytes, this unique brain endothelial physiological barrier seals the CNS and controls substance influx and efflux(4-6). Although BBB breakdown has recently been associated with initiation and perpetuation of various neurological disorders, an intact BBB is a major obstacle for drug delivery to the CNS7-10. A limited understanding of the molecular mechanisms that control BBB formation has hindered our ability to manipulate the BBB in disease and therapy. Here we identify mechanisms governing the establishment of a functional BBB. First, using a novel tracer-injection method for embryos, we demonstrate spatiotemporal developmental profiles of BBB functionality and find that the mouse BBB becomes functional at embryonic day 15.5 (E15.5). We then screen for BBB-specific genes expressed during BBB formation, and find that major facilitator super family domain containing 2a (Mfsd2a) is selectively expressed in BBB-containing blood vessels in the CNS. Genetic ablation of Mfsd2a results in a leaky BBB from embryonic stages through to adulthood, but the normal patterning of vascular networks is maintained. Electron microscopy examination reveals a dramatic increase in CNS-endothelial-cell vesicular transcytosis in Mfsd2a(-/-) mice, without obvious tight-junction defects. Finally we show that Mfsd2a endothelial expression is regulated by pericytes to facilitate BBB integrity. These findings identify Mfsd2a as a key regulator of BBB function that may act by suppressing transcytosis in CNS endothelial cells. Furthermore, our findings may aid in efforts to develop therapeutic approaches for CNS drug delivery.	[Ben-Zvi, Ayal; Lacoste, Baptiste; Kur, Esther; Andreone, Benjamin J.; Yan, Han; Gu, Chenghua] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mayshar, Yoav] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gu, CH (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	chenghua_gu@hms.harvard.edu	Lacoste, Baptiste/J-9663-2016	Lacoste, Baptiste/0000-0002-1922-8801; Mayshar, Yoav/0000-0002-5553-2472	Neural Imaging Center as part of an NINDS P30 Core Center grant [NS072030]; Harold Perlman postdoctoral fellowships; Goldenson postdoctoral fellowship; Lefler postdoctoral fellowship; DFG-German Research Foundation postdoctoral fellowship; Mahoney postdoctoral fellowship; NIH training grant [5T32MH20017-15]; Sloan research fellowship; Armenise junior faculty award; Genise Goldenson fund; Freudenberger award; NIH [R01NS064583]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030, R01NS064583] Funding Source: NIH RePORTER	Neural Imaging Center as part of an NINDS P30 Core Center grant; Harold Perlman postdoctoral fellowships; Goldenson postdoctoral fellowship; Lefler postdoctoral fellowship; DFG-German Research Foundation postdoctoral fellowship(German Research Foundation (DFG)); Mahoney postdoctoral fellowship; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan research fellowship(Alfred P. Sloan Foundation); Armenise junior faculty award; Genise Goldenson fund; Freudenberger award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Karnovsky, E. Raviola and T. Reese for advice and discussion; S. R. Datta, C. Weitz, M. Greenberg, Q. Ma, C. Harvey and members of the Gu laboratory for comments on the manuscript; D. Sabatini and J. Reeling for sharing unpublished data; C. Betsholtz and C. Olsson for providing Pdgfb<SUP>ret/ret</SUP> mouse brain samples; T. Schwarz and A. Oztan for discussion and advice on cell trafficking; W.-J. Oh for help with graphic illustrations; the Flow Cytometry Facility in the department of Systems Biology at Harvard Medical School for cell sorting; the Microarray Core at Dana-Farber Cancer Institute for Affymetrix assay; HSPH Bioinformatics Core, Harvard School of Public Health, for assistance with microarray analysis and Gene Expression Omnibus (GEO) submission; the Enhanced Neuroimaging Core at Harvard NeuroDiscovery Center for helping with confocal imaging and image analysis; the HMS Electron Microscopy Core Facility, the Neurobiology Imaging Facility for consultation and instrument availability that supported this work (this facility is supported in part by the Neural Imaging Center as part of an NINDS P30 Core Center grant no. NS072030); R. Polakiewicz and J. Xie from CST for generating Mfsd2a antibodies. This work was supported by the Harold Perlman postdoctoral fellowships, the Goldenson postdoctoral fellowship, and the Lefler postdoctoral fellowship (A.B.-Z.); the DFG-German Research Foundation postdoctoral fellowship (E. K.); the Mahoney postdoctoral fellowship (B. L.); NIH training grant 5T32MH20017-15 (B. J. A.); and the Sloan research fellowship, Armenise junior faculty award, the Genise Goldenson fund, the Freudenberger award, and NIH grant R01NS064583 (C.G.).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BAUER H, 1995, DEV BRAIN RES, V86, P317, DOI 10.1016/0165-3806(95)00044-E; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Chen F., 2010, MOL CELL SPECIAL REV, V40; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Nag S., 2003, BLOOD BRAIN BARRIE 2, P99; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Siegenthaler JA, 2013, CURR OPIN NEUROBIOL, V23, P1057, DOI 10.1016/j.conb.2013.06.006; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stern L, 1929, CR SOC BIOL, V100, P231; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	31	528	549	10	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					507	+		10.1038/nature13324	http://dx.doi.org/10.1038/nature13324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828040	Green Accepted			2022-12-28	WOS:000336126000042
J	Kris, MG; Johnson, BE; Berry, LD; Kwiatkowski, DJ; Iafrate, AJ; Wistuba, II; Varella-Garcia, M; Franklin, WA; Aronson, SL; Su, PF; Shyr, Y; Camidge, DR; Sequist, LV; Glisson, BS; Khuri, FR; Garon, EB; Pao, W; Rudin, C; Schiller, J; Haura, EB; Socinski, M; Shirai, K; Chen, HD; Giaccone, G; Ladanyi, M; Kugler, K; Minna, JD; Bunn, PA				Kris, Mark G.; Johnson, Bruce E.; Berry, Lynne D.; Kwiatkowski, David J.; Iafrate, A. John; Wistuba, Ignacio I.; Varella-Garcia, Marileila; Franklin, Wilbur A.; Aronson, Samuel L.; Su, Pei-Fang; Shyr, Yu; Camidge, D. Ross; Sequist, Lecia V.; Glisson, Bonnie S.; Khuri, Fadlo R.; Garon, Edward B.; Pao, William; Rudin, Charles; Schiller, Joan; Haura, Eric B.; Socinski, Mark; Shirai, Keisuke; Chen, Heidi; Giaccone, Giuseppe; Ladanyi, Marc; Kugler, Kelly; Minna, John D.; Bunn, Paul A.			Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEIN EXPRESSION; MUTATIONS; GENE; EGFR; GEFITINIB; ADENOCARCINOMA; IDENTIFICATION; MULTICENTER; SENSITIVITY; PREVALENCE	IMPORTANCE Targeting oncogenic drivers (genomic alterations critical to cancer development and maintenance) has transformed the care of patients with lung adenocarcinomas. The Lung Cancer Mutation Consortium was formed to perform multiplexed assays testing adenocarcinomas of the lung for drivers in 10 genes to enable clinicians to select targeted treatments and enroll patients into clinical trials. OBJECTIVES To determine the frequency of oncogenic drivers in patients with lung adenocarcinomas and to use the data to select treatments targeting the identified driver(s) and measure survival. DESIGN, SETTING, AND PARTICIPANTS From 2009 through 2012, 14 sites in the United States enrolled patients with metastatic lung adenocarcinomas and a performance status of 0 through 2 and tested their tumors for 10 drivers. Information was collected on patients, therapies, and survival. INTERVENTIONS Tumors were tested for 10 oncogenic drivers, and results were used to select matched targeted therapies. MAIN OUTCOMES AND MEASURES Determination of the frequency of oncogenic drivers, the proportion of patients treated with genotype-directed therapy, and survival. RESULTS From 2009 through 2012, tumors from 1007 patients were tested for at least 1 gene and 733 for 10 genes (patients with full genotyping). An oncogenic driver was found in 466 of 733 patients (64%). Among these 733 tumors, 182 tumors (25%) had the KRAS driver; sensitizing EGFR, 122 (17%); ALK rearrangements, 57 (8%); other EGFR, 29 (4%); 2 or more genes, 24 (3%); ERBB2 (formerly HER2), 19 (3%); BRAF, 16 (2%); PIK3CA, 6 (<1%); MET amplification, 5 (<1%); NRAS, 5 (<1%); MEK1, 1 (<1%); AKT1, 0. Results were used to select a targeted therapy or trial in 275 of 1007 patients (28%). The median survival was 3.5 years (interquartile range [IQR], 1.96-7.70) for the 260 patients with an oncogenic driver and genotype-directed therapy compared with 2.4 years (IQR, 0.88-6.20) for the 318 patients with any oncogenic driver(s) who did not receive genotype-directed therapy (propensity score-adjusted hazard ratio, 0.69 [95% CI, 0.53-0.9], P = .006). CONCLUSIONS AND RELEVANCE Actionable drivers were detected in 64% of lung adenocarcinomas. Multiplexed testing aided physicians in selecting therapies. Although individuals with drivers receiving a matched targeted agent lived longer, randomized trials are required to determine if targeting therapy based on oncogenic drivers improves survival.	[Kris, Mark G.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Johnson, Bruce E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Berry, Lynne D.; Su, Pei-Fang; Shyr, Yu; Pao, William; Chen, Heidi] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Kwiatkowski, David J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Iafrate, A. John; Sequist, Lecia V.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wistuba, Ignacio I.; Glisson, Bonnie S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Varella-Garcia, Marileila; Franklin, Wilbur A.; Camidge, D. Ross; Kugler, Kelly; Bunn, Paul A.] Univ Colorado, Canc Ctr Denver, Aurora, CO USA; [Aronson, Samuel L.] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Khuri, Fadlo R.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rudin, Charles] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Schiller, Joan; Minna, John D.] Univ Texas Southwestern, Med Ctr, Dallas, TX USA; [Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Socinski, Mark] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Shirai, Keisuke] Med Univ S Carolina, Charleston, SC USA; [Giaccone, Giuseppe] NCI, Bethesda, MD 20892 USA; [Giaccone, Giuseppe] Georgetown Univ, Sch Med, Washington, DC USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Partners Healthcare System; Emory University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University	Kris, MG (corresponding author), Mem Sloan Kettering Canc Ctr, 300 E 66th St, New York, NY 10065 USA.	krism@mskcc.org	Khuri, Fadlo R./AAU-4942-2020; Giaccone, Giuseppe/E-8297-2017; Ladanyi, Marc/AAG-8585-2019; Camidge, David Ross/AAG-9144-2019; Rudin, Charles/R-2530-2019	Khuri, Fadlo R./0000-0002-8638-7618; Giaccone, Giuseppe/0000-0002-5023-7562; Rudin, Charles/0000-0001-5204-3465; Kris, Mark/0000-0002-7317-5341	National Institutes of Health, National Cancer Institute [HSS NIH NCI 1RC2CA148394-010]; NATIONAL CANCER INSTITUTE [K23CA149079, RC2CA148394, P01CA129243, P30CA016672, P30CA008748, P30CA046934, P50CA058187] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was entirely supported by a grant from the National Institutes of Health, National Cancer Institute (HSS NIH NCI 1RC2CA148394-010).	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Aronson SJ, 2011, HUM MUTAT, V32, P532, DOI 10.1002/humu.21470; Atherly AJ, 2012, BRIT J CANCER, V106, P1100, DOI 10.1038/bjc.2012.60; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Cardarella S, 2012, J THORAC ONCOL, V7, P1767, DOI 10.1097/JTO.0b013e3182745bcb; Chaft JE, 2012, MOL CANCER THER, V11, P485, DOI 10.1158/1535-7163.MCT-11-0692; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Dziadziuszko R, 2012, J THORAC ONCOL, V7, P340, DOI 10.1097/JTO.0b013e318240ca0d; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Oxnard GR, 2013, J THORAC ONCOL, V8, P179, DOI 10.1097/JTO.0b013e3182779d18; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358	41	1093	1148	4	86	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1998	2006		10.1001/jama.2014.3741	http://dx.doi.org/10.1001/jama.2014.3741			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846037	Bronze, Green Accepted			2022-12-28	WOS:000336122800022
J	Rich, JD; Allen, SA; Williams, BA				Rich, Josiah D.; Allen, Scott A.; Williams, Brie A.			Responding to Hepatitis C through the Criminal Justice System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Rich, Josiah D.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Rich, Josiah D.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Rich, Josiah D.; Allen, Scott A.] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA; [Allen, Scott A.] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Williams, Brie A.] Univ Calif San Francisco, Dept Med, Dept Geriatr, San Francisco, CA USA	Brown University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of California System; University of California Riverside; University of California System; University of California San Francisco	Rich, JD (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.		Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030778, K24DA022112] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA030778, K24 DA022112] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Institute of Medicine, 2010, HEP LIV CANC NAT STR; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Varan AK, 2014, PUBLIC HEALTH REP, V129, P187, DOI 10.1177/003335491412900213	5	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1871	1874		10.1056/NEJMp1311941	http://dx.doi.org/10.1056/NEJMp1311941			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UH	24827032	Green Published			2022-12-28	WOS:000336123600002
J	Crotty, BH; Mostaghimi, A				Crotty, Bradley H.; Mostaghimi, Arash			PRACTICE POINTER Confidentiality in the digital age	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; HIPAA; PATIENT; PROFESSIONALISM; SECURITY; PRIVACY; CARE		[Crotty, Bradley H.] Beth Israel Deaconess Med Ctr, Div Clin Informat, Brookline, MA 02446 USA; [Crotty, Bradley H.] Harvard Univ, Sch Med, Brookline, MA 02446 USA; [Mostaghimi, Arash] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Mostaghimi, Arash] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Crotty, BH (corresponding author), Beth Israel Deaconess Med Ctr, Div Clin Informat, Brookline, MA 02446 USA.	bcrotty@bidmc.harvard.edu	Crotty, Bradley/E-6332-2015	Crotty, Bradley/0000-0001-6271-4816; Mostaghimi, Arash/0000-0002-6084-5617				American Medical Association, 2011, AMA COD MED ETH OP 9; Department of Health and Human Services, 2013, HLTH INF PRIV BUS AS; Department of Health and Human Services, 2013, FED REGISTER, P5566; Department of Health Human Services. Office of the Secretary, 2002, FED REGISTER, P1; Farnan JM, 2013, ANN INTERN MED, V158, P620, DOI 10.7326/0003-4819-158-8-201304160-00100; General Medical Council, 2013, DOCT US SOC MED; Greene Adam H, 2012, J AHIMA, V83, P34; Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361; Kane B, 1998, J AM MED INFORM ASSN, V5, P104, DOI 10.1136/jamia.1998.0050104; Karasz HN, 2013, AM J PUBLIC HEALTH, V103, P617, DOI 10.2105/AJPH.2012.300999; Kopytoff V. G., 2011, NY TIMES; Lo B, 2005, JAMA-J AM MED ASSOC, V293, P1766, DOI 10.1001/jama.293.14.1766; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P861, DOI 10.1001/jama.2013.806; Mostaghimi A, 2011, ANN INTERN MED, V154, P560, DOI 10.7326/0003-4819-154-8-201104190-00008; Rosenthal David A, 2008, Perspect Health Inf Manag, V5, P3; Slack WV, 1997, M D COMPUT, V14, P8; The European Parliament and the Council of the European Union, 1996, STUD HLTH TECHNOL IN, V27, P83; Wang CJ, 2013, JAMA-J AM MED ASSOC, V310, P1121, DOI 10.1001/jama.2013.219869; Williams C, 2012, HEALTH AFFAIR, V31, P527, DOI 10.1377/hlthaff.2011.1314	19	8	8	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2014	348								g2943	10.1136/bmj.g2943	http://dx.doi.org/10.1136/bmj.g2943			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH0OT	24816731	Green Submitted			2022-12-28	WOS:000335820400002
J	Orleans, RJ; Li, L; Kim, MJ; Guo, J; Sobhan, M; Soule, L; Joffe, HV				Orleans, Ronald J.; Li, Li; Kim, Myong-Jin; Guo, Jia; Sobhan, Mahboob; Soule, Lisa; Joffe, Hylton V.			FDA Approval of Paroxetine for Menopausal Hot Flushes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN; ESTROGEN; CYP2D6	An FDA advisory committee recommended against approving paroxetine for menopausal vasomotor symptoms. But recognizing the lack of hormone-free products for this indication, and after reviewing the drug's efficacy and safety, the FDA decided it can benefit some women. The recent approval by the Food and Drug Administration (FDA) of paroxetine (Brisdelle, Noven) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause was distinctive for at least two reasons. First, it offered the first nonhormonal option to women who cannot or do not want to use hormonal medications to treat their menopausal vasomotor symptoms. Second, the approval ran counter to the recommendation of the FDA Reproductive Health Drugs Advisory Committee, which had concluded, by a vote of 10 to 4, that the overall benefit-risk profile of Brisdelle did not support approval. The FDA always carefully considers the advice ...	[Orleans, Ronald J.; Li, Li; Kim, Myong-Jin; Guo, Jia; Sobhan, Mahboob; Soule, Lisa; Joffe, Hylton V.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Orleans, RJ (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Hertz DL, 2012, ONCOLOGIST, V17, P620, DOI 10.1634/theoncologist.2011-0418; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Zembutsu H, 2011, EXPERT REV ANTICANC, V11, P185, DOI [10.1586/era.10.228, 10.1586/ERA.10.228]	5	34	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1777	1779		10.1056/NEJMp1402080	http://dx.doi.org/10.1056/NEJMp1402080			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806158				2022-12-28	WOS:000335997900004
J	Dyer, O				Dyer, Owen			The slow death of lethal injection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						Colburn D., 2005, SEATTLE TIMES; Hasselle D., 2013, LENS            1021; Moore P, 2014, YOUGOV          0121; Shaughnessy AF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7432; State of Florida Florida Department of Corrections, 2013, EX LETH INJ PROC; Ward M, 2013, AUSTIN AM STATE 1007	6	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2670	10.1136/bmj.g2670	http://dx.doi.org/10.1136/bmj.g2670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24781110				2022-12-28	WOS:000335475500005
J	Freemantle, N; Shallcross, LJ; Kyte, D; Rader, T; Calvert, MJ				Freemantle, Nick; Shallcross, L. J.; Kyte, D.; Rader, T.; Calvert, M. J.			Oseltamivir: the real world data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA-RELATED COMPLICATIONS; ANTIVIRAL TREATMENT; PROPENSITY SCORES; H1N1 INFLUENZA; CARE SERVICES; CHILDREN; INFECTION; OUTCOMES; RISK; HOSPITALIZATION		[Freemantle, Nick] UCL Med Sch, Res Dept Primary Care & Populat Hlth, PRIMENT Clin Trials Unit, London NW3 2PF, England; [Shallcross, L. J.] UCL Med Sch, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Kyte, D.] Univ Birmingham, Sch Sport Exercise & Rehabil, Birmingham, W Midlands, England; [Kyte, D.; Calvert, M. J.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Rader, T.] Univ Ottawa, Ctr Global Hlth, Cochrane Musculoskeletal Grp, Ottawa, ON, Canada	University of London; University College London; University of London; University College London; University of Birmingham; University of Birmingham; University of Ottawa	Freemantle, N (corresponding author), UCL Med Sch, Res Dept Primary Care & Populat Hlth, PRIMENT Clin Trials Unit, Royal Free Campus, London NW3 2PF, England.	nicholas.freemantle@ucl.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Freemantle, Nick/0000-0001-5807-5740; Shallcross, Laura/0000-0003-1713-2555; kyte, Derek/0000-0002-7679-6741	National Institute for Health Research [SPCR-017] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD008965; Barr CE, 2007, CURR MED RES OPIN, V23, P523, DOI 10.1185/030079906X167499; Beau AB, 2014, BJOG; Blumentals William A, 2007, MedGenMed, V9, P23; Casscells SW, 2009, CIRC-CARDIOVASC QUAL, V2, P108, DOI 10.1161/CIRCOUTCOMES.108.820357; *CIOMS, 2002, INT ETH GUID BIOM RE; Coffin SE, 2011, PEDIATR INFECT DIS J, V30, P962, DOI 10.1097/INF.0b013e318232ede9; Dharan NJ, 2010, CLIN INFECT DIS, V50, P621, DOI 10.1086/650178; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Freemantle N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5248; Funch D, 2012, PHARMACOEPIDEM DR S, V21, P92; Greene SK, 2013, PHARMACOEPIDEM DR S, V22, P335, DOI 10.1002/pds.3363; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Martin A, 2013, MATERN CHILD HLTH J, V17, P1325, DOI 10.1007/s10995-012-1135-3; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Murthuri SG, 2014, LANCET RESP MED 0319; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nordstrom BL, 2005, CURR MED RES OPIN, V21, P761, DOI 10.1185/030079905X46214; Piedra PA, 2009, PEDIATRICS, V124, P170, DOI 10.1542/peds.2008-0977; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Sato M, 2008, TOHOKU J EXP MED, V214, P113, DOI 10.1620/tjem.214.113; Svensson T, 2011, PHARMACOEPIDEM DR S, V20, P1030, DOI 10.1002/pds.2194; Wang YG, 2012, J TRADIT CHIN MED, V32, P148, DOI 10.1016/S0254-6272(13)60004-7; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; World Health Organization, 2003, INFL FACT SHEET; Xie HY, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.015	33	13	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2371	10.1136/bmj.g2371	http://dx.doi.org/10.1136/bmj.g2371			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811409				2022-12-28	WOS:000334348700015
J	Watkins, K				Watkins, Kevin			Leaving no one behind: an agenda for equity	LANCET			English	Editorial Material							COVERAGE		Overseas Dev Inst, London SE1 8NJ, England		Watkins, K (corresponding author), Overseas Dev Inst, London SE1 8NJ, England.	k.watkins@odi.org.uk						[Anonymous], DHS COMP REPORTS, V26; [Anonymous], 2013, POLICY RES WORKING P; Chandy L, FINAL COUNTDOWN ENDI; Chenery Hollis, 1979, REDISTRIBUTION GROWT; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Hacker J., 2010, WINNER TAKES ALL POL; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Klaesen S, THE BROKER; Krueger A. B, RISE CONSEQUENCES IN; Macarthur JW, 2013, FOREIGN AFFAIRS; Pedro HG, POVERTY INEQUALITY S; Ravallion M, COMP PERSPECTIVE POV; Ravallion M, THE BROKER; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Save the Children, 2013, UN HLTH COV COMM CLO; Sen A, 1992, INEQUALITY RE EXAMIN; Tangcharoensathien V, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-25; UNESCO, ED ALL GLOB MON REP; UNESCO, 2010, ED ALL GLOB MON REP; UNICEF, 1989, CONV RIGHTS CHILD; United Nations, 2010, MILL DEV GOALS REP 2; Victora C, 2012, LANCET, V379, P2121, DOI 10.1016/S0140-6736(12)60914-3; Whitehead M, CONCEPT PRINCIPLES E; World Bank, 2006, WORLD DEV REP 206 EQ; Zaidi SA, PAKISTANS ROLLER COA	26	14	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2248	2255		10.1016/S0140-6736(13)62421-6	http://dx.doi.org/10.1016/S0140-6736(13)62421-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	24814087				2022-12-28	WOS:000346655700029
J	Gierisch, JM; Myers, ER; Schmit, KM; McCrory, DC; Coeytaux, RR; Crowley, MJ; Chatterjee, R; Kendrick, AS; Sanders, GD				Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; McCrory, Douglas C.; Coeytaux, Remy R.; Crowley, Matthew J.; Chatterjee, Ranee; Kendrick, Amy S.; Sanders, Gillian D.			Prioritization of Patient-Centered Comparative Effectiveness Research for Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; RHEUMATIC CONDITIONS; KNEE OSTEOARTHRITIS; ARTHRITIS; PREVALENCE; HEALTH; CARE; PAIN	Osteoarthritis is a leading cause of disability in the United States. This article describes a prioritized research agenda about osteoarthritis management developed for the Patient-Centered Outcomes Research Institute. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to expand and refine gaps. Stakeholders ranked evidence gaps by importance from their perspectives. Prioritized evidence gaps included the need to determine or evaluate key patient-centered outcomes; optimal duration, intensity, and frequency of nonsurgical interventions; whether the comparative effectiveness of nonsurgical interventions varies by socioeconomic factors; when and how to transition from nonsurgical to surgical interventions; effective ways to engage patients in self-management and promote long-term behavior change; standardized screening tools that improve early diagnosis; biomechanical strategies that improve symptoms; mechanisms for promoting and delivering coordinated, longitudinal care; and comparative effectiveness of nonsurgical therapies. Searches of PubMed and ClinicalTrials.gov showed many recent and ongoing studies addressing comparative effectiveness of nonsurgical interventions; relatively few of these evaluated treatments across categories (for example, drug therapy vs. weight management) or combined categories of treatment. Few studies addressed other high-priority evidence gaps.	Duke Clin Res Inst, Duke Evidence Synth Grp, Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Duke Univ, Sch Med, Durham, NC 27701 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Gierisch, JM (corresponding author), Duke Univ, Med Ctr, Dept Med, Campus Box 104427 DUMC, Durham, NC 27701 USA.	j.gierisch@dm.duke.edu	Gierisch, Jennifer/GLU-1269-2022	Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By PCORI.	Brasure M, 2013, 13EHC048EF AG HEALTH; Centers for Disease Control and Prevention, NHIS ARTHR SURV SPEC; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Gabriel SE, 1999, J RHEUMATOL, V26, P2475; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Ip S, 2013, AHRQ PUBLICATION, V13-EHC016-EF; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee D W, 2001, Value Health, V4, P329, DOI 10.1046/j.1524-4733.2001.44012.x; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Nuki G, 1999, Z RHEUMATOL, V58, P142, DOI 10.1007/s003930050164; Patient-Centered Outcomes Research Institute, 2014, PRAGM CLIN STUD LARG; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Rosemann T, 2008, PAIN MED, V9, P903, DOI 10.1111/j.1526-4637.2008.00498.x; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565	19	25	25	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					836	U52		10.7326/M14-0318	http://dx.doi.org/10.7326/M14-0318			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24821227				2022-12-28	WOS:000337374900017
J	Moreno, E				Moreno, Eduardo			CANCER Darwinian tumour suppression	NATURE			English	Editorial Material							CELL; DROSOPHILA; SURVIVAL; FITNESS		Univ Bern, Inst Cell Biol, IZB, CH-3012 Bern, Switzerland	University of Bern	Moreno, E (corresponding author), Univ Bern, Inst Cell Biol, IZB, CH-3012 Bern, Switzerland.	emoreno@izb.unibe.ch		moreno, eduardo/0000-0001-5040-452X				FREY JR, 1992, J EXP MED, V175, P1067, DOI 10.1084/jem.175.4.1067; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Merino MM, 2013, CURR BIOL, V23, P1300, DOI 10.1016/j.cub.2013.05.053; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Patel PH, 2014, SEMIN CELL DEV BIOL; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639	10	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					435	436		10.1038/nature13337	http://dx.doi.org/10.1038/nature13337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828043				2022-12-28	WOS:000336126000027
J	Bennell, KL; Egerton, T; Martin, J; Abbott, JH; Metcalf, B; McManus, F; Sims, K; Pua, YH; Wrigley, TV; Forbes, A; Smith, C; Harris, A; Buchbinder, R				Bennell, Kim L.; Egerton, Thorlene; Martin, Joel; Abbott, J. Haxby; Metcalf, Ben; McManus, Fiona; Sims, Kevin; Pua, Yong-Hao; Wrigley, Tim V.; Forbes, Andrew; Smith, Catherine; Harris, Anthony; Buchbinder, Rachelle			Effect of Physical Therapy on Pain and Function in Patients With Hip Osteoarthritis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PHYSIOTHERAPY MANAGEMENT; MANUAL THERAPY; EXERCISE THERAPY; MUSCLE STRENGTH; WESTERN-ONTARIO; KNEE; INTERVENTION; PERFORMANCE; DISABILITY	IMPORTANCE There is limited evidence supporting use of physical therapy for hip osteoarthritis. OBJECTIVE To determine efficacy of physical therapy on pain and physical function in patients with hip osteoarthritis. DESIGN, SETTING, AND PARTICIPANTS Randomized, placebo-controlled, participant-and assessor-blinded trial involving 102 community volunteers with hip pain levels of 40 or higher on a visual analog scale of 100 mm(range, 0-100 mm; 100 indicates worst pain possible) and hip osteoarthritis confirmed by radiograph. Forty-nine patients in the active group and 53 in the sham group underwent 12 weeks of intervention and 24 weeks of follow-up (May 2010-February 2013) INTERVENTIONS Participants attended 10 treatment sessions over 12 weeks. Active treatment included education and advice, manual therapy, home exercise, and gait aid if appropriate. Sham treatment included inactive ultrasound and inert gel. For 24 weeks after treatment, the active group continued unsupervised home exercise while the sham group self-applied gel 3 times weekly. MAIN OUTCOMES AND MEASURES Primary outcomes were average pain (0 mm, no pain; 100 mm, worst pain possible) and physical function (Western Ontario and McMaster Universities Osteoarthritis Index, 0 no difficulty to 68 extreme difficulty) at week 13. Secondary outcomes were these measures at week 36 and impairments, physical performance, global change, psychological status, and quality of life at weeks 13 and 36. RESULTS Ninety-six patients (94%) completed week 13 measurements and 83 (81%) completed week 36 measurements. The between-group differences for improvements in pain were not significant. For the active group, the baseline mean (SD) visual analog scale score was 58.8 mm(13.3) and the week-13 score was 40.1 mm(24.6); for the sham group, the baseline score was 58.0 mm (11.6) and the week-13 score was 35.2 mm(21.4). The mean difference was 6.9 mm favoring sham treatment (95% CI, -3.9 to 17.7). The function scores were not significantly different between groups. The baseline mean (SD) physical function score for the active group was 32.3 (9.2) and the week-13 score was 27.5 (12.9) units, whereas the baseline score for the sham treatment group was 32.4 (8.4) units and the week-13 score was 26.4 (11.3) units, for a mean difference of 1.4 units favoring sham (95% CI, -3.8 to 6.5) at week 13. There were no between-group differences in secondary outcomes (except greater week-13 improvement in the balance step test in the active group). Nineteen of 46 patients (41%) in the active group reported 26 mild adverse effects and 7 of 49 (14%) in the sham group reported 9 mild adverse events (P = .003). CONCLUSIONS AND RELEVANCE Among adults with painful hip osteoarthritis, physical therapy did not result in greater improvement in pain or function compared with sham treatment, raising questions about its value for these patients.	[Bennell, Kim L.; Egerton, Thorlene; Martin, Joel; Metcalf, Ben; McManus, Fiona; Wrigley, Tim V.] Univ Melbourne, Sch Hlth Sci, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia; [Abbott, J. Haxby] Univ Otago, Dept Surg Sci, Dunedin Sch Med, Ctr Musculoskeletal Outcomes Res, Dunedin, New Zealand; [Sims, Kevin] Cricket Australia Ctr Excellence, Brisbane, Qld, Australia; [Pua, Yong-Hao] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore; [Forbes, Andrew; Smith, Catherine; Buchbinder, Rachelle] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Harris, Anthony] Monash Univ, Ctr Hlth Econ, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Cabrini Hlth, Dept Clin Epidemiol, Melbourne, Vic, Australia	University of Melbourne; University of Otago; Singapore General Hospital; Monash University; Monash University; Cabrini Health	Bennell, KL (corresponding author), Univ Melbourne, Sch Hlth Sci, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia.	k.bennell@unimelb.edu.au	Abbott, J. Haxby/AAK-4346-2020; Egerton, Thorlene/AAN-5810-2020; Buchbinder, Rachelle/G-2952-2011; ABBOTT, J. Haxby/AAH-3262-2019; Bennell, Kim/C-7022-2014	Abbott, J. Haxby/0000-0001-6468-7284; Egerton, Thorlene/0000-0003-4751-7624; Buchbinder, Rachelle/0000-0002-0597-0933; Smith, Catherine/0000-0001-9327-0154; McManus, Fiona/0000-0002-1001-8146; Harris, Anthony/0000-0003-1641-3320; Pua, Yong-Hao/0000-0003-2313-9665; WRIGLEY, TIM/0000-0003-3222-4706; Bennell, Kim/0000-0003-4982-5639; Metcalf, Ben/0000-0002-4945-3217; Forbes, Andrew/0000-0003-4269-914X	National Health and Medical Research Council [628556]; Australian Research Council Future Fellowship; Australian National Health and Medical Research Council Practitioner Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by project 628556 from the National Health and Medical Research Council. Dr Bennell is funded in part by an Australian Research Council Future Fellowship. Dr Buchbinder is funded in part by an Australian National Health and Medical Research Council Practitioner Fellowship.	Abbott JH, 2013, OSTEOARTHR CARTILAGE, V21, P525, DOI 10.1016/j.joca.2012.12.014; Abhishek A, 2013, OSTEOARTHR CARTILAGE, V21, P1229, DOI 10.1016/j.joca.2013.04.018; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Bellamy N, 1997, J RHEUMATOL, V24, P768; BELLAMY N, 1992, J RHEUMATOL, V19, P451; Bennell K, 2013, J PHYSIOTHER, V59, P145, DOI 10.1016/S1836-9553(13)70179-6; Bennell K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2756; Bennell KL, 2011, PHYS THER, V91, P1525, DOI 10.2522/ptj.20100430; Bennell KL, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-238; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Cibulka Michael T, 2009, J Orthop Sports Phys Ther, V39, pA1, DOI 10.2519/jospt.2009.0301; Cowan SM, 2010, PHYSIOTHERAPY, V96, P289, DOI 10.1016/j.physio.2010.02.004; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; French HP, 2007, PHYSIOTHERAPY, V93, P253, DOI 10.1016/j.physio.2006.12.008; French HP, 2013, ARCH PHYS MED REHAB, V94, P302, DOI 10.1016/j.apmr.2012.09.030; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hoeksma HL, 2004, ARTHRIT RHEUM-ARTHR, V51, P722, DOI 10.1002/art.20685; James KE, 1996, STAT MED, V15, P1421; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Klassbo M, 2003, SCAND J RHEUMATOL, V32, P46, DOI 10.1080/03009740310000409; Little R. J. A., 2002, STAT ANAL MISSING DA; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Pua YH, 2008, ARCH PHYS MED REHAB, V89, P1146, DOI 10.1016/j.apmr.2007.10.028; Pua YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P442, DOI 10.1002/art.24344; REJESKI WJ, 1995, OSTEOARTHR CARTILAGE, V3, P157, DOI 10.1016/S1063-4584(05)80050-0; Stuart E, 2008, PREV SCI, V9, P288, DOI 10.1007/s11121-008-0104-y; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098; Whitfield K, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-19; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	41	98	100	0	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1987	1997		10.1001/jama.2014.4591	http://dx.doi.org/10.1001/jama.2014.4591			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846036				2022-12-28	WOS:000336122800021
J	Danese, S; Fiorino, G; Peyrin-Biroulet, L; Lucenteforte, E; Virgili, G; Moja, L; Bonovas, S				Danese, Silvio; Fiorino, Gionata; Peyrin-Biroulet, Laurent; Lucenteforte, Ersilia; Virgili, Gianni; Moja, Lorenzo; Bonovas, Stefanos			Biological Agents for Moderately to Severely Active Ulcerative Colitis A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; MAINTENANCE THERAPY; INDUCTION; GASTROENTEROLOGY; DEFINITIONS; VEDOLIZUMAB; ADALIMUMAB; MANAGEMENT; DIAGNOSIS	Background: Biological agents are emerging treatment options for the management of ulcerative colitis (UC). Purpose: To assess the comparative efficacy and harm of biological agents in adult patients with moderately to severely active UC who are naive to biological agents. Data Sources: MEDLINE, EMBASE, and Cochrane Library from inception through December 2013, without language restrictions, and ClinicalTrials.gov, European Medicines Agency, and U. S. Food and Drug Administration Web sites. Study Selection: Randomized, placebo-controlled or head-to-head trials assessing biological agents as induction or maintenance therapy for moderately to severely active UC. Data Extraction: Two reviewers independently abstracted study data and outcomes and rated each trial's risk of bias. Data Synthesis: There were no head-to-head trials. There were 7 double-blind, placebo-controlled trials that were rated as low risk of bias and showed that all biological agents (adalimumab, golimumab, infliximab, and vedolizumab) resulted in more clinical responses, clinical remissions, and mucosal healings than placebo for induction therapy. The results of network meta-analysis suggested that infliximab is more effective to induce clinical response (odds ratio, 2.36 [95% credible interval, 1.22 to 4.63]) and mucosal healing (odds ratio, 2.02 [95% credible interval, 1.13 to 3.59]) than adalimumab. No other indirect comparison reached statistical significance. For maintenance, 6 double-blind, placebo-controlled trials that were rated high risk of bias showed that all biological agents have greater clinical efficacy than placebo. The occurrence of adverse events was not different between biological agents and placebo. Limitation: Few trials, no head-to-head comparisons, and inadequate follow-up in maintenance trials. Conclusion: Biological agents are effective treatments for UC, but head-to-head trials are warranted to establish the best therapeutic option.	Univ Milan, Ctr Inflammatory Bowel Dis, IRCCS Humanitas Res Hosp, IRCCS Galeazzi Orthoped Inst, Milan, Italy; IRCCS Mario Negri Inst Pharmacol Res, Lab Drug Regulatory Policies, Milan, Italy; Univ Lorraine, Univ Hosp Nancy, Vandoeuvre Les Nancy, France; Univ Florence, Florence, Italy; Univ Athens, Sch Med, GR-11527 Athens, Greece	IRCCS Istituto Ortopedico Galeazzi; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; CHU de Nancy; Universite de Lorraine; University of Florence; Athens Medical School; National & Kapodistrian University of Athens	Danese, S (corresponding author), IRCCS Humanitas Res Hosp, Dept Gastroenterol, Ctr Inflammatory Bowel Dis, Via Manzoni 56, I-20089 Milan, Italy.	silvio.danese@humanitas.it	Bonovas, Stefanos/H-5653-2011; Fiorino, Gionata/G-3124-2013; Bonovas, Stefanos/GZG-4609-2022; Danese, Silvio/ABH-9571-2020; Lucenteforte, Ersilia/AAB-9055-2019; Moja, Pasquale Lorenzo/CAH-0318-2022	Fiorino, Gionata/0000-0001-5623-2968; Danese, Silvio/0000-0001-7341-1351; Lucenteforte, Ersilia/0000-0001-5608-5902; Moja, Pasquale Lorenzo/0000-0001-6680-6507; peyrin-biroulet, laurent/0000-0003-2536-6618	Centro Ricerca e Cura delle Malattie Infiammatorie Croniche Intestinali, IRCCS Istituto Clinico Humanitas	Centro Ricerca e Cura delle Malattie Infiammatorie Croniche Intestinali, IRCCS Istituto Clinico Humanitas	By the Centro Ricerca e Cura delle Malattie Infiammatorie Croniche Intestinali, IRCCS Istituto Clinico Humanitas.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Biological therapies audit subgroup, 2013, NAT CLIN AUD REP BIO; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Danese S, 2013, PROSPERO; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dias S, 2011, NICE DSU TECHNICAL S; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Feagan BG, 2012, DIS WEEK SAN DIEG; Feagan B, 2012, AM J GASTROENTEROL, V107, pS609, DOI 10.14309/00000434-201210001-01522; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutgeerts P, 2012, 20 UN EUR GASTR WEE; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Sandborn WJ, 2013, ALIMENT PHARM THER, V37, P204, DOI 10.1111/apt.12145; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P96, DOI 10.1053/j.gastro.2013.06.010; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Suzuki Y, 2014, J GASTROENTEROL, V49, P283, DOI 10.1007/s00535-013-0922-y; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; U.S. Food and Drug Administration, 2012, GAST DRUGS ADV COM M; Wells G, 2009, INDIRECT EVIDENCE IN	35	163	168	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					704	+		10.7326/M13-2403	http://dx.doi.org/10.7326/M13-2403			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842416				2022-12-28	WOS:000337347100017
J	Gillespie, RG; Roderick, GK				Gillespie, Rosemary G.; Roderick, George K.			EVOLUTION Geology and climate drive diversification	NATURE			English	Editorial Material							POPULATIONS; SPECIATION; ORIGINS		[Gillespie, Rosemary G.; Roderick, George K.] Univ Calif Berkeley, Dept Environm Sci, Berkeley, CA 94720 USA; [Gillespie, Rosemary G.; Roderick, George K.] Univ Calif Berkeley, Berkeley Nat Hist Museums, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gillespie, RG (corresponding author), Univ Calif Berkeley, Dept Environm Sci, Berkeley, CA 94720 USA.	gillespie@berkeley.edu; roderick@berkeley.edu	Gillespie, Rosemary/AAF-4244-2019	Gillespie, Rosemary/0000-0003-0086-7424; Roderick, George/0000-0001-7557-2415				ALI, J BIOGEOGRAPHY; Ali J. R., 2014, J BIOGEOGR; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; CARSON HL, 1990, P NATL ACAD SCI USA, V87, P7055, DOI 10.1073/pnas.87.18.7055; Feder JL, 2013, ANNU REV ECOL EVOL S, V44, P73, DOI 10.1146/annurev-ecolsys-110512-135825; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Loh YHE, 2013, MOL BIOL EVOL, V30, P906, DOI 10.1093/molbev/mss326; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003	9	70	69	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					297	298		10.1038/509297a	http://dx.doi.org/10.1038/509297a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828187				2022-12-28	WOS:000336121200026
J	Press, MJ; Judson, TJ; Detsky, AS				Press, Matthew J.; Judson, Timothy J.; Detsky, Allan S.			Filling Buckets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Press, Matthew J.] Weill Cornell Med Coll, Div Hlth Policy & Econ, Dept Healthcare Policy & Res, New York, NY USA; [Press, Matthew J.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Judson, Timothy J.] Weill Cornell Med Coll, New York, NY USA; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	Cornell University; Cornell University; Cornell University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	adetsky@mtsinai.on.ca						Friedberg M.W., 2013, FACTORS AFFECTING PH; Goitein L, 2014, JAMA INTERN MED, V174, P533, DOI 10.1001/jamainternmed.2013.13253; McCloud C, 2008, FILL BUCKET GUIDE DA; Mullan F, 2001, HEALTH AFFAIR, V20, P137, DOI 10.1377/hlthaff.20.1.137; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387	6	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1859	1860		10.1001/jama.2014.2648	http://dx.doi.org/10.1001/jama.2014.2648			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825639				2022-12-28	WOS:000335798100016
J	Gamerdinger, M; Deuerling, E				Gamerdinger, Martin; Deuerling, Elke			Trigger Factor Flexibility	SCIENCE			English	Editorial Material							CHAPERONE; RIBOSOME; PROTEIN; DNAK		[Gamerdinger, Martin; Deuerling, Elke] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Gamerdinger, M (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	elke.deuerling@uni-konstanz.de		Gamerdinger, Martin/0000-0003-1483-8181				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4	12	18	19	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					590	591		10.1126/science.1254064	http://dx.doi.org/10.1126/science.1254064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812390	Green Submitted			2022-12-28	WOS:000335537400029
J	Sinha, M; Jang, YC; Oh, J; Khong, D; Wu, EY; Manohar, R; Miller, C; Regalado, SG; Loffredo, FS; Pancoast, JR; Hirshman, MF; Lebowitz, J; Shadrach, JL; Cerletti, M; Kim, MJ; Serwold, T; Goodyear, LJ; Rosner, B; Lee, RT; Wagers, AJ				Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Hirshman, Michael F.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Kim, Mi-Jeong; Serwold, Thomas; Goodyear, Laurie J.; Rosner, Bernard; Lee, Richard T.; Wagers, Amy J.			Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle	SCIENCE			English	Article							DIFFERENTIATION FACTOR 11; DNA-DAMAGE; STEM-CELLS; MYOSTATIN; REJUVENATION; HYPERTROPHY; REPAIR	Parabiosis experiments indicate that impaired regeneration in aged mice is reversible by exposure to a young circulation, suggesting that young blood contains humoral "rejuvenating" factors that can restore regenerative function. Here, we demonstrate that the circulating protein growth differentiation factor 11 (GDF11) is a rejuvenating factor for skeletal muscle. Supplementation of systemic GDF11 levels, which normally decline with age, by heterochronic parabiosis or systemic delivery of recombinant protein, reversed functional impairments and restored genomic integrity in aged muscle stem cells (satellite cells). Increased GDF11 levels in aged mice also improved muscle structural and functional features and increased strength and endurance exercise capacity. These data indicate that GDF11 systemically regulates muscle aging and may be therapeutically useful for reversing age-related skeletal muscle and stem cell dysfunction.	[Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Lee, Richard T.; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Regalado, Samuel G.; Loffredo, Francesco S.; Pancoast, James R.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Lee, Richard T.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Hirshman, Michael F.; Lebowitz, Jessica; Shadrach, Jennifer L.; Cerletti, Massimiliano; Kim, Mi-Jeong; Serwold, Thomas; Goodyear, Laurie J.; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Sinha, Manisha; Shadrach, Jennifer L.; Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA; [Sinha, Manisha; Jang, Young C.; Oh, Juhyun; Khong, Danika; Wu, Elizabeth Y.; Manohar, Rohan; Miller, Christine; Lebowitz, Jessica; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA USA; [Regalado, Samuel G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Loffredo, Francesco S.; Pancoast, James R.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Loffredo, Francesco S.; Pancoast, James R.] Brigham Regenerat Med Ctr, Boston, MA USA; [Goodyear, Laurie J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wagers, AJ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Lee, Richard/0000-0003-4687-1381; Oh, Juhyun/0000-0002-4492-6978; Wu, Elizabeth/0000-0002-6537-9790; Khong, Danika/0000-0002-2128-8619	American Heart Association; NIH [R01 AR42238, 1R01 AG033053, 1DP2 OD004345, 5U01 HL100402, R01 AG032977 1R01 AG040019]; Glenn Foundation for Medical Research; Harvard Stem Cell Institute; Project Ascelegen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R01AG032977, R01AG033053] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Harvard Stem Cell Institute; Project Ascelegen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Harvard Stem Cell Institute/Department of Stem Cell and Regenerative Biology's Flow Cytometry Core, Harvard's Center for Biological Imaging, and C. Dall'Osso and B. Hunter for technical assistance. This work was funded in part by grants from the American Heart Association to F. S. L. (postdoctoral fellowship); NIH (R01 AR42238) to L. J. G.; Glenn Foundation for Medical Research, Harvard Stem Cell Institute, and NIH (1R01 AG033053, 1DP2 OD004345, and 5U01 HL100402) to A. J. W.; NIH (R01 AG032977 1R01 AG040019) to R. T. L.; and Project Ascelegen to A. J. W. and R. T. L. A. J. W. is an Early Career Scientist of the Howard Hughes Medical Institute. M. F. H. owns shares in Abbott Laboratories, Amgen Inc., Colgate Palmolive Co., Eli Lilly and Co., Medtronic Inc., and Abbvie Inc. A. J. W. and R. T. L. are inventors on patent applications filed by Harvard University and Brigham and Women's Hospital entitled 'Methods and Compositions for Rejuvenating Skeletal Muscle Stem Cells' and 'Methods and Compositions for Rejuvenating Neuromuscular Junctions.'	Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; De Santis C, 2011, J EXP BIOL, V214, P2671, DOI 10.1242/jeb.056374; Hakim CH, 2011, METHODS MOL BIOL, V709, P75, DOI 10.1007/978-1-61737-982-6_5; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lee YJ, 2010, DEV BIOL, V347, P195, DOI 10.1016/j.ydbio.2010.08.022; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021	23	544	587	9	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					649	652		10.1126/science.1251152	http://dx.doi.org/10.1126/science.1251152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24797481	Green Accepted			2022-12-28	WOS:000335537400048
J	White, SR; Moore, JS; Sottos, NR; Krull, BP; Cruz, WAS; Gergely, RCR				White, S. R.; Moore, J. S.; Sottos, N. R.; Krull, B. P.; Cruz, W. A. Santa; Gergely, R. C. R.			Restoration of Large Damage Volumes in Polymers	SCIENCE			English	Article							LIMB REGENERATION; DEDIFFERENTIATION; COMPOSITES; CHEMISTRY; SURFACE; WEIGHT; CELLS	The regenerative power of tissues and organs in biology has no analog in synthetic materials. Although self-healing of microscopic defects has been demonstrated, the regrowth of material lost through catastrophic damage requires a regenerative-like approach. We demonstrate a vascular synthetic system that restores mechanical performance in response to large-scale damage. Gap-filling scaffolds are created through a two-stage polymer chemistry that initially forms a shape-conforming dynamic gel but later polymerizes to a solid structural polymer with robust mechanical properties. Through the control of reaction kinetics and vascular delivery rate, we filled impacted regions that exceed 35 mm in diameter within 20 min and restored mechanical function within 3 hours. After restoration of impact damage, 62% of the total absorbed energy was recovered in comparison with that in initial impact tests.	[White, S. R.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA; [White, S. R.; Moore, J. S.; Sottos, N. R.; Krull, B. P.; Cruz, W. A. Santa; Gergely, R. C. R.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Moore, J. S.; Cruz, W. A. Santa] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Sottos, N. R.; Krull, B. P.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Gergely, R. C. R.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	White, SR (corresponding author), Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA.	swhite@illinois.edu	; White, Scott/G-9667-2013	Moore, Jeffrey/0000-0001-5841-6269; White, Scott/0000-0002-0831-9097	Air Force Office of Scientific Research [FA9550-10-1-0255]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research has been financially supported by the Air Force Office of Scientific Research (grant FA9550-10-1-0255). We extend our gratitude to the Mechanical Testing Instructional Laboratory (MTIL) and the Beckman Institute for facilities; Y. Fedonina, J. Carlson, A. Komnick, and C. Kirk for assistance with sample fabrication and material synthesis; and G. Milner for test fixture construction.	Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Beiermann BA, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/8/085001; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; CARNEVALI MDC, 1995, J EXP ZOOL, V272, P464, DOI 10.1002/jez.1402720608; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Esfandiari P, 2013, J POLYM SCI POL CHEM, V51, P4261, DOI 10.1002/pola.26848; Harkins WD, 1919, J AM CHEM SOC, V41, P499, DOI 10.1021/ja01461a003; Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim YB, 2005, J APPL POLYM SCI, V95, P342, DOI 10.1002/app.21248; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; LANDO JL, 1967, J COLLOID INTERF SCI, V25, P526, DOI 10.1016/0021-9797(67)90064-1; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; Mark JE, 1999, POLYM DATA HDB, P656; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Odelberg Shannon J., 2005, Anatomical Record Part B:The New Anatomist, V287, P25, DOI 10.1002/ar.b.20080; Patrick JF, 2014, ADV MATER, V26, P4302, DOI 10.1002/adma.201400248; SHEPPARD CS, 1979, POLYM ENG SCI, V19, P597, DOI 10.1002/pen.760190902; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; TATE T., 1864, PHILOS MAG, V27, P176; Toohey KS, 2009, ADV FUNCT MATER, V19, P1399, DOI 10.1002/adfm.200801824; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g	31	179	188	5	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					620	623		10.1126/science.1251135	http://dx.doi.org/10.1126/science.1251135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812399				2022-12-28	WOS:000335537400040
J	Meador, KJ				Meador, Kimford J.			Breastfeeding and Antiepileptic Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILD-DEVELOPMENT; EXPOSURE; WOMEN; FETAL	IMPORTANCE Exposure to antiepileptic drugs during pregnancy is associated with adverse effects on psychomotor development. OBJECTIVES To determine whether signs of impaired development appear already during the first months of life in children exposed prenatally to antiepileptic drugs, and to explore potential adverse effects of antiepileptic drug exposure through breastfeeding. DESIGN, SETTING, AND PARTICIPANTS Mothers at 13 to 17 weeks of pregnancy were recruited in the population-based, prospective Norwegian Mother and Child Cohort Study from 1999 to 2009. The mothers reported on their child's motor and social skills, language, and behavior using items from standardized screening tools at 6 months (n = 78 744), 18 months (n = 61 351), and 36 months (n = 44 147) of age. The mothers also provided detailed information on breastfeeding during the first year. MAIN OUTCOMES AND MEASURES The risk of adverse development in children according to maternal or paternal epilepsy was estimated as the odds ratio with corresponding 95% confidence interval, adjusted for maternal age, parity, education, smoking, breastfeeding, depression/anxiety, folate supplementation, and congenital malformation in the child. RESULTS At age 6 months, infants of mothers using antiepileptic drugs (n = 223) had a higher risk of impaired fine motor skills compared with the reference group (11.5% vs 4.8%, respectively; odds ratio = 2.1; 95% CI, 1.3-3.2). Use of multiple antiepileptic drugs compared with the reference group was associated with adverse outcome for both fine motor skills (25.0% vs 4.8%, respectively; odds ratio = 4.3; 95% CI, 2.0-9.1) and social skills (22.5% vs 10.2%, respectively; odds ratio = 2.6; 95% CI, 1.2-5.5). Continuous breastfeeding in children of women using antiepileptic drugs was associated with less impaired development at ages 6 and 18 months compared with those with no breastfeeding or breastfeeding for less than 6 months. At 36 months, prenatal antiepileptic drug exposure was associated with adverse development regardless of breastfeeding status during the first year. Children of women with epilepsy who did not use antiepileptic drugs and children of fathers with epilepsy had normal development at 6 months. CONCLUSIONS AND RELEVANCE Prenatal exposure to antiepileptic drugs was associated with impaired fine motor skills already at age 6 months, especially when the child was exposed to multiple drugs. There were no harmful effects of breastfeeding. Women with epilepsy should be encouraged to breastfeed their children irrespective of antiepileptic drug treatment.	[Meador, Kimford J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford Comprehens Epilepsy Ctr, Stanford, CA 94305 USA	Stanford University	Meador, KJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 300 Pasteur Dr,Room A343, Stanford, CA 94305 USA.	kmeador@stanford.edu	Meador, Kimford/W-6167-2019	Meador, Kimford/0000-0002-7471-882X	National Institutes of Health [U01 NS038455]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS038455, R01NS038455, R01NS076665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health (U01 NS038455).	Hovinga CA, 2008, INT REV NEUROBIOL, V83, P241, DOI 10.1016/S0074-7742(08)00014-7; Ikonomidou C, 2010, EPILEPSY RES, V88, P11, DOI 10.1016/j.eplepsyres.2009.09.019; Ip S, 2009, BREASTFEED MED, V4, pS17, DOI 10.1089/bfm.2009.0050; Meador KJ, 2010, NEUROLOGY, V75, P1954, DOI 10.1212/WNL.0b013e3181ffe4a9; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Veiby G, 2013, JAMA NEUROL, V70, P1367, DOI 10.1001/jamaneurol.2013.4290; Veiby G, 2013, EPILEPSIA, V54, P1462, DOI 10.1111/epi.12226	7	5	5	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1797	+		10.1001/jama.2014.967	http://dx.doi.org/10.1001/jama.2014.967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794373	Green Accepted			2022-12-28	WOS:000335382300025
J	Walsh, KE; Bundy, DG; Landrigan, CP				Walsh, Kathleen E.; Bundy, David G.; Landrigan, Christopher P.			Preventing Health Care-Associated Harm in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE EVENTS; TRIGGER TOOL; ERRORS; RATES		[Walsh, Kathleen E.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH 45229 USA; [Bundy, David G.] Med Univ S Carolina, Dept Pediat, Charleston, SC USA; [Landrigan, Christopher P.] Harvard Univ, Sch Med, Dept Pediat, Boston Childrens Hosp,Div Gen Pediat, Boston, MA 02115 USA; [Landrigan, Christopher P.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Sleep Med,Sch Med, Boston, MA 02115 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Medical University of South Carolina; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Walsh, KE (corresponding author), Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Kathleen.walsh@cchmc.org		Landrigan, Christopher/0000-0001-8386-4100				Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Kirkendall ES, 2012, PEDIATRICS, V130, pE1206, DOI 10.1542/peds.2012-0179; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Miller MR, 2011, PEDIATRICS, V128, pE1077, DOI 10.1542/peds.2010-3675; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Walsh KE, 2013, PEDIATRICS, V131, pE1405, DOI 10.1542/peds.2012-2434	7	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1731	1732		10.1001/jama.2014.2038	http://dx.doi.org/10.1001/jama.2014.2038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794361				2022-12-28	WOS:000335382300013
J	Zylke, JW				Zylke, Jody W.			Building Blocks The Child Health Theme Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									JAMA, Chicago, IL 60611 USA		Zylke, JW (corresponding author), JAMA, 330 N Wabash Ave,Ste 39300, Chicago, IL 60611 USA.	jody.zylke@jamanetwork.org						Batshaw ML, 2014, JAMA-J AM MED ASSOC, V311, P1729, DOI 10.1001/jama.2013.285873; Benjamin DK, 2014, JAMA-J AM MED ASSOC, V311, P1742, DOI 10.1001/jama.2014.2624; Bezerra JA, 2014, JAMA-J AM MED ASSOC, V311, P1750, DOI 10.1001/jama.2014.2623; Cheng TL, 2014, JAMA-J AM MED ASSOC, V311, P1733, DOI 10.1001/jama.2014.930; Cohen LE, 2014, JAMA-J AM MED ASSOC, V311, P1787, DOI 10.1001/jama.2014.3970; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Insel TR, 2014, JAMA-J AM MED ASSOC, V311, P1727, DOI 10.1001/jama.2014.1193; Makrides M, 2014, JAMA-J AM MED ASSOC, V311, P1802, DOI 10.1001/jama.2014.2194; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Vinci SR, 2014, JAMA-J AM MED ASSOC, V311, P1804, DOI 10.1001/jama.2014.2410; Walsh KE, 2014, JAMA-J AM MED ASSOC, V311, P1731, DOI 10.1001/jama.2014.2038	12	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1740	1741		10.1001/jama.2014.4174	http://dx.doi.org/10.1001/jama.2014.4174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794366				2022-12-28	WOS:000335382300018
J	Motzer, RJ; Hutson, TE; McCann, L; Deen, K; Choueiri, TK				Motzer, Robert J.; Hutson, Thomas E.; McCann, Lauren; Deen, Keith; Choueiri, Toni K.			Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter								Survival results are now mature for a noninferiority trial comparing pazopanib with sunitinib in renal-cell carcinoma. Median survival was 42.5 months with pazopanib and 43.6 months with sunitinib, a difference that wasnot significant.To the Editor: In the August 22 issue,(1) we reported on a phase 3 trial showing the noninferiority, with respect to progression-free survival, of pazopanib versus sunitinib as first-line treatment for clear-cell, metastatic renal-cell carcinoma, as assessed by independent review. We now report the results of the final analysis of overall survival. Overall survival, a secondary end point, was defined as the time from randomization to death from any cause. The final analysis of overall survival in the intention-to-treat population was to be performed when 650 patients had died or 2 years after the last patient was enrolled. Overall survival ...	[Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hutson, Thomas E.] Baylor Sammons Canc Ctr Texas Oncol, Dallas, TX USA; [McCann, Lauren; Deen, Keith] GlaxoSmithKline, Collegeville, PA USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; GlaxoSmithKline; Harvard University; Dana-Farber Cancer Institute	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	motzerr@mskcc.org	Choueiri, Toni/K-5238-2019; Hutson, Thomas/AAS-9639-2020	Choueiri, Toni/0000-0002-9201-3217; Hutson, Thomas/0000-0002-4529-4212; Motzer, Robert/0000-0001-6925-2327	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989	2	214	222	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1769	1770		10.1056/NEJMc1400731	http://dx.doi.org/10.1056/NEJMc1400731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785224				2022-12-28	WOS:000335405200032
J	Fan, J; Ye, JB; Kamphorst, JJ; Shlomi, T; Thompson, CB; Rabinowitz, JD				Fan, Jing; Ye, Jiangbin; Kamphorst, Jurre J.; Shlomi, Tomer; Thompson, Craig B.; Rabinowitz, Joshua D.			Quantitative flux analysis reveals folate-dependent NADPH production	NATURE			English	Article							PYRUVATE-KINASE M2; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; METABOLOMIC ANALYSIS; SERINE SYNTHESIS; CANCER; DEHYDROGENASE; GLYCINE; CONTRIBUTES; INHIBITION; MECHANISM	ATP is the dominant energy source in animals for mechanical and electrical work (for example, muscle contraction or neuronal firing). For chemical work, there is an equally important role for NADPH, which powers redox defence and reductive biosynthesis(1). The most direct route to produce NADPH from glucose is the oxidative pentose phosphate pathway, with malic enzyme sometimes also important(2,3). Although the relative contribution of glycolysis and oxidative phosphorylation to ATP production has been extensively analysed, similar analysis of NADPH metabolism has been lacking. Here we demonstrate the ability to directly track, by liquid chromatography-mass spectrometry, the passage of deuterium from labelled substrates into NADPH, and combine this approach with carbon labelling and mathematical modelling to measure NADPH fluxes. In proliferating cells, the largest contributor to cytosolic NADPH is the oxidative pentose phosphate pathway. Surprisingly, a nearly comparable contribution comes from serine-driven one-carbon metabolism, in which oxidation of methylene tetrahydrofolate to 10-formyl-tetrahydrofolate is coupled to reduction of NADP(+) to NADPH. Moreover, tracing of mitochondrial one-carbon metabolism revealed complete oxidation of 10-formyl-tetrahydrofolate to make NADPH. As folate metabolism has not previously been considered an NADPH producer, confirmation of its functional significance was undertaken through knockdown of methylenetetrahydrofolate dehydrogenase (MTHFD) genes. Depletion of either the cytosolic or mitochondrial MTHFD isozyme resulted in decreased cellular NADPH/NADP(+) and reduced/oxidized glutathione ratios (GSH/GSSG) and increased cell sensitivity to oxidative stress. Thus, although the importance of folate metabolism for proliferating cells has been long recognized and attributed to its function of producing one-carbon units for nucleic acid synthesis, another crucial function of this pathway is generating reducing power.	[Fan, Jing; Kamphorst, Jurre J.; Shlomi, Tomer; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Ye, Jiangbin; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Princeton University; Memorial Sloan Kettering Cancer Center; Technion Israel Institute of Technology	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08540 USA.	joshr@genomics.princeton.edu	Rabinowitz, Joshua/GPP-4019-2022; Ye, Jiangbin/A-1094-2007	Rabinowitz, Joshua/0000-0002-1247-4727; Fan, Jing/0000-0002-5326-5358; Kamphorst, Jurre/0000-0002-2042-5474; Ye, Jiangbin/0000-0003-1117-4869	Stand Up To Cancer; NIH [CA163591, AI097382, CA105463, CA104838, GM071508]; Hope [HFCR-11-03-01]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA105463, R01CA163591, P01CA104838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Stand Up To Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The iBMK parental and Akt cell lines were generously provided by E. White. The <SUP>14</SUP>C-labelled CO<INF>2</INF> release experiments were conducted with the help of E. Suh and H. Coller. NMR measurement of formate was carried out with the help of I. Lewis. We thank H. Djaballah and the High-Throughput Drug Screening Facility at MSKCC for supplying the hairpins, and M. Vander Heiden and his laboratory members for discussions. This work was supported by Stand Up To Cancer and NIH R01 grants CA163591, AI097382, and CA105463, P01 grant CA104838 and P50 grant GM071508. J.F. is a Howard Hughes Medical Institute (HHMI) international student research fellow. J.J.K. is a Hope Funds for Cancer Research fellow (HFCR-11-03-01).	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ayromlou H, 2011, J PAK MED ASSOC, V61, P1096; Bradley KK, 2001, J PHARMACOL EXP THER, V299, P748; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christensen KE, 2008, VITAM HORM, V79, P393, DOI 10.1016/S0083-6729(08)00414-7; Circu ML, 2011, ANTIOXID REDOX SIGN, V14, P2151, DOI 10.1089/ars.2010.3489; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LORANS G, 1981, BIOCHEM BIOPH RES CO, V101, P1018, DOI 10.1016/0006-291X(81)91850-7; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Pawelek PD, 1998, BIOCHEMISTRY-US, V37, P1109, DOI 10.1021/bi971906t; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Price NE, 1996, ARCH BIOCHEM BIOPHYS, V336, P215, DOI 10.1006/abbi.1996.0551; SHREVE DS, 1980, J BIOL CHEM, V255, P2670; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Voet D., 2005, BIOCHEMISTRY-US; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; YUAN ZY, 1984, J BIOL CHEM, V259, P6748; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	40	678	691	10	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					298	+		10.1038/nature13236	http://dx.doi.org/10.1038/nature13236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805240	Green Accepted			2022-12-28	WOS:000337032400056
J	Guterman, S				Guterman, Stuart			The "Doc Fix" - Another Missed Opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Commonwealth Fund, Washington, DC 20036 USA	Commonwealth Fund	Guterman, S (corresponding author), Commonwealth Fund, Washington, DC 20036 USA.							Centers for Medicare and Medicaid Services Office of the Actuary, 2013, EST SUST GROWTH RAT; Congressional Budget Office, 2012, MED PAYM PHYS BUDG I; Idem, 2013, MED PAYM PHYS BUDG I	3	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2261	2263		10.1056/NEJMp1401460	http://dx.doi.org/10.1056/NEJMp1401460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7BB	24784783				2022-12-28	WOS:000337033700005
J	Mataix-Cols, D				Mataix-Cols, David			Hoarding Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; OPEN TRIAL; LIFE; COMORBIDITY; CLUTTER	A physically healthy 53-year-old woman is referred to her local mental health team for the management of depression and anxiety. On questioning, she reports that she has been living in the basement of her apartment building, eating in restaurants, and using a local gym for showers; her own apartment is so full of clothes, magazines, books, suitcases, and boxes jam-packed with items that she is no longer able to get in the door. The mere thought of discarding anything makes her intolerably anxious and upset. She reports having had difficulties discarding possessions for as long as she can remember. How should she be evaluated and treated?	[Mataix-Cols, David] Karolinska Inst, SE-11330 Stockholm, Sweden	Karolinska Institutet	Mataix-Cols, D (corresponding author), Karolinska Inst, Dept Clin Neurosci, Child & Adolescent Psychiat Res Ctr, Gavlegatan 22 Entre B,Fl 8, SE-11330 Stockholm, Sweden.	david.mataix.cols@ki.se	Mataix-Cols, David/AAF-3347-2021	Mataix-Cols, David/0000-0002-4545-0924				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ayers CR, 2014, AM J GERIAT PSYCHIAT, V22, P248, DOI 10.1016/j.jagp.2013.02.010; Ayers CR, 2014, AGING MENT HEALTH, V18, P148, DOI 10.1080/13607863.2013.814105; Ayers CR, 2011, BEHAV RES THER, V49, P689, DOI 10.1016/j.brat.2011.07.002; Bratiotis C, 2013, HEALTH SOC CARE COMM, V21, P245, DOI 10.1111/hsc.12010; Diefenbach GJ, 2013, AM J GERIAT PSYCHIAT, V21, P1043, DOI 10.1016/j.jagp.2013.01.028; Fernandez de la Cruz L, 2013, DEPRESS ANXIETY, V30, P61, DOI 10.1002/da.21989; Frost RO, 2008, J PSYCHOPATHOL BEHAV, V30, P193, DOI 10.1007/s10862-007-9068-7; Frost RO, 2012, BEHAV RES THER, V50, P661, DOI 10.1016/j.brat.2012.08.004; Frost RO, 2011, DEPRESS ANXIETY, V28, P876, DOI 10.1002/da.20861; Frost RO, 2011, DEPRESS ANXIETY, V28, P885, DOI 10.1002/da.20826; Frost RO, 2009, J ANXIETY DISORD, V23, P632, DOI 10.1016/j.janxdis.2009.01.013; Frost RO, 2000, HEALTH SOC CARE COMM, V8, P229, DOI 10.1046/j.1365-2524.2000.00245.x; FROST RO, 1993, BEHAV RES THER, V31, P367, DOI 10.1016/0005-7967(93)90094-B; Frost RO, 1996, BEHAV RES THER, V34, P341, DOI 10.1016/0005-7967(95)00071-2; Gilliam CM, 2011, BEHAV RES THER, V49, P802, DOI 10.1016/j.brat.2011.08.008; Grisham JR, 2006, J ANXIETY DISORD, V20, P675, DOI 10.1016/j.janxdis.2005.07.004; Harris J., 2010, 27 INT C APPL PSYCH; Iervolino AC, 2009, AM J PSYCHIAT, V166, P1156, DOI 10.1176/appi.ajp.2009.08121789; Ivanov VZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069140; Landau D, 2011, J ANXIETY DISORD, V25, P192, DOI 10.1016/j.janxdis.2010.09.002; Lucini G., 2009, ANAL FIRE INCIDENTS; Mataix-Cols D, 2013, PSYCHOL MED, V43, P837, DOI 10.1017/S0033291712001560; Mataix-Cols D, 2010, DEPRESS ANXIETY, V27, P556, DOI 10.1002/da.20693; Muroff J, 2013, DEPRESS ANXIETY; Muroff J, 2012, DEPRESS ANXIETY, V29, P597, DOI 10.1002/da.21923; Muroff J, 2010, BEHAV RES THER, V48, P79, DOI 10.1016/j.brat.2009.09.006; Nordsletten AE, 2013, J OBSESS-COMPULS REL, V2, P346, DOI 10.1016/j.jocrd.2013.06.003; Nordsletten AE, 2013, BRIT J PSYCHIAT, V203, P445, DOI 10.1192/bjp.bp.113.130195; Nordsletten AE, 2013, COMPR PSYCHIAT, V54, P229, DOI 10.1016/j.comppsych.2012.07.063; Nordsletten AE, 2012, CLIN PSYCHOL REV, V32, P165, DOI 10.1016/j.cpr.2011.12.003; Perroud N, 2011, AM J MED GENET B, V156B, P240, DOI 10.1002/ajmg.b.31152; Pertusa A, 2008, AM J PSYCHIAT, V165, P1289, DOI 10.1176/appi.ajp.2008.07111730; Pertusa A, 2010, BEHAV RES THER, V48, P1012, DOI 10.1016/j.brat.2010.07.003; Pertusa A, 2010, CLIN PSYCHOL REV, V30, P371, DOI 10.1016/j.cpr.2010.01.007; Samuels J, 2007, AM J PSYCHIAT, V164, P493, DOI 10.1176/appi.ajp.164.3.493; Saxena S, 2007, J PSYCHIATR RES, V41, P481, DOI 10.1016/j.jpsychires.2006.05.001; Saxena S, 2011, J PSYCHIATR RES, V45, P475, DOI 10.1016/j.jpsychires.2010.08.007; Snowdon J, 2012, DEPRESS ANXIETY, V29, P417, DOI 10.1002/da.21943; Steketee G., 2007, COMPULSIVE HOARDING; Steketee G., 2000, BEHAV COGN PSYCHOTH, V28, P259, DOI [10.1017/S1352465800003064, DOI 10.1017/S1352465800003064, 10.1017/s1352465800003064]; Steketee Gail, 2003, Clin Psychol Rev, V23, P905, DOI 10.1016/j.cpr.2003.08.002; Steketee G, 2010, DEPRESS ANXIETY, V27, P476, DOI 10.1002/da.20673; Tolin DF, 2008, BEHAV RES THER, V46, P334, DOI 10.1016/j.brat.2007.12.008; Tolin DF, 2007, BEHAV RES THER, V45, P1461, DOI 10.1016/j.brat.2007.01.001; Tolin DF, 2011, J ANXIETY DISORD, V25, P43, DOI 10.1016/j.janxdis.2010.08.001; Tolin DF, 2010, DEPRESS ANXIETY, V27, P829, DOI 10.1002/da.20684; Tolin DF, 2010, COGNITIVE THER RES, V34, P69, DOI 10.1007/s10608-008-9217-7; Turner K, 2010, COGN BEHAV PRACT, V17, P449, DOI 10.1016/j.cbpra.2010.04.001	49	30	33	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					2023	2030		10.1056/NEJMcp1313051	http://dx.doi.org/10.1056/NEJMcp1313051			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UZ	24849085				2022-12-28	WOS:000336125500010
J	Myers, DL				Myers, Deborah L.			Female Mixed Urinary Incontinence A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; STRESS-INCONTINENCE; OVERACTIVE BLADDER; IMPACT QUESTIONNAIRE; MIDURETHRAL SLINGS; URGE-PREDOMINANT; WOMEN; SOLIFENACIN; DIAGNOSIS; SYMPTOMS	IMPORTANCE Mixed urinary incontinence, a condition of both stress and urge urinary incontinence, is prevalent in 20% to 36% of women and is challenging to diagnosis and treat because urinary symptoms are variable and guidelines for treatment are not clear. OBJECTIVE To review the diagnosis and management of mixed urinary incontinence in women, with a focus on current available evidence. EVIDENCE REVIEW MEDLINE was searched from January 1, 1992, to December 31, 2013. Additional citations were obtained from references of the selected articles and reviews. Articles that discussed the prevalence, diagnosis, results, and treatment of mixed urinary incontinence were selected for review. Evidence was graded using Oxford Centre for Evidence-Based Medicine levels of evidence for treatment recommendations. FINDINGS tj; 2The MEDLINE search resulted in 785 articles. After selection and obtainment of additional citations, a total of 73 articles were reviewed. There is high-quality ( level 1) evidence for treating urinary incontinence with weight loss, for treating stress urinary incontinence by performing anti-incontinence procedures of both traditional and mid-urethral slings and retropubic urethropexies, and for managing urge urinary incontinence with anticholinergic medications. However, direct high-quality evidence for treatment of women with mixed urinary incontinence is lacking, as are clear diagnostic criteria and management guidelines. CONCLUSION AND RELEVANCE High-quality, level 1 evidence for urinary incontinence therapy can guide clinicians in the treatment of the components of mixed urinary incontinence. Because high-quality evidence is lacking regarding the treatment of mixed urinary incontinence, treatment generally begins with conservative management emphasizing the most bothersome component. Randomized trials in women with mixed urinary incontinence populations are needed.	[Myers, Deborah L.] Brown Univ, Dept Obstet & Gynecol, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Myers, DL (corresponding author), Women & Infants Hosp Rhode Isl, 695 Eddy St, Providence, RI 02903 USA.	dmyers@wihri.org			Pfizer	Pfizer(Pfizer)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Myers reports receipt of research support from Pfizer; honoraria/travel expenses for lectures from Northwestern University, St John's Mercy Medical Center (St Louis, Missouri), New England Obstetrical and Gynecological Society, MedStar Health, American College of Nurse Midwives, Buffalo Obstetrical Society (Buffalo, New York), Brigham and Women's Hospital, and St Francis Hospital (Hartford, Connecticut); and travel expenses for meetings from the American Urogynecologic Society, American College of Obstetrics and Gynecology, American Board of Obstetrics and Gynecology, and National Institute of Diabetes and Digestive and Kidney Diseases Urinary Incontinence Treatment Network.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; Bradley CS, 2005, AM J OBSTET GYNECOL, V192, P66, DOI 10.1016/j.ajog.2004.07.037; Brown JS, 2006, ANN INTERN MED, V144, P715, DOI 10.7326/0003-4819-144-10-200605160-00005; Brubaker L, 2011, NEUROUROL URODYNAM, V30, P47, DOI 10.1002/nau.20922; Brubaker L, 2009, CLIN TRIALS, V6, P355, DOI 10.1177/1740774509339239; Brubaker L, 2009, NEUROUROL URODYNAM, V28, P268, DOI 10.1002/nau.20698; Burgio KL, 2008, ANN INTERN MED, V149, P161, DOI 10.7326/0003-4819-149-3-200808050-00005; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Cody JD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001405.pub2; Duckett J, 2011, INT UROGYNECOL J, V22, P971, DOI 10.1007/s00192-011-1410-7; Dumoulin C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub3; Farrell SA, 2013, INT UROGYNECOL J, V24, P759, DOI 10.1007/s00192-012-1925-6; Frick AC, 2009, J UROLOGY, V182, P596, DOI 10.1016/j.juro.2009.04.005; Furuta A, 2008, AM J PHYSIOL-REG I, V294, pR1510, DOI 10.1152/ajpregu.00838.2007; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Jain P, 2011, INT UROGYNECOL J, V22, P923, DOI 10.1007/s00192-011-1406-3; Jung SY, 1999, J UROLOGY, V162, P204, DOI 10.1097/00005392-199907000-00069; KARRAM MM, 1989, OBSTET GYNECOL, V73, P4; KEGEL AH, 1948, AM J OBSTET GYNECOL, V56, P238, DOI 10.1016/0002-9378(48)90266-X; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Kirchin V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003881.pub3; Kulseng-Hanssen S, 2008, INT UROGYNECOL J, V19, P391, DOI 10.1007/s00192-007-0449-y; Kulseng-Hanssen S, 2007, NEUROUROL URODYNAM, V26, P115, DOI 10.1002/nau.20248; Lapitan MC, 2012, COCHRANE DB SYST REV, V6; Lee JKS, 2011, BJOG-INT J OBSTET GY, V118, P798, DOI 10.1111/j.1471-0528.2011.02915.x; Lewis JB, 2007, NEUROUROL URODYNAM, V26, P204, DOI 10.1002/nau.20359; Minassian VA, 2003, INT J GYNECOL OBSTET, V82, P327, DOI 10.1016/S0020-7292(03)00220-0; Minassian VA, 2013, OBSTET GYNECOL, V121, P1083, DOI 10.1097/AOG.0b013e31828ca761; Ogah J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub2; Osman T, 2003, BJU INT, V92, P964, DOI 10.1111/j.1464-410X.2003.04519.x; Oxford Centre for Evidence-Based Medicine Levels of Evidence Working Group, OECBM LEV EV SYST; Panayi DC, 2009, NEUROUROL URODYNAM, V28, P82, DOI 10.1002/nau.20576; Rehman H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001754.pub3; SAND PK, 1988, OBSTET GYNECOL, V71, P818; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Staskin DR, 2006, BJU INT, V97, P1256, DOI 10.1111/j.1464-410X.2006.06150.x; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375; Svenningsen R, 2014, NEUROUROL URODYNAM, V33, P1140, DOI 10.1002/nau.22466; Tennstedt SL, 2007, INT UROGYNECOL J, V18, P543, DOI 10.1007/s00192-006-0188-5; Townsend MK, 2013, INT UROGYNECOL J, V24, P605, DOI 10.1007/s00192-012-1914-9; Townsend MK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.054; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206; Yoo EH, 2013, INT UROGYNECOL J, V24, P401, DOI 10.1007/s00192-012-1880-2	48	29	30	3	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2007	2014		10.1001/jama.2014.4299	http://dx.doi.org/10.1001/jama.2014.4299			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846038				2022-12-28	WOS:000336122800023
J	William, L				William, Leeroy			PERSONAL VIEW Non-palliative care staff need to deliver generalist end of life care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATHWAYS		[William, Leeroy] Monash Hlth, Monash Med Ctr, Melbourne, Vic, Australia; [William, Leeroy] Eastern Hlth, Box Hill Hosp, Melbourne, Vic, Australia; [William, Leeroy] Monash Univ, Melbourne, Vic 3004, Australia	Monash University; Box Hill Hospital; Monash University	William, L (corresponding author), Monash Hlth, Monash Med Ctr, Melbourne, Vic, Australia.	leeroy.william@monashhealth.org.au	Ram, Prem/K-4511-2012; William, Leeroy/D-7029-2017; William, Leeroy/AAY-4041-2021; William, Leeroy/Q-4186-2019	William, Leeroy/0000-0002-8661-2221; 				Boyd K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7718; Campbell H, 1998, BMJ-BRIT MED J, V316, P133; Chinthapalli K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4669; Department of Health, 2013, MOR CAS LESS PATHW R; Egan T, 2009, HEALTH, V13, P107, DOI 10.1177/1363459308097363; Heyland DK, 2006, CAN MED ASSOC J, V174, P627, DOI 10.1503/cmaj.050626; Janssen AL, 2010, PATIENT EDUC COUNS, V81, P251, DOI 10.1016/j.pec.2010.02.009; MacLeod RD, 2001, SOC SCI MED, V52, P1719, DOI 10.1016/S0277-9536(00)00289-6; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Roach MS, 1984, PERSPECTIVES CARING, V1; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Sleeman KE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4779	12	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3426	10.1136/bmj.g3426	http://dx.doi.org/10.1136/bmj.g3426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846881				2022-12-28	WOS:000336429100011
J	McClung, CR				McClung, C. Robertson			Making Hunger Yield	SCIENCE			English	Editorial Material							FOOD SECURITY; AGRICULTURE; PROGRESS		Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	McClung, CR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	c.robertson.mcclung@dartmouth.edu		McClung, C. Robertson/0000-0002-7875-3614				Alberts B, 2013, SCIENCE, V341, P1320, DOI 10.1126/science.1245017; Bailey-Serres J, 2010, RICE, V3, P138, DOI 10.1007/s12284-010-9048-5; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Duvick DN, 2005, MAYDICA, V50, P193; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Johns T, 2007, FOOD POLICY, V32, P1, DOI 10.1016/j.foodpol.2006.03.014; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177	15	27	27	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					699	700		10.1126/science.1254135	http://dx.doi.org/10.1126/science.1254135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH1WQ	24833378				2022-12-28	WOS:000335912900023
J	Verma, S; Siu, SC				Verma, Subodh; Siu, Samuel C.			Aortic Dilatation in Patients with Bicuspid Aortic Valve	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ASSOCIATION TASK-FORCE; ASCENDING AORTA; CARDIOVASCULAR ANGIOGRAPHY; PRACTICE GUIDELINES; AMERICAN-COLLEGE; NATURAL-HISTORY; DISEASE; AORTOPATHY; MANAGEMENT; DILATION	BICUSPID AORTIC VALVE IS THE MOST COMMON CONGENITAL HEART DEFECT in adults, affecting 1.3% of the population worldwide, and is responsible for more deaths and complications than the combined effects of all the other congenital heart defects. 1,2 Although aortic stenosis and regurgitation are the most common complications of a bicuspid aortic valve, dilatation of any or all segments of the proximal aorta from the aortic root to the aortic arch, called bicuspid aortopathy, is also present in approximately 50% of affected persons.(1-4) Accumulating evidence suggests that the pattern of aortic dilatation in persons with a bicuspid aortic valve is diverse, possibly reflecting heterogeneity in molecular, rheologic, and clinical features.(4-9) This article provides a brief overview of the basic principles, recent advances, and recommendations for the treatment of adults with bicuspid aortopathy.	[Verma, Subodh] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Dept Surg, Toronto, ON, Canada; [Siu, Samuel C.] Univ Western Ontario, Dept Med, Div Cardiol, Lawson Res Inst,London Hlth Sci Ctr, London, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; London Health Sciences Centre; Western University (University of Western Ontario)	Verma, S (corresponding author), St Michaels Hosp, Div Cardiac Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	vermasu@smh.ca	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669				Anderson RH, 1996, J HEART VALVE DIS, V5, pS249; Barker AJ, 2012, CIRC-CARDIOVASC IMAG, V5, P457, DOI 10.1161/CIRCIMAGING.112.973370; Beroukhim RS, 2006, AM J CARDIOL, V98, P828, DOI 10.1016/j.amjcard.2006.04.022; Biner S, 2009, J AM COLL CARDIOL, V53, P2288, DOI 10.1016/j.jacc.2009.03.027; Boodhwani M, CAN J CARDI IN PRESS; Borger MA, 2004, J THORAC CARDIOV SUR, V128, P677, DOI 10.1016/j.jtcvs.2004.07.009; Borger MA, 2005, SEMIN THORAC CARDIOV, V17, P143, DOI 10.1053/j.semtcvs.2005.02.005; Buchner S, 2010, HEART, V96, P1233, DOI 10.1136/hrt.2009.186254; Carro A, 2012, REV ESP CARDIOL, V65, P977, DOI [10.1016/j.rec.2012.04.018, 10.1016/j.recesp.2012.04.025]; Davies RR, 2007, ANN THORAC SURG, V83, P1338, DOI 10.1016/j.athoracsur.2006.10.074; de Wit A, 2013, HEART LUNG CIRC, V22, P3, DOI 10.1016/j.hlc.2012.08.049; Della Corte A, 2007, EUR J CARDIO-THORAC, V31, P397, DOI 10.1016/j.ejcts.2006.12.006; Della Corte A, 2012, EUR J CARDIO-THORAC, V41, P1404, DOI 10.1093/ejcts/ezr216; Etz CD, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/313879; Etz CD, 2010, ANN THORAC SURG, V90, P1884, DOI 10.1016/j.athoracsur.2010.06.115; Fazel SS, 2008, J THORAC CARDIOV SUR, V135, P901, DOI 10.1016/j.jtcvs.2008.01.022; Fedak Paul W M, 2005, Expert Rev Cardiovasc Ther, V3, P295, DOI 10.1586/14779072.3.2.295; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Ferencik M, 2003, AM J CARDIOL, V92, P43, DOI 10.1016/S0002-9149(03)00462-4; Fernandes S, 2012, HEART, V98, P1014, DOI 10.1136/heartjnl-2012-301773; Girdauskas E, 2012, EUR J CARDIO-THORAC, V42, P832, DOI 10.1093/ejcts/ezs137; Girdauskas E, 2011, EUR J CARDIO-THORAC, V39, P809, DOI 10.1016/j.ejcts.2011.01.001; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; HAHN RT, 1992, J AM COLL CARDIOL, V19, P283, DOI 10.1016/0735-1097(92)90479-7; Hiratzka Loren F, 2010, Catheter Cardiovasc Interv, V76, pE43; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Ikonomidis JS, 2012, ANN THORAC SURG, V93, P457, DOI 10.1016/j.athoracsur.2011.09.057; Jackson V, 2012, EUR J CARDIO-THORAC, V41, P471, DOI 10.1093/ejcts/ezr168; Leone O, 2012, EUR J CARDIO-THORAC, V41, P322, DOI 10.1016/j.ejcts.2011.05.064; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Michelena HI, 2011, JAMA-J AM MED ASSOC, V306, P1104, DOI 10.1001/jama.2011.1286; Nazer RI, 2010, ANN THORAC SURG, V89, P1918, DOI 10.1016/j.athoracsur.2010.02.070; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Novara GM, 2004, AM J CARDIOL, V93, P525, DOI 10.1016/j.amjcard.2003.08.082; Russo CF, 2008, J THORAC CARDIOV SUR, V136, P937, DOI 10.1016/j.jtcvs.2007.11.072; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; Shimada I, 1999, ANN THORAC SURG, V67, P1968, DOI 10.1016/S0003-4975(99)00435-X; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Thanassoulis G, 2008, NAT CLIN PRACT CARD, V5, P821, DOI 10.1038/ncpcardio1369; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Verma S, 2013, J THORAC CARDIOV SUR, V146, P1033, DOI 10.1016/j.jtcvs.2013.06.037; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]	47	319	331	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1920	1929		10.1056/NEJMra1207059	http://dx.doi.org/10.1056/NEJMra1207059			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827036				2022-12-28	WOS:000336123600008
J	Zhang, WK; Alonso-Mori, R; Bergmann, U; Bressler, C; Chollet, M; Galler, A; Gawelda, W; Hadt, RG; Hartsock, RW; Kroll, T; Kjaer, KS; Kubicek, K; Lemke, HT; Liang, HYW; Meyer, DA; Nielsen, MM; Purser, C; Robinson, JS; Solomon, EI; Sun, Z; Sokaras, D; van Driel, TB; Vanko, G; Weng, TC; Zhu, DL; Gaffney, KJ				Zhang, Wenkai; Alonso-Mori, Roberto; Bergmann, Uwe; Bressler, Christian; Chollet, Matthieu; Galler, Andreas; Gawelda, Wojciech; Hadt, Ryan G.; Hartsock, Robert W.; Kroll, Thomas; Kjaer, Kasper S.; Kubicek, Katharina; Lemke, Henrik T.; Liang, Huiyang W.; Meyer, Drew A.; Nielsen, Martin M.; Purser, Carola; Robinson, Joseph S.; Solomon, Edward I.; Sun, Zheng; Sokaras, Dimosthenis; van Driel, Tim B.; Vanko, Gyoergy; Weng, Tsu-Chien; Zhu, Diling; Gaffney, Kelly J.			Tracking excited-state charge and spin dynamics in iron coordination complexes	NATURE			English	Article							X-RAY-EMISSION; TRANSITION-METAL-COMPLEXES; ABSORPTION SPECTROSCOPY; CROSSOVER	Crucial to many light-driven processes in transition metal complexes is the absorption and dissipation of energy by 3d electrons(1-4). But a detailed understanding of such non-equilibrium excited-state dynamics and their interplay with structural changes is challenging: a multitude of excited states and possible transitions result in phenomena too complex to unravel when faced with the indirect sensitivity of optical spectroscopy to spin dynamics(5) and the flux limitations of ultrafast X-ray sources(6,7). Such a situation exists for archetypal poly-pyridyl iron complexes, such as [Fe(2,2'-bipyridine)(3)](2+), where the excited-state charge and spin dynamics involved in the transition from a low-to a high-spin state (spin crossover) have long been a source of interest and controversy(6-15). Here we demonstrate that femtosecond resolution X-ray fluorescence spectroscopy, with its sensitivity to spin state, can elucidate the spin crossover dynamics of [Fe(2,2'-bipyridine)(3)](2+) on photoinduced metal-to-ligand charge transfer excitation. We are able to track the charge and spin dynamics, and establish the critical role of intermediate spin states in the crossover mechanism. We anticipate that these capabilities will make our method a valuable tool for mapping in unprecedented detail the fundamental electronic excited-state dynamics that underpin many useful light-triggered molecular phenomena involving 3d transition metal complexes.	[Zhang, Wenkai; Hartsock, Robert W.; Liang, Huiyang W.; Meyer, Drew A.; Purser, Carola; Sun, Zheng; Gaffney, Kelly J.] Stanford Univ, PULSE Inst, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Alonso-Mori, Roberto; Bergmann, Uwe; Chollet, Matthieu; Lemke, Henrik T.; Robinson, Joseph S.; Zhu, Diling] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Bressler, Christian; Galler, Andreas; Gawelda, Wojciech] European XFEL, D-22761 Hamburg, Germany; [Hadt, Ryan G.; Hartsock, Robert W.; Kroll, Thomas; Liang, Huiyang W.; Meyer, Drew A.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Kjaer, Kasper S.] Univ Copenhagen, Niels Bohr Inst, Ctr Mol Movies, DK-2100 Copenhagen, Denmark; [Kjaer, Kasper S.; Nielsen, Martin M.; van Driel, Tim B.] Tech Univ Denmark, Dept Phys, Ctr Mol Movies, DK-2800 Lyngby, Denmark; [Kubicek, Katharina] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Kubicek, Katharina] DESY, D-22607 Hamburg, Germany; [Solomon, Edward I.; Sokaras, Dimosthenis; Weng, Tsu-Chien] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Vanko, Gyoergy] Hungarian Acad Sci, Wigner Res Ctr Phys, H-1525 Budapest, Hungary	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; European XFEL; Stanford University; University of Copenhagen; Niels Bohr Institute; Technical University of Denmark; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics	Gaffney, KJ (corresponding author), Stanford Univ, PULSE Inst, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA.	kgaffney@slac.stanford.edu	Vankó, György/B-8176-2012; Gaffney, Kelly/AAG-7136-2020; Gaffney, Kelly J/N-1597-2017; Kroll, Thomas/D-3636-2009; Gawelda, Wojciech M/B-7878-2014; Zhang, Wenkai/H-1301-2012; Sokaras, Dimosthenis/G-6037-2010; Bressler, Christian/G-1864-2010; Nielsen, Martin/A-5133-2009; Lemke, Henrik Till T/N-7419-2016; Kubicek, Katharina/AAE-5683-2019; Young, Michelle A/N-7228-2017; alonso mori, roberto/G-2638-2013	Vankó, György/0000-0002-3095-6551; Gaffney, Kelly J/0000-0002-0525-6465; Gawelda, Wojciech M/0000-0001-7824-9197; Sokaras, Dimosthenis/0000-0001-8117-1933; Nielsen, Martin/0000-0002-8135-434X; Lemke, Henrik Till T/0000-0003-1577-8643; Kubicek, Katharina/0000-0001-8481-2249; Kjaer, Kasper Skov/0000-0002-5580-7851; alonso mori, roberto/0000-0002-5357-0934; Solomon, Edward/0000-0003-0291-3199; , C/0000-0001-9694-5495	AMOS programme within the Chemical Sciences, Geosciences and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy; NSF [CHE-0948211]; German Research Foundation (DFG) [KR3611/2-1]; Danish National Research Foundation; DANSCATT; Volkswagen Foundation [I/85832]; European Research Council [ERC-StG-259709]; Lendulet Programme of the Hungarian Academy of Sciences; DFG [SFB925]; European XFEL; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	AMOS programme within the Chemical Sciences, Geosciences and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond); DANSCATT; Volkswagen Foundation(Volkswagen); European Research Council(European Research Council (ERC)European Commission); Lendulet Programme of the Hungarian Academy of Sciences; DFG(German Research Foundation (DFG)); European XFEL; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Frank, B. Lin and S. DeBeer for discussion, S. DeBeer for some model iron complex X-ray fluorescence spectra, and D. Stanbury for providing some iron complexes. Experiments were carried out at LCLS and SSRL, which are National User Facilities operated for DOE and OBES respectively by Stanford University. W.Z., R. W. H., H. W. L., D. A. M., Z.S. and K.J.G. acknowledge support from the AMOS programme within the Chemical Sciences, Geosciences and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy. E. I. S. acknowledges support from the NSF (CHE-0948211). R. G. H. acknowledges a Gerhard Casper Stanford Graduate Fellowship and the Achievements Rewards for College Scientists (ARCS) Foundation. T. K. acknowledges the German Research Foundation (DFG), grant KR3611/2-1. K. S. K., M.M.N. and T. B. v. D. acknowledge support from the Danish National Research Foundation and from DANSCATT. K. K. thanks the Volkswagen Foundation for support under the Peter Paul Ewald fellowship program (I/85832). G. V. acknowledges support from the European Research Council (ERC-StG-259709) and the Lendulet Programme of the Hungarian Academy of Sciences. C. B., W. G. and A. G. thank the DFG (SFB925), as well as the European XFEL, for financial support.	Alonso-Mori R, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737630; Alvarez S, 2003, J AM CHEM SOC, V125, P6795, DOI 10.1021/ja0283450; Bionta MR, 2011, OPT EXPRESS, V19, P21855, DOI 10.1364/OE.19.021855; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Cannizzo A, 2010, COORDIN CHEM REV, V254, P2677, DOI 10.1016/j.ccr.2009.12.007; Consani C, 2009, ANGEW CHEM INT EDIT, V48, P7184, DOI 10.1002/anie.200902728; CREUTZ C, 1980, J AM CHEM SOC, V102, P1309, DOI 10.1021/ja00524a014; De Graaf C, 2011, INT J QUANTUM CHEM, V111, P3385, DOI 10.1002/qua.22991; de Graaf C, 2010, CHEM-EUR J, V16, P4550, DOI 10.1002/chem.200903423; de Groot F, 2001, CHEM REV, V101, P1779, DOI 10.1021/cr9900681; de Groot F, 2008, ADV CONDENS MAT SCI, V6, P1; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Feng Y. P., 2011, P SOC PHOTO-OPT INS, V8140; Ferrere S, 1998, J AM CHEM SOC, V120, P843, DOI 10.1021/ja973504e; Gawelda W., 2006, THESIS ECOLE POLYTEC; Gawelda W, 2007, J AM CHEM SOC, V129, P8199, DOI 10.1021/ja070454x; Glatzel P, 2005, COORDIN CHEM REV, V249, P65, DOI 10.1016/j.ccr.2004.04.011; Goldbeck RA, 1997, ANNU REV PHYS CHEM, V48, P453, DOI 10.1146/annurev.physchem.48.1.453; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Gutlich P, 2004, TOP CURR CHEM, V233, P1, DOI 10.1007/b13527; Haldrup K, 2012, J PHYS CHEM A, V116, P9878, DOI 10.1021/jp306917x; Harmand M, 2013, NAT PHOTONICS, V7, P215, DOI [10.1038/nphoton.2013.11, 10.1038/NPHOTON.2013.11]; HAUSER A, 1991, J CHEM PHYS, V94, P2741, DOI 10.1063/1.459851; Heyduk AF, 2001, SCIENCE, V293, P1639, DOI 10.1126/science.1062965; Huse N, 2011, J PHYS CHEM LETT, V2, P880, DOI 10.1021/jz200168m; Khalil M, 2006, J PHYS CHEM A, V110, P38, DOI 10.1021/jp055002q; Koerner LJ, 2009, J INSTRUM, V4, DOI 10.1088/1748-0221/4/03/P03001; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329, DOI 10.1063/1.555595; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lee N, 2010, J AM CHEM SOC, V132, P9715, DOI 10.1021/ja101281e; Lemke HT, 2013, J PHYS CHEM A, V117, P735, DOI 10.1021/jp312559h; MCCUSKER JK, 1993, J AM CHEM SOC, V115, P298, DOI 10.1021/ja00054a043; Monat JE, 2000, J AM CHEM SOC, V122, P4092, DOI 10.1021/ja992436o; Nozawa S, 2010, J AM CHEM SOC, V132, P61, DOI 10.1021/ja907460b; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; Sousa C, 2013, CHEM-EUR J, V19, P17541, DOI 10.1002/chem.201302992; Stepanow S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220401; Vanko G, 2006, J PHYS CHEM B, V110, P11647, DOI 10.1021/jp0615961; Vanko G, 2013, J ELECTRON SPECTROSC, V188, P166, DOI 10.1016/j.elspec.2012.09.012; Vanko G, 2010, ANGEW CHEM INT EDIT, V49, P5910, DOI 10.1002/anie.201000844	40	309	309	34	428	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					345	+		10.1038/nature13252	http://dx.doi.org/10.1038/nature13252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805234	Green Accepted, Green Published			2022-12-28	WOS:000336121200035
J	Guo, XG; Fang, GZ; Li, G; Ma, H; Fan, HJ; Yu, L; Ma, C; Wu, X; Deng, DH; Wei, MM; Tan, DL; Si, R; Zhang, S; Li, JQ; Sun, LT; Tang, ZC; Pan, XL; Bao, XH				Guo, Xiaoguang; Fang, Guangzong; Li, Gang; Ma, Hao; Fan, Hongjun; Yu, Liang; Ma, Chao; Wu, Xing; Deng, Dehui; Wei, Mingming; Tan, Dali; Si, Rui; Zhang, Shuo; Li, Jianqi; Sun, Litao; Tang, Zichao; Pan, Xiulian; Bao, Xinhe			Direct, Nonoxidative Conversion of Methane to Ethylene, Aromatics, and Hydrogen	SCIENCE			English	Article							LOWER OLEFINS; CATALYSTS; CARBON; BENZENE; AROMATIZATION; DECOMPOSITION; PYROLYSIS; PROGRESS; GAS; CO	The efficient use of natural gas will require catalysts that can activate the first C-H bond of methane while suppressing complete dehydrogenation and avoiding overoxidation. We report that single iron sites embedded in a silica matrix enable direct, nonoxidative conversion of methane, exclusively to ethylene and aromatics. The reaction is initiated by catalytic generation of methyl radicals, followed by a series of gas-phase reactions. The absence of adjacent iron sites prevents catalytic C-C coupling, further oligomerization, and hence, coke deposition. At 1363 kelvin, methane conversion reached a maximum at 48.1% and ethylene selectivity peaked at 48.4%, whereas the total hydrocarbon selectivity exceeded 99%, representing an atom-economical transformation process of methane. The lattice-confined single iron sites delivered stable performance, with no deactivation observed during a 60-hour test.	[Guo, Xiaoguang; Fang, Guangzong; Ma, Hao; Yu, Liang; Deng, Dehui; Wei, Mingming; Tan, Dali; Pan, Xiulian; Bao, Xinhe] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China; [Li, Gang; Fan, Hongjun; Tang, Zichao] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China; [Li, Gang] Dalian Univ Technol, State Key Lab Fine Chem, Inst Coal Chem Engn, Sch Chem Engn, Dalian 116012, Peoples R China; [Li, Jianqi] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China; [Wu, Xing; Sun, Litao] Southeast Univ, Nanopico Ctr, Key Lab Microelectromech Syst MEMS, Minist Educ, Nanjing 210096, Jiangsu, Peoples R China; [Si, Rui; Zhang, Shuo] Chinese Acad Sci, Shanghai Synchrotron Radiat Facil, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University of Technology; Chinese Academy of Sciences; Institute of Physics, CAS; Southeast University - China; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Bao, XH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China.	xhbao@dicp.ac.cn	Li, Gang/AAK-8711-2020; Ma, Chao/J-4569-2015; Wu, Xing/D-9945-2016; Sun, Litao/D-4289-2013; Bao, Xinhe/P-5373-2014; Ma, Hao/N-7388-2016; Yakovlev, Vladislav V/P-4668-2015; Li, Jianqi/R-3908-2018; Wu, Xing/AAC-7534-2020	Li, Gang/0000-0001-5984-111X; Sun, Litao/0000-0002-2750-5004; Bao, Xinhe/0000-0001-9404-6429; Ma, Hao/0000-0001-6025-3315; Wu, Xing/0000-0002-9207-6744	"Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA09030101]; National Natural Science Foundation of China [21321002, 11079005, 21033009, 21103181]; Ministry of Science and Technology of China [2011CBA00503, 2013CB933100]	"Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by the "Strategic Priority Research Program" of the Chinese Academy of Sciences (grant XDA09030101), the National Natural Science Foundation of China (grants 21321002, 11079005, 21033009, and 21103181), and the Ministry of Science and Technology of China (grants 2011CBA00503 and 2013CB933100). We thank S. L. Scott and H. Metiu for fruitful discussion. An international patent application under the Patent Cooperation Treaty is pending (PCT/CN2013/079977).	Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; Arndt S, 2011, CATAL REV, V53, P424, DOI 10.1080/01614940.2011.613330; Borry RW, 1999, J PHYS CHEM B, V103, P5787, DOI 10.1021/jp990866v; Che RC, 2004, ADV MATER, V16, P401, DOI 10.1002/adma.200306460; Choudhary TV, 2001, J CATAL, V199, P9, DOI 10.1006/jcat.2000.3142; de Smit E, 2009, J CATAL, V262, P244, DOI 10.1016/j.jcat.2008.12.021; Diederich F, 2013, ANGEW CHEM INT EDIT, V52, P6, DOI 10.1002/anie.201205551; Ermakova MA, 2001, J CATAL, V201, P183, DOI 10.1006/jcat.2001.3243; Galvis HMT, 2012, J AM CHEM SOC, V134, P16207, DOI 10.1021/ja304958u; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; HOLMEN A, 1995, FUEL PROCESS TECHNOL, V42, P249, DOI 10.1016/0378-3820(94)00109-7; KELLER GE, 1982, J CATAL, V73, P9, DOI 10.1016/0021-9517(82)90075-6; LARKINS FP, 1989, AUST J CHEM, V42, P1655, DOI 10.1071/CH9891655; Li JZ, 2012, J AM CHEM SOC, V134, P836, DOI 10.1021/ja209950x; LUNSFORD JH, 1995, ANGEW CHEM INT EDIT, V34, P970, DOI 10.1002/anie.199509701; Luo LF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01625; Ma D, 2002, J CATAL, V208, P260, DOI 10.1006/jcat.2002.3540; Ma SQ, 2013, J ENERGY CHEM, V22, P1; McFarland EW, 2013, CHEM REV, V113, P4391, DOI 10.1021/cr300418s; Ohnishi R, 1999, J CATAL, V182, P92, DOI 10.1006/jcat.1998.2319; Pan XL, 2007, NAT MATER, V6, P507, DOI 10.1038/nmat1916; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Redondo AB, 2012, FUEL PROCESS TECHNOL, V104, P265, DOI 10.1016/j.fuproc.2012.05.021; Schwarz H, 2011, ANGEW CHEM INT EDIT, V50, P10096, DOI 10.1002/anie.201006424; VanDerZwet G.P., 1989, CATAL TODAY, V4, P365; Wang DJ, 1997, J CATAL, V169, P347, DOI 10.1006/jcat.1997.1712; WANG LS, 1993, CATAL LETT, V21, P35, DOI 10.1007/BF00767368; Weckhuysen BM, 1998, J CATAL, V175, P338, DOI 10.1006/jcat.1998.2010; Zavyalova U, 2011, CHEMCATCHEM, V3, P1935, DOI 10.1002/cctc.201100186; Zhou ZY, 2011, TRAC-TREND ANAL CHEM, V30, P1400, DOI 10.1016/j.trac.2011.05.007; Zhu QJ, 2013, NAT CHEM, V5, P104, DOI [10.1038/NCHEM.1527, 10.1038/nchem.1527]	31	868	951	138	3032	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					616	619		10.1126/science.1253150	http://dx.doi.org/10.1126/science.1253150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812398				2022-12-28	WOS:000335537400039
J	Svetlizky, I; Fineberg, J				Svetlizky, Ilya; Fineberg, Jay			Classical shear cracks drive the onset of dry frictional motion	NATURE			English	Article							STICK-SLIP; DYNAMIC FRACTURE; SLOW EARTHQUAKES; SURFACE; FRONTS; INSTABILITY; RUPTURES; ENERGY	Frictional processes entail the rupture(1,2) of the ensemble of discrete contacts defining a frictional interface(3,4). There are a variety of views on how best to describe the onset of dry frictional motion. These range from modelling friction with a single degree of freedom, a 'friction coefficient'(3,5), to theoretical treatments using dynamic fracture(5-8) to account for spatial and temporal dynamics along the interface. We investigated the onset of dry frictional motion by performing simultaneous high-speed measurements of the real contact area and the strain fields in the region surrounding propagating rupture tips within the dry (nominally flat) rough interfaces formed by brittle polymer blocks. Here we show that the transition from 'static' to 'dynamic' friction is quantitatively described by classical singular solutions for the motion of a rapid shear crack(5,9-13). We find that these singular solutions, originally derived to describe brittle fracture, are in excellent agreement with the experiments for slow propagation, whereas some significant discrepancies arise as the rupture velocity approaches the Rayleigh wave speed. In addition, the energy dissipated in the fracture of the contacts remains nearly constant throughout the entire range in which the rupture velocity is less than the Rayleigh wave speed, whereas the size of the dissipative zone undergoes a Lorentz-like contraction as the rupture velocity approaches the Rayleigh wave speed. This coupling between friction and fracture is critical to our fundamental understanding of frictional motion and related processes, such as earthquake dynamics.	[Svetlizky, Ilya; Fineberg, Jay] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Fineberg, J (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	jay@mail.huji.ac.il		Fineberg, Jay/0000-0002-8381-6675	James S. McDonnell Fund; European Research Council [267256]; Israel Science Foundation [76/11]	James S. McDonnell Fund; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by the James S. McDonnell Fund, the European Research Council (grant no. 267256) and the Israel Science Foundation (grant 76/11). We thank E. Bouchbinder and G. Cohen for comments. We especially thank M. Adda-Bedia for insights that helped us understand the data's relation to LEFM.	Bar Sinai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050554; Ben-David O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.254301; Ben-David O, 2010, SCIENCE, V330, P211, DOI 10.1126/science.1194777; Ben-David O, 2010, NATURE, V463, P76, DOI 10.1038/nature08676; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Beroza GC, 2011, ANNU REV EARTH PL SC, V39, P271, DOI 10.1146/annurev-earth-040809-152531; Borcherdt RD, 2006, B SEISMOL SOC AM, V96, pS73, DOI 10.1785/0120050827; Bowden F, 2001, AM J PHYS, DOI DOI 10.1119/1.1933017; Brener EA, 2002, JETP LETT+, V76, P211, DOI 10.1134/1.1517386; Dieterich JH, 1996, TECTONOPHYSICS, V256, P219, DOI 10.1016/0040-1951(95)00165-4; Dunham EM, 2004, B SEISMOL SOC AM, V94, pS256, DOI 10.1785/0120040616; Fineberg J, 1999, PHYS REP, V313, P1, DOI 10.1016/S0370-1573(98)00085-4; Freund LB, 1990, DYNAMIC FRACTURE MEC, DOI [10.1017/oretCBO9780511546761-en, DOI 10.1017/ORETCBO9780511546761-EN]; Gabriel AA, 2013, J GEOPHYS RES-SOL EA, V118, P4117, DOI 10.1002/jgrb.50213; IDA Y, 1972, J GEOPHYS RES, V77, P3796, DOI 10.1029/JB077i020p03796; Johnson KL, 1997, P ROY SOC A-MATH PHY, V453, P163, DOI 10.1098/rspa.1997.0010; Kammer DS, 2012, TRIBOL LETT, V48, P27, DOI 10.1007/s11249-012-9920-0; Kaproth BM, 2013, SCIENCE, V341, P1229, DOI 10.1126/science.1239577; Latour S, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/59003; Lykotrafitis G, 2006, SCIENCE, V313, P1765, DOI 10.1126/science.1128359; Nielsen S, 2010, GEOPHYS J INT, V180, P697, DOI 10.1111/j.1365-246X.2009.04444.x; Ohnaka M., 2013, PHYS ROCK FAILURE EA; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; PALMER AC, 1973, P ROY SOC LOND A MAT, V332, P527, DOI 10.1098/rspa.1973.0040; Passelegue FX, 2013, SCIENCE, V340, P1208, DOI 10.1126/science.1235637; Poliakov ANB, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000572; READ BE, 1981, POLYM TEST, V2, P135, DOI 10.1016/0142-9418(81)90031-3; Rice J. R., 1980, PHYS EARTHS INTERIOR, P555; Rubinstein SM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/21/214016; Rubinstein SM, 2006, INT J FRACTURE, V140, P201, DOI 10.1007/s10704-006-0049-8; Rubinstein SM, 2004, NATURE, V430, P1005, DOI 10.1038/nature02830; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Sharon E, 1996, PHYS REV LETT, V76, P2117, DOI 10.1103/PhysRevLett.76.2117; Tromborg J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.074301; Yamaguchi T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008415	35	148	148	11	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					205	+		10.1038/nature13202	http://dx.doi.org/10.1038/nature13202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805344				2022-12-28	WOS:000335454300034
J	Yee, C; Yang, W; Hekimi, S				Yee, Callista; Yang, Wen; Hekimi, Siegfried			The Intrinsic Apoptosis Pathway Mediates the Pro-Longevity Response to Mitochondrial ROS in C. elegans	CELL			English	Article							LIFE-SPAN EXTENSION; ELECTRON-TRANSPORT; SUPEROXIDE DISMUTASES; OXIDATIVE DAMAGE; DNA-DAMAGE; RESPIRATION; STRESS; INCREASE; BEHAVIOR; CELLS	The increased longevity of the C. elegans electron transport chain mutants isp-1 and nuo-6 is mediated by mitochondrial ROS (mtROS) signaling. Here we show that the mtROS signal is relayed by the conserved, mitochondria-associated, intrinsic apoptosis signaling pathway (CED-9/Bcl2, CED-4/Apaf1, and CED-3/Casp9) triggered by CED-13, an alternative BH3-only protein. Activation of the pathway by an elevation of mtROS does not affect apoptosis but protects from the consequences of mitochondrial dysfunction by triggering a unique pattern of gene expression that modulates stress sensitivity and promotes survival. In vertebrates, mtROS induce apoptosis through the intrinsic pathway to protect from severely damaged cells. Our observations in nematodes demonstrate that sensing of mtROS by the apoptotic pathway can, independently of apoptosis, elicit protective mechanisms that keep the organism alive under stressful conditions. This results in extended longevity when mtROS generation is inappropriately elevated. These findings clarify the relationships between mitochondria, ROS, apoptosis, and aging.	[Yee, Callista; Yang, Wen; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	siegfried.hekimi@mcgill.ca	Yee, Callista/N-9574-2019	Yee, Callista/0000-0002-2928-492X	Canadian Institutes of Health Research [MOP-114891, MOP-123295, MOP-97869, INE-117889]; McGill University; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Robyn Branicky for thoughtfully commenting on the manuscript, Eve Bigras for technical assistance, and Steve Hodgkinson for technical advice. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The work was funded by grants from the Canadian Institutes of Health Research to S.H.: MOP-114891, MOP-123295, MOP-97869 and INE-117889 (through the CoEN initiative (www.coen.org), as well as by McGill University. S.H. is Strathcona Chair of Zoology and Campbell Chair of Developmental Biology.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lu N, 2009, METHODS MOL BIOL, V559, P357, DOI 10.1007/978-1-60327-017-5_25; Lu Y, 2011, P NATL ACAD SCI USA, V108, pE813, DOI 10.1073/pnas.1103218108; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suthammarak W, 2013, AGING CELL, V12, P1132, DOI 10.1111/acel.12144; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x; Walter L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001084; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	40	258	270	1	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					897	909		10.1016/j.cell.2014.02.055	http://dx.doi.org/10.1016/j.cell.2014.02.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813612	Green Accepted, Bronze			2022-12-28	WOS:000335765500017
J	Mainous, AG				Mainous, Arch G., III			PERSONAL VIEW Physicians should declare financial incentives for recruiting minority ethnic patients into clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAYMENTS		[Mainous, Arch G., III] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL 32610 USA; [Mainous, Arch G., III] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mainous, AG (corresponding author), Univ Florida, Dept Hlth Serv Res Management & Policy, POB 100195, Gainesville, FL 32610 USA.	arch.mainous@ufl.edu		Mainous, Arch/0000-0002-2535-7685	National Institute on Minority Health and Health Disparities [U24MD006941] Funding Source: NIH RePORTER; NIMHD NIH HHS [5U24MD006941-03] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Cuffee YL, 2013, AM J PUBLIC HEALTH, V103, pE55, DOI 10.2105/AJPH.2013.301554; Ford ME, 2013, HEALTH SOC WORK, V38, P29, DOI 10.1093/hsw/hlt001; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Hall MA, 2010, ACAD MED, V85, P1554, DOI 10.1097/ACM.0b013e3181ef9cc6; Hall W. Dallas, 1999, Ethnicity and Disease, V9, P333; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; Mainous AG, 2006, ANN FAM MED, V4, P247, DOI 10.1370/afm.541; Mainous AG, 2008, J NATL MED ASSOC, V100, P1298, DOI 10.1016/S0027-9684(15)31508-X; NIH, 2017, NIH POLICY GUIDELINE; Raftery J, 2008, HEALTH TECHNOL ASSES, V12, P1; Rao JN, 2002, BRIT MED J, V325, P36, DOI 10.1136/bmj.325.7354.36; Rooney LK, 2011, J PUBLIC HEALTH-UK, V33, P604, DOI 10.1093/pubmed/fdq100; Sherber NS, 2009, CONTEMP CLIN TRIALS, V30, P227, DOI 10.1016/j.cct.2009.01.002; Weinfurt KP, 2008, J GEN INTERN MED, V23, P860, DOI 10.1007/s11606-008-0590-4; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2014	348								g2985	10.1136/bmj.g2985	http://dx.doi.org/10.1136/bmj.g2985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH0OI	24806316	Green Published			2022-12-28	WOS:000335819200001
J	Holmes, D				Holmes, David			Francine Ducharme: the art and the science of childhood asthma	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1539	1539		10.1016/S0140-6736(14)60736-4	http://dx.doi.org/10.1016/S0140-6736(14)60736-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792845				2022-12-28	WOS:000335495400012
J	Albertazzi, L; van der Zwaag, D; Leenders, CMA; Fitzner, R; van der Hofstad, RW; Meijer, EW				Albertazzi, Lorenzo; van der Zwaag, Daan; Leenders, Christianus M. A.; Fitzner, Robert; van der Hofstad, Remco W.; Meijer, E. W.			Probing Exchange Pathways in One-Dimensional Aggregates with Super-Resolution Microscopy	SCIENCE			English	Article							SUPRAMOLECULAR POLYMERIZATION; POLYMERS; KINETICS; IMAGES	Supramolecular fibers are prominent structures in biology and chemistry. A quantitative understanding of molecular exchange pathways in these one-dimensional aggregates was obtained by a combination of super-resolution stochastic optical reconstruction microscopy and stochastic simulation. The potential of this methodology is demonstrated with a set of well-defined synthetic building blocks that self-assemble into supramolecular fibrils. Previous ensemble measurements hid all molecular phenomena underpinning monomer exchange, but the molecular pathway determined from single-aggregate studies revealed unexpected homogeneous exchange along the polymer backbone. These results pave the way for experimental investigation of the structure and exchange pathways of synthetic and natural supramolecular fibers.	[Albertazzi, Lorenzo; van der Zwaag, Daan; Leenders, Christianus M. A.; van der Hofstad, Remco W.; Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MD Eindhoven, Netherlands; [Albertazzi, Lorenzo; Meijer, E. W.] Eindhoven Univ Technol, Lab Chem Biol, NL-5600 MD Eindhoven, Netherlands; [van der Zwaag, Daan; Leenders, Christianus M. A.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MD Eindhoven, Netherlands; [Fitzner, Robert; van der Hofstad, Remco W.] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MD Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Albertazzi, L (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MD Eindhoven, Netherlands.	l.albertazzi@tue.nl; e.w.meijer@tue.nl	Albertazzi, Lorenzo/E-8323-2013; Meijer, E.W./K-7632-2013	Albertazzi, Lorenzo/0000-0002-6837-0812; Meijer, E.W./0000-0003-4126-7492; van der Zwaag, Daan/0000-0003-0320-8715; van der Hofstad, Remco/0000-0003-1331-9697	European Research Council; Dutch Science Foundation (NWO); Netherlands Initiative for Regenerative Medicine; Dutch Ministry of Education, Culture and Science [024.001.035]	European Research Council(European Research Council (ERC)European Commission); Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Initiative for Regenerative Medicine; Dutch Ministry of Education, Culture and Science	We thank X. Zhuang and Nikon Europe for sharing data sets. Data sets for in vitro microtubules (18) were provided by X. Zhuang; data sets for microtubules in BSC-1 cells were provided by Nikon Europe. We thank T. de Greef and A. Palmans for useful discussions and the Institute for Complex Molecular Systems animation studio for the artwork. This work was supported by the European Research Council; the Dutch Science Foundation (NWO); the Netherlands Initiative for Regenerative Medicine; and the Dutch Ministry of Education, Culture and Science (Gravity program 024.001.035).	Adamcik J, 2010, NAT NANOTECHNOL, V5, P423, DOI [10.1038/nnano.2010.59, 10.1038/NNANO.2010.59]; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Albertazzi L, 2013, P NATL ACAD SCI USA, V110, P12203, DOI 10.1073/pnas.1303109110; Cantekin S, 2012, CHEM SOC REV, V41, P6125, DOI 10.1039/c2cs35156k; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Leenders CMA, 2013, CHEM COMMUN, V49, P1963, DOI 10.1039/c3cc38949a; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Shikata T, 2004, J PHYS CHEM B, V108, P508, DOI 10.1021/jp030510q; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c	21	184	185	5	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					491	495		10.1126/science.1250945	http://dx.doi.org/10.1126/science.1250945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786073				2022-12-28	WOS:000335157700036
J	Bechler, ME; Ffrench-Constant, C				Bechler, Marie E.; Ffrench-Constant, Charles			A New Wrap for Neuronal Activity?	SCIENCE			English	Editorial Material							WHITE-MATTER; MYELINATION; GLIA; GRAY		[Bechler, Marie E.; Ffrench-Constant, Charles] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Bechler, ME (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.	mbechler@staffmail.ed.ac.uk; cffc@ed.ac.uk			MRC [G0601744] Funding Source: UKRI; Medical Research Council [G0601744] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Maldonado PP, 2013, J NEUROSCI, V33, P2432, DOI 10.1523/JNEUROSCI.1961-12.2013; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Seidl AH, 2014, NEUROSCIENCE, V276, P126, DOI 10.1016/j.neuroscience.2013.06.047; Wu LMN, 2012, CURR BIOL, V22, P1957, DOI 10.1016/j.cub.2012.08.025; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	13	8	9	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					479	480		10.1126/science.1254446	http://dx.doi.org/10.1126/science.1254446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786068				2022-12-28	WOS:000335157700029
J	Anderson, ST; Kaforou, M; Brent, AJ; Wright, VJ; Banwell, CM; Chagaluka, G; Crampin, AC; Dockrell, HM; French, N; Hamilton, MS; Hibberd, ML; Kern, F; Langford, PR; Ling, L; Mlotha, R; Ottenhoff, THM; Pienaar, S; Pillay, V; Scott, JAG; Twahir, H; Wilkinson, RJ; Coin, LJ; Heyderman, RS; Levin, M; Eley, B				Anderson, Suzanne T.; Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Banwell, Claire M.; Chagaluka, George; Crampin, Amelia C.; Dockrell, Hazel M.; French, Neil; Hamilton, Melissa S.; Hibberd, Martin L.; Kern, Florian; Langford, Paul R.; Ling, Ling; Mlotha, Rachel; Ottenhoff, Tom H. M.; Pienaar, Sandy; Pillay, Vashini; Scott, J. Anthony G.; Twahir, Hemed; Wilkinson, Robert J.; Coin, Lachlan J.; Heyderman, Robert S.; Levin, Michael; Eley, Brian		ILULU Consortium; KIDS TB Study Grp	Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA RELEASE ASSAYS; PULMONARY TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; LATENT TUBERCULOSIS; CHILDREN; CONSENSUS; DISEASE; BIOMARKERS; SIGNATURE; INFECTION	BackgroundImproved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV). MethodsThe study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood. ResultsWe identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%. ConclusionsRNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).	[Anderson, Suzanne T.; Banwell, Claire M.; Kern, Florian] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Hamilton, Melissa S.; Langford, Paul R.; Wilkinson, Robert J.; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, Paediat Sect, London, England; [Kaforou, Myrsini; Brent, Andrew J.; Wright, Victoria J.; Hamilton, Melissa S.; Langford, Paul R.; Heyderman, Robert S.; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, Wellcome Trust Ctr Clin Trop Med, London, England; [Kaforou, Myrsini; Coin, Lachlan J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Crampin, Amelia C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Brent, Andrew J.] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England; [French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Anderson, Suzanne T.; Banwell, Claire M.; Chagaluka, George; Mlotha, Rachel; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Chagaluka, George; Mlotha, Rachel] Queen Elizabeth Cent Hosp, Dept Pediat, Blantyre, Malawi; [Crampin, Amelia C.; French, Neil] Karonga Prevent Study, Chilumba, Karonga Distric, Malawi; [Brent, Andrew J.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Twahir, Hemed] Coast Prov Gen Hosp, Dept Paediat, Mombasa, Kenya; [Hibberd, Martin L.; Ling, Ling] Genome Inst Singapore, Singapore, Singapore; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Pienaar, Sandy; Pillay, Vashini; Eley, Brian] Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Coin, Lachlan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Brighton; University of Sussex; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi; Malawi Epidemiology and Intervention Research Unit; Kenya Medical Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cape Town; University of Queensland	Levin, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, Norfolk Pl, London W2 1PG, England.		Kaforou, Myrsini/L-2470-2019; Coin, Lachlan JM/A-9001-2014; Langford, Paul/AAU-4189-2020; Coin, Lachlan/O-4976-2019; Kern, Florian/AAE-6784-2022	Kaforou, Myrsini/0000-0001-9878-4007; Coin, Lachlan JM/0000-0002-4300-455X; Langford, Paul/0000-0002-6368-4724; Coin, Lachlan/0000-0002-4300-455X; Kern, Florian/0000-0002-0368-8408; Gideon, Hannah/0000-0002-4443-2134; Wright, Victoria/0000-0001-7826-1516; Wilkinson, Robert/0000-0002-2753-1800; Hibberd, Martin/0000-0001-8587-1849; French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330; Levin, Michael/0000-0003-2767-6919; Heyderman, Robert/0000-0003-4573-449X; Berkley, James/0000-0002-1236-849X; Maitland, Kathryn/0000-0002-0007-0645; Mendelson, Marc/0000-0001-6668-3893; Dockrell, Hazel/0000-0003-1869-9107	European Union Action for Diseases of Poverty Program [Sante-2006-105-061]; Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom [084679-Z-08-Z]; Wellcome Trust [084323, 088316, 081835, 081697, 077092]; National Institute for Health Research [NF-SI-0611-10230] Funding Source: researchfish	European Union Action for Diseases of Poverty Program; Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant from the European Union Action for Diseases of Poverty Program (Sante-2006-105-061), a Malawi-Liverpool-Wellcome Trust Clinical Research Program Core Grant, United Kingdom (084679-Z-08-Z, to Dr. Heyderman), and additional grants from the Wellcome Trust (084323 and 088316, to Dr. Wilkinson; 081835, to Dr. Scott; and 081697, to Dr. Brent); the study also made use of infrastructure and staff at the Wellcome Trust-supported programs in Blantyre, Malawi, and Kilifi, Kenya, the University of Cape Town (084323, 077092), the Imperial College Wellcome Trust Centre for Clinical Tropical Medicine, and the Imperial College Wellcome Trust Centre for Global Health Research.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cuevas LE, 2012, PAEDIATR INT CHILD H, V32, DOI 10.1179/2046904712Z.00000000076; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Drobac PC, 2012, PEDIATRICS, V130, pE373, DOI 10.1542/peds.2011-3048; Eamranond P, 2001, INT J TUBERC LUNG D, V5, P594; Graham SM, 2009, TUBERCULOSIS COMPREH, P154; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hatherill M, 2012, CLIN INFECT DIS, V54, P493, DOI 10.1093/cid/cir823; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2005, ARCH DIS CHILD, V90, P1162, DOI 10.1136/adc.2004.070797; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pearce EC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/401896; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Swingler GH, 2005, ARCH DIS CHILD, V90, P1153, DOI 10.1136/adc.2004.062315; Verhagen LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-74; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Whittaker E, 2012, EXPERT REV RESP MED, V6, P385, DOI [10.1586/ers.12.36, 10.1586/ERS.12.36]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	237	252	3	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1712	1723		10.1056/NEJMoa1303657	http://dx.doi.org/10.1056/NEJMoa1303657			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785206	Green Accepted, Green Published			2022-12-28	WOS:000335405200009
J	Loscalzo, J				Loscalzo, Joseph			Keshan Disease, Selenium Deficiency, and the Selenoproteome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLOSTRIDIAL GLYCINE REDUCTASE; GLUTATHIONE-PEROXIDASE; MUSCLE DISEASE; SELENOCYSTEINE; IDENTIFICATION; MOUSE; HEART; APOPTOSIS; COMPONENT; CODON		[Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					[Anonymous], 1979, CHINESE MED J-PEKING, V92, P471; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHEN CS, 1980, P NATL ACAD SCI-BIOL, V77, P1403, DOI 10.1073/pnas.77.3.1403; Chen JS, 2012, ASIA PAC J CLIN NUTR, V21, P320; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Horn MJ, 1941, J BIOL CHEM, V139, P649; Ishihara H, 1999, J NEUROL NEUROSUR PS, V67, P829, DOI 10.1136/jnnp.67.6.829; Jin RC, 2011, CIRCULATION, V123, P1963, DOI 10.1161/CIRCULATIONAHA.110.000034; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Li Y, 1995, Zhonghua Yi Xue Za Zhi, V75, P344; LI Y, 1995, ZHONGHUA YIXUE ZAZHI, V75, P382; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Longtin R, 2004, J NATL CANCER I, V96, P504, DOI 10.1093/jnci/96.7.504; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Maulik N, 1999, MOL CELL BIOCHEM, V196, P13, DOI 10.1023/A:1006905910140; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; Ottaviano FG, 2008, CIRC J, V72, P1, DOI 10.1253/circj.72.1; Ottaviano FG, 2009, MOL CELL BIOCHEM, V327, P111, DOI 10.1007/s11010-009-0049-x; Peng TQ, 2000, J CLIN MICROBIOL, V38, P3538, DOI 10.1128/JCM.38.10.3538-3543.2000; PINSENT J, 1954, BIOCHEM J, V57, P10, DOI 10.1042/bj0570010; Rivera MT, 2002, AM J TROP MED HYG, V66, P706, DOI 10.4269/ajtmh.2002.66.706; ROTRUCK JT, 1971, NATURE-NEW BIOL, V231, P223, DOI 10.1038/newbio231223a0; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SHRIFT A, 1963, BIOCHIM BIOPHYS ACTA, V71, P483, DOI 10.1016/0006-3002(63)91113-2; TRELEASE SF, 1960, SCIENCE, V132, P618, DOI 10.1126/science.132.3427.618; TURNER DC, 1973, ARCH BIOCHEM BIOPHYS, V154, P366, DOI 10.1016/0003-9861(73)90069-6; Voetsch B, 2007, STROKE, V38, P41, DOI 10.1161/01.STR.0000252027.53766.2b; Wang G Y, 1979, Zhonghua Yu Fang Yi Xue Za Zhi, V13, P204; WELZ B, 1987, PURE APPL CHEM, V59, P927, DOI 10.1351/pac198759070927; Yang G Q, 1984, Adv Nutr Res, V6, P203; Yang G Q, 1988, World Rev Nutr Diet, V55, P98; Zhang Y, 2011, J BIOL CHEM, V286, P23623, DOI 10.1074/jbc.R110.172833; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	44	141	152	5	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1756	1760		10.1056/NEJMcibr1402199	http://dx.doi.org/10.1056/NEJMcibr1402199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785212				2022-12-28	WOS:000335405200017
J	Fazel, S; Zetterqvist, J; Larsson, H; Langstrom, N; Lichtenstein, P				Fazel, Seena; Zetterqvist, Johan; Larsson, Henrik; Langstroem, Nikfas; Lichtenstein, Paul			Antipsychotics, mood stabilisers, and risk of violent crime	LANCET			English	Article							BIPOLAR DISORDER; SCHIZOPHRENIA; MEDICATIONS; TRENDS; INTERVENTIONS; METAANALYSIS; AGGRESSION; PREVENTION; MORTALITY; REGISTER	Background Antipsychotics and mood stabilisers are prescribed widely to patients with psychiatric disorders worldwide. Despite clear evidence for their efficacy in relapse prevention and symptom relief, their effect on some adverse outcomes, including the perpetration of violent crime, is unclear. We aimed to establish the effect of antipsychotics and mood stabilisers on the rate of violent crime committed by patients with psychiatric disorders in Sweden. Methods We used linked Swedish national registers to study 82 647 patients who were prescribed antipsychotics or mood stabilisers, their psychiatric diagnoses, and subsequent criminal convictions in 2006-09. We did withinindividual analyses to compare the rate of violent criminality during the time that patients were prescribed these medications versus the rate for the same patients while they were not receiving the drugs to adjust for all confounders that remained constant within each participant during follow-up. The primary outcome was the occurrence of violent crime, according to Sweden's national crime register. Findings In 2006-09, 40 937 men in Sweden were prescribed antipsychotics or mood stabilisers, of whom 2657 (6.5%) were convicted of a violent crime during the study period. In the same period, 41 710 women were prescribed these drugs, of whom 604 (1.4 %) had convictions for violent crime. Compared with periods when participants were not on medication, violent crime fell by 45% in patients receiving antipsychotics (hazard ratio [HR] 0.55, 95% CI 0.47-0.64) and by 24% in patients prescribed mood stabilisers (0. 76, 0.62-0.93). However, we identified potentially important differences by diagnosis mood stabilisers were associated with a reduced rate of violent crime only in patients with bipolar disorder. The rate of violence reduction for antipsychotics remained between 22% and 29% in sensitivity analyses that used different outcomes (any crime, drug-related crime, less severe crime, and violent arrest), and was stronger in patients who were prescribed higher drug doses than in those prescribed low doses. Notable reductions in violent crime were also recorded for depot medication (HR adjusted for concomitant oral medications 0. 60, 95% CI 0.39-0.92). Interpretation In addition to relapse prevention and psychiatric symptom relief, the benefits of antipsychotics and mood stabilisers might also include reductions in the rates of violent crime. The potential effects of these drugs on violence and crime should be taken into account when treatment options for patients with psychiatric disorders are being considered.	[Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Zetterqvist, Johan; Larsson, Henrik; Langstroem, Nikfas; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oxford; Karolinska Institutet	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Langstrom, Niklas/C-5615-2009; Fazel, Seena/B-5307-2008; Larsson, Henrik/GYD-5161-2022	Langstrom, Niklas/0000-0002-2686-6799; Fazel, Seena/0000-0002-5383-5365; Larsson, Henrik/0000-0002-6851-3297; lichtenstein, paul/0000-0003-3037-5287	Welcome Trust [095806]; Swedish Prison and Probation Service; Swedish Research Council; Swedish Research Council for Health, Working Life and Welfare	Welcome Trust(Wellcome Trust); Swedish Prison and Probation Service; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by grants from the Welcome Trust (095806), the Swedish Prison and Probation Service, the Swedish Research Council, and the Swedish Research Council for Health, Working Life and Welfare.	Allison PD, 1996, SOCIOL METHOD RES, V25, P207, DOI 10.1177/0049124196025002003; American Psychiatric Association, 2004, PRACT GUID TREATM PA; [Anonymous], 2010, INT STAT CRIME JUSTI; Arango C, 2006, EUR PSYCHIAT, V21, P34, DOI 10.1016/j.eurpsy.2005.07.006; Baldwin DS, 2007, ADV PSYCHIAT TREAT, V13, P414, DOI DOI 10.1192/APT.BP.107.004184; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Beynon S, 2009, J PSYCHOPHARMACOL, V23, P574, DOI 10.1177/0269881108093885; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Citrome L, 2002, PSYCHIATR SERV, V53, P1212, DOI 10.1176/appi.ps.53.10.1212; Citrome L, 2007, J CLIN PSYCHIAT, V68, P331, DOI 10.4088/JCP.v68n0220; Citrome L, 2010, PSYCHIAT SERV, V61, P9, DOI 10.1176/appi.ps.61.1.9; Coid JW, 2013, JAMA PSYCHIAT, V70, P465, DOI 10.1001/jamapsychiatry.2013.12; De Hert M, 2010, SCHIZOPHR RES, V117, P68, DOI 10.1016/j.schres.2009.12.029; Dove D, 2012, PEDIATRICS, V130, P717, DOI 10.1542/peds.2012-0683; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Frogley C, 2012, INT J NEUROPSYCHOPH, V15, P1351, DOI 10.1017/S146114571100201X; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Haw C, 2005, J PSYCHOPHARMACOL, V19, P402, DOI 10.1177/0269881105053307; Hockenhull J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16120; Huband N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003499.pub3; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Jones RM, 2011, BRIT J PSYCHIAT, V198, P93, DOI 10.1192/bjp.bp.110.083030; Kishimoto T, 2014, SCHIZOPHRENIA BULL, V40, P192, DOI 10.1093/schbul/sbs150; Kooyman I, 2007, BRIT J PSYCHIAT, V191, pS29, DOI 10.1192/bjp.191.50.s29; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Leucht C, 2011, SCHIZOPHR RES, V127, P83, DOI 10.1016/j.schres.2010.11.020; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2007, PHYSICAL ILLNESS AND SCHIZOPHRENIA: A REVIEW OF THE EVIDENCE, P3, DOI 10.1017/CBO9780511543951.003; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Loy JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008559.pub2; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McGuire J, 2008, PHILOS T R SOC B, V363, P2577, DOI 10.1098/rstb.2008.0035; Mercer D, 2009, J PERS DISORD, V23, P156, DOI 10.1521/pedi.2009.23.2.156; *NAT I CLIN EXC, 2003, SCHIZ FULL NAT CLIN; National Council for Crime Prevention, 2011, KRIM 2010; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Pamer CA, 2010, PHARMACOEPIDEM DR S, V19, P158, DOI 10.1002/pds.1886; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pringsheim T, 2012, CAN J PSYCHIAT, V57, P722, DOI 10.1177/070674371205701203; Raschi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081208; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schwarz C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004028.pub3; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Stagnitti M, 2010, TRENDS ANTIPSYCHOTIC; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; Topiwala A, 2011, EXPERT REV NEUROTHER, V11, P53, DOI [10.1586/ern.10.180, 10.1586/ERN.10.180]; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	57	122	124	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 27	2014	384	9949					1206	1214		10.1016/S0140-6736(14)60379-2	http://dx.doi.org/10.1016/S0140-6736(14)60379-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AQ7MT	24816046	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000343002600027
J	Criner, GJ; Connett, JE; Aaron, SD; Albert, RK; Bailey, WC; Casaburi, R; Cooper, JAD; Curtis, JL; Dransfield, MT; Han, MK; Make, B; Marchetti, N; Martinez, FJ; Niewoehner, DE; Scanlon, PD; Sciurba, FC; Scharf, SM; Sin, DD; Voelker, H; Washko, GR; Woodruff, PG; Lazarus, SC				Criner, G. J.; Connett, J. E.; Aaron, S. D.; Albert, R. K.; Bailey, W. C.; Casaburi, R.; Cooper, J. A. D., Jr.; Curtis, J. L.; Dransfield, M. T.; Han, M. K.; Make, B.; Marchetti, N.; Martinez, F. J.; Niewoehner, D. E.; Scanlon, P. D.; Sciurba, F. C.; Scharf, S. M.; Sin, D. D.; Voelker, H.; Washko, G. R.; Woodruff, P. G.; Lazarus, S. C.		COPD Clinical Res Network; Canadian Inst Hlth Res	Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MRC/BHF HEART PROTECTION; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; STATIN USE; RANDOMIZED-TRIAL; LUNG-FUNCTION; MORTALITY; INHIBITORS; POPULATION	BACKGROUND Retrospective studies have shown that statins decrease the rate and severity of exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary disease (COPD). We prospectively studied the efficacy of simvastatin in preventing exacerbations in a large, multicenter, randomized trial. METHODS We designed the Prospective Randomized Placebo-Controlled Trial of Simvastatin in the Prevention of COPD Exacerbations (STATCOPE) as a randomized, controlled trial of simvastatin (at a daily dose of 40 mg) versus placebo, with annual exacerbation rates as the primary outcome. Patients were eligible if they were 40 to 80 years of age, had COPD (defined by a forced expiratory volume in 1 second [FEV1] of less than 80% and a ratio of FEV1 to forced vital capacity of less than 70%), and had a smoking history of 10 or more pack-years, were receiving supplemental oxygen or treatment with glucocorticoids or antibiotic agents, or had had an emergency department visit or hospitalization for COPD within the past year. Patients with diabetes or cardiovascular disease and those who were taking statins or who required statins on the basis of Adult Treatment Panel III criteria were excluded. Participants were treated from 12 to 36 months at 45 centers. RESULTS A total of 885 participants with COPD were enrolled for approximately 641 days; 44% of the patients were women. The patients had a mean (+/-SD) age of 62.2+/-8.4 years, an FEV1 that was 41.6+/-17.7% of the predicted value, and a smoking history of 50.6+/-27.4 pack-years. At the time of study closeout, the low-density lipoprotein cholesterol levels were lower in the simvastatin-treated patients than in those who received placebo. The mean number of exacerbations per person-year was similar in the simvastatin and placebo groups: 1.36+/-1.61 exacerbations and 1.39+/-1.73 exacerbations, respectively (P = 0.54). The median number of days to the first exacerbation was also similar: 223 days (95% confidence interval [CI], 195 to 275) and 231 days (95% CI, 193 to 303), respectively (P = 0.34). The number of nonfatal serious adverse events per person-year was similar, as well: 0.63 events with simvastatin and 0.62 events with placebo. There were 30 deaths in the placebo group and 28 in the simvastatin group (P = 0.89). CONCLUSIONS Simvastatin at a daily dose of 40 mg did not affect exacerbation rates or the time to a first exacerbation in patients with COPD who were at high risk for exacerbations. (Funded by the National Heart, Lung, and Blood Institute and the Canadian Institutes of Health Research; STATCOPE ClinicalTrials.gov number, NCT01061671.)	[Criner, G. J.; Marchetti, N.] Temple Univ, Sch Med, Dept Pulm & Crit Care Med, Philadelphia, PA 19140 USA; [Connett, J. E.] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN USA; [Connett, J. E.] Univ Minnesota, Data Coordinating Ctr, Minneapolis, MN USA; [Niewoehner, D. E.] Univ Minnesota, Dept Pulm Allergy Crit Care & Sleep Med, Minneapolis, MN USA; [Scanlon, P. D.] Mayo Clin, Dept Pulm & Crit Care Med, Rochester, MN USA; [Aaron, S. D.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Sin, D. D.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Sin, D. D.] Univ British Columbia, Inst Heart & Lung Hlth, James Hogg Res Ctr, Vancouver, BC, Canada; [Albert, R. K.] Denver Hlth Med Ctr, Dept Med, Denver, CO USA; [Make, B.] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Denver, CO USA; [Bailey, W. C.; Dransfield, M. T.] Univ Alabama Birmingham, Dept Pulm Allergy & Crit Care Med, Birmingham, AL 35205 USA; [Cooper, J. A. D., Jr.] Univ Alabama Birmingham, Pulm Sect, Birmingham, AL USA; Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Casaburi, R.] Harbor UCLA Res & Educ Inst, Los Angeles, CA USA; [Curtis, J. L.] Vet Affairs Med Ctr, Dept Pulm Med, Ann Arbor, MI USA; [Curtis, J. L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Han, M. K.; Martinez, F. J.] Univ Michigan Hlth Syst, Dept Pulm & Crit Care Med, Ann Arbor, MI USA; [Sciurba, F. C.] Univ Pittsburgh, Med Ctr, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Scharf, S. M.] Univ Maryland, Dept Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Washko, G. R.] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Woodruff, P. G.; Lazarus, S. C.] Univ Calif San Francisco, Dept Pulm & Crit Care Med, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; University of British Columbia; Denver Health Medical Center; National Jewish Health; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Criner, GJ (corresponding author), Temple Univ, Sch Med, Temple Lung Ctr, 745 Parkinson Pavil,3401 N Broad St, Philadelphia, PA 19140 USA.	gerard.criner@tuhs.temple.edu	Sciurba, Frank/AAZ-9339-2021; Sin, Don/AAC-2219-2021	Curtis, Jeffrey/0000-0001-5191-4847; Aaron, Shawn/0000-0002-4762-3542; sciurba, frank/0000-0001-7468-2225	National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074431, U10HL074422, U10HL074439, U10HL074409, U10HL074424, U10HL074407, U10HL074428, U10HL074441, U10HL074418, U10HL074416, U10HL074408] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and the Canadian Institutes of Health Research; STATCOPE ClinicalTrials.gov number, NCT01061671.	Albert RK, 2012, NEW ENGL J MED, V366, P1356; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Alexeeff SE, 2007, AM J RESP CRIT CARE, V176, P742, DOI 10.1164/rccm.200705-656OC; Andell P, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000002; [Anonymous], 2014, FDA DRUG SAFETY COMM; [Anonymous], 2014, DET EV TREATM HIGH B; Balk EM, 2003, ANN INTERN MED, V139, P670, DOI 10.7326/0003-4819-139-8-200310210-00011; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Blamoun AI, 2008, INT J CLIN PRACT, V62, P1373, DOI 10.1111/j.1742-1241.2008.01731.x; Calverley P, 2003, LANCET, V361, P1660; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; Dalal Anand A, 2010, Int J Chron Obstruct Pulmon Dis, V5, P341, DOI 10.2147/COPD.S13771; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Ferns GAA, 2003, ATHEROSCLEROSIS, V169, P349, DOI 10.1016/S0021-9150(03)00191-6; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Inoue I, 2000, LIFE SCI, V67, P863, DOI 10.1016/S0024-3205(00)00680-9; Ishida W, 2007, TOHOKU J EXP MED, V212, P265, DOI 10.1620/tjem.212.265; Jialal I, 2001, AM J RESP CRIT CARE, V103, P1933; Keddissi JI, 2007, CHEST, V132, P1764, DOI 10.1378/chest.07-0298; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Lahousse L, 2013, PULM PHARMACOL THER, V26, P212, DOI 10.1016/j.pupt.2012.10.008; Lan KKG, 1987, BIOMETRIKA, V74, P149; Lee TM, 2009, CLIN SCI, V116, P497, DOI 10.1042/CS20080241; Li JJ, 2003, CLIN CARDIOL, V26, P472, DOI 10.1002/clc.4960261008; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; OLIVER MF, 1994, LANCET, V344, P633; PEDERSEN TR, 1994, LANCET, V344, P1383; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wyrwich KW, 2003, J GEN INTERN MED, V18, P196, DOI 10.1046/j.1525-1497.2003.20203.x	44	227	241	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2201	2210		10.1056/NEJMoa1403086	http://dx.doi.org/10.1056/NEJMoa1403086			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24836125	Green Accepted			2022-12-28	WOS:000336729900008
J	Moroz, LL; Kocot, KM; Citarella, MR; Dosung, S; Norekian, TP; Povolotskaya, IS; Grigorenko, AP; Dailey, C; Berezikov, E; Buckley, KM; Ptitsyn, A; Reshetov, D; Mukherjee, K; Moroz, TP; Bobkova, Y; Yu, FH; Kapitonov, VV; Jurka, J; Bobkov, YV; Swore, JJ; Girardo, DO; Fodor, A; Gusev, F; Sanford, R; Bruders, R; Kittler, E; Mills, CE; Rast, JP; Derelle, R; Solovyev, VV; Kondrashov, FA; Swalla, BJ; Sweedler, JV; Rogaev, EI; Halanych, KM; Kohn, AB				Moroz, Leonid L.; Kocot, Kevin M.; Citarella, Mathew R.; Dosung, Sohn; Norekian, Tigran P.; Povolotskaya, Inna S.; Grigorenko, Anastasia P.; Dailey, Christopher; Berezikov, Eugene; Buckley, Katherine M.; Ptitsyn, Andrey; Reshetov, Denis; Mukherjee, Krishanu; Moroz, Tatiana P.; Bobkova, Yelena; Yu, Fahong; Kapitonov, Vladimir V.; Jurka, Jerzy; Bobkov, Yuri V.; Swore, Joshua J.; Girardo, David O.; Fodor, Alexander; Gusev, Fedor; Sanford, Rachel; Bruders, Rebecca; Kittler, Ellen; Mills, Claudia E.; Rast, Jonathan P.; Derelle, Romain; Solovyev, Victor V.; Kondrashov, Fyodor A.; Swalla, Billie J.; Sweedler, Jonathan V.; Rogaev, Evgeny I.; Halanych, Kenneth M.; Kohn, Andrea B.			The ctenophore genome and the evolutionary origins of neural systems	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CAPILLARY-ELECTROPHORESIS; COMPLEX BRAINS; TRANSCRIPTOME; DATABASE; GENES; PHYLOGENOMICS; PROTEINS; BLAST; KEGG	The origins of neural systems remain unresolved. In contrast to other basal metazoans, ctenophores (comb jellies) have both complex nervous and mesoderm-derived muscular systems. These holoplanktonic predators also have sophisticated ciliated locomotion, behaviour and distinct development. Here we present the draft genome of Pleurobrachia bachei, Pacific sea gooseberry, together with ten other ctenophore transcriptomes, and show that they are remarkably distinct from other animal genomes in their content of neurogenic, immune and developmental genes. Our integrative analyses place Ctenophora as the earliest lineage within Metazoa. This hypothesis is supported by comparative analysis of multiple gene families, including the apparent absence of HOX genes, canonical microRNA machinery, and reduced immune complement in ctenophores. Although two distinct nervous systems are well recognized in ctenophores, many bilaterian neuron-specific genes and genes of 'classical' neurotransmitter pathways either are absent or, if present, are not expressed in neurons. Our metabolomic and physiological data are consistent with the hypothesis that ctenophore neural systems, and possibly muscle specification, evolved independently from those in other animals.	[Moroz, Leonid L.; Citarella, Mathew R.; Dosung, Sohn; Norekian, Tigran P.; Ptitsyn, Andrey; Mukherjee, Krishanu; Moroz, Tatiana P.; Bobkova, Yelena; Bobkov, Yuri V.; Swore, Joshua J.; Girardo, David O.; Fodor, Alexander; Sanford, Rachel; Bruders, Rebecca; Kohn, Andrea B.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.; Yu, Fahong] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Moroz, Leonid L.; Yu, Fahong] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Moroz, Leonid L.; Norekian, Tigran P.; Swore, Joshua J.; Girardo, David O.; Bruders, Rebecca; Mills, Claudia E.; Swalla, Billie J.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Kocot, Kevin M.; Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Povolotskaya, Inna S.; Derelle, Romain; Kondrashov, Fyodor A.] CRG, Barcelona 08003, Spain; [Povolotskaya, Inna S.; Derelle, Romain; Kondrashov, Fyodor A.] UPF, Barcelona 08003, Spain; [Grigorenko, Anastasia P.; Gusev, Fedor; Rogaev, Evgeny I.] Univ Massachusetts, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Sch Med, Worcester, MA 01604 USA; [Grigorenko, Anastasia P.; Reshetov, Denis; Gusev, Fedor; Rogaev, Evgeny I.] RAS, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Dailey, Christopher; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Dailey, Christopher; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AB Groningen, Netherlands; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Sunnybrook Res Inst, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Kapitonov, Vladimir V.; Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kittler, Ellen] Univ Massachusetts, Sch Med, Program Mol Med, Shrewsbury, MA 01545 USA; [Solovyev, Victor V.] Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England; [Kondrashov, Fyodor A.] ICREA, Barcelona 08010, Spain; [Rogaev, Evgeny I.] RAS, Ctr Brain Neurobiol & Neurogenet, Novosibirsk 630090, Russia; [Rogaev, Evgeny I.] RAS, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Rogaev, Evgeny I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; Auburn University System; Auburn University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Groningen; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Massachusetts System; University of London; Royal Holloway University London; ICREA; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Lomonosov Moscow State University	Moroz, LL (corresponding author), Univ Florida, Whitney Lab Marine Biosci, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.	moroz@whitney.ufl.edu; Evgeny.Rogaev@umassmed.edu; abkohn@msn.com	Berezikov, Eugene/D-3363-2013; Buckley, Katherine Michele/AAY-8151-2021; Grigorenko, Anastasia/AAN-8226-2020; Kondrashov, Fyodor Alexeevich/H-6331-2015; Rogaev, Evgeny/AAN-7662-2020; Sweedler, Jonathan V/A-9405-2009; Gusev, Fedor/AAN-9347-2020; Solovyev, Victor/C-4614-2013	Berezikov, Eugene/0000-0002-1145-2884; Buckley, Katherine Michele/0000-0002-6585-8943; Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Sweedler, Jonathan V/0000-0003-3107-9922; Gusev, Fedor/0000-0001-9859-4721; Povolotskaya, Inna/0000-0001-6621-232X; Moroz, Leonid/0000-0002-1333-3176; Ptitsyn, Andrey/0000-0003-1196-8757; Norekian, Tigran/0000-0002-7022-1381; Solovyev, Victor/0000-0001-8885-493X	NSF [NSF-0744649, CNS-0821622, CHE-1111705]; NIH [1R01GM097502, R01MH097062, R21RR025699, 5R21DA030118, P30 DA018310, R01 AG029360, 1S10RR027052]; NASA [NNX13AJ31G]; NSERC [458115, 211598]; University of Florida Opportunity Funds/McKnight Brain Research; Florida Biodiversity Institute; Rostock Inc.; Russian Federation Government [14.B25.31.0033, 220]; HHMI [55007424]; EMBO; MINECO [BFU2012-31329, Sev-2012-0208]; AU Marine Biology Program [117]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027052, R21RR025699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R21DA030118] Funding Source: NIH RePORTER; Direct For Biological Sciences [1146575, 1156528] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1111705] Funding Source: National Science Foundation; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Florida Opportunity Funds/McKnight Brain Research; Florida Biodiversity Institute; Rostock Inc.; Russian Federation Government; HHMI(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); MINECO(Spanish Government); AU Marine Biology Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); ICREA(ICREA)	We thank Friday Harbor Laboratories for facilities during animal collection and Marine Genomics apprenticeships (L. L. M., B.J.S.); E. Dabe, G. Winters, J. Netherton, N. Churches and C. Bostwick for help with animal, tissue, in situ, RNA and DNA assays; and X.-X. Tan, F. Lu and T. Tyazelova for sequencing. We thank F. Nivens for videos and P. L. Williams for database support. This work was supported by NSF (NSF-0744649 and NSF CNS-0821622 to L. L. M.; NSF CHE-1111705 to J. V. S.), NIH (1R01GM097502, R01MH097062, R21RR025699 and 5R21DA030118 to L. L. M.; P30 DA018310 to J. V. S.; R01 AG029360 and 1S10RR027052 to E. I. R.), NASA NNX13AJ31G (to K. M. H., L. L. M. and K. M. K.), NSERC 458115 and 211598 (J. P. R.), University of Florida Opportunity Funds/McKnight Brain Research and Florida Biodiversity Institute (L. L. M.), Rostock Inc./A.V. Chikunov (E. I. R.), grant from Russian Federation Government 14.B25.31.0033 (Resolution No. 220) (E. I. R.). F. A. K., I. S. P. and R. D. were supported by HHMI (55007424), EMBO and MINECO (BFU2012-31329 and Sev-2012-0208). Contributions of AU Marine Biology Program 117 and Molette laboratory 22.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dzik J, 2002, J MORPHOL, V252, P315, DOI 10.1002/jmor.1108; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Fuller RR, 1998, NEURON, V20, P173, DOI 10.1016/S0896-6273(00)80446-8; Girardo D. O., 2012, INT COMP BIOL; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hernandez-Nicaise M.-L., 1991, P359; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapitonov VV, 2009, GENE, V448, P207, DOI 10.1016/j.gene.2009.07.019; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kohn AB, 2013, METHODS MOL BIOL, V1048, P247, DOI 10.1007/978-1-62703-556-9_18; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Lapainis T, 2009, ANAL CHEM, V81, P5858, DOI 10.1021/ac900936g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Moroz LL, 2012, ACTA BIOL HUNG, V63, P3, DOI 10.1556/ABiol.63.2012.Suppl.2.1; Moroz L. L., METHODS MOL IN PRESS; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Moroz LL, 2013, METHODS MOL BIOL, V1048, P323, DOI 10.1007/978-1-62703-556-9_21; Moroz LL, 2009, BRAIN BEHAV EVOLUT, V74, P177, DOI 10.1159/000258665; Nemes P, 2011, ANAL CHEM, V83, P6810, DOI 10.1021/ac2015855; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; Palczewski K, 2013, ANNU REV NEUROSCI, V36, P139, DOI 10.1146/annurev-neuro-062012-170313; Panchin YV, 2005, J EXP BIOL, V208, P1415, DOI 10.1242/jeb.01547; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pennisi E, 2013, SCIENCE, V339, P390, DOI [10.1126/science.339.6118.390, 10.1126/science.339.6118.391-a]; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Ptitsyn A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S5; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Solovyev VV., 2007, HDB STAT GENETICS, P1616, DOI DOI 10.1002/9780470061619.CH4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Tamm S.L., 1982, P266; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang F, 2011, EVOL DEV, V13, P408, DOI 10.1111/j.1525-142X.2011.00499.x; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	69	418	430	3	255	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					109	+		10.1038/nature13400	http://dx.doi.org/10.1038/nature13400			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24847885	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000336768900038
J	Chalker, DL				Chalker, Douglas L.			Keeping one's sex	NATURE			English	Editorial Material							C. ELEGANS; EPIGENETIC MEMORY; GERMLINE; PIRNAS; TRANSCRIPTS; GENOME; RNA		Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Chalker, DL (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	dchalker@wustl.edu		Chalker, Douglas/0000-0002-0285-3344				Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Singh DP, 2014, NATURE, V509, P447, DOI 10.1038/nature13318; SONNEBORN TM, 1947, ADV GENET, V1, P263, DOI 10.1016/S0065-2660(08)60488-5	9	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					430	431		10.1038/nature13333	http://dx.doi.org/10.1038/nature13333			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24805241				2022-12-28	WOS:000336126000023
J	Roizenblatt, S; Rosa, NS				Roizenblatt, Suely; Rosa, Nilton Salles			Herpes Zoster Involving the S1 Dermatome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roizenblatt, Suely] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Rosa, Nilton Salles] Hosp Nove de Julho, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Roizenblatt, S (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	suely.roizenblatt@unifesp.br	Roizenblatt, Suely/J-6538-2012	Roizenblatt, Suely/0000-0003-3474-4481					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					2031	2031		10.1056/NEJMicm1311499	http://dx.doi.org/10.1056/NEJMicm1311499			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24849086				2022-12-28	WOS:000336125500011
J	Coombes, R				Coombes, Rebecca			Cannabis regulation: high time for change?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Coombes, R (corresponding author), BMJ, London, England.	rcoombes@bmj.com						ALICE RAP, 2014, 5 ALICE RAP; [Anonymous], TREATM EP DAT SETS T; [Anonymous], 2014, AMSTERDAM HERAL 0127; David Remnick, 2014, NEW YORKER; Drugscope, CANN LAWS; Transform, REG CANN PRACT GUID; Transform, 2013, UK SUPP CANN LAW REF; United Nations Office on Drugs and Crime, WORLD DRUG REP 2012; Vindenes V, 2013, FORENSIC SCI INT, V226, P197, DOI 10.1016/j.forsciint.2013.01.017	9	6	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2014	348								g3382	10.1136/bmj.g3382	http://dx.doi.org/10.1136/bmj.g3382			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZX	24850823				2022-12-28	WOS:000336429200004
J	Yeh, JM; Nohria, A; Diller, L				Yeh, Jennifer M.; Nohria, Anju; Diller, Lisa			Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors: A Model-Based Estimation of the Clinical and Economic Effects	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; MEDICAL DECISION-MAKING; LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; LATE MORTALITY; SYSTOLIC DYSFUNCTION; ADOLESCENT CANCER; ADULT SURVIVORS; UNITED-STATES; TASK-FORCE	Background: Childhood cancer survivors treated with cardiotoxic therapies are recommended to have routine cardiac assessment every 1 to 5 years, but the long-term benefits are uncertain. Objective: To estimate the cost-effectiveness of routine cardiac assessment to detect asymptomatic left ventricular dysfunction and of angiotensin-converting enzyme inhibitor and beta-blocker treatment to reduce congestive heart failure (CHF) incidence in childhood cancer survivors. Design: Simulation model. Data Sources: Literature, including data from the Childhood Cancer Survivor Study. Target Population: Childhood cancer survivors. Time Horizon: Lifetime. Perspective: Societal. Intervention: Interval-based echocardiography assessment every 1, 2, 5, or 10 years, with subsequent angiotensin-converting enzyme inhibitor or beta-blocker treatment for patients with positive test results. Outcome Measures: Lifetime risk for systolic CHF, lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The lifetime risk for systolic CHF among 5-year childhood cancer survivors aged 15 years was 18.8% without routine cardiac assessment (average age at onset, 58.8 years). Routine echocardiography reduced lifetime risk for CHF by 2.3% (with assessment every 10 years) to 8.7% (annual assessment). The ICER for assessment every 10 years was $111600 per quality-adjusted life-year (QALY) compared with no assessment. Assessment every 5 years had an ICER of $117900 per QALY, and ICERs for more frequent assessment exceeded $165000 per QALY. Results of Sensitivity Analysis: Results were sensitive to treatment effectiveness, absolute excess risk for CHF, and asymptomatic left ventricular dysfunction asymptomatic period. The probability that assessment every 10 or 5 years was preferred at a $100000-per-QALY threshold was 0.33 for the overall cohort. Limitation: Treatment effectiveness was based on adult data. Conclusion: Current recommendations for cardiac assessment may reduce CHF incidence, but less frequent assessment may be preferable.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health	Yeh, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	jyeh@hsph.harvard.edu	Nohria, Anju/AAD-4925-2022		National Cancer Institute [K07-CA143044]; NATIONAL CANCER INSTITUTE [K07CA143044] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Yeh was supported by the National Cancer Institute (grant K07-CA143044).	[Anonymous], 2013, TRUV HLTH AN; Armstrong GT, 2012, J CLIN ONCOL, V30, P2876, DOI 10.1200/JCO.2011.40.3584; BECK JR, 1983, MED DECIS MAKING, V3, P3, DOI 10.1177/0272989X8300300102; Bureau of Labor Statistics, 2012, OCC EMPL WAG; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Centers for Disease Control and Prevention, 2009, CDCP SERIES, V20; Centers for Medicare and Medicaid Services, 2012, RES STAT DAT SYST; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356; Exner DV, 1999, J AM COLL CARDIOL, V33, P916, DOI 10.1016/S0735-1097(98)00675-5; Foerster Susan R, 2008, Paediatr Drugs, V10, P125, DOI 10.2165/00148581-200810020-00007; Gohler A, 2009, VALUE HEALTH, V12, P185, DOI 10.1111/j.1524-4733.2008.00425.x; Gold MR, 1996, COST EFFECTIVENESS H; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heidenreich PA, 2004, J AM COLL CARDIOL, V43, P1019, DOI 10.1016/j.jacc.2003.10.043; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Lawless SCW, 2007, PEDIATR BLOOD CANCER, V48, P333, DOI 10.1002/pbc.20723; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Lipshultz SE, 2004, J CLIN ONCOL, V22, P769, DOI 10.1200/JCO.2004.12.937; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Lipshultz SE, 2013, CIRCULATION, V128, P1927, DOI 10.1161/CIR.0b013e3182a88099; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; National Heart Lung and Blood Institute, 2006, BLOOD; Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Sieswerda E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008011.pub2; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeh JM, 2010, ANN INTERN MED, V152, P409, DOI 10.7326/0003-4819-152-7-201004060-00005; Yusuf S, 2000, NEW ENGL J MED, V342, P145	45	67	67	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					661	+		10.7326/M13-2266	http://dx.doi.org/10.7326/M13-2266			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842413	Green Accepted			2022-12-28	WOS:000337347100013
J	Chalmers, I				Chalmers, Iain			The development of fair tests of treatments	LANCET			English	Editorial Material									James Lind Initiat, Oxford OX2 7LG, England		Chalmers, I (corresponding author), James Lind Initiat, Oxford OX2 7LG, England.	ichalmers@jameslind.net						Dickersin K, 2010, JLL B COMMENTARIES H; Hill AB, 1960, CONTROLLED CLIN TRIA; Opinel A, 2013, INT J EPIDEMIOL, V42, P662, DOI 10.1093/ije/dyr162; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Tibi S, 2005, JLL B COMMENTARIES H; Trohler U., 2000, IMPROVE EVIDENCE MED	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1713	1714		10.1016/S0140-6736(14)60821-7	http://dx.doi.org/10.1016/S0140-6736(14)60821-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24843877				2022-12-28	WOS:000336267300013
J	Tasker, SZ; Standley, EA; Jamison, TF				Tasker, Sarah Z.; Standley, Eric A.; Jamison, Timothy F.			Recent advances in homogeneous nickel catalysis	NATURE			English	Review							CROSS-COUPLING REACTIONS; SECONDARY ALKYL-HALIDES; C-O BOND; BIDENTATE-CHELATION ASSISTANCE; ARYL GRIGNARD-REAGENTS; OXIDATIVE-ADDITION; HECK REACTIONS; BORONIC ACIDS; STEREOSPECIFIC FORMATION; ORGANOZINC REAGENTS	Tremendous advances have been made in nickel catalysis over the past decade. Several key properties of nickel, such as facile oxidative addition and ready access to multiple oxidation states, have allowed the development of a broad range of innovative reactions. In recent years, these properties have been increasingly understood and used to perform transformations long considered exceptionally challenging. Here we discuss some of the most recent and significant developments in homogeneous nickel catalysis, with an emphasis on both synthetic outcome and mechanism.	[Tasker, Sarah Z.; Standley, Eric A.; Jamison, Timothy F.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jamison, TF (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	tfj@mit.edu		Tasker, Sarah/0000-0003-2315-6983	NIGMS [GM62755]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063755] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS (GM62755) and the NSF (Graduate Research Fellowship to S.Z.T. and E.A.S.).	Aihara Y, 2014, J AM CHEM SOC, V136, P898, DOI 10.1021/ja411715v; Aihara Y, 2013, J AM CHEM SOC, V135, P5308, DOI 10.1021/ja401344e; Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Amaike K, 2012, J AM CHEM SOC, V134, P13573, DOI 10.1021/ja306062c; Antoft-Finch A, 2009, J AM CHEM SOC, V131, P17750, DOI 10.1021/ja907700e; Beaver MG, 2011, ORG LETT, V13, P4140, DOI 10.1021/ol201702a; Biswas S, 2013, J AM CHEM SOC, V135, P16192, DOI 10.1021/ja407589e; Breitenfeld J, 2013, J AM CHEM SOC, V135, P12004, DOI 10.1021/ja4051923; CABRI W, 1995, ACCOUNTS CHEM RES, V28, P2, DOI 10.1021/ar00049a001; Cherney AH, 2013, J AM CHEM SOC, V135, P7442, DOI 10.1021/ja402922w; CHUIT C, 1977, J ORGANOMET CHEM, V127, P371, DOI 10.1016/S0022-328X(00)98073-2; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Cornella J, 2013, J AM CHEM SOC, V135, P1997, DOI 10.1021/ja311940s; Correa A, 2014, J AM CHEM SOC, V136, P1062, DOI 10.1021/ja410883p; Csok Z, 2008, J AM CHEM SOC, V130, P8156, DOI 10.1021/ja8025938; Dankwardt JW, 2004, ANGEW CHEM INT EDIT, V43, P2428, DOI 10.1002/anie.200453765; Devasagayaraj A, 1995, ANGEW CHEM INT EDIT, V34, P2723; Diederich F., 1998, METAL CATALYZED CROS; Dudnik AS, 2012, J AM CHEM SOC, V134, P10693, DOI 10.1021/ja304068t; Ehle AR, 2012, ORG LETT, V14, P1202, DOI 10.1021/ol203322v; Everson DA, 2012, J AM CHEM SOC, V134, P6146, DOI 10.1021/ja301769r; Everson DA, 2010, J AM CHEM SOC, V132, P920, DOI 10.1021/ja9093956; Firmansjah L, 2007, J AM CHEM SOC, V129, P11340, DOI 10.1021/ja075245r; Fischer C, 2005, J AM CHEM SOC, V127, P4594, DOI 10.1021/ja0506509; Frisch AC, 2005, ANGEW CHEM INT EDIT, V44, P674, DOI 10.1002/anie.200461432; Garcia JJ, 2002, J AM CHEM SOC, V124, P9547, DOI 10.1021/ja0204933; Ge SZ, 2012, ANGEW CHEM INT EDIT, V51, P12837, DOI 10.1002/anie.201207428; Giovannini R, 1998, J AM CHEM SOC, V120, P11186, DOI 10.1021/ja982520o; Gogsig TM, 2012, J AM CHEM SOC, V134, P443, DOI 10.1021/ja2084509; Gong HG, 2008, J AM CHEM SOC, V130, P12177, DOI 10.1021/ja8041564; Greene MA, 2012, ORG LETT, V14, P4293, DOI 10.1021/ol300891k; Guan BT, 2008, J AM CHEM SOC, V130, P14468, DOI 10.1021/ja8056503; Guan BT, 2008, J AM CHEM SOC, V130, P3268, DOI 10.1021/ja710944j; Harris MR, 2013, J AM CHEM SOC, V135, P3303, DOI 10.1021/ja311783k; Herath A, 2008, J AM CHEM SOC, V130, P469, DOI 10.1021/ja0781846; Hie L, 2012, ORG LETT, V14, P4182, DOI 10.1021/ol301847m; Hills ID, 2003, ANGEW CHEM INT EDIT, V42, P5749, DOI 10.1002/anie.200352858; Hu XL, 2011, CHEM SCI, V2, P1867, DOI 10.1039/c1sc00368b; Huang CY, 2012, J AM CHEM SOC, V134, P9541, DOI 10.1021/ja3013825; ISHIYAMA T, 1992, CHEM LETT, P691, DOI 10.1246/cl.1992.691; Jones GD, 2006, J AM CHEM SOC, V128, P13175, DOI 10.1021/ja063334i; KLEIMAN JP, 1963, J AM CHEM SOC, V85, P1544, DOI 10.1021/ja00893a040; Kocienski P, 1989, SYNLETT, P52; Lanni EL, 2009, J AM CHEM SOC, V131, P16573, DOI 10.1021/ja904197q; Leon T, 2013, J AM CHEM SOC, V135, P1221, DOI 10.1021/ja311045f; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; Li BJ, 2008, ANGEW CHEM INT EDIT, V47, P10124, DOI 10.1002/anie.200803814; Lin BL, 2004, ORGANOMETALLICS, V23, P2114, DOI 10.1021/om034067h; Lin BL, 2002, J AM CHEM SOC, V124, P2890, DOI 10.1021/ja017652n; Lipschutz MI, 2013, J AM CHEM SOC, V135, P15298, DOI 10.1021/ja408151h; Liu P, 2011, J AM CHEM SOC, V133, P6956, DOI 10.1021/ja202007s; Maity P, 2013, J AM CHEM SOC, V135, P280, DOI 10.1021/ja3089422; Malik HA, 2010, J AM CHEM SOC, V132, P6304, DOI 10.1021/ja102262v; Massera C, 2003, ORGANOMETALLICS, V22, P2758, DOI 10.1021/om0301637; Matsubara R, 2011, J AM CHEM SOC, V133, P19020, DOI 10.1021/ja209235d; Mesganaw T, 2013, ORG PROCESS RES DEV, V17, P29, DOI 10.1021/op300236f; Milburn RR, 2004, ANGEW CHEM INT EDIT, V43, P888, DOI 10.1002/anie.200352633; Miller KM, 2004, J AM CHEM SOC, V126, P15342, DOI 10.1021/ja0446799; Montgomery J, 2004, ANGEW CHEM INT EDIT, V43, P3890, DOI 10.1002/anie.200300634; Moslin RM, 2006, ORG LETT, V8, P455, DOI 10.1021/ol052719n; Moslin RM, 2007, CHEM COMMUN, P4441, DOI 10.1039/b707737h; Muto K, 2013, J AM CHEM SOC, V135, P16384, DOI 10.1021/ja409803x; Muto K, 2012, J AM CHEM SOC, V134, P169, DOI 10.1021/ja210249h; Netherton MR, 2004, ADV SYNTH CATAL, V346, P1525, DOI 10.1002/adsc.200404223; Ng SS, 2008, PURE APPL CHEM, V80, P929, DOI 10.1351/pac200880050929; Nielsen DK, 2013, J AM CHEM SOC, V135, P13605, DOI 10.1021/ja4076716; OConnor C. T., 1990, CATAL TODAY, V6, P329, DOI DOI 10.1016/0920-5861(90)85008-C; Oestreich M., 2009, MIZOROKI HECK REACTI; Powell DA, 2005, J AM CHEM SOC, V127, P510, DOI 10.1021/ja0436300; Powell DA, 2004, J AM CHEM SOC, V126, P7788, DOI 10.1021/ja047433c; Quasdorf KW, 2008, J AM CHEM SOC, V130, P14422, DOI 10.1021/ja806244b; Quasdorf KW, 2011, J AM CHEM SOC, V133, P6352, DOI 10.1021/ja200398c; Ramgren SD, 2013, ORG LETT, V15, P3950, DOI 10.1021/ol401727y; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Rudolph A, 2009, ANGEW CHEM INT EDIT, V48, P2656, DOI 10.1002/anie.200803611; Saito B, 2007, J AM CHEM SOC, V129, P9602, DOI 10.1021/ja074008l; SENGUPTA S, 1992, J ORG CHEM, V57, P4066, DOI 10.1021/jo00041a004; Shiota H, 2011, J AM CHEM SOC, V133, P14952, DOI 10.1021/ja206850s; Son S, 2008, J AM CHEM SOC, V130, P2756, DOI 10.1021/ja800103z; Standley EA, 2013, J AM CHEM SOC, V135, P1585, DOI 10.1021/ja3116718; Tamaru Y, 2005, MODERN ORGANONICKEL CHEMISTRY, P1; Tasker SZ, 2014, ANGEW CHEM INT EDIT, V53, P1858, DOI 10.1002/anie.201308391; Taylor BLH, 2011, J AM CHEM SOC, V133, P389, DOI 10.1021/ja108547u; Terao J, 2002, J AM CHEM SOC, V124, P4222, DOI 10.1021/ja025828v; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Tobisu M, 2012, TETRAHEDRON, V68, P5157, DOI 10.1016/j.tet.2012.04.005; Tobisu M, 2011, J AM CHEM SOC, V133, P19505, DOI 10.1021/ja207759e; TSOU TT, 1979, J AM CHEM SOC, V101, P6319, DOI 10.1021/ja00515a028; Vechorkin O, 2009, J AM CHEM SOC, V131, P12078, DOI 10.1021/ja906040t; Vechorkin O, 2009, ANGEW CHEM INT EDIT, V48, P2937, DOI 10.1002/anie.200806138; WILKE G, 1988, ANGEW CHEM INT EDIT, V27, P185, DOI 10.1002/anie.198801851; Yamaguchi J, 2013, EUR J ORG CHEM, V2013, P19, DOI 10.1002/ejoc.201200914; Yu DG, 2012, J AM CHEM SOC, V134, P14638, DOI 10.1021/ja307045r; Yu DG, 2011, ANGEW CHEM INT EDIT, V50, P7097, DOI 10.1002/anie.201101461; Yu DG, 2010, ANGEW CHEM INT EDIT, V49, P4566, DOI 10.1002/anie.200907359; Zhou J, 2004, J AM CHEM SOC, V126, P1340, DOI 10.1021/ja039889k; Zhou JR, 2003, J AM CHEM SOC, V125, P14726, DOI 10.1021/ja0389366; Zhou Q, 2013, J AM CHEM SOC, V135, P3307, DOI 10.1021/ja312087x; Zultanski SL, 2013, J AM CHEM SOC, V135, P624, DOI 10.1021/ja311669p; Zultanski SL, 2011, J AM CHEM SOC, V133, P15362, DOI 10.1021/ja2079515	100	1379	1391	36	714	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					299	309		10.1038/nature13274	http://dx.doi.org/10.1038/nature13274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828188	Green Submitted, Green Accepted			2022-12-28	WOS:000336121200027
J	Katsimpardi, L; Litterman, NK; Schein, PA; Miller, CM; Loffredo, FS; Wojtkiewicz, GR; Chen, JW; Lee, RT; Wagers, AJ; Rubin, LL				Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Wojtkiewicz, Gregory R.; Chen, John W.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.			Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; DENTATE GYRUS; ADULT; PROLIFERATION; DIFFERENTIATION; EXPRESSION; HIPPOCAMPUS; MICE	In the adult central nervous system, the vasculature of the neurogenic niche regulates neural stem cell behavior by providing circulating and secreted factors. Age-related decline of neurogenesis and cognitive function is associated with reduced blood flow and decreased numbers of neural stem cells. Therefore, restoring the functionality of the niche should counteract some of the negative effects of aging. We show that factors found in young blood induce vascular remodeling, culminating in increased neurogenesis and improved olfactory discrimination in aging mice. Further, we show that GDF11 alone can improve the cerebral vasculature and enhance neurogenesis. The identification of factors that slow the age-dependent deterioration of the neurogenic niche in mice may constitute the basis for new methods of treating age-related neurodegenerative and neurovascular diseases.	[Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Katsimpardi, Lida; Litterman, Nadia K.; Schein, Pamela A.; Miller, Christine M.; Loffredo, Francesco S.; Lee, Richard T.; Wagers, Amy J.; Rubin, Lee L.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Miller, Christine M.; Wagers, Amy J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, Boston, MA 02115 USA; [Miller, Christine M.; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Loffredo, Francesco S.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Harvard Univ, Sch Med, Ctr Syst Biol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Katsimpardi, L (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lida_katsimpardi@harvard.edu; lee_rubin@harvard.edu	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019; Wojtkiewicz, Gregory/L-3660-2018	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Lee, Richard/0000-0003-4687-1381; Wojtkiewicz, Gregory/0000-0002-3148-8411; Rubin, Lee/0000-0002-8658-841X	Ellison Medical Foundation; GlaxoSmithKline; Harvard Stem Cell Institute; NIH [R01 AG032977 1R01 AG040019, 1R01 AG033053, 1DP2 OD004345, 5U01 HL100402, R01NS070835, R01NS072167]; Paul F. Glenn Foundation for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072167, R01NS070835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032977, R01AG040019, R01AG033053] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); GlaxoSmithKline(GlaxoSmithKline); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. McGillivray and D. Faria at the HSCRB Histology Core for providing help with sectioning and D. Smith and B. Gotze at the HCBI for providing microscope facilities. We also thank W. Stallcup for providing the anti-NG2 antibody, C. Bonal for technical help and J. LaLonde for editorial assistance. This work was supported by a Senior Scholar in Aging Award from The Ellison Medical Foundation to L. L. R.; awards from GlaxoSmithKline and the Harvard Stem Cell Institute to L. L. R.; NIH (R01 AG032977 1R01 AG040019) to R. T. L.; and the Paul F. Glenn Foundation for Medical Research, NIH (1R01 AG033053, 1DP2 OD004345, and 5U01 HL100402), and Harvard Stem Cell Institute to A. J. W. Additional data are in the Supplement. J. C. was funded by NIH R01NS070835 and R01NS072167. L. L. R., A. J. W., R. T. L., and L. K. are inventors on a U.S. patent application filed by Harvard University and Brigham and Women's Hospital entitled "Methods and Compositions for Increasing Neurogenesis and Angiogenesis" (61/833, 813).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Balabanov R, 1998, J NEUROSCI RES, V53, P637, DOI 10.1002/(SICI)1097-4547(19980915)53:6<637::AID-JNR1>3.0.CO;2-6; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Grady CL, 1998, NEUROIMAGE, V8, P409, DOI 10.1006/nimg.1998.0376; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Matarredona ER, 2005, BRAIN RES REV, V49, P355, DOI 10.1016/j.brainresrev.2005.01.001; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Reed May J, 2004, Sci Aging Knowledge Environ, V2004, ppe7, DOI 10.1126/sageke.2004.7.pe7; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tropepe V, 1997, J NEUROSCI, V17, P7850; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Witt R. M., 2009, JOVE-J VIS EXP, V28, P949; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu P, 2008, NEUROBIOL AGING, V29, P1502, DOI 10.1016/j.neurobiolaging.2007.03.028	32	630	677	4	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					630	634		10.1126/science.1251141	http://dx.doi.org/10.1126/science.1251141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24797482	Green Accepted			2022-12-28	WOS:000335537400043
J	Alpatov, R; Lesch, BJ; Nakamoto-Kinoshita, M; Blanco, A; Chen, SZ; Stutzer, A; Armache, KJ; Simon, MD; Xu, C; Ali, M; Murn, J; Prisic, S; Kutateladze, TG; Vakoc, CR; Min, JR; Kingston, RE; Fischle, W; Warren, ST; Page, DC; Shi, Y				Alpatov, Roman; Lesch, Bluma J.; Nakamoto-Kinoshita, Mika; Blanco, Andres; Chen, Shuzhen; Stuetzer, Alexandra; Armache, Karim J.; Simon, Matthew D.; Xu, Chao; Ali, Muzaffar; Murn, Jernej; Prisic, Sladjana; Kutateladze, Tatiana G.; Vakoc, Christopher R.; Min, Jinrong; Kingston, Robert E.; Fischle, Wolfgang; Warren, Stephen T.; Page, David C.; Shi, Yang			A Chromatin-Dependent Role of the Fragile X Mental Retardation Protein FMRP in the DNA Damage Response	CELL			English	Article							H3K79 METHYLATION; MICE LACKING; DYNAMICS; TARGETS; BRCA1; SURVIVAL; MUTATION; DOMAIN; TUDOR	Fragile X syndrome, a common form of inherited intellectual disability, is caused by loss of the fragile X mental retardation protein FMRP. FMRP is present predominantly in the cytoplasm, where it regulates translation of proteins that are important for synaptic function. We identify FMRP as a chromatin-binding protein that functions in the DNA damage response (DDR). Specifically, we show that FMRP binds chromatin through its tandem Tudor (Agenet) domain in vitro and associates with chromatin in vivo. We also demonstrate that FMRP participates in the DDR in a chromatin-binding-dependent manner. The DDR machinery is known to play important roles in developmental processes such as gametogenesis. We show that FMRP occupies meiotic chromosomes and regulates the dynamics of the DDR machinery during mouse spermatogenesis. These findings suggest that nuclear FMRP regulates genomic stability at the chromatin interface and may impact gametogenesis and some developmental aspects of fragile X syndrome.	[Alpatov, Roman; Blanco, Andres; Chen, Shuzhen; Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Alpatov, Roman; Blanco, Andres; Chen, Shuzhen; Murn, Jernej; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lesch, Bluma J.; Page, David C.] MIT, Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Lesch, Bluma J.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Nakamoto-Kinoshita, Mika; Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Stuetzer, Alexandra; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Armache, Karim J.; Simon, Matthew D.; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Armache, Karim J.; Simon, Matthew D.; Kingston, Robert E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Xu, Chao; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Xu, Chao; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Ali, Muzaffar; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Prisic, Sladjana] Harvard Univ, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Prisic, Sladjana] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Emory University; Emory University; Emory University; Max Planck Society; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Cold Spring Harbor Laboratory	Shi, Y (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Murn, Jernej/ABD-3624-2020; Simon, Matthew/ABF-9127-2020; Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Blanco, M. Andres/0000-0003-4404-2301; Vakoc, Christopher/0000-0002-1158-7180; Simon, Matthew/0000-0001-7423-5265; Prisic, Sladjana/0000-0003-3137-4358; Kutateladze, Tatiana/0000-0001-7375-6990	NIH [NCI118487, MH096066, HD020521, HD024064]; National Research Training [AG00222-7]; NRSA [HD075591]; Hope Funds for Cancer Research postdoctoral fellowship; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075591, P30HD018655, P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020521, R37HD020521] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043901, R01GM101664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102690, R01MH096066, R01MH080129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Training; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Funds for Cancer Research postdoctoral fellowship; HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Elledge and B. Yankner for advice and helpful suggestions; A. Ciccia for help with DNA damage experiments; D. Reinberg and P. Voigt for help with nucleosomal preparations; J. Griesbach, A. Lazic, and S. Duhr from NanoTemper Technologies, and K. Yamagata, Y. Zheng, and X. Shang for help with microscale thermophoresis and kinetic data analysis; and E. Greer, A. Alekseyenko, and G. Shanower for logistical support. We also thank J. Mowrey, S. Ceman, S. Keeney, and U. Fischer for reagents; M. Bear for Fmr1 KO mice; S. Armstrong for Dot1L<SUP>fl/fl</SUP> mice; K. Luger, G. Narlikar, S. Ceman, and U. Fischer for helpful comments; and M. Goodheart, D. Cooper, E. Derby, L. Elow, K. Igarashi, L. Kolinski, L. Pomponi, and M. Schuck for technical assistance. We also thank our collaborators who contributed to this project but whose work was not included in the manuscript: B. Ren, U. Wagner, and the Ren laboratory for FMRP genome-wide analysis; K. Zhao and his group for H3K79me2 genome-wide analysis; A. Vaquero for Suv39h double-null MEFs; and G. Schotta and T. Jenuwein for Suv4-20h double null MEFs. This work was supported by NIH grants NCI118487 and MH096066 to Y.S., National Research Training Grant AG00222-7 to R.A., NRSA grant HD075591 and a Hope Funds for Cancer Research postdoctoral fellowship to B.J.L., and HHMI funding to D.C.P., and in part by NIH grants HD020521 and HD024064 to S.T.W.Y.S. is an American Cancer Society Research Professor, and is a cofounder of Constellation Pharmaceuticals and a member of its scientific advisory board.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Cabart P, 2004, ONCOGENE, V23, P5316, DOI 10.1038/sj.onc.1207684; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Garcia-Cruz R, 2009, REPROD BIOMED ONLINE, V18, P37, DOI 10.1016/S1472-6483(10)60422-1; Isabelle M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-22; Jenkins EC, 2008, AM J MED GENET A, V146A, P1543, DOI 10.1002/ajmg.a.32342; Jeon SJ, 2012, J NEUROCHEM, V123, P226, DOI 10.1111/j.1471-4159.2012.07886.x; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; JOHANNISSON R, 1987, HUM GENET, V76, P141, DOI 10.1007/BF00284911; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Liu W, 2012, HUM MOL GENET, V21, P4655, DOI 10.1093/hmg/dds307; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ontoso D, 2014, CHROMOSOMA, V123, P147, DOI 10.1007/s00412-013-0438-5; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; Sabra M, 2013, J CELL SCI, V126, P3664, DOI 10.1242/jcs.126003; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Tian H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.138; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	103	110	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					869	881		10.1016/j.cell.2014.03.040	http://dx.doi.org/10.1016/j.cell.2014.03.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813610	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000335765500015
J	Sandin, S; Lichtenstein, P; Kuja-Halkola, R; Larsson, H; Hultman, CM; Reichenberg, A				Sandin, Sven; Lichtenstein, Paul; Kuja-Halkola, Ralf; Larsson, Henrik; Hultman, Christina M.; Reichenberg, Abraham			The Familial Risk of Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERVASIVE DEVELOPMENTAL DISORDER; SPECTRUM DISORDERS; ENVIRONMENTAL-FACTORS; EPIDEMIOLOGIC SURVEY; RECURRENCE RISK; TWIN; REGISTER; SCHIZOPHRENIA; HERITABILITY; GENETICS	IMPORTANCE Autism spectrum disorder (ASD) aggregates in families, but the individual risk and to what extent this is caused by genetic factors or shared or nonshared environmental factors remains OBJECTIVE To provide estimates of familial aggregation and heritability of ASD. DESIGN, SETTING, AND PARTICIPANTS A population-based cohort including 2 049 973 Swedish children born 1982 through 2006. We identified 37 570 twin pairs, 2 642 064 full sibling pairs, 432 281 maternal and 445 531 paternal half sibling pairs, and 5 799 875 cousin pairs. Diagnoses of ASD to December 31, 2009 were ascertained. MAIN OUTCOMES AND MEASURES The relative recurrence risk (RRR) measures familial aggregation of disease. The RRR is the relative risk of autism in a participant with a sibling or cousin who has the diagnosis (exposed) compared with the risk in a participant with no diagnosed family member (unexposed). We calculated RRR for both ASD and autistic disorder adjusting for age, birth year, sex, parental psychiatric history, and parental age. We estimated how much of the probability of developing ASD can be related to genetic (additive and dominant) and environmental (shared and nonshared) factors. RESULTS In the sample, 14 516 children were diagnosed with ASD, of whom 5689 had autistic disorder. The RRR and rate per 100 000 person-years for ASD among monozygotic twins was estimated to be 153.0 (95% CI, 56.7-412.8; rate, 6274 for exposed vs 27 for unexposed); for dizygotic twins, 8.2 (95% CI, 3.7-18.1; rate, 805 for exposed vs 55 for unexposed); for full siblings, 10.3 (95% CI, 9.4-11.3; rate, 829 for exposed vs 49 for unexposed); for maternal half siblings, 3.3 (95% CI, 2.6-4.2; rate, 492 for exposed vs 94 for unexposed); for paternal half siblings, 2.9 (95% CI, 2.2-3.7; rate, 371 for exposed vs 85 for unexposed); and for cousins, 2.0 (95% CI, 1.8-2.2; rate, 155 for exposed vs 49 for unexposed). The RRR pattern was similar for autistic disorder but of slightly higher magnitude. We found support for a disease etiology including only additive genetic and nonshared environmental effects. The ASD heritability was estimated to be 0.50 (95% CI, 0.45-0.56) and the autistic disorder heritability was estimated to 0.54 (95% CI, 0.44-0.64). CONCLUSIONS AND RELEVANCE Among children born in Sweden, the individual risk of ASD and autistic disorder increased with increasing genetic relatedness. Heritability of ASD and autistic disorder were estimated to be approximately 50%. These findings may inform the counseling of families with affected children.	[Sandin, Sven; Lichtenstein, Paul; Kuja-Halkola, Ralf; Larsson, Henrik; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Sandin, Sven] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Reichenberg, Abraham] Ichan Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Reichenberg, Abraham] Ichan Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA; [Reichenberg, Abraham] Ichan Sch Med Mt Sinai, Seaver Autism Ctr, New York, NY USA; [Reichenberg, Abraham] Ichan Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA	Karolinska Institutet; University of London; King's College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sandin, S (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	sven.sandin@ki.se	Reichenberg, Abraham/GQB-1227-2022; Sandin, Sven/ABE-2959-2021; Sandin, Sven/L-5357-2015; Larsson, Henrik/GYD-5161-2022; Kuja-Halkola, Ralf/ABA-5061-2020	Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884; Kuja-Halkola, Ralf/0000-0002-3765-2067; lichtenstein, paul/0000-0003-3037-5287; Larsson, Henrik/0000-0002-6851-3297	National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences [HD073978]; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health [MH097849]; Beatrice and Samuel A. Seaver Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD073978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097849, R56MH097849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Beatrice and Samuel A. Seaver Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported, in part, by grants from the National Institutes of Health; grant HD073978 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, and National Institute of Neurological Disorders and Stroke; grant MH097849 from the National Institute of Mental Health; and by the Beatrice and Samuel A. Seaver Foundation.	Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Chudley AE, 1998, J DEV BEHAV PEDIATR, V19, P321, DOI 10.1097/00004703-199810000-00001; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gronborg TK, 2013, JAMA PEDIATR, V167, P947, DOI 10.1001/jamapediatrics.2013.2259; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hollander E, 2010, TXB AUTISM SPECTRUM; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lindstrom L, 2006, STAT MED, V25, P3110, DOI 10.1002/sim.2266; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Ronald A, 2011, MOL PSYCHIATR, V16, P1039, DOI 10.1038/mp.2010.82; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stone William S, 2011, N Am J Med Sci (Boston), V4, P124; Sumi S, 2006, J HUM GENET, V51, P518, DOI 10.1007/s10038-006-0392-7; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946	34	611	626	9	171	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1770	1777		10.1001/jama.2014.4144	http://dx.doi.org/10.1001/jama.2014.4144			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4IG	24794370	Green Accepted, Bronze			2022-12-28	WOS:000335382300022
J	Treves, A; Bruskotter, J				Treves, Adrian; Bruskotter, Jeremy			Tolerance for Predatory Wildlife	SCIENCE			English	Editorial Material							CARNIVORE CONSERVATION; WOLVES		[Treves, Adrian] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Bruskotter, Jeremy] Ohio State Univ, Sch Environment & Nat Resources, Columbus, OH 43210 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University	Treves, A (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.	atreves@wisc.edu	Treves, Adrian/P-3707-2018; Bruskotter, Jeremy T/B-3240-2012	Treves, Adrian/0000-0002-3052-4708; Bruskotter, Jeremy T/0000-0002-1782-7835				[Anonymous], 2013, FED REG, V78, P35664; Bruskotter JT, 2014, CONSERV LETT, V7, P401, DOI 10.1111/conl.12081; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Hazzah L, 2014, CONSERV BIOL, V28, P851, DOI 10.1111/cobi.12244; Hogberg J., 2014, THESIS U WISCONSIN; Karlsson J, 2011, ECOL SOC, V16; Liberg O., 2011, P ROY SOC LOND B BIO, V270, P91; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Slagle K, 2013, J WILDLIFE MANAGE, V77, P863, DOI 10.1002/jwmg.515; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	14	169	179	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					475	476		10.1126/science.1252690	http://dx.doi.org/10.1126/science.1252690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786065				2022-12-28	WOS:000335157700026
J	Gosavi, TD; Lo, YL				Gosavi, Tushar D.; Lo, Yew Long			Superficial Abdominal Reflex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gosavi, Tushar D.; Lo, Yew Long] Natl Neurosci Inst, Singapore, Singapore	National Neuroscience Institute (NNI)	Gosavi, TD (corresponding author), Natl Neurosci Inst, Singapore, Singapore.	tgosavi@hotmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					E29	E29		10.1056/NEJMicm1308153	http://dx.doi.org/10.1056/NEJMicm1308153			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24785227				2022-12-28	WOS:000335405200001
J	Gostin, LO; Sridhar, D				Gostin, Lawrence O.; Sridhar, Devi			Global Health and the Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFLUENZA PREPAREDNESS FRAMEWORK; CONVENTION; GOVERNANCE; ALCOHOL		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Gostin, Lawrence O.] World Hlth Org WHO Collaborating Ctr Publ Hlth La, Washington, DC USA; [Sridhar, Devi] Univ Edinburgh, WHO Collaborating Ctr Populat Hlth Res & Training, Edinburgh, Midlothian, Scotland; [Sridhar, Devi] Univ Oxford, Blavatnik Sch Govt, Oxford, England	Georgetown University; World Health Organization; University of Edinburgh; University of Oxford	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 574 McDonough Hall,600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Abbott KW, 2000, INT ORGAN, V54, P421, DOI 10.1162/002081800551280; [Anonymous], INT CONV EC SOC CULT; [Anonymous], 2010, INT STAT CLASS DIS, V2; [Anonymous], 1981, INT COD MARK BREAT M; [Anonymous], 2012, GLOB PROGR ERP IMPL; [Anonymous], 2008, PUBLIC HLTH LAW POWE; Becker AE, 2013, NEW ENGL J MED, V369, P66, DOI 10.1056/NEJMra1110827; Bollyky T, 2012, TRANSPACIFIC IPARTNE; Brandt AM, 2013, NEW ENGL J MED, V368, P2149, DOI 10.1056/NEJMp1305297; Cohen IG, 2013, GLOBALIZATION HLTH A; David PF., 2005, CHIN J INT LAW, V4, P325, DOI 10.1093/chinesejil/jmi029; Feldbaum H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000226; Fidler D., 2004, GOVERNANCE GLOBALIZA; Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960; Fidler DP, 2013, FOREIGN AFFAIRS; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Friedman EA, 2013, HEALTH HUM RIGHTS, V15, P71; Friedman Eric A, 2012, Health Hum Rights, V14, pE4; Garay J, 2012, GLOBAL HLTH GH GH EQ; Garrett L, 2012, FOREIGN AFFAIRS; Gostin LO, 2013, B WORLD HEALTH ORGAN, V91, P790, DOI 10.2471/BLT.12.114447; Gostin LO, 2014, GLOBAL HLTH; Implementation of the International Health Regulations, 2005, REP REV COMM FUNCT I; Joossens L, 2010, ADDICTION, V105, P1640, DOI 10.1111/j.1360-0443.2010.03018.x; Kamradt-Scott A, 2011, POLIT STUD-LONDON, V59, P831, DOI 10.1111/j.1467-9248.2011.00926.x; Kapczynski A, 2013, NEW ENGL J MED, V369, P497, DOI 10.1056/NEJMp1304400; Magnusson RS, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-2; McGrady B, 2012, PUBLIC HEALTH AND PLAIN PACKAGING OF CIGARETTES: LEGAL ISSUES, P173; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; Roemer R, 2005, AM J PUBLIC HEALTH, V95, P936, DOI 10.2105/AJPH.2003.025908; Rottingen JA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001219; Silberschmidt G, 2008, LANCET, V371, P1483, DOI 10.1016/S0140-6736(08)60634-0; Singh JA, 2007, LANCET, V370, P1686; Singh JA, 2007, LANCET, V370, P521, DOI 10.1016/S0140-6736(07)61236-7; Sridhar D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001312; Sridhar D, 2012, NATURE, V482, P302, DOI 10.1038/482302a; Sridhar D, 2011, JAMA-J AM MED ASSOC, V305, P1585, DOI 10.1001/jama.2011.418; Taylor AL, 2013, ADDICTION, V108, P450, DOI 10.1111/j.1360-0443.2012.03919.x; The Institute for Health Metrics and Evaluation, 2012, FIN GLOB HLTH END GO; United Nations Office of the High Commissioner for Human Rights, 2000, 22 SESS COMM EC SOC; Voon T, 2011, J INT ECON LAW, V14, P515, DOI 10.1093/jiel/jgr030; WHO, PART WHO FRAM CONV T; Zuniga Jose M., 2013, ADV HUMAN RIGHT HLTH	43	47	48	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1732	1740		10.1056/NEJMra1314094	http://dx.doi.org/10.1056/NEJMra1314094			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4QM	24785208	Bronze			2022-12-28	WOS:000335405200011
J	Kanthor, R				Kanthor, Rebecca			DIAGNOSTICS Detection drives defence	NATURE			English	Editorial Material																		Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Li ZL, 2013, INT J CLIN EXP MED, V6, P693; Lin CY, 2013, J AM SOC NEPHROL, V24, P2002, DOI 10.1681/ASN.2013040332; Liong M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2745; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e	5	8	9	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S14	S15		10.1038/509S14a	http://dx.doi.org/10.1038/509S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784424	Bronze			2022-12-28	WOS:000335199100008
J	Mohtadi, M; Prange, M; Oppo, DW; De Pol-Holz, R; Merkel, U; Zhang, X; Steinke, S; Luckge, A				Mohtadi, Mahyar; Prange, Matthias; Oppo, Delia W.; De Pol-Holz, Ricardo; Merkel, Ute; Zhang, Xiao; Steinke, Stephan; Lueckge, Andreas			North Atlantic forcing of tropical Indian Ocean climate	NATURE			English	Article							LAST GLACIAL MAXIMUM; PLANKTONIC-FORAMINIFERA; BARRIER LAYER; MONSOON RAINFALL; MILLENNIAL-SCALE; ASIAN MONSOON; FRESH-WATER; SEA-LEVEL; SURFACE; VARIABILITY	The response of the tropical climate in the Indian Ocean realm to abrupt climate change events in the North Atlantic Ocean is contentious. Repositioning of the intertropical convergence zone is thought to have been responsible for changes in tropical hydroclimate during North Atlantic cold spells(1-5), but the dearth of high-resolution records outside the monsoon realm in the Indian Ocean precludes a full understanding of this remote relationship and its underlying mechanisms. Here we show that slowdowns of the Atlantic meridional overturning circulation during Heinrich stadials and the Younger Dryas stadial affected the tropical Indian Ocean hydroclimate through changes to the Hadley circulation including a southward shift in the rising branch (the intertropical convergence zone) and an overall weakening over the southern Indian Ocean. Our results are based on new, high-resolution sea surface temperature and seawater oxygen isotope records of well-dated sedimentary archives from the tropical eastern Indian Ocean for the past 45,000 years, combined with climate model simulations of Atlantic circulation slowdown under Marine Isotope Stages 2 and 3 boundary conditions. Similar conditions in the east and west of the basin rule out a zonal dipole structure as the dominant forcing of the tropical Indian Ocean hydroclimate of millennial-scale events. Results from our simulations and proxy data suggest dry conditions in the northern Indian Ocean realm and wet and warm conditions in the southern realm during North Atlantic cold spells.	[Mohtadi, Mahyar; Prange, Matthias; Merkel, Ute; Zhang, Xiao; Steinke, Stephan] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Oppo, Delia W.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [De Pol-Holz, Ricardo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Lueckge, Andreas] Fed Inst Geosci & Nat Resources, D-30655 Hannover, Germany	University of Bremen; Woods Hole Oceanographic Institution; Universidad de Concepcion	Mohtadi, M (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	mmohtadi@marum.de	De Pol-Holz, Ricardo/E-3740-2013; Mohtadi, Mahyar/N-2106-2014	De Pol-Holz, Ricardo/0000-0002-3281-8232; Mohtadi, Mahyar/0000-0003-3306-0969	German Bundesministerium fur Bildung und Forschung [03G0189A]; Deutsche Forschungsgemeinschaft (DFG) [HE3412/15-1, STE1044/4-1]; DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System'); US NSF; Chilean FONDAP [15110009/ICM Nucleus NC120066]; Directorate For Geosciences [1060743] Funding Source: National Science Foundation	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System'); US NSF(National Science Foundation (NSF)); Chilean FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful to K. Olafsdottir, M. Segl and B. Meyer-Schack for technical support. This study was funded by the German Bundesministerium fur Bildung und Forschung (grant 03G0189A) and the Deutsche Forschungsgemeinschaft (DFG grants HE3412/15-1 and STE1044/4-1, and the DFG Research Centre/Cluster of Excellence 'The Ocean in the Earth System'). Climate model simulations were performed on the SGI Altix supercomputer of the Norddeutscher Verbund fur Hoch-und Hochstleistungsrechnen. D.W.O. is funded by the US NSF, R.D.P.-H. is supported by Chilean FONDAP 15110009/ICM Nucleus NC120066.	Ahn JH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029551; Aldrian E, 2003, INT J CLIMATOL, V23, P1435, DOI 10.1002/joc.950; Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Antonov J.I., 2006, NOAA ATLAS NESDIS, V62, P182; Arbuszewski JA, 2013, NAT GEOSCI, V6, P959, DOI [10.1038/NGEO1961, 10.1038/ngeo1961]; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bevington P. R, 2003, DATA REDUCTION ERROR, P320; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Carolin SA, 2013, SCIENCE, V340, P1564, DOI 10.1126/science.1233797; Clement AC, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000204; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Condron A, 2012, P NATL ACAD SCI USA, V109, P19928, DOI 10.1073/pnas.1207381109; De Deckker P, 2012, NAT GEOSCI, V5, P266, DOI [10.1038/ngeo1431, 10.1038/NGEO1431]; Deplazes G, 2013, NAT GEOSCI, V6, P213, DOI 10.1038/ngeo1712; Ding QH, 2005, J CLIMATE, V18, P3483, DOI 10.1175/JCLI3473.1; Ding QH, 2007, J CLIMATE, V20, P3751, DOI 10.1175/JCLI4221.1; Du Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002845; Dutta K, 2001, RADIOCARBON, V43, P483; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Frierson DMW, 2013, NAT GEOSCI, V6, P940, DOI [10.1038/ngeo1987, 10.1038/NGEO1987]; Gibbons FT, 2014, EARTH PLANET SC LETT, V387, P240, DOI 10.1016/j.epsl.2013.11.032; Greaves M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001974; Griffiths ML, 2009, NAT GEOSCI, V2, P636, DOI 10.1038/NGEO605; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Janowiak JE, 1999, J CLIMATE, V12, P3335, DOI 10.1175/1520-0442(1999)012<3335:COAGSR>2.0.CO;2; Kageyama M, 2013, CLIM PAST, V9, P935, DOI 10.5194/cp-9-935-2013; Levi C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001514; Levis S, 2004, COMMUNITY LAND MODEL; Lewis SC, 2011, EARTH PLANET SC LETT, V303, P133, DOI 10.1016/j.epsl.2010.12.048; Marzin C, 2013, CLIM PAST, V9, P2135, DOI 10.5194/cp-9-2135-2013; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Merkel U, 2010, QUATERNARY SCI REV, V29, P86, DOI 10.1016/j.quascirev.2009.11.006; Mohtadi M, 2007, MAR MICROPALEONTOL, V65, P96, DOI 10.1016/j.marmicro.2007.06.004; Mohtadi M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002132; Mohtadi M, 2011, NAT GEOSCI, V4, P540, DOI [10.1038/ngeo1209, 10.1038/NGEO1209]; Mohtadi M, 2010, EARTH PLANET SC LETT, V292, P89, DOI 10.1016/j.epsl.2010.01.024; Mohtadi M, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001636; Moreno PI, 2001, NATURE, V409, P804, DOI 10.1038/35057252; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Mudelsee M, 2003, MATH GEOL, V35, P651, DOI 10.1023/B:MATG.0000002982.52104.02; Mudelsee M, 2000, COMPUT GEOSCI, V26, P293, DOI 10.1016/S0098-3004(99)00141-7; Muller J, 2008, QUATERNARY SCI REV, V27, P468, DOI 10.1016/j.quascirev.2007.11.006; Muller J, 2012, GEOLOGY, V40, P635, DOI 10.1130/G32878.1; Oleson KW, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000563; Oleson KW, 2004, TECHNICAL DESCRIPTIO; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2567, DOI 10.1175/JCLI3754.1; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pourmand A, 2004, EARTH PLANET SC LETT, V221, P39, DOI 10.1016/S0012-821X(04)00109-8; Qiu Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051441; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Qu TD, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002816; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Sengupta D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027573; Southon J, 2002, RADIOCARBON, V44, P167, DOI 10.1017/S0033822200064778; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Sprintall J, 2003, DEEP-SEA RES PT II, V50, P2183, DOI 10.1016/S0967-0645(03)00052-3; SPRINTALL J, 1992, J GEOPHYS RES-OCEANS, V97, P7305, DOI 10.1029/92JC00407; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Thomas DSG, 2012, J QUATERNARY SCI, V27, P7, DOI 10.1002/jqs.1557; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2013, SCIENCE, V342, P843, DOI 10.1126/science.1240411; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; Vinayachandran PN, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000831; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang B, 2008, DYNAM ATMOS OCEANS, V44, P165, DOI 10.1016/j.dynatmoce.2007.05.002; Wang LJ, 2000, PALAEOGEOGR PALAEOCL, V161, P381, DOI 10.1016/S0031-0182(00)00094-8; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wiedicke-Hombach M., 2007, SUMATRA HYDROCARBON; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Yoo SH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006001; Zuraida R, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001653	84	154	161	12	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					76	+		10.1038/nature13196	http://dx.doi.org/10.1038/nature13196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784218	Green Submitted			2022-12-28	WOS:000335199100042
J	Davies, P				Davies, Peter			Is the great NHS sell-off under way?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						European Commission, ONL PUBL CONS INV PR; O'Dowd A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2876; West D, 2014, HLTH SERV J	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2912	10.1136/bmj.g2912	http://dx.doi.org/10.1136/bmj.g2912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24780193				2022-12-28	WOS:000335475500013
J	Sugarman, J; Califf, RM				Sugarman, Jeremy; Califf, Robert M.			Ethics and Regulatory Complexities for Pragmatic Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Califf, Robert M.] Duke Univ, Sch Med, Div Cardiol, Dept Med, Durham, NC 27710 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27710 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Duke University	Califf, RM (corresponding author), Duke Univ, Sch Med, Duke Translat Med Inst, Dept Med, 200 Trent Dr,1117 Davison Bldg,DUMC 3701, Durham, NC 27710 USA.	robert.califf@duke.edu		Sugarman, Jeremy/0000-0001-7022-8332	National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NCCIH NIH HHS [U54 AT007748] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Check DK, 2013, CLIN TRIALS, V10, P560, DOI 10.1177/1740774513484393; Nayak RK, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.1821, DOI 10.1001/JAMA.2014.1821]; Solomon MZ, 2013, ETHICAL OVERSIGHT LE; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; US Department of Health & Human Services, 2013, PUBL M MATT REL PROT; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346	6	97	97	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2381	2382		10.1001/jama.2014.4164	http://dx.doi.org/10.1001/jama.2014.4164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24810723				2022-12-28	WOS:000337301500016
J	Duss, O; Michel, E; Yulikov, M; Schubert, M; Jeschke, G; Allain, FHT				Duss, Olivier; Michel, Erich; Yulikov, Maxim; Schubert, Mario; Jeschke, Gunnar; Allain, Frederic H. -T.			Structural basis of the non-coding RNA RsmZ acting as a protein sponge	NATURE			English	Article							PSEUDOMONAS-FLUORESCENS CHA0; ESCHERICHIA-COLI; REGULATORY RNAS; RECOGNITION; SENSITIVITY; AERUGINOSA; BIOCONTROL; PRINCIPLES; EFFICIENT; SEQUENCE	MicroRNA and protein sequestration by non-coding RNAs (ncRNAs) has recently generated much interest. In the bacterial Csr/Rsm system, which is considered to be the most general global post-transcriptional regulatory system responsible for bacterial virulence, ncRNAs such as CsrB or RsmZ activate translation initiation by sequestering homodimeric CsrA-type proteins from the ribosome-binding site of a subset of messenger RNAs. However, the mechanism of ncRNA-mediated protein sequestration is not understood at the molecular level. Here we show for Pseudomonas fluorescens that RsmE protein dimers assemble sequentially, specifically and cooperatively onto the ncRNA RsmZ within a narrow affinity range. This assembly yields two different native ribonucleoprotein structures. Using a powerful combination of nuclear magnetic resonance and electron paramagnetic resonance spectroscopy we elucidate these 70-kilodalton solution structures, thereby revealing the molecular mechanism of the sequestration process and how RsmE binding protects the ncRNA from RNase E degradation. Overall, our findings suggest that RsmZ is well-tuned to sequester, store and release RsmE and therefore can be viewed as an ideal protein 'sponge'.	[Duss, Olivier; Michel, Erich; Schubert, Mario; Allain, Frederic H. -T.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Yulikov, Maxim; Jeschke, Gunnar] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch	Schubert, Mario/B-3972-2008; Yulikov, Maxim/AAU-3685-2020	Schubert, Mario/0000-0003-0278-4091; Duss, Olivier/0000-0003-0929-3471; Jeschke, Gunnar/0000-0001-6853-8585	Swiss National Science Foundation (SNF) [3100A0-118118, 31003ab-133134, 31003A-149921]; SNF-NCCR structural biology Iso-lab	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF-NCCR structural biology Iso-lab	We thank G. A. Mackie for providing the RNase E (12529) clone; N. Diarra Dit Konte and B. Alila for the help with RNA production; M. Blatter for help with structure calculations; G. Wider, T. Stahel, C. Maris and F. Damberger for help with NMR spectroscopy setup; G. Braach, Y. Nikolaev and M. Sattler for discussions. This work was supported by the Swiss National Science Foundation (SNF) grant numbers 3100A0-118118, 31003ab-133134 and 31003A-149921 to F.H.-T.A. and the SNF-NCCR structural biology Iso-lab.	[Anonymous], 2006, V AMBER 9; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Dominguez C, 2011, PROG NUCL MAG RES SP, V58, P1, DOI 10.1016/j.pnmrs.2010.10.001; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Duss O., 2014, NUCL ACIDS RES; Duss O., 2014, NATURE COMMUN; Duss O, 2012, ADV EXP MED BIOL, V992, P121, DOI 10.1007/978-94-007-4954-2_7; Duss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq756; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; Gromov I, 2001, J MAGN RESON, V149, P196, DOI 10.1006/jmre.2001.2298; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G., 2014, STRUCTURE B IN PRESS, V152; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Michel E, 2012, J BIOMOL NMR, V53, P43, DOI 10.1007/s10858-012-9619-4; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ramos A, 1998, J AM CHEM SOC, V120, P10992, DOI 10.1021/ja982496e; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Woodson SA, 2011, ACCOUNTS CHEM RES, V44, P1312, DOI 10.1021/ar2000474	51	141	143	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					588	+		10.1038/nature13271	http://dx.doi.org/10.1038/nature13271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24828038				2022-12-28	WOS:000336457100042
J	Bowles, MW; Mogollon, JM; Kasten, S; Zabel, M; Hinrichs, KU				Bowles, Marshall W.; Mogollon, Jose M.; Kasten, Sabine; Zabel, Matthias; Hinrichs, Kai-Uwe			Global rates of marine sulfate reduction and implications for sub-sea-floor metabolic activities	SCIENCE			English	Article							SEDIMENT AARHUS BAY; REDUCING BACTERIA; MICROBIAL LIFE; ABUNDANCE; DIVERSITY; FLUXES; ZONE	Sulfate reduction is a globally important redox process in marine sediments, yet global rates are poorly quantified. We developed an artificial neural network trained with 199 sulfate profiles, constrained with geomorphological and geochemical maps to estimate global sulfate-reduction rate distributions. Globally, 11.3 teramoles of sulfate are reduced yearly (similar to 15% of previous estimates), accounting for the oxidation of 12 to 29% of the organic carbon flux to the sea floor. Combined with global cell distributions in marine sediments, these results indicate a strong contrast in sub-sea-floor prokaryote habitats: In continental margins, global cell numbers in sulfate-depleted sediment exceed those in the overlying sulfate-bearing sediment by one order of magnitude, whereas in the abyss, most life occurs in oxic and/or sulfate-reducing sediments.	[Bowles, Marshall W.; Mogollon, Jose M.; Kasten, Sabine; Zabel, Matthias; Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Mogollon, Jose M.; Kasten, Sabine] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Mogollon, Jose M.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, NL-3508 TC Utrecht, Netherlands	University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Utrecht University	Bowles, MW (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	bowlesmw@uni-bremen.de	Zabel, Matthias/E-5044-2011; Hinrichs, Kai-Uwe/C-7675-2009	Zabel, Matthias/0000-0003-4681-1821; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Kasten, Sabine/0000-0001-7453-5137; Bowles, Marshall/0000-0002-0464-5880; Mogollon, Jose Manuel/0000-0002-7110-5470	Deutsche Forschungsgemeinschaft; European Research Council (ERC) under the European Union [247153]; Helmholtz Association (AWI Bremerhaven); Utrecht University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Helmholtz Association (AWI Bremerhaven)(Helmholtz Association); Utrecht University	All data used in this study are publically available via Janus and Pangea (www.pangea.de). We thank Deep Sea Drilling Project/Ocean Drilling Program/Integrated Ocean Drilling Program, Janus, and Pangea for compiling and providing these data sets. We thank A. Boetius, J. J. Middelburg, and S. Joye for helpful comments during the development of this work. Primary support for this work was provided by the Research Center/Cluster of Excellence "The Ocean in the Earth System" (MARUM) funded by the Deutsche Forschungsgemeinschaft in the framework of a Postdoctoral Fellowship awarded to M. W. B. Additional funding was provided by the European Research Council (ERC) under the European Union's Seventh Framework Programme-"Ideas" Specific Programme, ERC grant agreement no. 247153, the Helmholtz Association (AWI Bremerhaven), and Utrecht University through its strategic theme Sustainability, sub-theme Water, Climate, and Ecosystems.	Canfield DE, 2005, ADV MAR BIOL, V48, P313; CANFIELD DE, 1991, AM J SCI, V291, P177, DOI 10.2475/ajs.291.2.177; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Dale AW, 2009, GEOLOGY, V37, P235, DOI 10.1130/G25323A.1; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002907; EMERY KO, 1968, AM ASSOC PETR GEOL B, V0052, P00445; Feldman G. C., 2013, OCEAN COLOR WEB; Fischer D, 2013, NAT GEOSCI, V6, P647, DOI [10.1038/NGEO1886, 10.1038/ngeo1886]; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Heuer VB, 2009, GEOCHIM COSMOCHIM AC, V73, P3323, DOI 10.1016/j.gca.2009.03.001; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Holm N., 2003, PROC OCEAN DRILL INI, V201, DOI [10.2973/odp.proc.ir.201.2003, DOI 10.2973/ODP.PROC.IR.201.2003]; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Knauer G. A., 1993, NATO ASI SERIES 1, V14, P211; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Lin YS, 2012, GEOCHIM COSMOCHIM AC, V77, P186, DOI 10.1016/j.gca.2011.11.008; Mogollon JM, 2012, BIOGEOSCIENCES, V9, P1915, DOI 10.5194/bg-9-1915-2012; Mogollon JM, 2013, GEO-MAR LETT, V33, P299, DOI 10.1007/s00367-013-0329-z; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Wallmann K, 2012, ENERGIES, V5, P2449, DOI 10.3390/en5072449	28	155	158	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					889	891		10.1126/science.1249213	http://dx.doi.org/10.1126/science.1249213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24812207	Green Submitted			2022-12-28	WOS:000336233800044
J	Singh, DP; Saudemont, B; Guglielmi, G; Arnaiz, O; Gout, JF; Prajer, M; Potekhin, A; Przybos, E; Aubusson-Fleury, A; Bhullar, S; Bouhouche, K; Lhuillier-Akakpo, M; Tanty, V; Blugeon, C; Alberti, A; Labadie, K; Aury, JM; Sperling, L; Duharcourt, S; Meyer, E				Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Arnaiz, Olivier; Gout, Jean-Francois; Prajer, Malgorzata; Potekhin, Alexey; Przybos, Ewa; Aubusson-Fleury, Anne; Bhullar, Simran; Bouhouche, Khaled; Lhuillier-Akakpo, Maoussi; Tanty, Veronique; Blugeon, Corinne; Alberti, Adriana; Labadie, Karine; Aury, Jean-Marc; Sperling, Linda; Duharcourt, Sandra; Meyer, Eric			Genome-defence small RNAs exapted for epigenetic mating-type inheritance	NATURE			English	Article							PROGRAMMED DNA ELIMINATION; PARAMECIUM-TETRAURELIA; DEVELOPMENTAL EXCISION; SEX DETERMINATION; GENETIC-ANALYSIS; SEQUENCE; DIFFERENTIATION; REARRANGEMENTS; PROTEINS; EXPRESSION	In the ciliate Paramecium, transposable elements and their single-copy remnants are deleted during the development of somatic macronuclei from germline micronuclei, at each sexual generation. Deletions are targeted by scnRNAs, small RNAs produced from the germ line during meiosis that first scan the maternal macronuclear genome to identify missing sequences, and then allow the zygotic macronucleus to reproduce the same deletions. Here we show that this process accounts for the maternal inheritance of mating types in Paramecium tetraurelia, a long-standing problem in epigenetics. Mating type E depends on expression of the transmembrane protein mtA, and the default type O is determined during development by scnRNA-dependent excision of the mtA promoter. In the sibling species Paramecium septaurelia, mating type O is determined by coding-sequence deletions in a different gene, mtB, which is specifically required for mtA expression. These independently evolved mechanisms suggest frequent exaptation of the scnRNA pathway to regulate cellular genes and mediate transgene-rational epigenetic inheritance of essential phenotypic polymorphisms.	[Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] Ecole Normale Super, Inst Biol, ENS, IBENS, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] INSERM, U1024, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Guglielmi, Gerard; Bhullar, Simran; Bouhouche, Khaled; Tanty, Veronique; Blugeon, Corinne; Meyer, Eric] CNRS, UMR 8197, F-75005 Paris, France; [Singh, Deepankar Pratap; Saudemont, Baptiste; Lhuillier-Akakpo, Maoussi] UPMC Univ, Sorbonne Univ, IFD, F-75252 Paris 05, France; [Arnaiz, Olivier; Aubusson-Fleury, Anne] Ctr Genet Molec, CNRS, UMR 8197, F-91198 Gif Sur Yvette, France; [Arnaiz, Olivier; Aubusson-Fleury, Anne] Univ Paris Sud, Dept Biol, F-91405 Orsay 05, France; [Gout, Jean-Francois] Univ Lyon, UMR5558, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Prajer, Malgorzata; Przybos, Ewa] Polish Acad Sci, Inst Systemat & Evolut Anim, PL-31016 Krakow, Poland; [Potekhin, Alexey] St Petersburg State Univ, Dept Microbiol, Fac Biol, St Petersburg 199034, Russia; [Lhuillier-Akakpo, Maoussi; Duharcourt, Sandra] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod,UMR 7592, F-75205 Paris, France; [Alberti, Adriana; Labadie, Karine; Aury, Jean-Marc] CEA, IG, Genoscope, F-91057 Evry, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Saint Petersburg State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA	Meyer, E (corresponding author), Ecole Normale Super, Inst Biol, ENS, IBENS, F-75005 Paris, France.	emeyer@biologie.ens.fr	Labadie, Karine/AAG-7355-2022; Potekhin, Alexey A./K-3633-2013; Bouhouche, khaled/AGR-4456-2022; Alberti, Adriana/E-7142-2017; Sperling, Linda/C-9734-2014; Labadie, Karine/AFL-7408-2022; Aury, Jean-Marc/N-1621-2019; Alberti, Adriana/AAZ-2013-2021; Duharcourt, Sandra/ABD-4460-2020	Labadie, Karine/0000-0001-7467-8509; Potekhin, Alexey A./0000-0003-4162-5923; Alberti, Adriana/0000-0003-3372-9423; Labadie, Karine/0000-0001-7467-8509; Aury, Jean-Marc/0000-0003-1718-3010; Alberti, Adriana/0000-0003-3372-9423; Duharcourt, Sandra/0000-0002-8913-8799; Przybos, Ewa/0000-0003-0523-0465; Gout, Jean-Francois/0000-0002-4549-5647; Sperling, Linda/0000-0002-7772-4774; Bhullar, Simran/0000-0002-2212-902X; Meyer, Eric/0000-0002-3161-8597; ARNAIZ, Olivier/0000-0002-9626-1015	'Investissements d'Avenir' program, Paris Sciences et Lettres* Research University [ANR-10-LABX-54 MEMO LIFE/ANR-11-IDEX-0001-02]; 'Equipe FRM' grant; CNRS ATIP-Avenir; National Science Foundation [MCB-1050161]; Erasmus Mundus program; Ligue Nationale Contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Fondation de la Recherche Medicale; CNRS;  [ANR-08-BLAN-0233];  [ANR-12-BSV6-0017];  [ANR-2010-BLAN-1603];  [RFBR 13-04-01683a]	'Investissements d'Avenir' program, Paris Sciences et Lettres* Research University(French National Research Agency (ANR)); 'Equipe FRM' grant; CNRS ATIP-Avenir; National Science Foundation(National Science Foundation (NSF)); Erasmus Mundus program; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); ; ; ; 	We thank S. Malinsky, C. Ciaudo and M.-A. Felix for critical reading of the manuscript, and S. Marker and all other laboratory members for continuous support and discussions. This work was supported by the 'Investissements d'Avenir' program ANR-10-LABX-54 MEMO LIFE/ANR-11-IDEX-0001-02 Paris Sciences et Lettres* Research University and by grants ANR-08-BLAN-0233 'ParaDice' and ANR-12-BSV6-0017 'INFERNO' to E. M., L. S. and S. D., an 'Equipe FRM' grant to E. M., grants ANR-2010-BLAN-1603 'GENOMAC' and CNRS ATIP-Avenir to S. D., and National Science Foundation grant MCB-1050161 to M. Lynch (JFG). D. P. S. was supported by Ph.D. fellowships from the Erasmus Mundus program and from the Ligue Nationale Contre le Cancer. M. L.-A. was supported by Ph.D. fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation de la Recherche Medicale. A. P. was supported by grant RFBR 13-04-01683a. Some strains used in this study are maintained at the Centre of Core Facilities 'Culture Collection of Microorganisms' in St Petersburg State University. The sequencing of the mtB<SUP>O</SUP> and mtC<SUP>O</SUP> MAC genomes benefited from the facilities and expertise of the high-throughput sequencing platform of IMAGIF (Centre de Recherche de Gif, http://www.imagif.cnrs.fr). The mtB<SUP>O</SUP> and mtC<SUP>O</SUP> transcriptomes were sequenced at the Genomic Paris Centre - IBENS platform, member of 'France Genomique' (ANR10-INBS-09-08). This study was carried out in the context of the CNRS-supported European Research Group 'Paramecium Genome Dynamics and Evolution' and the European COST Action BM1102.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Beisson J., 2010, COLD SPRING HARB PRO; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; BRYGOO Y, 1977, GENETICS, V87, P633; BRYGOO Y, 1980, GENETICS, V94, P951; BUTZEL HM, 1955, GENETICS, V40, P321; BYRNE BC, 1973, GENETICS, V74, P63; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Catania F, 2013, GENOME BIOL EVOL, V5, P1200, DOI 10.1093/gbe/evt087; Catania F, 2009, MOL BIOL EVOL, V26, P421, DOI 10.1093/molbev/msn266; Cervantes MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001518; Chalker DL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017764; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Coyne RS, 2012, BIOL CELL, V104, P309, DOI 10.1111/boc.201100057; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dubois Emeline, 2012, Int J Evol Biol, V2012, P436196, DOI 10.1155/2012/436196; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Duret L, 2008, GENOME RES, V18, P585, DOI 10.1101/gr.074534.107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; HAGGARD BW, 1974, J PROTOZOOL, V21, P152, DOI 10.1111/j.1550-7408.1974.tb03630.x; Hall MS, 2011, GENETICA, V139, P677, DOI 10.1007/s10709-011-9571-3; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Meyer E, 1996, GENETICS, V143, P191; Meyer E, 2002, ADV GENET, V46, P305; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NANNEY DL, 1957, J PROTOZOOL, V4, P89, DOI 10.1111/j.1550-7408.1957.tb02492.x; Nowacki M, 2005, CURR BIOL, V15, P1616, DOI 10.1016/j.cub.2005.07.033; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Phadke SS, 2009, BIOL J LINN SOC, V98, P187, DOI 10.1111/j.1095-8312.2009.01250.x; Sandoval PY, 2014, DEV CELL, V28, P174, DOI 10.1016/j.devcel.2013.12.010; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Schoeberl UE, 2011, J BIOL CHEM, V286, P37045, DOI 10.1074/jbc.R111.276964; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonneborn T. M., 1954, Caryologia, P307; Sonneborn TM, 1937, P NATL ACAD SCI USA, V23, P378, DOI 10.1073/pnas.23.7.378; SONNEBORN TM, 1947, ADV GENET, V1, P263, DOI 10.1016/S0065-2660(08)60488-5; SONNEBORN TM, 1977, ANNU REV GENET, V11, P349, DOI 10.1146/annurev.ge.11.120177.002025; Sonneborn TM, 1974, HDB GENETICS PLANTS, V2, P469, DOI DOI 10.1007/978-1-4684-2994-7_20; TAUB SR, 1963, GENETICS, V48, P815; Xu XH, 2001, J EUKARYOT MICROBIOL, V48, P683, DOI 10.1111/j.1550-7408.2001.tb00209.x	64	71	74	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					447	+		10.1038/nature13318	http://dx.doi.org/10.1038/nature13318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24805235				2022-12-28	WOS:000336126000030
J	Vaisrub, S				Vaisrub, Samuel			Be Your Own Philosopher (Reprinted from vol 230, pg 443, 1974)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Harrison III FR, 1974, JAMA-J AM MED ASSOC, V230, P401; VAISRUB S, 1974, JAMA-J AM MED ASSOC, V230, P443	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2026	2026		10.1001/jama.2013.279509	http://dx.doi.org/10.1001/jama.2013.279509			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846048				2022-12-28	WOS:000336122800032
J	Sinsky, CA; Beasley, JW; Simmons, GE; Baron, RJ				Sinsky, Christine A.; Beasley, John W.; Simmons, Greg E.; Baron, Richard J.			Electronic Health Records: Design, Implementation, and Policy for Higher-Value Primary Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIAN; QUALITY		Med Associates Clin & Hlth Plans, Dubuque, IA 52002 USA; Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Simmons, Greg E.] MetaStar, Madison, WI 53713 USA; [Baron, Richard J.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Baron, Richard J.] ABIM Fdn, Philadelphia, PA 19106 USA	University of Wisconsin System; University of Wisconsin Madison; American Board of Internal Medicine; American Board of Internal Medicine	Sinsky, CA (corresponding author), Med Associates Clin & Hlth Plans, Dept Internal Med, 1000 Langworthy St, Dubuque, IA 52002 USA.	csinsky1@mahealthcare.com						Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Beasley JW, 2011, J AM BOARD FAM MED, V24, P745, DOI 10.3122/jabfm.2011.06.100255; Beasley JW, 2011, BRIT J GEN PRACT, V61, P604, DOI 10.3399/bjgp11X601244; Friedberg M.W., 2013, FACTORS AFFECTING PH; Hess DR, 2010, CHEST, V138, P1475, DOI 10.1378/chest.09-2140; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; Shipman SA, 2013, HEALTH AFFAIR, V32, P1990, DOI 10.1377/hlthaff.2013.0539; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stetson PD, 2012, APPL CLIN INFORM, V3, P164, DOI 10.4338/ACI-2011-11-RA-0070; Toll E, 2012, JAMA-J AM MED ASSOC, V307, P2497, DOI 10.1001/jama.2012.4946	10	40	41	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					727	+		10.7326/M13-2589	http://dx.doi.org/10.7326/M13-2589			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842418				2022-12-28	WOS:000337347100019
J	Mengerink, KJ; Van Dover, CL; Ardron, J; Baker, M; Escobar-Briones, E; Gjerde, K; Koslow, JA; Ramirez-Llodra, E; Lara-Lopez, A; Squires, D; Sutton, T; Sweetman, AK; Levin, LA				Mengerink, Kathryn J.; Van Dover, Cindy L.; Ardron, Jeff; Baker, Maria; Escobar-Briones, Elva; Gjerde, Kristina; Koslow, J. Anthony; Ramirez-Llodra, Eva; Lara-Lopez, Ana; Squires, Dale; Sutton, Tracey; Sweetman, Andrew K.; Levin, Lisa A.			A Call for Deep-Ocean Stewardship	SCIENCE			English	Editorial Material							SEA; IMPACT; DEPTH; OIL		[Mengerink, Kathryn J.] Environm Law Inst, Washington, DC 20036 USA; [Mengerink, Kathryn J.; Koslow, J. Anthony; Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Van Dover, Cindy L.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Ardron, Jeff] Inst Adv Sustainabil Studies, Potsdam, Germany; [Baker, Maria] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, ICML, Mexico City 04510, DF, Mexico; [Gjerde, Kristina] Wycliffe Management, PL-05510 Warsaw, Poland; [Ramirez-Llodra, Eva] Norwegian Inst Water Res NIVA, Oslo, Norway; [Lara-Lopez, Ana] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Squires, Dale] Univ Calif San Diego, La Jolla, CA 92093 USA; [Sutton, Tracey] Nova SE Univ, Coll Oceanog, Oceanog Ctr, Dania, FL 33004 USA; [Sweetman, Andrew K.] Int Res Inst Stavanger, Stavanger, Norway	University of California System; University of California San Diego; Scripps Institution of Oceanography; Duke University; NERC National Oceanography Centre; University of Southampton; Universidad Nacional Autonoma de Mexico; Norwegian Institute for Water Research (NIVA); University of Tasmania; University of California System; University of California San Diego; Nova Southeastern University	Levin, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	llevin@ucsd.edu	Sutton, Tracey/AAW-7644-2021; Ardron, Jeff/ABI-7397-2020	Sutton, Tracey/0000-0002-5280-7071; Van Dover, Cindy/0000-0001-9845-8391; Escobar Briones, Elva/0000-0002-8485-7495; Levin, Lisa/0000-0002-2858-8622; Lara-Lopez, Ana/0000-0003-2896-1367; Ramirez-Llodra, Eva/0000-0003-0137-1906				[Anonymous], REST PLAN; [Anonymous], 2007, OIL GAS J; Barbier EB, 2014, NATURE, V505, P475, DOI 10.1038/505475a; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; House KZ, 2006, P NATL ACAD SCI USA, V103, P12291, DOI 10.1073/pnas.0605318103; Lehmann F., 2007, NZ J ENV LAW, V11, P33; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; Muehlenbachs L, 2013, ENERG POLICY, V55, P699, DOI 10.1016/j.enpol.2012.12.074; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Ocean Conservancy and the Gulf of Mexico University Research Collaborative, 2012, MAR REST PRIOR SCI P; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Van Dover CL, 2014, MAR POLICY, V44, P98, DOI 10.1016/j.marpol.2013.07.006; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Wedding LM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1684; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109	17	157	161	11	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					696	698		10.1126/science.1251458	http://dx.doi.org/10.1126/science.1251458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH1WQ	24833377	Green Submitted			2022-12-28	WOS:000335912900022
J	Thyer, R; Ellefson, J				Thyer, Ross; Ellefson, Jared			SYNTHETIC BIOLOGY New letters for life's alphabet	NATURE			English	Editorial Material							UNNATURAL BASE-PAIR; DNA; AMPLIFICATION; REPLICATION		[Thyer, Ross; Ellefson, Jared] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Thyer, R (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ross.thyer@utexas.edu		Thyer, Ross/0000-0002-0356-5790				BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Rich A., 1962, HORIZONS BIOCH, P103; SCHWEITZER BA, 1995, J AM CHEM SOC, V117, P1863, DOI 10.1021/ja00112a001; Seo YJ, 2009, J AM CHEM SOC, V131, P3246, DOI 10.1021/ja807853m; SWITZER C, 1989, J AM CHEM SOC, V111, P8322, DOI 10.1021/ja00203a067; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	10	8	9	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					291	292		10.1038/nature13335	http://dx.doi.org/10.1038/nature13335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805244				2022-12-28	WOS:000336121200022
J	O'Doherty, LJ; Taft, A; Hegarty, K; Ramsay, J; Davidson, LL; Feder, G				O'Doherty, Lorna J.; Taft, Angela; Hegarty, Kelsey; Ramsay, Jean; Davidson, Leslie L.; Feder, Gene			Screening women for intimate partner violence in healthcare settings: abridged Cochrane systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; DOMESTIC VIOLENCE; COMPUTER; SUPPORT; ABUSE; FORM	Objective To examine the effectiveness of screening for intimate partner violence conducted within healthcare settings to determine whether or not screening increases identification and referral to support agencies, improves women's wellbeing, decreases further violence, or causes harm. Design Systematic review and meta-analysis of trials assessing effectiveness of screening. Study assessment, data abstraction, and quality assessment were conducted independently by two of the authors. Standardised estimations of the risk ratios and 95% confidence intervals were calculated. Data sources Nine databases searched up to July 2012 (CENTRAL, Medline, Medline(R), Embase, DARE, CINAHL, PsycINFO, Sociological Abstracts, and ASSIA), and five trials registers searched up to 2010. Eligibility criteria for selecting studies Randomised or quasi-randomised trials of screening programmes for intimate partner violence involving all women aged = 16 attending a healthcare setting. We included only studies in which clinicians in the intervention arm personally conducted the screening, or were informed of the screening result at the time of the consultation, compared with usual care (or no screening). Studies of screening programmes that were followed by structured interventions such as advocacy or therapeutic intervention were excluded. Results 11 eligible trials (n = 13 027) were identified. In six pooled studies (n = 3564), screening increased the identification of intimate partner violence (risk ratio 2.33, 95% confidence interval 1.39 to 3.89), particularly in antenatal settings (4.26, 1.76 to 10.31). Based on three studies (n = 1400), we detected no evidence that screening increases referrals to domestic violence support services (2.67, 0.99 to 7.20). Only two studies measured women's experience of violence after screening (three to 18 months after screening) and found no reduction in intimate partner violence. One study reported that screening does not cause harm. Conclusions Though screening is likely to increase identification of intimate partner violence in healthcare settings, rates of identification from screening interventions were low relative to best estimates of prevalence of such violence. It is uncertain whether screening increases effective referral to supportive agencies. Screening does not seem to cause harm in the short term, but harm was measured in only one study. As the primary studies did not detect improved outcomes for women screened for intimate partner violence, there is insufficient evidence for screening in healthcare settings. Studies comparing screening versus case finding, or screening in combination with therapeutic intervention for women's long term wellbeing, are needed to inform the implementation of identification policies in healthcare settings.	[O'Doherty, Lorna J.; Hegarty, Kelsey] Univ Melbourne, Dept Gen Practice, Carlton, Vic 3010, Australia; [Taft, Angela] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic 3000, Australia; [Ramsay, Jean] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Hlth Care & Publ Hlth, London E1 4NS, England; [Davidson, Leslie L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Feder, Gene] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England	University of Melbourne; La Trobe University; University of London; Queen Mary University London; Columbia University; University of Bristol	O'Doherty, LJ (corresponding author), Univ Melbourne, Dept Gen Practice, Carlton, Vic 3010, Australia.	lornajaneodoherty@hotmail.com		O'Doherty, Lorna Jane/0000-0003-0816-9321; Hegarty, Kelsey/0000-0002-7532-5147; Taft, Angela/0000-0002-6350-843X; Feder, Gene/0000-0002-7890-3926	La Trobe University	La Trobe University	La Trobe University provided funding for work undertaken towards the original Cochrane Review; the university had no role in the research or its publication.	Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; [Anonymous], NAT CONS GUID ID RES; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bacchus L., 2012, HLTH SECTOR RESPONSE; Carroll JC, 2005, CAN MED ASSOC J, V173, P253, DOI 10.1503/cmaj.1040610; Cochrane Collaboration, 2011, REV MAN REVMAN; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Davidson LL, 2000, REDUCING DOMESTIC VI; Devine A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001008; Eldridge SM, 2005, CLIN TRIALS, V2, P91, DOI 10.1191/1740774505cn070oa; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2009, HEALTH TECHNOL ASSES, V13, pxi; Feder G, 2013, JAMA-J AM MED ASSOC, V310, P479, DOI 10.1001/jama.2013.167453; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Hegarty K, 2006, INTIMATE PARTNER ABU; Hegarty K., 2006, INTIMATE PARTNER ABU, P19; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Hegarty KL, 2001, AUST NZ J PUBL HEAL, V25, P433, DOI 10.1111/j.1467-842X.2001.tb00288.x; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Humphreys J, 2011, WOMEN HEALTH ISS, V21, P136, DOI 10.1016/j.whi.2010.09.006; Jewkes R, 2002, BMJ-BRIT MED J, V324, P253, DOI 10.1136/bmj.324.7332.253; Kataoka Y, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-84; Klevens J, 2012, WOMEN HEALTH ISS, V22, pE45, DOI 10.1016/j.whi.2011.06.008; Koziol-McLain J, 2010, ANN EMERG MED, V56, P413, DOI 10.1016/j.annemergmed.2010.05.001; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; May CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-245; McFarlane J, 2004, AM J NURS, V104, P40, DOI 10.1097/00000446-200403000-00019; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; National Institute for Health and Care Excellence, 2014, DOM VIOL AB HLTH SER; Nelson HD, 2012, ANN INTERN MED, V156, pW11; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Rhodes KV, 2002, ANN EMERG MED, V40, P476, DOI 10.1067/mem.2002.127181; Spangaro J, 2009, TRAUMA VIOLENCE ABUS, V10, P55, DOI 10.1177/1524838008327261; Taft A, 2009, COCHRANE DB SYST REV, V1; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Taft AJ, 2010, JAMA-J AM MED ASSOC, V304, P577, DOI 10.1001/jama.2010.1093; Trautman DE, 2007, ANN EMERG MED, V49, P526, DOI 10.1016/j.annemergmed.2006.11.022; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wathen CN, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-13; Wathen CN, 2012, JAMA-J AM MED ASSOC, V308, P712, DOI 10.1001/jama.2012.9913; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2021, VIOL WOM PREV EST 20	49	69	70	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g2913	10.1136/bmj.g2913	http://dx.doi.org/10.1136/bmj.g2913			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH5CN	24821132	Green Published, hybrid			2022-12-28	WOS:000336146200004
J	Tran, E; Turcotte, S; Gros, A; Robbins, PF; Lu, YC; Dudley, ME; Wunderlich, JR; Somerville, RP; Hogan, K; Hinrichs, CS; Parkhurst, MR; Yang, JC; Rosenberg, SA				Tran, Eric; Turcotte, Simon; Gros, Alena; Robbins, Paul F.; Lu, Yong-Chen; Dudley, Mark E.; Wunderlich, John R.; Somerville, Robert P.; Hogan, Katherine; Hinrichs, Christian S.; Parkhurst, Maria R.; Yang, James C.; Rosenberg, Steven A.			Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer	SCIENCE			English	Article							CD4(+) T-CELLS; METASTATIC MELANOMA; ESTABLISHED MELANOMA; TUMOR-REGRESSION; LUNG-CARCINOMA; IFN-GAMMA; IN-VIVO; LYMPHOCYTES; GENE; RESPONSES	Limited evidence exists that humans mount a mutation-specific T cell response to epithelial cancers. We used a whole-exomic-sequencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with metastatic cholangiocarcinoma contained CD4+ T helper 1 (T(H)1) cells recognizing a mutation in erbb2 interacting protein (ERBB2IP) expressed by the cancer. After adoptive transfer of TIL containing about 25% mutation-specific polyfunctional T(H)1 cells, the patient achieved a decrease in target lesions with prolonged stabilization of disease. Upon disease progression, the patient was retreated with a >95% pure population of mutation-reactive T(H)1 cells and again experienced tumor regression. These results provide evidence that a CD4+ T cell response against a mutated antigen can be harnessed to mediate regression of a metastatic epithelial cancer.	[Tran, Eric; Turcotte, Simon; Gros, Alena; Robbins, Paul F.; Lu, Yong-Chen; Dudley, Mark E.; Wunderlich, John R.; Somerville, Robert P.; Hogan, Katherine; Hinrichs, Christian S.; Parkhurst, Maria R.; Yang, James C.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	sar@nih.gov	Lu, Yong-Chen/G-4520-2014; Hinrichs, Christian/V-9851-2019; Gros, Alena/AAH-2007-2019	Lu, Yong-Chen/0000-0002-0275-9825; Hinrichs, Christian/0000-0001-5597-2841; Gros, Alena/0000-0002-1207-1880; Balmana, Judith/0000-0002-0762-6415	Intramural Research Program of the NIH; NCI;  [PRJNA243084]; NATIONAL CANCER INSTITUTE [ZIABC010984, ZICBC011569, ZIABC011337] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Milstein Family Foundation for their generous support; C.-C. R. Lee, Y. F. Li, A. Mixon, S. Farid, and J. Gartner for helpful technical support and reagents; and the Surgery Branch clinical team for outstanding patient care. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The raw whole-exome sequence data are available on the Sequence Read Archive database: Bioproject PRJNA243084. This research was supported by the Intramural Research Program of the NIH and NCI.	Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Ding ZC, 2012, BLOOD, V120, P2229, DOI 10.1182/blood-2011-12-398321; Echchakir H, 2001, CANCER RES, V61, P4078; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; Hogan KT, 1998, CANCER RES, V58, P5144; Huang JP, 2004, J IMMUNOL, V172, P6057, DOI 10.4049/jimmunol.172.10.6057; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Karanikas V, 2001, CANCER RES, V61, P3718; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; van der Bruggen P., 2013, CANC IMMUNITY; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weden S, 2011, INT J CANCER, V128, P1120, DOI 10.1002/ijc.25449; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	25	1076	1168	11	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					641	645		10.1126/science.1251102	http://dx.doi.org/10.1126/science.1251102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812403	Green Accepted			2022-12-28	WOS:000335537400046
J	Bai, XM; Shi, PJ; Liu, YS				Bai, Xuemei; Shi, Peijun; Liu, Yansui			Realizing China's urban dream	NATURE			English	Editorial Material							URBANIZATION; VILLAGES		[Bai, Xuemei] Australian Natl Univ, Canberra, ACT, Australia; [Shi, Peijun] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resources Ecol, Beijing 100875, Peoples R China; [Liu, Yansui] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China	Australian National University; Beijing Normal University; Beijing Normal University	Bai, XM (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	xuemei.bai@anu.edu.au	Liu, Yansui/L-7289-2019; LIU, Yansui/T-6954-2019; Bai, Xuemei/A-5443-2012	Liu, Yansui/0000-0001-6636-7313; Bai, Xuemei/0000-0001-6556-8041; Shi, Peijun/0000-0002-2968-7331				Bai XM, 2012, ENVIRON SCI TECHNOL, V46, P132, DOI 10.1021/es202329f; Bai XM, 2010, ENVIRON SCI POLICY, V13, P312, DOI 10.1016/j.envsci.2010.03.011; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Chen Z, 2013, LANCET, V382, P1959, DOI 10.1016/S0140-6736(13)62064-4; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; Liu L, 2010, ENVIRONMENT, V52, P8, DOI 10.1080/00139151003618118; Liu YS, 2013, J RURAL STUD, V32, P320, DOI 10.1016/j.jrurstud.2013.08.004; Liu YS, 2013, J GEOGR SCI, V23, P503, DOI 10.1007/s11442-013-1024-8; Shen L, 2005, CITIES, V22, P287, DOI 10.1016/j.cities.2005.05.007	10	696	795	60	537	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					158	160		10.1038/509158a	http://dx.doi.org/10.1038/509158a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG5JC	24812683	Bronze, Green Published			2022-12-28	WOS:000335454300013
J	Chung, JJ; Shim, SH; Everley, RA; Gygi, SP; Zhuang, XW; Clapham, DE				Chung, Jean-Ju; Shim, Sang-Hee; Everley, Robert A.; Gygi, Steven P.; Zhuang, Xiaowei; Clapham, David E.			Structurally Distinct Ca2+ Signaling Domains of Sperm Flagella Orchestrate Tyrosine Phosphorylation and Motility	CELL			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; SOLUBLE ADENYLYL-CYCLASE; CATSPER2 NULL SPERM; MOUSE SPERMATOZOA; FIBROUS SHEATH; MALE-FERTILITY; PROTEIN-PHOSPHORYLATION; MAMMALIAN SPERMATOZOA; CHANNEL; CAPACITATION	Spermatozoa must leave one organism, navigate long distances, and deliver their paternal DNA into a mature egg. For successful navigation and delivery, a sperm-specific calcium channel is activated in the mammalian flagellum. The genes encoding this channel (CatSpers) appear first in ancient uniflagellates, suggesting that sperm use adaptive strategies developed long ago for single-cell navigation. Here, using genetics, super-resolution fluorescence microscopy, and phosphoproteomics, we investigate the CatSper-dependent mechanisms underlying this flagellar switch. We find that the CatSper channel is required for four linear calcium domains that organize signaling proteins along the flagella. This unique structure focuses tyrosine phosphorylation in time and space as sperm acquire the capacity to fertilize. In heterogeneous sperm populations, we find unique molecular phenotypes, but only sperm with intact CatSper domains that organize time-dependent and spatially specific protein tyrosine phosphorylation successfully migrate. These findings illuminate flagellar adaptation, signal transduction cascade organization, and fertility.	[Chung, Jean-Ju; Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Chung, Jean-Ju; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shim, Sang-Hee; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Howard Hughes Medical Institute	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu; dclapham@enders.tch.harvard.edu	Shim, Sang-Hee/A-9051-2012; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Shim, Sang-Hee/AAO-5492-2020	Shim, Sang-Hee/0000-0001-9964-7231; Clapham, David/0000-0002-4459-9428; Shim, Sang-Hee/0000-0001-9964-7231; Chung, Jean-Ju/0000-0001-8018-1355	NIH [U01 HDO45857, 1R01 GM 068518, 1R01 GM 096450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD045857] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518, R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Miki and B. Navarro for discussions; L. Zhao, Y. Shang, and H. Warren for help with mice and western blots; and M. Ericsson and E. Benecchi at the Harvard Medical School EM facility for assistance with electron microscopy. This work was supported by NIH U01 HDO45857 (to D.E.) and by NIH 1R01 GM 068518 and 1R01 GM 096450 (to X.Z.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; BALDI E, 1991, J ANDROL, V12, P323; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Johnson LR, 1997, DEV BIOL, V192, P340, DOI 10.1006/dbio.1997.8767; Kierszenbaum AL, 2008, DEV DYNAM, V237, P3882, DOI 10.1002/dvdy.21789; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Li YF, 2007, J BIOL CHEM, V282, P34104, DOI 10.1074/jbc.M702238200; Lin Y, 1996, BIOL REPROD, V55, P1133, DOI 10.1095/biolreprod55.5.1133; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; MURAMATSU T, 1992, P NATL ACAD SCI USA, V89, P529, DOI 10.1073/pnas.89.2.529; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; NEILL JM, 1987, GAMETE RES, V18, P121, DOI 10.1002/mrd.1120180204; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sakkas D, 2003, BIOL REPROD, V68, P1463, DOI 10.1095/biolreprod.102.011023; Sala-Newby GB, 2001, BBA-GENE STRUCT EXPR, V1521, P12, DOI 10.1016/S0167-4781(01)00278-0; Schalles U, 1998, DEV BIOL, V199, P250, DOI 10.1006/dbio.1998.8931; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Williams AC, 2001, J ANDROL, V22, P680; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; Yanagimachi R., 1994, P189; Zeng XH, 2013, J GEN PHYSIOL, V142, P305, DOI 10.1085/jgp.201311011	70	155	163	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					808	822		10.1016/j.cell.2014.02.056	http://dx.doi.org/10.1016/j.cell.2014.02.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813608	Green Accepted, Bronze			2022-12-28	WOS:000335765500010
J	Flower, TP; Gribble, M; Ridley, AR				Flower, Tom P.; Gribble, Matthew; Ridley, Amanda R.			Deception by Flexible Alarm Mimicry in an African Bird	SCIENCE			English	Article							SIGNALS; SONGBIRDS; EVOLUTION; HANDICAP	Deception is common in nature, but victims of deception discriminate against and ultimately ignore deceptive signals when they are produced too frequently. Flexible variation of signals could allow evasion of such constraints. Fork-tailed drongos (Dicrurus adsimilis) use false alarm calls to scare other species away from food that they then steal. We show that drongos mimic the alarms of targeted species. Further, target species reduce their response to false alarm calls when they are repeated. However, the fear response is maintained when the call is varied. Drongos exploit this propensity by changing their alarm-call type when making repeated theft attempts on a particular species. Our results show that drongos can evade the frequency-dependent constraints that typically limit deception payoffs through flexible variation of their alarm calls.	[Flower, Tom P.; Ridley, Amanda R.] Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; [Flower, Tom P.; Gribble, Matthew] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Ridley, Amanda R.] Univ Western Australia, Sch Anim Biol M092, Ctr Evolutionary Biol, Crawley, WA 6009, Australia	National Research Foundation - South Africa; University of Cape Town; University of Cambridge; University of Western Australia	Flower, TP (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa.	thomas.flower@uct.ac.za	Ridley, Amanda/D-2636-2011	Ridley, Amanda/0000-0001-5886-0992; Flower, Thomas/0000-0003-0531-8010	Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Kalahari Research Trust, T. H. Clutton-Brock, and M. Manser kindly provided study site access. Northern Cape Conservation provided research permission (FAUNA 270/2008), and the University of Cape Town provided ethical permission (2010/V20/TF). We thank N. Davies for supervision and M. Nelson-Flower, A. Thornton, R. Sutcliffe, J. Samson, and three anonymous reviewers for their help and comments. Work was funded by a Natural Environment Research Council grant awarded to T. P. F. Data available from the Dryad Digital Repository (10.5061/dryad.f60j5).	Broom M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1560; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; CHENEY DL, 1988, ANIM BEHAV, V36, P477, DOI 10.1016/S0003-3472(88)80018-6; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Fisher R.A., 1930, GENETICAL THEORY NAT; Flower T, 2011, P ROY SOC B-BIOL SCI, V278, P1548, DOI 10.1098/rspb.2010.1932; Flower TP, 2013, J ANIM ECOL, V82, P245, DOI 10.1111/j.1365-2656.2012.02026.x; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; JACKSON RR, 1993, BEHAVIOUR, V127, P21, DOI 10.1163/156853993X00407; JOHNSTONE RA, 1993, ANIM BEHAV, V46, P759, DOI 10.1006/anbe.1993.1253; Kelley LA, 2008, ANIM BEHAV, V76, P521, DOI 10.1016/j.anbehav.2008.04.012; Langmore NE, 2008, EVOLUTION, V62, P1689, DOI 10.1111/j.1558-5646.2008.00405.x; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Mitchell RW, 1986, DECEPTION PERSPECTIV; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Radford AN, 2011, EVOLUTION, V65, P900, DOI 10.1111/j.1558-5646.2010.01180.x; Ridley AR, 2007, BEHAV ECOL, V18, P324, DOI 10.1093/beheco/arl092; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; Thorogood R, 2012, SCIENCE, V337, P578, DOI 10.1126/science.1220759; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	27	67	68	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					513	516		10.1126/science.1249723	http://dx.doi.org/10.1126/science.1249723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786078				2022-12-28	WOS:000335157700042
J	Yin, XB; Ye, ZL; Chenet, DA; Ye, Y; O'Brien, K; Hone, JC; Zhang, X				Yin, Xiaobo; Ye, Ziliang; Chenet, Daniel A.; Ye, Yu; O'Brien, Kevin; Hone, James C.; Zhang, Xiang			Edge Nonlinear Optics on a MoS2 Atomic Monolayer	SCIENCE			English	Article							VALLEY POLARIZATION; GRAIN-BOUNDARIES; TRANSPORT; STATES	The translational symmetry breaking of a crystal at its surface may form two-dimensional (2D) electronic states. We observed one-dimensional nonlinear optical edge states of a single atomic membrane of molybdenum disulfide (MoS2), a transition metal dichalcogenide. The electronic structure changes at the edges of the 2D crystal result in strong resonant nonlinear optical susceptibilities, allowing direct optical imaging of the atomic edges and boundaries of a 2D material. Using the symmetry of the nonlinear optical responses, we developed a nonlinear optical imaging technique that allows rapid and all-optical determination of the crystal orientations of the 2D material at a large scale. Our technique provides a route toward understanding and making use of the emerging 2D materials and devices.	[Yin, Xiaobo; Ye, Ziliang; Ye, Yu; O'Brien, Kevin; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Chenet, Daniel A.; Hone, James C.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Columbia University	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Ye, Ziliang/AGU-2783-2022; Zhang, Xiang/F-6905-2011; Yin, Xiaobo/A-4142-2011; Hone, James C/E-1879-2011; Ye, Ziliang/A-2104-2011	Ye, Ziliang/0000-0001-8314-6977; Hone, James C/0000-0002-8084-3301; Zhang, Xiang/0000-0002-3272-894X	U.S. Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program [FA9550-12-1-0024]; Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001085]	U.S. Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program; Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences	Supported by the U.S. Air Force Office of Scientific Research, Multidisciplinary University Research Initiative program, under grant FA9550-12-1-0024. The synthesis of the material was supported by the Center for Re-Defining Photovoltaic Efficiency Through Molecular-Scale Control, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001085 (D.A.C. and J.C.H.).	BLOEMBERGEN N, 1962, PHYS REV, V128, P606, DOI 10.1103/PhysRev.128.606; Bollinger MV, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.196803; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; CHEN CK, 1981, PHYS REV LETT, V46, P145, DOI 10.1103/PhysRevLett.46.145; Crain JN, 2005, SCIENCE, V307, P703, DOI 10.1126/science.1106911; Helveg S, 2000, PHYS REV LETT, V84, P951, DOI 10.1103/PhysRevLett.84.951; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161403; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Li YL, 2013, NANO LETT, V13, P3329, DOI 10.1021/nl401561r; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Malard LM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201401; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Sepioni M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.207205; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; SIPE JE, 1987, PHYS REV B, V35, P1129, DOI 10.1103/PhysRevB.35.1129; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Steel WH, 2003, NATURE, V424, P296, DOI 10.1038/nature01791; Tao CG, 2011, NAT PHYS, V7, P616, DOI [10.1038/NPHYS1991, 10.1038/nphys1991]; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Yazyev OV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047209; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/nmat2830, 10.1038/NMAT2830]; Yazyev OV, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/5/056501; Zeng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01608; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]	30	522	532	28	795	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					488	490		10.1126/science.1250564	http://dx.doi.org/10.1126/science.1250564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786072	Green Published			2022-12-28	WOS:000335157700035
J	Martin-Blondel, G; Ysebaert, L				Martin-Blondel, Guillaume; Ysebaert, Loic			Disseminated Cryptococcosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Martin-Blondel, Guillaume; Ysebaert, Loic] Toulouse Univ Hosp, Toulouse, France	CHU de Toulouse	Martin-Blondel, G (corresponding author), Toulouse Univ Hosp, Toulouse, France.	martin-blondel.g@chu-toulouse.fr	Martin-Blondel, Guillaume/K-6762-2014	Martin-Blondel, Guillaume/0000-0002-8363-7028					0	5	5	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1741	1741		10.1056/NEJMicm1309435	http://dx.doi.org/10.1056/NEJMicm1309435			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4QM	24785209				2022-12-28	WOS:000335405200012
J	Lawn, JE; Blencowe, H; Oza, S; You, DZ; Lee, ACC; Waiswa, P; Lalli, M; Bhutta, Z; Barros, AJD; Christian, P; Mathers, C; Cousens, SN				Lawn, Joy E.; Blencowe, Hannah; Oza, Shefali; You, Danzhen; Lee, Anne C. C.; Waiswa, Peter; Lalli, Marek; Bhutta, Zulfiqar; Barros, Aluisio J. D.; Christian, Parul; Mathers, Colin; Cousens, Simon N.		Lancet Every Newborn Study Grp	Every Newborn: progress, priorities, and potential beyond survival	LANCET			English	Article							FOR-GESTATIONAL-AGE; OFFICIAL DEVELOPMENT ASSISTANCE; 4-MILLION NEONATAL DEATHS; MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; LOW-BIRTH-WEIGHT; PRETERM BIRTH; GLOBAL LEVELS; SYSTEMATIC ANALYSIS; CHILD HEALTH	In this Series paper, we review trends since the 2005 Lancet Series on Neonatal Survival to inform acceleration of progress for newborn health post-2015. On the basis of multicountry analyses and multi-stakeholder consultations, we propose national targets for 2035 of no more than 10 stillbirths per 1000 total births, and no more than 10 neonatal deaths per 1000 livebirths, compatible with the under-5 mortality targets of no more than 20 per 1000 livebirths. We also give targets for 2030. Reduction of neonatal mortality has been slower than that for maternal and child (1-59 months) mortality, slowest in the highest burden countries, especially in Africa, and reduction is even slower for stillbirth rates. Birth is the time of highest risk, when more than 40% of maternal deaths (total about 290 000) and stillbirths or neonatal deaths (5.5 million) occur every year. These deaths happen rapidly, needing a rapid response by health-care workers. The 2.9 million annual neonatal deaths worldwide are attributable to three main causes: infections (0.6 million), intrapartum conditions (0.7 million), and preterm birth complications (1.0 million). Boys have a higher biological risk of neonatal death, but girls often have a higher social risk. Small size at birth-due to preterm birth or small-for-gestational-age (SGA), or both-is the biggest risk factor for more than 80% of neonatal deaths and increases risk of post-neonatal mortality, growth failure, and adult-onset non-communicable diseases. South Asia has the highest SGA rates and sub-Saharan Africa has the highest preterm birth rates. Babies who are term SGA low birthweight (10.4 million in these regions) are at risk of stunting and adult-onset metabolic conditions. 15 million preterm births, especially of those younger than 32 weeks' gestation, are at the highest risk of neonatal death, with ongoing post-neonatal mortality risk, and important risk of long-term neurodevelopmental impairment, stunting, and non-communicable conditions. 4 million neonates annually have other life-threatening or disabling conditions including intrapartum-related brain injury, severe bacterial infections, or pathological jaundice. Half of the world's newborn babies do not get a birth certificate, and most neonatal deaths and almost all stillbirths have no death certificate. To count deaths is crucial to change them. Failure to improve birth outcomes by 2035 will result in an estimated 116 million deaths, 99 million survivors with disability or lost development potential, and millions of adults at increased risk of non-communicable diseases after low birthweight. In the post-2015 era, improvements in child survival, development, and human capital depend on ensuring a healthy start for every newborn baby-the citizens and workforce of the future.	[Lawn, Joy E.; Blencowe, Hannah; Oza, Shefali; Lalli, Marek; Cousens, Simon N.] London Sch Hyg & Trop Med, Ctr Maternal Reprod & Child Hlth, London WC1E 7HT, England; [Lawn, Joy E.; Blencowe, Hannah; Oza, Shefali; Lalli, Marek; Cousens, Simon N.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Lawn, Joy E.] Save Children USA, Saving Newborn Lives, Washington, DC USA; [Lawn, Joy E.] Dept Int Dev, Res & Evidence Div, London, England; [You, Danzhen] UNICEF, Div Policy & Strategy, New York, NY USA; [Lee, Anne C. C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Lee, Anne C. C.; Christian, Parul] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Waiswa, Peter] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Waiswa, Peter] Karolinska Inst, Div Global Hlth, Stockholm, Sweden; [Bhutta, Zulfiqar] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Barros, Aluisio J. D.] Univ Fed Pelotas, Pelotas, Brazil; [Barros, Aluisio J. D.] Countdown 2015 Equ Tech Working Grp, Pelotas, Brazil; [Mathers, Colin] WHO, Mortal & Burden Dis Unit, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Save the Children; UNICEF; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Karolinska Institutet; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Universidade Federal de Pelotas; World Health Organization	Lawn, JE (corresponding author), London Sch Hyg & Trop Med, Ctr Maternal Reprod & Child Hlth, London WC1E 7HT, England.	joy.lawn@lshtm.ac.uk	pan, tao/O-7308-2014; Lawn, Joy/ABE-6382-2020; Barros, Aluisio JD/A-7417-2008	Lawn, Joy/0000-0002-4573-1443; Barros, Aluisio JD/0000-0002-2022-8729; Oza, Shefali/0000-0001-5872-486X; McDougall, Lori/0000-0002-1885-5344; Mathers, Colin/0000-0002-0617-6731; Blencowe, Hannah/0000-0003-1556-3159	Children's Investment Fund Foundation (CIFF); Bill & Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG), Saving Newborn Lives, Save the Children; US fund for UNICEF; UN Interagency Group for Child Mortality Estimation (UN-IGME)	Children's Investment Fund Foundation (CIFF); Bill & Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG), Saving Newborn Lives, Save the Children; US fund for UNICEF; UN Interagency Group for Child Mortality Estimation (UN-IGME)	Work for this Series paper was funded through a grant from the Children's Investment Fund Foundation (CIFF) and also draws on analyses funded by the Bill & Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG), Saving Newborn Lives, Save the Children, and US fund for UNICEF to the Countdown Equity Analysis group and the UN Interagency Group for Child Mortality Estimation (UN-IGME). We acknowledge the valuable contribution of the work of Naoko Kozuki, Joanne Katz, Sun Eun Lee, and others in the CHERG SGA-Preterm Birth analyses team, and the CHERG team for review and teamwork on the cause of death estimates. We thank Daniel Hogan for data on child deaths and the International Centre for Equity in Health for equity analyses. We thank Mary Kinney and Kate Kerber of Save the Children for data inputs. We thank Liz Mason and Matthews Mathai for co-chairing the Every Newborn target setting global review group, and the members including Robert Black, Danzhen You, Suzanne Fournier, John Grove, Marge Koblinsky, and Lily Kak.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Alkema L, 2013, GENDER DIFFERENCES I; [Anonymous], 2013, GLOB NEWB HLTH C JOH; [Anonymous], PARTN ACT 2012 13; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bhutta ZA, 2014, LANCET; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Chalumeau M, 2002, INT J EPIDEMIOL, V31, P661, DOI 10.1093/ije/31.3.661; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Gascoin G, 2013, J GYNECOL OBST BIO R, V42, P911, DOI 10.1016/j.jgyn.2013.09.014; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Independent Expert Review Group (iERG), 2013, EV WOM EV CHILD STRE; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Katz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092074; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Khera R, 2014, ARCH DIS CHILD, V99, P369, DOI 10.1136/archdischild-2013-303889; Kulmala T, 2000, ACTA OBSTET GYN SCAN, V79, P984, DOI 10.1034/j.1600-0412.2000.079011984.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2013, PEDIATR RES, V74, P1, DOI 10.1038/pr.2013.202; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Marlow N, 2012, ARCH DIS CHILD-FETAL, V97, pF158, DOI 10.1136/fetalneonatal-2011-301507; Modell B, 2012, LANCET, V380, P1556, DOI 10.1016/S0140-6736(12)61878-9; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nie JB, 2011, BRIT MED BULL, V98, P7, DOI 10.1093/bmb/ldr015; Nielsen BB, 1997, BMJ-BRIT MED J, V314, P1521, DOI 10.1136/bmj.314.7093.1521; Oza S, NEONATAL CAUSES DEAT; Peebles DM, 2002, BJOG-INT J OBSTET GY, V109, P737; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Restrepo-Mendez MC, 2014, LANCET GLOB HEALTH, V2, pE120, DOI 10.1016/S2214-109X(14)70007-5; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Save the Children, 2013, STAT WORLDS MOTH SUR; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Stanley F, 2000, CLIN DEV MED; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; UNICEF, 2013, EV CHILDS RIGHT; UNICEF, 2017, LEVELS TRENDS CHILD; UNICEF, BOYS GIRLS LIF CYCL; UNICEF WHO, 2013, EV NEWB ACT PLAN END; United Nations, MILL DEV GOALS REP 2; United Nations Department of Economic and Social Affairs Population Division, 2013, POPDBFERTAMDG2013; van Lonkhuijzen L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006759.pub3; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, COMPR IMPL PLAN MAT; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wiedmeier JE, 2011, NUTR REV, V69, P76, DOI 10.1111/j.1753-4887.2010.00370.x; World Health Organization, GLOB STAT REP NONC D; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762	92	949	972	10	148	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					189	205		10.1016/S0140-6736(14)60496-7	http://dx.doi.org/10.1016/S0140-6736(14)60496-7			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL1YC	24853593				2022-12-28	WOS:000338921500038
J	Chin, RM; Fu, XD; Pai, MY; Vergnes, L; Hwang, H; Deng, G; Diep, S; Lomenick, B; Meli, VS; Monsalve, GC; Hu, E; Whelan, SA; Wang, JX; Jung, G; Solis, GM; Fazlollahi, F; Kaweeteerawat, C; Quach, A; Nili, M; Krall, AS; Godwin, HA; Chang, HR; Faull, KF; Guo, F; Jiang, MS; Trauger, SA; Saghatelian, A; Braas, D; Christofk, HR; Clarke, CF; Teitell, MA; Petrascheck, M; Reue, K; Jung, ME; Frand, AR; Huang, J				Chin, Randall M.; Fu, Xudong; Pai, Melody Y.; Vergnes, Laurent; Hwang, Heejun; Deng, Gang; Diep, Simon; Lomenick, Brett; Meli, Vijaykumar S.; Monsalve, Gabriela C.; Hu, Eileen; Whelan, Stephen A.; Wang, Jennifer X.; Jung, Gwanghyun; Solis, Gregory M.; Fazlollahi, Farbod; Kaweeteerawat, Chitrada; Quach, Austin; Nili, Mahta; Krall, Abby S.; Godwin, Hilary A.; Chang, Helena R.; Faull, Kym F.; Guo, Feng; Jiang, Meisheng; Trauger, Sunia A.; Saghatelian, Alan; Braas, Daniel; Christofk, Heather R.; Clarke, Catherine F.; Teitell, Michael A.; Petrascheck, Michael; Reue, Karen; Jung, Michael E.; Frand, Alison R.; Huang, Jing			The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION; DEVELOPMENTAL ARREST; DIETARY RESTRICTION; PHOSPHORYLATION; AUTOPHAGY; LONGEVITY; GENETICS; DEFICIENCY; PHA-4/FOXA	Metabolism and ageing are intimately linked. Compared with ad libitum feeding, dietary restriction consistently extends lifespan and delays age-related diseases in evolutionarily diverse organisms(1,2). Similar conditions of nutrient limitation and genetic or pharmacological perturbations of nutrient or energy metabolism also have longevity benefits(3,4). Recently, several metabolites have been identified that modulate ageing(5,6); however, the molecular mechanisms underlying this are largely undefined. Here we show that alpha-ketoglutarate (alpha-KG), a tricarboxylic acid cycle intermediate, extends the lifespan of adult Caenorhabditis elegans. ATP synthase subunit beta is identified as a novel binding protein of alpha-KG using a small-molecule target identification strategy termed drug affinity responsive target stability (DARTS)(7). The ATP synthase, also known as complex V of the mitochondrial electron transport chain, is the main cellular energy generating machinery and is highly conserved throughout evolution(8,9). Although complete loss of mitochondrial function is detrimental, partial suppression of the electron transport chain has been shown to extend C. elegans lifespan(10-13). We show that alpha-KG inhibits ATP synthase and, similar to ATP synthase knockdown, inhibition by alpha-KG leads to reduced ATP content, decreased oxygen consumption, and increased autophagy in both C. elegans and mammalian cells. We provide evidence that the lifespan increase by alpha-KG requires ATP synthase subunit b and is dependent on target of rapamycin (TOR) downstream. Endogenous alpha-KG levels are increased on starvation and alpha-KG does not extend the lifespan of dietary-restricted animals, indicating that alpha-KG is a key metabolite that mediates longevity by dietary restriction. Our analyses uncover new molecular links between a common metabolite, a universal cellular energy generator and dietary restriction in the regulation of organismal lifespan, thus suggesting new strategies for the prevention and treatment of ageing and age-related diseases.	[Chin, Randall M.; Pai, Melody Y.; Clarke, Catherine F.; Teitell, Michael A.; Reue, Karen; Jung, Michael E.; Huang, Jing] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Fu, Xudong; Hwang, Heejun; Diep, Simon; Lomenick, Brett; Hu, Eileen; Jung, Gwanghyun; Quach, Austin; Krall, Abby S.; Jiang, Meisheng; Braas, Daniel; Christofk, Heather R.; Huang, Jing] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Deng, Gang; Clarke, Catherine F.; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Meli, Vijaykumar S.; Monsalve, Gabriela C.; Guo, Feng; Frand, Alison R.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Whelan, Stephen A.; Chang, Helena R.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; [Wang, Jennifer X.; Trauger, Sunia A.] Harvard Univ, FAS Div Sci, Small Mol Mass Spectrometry Facil, Cambridge, MA 02138 USA; [Solis, Gregory M.; Petrascheck, Michael] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Fazlollahi, Farbod; Faull, Kym F.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Fazlollahi, Farbod; Faull, Kym F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Kaweeteerawat, Chitrada; Godwin, Hilary A.] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA; [Nili, Mahta; Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Braas, Daniel; Christofk, Heather R.] Univ Calif Los Angeles, UCLA Metabol Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; University of California System; University of California Los Angeles	Huang, J (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	jinghuang@mednet.ucla.edu	Meli, Vijaykumar S/A-1879-2018; Petrascheck, Michael/R-7832-2019; Guo, Feng/HIK-3259-2022; Fu, Xudong/AAT-4400-2021; Fu, Xudong/AAM-9493-2020; Lomenick, Brett/AAR-3294-2020; Whelan, Stephen A/I-9502-2012	Meli, Vijaykumar S/0000-0002-8690-4363; Petrascheck, Michael/0000-0002-1010-145X; Fu, Xudong/0000-0001-7024-0200; Whelan, Stephen A/0000-0002-4740-0795; Hu, Eileen/0000-0002-7720-3522; Solis, Gregory/0000-0002-3347-5980; Frand, Alison/0000-0001-5972-989X; Lomenick, Brett/0000-0002-5023-9998; Christofk, Heather/0000-0002-8662-4425; Fazlollahi, Farbod/0000-0002-0954-5731; Chin, Randall/0000-0003-0721-3204; vergnes, laurent/0000-0002-8804-589X; Whelan, Stephen A/0000-0002-5439-6501; Trauger, Sunia/0000-0002-1678-8715	National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; NIH [T32 GM007104, T32 GM007185, T32 GM008496, T32 CA009120]; China Scholarship Council Scholarship; Ford Foundation; National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496, T32GM007104, T32GM007185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440, DP2OD008398] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council Scholarship(China Scholarship Council); Ford Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Lee, M. Hansen, B. Lemire, A. van der Bliek, S. Clarke, T. K. Blackwell, R. Johnson, J. E. Walker, A. G. W. Leslie, K. N. Houk, B. Martin, J. Lusis, J. Gober, Y. Wang and H. Sun for advice and discussions. J. Avruch for the let-363 RNAi vector; J. Powell-Coffman for strains and advice; and K. Yan for technical assistance. Worm strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs(P40 OD010440). We thank the NIH for traineeship support of R. M. C. (T32 GM007104), M. Y. P. (T32 GM007185), B. L. (T32 GM008496) and M. N. (T32 CA009120). X. F. is a recipient of the China Scholarship Council Scholarship. G. C. M. was supported by Ford Foundation and National Science Foundation Graduate Research Fellowships.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alberti A, 2010, AUTOPHAGY, V6, P622, DOI 10.4161/auto.6.5.12252; Alberts B., 1994, MOL BIOL CELL; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BRENNER S, 1974, GENETICS, V77, P71; Brugnara L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040600; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gems D, 2000, GENETICS, V154, P1597; Gingras AC, 2001, GENE DEV, V15, P2852; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, WESTERN HUM REV, V61, P6; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Jung ME, 2012, J ORG CHEM, V77, P11002, DOI 10.1021/jo302308q; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAMINSKY YG, 1982, COMP BIOCHEM PHYS B, V73, P957, DOI 10.1016/0305-0491(82)90343-1; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Williams DS, 2009, AGING CELL, V8, P765, DOI 10.1111/j.1474-9726.2009.00527.x; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	59	329	354	7	171	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					397	401		10.1038/nature13264	http://dx.doi.org/10.1038/nature13264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24828042	Green Accepted, Green Submitted			2022-12-28	WOS:000337350200035
J	Kirschvink, JL				Kirschvink, Joseph L.			SENSORY BIOLOGY Radio waves zap the biomagnetic compass	NATURE			English	Editorial Material							MAGNETIC ORIENTATION; DESIGN; BIRDS		[Kirschvink, Joseph L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Kirschvink, Joseph L.] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo, Japan	California Institute of Technology; Tokyo Institute of Technology	Kirschvink, JL (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	kirschvink@gmail.com	Kirschvink, Joseph L/U-5844-2017					BLOCK SM, 1992, SOC GEN PHY, V47, P1; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; KIRSCHVINK JL, 1992, P NATL ACAD SCI USA, V89, P7683, DOI 10.1073/pnas.89.16.7683; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; KOBAYASHI AK, 1995, NATURE, V374, P123, DOI 10.1038/374123a0; Labelle J, 2002, SPACE SCI REV, V101, P295, DOI 10.1023/A:1020850022070; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Schumann D, 2008, P NATL ACAD SCI USA, V105, P17648, DOI 10.1073/pnas.0803634105; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7	11	9	9	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					296	297		10.1038/nature13334	http://dx.doi.org/10.1038/nature13334			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805230				2022-12-28	WOS:000336121200025
J	Jackson, E				Jackson, Edward			The Recognition of Glaucoma by the General Practitioner (Reprinted from vol 3, pg 456, 1884)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		JACKSON E, 1884, JAMA-J AM MED ASSOC, V3, P456	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1925	1925		10.1001/jama.2013.279495	http://dx.doi.org/10.1001/jama.2013.279495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825656				2022-12-28	WOS:000335798100032
J	Singh, R; Meier, TB; Kuplicki, R; Savitz, J; Mukai, I; Cavanagh, L; Allen, T; Teague, TK; Nerio, C; Polanski, D; Bellgowan, PSF				Singh, Rashmi; Meier, Timothy B.; Kuplicki, Rayus; Savitz, Jonathan; Mukai, Ikuko; Cavanagh, LaMont; Allen, Thomas; Teague, T. Kent; Nerio, Christopher; Polanski, David; Bellgowan, Patrick S. F.			Relationship of Collegiate Football Experience and Concussion With Hippocampal Volume and Cognitive Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; DEFICITS; PLAYERS; STRESS; IDENTIFICATION; PERFORMANCE; RECOVERY; IMPACT; MODEL	IMPORTANCE Concussion and subconcussive impacts have been associated with short-term disrupted cognitive performance in collegiate athletes, but there are limited data on their long-term neuroanatomic and cognitive consequences. OBJECTIVE To assess the relationships of concussion history and years of football experience with hippocampal volume and cognitive performance in collegiate football athletes. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study conducted between June 2011 and August 2013 at a US psychiatric research institute specializing in neuroimaging among collegiate football players with a history of clinician-diagnosed concussion (n = 25), collegiate football players without a history of concussion (n = 25), and non-football-playing, age-, sex-, and education-matched healthy controls (n = 25). EXPOSURES History of clinician-diagnosed concussion and years of football experience. MAIN OUTCOMES AND MEASURES High-resolution anatomical magnetic resonance imaging was used to quantify brain volumes. Baseline scores on a computerized concussion-related cognitive battery were used for cognitive assessment in athletes. RESULTS Players with and without a history of concussion had smaller hippocampal volumes relative to healthy control participants (with concussion: t(48) = 7.58; P < .001; mean difference, 1788 mu L; 95% CI, 1317-2258 mu L; without concussion: t(48) = 4.35; P < .001, mean difference, 1027 mu L; 95% CI, 556-1498 mu L). Players with a history of concussion had smaller hippocampal volumes than players without concussion (t(48) = 3.15; P < .001; mean difference, 761 mu L; 95% CI, 280-1242 mu L). In both athlete groups, there was a statistically significant inverse relationship between left hippocampal volume and number of years of football played (t(46) = -3.62; P < .001; coefficient = -43.54; 95% CI, -67.66 to -19.41). Behavioral testing demonstrated no differences between athletes with and without a concussion history on 5 cognitive measures but did show an inverse correlation between years of playing football and reaction time (rho(42) = -0.43; 95% CI, -0.46 to -0.40; P = .005). CONCLUSIONS AND RELEVANCE Among a group of collegiate football athletes, there was a significant inverse relationship of concussion and years of football played with hippocampal volume. Years of football experience also correlated with slower reaction time. Further research is needed to determine the temporal relationships of these findings.	[Singh, Rashmi; Meier, Timothy B.; Kuplicki, Rayus; Savitz, Jonathan; Mukai, Ikuko; Bellgowan, Patrick S. F.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Kuplicki, Rayus] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [Savitz, Jonathan; Bellgowan, Patrick S. F.] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Cavanagh, LaMont; Allen, Thomas] Univ Oklahoma, Dept Family Med, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Surg, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Psychiat, Oklahoma Sch Community Med, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Dept Pharmaceut Sci, Oklahoma Coll Pharm, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Nerio, Christopher; Polanski, David] Univ Tulsa, Dept Athlet, Tulsa, OK 74104 USA	Laureate Institute for Brain Research, Inc.; University of Tulsa; University of Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa; Oklahoma State University System; Oklahoma State University Center for Health Sciences; University of Tulsa	Bellgowan, PSF (corresponding author), Laureate Inst Brain Res, 6655 S Yale Ave, Tulsa, OK 74136 USA.	pbellgowan@laureateinstitute.org	Savitz, Jonathan/C-3088-2009; Teague, T. Kent/A-2527-2008	Savitz, Jonathan/0000-0001-8143-182X; Teague, T. Kent/0000-0002-4680-5440; Bellgowan, Patrick/0000-0002-6753-8302	Laureate Institute for Brain Research; William K. Warren Foundation	Laureate Institute for Brain Research; William K. Warren Foundation	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by the William K. Warren Foundation.	Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Erk S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.57; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Franko E, 2014, HUM BRAIN MAPP, V35, P248, DOI 10.1002/hbm.22170; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	30	90	91	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1883	1888		10.1001/jama.2014.3313	http://dx.doi.org/10.1001/jama.2014.3313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825643	Bronze			2022-12-28	WOS:000335798100020
J	Atkinson, P; French, J; Nice, CA				Atkinson, Paul; French, James; Nice, C. Andrew			THERAPEUTICS Procedural sedation and analgesia for adults in the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROPOFOL; KETAMINE; ASSOCIATION; RELOCATION; MIDAZOLAM; THEATER; SAFETY		[Atkinson, Paul; French, James] Dalhousie Univ, St John Reg Hosp, Dept Emergency Med, St John, NB E2L 4L4, Canada; [Atkinson, Paul] Mem Univ Newfoundland, Discipline Emergency Med, St John Reg Hosp, St John, NB, Canada; [Nice, C. Andrew] Dalhousie Univ, St John Reg Hosp, Dept Anesthesia Pain Management & Perioperat Med, St John, NB E2L 4L4, Canada; [Nice, C. Andrew] Mem Univ Newfoundland, St John Reg Hosp, Discipline Anesthesia, St John, NB, Canada	Dalhousie University; Memorial University Newfoundland; Dalhousie University; Memorial University Newfoundland	Atkinson, P (corresponding author), Dalhousie Univ, St John Reg Hosp, Dept Emergency Med, St John, NB E2L 4L4, Canada.	Paul.atkinson@dal.ca						Andolfatto G, 2012, ANN EMERG MED, V59, P504, DOI 10.1016/j.annemergmed.2012.01.017; Baker Stephanie N, 2011, J Pharm Pract, V24, P189, DOI 10.1177/0897190011400554; Boyle A, 2011, EMERG MED J, V28, P383, DOI 10.1136/emj.2010.092965; Campbell Sam G, 2006, CJEM, V8, P85; Dawson N, 2014, EMERG MED J, V31, P207, DOI 10.1136/emermed-2012-202147; Deitch K, 2010, ANN EMERG MED, V55, P258, DOI 10.1016/j.annemergmed.2009.07.030; Frank RL, 2013, UPTODATE; Gagg J, 2009, EMERG MED J, V26, P39, DOI 10.1136/emj.2008.057737; Godwin SA, 2005, ANN EMERG MED, V45, P177, DOI 10.1016/j.annemergmed.2004.11.002; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Hohl CM, 2008, ACAD EMERG MED, V15, P1, DOI 10.1111/j.1553-2712.2007.00022.x; Hohl CM, 2008, ACAD EMERG MED, V15, P32, DOI 10.1111/j.1553-2712.2007.00023.x; Mathieu N, 2009, EMERG MED J, V26, P37, DOI 10.1136/emj.2008.057729; Mellin-Olsen J, 2010, EUR J ANAESTH, V27, P592, DOI 10.1097/EJA.0b013e32833b1adf; Messenger DW, 2008, ACAD EMERG MED, V15, P877, DOI 10.1111/j.1553-2712.2008.00219.x; Miner JR, 2007, ANN EMERG MED, V49, P15, DOI 10.1016/j.annemergmed.2006.06.042; Miner JR, 2003, ACAD EMERG MED, V10, P638, DOI 10.1111/j.1553-2712.2003.tb00048.x; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Newton A, 2008, EMERG MED J, V25, P498, DOI 10.1136/emj.2007.053421; O'Connor RE, 2011, ANN EMERG MED, V58, P365, DOI 10.1016/j.annemergmed.2011.06.020; O'Sullivan I, 2003, EMERG MED J, V20, P214, DOI 10.1136/emj.20.3.214; Reves JG, 2010, MILLERS ANESTHESIA; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; Sivilotti MLA, 2010, CAN J EMERG MED, V12, P397; Stoelting RK., 2006, PHARM PHYSL ANESTHET, V4; The Royal College of Anaesthetists & The College of Emergency Medicine, 2012, SAF SED AD EM DEP; Tobias JD, 2011, SAUDI J ANAESTH, V5, P395, DOI 10.4103/1658-354X.87270; WHO, 2006, 36 ECDD 2006 4 3 CRI	28	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g2965	10.1136/bmj.g2965	http://dx.doi.org/10.1136/bmj.g2965			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812113				2022-12-28	WOS:000335819700005
J	Fernandez, IS; Bai, XC; Murshudov, G; Scheres, SHW; Ramakrishnan, V				Fernandez, Israel S.; Bai, Xiao-Chen; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.			Initiation of Translation by Cricket Paralysis Virus IRES Requires Its Translocation in the Ribosome	CELL			English	Article							EM STRUCTURE DETERMINATION; TRANSFER-RNA DYNAMICS; ENTRY SITE; CRYO-EM; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; TERTIARY STRUCTURE; MESSENGER-RNA; DENSITY MAPS; HYBRID-STATE	The cricket paralysis virus internal ribosome entry site (CrPV-IRES) is a folded structure in a viral mRNA that allows initiation of translation in the absence of any host initiation factors. By using recent advances in single-particle electron cryomicroscopy, we have solved the structure of CrPV-IRES bound to the ribosome of the yeast Kluyveromyces lactis in both the canonical and rotated states at overall resolutions of 3.7 and 3.8 A, respectively. In both states, the pseudoknot PKI of the CrPV-IRES mimics a tRNA/mRNA interaction in the decoding center of the A site of the 40S ribosomal subunit. The structure and accompanying factor-binding data show that CrPV-IRES binding mimics a pretranslocation rather than initiation state of the ribosome. Translocation of the IRES by elongation factor 2 (eEF2) is required to bring the first codon of the mRNA into the A site and to allow the start of translation.	[Fernandez, Israel S.; Bai, Xiao-Chen; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Bai, Xiao-chen/HGV-1244-2022; Scheres, Sjors H.W./AAY-2265-2021	Bai, Xiao-chen/0000-0002-4234-5686; Scheres, Sjors H.W./0000-0002-0462-6540; Fernandez, Israel/0000-0001-7218-1603; Ramakrishnan, V/0000-0002-4699-2194	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust Senior Investigator award [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_U105184332, MC_UP_A025_1013, MC_UP_A025_1012] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1012, MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Investigator award(Wellcome Trust); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Shaoxia Chen for technical support with cryo-EM, Greg McMullan for help in movie data acquisition, Toby Darling and Jake Grimmett for help with computing, David Tourigny and Alan Brown for discussions, Ann C. Kelley for advice and help in RNA production, and Wojciech Galej and Andrew Newman for advice in yeast protein expression. X.-C. B. is supported by an EU FP7 Marie Curie postdoctoral fellowship. This work was funded by grants from the UK Medical Research Council (MC_U105184332 to V. R. and MC_UP_A025_1013 to SHWS) and a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V.R.).	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nixon PL, 2000, J MOL BIOL, V296, P659, DOI 10.1006/jmbi.1999.3464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rodicio R, 2013, YEAST, V30, P165, DOI 10.1002/yea.2954; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yamamoto H, 2007, J BIOL CHEM, V282, P7770, DOI 10.1074/jbc.M610887200	46	141	143	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					823	831		10.1016/j.cell.2014.04.015	http://dx.doi.org/10.1016/j.cell.2014.04.015			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24792965	Green Published, hybrid			2022-12-28	WOS:000335765500011
J	Gulen, T; Hagglund, H; Dahlen, SE; Sander, B; Dahlen, B; Nilsson, G				Gulen, Theo; Hagglund, Hans; Dahlen, Sven-Erik; Sander, Birgitta; Dahlen, Barbro; Nilsson, Gunnar			Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis	LANCET			English	Editorial Material							SYSTEMIC MASTOCYTOSIS		[Gulen, Theo; Dahlen, Sven-Erik] Karolinska Univ Hosp Huddinge, Dept Resp Med & Allergy, Stockholm, Sweden; [Hagglund, Hans] Karolinska Univ Hosp Huddinge, Dept Hematol, Stockholm, Sweden; [Dahlen, Sven-Erik] Karolinska Inst, Natl Inst Environm Med, Stockholm, Sweden; [Sander, Birgitta] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Nilsson, Gunnar] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Res Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Nilsson, G (corresponding author), Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden.	gunnar.p.nilsson@ki.se	Gulen, Theo/D-8682-2018	Gulen, Theo/0000-0002-1683-8882; Nilsson, Gunnar/0000-0001-6795-5512				Butterfield JH, 2006, IMMUNOL ALLERGY CLIN, V26, P487, DOI 10.1016/j.iac.2006.05.006; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; Tolar J, 2004, NEW ENGL J MED, V350, P735, DOI 10.1056/NEJM200402123500723; YOUNG WF, 1995, MAYO CLIN PROC, V70, P757, DOI 10.4065/70.8.757	5	17	17	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1608	1608						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792857				2022-12-28	WOS:000335495400033
J	Hempel, S				Hempel, Sandra			The art of medicine John St John Long: quackery and manslaughter	LANCET			English	Editorial Material												palewell@globalnet.co.uk						[Anonymous], 1831, DEFENCE JS LONG CASE; Long Hutt M., 1798, OXFORD DICT NATL BIO; Long John St John, 1829, LANCET, V1, P506; Long JSJ, 1834, PLAIN STATEMENT AUTH; The Lancet, 1837, LANCET, V2, P485	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1540	1541		10.1016/S0140-6736(14)60737-6	http://dx.doi.org/10.1016/S0140-6736(14)60737-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AG5YO	24800298				2022-12-28	WOS:000335495400013
J	Jahrling, PB; Tomori, O				Jahrling, Peter B.; Tomori, Owale			Variola virus archives: a new century, a new approach	LANCET			English	Editorial Material									[Jahrling, Peter B.] NIAID, NIH, Ft Detrick, MD 21702 USA; [Tomori, Owale] Redeemers Univ, Redemption City, Ogin State, Nigeria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Redeemers University	Jahrling, PB (corresponding author), NIAID, NIH, Ft Detrick, MD 21702 USA.	jahrlingp@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Farlow J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-110; Henderson DA, 2014, BIOSECUR BIOTERROR, V12, P117, DOI 10.1089/bsp.2014.1509.comm; Kindrachuk J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015701; Kugelman JR, 2014, EMERG INFECT DIS, V20, P232, DOI 10.3201/eid2002.130118; Law GL, 2013, CURR OPIN IMMUNOL, V25, P588, DOI 10.1016/j.coi.2013.08.004; McFadden G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000727; Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13; Reynolds MG, 2013, AM J TROP MED HYG, V88, P982, DOI 10.4269/ajtmh.12-0758	9	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1525	1526		10.1016/S0140-6736(14)60693-0	http://dx.doi.org/10.1016/S0140-6736(14)60693-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792843				2022-12-28	WOS:000335495400005
J	Barman, T				Barman, Travis			ASTRONOMY A new spin on exoplanets	NATURE			English	Editorial Material							BROWN DWARFS		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Barman, T (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	barman@lpl.arizona.edu			Division Of Astronomical Sciences [1405505] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Binks AS, 2014, MON NOT R ASTRON SOC, V438, pL11, DOI 10.1093/mnrasl/slt141; Bonnefoy M, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016224; Lodders K, 2002, ICARUS, V155, P393, DOI 10.1006/icar.2001.6740; Macintosh B., 2014, PREPRINT; Reiners A, 2008, ASTROPHYS J, V684, P1390, DOI 10.1086/590073; Showman AP, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/85; Snellen IAG, 2014, NATURE, V509, P63, DOI 10.1038/nature13253	8	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					41	42		10.1038/509041a	http://dx.doi.org/10.1038/509041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784213				2022-12-28	WOS:000335199100035
J	Fuller, G; Simpson, IA				Fuller, Geraint; Simpson, Iain A.			"Modernising Medical Careers" to "Shape of Training"-how soon we forget	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fuller, Geraint] Gloucestershire Royal Hosp, Gloucester, England; [Simpson, Iain A.] Univ Hosp Southampton NHS Fdn Trust, Wessex Reg Cardiac Unit, Southampton, Hants, England	Gloucestershire Royal Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Fuller, G (corresponding author), Gloucestershire Royal Hosp, Gloucester, England.	Geraint.Fuller@glos.nhs.uk						[Anonymous], CERT DAT; Delamothe T, 2007, BRIT MED J, V335, P733, DOI 10.1136/bmj.39364.512685.80; Department of Health, 2004, MOD MED CAR NEXT STE; Greenaway D, 2013, SECURING FUTURE EXCE; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Madden G, 2007, BMJ-BRIT MED J, V335, P426, DOI 10.1136/bmj.39300.591632.DE; National Institute for Cardiovascular Outcomes Research, NAT HEART FAIL AUD 2; Oates J., 2013, SHAPE TRAINING EVIDE; Tooke J., 2007, ASPIRING EXCELLENCE; Tooke J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7604	10	10	10	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2014	348								g2865	10.1136/bmj.g2865	http://dx.doi.org/10.1136/bmj.g2865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RZ	24789094				2022-12-28	WOS:000335477500002
J	Mason, E; McDougall, L; Lawn, JE; Gupta, A; Claeson, M; Pillay, Y; Presern, C; Lukong, MB; Mann, G; Wijnroks, M; Azad, K; Taylor, K; Beattie, A; Bhutta, ZA; Chopra, M				Mason, Elizabeth; McDougall, Lori; Lawn, Joy E.; Gupta, Anuradha; Claeson, Mariam; Pillay, Yogan; Presern, Carole; Lukong, Martina Baye; Mann, Gillian; Wijnroks, Marijke; Azad, Kishwar; Taylor, Katherine; Beattie, Allison; Bhutta, Zulfiqar A.; Chopra, Mickey		Lancet Every Newborn Study Grp; Every Newborn Steering Comm	From evidence to action to deliver a healthy start for the next generation	LANCET			English	Article							GLOBAL HEALTH; NEWBORN; CARE; STILLBIRTHS; FACILITIES; SURVIVAL	Remarkable progress has been made towards halving of maternal deaths and deaths of children aged 1-59 months, although the task is incomplete. Newborn deaths and stillbirths were largely invisible in the Millennium Development Goals, and have continued to fall between maternal and child health efforts, with much slower reduction. This Series and the Every Newborn Action Plan outline mortality goals for newborn babies (ten or fewer per 1000 livebirths) and stillbirths (ten or fewer per 1000 total births) by 2035, aligning with A Promise Renewed target for children and the vision of Every Woman Every Child. To focus political attention and improve performance, goals for newborn babies and stillbirths must be recognised in the post-2015 framework, with corresponding accountability mechanisms. The four previous papers in this Every Newborn Series show the potential for a triple return on investment around the time of birth: averting maternal and newborn deaths and preventing stillbirths. Beyond survival, being counted and optimum nutrition and development is a human right for all children, including those with disabilities. Improved human capital brings economic productivity. Efforts to reach every woman and every newborn baby, close gaps in coverage, and improve equity and quality for antenatal, intrapartum, and postnatal care, especially in the poorest countries and for underserved populations, need urgent attention. We have prioritised what needs to be done differently on the basis of learning from the past decade about what has worked, and what has not. Needed now are four most important shifts: (1) intensification of political attention and leadership; (2) promotion of parent voice, supporting women, families, and communities to speak up for their newborn babies and to challenge social norms that accept these deaths as inevitable; (3) investment for effect on mortality outcome as well as harmonisation of funding; (4) implementation at scale, with particular attention to increasing of health worker numbers and skills with attention to high-quality childbirth care for newborn babies as well as mothers and children; and (5) evaluation, tracking coverage of priority interventions and packages of care with clear accountability to accelerate progress and reach the poorest groups. The Every Newborn Action Plan provides an evidence-based roadmap towards care for every woman, and a healthy start for every newborn baby, with a right to be counted, survive, and thrive wherever they are born.	[Mason, Elizabeth] WHO, CH-1211 Geneva 27, Switzerland; [McDougall, Lori; Presern, Carole] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Lawn, Joy E.] London Sch Hyg & Trop Med, London WC1, England; [Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Lawn, Joy E.] Res & Evidence Div, London, England; [Mann, Gillian; Beattie, Allison] Dept Int Dev, London, England; [Gupta, Anuradha] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Claeson, Mariam] Bill & Melinda Gates Fdn, Seattle, WA USA; [Pillay, Yogan] Govt South Africa, Dept Hlth, Pretoria, South Africa; [Lukong, Martina Baye] Govt Cameroon, Minist Publ Hlth, Yaounde, Cameroon; [Wijnroks, Marijke] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Azad, Kishwar] Diabet Assoc Bangladesh, Perinatal Care Project, Dhaka, Bangladesh; [Taylor, Katherine] US Agcy Int Dev, Washington, DC 20523 USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Chopra, Mickey] UNICEF, New York, NY USA	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Save the Children; Bill & Melinda Gates Foundation; United States Agency for International Development (USAID); Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); UNICEF	Mason, E (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva 27, Switzerland.	masone@who.int	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Lackritz, Eve/0000-0002-5397-7291; McDougall, Lori/0000-0002-1885-5344	Bill & Melinda Gates Foundation; ESRC [ES/I033572/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033572/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	No specific funding was received for the work in this paper, but the Every Newborn Action Plan and The Lancet Every Newborn Series process and products are funded through a grant from the Bill & Melinda Gates Foundation to the US Fund for UNICEF. The content of this paper does not necessarily reflect the views of the author's organisations. We appreciate the valuable contributions of Every Newborn teams to the conceptual development and review of this paper including the Study Group, the Steering team, and the Advisory Group, as well as the many individuals, governments, and organisations that have given their ideas and criticism to strengthen the content. We particularly acknowledge the contributions of Rajiv Bahl, John Borrazzo, Bernadette Daelmans, Lily Kak, Viviana Mangiaterra, Lee Pyne-Mercier, Mathilde Pinto, Juana Willumsen, and Severin von Xylander. We thank Anshu Mohan and Shyama Kuruvilla for the help with the India panel presented in this paper, and to the Every Newborn metrics working group for its development of the impact framework, milestones, and indicators presented in this paper; members of the Every Newborn metrics working group include Joy E Lawn, Matthews Mathai, Aline Simen Kapeu, Suzanne Fournier, John Grove, as well as Lara Vaz and Kate Kerber for the Newborn Indicators Technical Working Group, with the support of Hannah Blencowe.	Africa Malaria Leaders Alliance, 2011, ALMA SCOR ACC ACT 20; [Anonymous], 2014, 2015 VIS; [Anonymous], BORN TOO SOON GLOB A; [Anonymous], 2012, EVIDENCE 4 ACTION CA; [Anonymous], 2013, STRAT APPR REPR MAT; [Anonymous], 2013, MILL DEV GOALS REP 2; Aubel J, 2004, SOC SCI MED, V59, P945, DOI 10.1016/j.socscimed.2003.11.044; Ban Ki-moon., 2010, GLOBAL STRATEGY WOME; Bhutta ZA, 2014, LANCET; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; CARMMA African Union, 2012, WHY CAMP ACC RED MAT; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dickson KE, 2014, LANCET; Duke T, 2003, ARCH DIS CHILD, V88, P563, DOI 10.1136/adc.88.7.563; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Inter-Parliamentary Union, 2012, 126 IPU ASS KAMP UG; International Institute for Population Sciences and Macro International, 2007, NAT HLTH FAM SURV NF; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Karas DJ, 2012, J TROP PEDIATRICS, V58, P200, DOI 10.1093/tropej/fmr057; Lassi Z, 2010, COCHRANE DB SYST REV, V11; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2014, LANCET; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lee AC, 2009, INT J GYNECOL OBS S1, V107, pS6, DOI DOI 10.1016/J.IJGO.2009.07.012; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Ministry of Health and Family Welfare, 2013, HLTH MAN INF SYST HM; Ministry of Health and Family Welfare, 2014, STRAT INT RMNCH A AP; New K, 2014, LANCET, V384, pE25, DOI 10.1016/S0140-6736(14)60692-9; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Parliament PA, 2011, 3 PAN AFR SPEAK C 20; Partnership for Maternal Newborn & Child Health, 2013, PMNCH 2013 REP AN PR; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Registrar General of India, 2013, SPEC B MAT MORT IND; Requejo J., 2013, ACCOUNTABILITY MATER; Saving Newborn Lives, 2013, SAV NEWB LIV GLOB HL; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Starrs AM, 2014, LANCET; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; The Global Fund to Fight AIDS TaM, 2012, GLOB FUND STRAT 2012; The World Bank, 2013, RES BAS FIN HLTH HLT; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; UN, 1989, CONV RIGHTS CHILD; UN-IGME, 2013, LEV TRENDS CHILD MOR; UNFPA, 2011, STAT WORLDS MIDW REP; UNICEF, 2015, COMMITTING CHILD SUR; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO, 2009, WHO UNICEF JOINT STA; WHO, 2014, GUID COMM MOB PART L; WHO, 2013, GLOB UPD HIV TREATM; Working Group on Accountability for Resources, 2011, WORK GROUP ACC RES F; World Health Organization, 2013, NAT HLTH ACC; World Health Organization, 2014, EV NEWB ACT PLAN END	61	112	115	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					455	467		10.1016/S0140-6736(14)60750-9	http://dx.doi.org/10.1016/S0140-6736(14)60750-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	24853599				2022-12-28	WOS:000340195800028
J	Nguyen-Van-Tam, JS; Openshaw, PJM; Nicholson, KG				Nguyen-Van-Tam, Jonathan S.; Openshaw, Peter J. M.; Nicholson, Karl G.			Antivirals for influenza: where now for clinical practice and pandemic preparedness?	LANCET			English	Editorial Material							NEURAMINIDASE INHIBITORS; VIRUS-INFECTION; METAANALYSIS; MORTALITY; BURDEN		[Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Nicholson, Karl G.] Univ Leicester, Dept Infect Immun & Infl ammat, Leicester, Leics, England	University of Nottingham; Imperial College London; University of Leicester	Nguyen-Van-Tam, JS (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.	jvt@nottingham.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Openshaw, Peter/AAL-9442-2020	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Openshaw, Peter/0000-0002-7220-2555	Medical Research Council [MC_G1001212, G1000758] Funding Source: Medline; MRC [MC_G1001212] Funding Source: UKRI; National Institute for Health Research [NF-SI-0513-10150] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD008965; Centers for Disease Control and Prevention, 2014, INFL ANT MED SUMM CL; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; JEFFERSON T, 2000, COCHRANE DB SYST REV, V2, P1265; Louie JK, 2013, PEDIATRICS, V132, pE1539, DOI 10.1542/peds.2013-2149; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; National Institute for Health and Care Excellence, 2009, AM OS ZAN TREATM INF; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	14	10	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					386	387		10.1016/S0140-6736(14)60726-1	http://dx.doi.org/10.1016/S0140-6736(14)60726-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24837882	Green Accepted			2022-12-28	WOS:000340195800008
J	Chandra, A; Khullar, D; Wilensky, GR				Chandra, Amitabh; Khullar, Dhruv; Wilensky, Gail R.			The Economics of Graduate Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REIMBURSEMENT; CUTS		[Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Khullar, Dhruv] Yale Univ, Sch Med, New Haven, CT USA; [Wilensky, Gail R.] Project HOPE, Bethesda, MD USA	Harvard University; Yale University	Chandra, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.							[Anonymous], 2012, HLTH POL BRIEF GRAD; Becker G.S., 1964, HUMAN CAPITAL THEORE; Iglehart JK, 1999, NEW ENGL J MED, V341, P299, DOI 10.1056/NEJM199907223410424; Seshamani M, 2006, HEALTH SERV RES, V41, P683, DOI 10.1111/j.1475-6773.2006.00507.x; Volpp KG, 2005, CIRCULATION, V112, P2268, DOI 10.1161/CIRCULATIONAHA.105.534164	5	49	50	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2357	2360		10.1056/NEJMp1402468	http://dx.doi.org/10.1056/NEJMp1402468			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24826947				2022-12-28	WOS:000337353000002
J	Deng, D; Xu, C; Sun, PC; Wu, JP; Yan, CY; Hu, MX; Yan, N				Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng			Crystal structure of the human glucose transporter GLUT1	NATURE			English	Article							BLOOD-BRAIN-BARRIER; DEFICIENCY SYNDROME; MUTATIONS; EPILEPSY; ONSET; EXPRESSION; PROTEINS; SPECTRUM; MODEL	The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 angstrom resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.	[Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Sun, Pengcheng; Wu, Jianping; Yan, Chuangye; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Deng, Dong; Xu, Chao; Wu, Jianping; Hu, Mingxu; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Deng, Dong/0000-0002-8590-9525; Yan, Chuangye/0000-0001-9338-8048; Sun, Pengcheng/0000-0002-7549-1161; Wu, Jianping/0000-0001-9869-7691	Ministry of Science and Technology [2011CB910501]; National Natural Science Foundation of China [31321062-20131319400, 31125009, 91017011]; Tsinghua-Peking Center for Life Sciences; Howard Hughes Medical Institute	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. He, L. Tang, F. Yu and S. Huang at Shanghai Synchrotron Radiation Facility (SSRF). This work was supported by funds from the Ministry of Science and Technology (grant number 2011CB910501), Projects 31321062-20131319400, 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua-Peking Center for Life Sciences. The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afawi Z, 2010, EPILEPSIA, V51, P2466, DOI 10.1111/j.1528-1167.2010.02726.x; Amann T, 2011, MOL MEMBR BIOL, V28, P181, DOI 10.3109/09687688.2011.554447; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Anheim M, 2011, J NEUROL, V258, P316, DOI 10.1007/s00415-010-5702-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DeLano W.L, PYMOL MOL GRAPHICS S; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsen S., 1978, NOBEL LECT CHEM 1971; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Henderson PJF, 2013, NAT STRUCT MOL BIOL, V20, P654, DOI 10.1038/nsmb.2604; Henderson PJF, 2012, NATURE, V490, P348, DOI 10.1038/490348a; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Klepper J, 2009, NEUROPEDIATRICS, V40, P207, DOI 10.1055/s-0030-1248264; Klepper J, 1999, NEUROCHEM RES, V24, P587, DOI 10.1023/A:1022544131826; Klepper J, 2001, HUM MOL GENET, V10, P63, DOI 10.1093/hmg/10.1.63; Leen WG, 2014, J NEUROL, V261, P589, DOI 10.1007/s00415-014-7240-z; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mullen SA, 2010, NEUROLOGY, V75, P432, DOI 10.1212/WNL.0b013e3181eb58b4; Nelson D.L., 2004, PRINCIPLES BIOCH, V4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overweg-Plandsoen WCG, 2003, J INHERIT METAB DIS, V26, P559, DOI 10.1023/A:1025999914822; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pascual JM, 2002, ANN NEUROL, V52, P458, DOI 10.1002/ana.10311; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Perez-Duenas B, 2009, ARCH NEUROL-CHICAGO, V66, P1410, DOI 10.1001/archneurol.2009.236; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Ramani P, 2013, VIRCHOWS ARCH, V462, P203, DOI 10.1007/s00428-012-1370-4; Sanderson NM, 1998, BIOCHEM SOC T, V26, pS306, DOI 10.1042/bst026s306; Saudubray J.-M., 2011, INBORN METABOLIC DIS, P656; Schneider SA, 2009, MOVEMENT DISORD, V24, P1684, DOI 10.1002/mds.22507; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shim BY, 2013, INT J COLORECTAL DIS, V28, P375, DOI 10.1007/s00384-012-1542-3; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Striano P, 2012, NEUROLOGY, V78, P557, DOI 10.1212/WNL.0b013e318247ff54; Suls A, 2009, ANN NEUROL, V66, P415, DOI 10.1002/ana.21724; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Urbizu A, 2010, J NEUROL SCI, V295, P110, DOI 10.1016/j.jns.2010.05.017; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	60	458	498	35	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					121	+		10.1038/nature13306	http://dx.doi.org/10.1038/nature13306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24847886				2022-12-28	WOS:000336768900040
J	Wolff, SBE; Grundemann, J; Tovote, P; Krabbe, S; Jacobson, GA; Muller, C; Herry, C; Ehrlich, I; Friedrich, RW; Letzkus, JJ; Luthi, A				Wolff, Steffen B. E.; Gruendemann, Jan; Tovote, Philip; Krabbe, Sabine; Jacobson, Gilad A.; Mueller, Christian; Herry, Cyril; Ehrlich, Ingrid; Friedrich, Rainer W.; Letzkus, Johannes J.; Luethi, Andreas			Amygdala interneuron subtypes control fear learning through disinhibition	NATURE			English	Article							RAT BASOLATERAL AMYGDALA; GABAERGIC NEURONS; LATERAL NUCLEUS; CIRCUIT; SOMATOSTATIN; INHIBITION; NETWORKS; IDENTIFICATION; ORGANIZATION; ACQUISITION	Learning is mediated by experience-dependent plasticity in neuronal circuits. Activity in neuronal circuits is tightly regulated by different subtypes of inhibitory interneurons, yet their role in learning is poorly understood. Using a combination of in vivo single-unit recordings and optogenetic manipulations, we show that in the mouse basolateral amygdala, interneurons expressing parvalbumin (PV) and somatostatin (SOM) bidirectionally control the acquisition of fear conditioning-a simple form of associative learning-through two distinct disinhibitory mechanisms. During an auditory cue, PV+ interneurons are excited and indirectly disinhibit the dendrites of basolateral amygdala principal neurons via SOM+ interneurons, thereby enhancing auditory responses and promoting cue-shock associations. During an aversive footshock, however, both PV+ and SOM+ interneurons are inhibited, which boosts postsynaptic footshock responses and gates learning. These results demonstrate that associative learning is dynamically regulated by the stimulus-specific activation of distinct disinhibitory microcircuits through precise interactions between different subtypes of local interneurons.	[Wolff, Steffen B. E.; Gruendemann, Jan; Tovote, Philip; Krabbe, Sabine; Jacobson, Gilad A.; Mueller, Christian; Friedrich, Rainer W.; Letzkus, Johannes J.; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Wolff, Steffen B. E.] Univ Basel, CH-4000 Basel, Switzerland; [Herry, Cyril] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Ehrlich, Ingrid] Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Friedrich Miescher Institute for Biomedical Research; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	johannes.letzkus@brain.mpg.de; andreas.luthi@fmi.ch	Herry, Cyril/AAP-9902-2020; Ehrlich, Ingrid/G-8551-2015; Tovote, Philip/AAC-5668-2019	Herry, Cyril/0000-0003-2973-0843; Ehrlich, Ingrid/0000-0001-9078-2429; Friedrich, Rainer/0000-0001-9107-0482; Jacobson, Gilad/0000-0001-8172-3144; Letzkus, Johannes/0000-0001-5678-3030; Grundemann, Jan/0000-0002-3149-0001; Krabbe, Sabine/0000-0002-5735-469X; Tovote, Philip/0000-0002-4598-722X	Novartis Research Foundation; National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' - (Swiss National Science Foundation); SNSF core grant; Schering Foundation Fellowship; Swiss National Science Foundation Ambizione Fellowship; EMBO Long-Term Fellowships; Marie Curie Action Fellowships	Novartis Research Foundation; National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' - (Swiss National Science Foundation); SNSF core grant; Schering Foundation Fellowship; Swiss National Science Foundation Ambizione Fellowship; EMBO Long-Term Fellowships; Marie Curie Action Fellowships	We thank all members of the Luthi laboratory and E. Schuman for discussions and critical comments on the manuscript. We would like to thank J. Ludke, P. Argast and P. Buchmann for technical assistance. We further thank the Facility for Imaging and Microscopy at the FMI, in particular S. Bourke and M. Kirschmann, for their assistance in image acquisition and analysis. We also thank K. Deisseroth, E. Boyden, J. Huang, R. Sprengel and S. Arber for sharing materials and mouse lines. This work was supported by the Novartis Research Foundation, by the National Center of Competences in Research: 'SYNAPSY-The Synaptic Bases of Mental Diseases' (financed by the Swiss National Science Foundation) as well as by a SNSF core grant to A. L. S. B. E. W. is supported by a Schering Foundation Fellowship. J. J. L. is supported by a Swiss National Science Foundation Ambizione Fellowship. J. G. and G. A. J. are supported by EMBO Long-Term Fellowships and Marie Curie Action Fellowships.	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Davis M., 2000, AMYGDALA, P213; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Harris JA, 1998, PSYCHOPHARMACOLOGY, V140, P105, DOI 10.1007/s002130050745; Heidi SA, 2007, EUR J NEUROSCI, V26, P3631, DOI 10.1111/j.1460-9568.2007.05970.x; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hill MN, 2013, MOL PSYCHIATR, V18, P1125, DOI 10.1038/mp.2012.90; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Humeau Y, 2007, NEUROPHARMACOLOGY, V52, P234, DOI 10.1016/j.neuropharm.2006.07.010; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McDonald AJ, 2002, BRAIN RES, V943, P237, DOI 10.1016/S0006-8993(02)02650-1; McDonald AJ, 2001, NEUROSCIENCE, V102, P413, DOI 10.1016/S0306-4522(00)00481-4; Muller JF, 2007, J COMP NEUROL, V500, P513, DOI 10.1002/cne.21185; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Spampanato J, 2011, NEUROPHARMACOLOGY, V60, P765, DOI 10.1016/j.neuropharm.2010.11.006; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Woodson W, 2000, SYNAPSE, V38, P124, DOI 10.1002/1098-2396(200011)38:2<124::AID-SYN3>3.0.CO;2-N; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	58	299	301	6	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					453	+		10.1038/nature13258	http://dx.doi.org/10.1038/nature13258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24814341				2022-12-28	WOS:000336126000031
J	Lillie, J; Coulter, F; Ganeshalingham, A				Lillie, Jonathan; Coulter, Finn; Ganeshalingham, Anusha			Severe Lactic Acidosis in an Amnesic Child	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ELECTRICAL INJURIES; SAFETY		[Lillie, Jonathan; Coulter, Finn; Ganeshalingham, Anusha] Starship Childrens Hosp, Auckland 1023, New Zealand	Starship Children's Hospital	Lillie, J (corresponding author), 58 Gordon Mans,Torrington Pl, London WC1E 7HG, England.	jonlillie@doctors.org.uk		Lillie, Jon/0000-0003-1776-5184				Cawley JC, 2003, J SAFETY RES, V34, P241, DOI 10.1016/S0022-4375(03)00028-8; Fish RM, 1999, J EMERG MED, V17, P977, DOI 10.1016/S0736-4679(99)00127-4; JENSEN PJ, 1987, BRIT HEART J, V57, P279; Rabban JT, 1997, ARCH PEDIAT ADOL MED, V151, P696, DOI 10.1001/archpedi.1997.02170440058010; Spies C, 2006, ANN INTERN MED, V145, P531, DOI 10.7326/0003-4819-145-7-200610030-00011; WRIGHT RK, 1980, J FORENSIC SCI, V25, P514	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2015	2016		10.1001/jama.2014.783	http://dx.doi.org/10.1001/jama.2014.783			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846039				2022-12-28	WOS:000336122800024
J	Molnar, AO; Garg, AX				Molnar, Amber O.; Garg, Amit X.			Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non-ST-elevation ACS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Molnar, Amber O.] Univ Ottawa, Ottawa, ON, Canada; [Garg, Amit X.] Univ Western Ontario, London, ON, Canada	University of Ottawa; Western University (University of Western Ontario)	Molnar, AO (corresponding author), Univ Ottawa, Ottawa, ON, Canada.		Molnar, Amber/K-6093-2019					Benjo AM, 2013, CATHETER CARDIOVASC; Han YL, 2014, J AM COLL CARDIOL, V63, P62, DOI 10.1016/j.jacc.2013.09.017; Mao S, 2014, REN FAIL	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC9	10.7326/0003-4819-160-10-201405200-02009	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842443				2022-12-28	WOS:000337347100008
J	Smith, DA				Smith, Donald A.			Review: Statins are not associated with cognitive impairment, Alzheimer disease, or dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; US Food and Drug Administration, 2012, CONS HLTH INF FDA EX	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC10	10.7326/0003-4819-160-10-201405200-02010	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842432				2022-12-28	WOS:000337347100009
J	Chemaly, RF; Ullmann, AJ; Stoelben, S; Richard, MP; Bornhauser, M; Groth, C; Einsele, H; Silverman, M; Mullane, KM; Brown, J; Nowak, H; Kolling, K; Stobernack, HP; Lischka, P; Zimmermann, H; Rubsamen-Schaeff, H; Champlin, RE; Ehninger, G				Chemaly, Roy F.; Ullmann, Andrew J.; Stoelben, Susanne; Richard, Marie Paule; Bornhaeuser, Martin; Groth, Christoph; Einsele, Hermann; Silverman, Margarida; Mullane, Kathleen M.; Brown, Janice; Nowak, Horst; Koelling, Katrin; Stobernack, Hans P.; Lischka, Peter; Zimmermann, Holger; Ruebsamen-Schaeff, Helga; Champlin, Richard E.; Ehninger, Gerhard		AIC246 Study Team	Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTICYTOMEGALOVIRUS COMPOUND AIC246; DOUBLE-BLIND; MARROW TRANSPLANT; GANCICLOVIR PROPHYLAXIS; MARIBAVIR PROPHYLAXIS; IN-VITRO; RECIPIENTS; DISEASE; PREVENTION; INFECTION	BackgroundCytomegalovirus (CMV) infection is a leading cause of illness and death in patients who have undergone allogeneic hematopoietic-cell transplantation. Available treatments are restricted by clinically significant toxic effects and drug resistance. MethodsIn this phase 2 study, we evaluated the effect of letermovir (also known as AIC246), a new anti-CMV drug with a novel mechanism of action, on the incidence and time to onset of prophylaxis failure in CMV-seropositive recipients of allogeneic hematopoietic-cell transplants from matched related or unrelated donors. From March 2010 through October 2011, we randomly assigned 131 transplant recipients in a 3:1 ratio to three sequential study cohorts according to a double-blind design. Patients received oral letermovir (at a dose of 60, 120, or 240 mg per day, or matching placebo) for 12 weeks after engraftment. The primary end point was all-cause prophylaxis failure, defined as discontinuation of the study drug because of CMV antigen or DNA detection, end-organ disease, or any other cause. Patients underwent weekly surveillance for CMV infection. ResultsThe reduction in the incidence of all-cause prophylaxis failure was dose-dependent. The incidence of prophylaxis failure with letermovir, as compared with placebo, was 48% versus 64% at a daily letermovir dose of 60 mg (P=0.32), 32% at a dose of 120 mg (P=0.01), and 29% at a dose of 240 mg (P=0.007). Kaplan-Meier time-to-onset profiles for prophylaxis failure showed a significant difference in the comparison of letermovir at a dose of 240 mg per day with placebo (P=0.002). The safety profile of letermovir was similar to placebo, with no indication of hematologic toxicity or nephrotoxicity. ConclusionsLetermovir, as compared with placebo, was effective in reducing the incidence of CMV infection in recipients of allogeneic hematopoietic-cell transplants. The highest dose (240 mg per day) had the greatest anti-CMV activity, with an acceptable safety profile. (Funded by AiCuris; ClinicalTrials.gov number, NCT01063829.) Letermovir is an antiviral with activity against CMV. In patients undergoing allogeneic hematopoietic-cell transplantation, the rate of prophylaxis failure with letermovir (240 mg per day) was 29%, as compared with 64% with placebo. Toxicity was similar for letermovir and placebo. Cytomegalovirus (CMV) disease that results from CMV replication through reactivation or new infection is a serious, potentially life-threatening condition in immunocompromised patients. This is especially true for recipients of allogeneic hematopoietic-cell transplants(1),(2); CMV viremia occurs in 50 to 60% of these patients and may progress to CMV disease.(3) The standard of care for treatment of CMV infection or disease has typically been intravenous ganciclovir or its oral prodrug, valganciclovir, or alternatively, intravenous foscarnet or cidofovir.(4) Although efficacious, these therapies are associated with clinically significant drug-specific effects, including myelosuppression (neutropenia or thrombocytopenia with ganciclovir, valganciclovir, and cidofovir) and renal ...	[Chemaly, Roy F.; Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Stoelben, Susanne; Richard, Marie Paule; Koelling, Katrin; Stobernack, Hans P.; Lischka, Peter; Zimmermann, Holger; Ruebsamen-Schaeff, Helga] AiCuris, Wuppertal, Germany; [Bornhaeuser, Martin; Ehninger, Gerhard] Univ Klinikum Dresden, Med Klin & Poliklin, Dresden, Germany; [Groth, Christoph] Univ Klinikum Munster, Munster, Germany; [Einsele, Hermann] Univ Wurzburg, Dept Internal Med, D-97070 Wurzburg, Germany; [Silverman, Margarida] Univ Iowa, Iowa City, IA USA; [Mullane, Kathleen M.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Brown, Janice] Stanford Univ Hosp, Stanford, CA 94305 USA	University of Texas System; UTMD Anderson Cancer Center; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster; University of Wurzburg; University of Iowa; University of Chicago; University of Chicago Medical Center; Stanford University	Ehninger, G (corresponding author), Univ Klinikum, Fetscherstr 74, D-01307 Dresden, Germany.	gerhard.ehninger@uniklinikum-dresden.de	Ullmann, AJ/AAQ-1724-2021		AiCuris; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	AiCuris; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by AiCuris.	Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Boeckh M, 2001, BIOL BLOOD MARROW TR, V7, P343, DOI 10.1016/S1083-8791(01)80005-7; Boeckh M, 2011, HEMATOL-AM SOC HEMAT, P305, DOI 10.1182/asheducation-2011.1.305; Ghaffari SH, 2008, PATHOL ONCOL RES, V14, P399, DOI 10.1007/s12253-008-9030-3; Goldner T, 2011, J VIROL, V85, P10884, DOI 10.1128/JVI.05265-11; GOODRICH JM, 1993, ANN INTERN MED, V118, P173, DOI 10.7326/0003-4819-118-3-199302010-00003; Kaul DR, 2011, AM J TRANSPLANT, V11, P1079, DOI 10.1111/j.1600-6143.2011.03530.x; Lischka P, 2010, ANTIMICROB AGENTS CH, V54, P1290, DOI 10.1128/AAC.01596-09; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Ljungman P, 2010, INFECT DIS CLIN N AM, V24, P319, DOI 10.1016/j.idc.2010.01.008; Marschall M, 2012, ANTIMICROB AGENTS CH, V56, P1135, DOI 10.1128/AAC.05908-11; Marty FM, 2013, NEW ENGL J MED, V369, P1227, DOI 10.1056/NEJMoa1303688; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Sampathkumar P, 2007, HUMAN CYTOMEGALOVIRU, V7, P1; Stoelben S, 2014, TRANSPL INT, V27, P77, DOI 10.1111/tri.12225; WINSTON DJ, 1993, ANN INTERN MED, V118, P179, DOI 10.7326/0003-4819-118-3-199302010-00004; Winston DJ, 2003, CLIN INFECT DIS, V36, P749, DOI 10.1086/367836; Winston DJ, 2008, BLOOD, V111, P5403, DOI 10.1182/blood-2007-11-121558	18	237	251	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1781	1789		10.1056/NEJMoa1309533	http://dx.doi.org/10.1056/NEJMoa1309533			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806159				2022-12-28	WOS:000335997900006
J	Lagu, T; Iezzoni, LI; Lindenauer, PK				Lagu, Tara; Iezzoni, Lisa I.; Lindenauer, Peter K.			The Axes of Access - Improving Care for Patients with Disabilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTIVE SERVICES; ACCESSIBILITY; BARRIERS; WOMEN	The authors describe barriers to high-quality care for patients with disabilities and argue that systematic changes are needed to eliminate physical and communication barriers to accessing excellent care.It was Friday afternoon, and I had promised my patient's family that I would discharge her. Despite trying all day to make a follow-up appointment with the appropriate subspecialist, I could not find a practice within 50 miles of her home that could accommodate a patient who used a wheelchair. After I explained the situation and apologized, the patient said to me, You know, Doctor, it's like discrimination or something.The statement of the patient in the vignette is supported by a growing body of evidence that persons with disabilities confront barriers when attempting to access the health care system. ...	[Lagu, Tara; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lagu, Tara; Lindenauer, Peter K.] Baystate Med Ctr, Div Gen Internal Med, Springfield, MA USA; [Lagu, Tara; Lindenauer, Peter K.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Iezzoni, Lisa I.] Harvard Univ, Sch Med, Boston, MA USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lagu, T (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA.		Lagu, Tara/GPT-5173-2022					Blocked Idem., 2008, HLTH AFF, V27, P203; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Disability Rights Education & Defense Fund, 2014, HEALTHC STOR; Field MJ, 2007, FUTURE DISABILITY AM; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; Iezzoni LI, 2011, HEALTH AFFAIR, V30, P1947, DOI 10.1377/hlthaff.2011.0613; Iezzoni LI, 2011, DISABIL HEALTH J, V4, P238, DOI 10.1016/j.dhjo.2011.06.001; Iezzoni LI, 2010, ONCOL NURS FORUM, V37, P711, DOI 10.1188/10.ONF.711-717; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Jette A., 2014, HEARING LOSS HLTH AG; Lagu T, 2013, ANN INTERN MED, V158, P441, DOI 10.7326/0003-4819-158-6-201303190-00003; Lupkin S., 2013, ABC NEWS; Mudrick NR, 2012, DISABIL HEALTH J, V5, P159, DOI 10.1016/j.dhjo.2012.02.002; Sanchez J, 2000, Rehabil Nurs, V25, P6; Story MF, 2008, HUM FACTORS, V50, P801, DOI 10.1518/001872008X354174; Sullivan AL, 2009, SPEC CARE DENT, V29, P117, DOI 10.1111/j.1754-4505.2009.00076.x; United States Access Board, 2013, ADV EQ ACC DIAGN SER	17	41	41	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1847	1851		10.1056/NEJMsb1315940	http://dx.doi.org/10.1056/NEJMsb1315940			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806165				2022-12-28	WOS:000335997900014
J	Guarnieri, M; Balmes, JR				Guarnieri, Michael; Balmes, John R.			Outdoor air pollution and asthma	LANCET			English	Article							DIESEL EXHAUST PARTICLES; NITROGEN-DIOXIDE EXPOSURE; GREENHOUSE-GAS EMISSIONS; TOBACCO-SMOKE EXPOSURE; EXHALED NITRIC-OXIDE; LUNG-FUNCTION; OXIDATIVE STRESS; CHILDHOOD ASTHMA; RESPIRATORY SYMPTOMS; AMBIENT PARTICULATE	Traffic and power generation are the main sources of urban air pollution. The idea that outdoor air pollution can cause exacerbations of pre-existing asthma is supported by an evidence base that has been accumulating for several decades, with several studies suggesting a contribution to new-onset asthma as well. In this Series paper, we discuss the effects of particulate matter (PM), gaseous pollutants (ozone, nitrogen dioxide, and sulphur dioxide), and mixed traffic-related air pollution. We focus on clinical studies, both epidemiological and experimental, published in the previous 5 years. From a mechanistic perspective, air pollutants probably cause oxidative injury to the airways, leading to inflammation, remodelling, and increased risk of sensitisation. Although several pollutants have been linked to new-onset asthma, the strength of the evidence is variable. We also discuss clinical implications, policy issues, and research gaps relevant to air pollution and asthma.	[Guarnieri, Michael; Balmes, John R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Guarnieri, Michael; Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Balmes, JR (corresponding author), Univ Calif San Francisco, Box 0843, San Francisco, CA 94143 USA.	jbalmes@medsfgh.ucsf.edu	Sepiashvili, Revaz/J-3221-2019		NHLBI NIH HHS [T32 HL007185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acciani TH, 2013, CLIN EXP ALLERGY, V43, P1406, DOI 10.1111/cea.12200; Adams C, 2009, J ENVIRON MONITOR, V11, P1331, DOI 10.1039/b903841h; Akinbami LJ, 2010, ENVIRON RES, V110, P294, DOI 10.1016/j.envres.2010.01.001; Anderson HR, 2013, AIR QUAL ATMOS HLTH, V6, P47, DOI 10.1007/s11869-011-0144-5; Anderson HR, 2013, AIR QUAL ATMOS HLTH, V6, P57, DOI 10.1007/s11869-011-0145-4; [Anonymous], 2014, LANCET, V383, P845, DOI 10.1016/S0140-6736(14)60427-X; ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; Balmes JR, 2014, RESPIR MED SER, V7, P383, DOI 10.1007/978-1-4614-8417-2_22; Balmes JR, 2009, J ALLERGY CLIN IMMUN, V123, P626, DOI 10.1016/j.jaci.2008.10.062; Barck C, 2002, RESP MED, V96, P907, DOI 10.1053/rmed.2002.1374; Barraza-Villarreal A, 2008, ENVIRON HEALTH PERSP, V116, P832, DOI 10.1289/ehp.10926; Bartoli ML, 2013, INHAL TOXICOL, V25, P127, DOI 10.3109/08958378.2013.763313; Bateson TF, 2008, J TOXICOL ENV HEAL A, V71, P238, DOI 10.1080/15287390701598234; Behndig AF, 2011, THORAX, V66, P12, DOI 10.1136/thx.2010.140053; Bloomer BJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037308; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Brunst KJ, 2013, J ALLERGY CLIN IMMUN, V131, P592, DOI 10.1016/j.jaci.2012.10.042; Carlsten C, 2011, OCCUP ENVIRON MED, V68, P291, DOI 10.1136/oem.2010.055152; Chan JKW, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-34; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; Cook AG, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-52; Dales R, 2008, ENVIRON HEALTH PERSP, V116, P1423, DOI 10.1289/ehp.10943; Delamater PL, 2012, SCI TOTAL ENVIRON, V425, P110, DOI 10.1016/j.scitotenv.2012.02.015; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P550, DOI 10.1289/ehp.10911; Delfino RJ, 2006, ENVIRON HEALTH PERSP, V114, P1736, DOI 10.1289/ehp.9141; Delfino RJ, 2014, EPIDEMIOLOGY, V25, P48, DOI 10.1097/EDE.0000000000000016; Delfino RJ, 2009, ANN ALLERG ASTHMA IM, V102, P138, DOI 10.1016/S1081-1206(10)60244-X; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, pA607, DOI 10.1289/ehp.021100607; Delucchi MA, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0325; DEVALIA JL, 1994, LANCET, V344, P1668, DOI 10.1016/S0140-6736(94)90458-8; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; Division UEONRTP, INT SCI ASS OX NITR; Dong GH, 2013, INT J OBESITY, V37, P94, DOI 10.1038/ijo.2012.125; Dong Guang-Hui, 2011, PLoS One, V6, pe22470, DOI 10.1371/journal.pone.0022470; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; FOLINSBEE LJ, 1992, TOXICOL IND HEALTH, V8, P273; Frampton MW, 2002, AM J PHYSIOL-LUNG C, V282, pL155, DOI 10.1152/ajplung.2002.282.1.L155; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Gale SL, 2012, J EXPO SCI ENV EPID, V22, P386, DOI 10.1038/jes.2012.29; Gehring U, 2006, EUR RESPIR J, V27, P95, DOI 10.1183/09031936.06.00017205; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Goodman JE, 2009, CRIT REV TOXICOL, V39, P719, DOI 10.3109/10408440903283641; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; GREER JR, 1993, J OCCUP ENVIRON MED, V35, P909, DOI 10.1097/00043764-199309000-00014; Hernandez-Cadena L, 2009, CHEST, V136, P1529, DOI 10.1378/chest.08-1463; Hesterberg TW, 2009, CRIT REV TOXICOL, V39, P743, DOI 10.3109/10408440903294945; International Institute for Applied Systems Analysis (IIASA), 2012, DATABASE; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Islam T, 2009, THORAX, V64, P197, DOI 10.1136/thx.2008.099366; Jacquemin B, 2012, J EPIDEMIOL COMMUN H, V66, P796, DOI 10.1136/jech.2010.130229; Jacquemin B, 2009, EPIDEMIOLOGY, V20, P119, DOI 10.1097/EDE.0b013e3181886e76; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Johns DO, 2011, INHAL TOXICOL, V23, P33, DOI 10.3109/08958378.2010.539290; Johnston NW, 2006, THORAX, V61, P722, DOI 10.1136/thx.2005.045161; Kaundinya DP, 2009, RENEW SUST ENERG REV, V13, P2041, DOI 10.1016/j.rser.2009.02.002; Kehrl HR, 1999, J ALLERGY CLIN IMMUN, V104, P1198, DOI 10.1016/S0091-6749(99)70013-8; Kelly Frank, 2011, Res Rep Health Eff Inst, P3; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Kim BJ, 2011, ANN ALLERG ASTHMA IM, V107, P214, DOI 10.1016/j.anai.2011.05.025; Kohli A, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-17; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Lewis TC, 2013, SCI TOTAL ENVIRON, V448, P48, DOI 10.1016/j.scitotenv.2012.11.070; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Li YF, 2006, AM J RESP CRIT CARE, V173, P970, DOI 10.1164/rccm.200508-1256OC; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Malig BJ, 2013, AM J EPIDEMIOL, V178, P58, DOI 10.1093/aje/kws451; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; Martin RA, 2013, AM J RESP CELL MOL, V48, P655, DOI 10.1165/rcmb.2012-0423OC; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; McConnell R, 2010, ENVIRON HEALTH PERSP, V118, P1021, DOI 10.1289/ehp.0901232; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; Melia S, 2011, TRANSPORT POLICY, V18, P46, DOI 10.1016/j.tranpol.2010.05.007; Meng YY, 2010, J EPIDEMIOL COMMUN H, V64, P142, DOI 10.1136/jech.2009.083576; Miller MD, 2010, ENVIRON HEALTH PERSP, V118, P1155, DOI 10.1289/ehp.0901856; Modig L, 2009, EUR RESPIR J, V33, P1261, DOI 10.1183/09031936.00101108; Moon KY, 2014, INT J TOXICOL, V33, P21, DOI 10.1177/1091581813518355; Mortimer KM, 2000, AM J RESP CRIT CARE, V162, P1838, DOI 10.1164/ajrccm.162.5.9908113; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; Neidell M, 2010, J EPIDEMIOL COMMUN H, V64, P921, DOI 10.1136/jech.2008.081489; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Neophytou AM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-105; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; On the Health Effects of Traffic-Related Air Pollution H. E. I, 2010, TRAFF REL AIR POLL C; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Patel MM, 2013, ENVIRON RES, V121, P71, DOI 10.1016/j.envres.2012.10.012; Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Perez L, 2013, EUR RESPIR J, V42, P594, DOI 10.1183/09031936.00031112; Perez L, 2012, ENVIRON HEALTH PERSP, V120, P1619, DOI 10.1289/ehp.1104785; Perez Laura, 2009, Am J Public Health, V99 Suppl 3, pS622, DOI 10.2105/AJPH.2008.154955; Poynter ME, 2006, AM J PHYSIOL-LUNG C, V290, pL144, DOI 10.1152/ajplung.00131.2005; Rabinovitch N, 2011, AM J RESP CRIT CARE, V184, P1350, DOI 10.1164/rccm.201010-1706OC; Rice MB, 2014, AM J RESP CRIT CARE, V189, P512, DOI 10.1164/rccm.201310-1924PP; Robinson CL, 2011, THORAX, V66, P1051, DOI 10.1136/thx.2011.158956; Rogers AJ, 2009, CLIN EXP ALLERGY, V39, P1721, DOI 10.1111/j.1365-2222.2009.03372.x; Rosa MJ, 2011, RESP MED, V105, P869, DOI 10.1016/j.rmed.2010.11.022; Rosenlund M, 2009, THORAX, V64, P573, DOI 10.1136/thx.2007.094953; Salon D, 2010, ENERG POLICY, V38, P2032, DOI 10.1016/j.enpol.2009.12.005; Samoli E, 2011, ENVIRON RES, V111, P418, DOI 10.1016/j.envres.2011.01.014; Schikowski T, 2013, ENVIRON HEALTH PERSP, V121, P1034, DOI 10.1289/ehp.1206145; Schultz EN, 2010, J ASTHMA, V47, P1049, DOI 10.1080/02770903.2010.508856; SELTZER J, 1986, J APPL PHYSIOL, V60, P1321, DOI 10.1152/jappl.1986.60.4.1321; Shankardass K, 2009, P NATL ACAD SCI USA, V106, P12406, DOI 10.1073/pnas.0812910106; Silverman RA, 2010, J ALLERGY CLIN IMMUN, V125, P367, DOI 10.1016/j.jaci.2009.10.061; Solomon C, 2000, EUR RESPIR J, V15, P922, DOI 10.1034/j.1399-3003.2000.15e19.x; Son JY, 2013, EPIDEMIOLOGY, V24, P545, DOI 10.1097/EDE.0b013e3182953244; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Stenfors N, 2004, EUR RESPIR J, V23, P82, DOI 10.1183/09031936.03.00004603; Sternthal MJ, 2011, J ALLERGY CLIN IMMUN, V128, P337, DOI 10.1016/j.jaci.2011.05.008; Strickland MJ, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-36; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Takahashi G, 2010, J PHARMACOL SCI, V112, P192, DOI 10.1254/jphs.09276FP; Thurston GD, 2013, NAT CLIM CHANGE, V3, P863, DOI 10.1038/nclimate2013; TUNNICLIFFE WS, 1994, LANCET, V344, P1733, DOI 10.1016/S0140-6736(94)92886-X; United States Environmental Protection Agency, INT SCI ASS OZ REL P; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Vrijheid M, 2012, ENVIRON HEALTH PERSP, V120, P29, DOI 10.1289/ehp.1103823; Wang PL, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-29; Wang PL, 2011, AM J RESP CELL MOL, V45, P977, DOI 10.1165/rcmb.2011-0001OC; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Wilhelm M, 2009, HEALTH PLACE, V15, P25, DOI 10.1016/j.healthplace.2008.02.002; Witten A, 2005, J OCCUP ENVIRON MED, V47, P1250, DOI 10.1097/01.jom.0000177081.62204.8d; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Zhou CL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-506; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797	139	948	975	54	2964	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1581	1592		10.1016/S0140-6736(14)60617-6	http://dx.doi.org/10.1016/S0140-6736(14)60617-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792855	Green Accepted			2022-12-28	WOS:000335495400030
J	Armuzzi, A; Felice, C				Armuzzi, Alessandro; Felice, Carla			Etrolizumab in moderate-to-severe ulcerative colitis	LANCET			English	Editorial Material							MAINTENANCE THERAPY; INDUCTION; REMISSION		[Armuzzi, Alessandro; Felice, Carla] Univ Cattolica Sacro Cuore, IBD Unit, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Armuzzi, A (corresponding author), Univ Cattolica Sacro Cuore, IBD Unit, Complesso Integrato Columbus, I-00168 Rome, Italy.	alearmuzzi@yahoo.com	Armuzzi, Alessandro/AIC-5188-2022; Felice, Carla/M-1914-2018	Felice, Carla/0000-0001-6646-6231				Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Feagan BG, 2013, GASTROENTEROLOGY, V145, P149, DOI 10.1053/j.gastro.2013.03.025; Lobaton T, 2014, ALIMENT PHARM THER, V39, P579, DOI 10.1111/apt.12639; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutgeerts PJ, 2013, GUT, V62, P1122, DOI 10.1136/gutjnl-2011-301769; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Vermeire S, 2014, LANCET	10	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					285	286		10.1016/S0140-6736(14)60529-8	http://dx.doi.org/10.1016/S0140-6736(14)60529-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24814088	hybrid			2022-12-28	WOS:000339722400005
J	Forsberg, KJ; Patel, S; Gibson, MK; Lauber, CL; Knight, R; Fierer, N; Dantas, G				Forsberg, Kevin J.; Patel, Sanket; Gibson, Molly K.; Lauber, Christian L.; Knight, Rob; Fierer, Noah; Dantas, Gautam			Bacterial phylogeny structures soil resistomes across habitats	NATURE			English	Article							ANTIBIOTIC-RESISTANCE GENES; MICROBIAL COMMUNITIES; PROTEIN; DIVERSITY; IDENTIFICATION; MECHANISMS; ECOLOGY; UNIFRAC; DRIVES; TOOL	Ancient and diverse antibiotic resistance genes (ARGs) have previously been identified from soil(1-3), including genes identical to those in human pathogens(4). Despite the apparent overlap between soil and clinical resistomes(4-6), factors influencing ARG composition in soil and their movement between genomes and habitats remain largely unknown(3). General metagenome functions often correlate with the underlying structure of bacterial communities(7-12). However, ARGs are proposed to be highly mobile(4,5,13), prompting speculation that resistomes may not correlate with phylogenetic signatures or ecological divisions(13,14). To investigate these relationships, we performed functional metagenomic selections for resistance to 18 antibiotics from 18 agricultural and grassland soils. The 2,895 ARGs we discovered were mostly new, and represent all major resistance mechanisms(15). We demonstrate that distinct soil types harbour distinct resistomes, and that the addition of nitrogen fertilizer strongly influenced soil ARG content. Resistome composition also correlated with microbial phylogenetic and taxonomic structure, both across and within soil types. Consistent with this strong correlation, mobility elements (genes responsible for horizontal gene transfer between bacteria such as transposases and integrases) syntenic with ARGs were rare in soil by comparison with sequenced pathogens, suggesting that ARGs may not transfer between soil bacteria as readily as is observed between human pathogens. Together, our results indicate that bacterial community composition is the primary determinant of soil ARG content, challenging previous hypotheses that horizontal gene transfer effectively decouples resistomes from phylogeny(13,14).	[Forsberg, Kevin J.; Patel, Sanket; Gibson, Molly K.; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Patel, Sanket; Dantas, Gautam] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Howard Hughes Med Inst, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL)	Dantas, G (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	dantas@wustl.edu	Knight, Rob/D-1299-2010	Knight, Rob/0000-0002-0975-9019; Dantas, Gautam/0000-0003-0455-8370; FIERER, NOAH/0000-0002-6432-4261; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives [SB2]; NIH Director's New Innovator Award [DP2-DK-098089]; Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University; NIGMS [GM 007067]; NHGRI Genome Analysis Training Program [T32 HG000045];  [DGE-1143954]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI Genome Analysis Training Program; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Pesesky for access to and assistance with the data set used to benchmark RAIphy's performance, B. Wang for suggested improvements to Illumina library preparation, the Genome Technology Access Center at Washington University in St Louis for generating Illumina sequence data, M. Sherman for discussions on modelling pathogen HGT potential, and members of the Dantas laboratory for discussions on the results and analyses presented here. This work was supported by awards to G. D. through the Children's Discovery Institute (MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, the National Academies Keck Futures Initiatives (Synthetic Biology, SB2), and the NIH Director's New Innovator Award (DP2-DK-098089). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M. K. G. is supported by a Mr and Mrs Spencer T. Olin Fellowship for Women in Graduate Study at Washington University. K.J.F. received support from the NIGMS Cell and Molecular Biology Training Grant (GM 007067) and from the NHGRI Genome Analysis Training Program (T32 HG000045). K.J.F. and M.K.G. are NSF graduate research fellows (award number DGE-1143954).	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke K. R., 2006, PRIMER V6 USER MANUA; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de la Bastide M., 2007, ASSEMBLING GENOMIC D, V11; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Pehrsson EC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00145; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	42	678	718	53	862	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					612	+		10.1038/nature13377	http://dx.doi.org/10.1038/nature13377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24847883	Green Submitted, Green Accepted			2022-12-28	WOS:000336457100047
J	Aveyard, P; Lindson-Hawley, N; Hastings, G; de Andrade, M				Aveyard, Paul; Lindson-Hawley, Nicola; Hastings, Gerard; de Andrade, Marisa			Should smokers be advised to cut down as well as quit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE REPLACEMENT; SMOKING REDUCTION; CESSATION; CIGARETTES		[Aveyard, Paul; Lindson-Hawley, Nicola] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Hastings, Gerard; de Andrade, Marisa] Univ Stirling, Stirling FK9 4LA, Scotland; [Hastings, Gerard] Ecole Hautes Etud Sante Publ, Rennes, France	University of Oxford; University of Stirling	Aveyard, P (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	paul.aveyard@phc.ox.ac.uk; gerard.hastings@stir.ac.uk		Lindson, Nicola/0000-0003-2539-9268; Aveyard, Paul/0000-0002-1802-4217	MRC [G0802135] Funding Source: UKRI; British Heart Foundation [PG/08/047/25082] Funding Source: researchfish; Cancer Research UK [15192] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, G0802135, MR/K023195/1B] Funding Source: researchfish; National Institute for Health Research [CSA/02/06/001] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Beard E, 2011, ADDICTION, V106, P197, DOI 10.1111/j.1360-0443.2010.03215.x; Beard E, 2012, DRUG ALCOHOL DEPEN, V126, P354, DOI 10.1016/j.drugalcdep.2012.05.039; British American Tobacco, 2013, FOC HARM RED WHY IT; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Chapman S., 2014, WHY IS BIG TOBACCO I; CINCIRIPINI PM, 1995, J CONSULT CLIN PSYCH, V63, P388, DOI 10.1037/0022-006X.63.3.388; Connock M, 2009, BMJ-BRIT MED J, V338, pb102; de Andrade M., 2013, MARKETING ELECT CIGA; De Andrade M, 2013, TOBACCO HARM REDUCTI; de Andrade Marisa, 2013, BMJ, V347, pf7473, DOI 10.1136/bmj.f7473; Hastings G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8412; Hughes JR, 2006, NICOTINE TOB RES, V8, P739, DOI 10.1080/14622200600789726; Hughes JR, 2013, DRUG ALCOHOL DEPEN, V128, P171, DOI 10.1016/j.drugalcdep.2012.08.010; Lindson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub2; National Institute for Health and Clinical Excellence, 2013, TOB HARM RED APPR SM; O'Reilly D, 2009, TOBACCO HARM REDUCTI; Office for National Statistics, 2013, GEN LIF SURV OV A RE; Pisinger C, 2007, NICOTINE TOB RES, V9, P631, DOI 10.1080/14622200701365327; Royal College of Physicians, 2007, HARM RED NIC ADD HEL; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Shiffman S, 2007, NICOTINE TOB RES, V9, P1177, DOI 10.1080/14622200701648441; Wang D, 2008, HEALTH TECHNOL ASSES, V12, P1; West R, 2014, LATEST TRENDS SMOKIN	24	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g2787	10.1136/bmj.g2787	http://dx.doi.org/10.1136/bmj.g2787			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24840739	Green Published			2022-12-28	WOS:000336428800001
J	Bardon, AB; Beattie, S; Luciuk, C; Cairncross, W; Fine, D; Cheng, NS; Edge, GJA; Taylor, E; Zhang, S; Trotzky, S; Thywissen, JH				Bardon, A. B.; Beattie, S.; Luciuk, C.; Cairncross, W.; Fine, D.; Cheng, N. S.; Edge, G. J. A.; Taylor, E.; Zhang, S.; Trotzky, S.; Thywissen, J. H.			Transverse Demagnetization Dynamics of a Unitary Fermi Gas	SCIENCE			English	Article							SPIN-DIFFUSION; THERMODYNAMICS; TRANSPORT	Understanding the quantum dynamics of strongly interacting fermions is a problem relevant to diverse forms of matter, including high-temperature superconductors, neutron stars, and quark-gluon plasma. An appealing benchmark is offered by cold atomic gases in the unitary limit of strong interactions. Here, we study the dynamics of a transversely magnetized unitary Fermi gas in an inhomogeneous magnetic field. We observe the demagnetization of the gas, caused by diffusive spin transport. At low temperatures, the diffusion constant saturates to the conjectured quantum-mechanical lower bound similar or equal to h/m, where m is the particle mass. The development of pair correlations, indicating the transformation of the initially noninteracting gas toward a unitary spin mixture, is observed by measuring Tan's contact parameter.	[Bardon, A. B.; Beattie, S.; Luciuk, C.; Cairncross, W.; Fine, D.; Cheng, N. S.; Edge, G. J. A.; Trotzky, S.; Thywissen, J. H.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Taylor, E.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Zhang, S.] Univ Hong Kong, Dept Phys, Ctr Theoret & Computat Phys, Hong Kong, Hong Kong, Peoples R China; [Thywissen, J. H.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Toronto; McMaster University; University of Hong Kong; Canadian Institute for Advanced Research (CIFAR)	Thywissen, JH (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	joseph.thywissen@utoronto.ca	Taylor, Edward/A-9817-2010; Thywissen, Joseph H/E-8235-2010; Zhang, Shizhong/H-4454-2012	Taylor, Edward/0000-0001-7374-0390; Thywissen, Joseph H/0000-0002-7007-8204; Beattie, Scott/0000-0003-2056-2871; Zhang, Shizhong/0000-0002-1910-5721	Centre for Quantum Information and Quantum Control; Ontario; NSERC; CIFAR; University of Hong Kong; AFOSR [FA955-13-1-0063]	Centre for Quantum Information and Quantum Control; Ontario; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); University of Hong Kong(University of Hong Kong); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We thank B. Braverman, I. Kivlichan, L. LeBlanc, and T. Pfau for experimental assistance; D. DeMille, T. Enss, L. Jiang, A. Leggett, and A. Paramekanti for discussions; A. Aspect for manuscript comments; and M. Ku and M. Zwierlein for sharing their unitary equation-of-state data. S.T. acknowledges support from the Centre for Quantum Information and Quantum Control. G.J.A.E. acknowledges support from Ontario. This work was supported by NSERC, CIFAR, the University of Hong Kong, and AFOSR under agreement no. FA955-13-1-0063.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Baker GA, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.054311; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Braaten E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223004; Braaten E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205301; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Du X, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.010401; Enss T, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033630; Enss T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.195303; Enss T, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013616; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; JEON JW, 1989, PHYS REV LETT, V62, P2691, DOI 10.1103/PhysRevLett.62.2691; Koschorreck M, 2013, NAT PHYS, V9, P405, DOI 10.1038/nphys2637; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Kuhnle ED, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.170402; LEGGETT AJ, 1970, J PHYS PART C SOLID, V3, P448, DOI 10.1088/0022-3719/3/2/027; LHUILLIER C, 1982, J PHYS-PARIS, V43, P225, DOI 10.1051/jphys:01982004302022500; Liao YA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145305; MEYEROVICH AE, 1985, PHYS LETT A, V107, P177, DOI 10.1016/0375-9601(85)90836-9; Nascimbene S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215303; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Nikolic P, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.033608; Partridge GB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020404; Pieri P, 2009, NAT PHYS, V5, P736, DOI 10.1038/NPHYS1345; Sanner C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.010402; Schneider W, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.021601; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Stewart JT, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.235301; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2952, DOI 10.1016/j.aop.2008.03.004; Veillette MY, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.043614; Werner F, 2009, EUR PHYS J B, V68, P401, DOI 10.1140/epjb/e2009-00040-8; Werner F, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013626; Wulin D, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100504; Zhang SZ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023601; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318	39	73	73	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					722	724		10.1126/science.1247425	http://dx.doi.org/10.1126/science.1247425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833387	Green Accepted			2022-12-28	WOS:000335912900034
J	Sedgwick, P				Sedgwick, Philip			Clinical trials: units of randomisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CROSSOVER TRIAL		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3191; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2820; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2573; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Vuillermin PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c843	5	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3297	10.1136/bmj.g3297	http://dx.doi.org/10.1136/bmj.g3297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838104				2022-12-28	WOS:000336158400003
J	Garraway, LA				Garraway, Levi A.			A Notch for Noncoding RNA in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.							Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Forloni M, 2014, ELIFE, V3, DOI 10.7554/eLife.01460; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1950	1951		10.1056/NEJMcibr1402173	http://dx.doi.org/10.1056/NEJMcibr1402173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827041				2022-12-28	WOS:000336123600013
J	Jou, C				Jou, Chin			HISTORY OF MEDICINE The Biology and Genetics of Obesity - A Century of Inquiries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University	Jou, C (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.							Begley S., 2012, REUTERS         0511; Dearborn GVN, 1917, INTERSTATE MED J, V24, P156; Kolata GB., 2007, RETHINKING THIN NEW; Shell ER, 2003, HUNGRY GENE INSIDE S; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	5	20	21	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1874	1877		10.1056/NEJMp1400613	http://dx.doi.org/10.1056/NEJMp1400613			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827033	Bronze			2022-12-28	WOS:000336123600003
J	Ramsay, H				Ramsay, Hamish			CLIMATE SCIENCE Shifting storms	NATURE			English	Editorial Material							TROPICAL BELT		[Ramsay, Hamish] Monash Univ, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia; [Ramsay, Hamish] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University; Monash University	Ramsay, H (corresponding author), Monash Univ, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia.	hamish.ramsay@monash.edu	Ramsay, Hamish A/G-9604-2011	Ramsay, Hamish A/0000-0002-4606-9615				Barnes EA, 2013, P NATL ACAD SCI USA, V110, P15211, DOI 10.1073/pnas.1308732110; Grassi B, 2012, J CLIMATE, V25, P3282, DOI 10.1175/JCLI-D-11-00244.1; Hartmann D. L., 2013, CLIMATE CHANGE 2013, P226; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kossin JP, 2014, NATURE, V509, P349, DOI 10.1038/nature13278; Kossin JP, 2013, J CLIMATE, V26, P9960, DOI 10.1175/JCLI-D-13-00262.1; Nguyen H, 2013, J CLIMATE, V26, P3357, DOI 10.1175/JCLI-D-12-00224.1; Ramsay HA, 2012, CLIM DYNAM, V39, P897, DOI 10.1007/s00382-011-1225-8; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38	10	3	3	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					290	291		10.1038/509290a	http://dx.doi.org/10.1038/509290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828183				2022-12-28	WOS:000336121200021
J	Barker, AF; Bergeron, A; Rom, WN; Hertz, MI				Barker, Alan F.; Bergeron, Anne; Rom, William N.; Hertz, Marshall I.			Obliterative Bronchiolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LUNG-TRANSPLANT RECIPIENTS; VERSUS-HOST-DISEASE; AIR-FLOW DECLINE; CHRONIC REJECTION; INTERNATIONAL SOCIETY; AZITHROMYCIN THERAPY; CELL TRANSPLANTATION; SULFUR MUSTARD; MURINE MODEL; RISK	First recognized as an occupational disorder, obliterative bronchiolitis is now the primary noninfectious pulmonary complication of allogeneic hematopoietic stem-cell transplantation and lung transplantation. This review includes an update on recognition, treatment, and prevention. The term bronchiolitis obliterans was historically used by pathologists to refer to two distinct patterns of small-airway disease. The first was characterized by intraluminal polyps in the small airways. It was subsequently named bronchiolitis obliterans with organizing pneumonia and, more recently, cryptogenic organizing pneumonia. The second pattern was characterized by subepithelial inflammatory and fibrotic narrowing of the bronchioles, which is now recognized as obliterative bronchiolitis or constrictive bronchiolitis.(1),(2) To add to the confusion, physicians may use the term bronchiolitis obliterans syndrome to denote the occurrence of an obstructive ventilatory defect that occurs after transplantation (Table 1), particularly in patients ...	[Barker, Alan F.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care, Dept Med, Portland, OR 97239 USA; [Bergeron, Anne] Hop St Louis, AP HP, Serv Pneumol, Paris, France; [Rom, William N.] NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Hertz, Marshall I.] Univ Minnesota, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Minneapolis, MN 55455 USA	Oregon Health & Science University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; New York University; University of Minnesota System; University of Minnesota Twin Cities	Barker, AF (corresponding author), Oregon Hlth & Sci Univ, UHN 67, Portland, OR 97239 USA.	barkera@ohsu.edu		Bergeron, Anne/0000-0003-2156-254X; Rom, William/0000-0002-8793-7028	Genzyme; Bristol-Myers Squibb; Pfizer; Gilead; MSD; Chiesi; French Ministry of Health; APT Pharmaceuticals; Alnylam; Novartis	Genzyme(Sanofi-AventisGenzyme Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Gilead(Gilead Sciences); MSD; Chiesi(Chiesi Pharmaceuticals Inc); French Ministry of Health; APT Pharmaceuticals; Alnylam; Novartis(Novartis)	Dr. Bergeron reports receiving lecture fees from Genzyme, Bristol-Myers Squibb, Pfizer, Gilead, MSD, and Chiesi, travel support from MSD, Chiesi, and VitalAire, and active and placebo treatment units from AstraZeneca for a trial funded by the French Ministry of Health; and Dr. Hertz, receiving grant support from APT Pharmaceuticals and consulting fees from Alnylam and Novartis. No other potential conflict of interest relevant to this article was reported.	Akpinar-Elci M, 2004, EUR RESPIR J, V24, P298, DOI 10.1183/09031936.04.00013903; Alam N, 2012, BIOL BLOOD MARROW TR, V18, P1905, DOI 10.1016/j.bbmt.2012.07.012; [Anonymous], 2002, JAMA, V287, P2939; Au BKC, 2011, BIOL BLOOD MARROW TR, V17, P1072, DOI 10.1016/j.bbmt.2010.11.018; Bankier AA, 2001, RADIOLOGY, V218, P533, DOI 10.1148/radiology.218.2.r01fe09533; Benden C, 2012, J HEART LUNG TRANSPL, V31, P1087, DOI 10.1016/j.healun.2012.08.005; Bergeron A, 2013, BONE MARROW TRANSPL, V48, P819, DOI 10.1038/bmt.2012.241; Burgel PR, 2013, EUR RESPIR REV, V22, P131, DOI 10.1183/09059180.00001313; Chang AB, 1998, PEDIATR RADIOL, V28, P23, DOI 10.1007/s002470050286; Chien JW, 2010, BIOL BLOOD MARROW TR, V16, pS106, DOI 10.1016/j.bbmt.2009.11.002; Chien JW, 2006, BLOOD, V107, P2200, DOI 10.1182/blood-2005-06-2338; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Colby TV, 2008, ATLAS PULMONARY MED, P69; Copeland CAF, 2010, AM J RESP CRIT CARE, V182, P784, DOI 10.1164/rccm.201002-0211OC; Dhillon GS, 2010, AM J RESP CRIT CARE, V182, P230, DOI 10.1164/rccm.200910-1573OC; Dudek AZ, 2003, BIOL BLOOD MARROW TR, V9, P657, DOI 10.1016/S1083-8791(03)00242-8; Erard V, 2006, J INFECT DIS, V193, P1619, DOI 10.1086/504268; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Federica M, 2011, CLIN TRANSPLANT, V25, pE381, DOI 10.1111/j.1399-0012.2011.01435.x; Gerhardt SG, 2003, AM J RESP CRIT CARE, V168, P121, DOI 10.1164/rccm.200212-1424BC; Ghanei M, 2004, EUR J RADIOL, V52, P164, DOI 10.1016/j.ejrad.2004.03.018; Ghanei M, 2008, RESP MED, V102, P825, DOI 10.1016/j.rmed.2008.01.016; Ghanei M, 2007, INHAL TOXICOL, V19, P889, DOI 10.1080/08958370701432132; Hachem RR, 2012, AM J TRANSPLANT, V12, P2164, DOI 10.1111/j.1600-6143.2012.04079.x; Hadjiliadis D, 2005, J HEART LUNG TRANSPL, V24, pS249, DOI 10.1016/j.healun.2004.06.022; Halldin CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057935; Hildebrandt GC, 2008, BIOL BLOOD MARROW TR, V14, P67, DOI 10.1016/j.bbmt.2007.09.009; Jain R, 2010, J HEART LUNG TRANSPL, V29, P531, DOI 10.1016/j.healun.2009.12.003; Kastelijn EA, 2010, J HEART LUNG TRANSPL, V29, P665, DOI 10.1016/j.healun.2009.12.013; Kelly FL, 2012, AM J TRANSPLANT, V12, P3076, DOI 10.1111/j.1600-6143.2012.04201.x; Khateri S, 2003, J OCCUP ENVIRON MED, V45, P1136, DOI 10.1097/01.jom.0000094993.20914.d1; Kim CK, 2001, CHEST, V120, P1101, DOI 10.1378/chest.120.4.1101; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Nousari HC, 1999, NEW ENGL J MED, V340, P1406, DOI 10.1056/NEJM199905063401805; O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC; Palmer SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017644; Palmer SM, 2002, TRANSPLANTATION, V74, P799, DOI 10.1097/00007890-200209270-00011; Panahi Y, 2014, J IMMUNOTOXICOL, V11, P72, DOI 10.3109/1547691X.2013.797525; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Parmet AJ, 2002, J OCCUP ENVIRON MED, V44, P216, DOI 10.1097/00043764-200203000-00002; Perez T, 1998, AM J RESP CRIT CARE, V157, P1658, DOI 10.1164/ajrccm.157.5.9710018; Pettersson GB, 2010, CURR OPIN ORGAN TRAN, V15, P549, DOI 10.1097/MOT.0b013e32833e4c10; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Seetharam A, 2010, CURR OPIN ORGAN TRAN, V15, P531, DOI 10.1097/MOT.0b013e32833b31f4; Shohrati M, 2008, RESP MED, V102, P443, DOI 10.1016/j.rmed.2007.10.004; Snell GI, 2006, AM J TRANSPLANT, V6, P169, DOI 10.1111/j.1600-6143.2005.01134.x; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Treede H, 2012, J HEART LUNG TRANSPL, V31, P797, DOI 10.1016/j.healun.2012.03.008; Vanaudenaerde BM, 2008, EUR RESPIR J, V32, P832, DOI 10.1183/09031936.00134307; Verleden GM, 2005, EUR RESPIR J, V25, P221, DOI 10.1183/09031936.05.00057404; Vos R, 2011, EUR RESPIR J, V37, P164, DOI 10.1183/09031936.00068310; Vos R, 2012, TRANSPLANTATION, V94, P101, DOI 10.1097/TP.0b013e31824db9da; Weigt SS, 2012, AM J TRANSPLANT, V12, P477, DOI 10.1111/j.1600-6143.2011.03859.x; Weinberger B, 2011, PULM PHARMACOL THER, V24, P92, DOI 10.1016/j.pupt.2010.09.004; White Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM; Wilkes DS, 2012, SEMIN IMMUNOL, V24, P131, DOI 10.1016/j.smim.2011.08.020; WRIGHT JL, 1985, BRIT J IND MED, V42, P556; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; Zarin AA, 2010, EXP LUNG RES, V36, P284, DOI 10.3109/01902140903578868	60	163	173	4	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1820	1828		10.1056/NEJMra1204664	http://dx.doi.org/10.1056/NEJMra1204664			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806161				2022-12-28	WOS:000335997900009
J	Cheng, TL; Wise, PH; Halfon, N				Cheng, Tina L.; Wise, Paul H.; Halfon, Neal			Promise and Perils of the Affordable Care Act for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH REFORM; ELIGIBILITY; MEDICAID		[Cheng, Tina L.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Cheng, Tina L.] Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Wise, Paul H.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Wise, Paul H.] Stanford Univ, Ctr Policy Outcomes & Prevent, Palo Alto, CA 94304 USA; [Halfon, Neal] David Geffen Univ Calif, Dept Pediat, Los Angeles, CA USA; [Halfon, Neal] Univ Calif Los Angeles, Sch Med, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Halfon, Neal] Univ Calif Los Angeles, Luskin Sch Publ Affairs, Dept Publ Policy, Los Angeles, CA USA; [Halfon, Neal] Univ Calif Los Angeles, Ctr Healthier Children Families & Communities, Los Angeles, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cheng, TL (corresponding author), Johns Hopkins Univ, Dept Gen Pediat & Adolescent Med, 200 N Wolfe St,Ste 2055, Baltimore, MD 21287 USA.	tcheng2@jhmi.edu			NIMHD NIH HHS [P20 MD000198] Funding Source: Medline; National Institute on Minority Health and Health Disparities [P20MD000198] Funding Source: NIH RePORTER	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Dolatshahi J, HEALTH CARE REFORM A; Hensley-Quinn M, HOW CHIP CAN HELP ME; Kenney GM, 2011, HEALTH AFFAIR, V30, P2371, DOI 10.1377/hlthaff.2011.0899; Kenney GM, GAINS FOR CHILDREN I; Mancini T, CHILDRENS HEALTH COV; McManus P., COMP REV ESSENTIAL H; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000; U.S. Bureau of the Census, CURRENT POPULATION S	8	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1733	1734		10.1001/jama.2014.930	http://dx.doi.org/10.1001/jama.2014.930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794362	Green Accepted			2022-12-28	WOS:000335382300014
J	Cohen, LE				Cohen, Laurie E.			Idiopathic Short Stature A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GROWTH-HORMONE THERAPY; PREDICTING ADULT HEIGHT; FINAL HEIGHT; FACTOR-I; GH DEFICIENCY; IGF-I; CHILDREN; SAFETY; DIAGNOSIS; CHILDHOOD	IMPORTANCE Approximately 2% of children are defined as having short stature. Deciding when to pursue recombinant human growth hormone therapy to increase adult height is controversial. OBJECTIVE To review the management of children with idiopathic short stature, including diagnostic evaluation and therapeutic options. EVIDENCE REVIEW Systematic literature search of PubMed, Embase, and the Cochrane Library databases. For height outcome, articles were limited to studies reporting adult height and to systematic reviews. FINDINGS Recombinant human growth hormone therapy of children with idiopathic short stature increases height in some children. The estimated mean gain in adult height is 5.2 cm ( 2 in). The cost-benefit ratio is controversial. Treatment with growth hormone appears safe in the short term, while data on long-term effects are limited because studies of long-term efficacy were not powered to determine safety. CONCLUSIONS AND RELEVANCE Growth hormone treatment may be considered in some children with idiopathic short stature.	[Cohen, Laurie E.] Boston Childrens Hosp, Div Endocrinol, Neuroendocrinol Program, Boston, MA 02115 USA; [Cohen, Laurie E.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Cohen, LE (corresponding author), Boston Childrens Hosp, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA.	laurie.cohen@childrens.harvard.edu						AHMED ML, 1993, ARCH DIS CHILD, V69, P361, DOI 10.1136/adc.69.3.361; Albertsson-Wikland K, 2008, J CLIN ENDOCR METAB, V93, P4342, DOI 10.1210/jc.2008-0707; Allen DB, 2006, PEDIATRICS, V118, P343, DOI 10.1542/peds.2006-0329; Allen DB, 2011, J CLIN ENDOCR METAB, V96, P3042, DOI 10.1210/jc.2011-1739; Allen DB, 2011, HORM RES PAEDIAT, V76, P45, DOI 10.1159/000330159; [Anonymous], 2004, NIH Consens State Sci Statements, V21, P1; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Benito-Sanz S, 2012, EUR J HUM GENET, V20, P125, DOI 10.1038/ejhg.2011.210; Bidlingmaier M, 2008, EUR J ENDOCRINOL, V159, pS41, DOI 10.1530/EJE-08-0284; Binder G, 2011, HORM RES PAEDIAT, V75, P81, DOI 10.1159/000324105; BLUM WF, 1990, HORM RES, V33, P31, DOI 10.1159/000181581; Bryant J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004440.pub2; Buchlis JG, 1998, J CLIN ENDOCR METAB, V83, P1075, DOI 10.1210/jc.83.4.1075; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Carel JC, 2006, MOL CELL ENDOCRINOL, V254, P226, DOI 10.1016/j.mce.2006.04.034; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Carel JC, 2010, ENDOCR DEV, V18, P40, DOI 10.1159/000316126; Cohen P, 2008, J CLIN ENDOCR METAB, V93, P4210, DOI 10.1210/jc.2008-0509; Collett-Solberg PF, 2008, J CLIN ENDOCR METAB, V93, P10, DOI 10.1210/jc.2007-1534; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; Cuttler L, 2009, MED CARE, V47, P858, DOI 10.1097/MLR.0b013e31819e1f04; De Sanctis Vincenzo, 2012, Pediatr Endocrinol Rev, V9, P727; Deodati A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7157; Diamond FB, 1998, PEDIATRICS, V102, P521; Dunkel L, 2011, HORM RES PAEDIAT, V76, P27, DOI 10.1159/000330150; Elder CJ, 2008, HORM RES, V70, P89, DOI 10.1159/000139150; Federico G, 2006, J ENDOCRINOL INVEST, V29, P732, DOI 10.1007/BF03344184; Finkelstein BS, 2002, ARCH PEDIAT ADOL MED, V156, P230, DOI 10.1001/archpedi.156.3.230; Geffner Mitchell E, 2009, J Clin Res Pediatr Endocrinol, V1, P256, DOI 10.4274/jcrpe.v1i6.256; GOODMAN HG, 1968, NEW ENGL J MED, V278, P57, DOI 10.1056/NEJM196801112780201; Greulich WW., 1959, CALIF MED, V91, P53; Grimberg A, 2005, J PEDIATR-US, V146, P212, DOI 10.1016/j.jpeds.2004.09.009; Grote FK, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-21; Hardin DS, 2008, BIOL-TARGETS THER, V2, P655; Hindmarsh PC, 1996, LANCET, V348, P13, DOI 10.1016/S0140-6736(96)01038-0; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; KAPLAN SL, 1968, PEDIATR RES, V2, P43, DOI 10.1203/00006450-196801000-00005; Kawai M, 1997, J PEDIATR-US, V130, P205, DOI 10.1016/S0022-3476(97)70344-5; Kemp SF, 2005, J CLIN ENDOCR METAB, V90, P5247, DOI 10.1210/jc.2004-2513; Lee JM, 2006, ARCH PEDIAT ADOL MED, V160, P263, DOI 10.1001/archpedi.160.3.263; Lee JM, 2009, PEDIATRICS, V124, P903, DOI 10.1542/peds.2008-0085; Leschek EW, 2004, J CLIN ENDOCR METAB, V89, P3140, DOI 10.1210/jc.2003-031457; Lopez-Siguero JP, 2000, J PEDIATR ENDOCR MET, V13, P1595; MacGillivray MH, 1996, J CLIN ENDOCR METAB, V81, P1806, DOI 10.1210/jc.81.5.1806; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; Martin DD, 2011, HORM RES PAEDIAT, V76, P1, DOI 10.1159/000329372; McCaughey ES, 1998, LANCET, V351, P940; Palmert MR, 2012, NEW ENGL J MED, V366, P443, DOI 10.1056/NEJMcp1109290; Peters CJ, 2012, ARCH DIS CHILDHOOD-E, V97, P114, DOI 10.1136/archdischild-2011-300265; Quigley CA, 2005, J CLIN ENDOCR METAB, V90, P5188, DOI 10.1210/jc.2004-2543; Radetti G, 1998, METABOLISM, V47, P1490, DOI 10.1016/S0026-0495(98)90075-0; Radetti G, 2003, CLIN ENDOCRINOL, V59, P27, DOI 10.1046/j.1365-2265.2003.01773.x; Ranke MB, 2007, HORM RES, V68, P53, DOI 10.1159/000098707; Ranke MB, 2011, HORM RES PAEDIAT, V76, P2, DOI 10.1159/000330132; Ranke MB, 2011, HORM RES PAEDIAT, V76, P48, DOI 10.1159/000330160; Richmond EJ, 2008, ADV THER, V25, P1276, DOI 10.1007/s12325-008-0124-9; Rogol AD, 2003, CLIN ENDOCRINOL, V58, P229, DOI 10.1046/j.1365-2265.2003.01701.x; Rose SR, 2005, PEDIATR REV, V26, P410; Rosenbloom AL, 2009, ADV THER, V26, P40, DOI 10.1007/s12325-008-0136-5; Rosenfeld RG, 2012, J CLIN ENDOCR METAB, V97, P68, DOI 10.1210/jc.2011-2294; Rosilio M, 2012, J CLIN ENDOCR METAB, V97, pE1257, DOI 10.1210/jc.2011-3460; Saenger P., 2008, PEDIAT ENDOCRINOLOGY, V3rd, P610; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138; Sisley S, 2013, J PEDIATR-US, V163, P1045, DOI 10.1016/j.jpeds.2013.04.002; SPERLICH M, 1995, EUR J PEDIATR, V154, P627; Stanley TL, 2009, J CLIN ENDOCR METAB, V94, P4875, DOI 10.1210/jc.2009-1369; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Topor LS, 2010, PEDIATRICS, V126, P938, DOI 10.1542/peds.2009-3649; van Gool SA, 2007, J CLIN ENDOCR METAB, V92, P1402, DOI 10.1210/jc.2006-2272; Visser-van Balen H, 2006, ARCH DIS CHILD, V91, P433, DOI 10.1136/adc.2005.086942; VOSS LD, 1992, BMJ-BRIT MED J, V305, P1400, DOI 10.1136/bmj.305.6866.1400; Wit CM, 2002, J CLIN ENDOCR METAB, V87, P604; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055; WIT JM, 1995, CLIN ENDOCRINOL, V42, P365, DOI 10.1111/j.1365-2265.1995.tb02644.x; Yanovski JA, 2003, NEW ENGL J MED, V348, P908, DOI 10.1056/NEJMoa013555; ZADIK Z, 1992, HORM RES, V37, P150, DOI 10.1159/000182300	79	25	28	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1787	1796		10.1001/jama.2014.3970	http://dx.doi.org/10.1001/jama.2014.3970			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794372				2022-12-28	WOS:000335382300024
J	Dabelea, D; Mayer-Davis, EJ; Saydah, S; Imperatore, G; Linder, B; Divers, J; Bell, R; Badaru, A; Talton, JW; Crume, T; Liese, AD; Merchant, AT; Lawrence, JM; Reynolds, K; Dolan, L; Liu, LL; Hamman, RF				Dabelea, Dana; Mayer-Davis, Elizabeth J.; Saydah, Sharon; Imperatore, Giuseppina; Linder, Barbara; Divers, Jasmin; Bell, Ronny; Badaru, Angela; Talton, Jennifer W.; Crume, Tessa; Liese, Angela D.; Merchant, Anwar T.; Lawrence, Jean M.; Reynolds, Kristi; Dolan, Lawrence; Liu, Lenna L.; Hamman, Richard F.		SEARCH Diabet Youth Study	Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDHOOD TYPE-1; UNITED-STATES; INCREASING INCIDENCE; RISK-FACTORS; US YOUTH; MELLITUS; POPULATION; OBESITY; SEARCH; COHORT	IMPORTANCE Despite concern about an "epidemic," there are limited data on trends in prevalence of either type 1 or type 2 diabetes across US race and ethnic groups. OBJECTIVE To estimate changes in the prevalence of type 1 and type 2 diabetes in US youth, by sex, age, and race/ethnicity between 2001 and 2009. DESIGN, SETTING, AND PARTICIPANTS Case patients were ascertained in 4 geographic areas and 1 managed health care plan. The study population was determined by the 2001 and 2009 bridged-race intercensal population estimates for geographic sites and membership counts for the health plan. MAIN OUTCOMES AND MEASURES Prevalence (per 1000) of physician-diagnosed type 1 diabetes in youth aged 0 through 19 years and type 2 diabetes in youth aged 10 through 19 years. RESULTS In 2001, 4958 of 3.3 million youth were diagnosed with type 1 diabetes for a prevalence of 1.48 per 1000 (95% CI, 1.44-1.52). In 2009, 6666 of 3.4 million youth were diagnosed with type 1 diabetes for a prevalence of 1.93 per 1000 (95% CI, 1.88-1.97). In 2009, the highest prevalence of type 1 diabetes was 2.55 per 1000 among white youth (95% CI, 2.48-2.62) and the lowest was 0.35 per 1000 in American Indian youth (95% CI, 0.26-0.47) and type 1 diabetes increased between 2001 and 2009 in all sex, age, and race/ethnic subgroups except for those with the lowest prevalence (age 0-4 years and American Indians). Adjusted for completeness of ascertainment, there was a 21.1% (95% CI, 15.6%-27.0%) increase in type 1 diabetes over 8 years. In 2001, 588 of 1.7 million youth were diagnosed with type 2 diabetes for a prevalence of 0.34 per 1000 (95% CI, 0.31-0.37). In 2009, 819 of 1.8 million were diagnosed with type 2 diabetes for a prevalence of 0.46 per 1000 (95% CI, 0.43-0.49). In 2009, the prevalence of type 2 diabetes was 1.20 per 1000 among American Indian youth (95% CI, 0.96-1.51); 1.06 per 1000 among black youth (95% CI, 0.93-1.22); 0.79 per 1000 among Hispanic youth (95% CI, 0.70-0.88); and 0.17 per 1000 among white youth (95% CI, 0.15-0.20). Significant increases occurred between 2001 and 2009 in both sexes, all age-groups, and in white, Hispanic, and black youth, with no significant changes for Asian Pacific Islanders and American Indians. Adjusted for completeness of ascertainment, there was a 30.5%(95% CI, 17.3%-45.1%) overall increase in type 2 diabetes. CONCLUSIONS AND RELEVANCE Between 2001 and 2009 in 5 areas of the United States, the prevalence of both type 1 and type 2 diabetes among children and adolescents increased. Further studies are required to determine the causes of these increases.	[Dabelea, Dana; Crume, Tessa; Hamman, Richard F.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA; [Mayer-Davis, Elizabeth J.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Saydah, Sharon; Imperatore, Giuseppina] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Linder, Barbara] NIDDK, Childhood Diabet Res Div Diabet Endocrinol & Meta, Bethesda, MD 20892 USA; [Divers, Jasmin; Talton, Jennifer W.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Bell, Ronny] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Badaru, Angela] Childrens Hosp & Reg Med Ctr, Dept Pediat Endocrinol & Diabet, Seattle, WA USA; [Liese, Angela D.; Merchant, Anwar T.] Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC USA; [Lawrence, Jean M.; Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Dolan, Lawrence] Childrens Hosp Med Ctr, Dept Endocrinol, Cincinnati, OH USA; [Liu, Lenna L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Liu, Lenna L.] Seattle Childrens Hosp, Seattle, WA USA	Colorado School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wake Forest University; Wake Forest University; Seattle Children's Hospital; Kaiser Permanente; Cincinnati Children's Hospital Medical Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Dabelea, D (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, 13001 East 17th Pl,Campus Box B-119, Aurora, CO 80045 USA.	dana.dabelea@ucdenver.edu	Crume, Tessa/T-9554-2019; Reynolds, Kristi/AAN-1434-2021	Crume, Tessa/0000-0002-5397-4154; Reynolds, Kristi/0000-0001-7619-1649; Lawrence, Jean/0000-0002-2480-8480; Maahs, David/0000-0002-4602-7909	CDC [PA00097, DP-05-069, DP-10-001]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIDDK; National Institutes of Health (NIH) National Center for Research Resources [UL1RR029882]; NIH [UL1 TR00423]; Clinical and Translational Research Center [UL1 TR000154]; Diabetes and Endocrinology Research Center, NIH [P30 DK57516]; National Center for Research Resources [8 UL1 TR000077]; National Center for Advancing Translational Sciences, NIH; Children with Medical Handicaps program;  [U48/CCU919219];  [U01 DP000246];  [U18DP002714];  [U48/CCU819241-3];  [U01 DP000247];  [U18DP000247-06A1];  [U48/CCU519239];  [U01 DP000248];  [1U18DP002709];  [U48/CCU419249];  [U01 DP000254];  [U18DP002708-01];  [U58/CCU019235-4];  [U01 DP000244];  [U18DP002710-01];  [U01 DP000250];  [200-2010-35171]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423, UL1TR001082, UL1TR000154, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000250, U01DP000254, U18DP003256, U01DP000248, U01DP000247, U18DP002709, U01DP000246, U18DP002710, U18DP002708, U01DP000244, U18DP002714] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104706, K23DK089017, P30DK057516] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Research Center; Diabetes and Endocrinology Research Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; Children with Medical Handicaps program; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SEARCH for Diabetes in Youth is funded by grants PA00097, DP-05-069, and DP-10-001 from the CDC and by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Additional funding was provided to the CDC for these cooperative agreements by the NIDDK. The site contracts grants are U48/CCU919219, U01 DP000246, and U18DP002714 to Kaiser Permanente Southern California; U48/CCU819241-3, U01 DP000247, and U18DP000247-06A1 to the University of Colorado Denver; U48/CCU519239, U01 DP000248, and 1U18DP002709 to the Children's Hospital Medical Center, Cincinnati, Ohio; U48/CCU419249, U01 DP000254, and U18DP002708-01 to the University of North Carolina at Chapel Hill; U58/CCU019235-4, U01 DP000244, and U18DP002710-01 to the University of Washington School of Medicine; U48/CCU919219, U01 DP000250, and 200-2010-35171 to the Wake Forest University School of Medicine. This project was also support by grants UL1RR029882 from the National Institutes of Health (NIH) National Center for Research Resources to the South Carolina Clinical & Translational Research [SCTR] Institute, at the Medical University of South Carolina; UL1 TR00423 from the NIH Clinical and Translational Science Award to the Seattle Children's Hospital of the University of Washington; UL1 TR000154 from the Clinical and Translational Research Center to the University of Colorado Pediatric Clinical; P30 DK57516 from the Diabetes and Endocrinology Research Center, NIH, to the Barbara Davis Center at the University of Colorado at Denver; 8 UL1 TR000077 from the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH; and the Children with Medical Handicaps program managed by the Ohio Department of Health.	Baranowski T, 2006, DIABETES CARE, V29, P212; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Dean H, 1998, CLIN PEDIATR, V37, P89, DOI 10.1177/000992289803700205; Demmer RT, 2013, AM J EPIDEMIOL, V178, P1106, DOI 10.1093/aje/kwt088; Diabet Children Adolescents Work G, 2004, PEDIATRICS, V114, P259; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; GART JJ, 1990, BIOMETRICS, V46, P637, DOI 10.2307/2532084; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; HELGASON T, 1992, DIABETOLOGIA, V35, P880, DOI 10.1007/BF00399936; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Ingram Deborah D, 2003, Vital Health Stat 2, P1; Kaufman FR, 2009, DIABETES CARE, V32, P953, DOI 10.2337/dc08-1774; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Lipman TH, 2013, J DIABETES, V5, P456, DOI 10.1111/1753-0407.12039; Lipman TH, 2013, DIABETES CARE, V36, P1597, DOI 10.2337/dc12-0767; Neufeld ND, 1998, DIABETES CARE, V21, P80, DOI 10.2337/diacare.21.1.80; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ortega-Rodriguez E, 2001, DIABETES METAB, V27, P574; Oster RT, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18501; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Petitti DB, 2009, J PEDIAT, V155, pe1; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; Pinhas-Hamiel O, 2000, PREV MED, V31, P702, DOI 10.1006/pmed.2000.0752; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; REUNANEN A, 1982, ACTA PAEDIATR SCAND, V71, P893, DOI 10.1111/j.1651-2227.1982.tb09545.x; Saydah Sharon, 2012, Morbidity and Mortality Weekly Report, V61, P869; SCHOBER E, 2009, J PEDIAT, V155, pE1; Schober E, 2009, J PEDIATR-US, V155, P190, DOI 10.1016/j.jpeds.2009.03.010; Smith TLS, 2007, J PEDIATR ENDOCR MET, V20, P1093; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Vehik K, 2007, DIABETES CARE, V30, P503, DOI 10.2337/dc06-1837; Verlato G, 2000, DIABETES CARE, V23, P759, DOI 10.2337/diacare.23.6.759; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	43	870	886	6	110	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1778	1786		10.1001/jama.2014.3201	http://dx.doi.org/10.1001/jama.2014.3201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794371	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000335382300023
J	Rosman, Y; Eisenkraft, A; Milk, N; Shiyovich, A; Ophir, N; Shrot, S; Kreiss, Y; Kassirer, M				Rosman, Yossi; Eisenkraft, Arik; Milk, Nadav; Shiyovich, Arthur; Ophir, Nimrod; Shrot, Shai; Kreiss, Yitshak; Kassirer, Michael			Lessons Learned From the Syrian Sarin Attack: Evaluation of a Clinical Syndrome Through Social Media	ANNALS OF INTERNAL MEDICINE			English	Article							TOKYO SUBWAY; MANAGEMENT; PROGRESS	On the night of 21 August 2013, sarin was dispersed in the eastern outskirts of Damascus, killing 1400 civilians and severely affecting thousands more. This article aims to delineate the clinical presentation and management of a mass casualty event caused by a nerve agent as shown in the social media. Authors searched YouTube for videos uploaded of this attack and identified 210 videos. Of these, 67 met inclusion criteria and were evaluated in the final analysis. These videos displayed 130 casualties; 119 (91.5%) of which were defined as moderately injured or worse. The most common clinical signs were dyspnea (53.0%), diaphoresis (48.5%), and loss of consciousness (40.7%). Important findings included a severe shortage of supporting measures and lack of antidotal autoinjectors. Decontamination, documented in 25% of the videos, was done in an inefficient manner. Protective gear was not noticed, except for sporadic use of latex gloves and surgical masks. This is believed to be the first time that social media was used to evaluate clinical data and management protocols to better prepare against future possible events.	Israel Def Forces, Med Corps, IL-52621 Tel Hashomer, Israel; Hebrew Univ Jerusalem, Jerusalem, Israel	Hebrew University of Jerusalem	Rosman, Y (corresponding author), Hashaked 4-19, IL-54044 Givat Shemuel, Israel.	rosmanyossi@gmail.com	shrot, shai/ABF-7714-2021	shrot, shai/0000-0001-8954-3244				Alasaad S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-94; Alexander J, 2013, J CANCER EDUC, V28, P744, DOI 10.1007/s13187-013-0534-5; Baker MD, 2007, CURR OPIN PEDIATR, V19, P211, DOI 10.1097/MOP.0b013e328012cba2; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Dizon DS, 2012, J ONCOL PRACT, V8, pE114, DOI 10.1200/JOP.2012.000610; DUNN MA, 1989, JAMA-J AM MED ASSOC, V262, P649, DOI 10.1001/jama.262.5.649; Fischer J, 2013, JCR-J CLIN RHEUMATOL, V19, P373, DOI 10.1097/RHU.0b013e3182a69fb2; Foltin G, 2006, PEDIATR EMERG CARE, V22, P239, DOI 10.1097/01.pec.0000214594.78261.65; Greene J., 2013, B ATOM SCI; Krivoy A, 2005, PREHOSPITAL DISASTER, V20, P155, DOI 10.1017/S1049023X00002375; Markel G, 2008, ISR MED ASSOC J, V10, P761; McDonough JH, 2000, EPILEPSY RES, V38, P1; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Plakht Y, 2011, ISR MED ASSOC J, V13, P69; Rebmann T, 2009, J EMERG MED, V37, P139, DOI 10.1016/j.jemermed.2007.09.043; Rosman Y, 2012, J APPL TOXICOL, V32, P409, DOI 10.1002/jat.1715; Shrot S, 2009, NEUROTOXICOLOGY, V30, P167, DOI 10.1016/j.neuro.2008.12.006; Tokuda Y, 2006, RESUSCITATION, V68, P193, DOI 10.1016/j.resuscitation.2005.05.023	21	108	110	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					644	U218		10.7326/M13-2799	http://dx.doi.org/10.7326/M13-2799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI0GO	24798526				2022-12-28	WOS:000336524400008
J	Roth, JA; Etzioni, R; Waters, TM; Pettinger, M; Rossouw, JE; Anderson, GL; Chlebowski, RT; Manson, JE; Hlatky, M; Johnson, KC; Ramsey, SD				Roth, Joshua A.; Etzioni, Ruth; Waters, Teresa M.; Pettinger, Mary; Rossouw, Jacques E.; Anderson, Garnet L.; Chlebowski, Rowan T.; Manson, JoAnn E.; Hlatky, Mark; Johnson, Karen C.; Ramsey, Scott D.			Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; REPLACEMENT THERAPY; SAMPLE INFORMATION; COST-EFFECTIVENESS; FOLLOW-UP; BENEFITS; RISKS; DISEASE; PREVENTION; BURDEN	Background: The findings of the Women's Health Initiative (WHI) estrogen plus progestin (E+P) trial led to a substantial reduction in use of combined hormone therapy (cHT) among postmenopausal women in the United States. The economic effect of this shift has not been evaluated relative to the trial's $260 million cost (2012 U. S. dollars). Objective: To estimate the economic return from the WHI E+P trial. Design: Decision model to simulate health outcomes for a "WHI scenario" with observed cHT use and a "no-WHI scenario" with cHT use extrapolated from the pretrial period. Data Sources: Primary analyses of WHI outcomes, peer-reviewed literature, and government sources. Target Population: Postmenopausal women in the United States, aged 50 to 79 years, who did not have a hysterectomy. Time Horizon: 2003 to 2012. Perspective: Payer. Intervention: Combined hormone therapy. Outcome Measures: Disease incidence, expenditure, quality-adjusted life-years, and net economic return. Results of Base-Case Analysis: The WHI scenario resulted in 4.3 million fewer cHT users, 126 000 fewer breast cancer cases, 76 000 fewer cardiovascular disease cases, 263 000 more fractures, 145 000 more quality-adjusted life-years, and expenditure savings of $35.2 billion. The corresponding net economic return of the trial was $37.1 billion ($140 per dollar invested in the trial) at a willingness-to-pay level of $100 000 per quality-adjusted life-year. Results of Sensitivity Analysis: The 95% CI for the net economic return of the trial was $23.1 to $51.2 billion. Limitation: No evaluation of indirect costs or outcomes beyond 2012. Conclusion: The WHI E+P trial made high-value use of public funds with a substantial return on investment. These results can contribute to discussions about the role of public funding for large, prospective trials with high potential for public health effects.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; NHLBI, NIH, Bethesda, MD 20824 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Stanford Univ, Stanford Med Sch, Stanford, CA 94305 USA	Fred Hutchinson Cancer Center; Group Health Cooperative; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University	Ramsey, SD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M3-B-232, Seattle, WA 98109 USA.	sramsey@fhcrc.org		Roth, Joshua/0000-0001-6621-8342; Anderson, Garnet/0000-0001-5087-7837; Waters, Teresa/0000-0002-3823-5177; Hlatky, Mark/0000-0003-4686-9441	National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE ON AGING [T32AG027677] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Heart, Lung, and Blood Institute.	Ades AE, 2006, HEALTH ECON, V15, P373, DOI 10.1002/hec.1068; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; [Anonymous], 1993, ASS NIH WOM HLTH IN; Bisias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034569; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Burkman RT, 2001, AM J OBSTET GYNECOL, V185, pS13, DOI 10.1067/mob.2001.117414; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Donaldson C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-8; Garber AF, 2003, BROOKINGS REV, V21, P44; Garrison LP, 2009, VALUE HEALTH, V12, pS36, DOI 10.1111/j.1524-4733.2009.00520.x; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Gyrd-Hansen D, 2003, HEALTH ECON, V12, P1049, DOI 10.1002/hec.799; Hall PS, 2012, MED DECIS MAKING, V32, pE11, DOI 10.1177/0272989X12443010; HARLAP S, 1992, AM J OBSTET GYNECOL, V166, P1986, DOI 10.1016/0002-9378(92)91399-U; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson FR, 2009, VALUE HEALTH, V12, pS38, DOI 10.1111/j.1524-4733.2009.00521.x; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kind P, 2009, VALUE HEALTH, V12, pS27, DOI 10.1111/j.1524-4733.2009.00519.x; Leary WE, NY TIMES; Lekander I, 2009, J WOMENS HEALTH, V18, P1669, DOI 10.1089/jwh.2008.1246; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roth J, 2013, VALUE HEALTH, V16, pA75, DOI 10.1016/j.jval.2013.03.341; Sasser AC, 2005, EXPERT OPIN PHARMACO, V6, P1803, DOI 10.1517/14656566.6.11.1803; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Smith MD, 2009, VALUE HEALTH, V12, pS1, DOI 10.1111/j.1524-4733.2009.00514.x; Sprague BL, 2012, OBSTET GYNECOL, V120, P595, DOI 10.1097/AOG.0b013e318265df42; Stagnitti MN., 2011, TRENDS HORMONE REPLA; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Steinkellner AR, 2012, MENOPAUSE, V19, P616, DOI 10.1097/gme.0b013e31824bb039; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Willan AR, 2005, STAT MED, V24, P1791, DOI 10.1002/sim.2069	42	36	37	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					594	U128		10.7326/M13-2348	http://dx.doi.org/10.7326/M13-2348			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI0GO	24798522	Green Accepted			2022-12-28	WOS:000336524400002
J	Ducharme, FM; Tse, SM; Chauhan, B				Ducharme, Francine M.; Tse, Sze M.; Chauhan, Bhupendrasinh			Diagnosis, management, and prognosis of preschool wheeze	LANCET			English	Article							1ST 6 YEARS; ASTHMA PREDICTIVE INDEX; EPISODIC VIRAL WHEEZE; REDUCED LUNG-FUNCTION; INHALED CORTICOSTEROIDS; CHILDHOOD ASTHMA; YOUNG-CHILDREN; RESPIRATORY-INFECTIONS; AIRWAY RESPONSIVENESS; RHINOVIRUS ILLNESSES	Preschool children (ie, those aged 5 years or younger) with wheeze consume a disproportionately high amount of health-care resources compared with older children and adults with wheeze or asthma, representing a diagnostic challenge. Although several phenotype classifications have been described, none have been validated to identify individuals responding to specific therapeutic approaches. Several risk factors related to genetic, prenatal, and postnatal environment are associated with preschool wheezing. Findings from several cohort studies have shown that preschool children with wheeze have deficits in lung function at 6 years of age that persisted until early and middle adulthood, suggesting increased susceptibility in the first years of life that might lead to persistent sequelae. Daily inhaled corticosteroids seem to be the most effective therapy for recurrent wheezing in trials of children with interim symptoms or atopy; intermittent high-dose inhaled corticosteroids are effective in moderate-to-severe viral-induced wheezing without interim symptoms. The role of leukotriene receptor antagonist is less clear. Interventions to modify the short-term and long-term outcomes of preschool wheeze should be a research priority.	[Ducharme, Francine M.; Tse, Sze M.; Chauhan, Bhupendrasinh] St Justine Univ, Ctr Hlth, Res Ctr, Clin Res & Knowledge Transfer Childhood Asthma Un, Montreal, PQ, Canada; [Ducharme, Francine M.; Tse, Sze M.] Univ Montreal, Dept Paediat, Montreal, PQ, Canada; [Ducharme, Francine M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Ducharme, FM (corresponding author), CHU St Justine, Dept Paediat, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	francine.m.ducharme@umontreal.ca	Ducharme, Francine/N-8332-2013	Ducharme, Francine/0000-0001-5096-0614	GlaxoSmithKline; Merck Frosst; Merck Canada; Novartis; Takeda	GlaxoSmithKline(GlaxoSmithKline); Merck Frosst; Merck Canada(Merck & Company); Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd)	FMD has received research funds, honorarium as speaker, and consulting fees from GlaxoSmithKline, Merck Frosst, Merck Canada, Novartis, and Takeda. SMT and BC declare no competing interests.	Amberbir A, 2011, AM J RESP CRIT CARE, V183, P165, DOI 10.1164/rccm.201006-0989OC; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Becker A, 2005, CAN MED ASSOC J, V173, pS12, DOI 10.1503/cmaj.045064; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bisgaard H, 2005, AM J RESP CRIT CARE, V171, P315, DOI 10.1164/rccm.200407-894OC; Bisgaard H, 2004, PEDIATRICS, V113, P87; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Brand PLP, 2011, RESP MED, V105, P1588, DOI 10.1016/j.rmed.2011.07.017; Brand PLP, 2011, J ALLERGY CLIN IMMUN, V127, P293, DOI 10.1016/j.jaci.2010.10.012; British Thoracic S Scottish Intercollegiate Guidelines N, 2011, BRITISH GUIDELINES O; Brussee JE, 2004, AM J RESP CRIT CARE, V169, P209, DOI 10.1164/rccm.200306-800OC; Butland BK, 2007, ANN ALLERG ASTHMA IM, V98, P337, DOI 10.1016/S1081-1206(10)60879-4; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2011, J ALLERGY CLIN IMMUN, V127, P1082, DOI 10.1016/j.jaci.2011.01.024; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; Castro-Rodriguez JA, 2009, PEDIATRICS, V123, pe519, DOI 10.1542/peds.2008-2867; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000052.pub3; Chauhan BF, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD009611.PUB3; Collins SA, 2013, PEDIATR PULM, V48, P683, DOI 10.1002/ppul.22766; Devulapalli CS, 2008, THORAX, V63, P8, DOI 10.1136/thx.2006.060616; Ducharme FM, 2012, CURR MED RES OPIN, V28, P1561, DOI 10.1185/03007995.2012.716031; Ducharme FM, 2012, CURR MED RES OPIN, V28, P111, DOI 10.1185/03007995.2011.640668; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Everard ML, 2002, COCHRANE DB SYST REV, V1; Fernandes RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub4; Firoozi F, 2010, RESP MED, V104, P1278, DOI 10.1016/j.rmed.2010.03.010; Flexeder C, 2012, ALLERGY, V67, P257, DOI 10.1111/j.1398-9995.2011.02748.x; Gadomski AM, 2010, COCHRANE DB SYST REV, V12; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Garner Rochelle, 2008, Health Rep, V19, P45; Global Initiative for Asthma, 2012, GLOBAL STRATEGY FOR; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Granell R, 2013, J ALLERGY CLIN IMMUN, V131, P685, DOI 10.1016/j.jaci.2012.09.021; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hartling L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003123.pub3; Hartling L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1714; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Holt PG, 2007, CURR OPIN ALLERGY CL, V7, P547, DOI 10.1097/ACI.0b013e3282f14a17; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Just J, 2008, CLIN EXP ALLERGY, V38, P767, DOI 10.1111/j.1365-2222.2008.02966.x; Karaca-Mandic P, 2012, JAMA-J AM MED ASSOC, V307, P1284, DOI 10.1001/jama.2012.340; Koehoorn M, 2008, PEDIATRICS, V122, P1196, DOI 10.1542/peds.2007-2231; Kurukulaaratchy RJ, 2003, EUR RESPIR J, V22, P767, DOI 10.1183/09031936.03.00005903; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lau S, 2003, EUR RESPIR J, V21, P834, DOI 10.1183/09031936.03.00037203; Leigh R, 2008, J ALLERGY CLIN IMMUN, V121, P1238, DOI 10.1016/j.jaci.2008.01.067; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Lougheed MD, 2012, CAN RESPIR J, V19, P127, DOI 10.1155/2012/635624; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Martel MJ, 2009, EUR RESPIR J, V34, P579, DOI 10.1183/09031936.00074608; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; National Heart Lung and Blood Institute/ National Asthma Education and Prevention Program, 2007, NIH PUBLICATION, V07-4051; Oddy WH, 2002, EUR RESPIR J, V19, P899, DOI 10.1183/09031936.02.00103602; Oostveen E, 2010, EUR RESPIR J, V35, P865, DOI 10.1183/09031936.00023409; Ostergaard MS, 2012, PRIM CARE RESP J, V21, P214, DOI 10.4104/pcrj.2012.00038; Pando S, 2010, PHARMACOTHERAPY, V30, P1109, DOI 10.1592/phco.30.11.1109; Papi A, 2009, ALLERGY, V64, P1463, DOI 10.1111/j.1398-9995.2009.02134.x; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Rasmussen F, 2002, J ALLERGY CLIN IMMUN, V110, P220, DOI 10.1067/mai.2002.125295; Rasmussen F, 2014, CURR OPIN ALLERGY CL, V14, P35, DOI 10.1097/ACI.0000000000000024; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; Ryan PH, 2009, AM J RESP CRIT CARE, V180, P1068, DOI 10.1164/rccm.200808-1307OC; Rzehak P, 2013, J ALLERGY CLIN IMMUN, V131, P1528, DOI 10.1016/j.jaci.2013.01.001; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schultz A, 2010, ACTA PAEDIATR, V99, P56, DOI 10.1111/j.1651-2227.2009.01508.x; Scottish Intercollegiate Guidelines Network, BRONCHIOLITIS IN CHI; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Smit LAM, 2010, EUR RESPIR J, V36, P57, DOI 10.1183/09031936.00154509; Smith JA, 2008, AM J RESP CRIT CARE, V177, P1358, DOI 10.1164/rccm.200709-1419OC; Sonnenschein-van der Voort AMM, 2012, AM J RESP CRIT CARE, V185, P731, DOI 10.1164/rccm.201107-1266OC; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Stein RT, 2008, AM J RESP CRIT CARE, V178, P1097, DOI 10.1164/rccm.200808-1305ED; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; STORR J, 1986, ARCH DIS CHILD, V61, P270, DOI 10.1136/adc.61.3.270; Strachan D, 1996, EUR RESPIR J, V9, pS42; Svedmyr J, 1999, ACTA PAEDIATR, V88, P42; Szefler SJ, 2011, ANN ALLERG ASTHMA IM, V107, P110, DOI 10.1016/j.anai.2011.04.008; Tantisira KG, 2001, THORAX, V56, P64; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; To T, 2007, ARCH PEDIAT ADOL MED, V161, P1197, DOI 10.1001/archpedi.161.12.1197; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; Umoren R, 2011, COCHRANE DB SYST REV, V1; Valovirta E, 2011, ANN ALLERG ASTHMA IM, V106, P518, DOI 10.1016/j.anai.2011.01.017; van der Gugten AC, 2012, EUR RESPIR J, V39, P403, DOI 10.1183/09031936.00188310; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; WILSON N, 1995, ARCH DIS CHILD, V72, P317, DOI 10.1136/adc.72.4.317; Wjst M, 2013, CURR OPIN ALLERGY CL, V13, P112, DOI 10.1097/ACI.0b013e32835c1674; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647; Zhang L, 2008, COCHRANE DB SYST REV, V7; Zhang LP, COCHRANE DA IN PRESS; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	119	140	152	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1593	1604		10.1016/S0140-6736(14)60615-2	http://dx.doi.org/10.1016/S0140-6736(14)60615-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24792856				2022-12-28	WOS:000335495400031
J	Aerts, JCJH; Botzen, WJW; Emanuel, K; Lin, N; de Moel, H; Michel-Kerjan, EO				Aerts, Jeroen C. J. H.; Botzen, W. J. Wouter; Emanuel, Kerry; Lin, Ning; de Moel, Hans; Michel-Kerjan, Erwann O.			Evaluating Flood Resilience Strategies for Coastal Megacities	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; YORK-CITY; CITIES; INSURANCE		[Aerts, Jeroen C. J. H.; Botzen, W. J. Wouter; de Moel, Hans] Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands; [Emanuel, Kerry] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Lin, Ning] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Michel-Kerjan, Erwann O.] Univ Penn, Wharton Sch, Ctr Risk Management & Operat, Philadelphia, PA 19104 USA; [Michel-Kerjan, Erwann O.] Univ Penn, Wharton Sch, Informat Managment Dept, Philadelphia, PA 19104 USA	Vrije Universiteit Amsterdam; Massachusetts Institute of Technology (MIT); Princeton University; University of Pennsylvania; University of Pennsylvania	Aerts, JCJH (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands.	jeroen.aerts@vu.nl; erwan-nmk@wharton.upenn.edu	Aerts, Jeroen Cjh/M-8431-2013; de Moel, Hans/L-1311-2013; Botzen, Wouter/L-3123-2013	Botzen, Wouter/0000-0002-8563-4963; de Moel, Hans/0000-0002-6826-1974				Aerts JCJH, 2013, ANN NY ACAD SCI, V1294, P1, DOI 10.1111/nyas.12200; Aerts JCJH, 2013, RISK ANAL, V33, P772, DOI 10.1111/risa.12008; Aerts JCJH, 2011, ANN NY ACAD SCI, V1227, P1, DOI 10.1111/j.1749-6632.2011.06074.x; [Anonymous], 2013, NYC SPEC IN REB RES; Dawson RJ, 2011, GLOBAL ENVIRON CHANG, V21, P628, DOI 10.1016/j.gloenvcha.2011.01.013; Federal Emergency Management Agency, 2009, HAZ MH MR4 TECHN MAN; Hallegatte S., 2012, INVESTMENT DECISION; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Intergovernmental Panel on Climate Change, 2012, MAN RISK EXTR EV DIS; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kabat P, 2005, NATURE, V438, P283, DOI 10.1038/438283a; Kunreuther H, 2013, NAT CLIM CHANGE, V3, P447, DOI [10.1038/NCLIMATE1740, 10.1038/nclimate1740]; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Michel-Kerjan E, 2012, NEW YORK TIMES  1125, pSR7; Michel-Kerjan E, 2012, NATURE, V491, P497, DOI 10.1038/491497a; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Nicholls R. J., 2008, WORKING PAPER; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; SwissRe, 2013, NAT CAT MAN MADE DIS; Tollefson J, 2012, NATURE, V491, P167, DOI 10.1038/491167a; World Bank, 2010, CLIMATE RISKS ADAPTA	23	279	294	20	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					472	474		10.1126/science.1248222	http://dx.doi.org/10.1126/science.1248222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG1EK	24786064	Green Submitted			2022-12-28	WOS:000335157700025
J	Tomasik, T				Tomasik, Tomasz			Back to red: allowing specialists to provide primary care would be a step backward for Poland	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tomasik, Tomasz] Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland; [Tomasik, Tomasz] Coll Family Phys Poland, Warsaw, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Tomasik, T (corresponding author), Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland.	mmtomasi@cyf-kr.edu.pl		Tomasik, Tomasz/0000-0002-9109-4174				[Anonymous], 2013, INFORMACJA NA POSIED; [Anonymous], 2014, HEALTH KEY TABLES FR; [Anonymous], 2013, APEL NIE POZWOLMY DE; [Anonymous], 2013, SPRAWOZDANIE STENOGR; [Anonymous], 2013, MEDYCYNA MOZE ZABRAK; [Anonymous], 2013, MEMORANDUM W SPRAWIE; [Anonymous], 2013, OPINIA MERYTORYCZNA; [Anonymous], 2013, KLRWP PRZECIW WPROWA; [Anonymous], 2013, PROJEKT USTAWY O ZMI; [Anonymous], 2013, OPINIA PRAWNA Z DNIA; Muszalik M, 2012, ARCH GERONTOL GERIAT, V55, P190, DOI 10.1016/j.archger.2011.07.015	11	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2014	348								g3030	10.1136/bmj.g3030	http://dx.doi.org/10.1136/bmj.g3030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RZ	24789095				2022-12-28	WOS:000335477500009
J	Kassebaum, NJ; Bertozzi-Villa, A; Coggeshall, MS; Shackelford, KA; Steiner, C; Heuton, KR; Gonzalez-Medina, D; Barber, R; Huynh, C; Dicker, D; Templin, T; Wolock, TM; Ozgoren, AA; Abd-Allah, F; Abera, SF; Abubakar, I; Achoki, T; Adelekan, A; Ademi, Z; Adou, AK; Adsuar, JC; Agardh, EE; Akena, D; Alasfoor, D; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, R; Al Kahbouri, MJ; Alla, F; Allen, PJ; AlMazroa, MA; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Amankwaa, AA; Amare, AT; Amini, H; Ammar, W; Antonio, CAT; Anwari, P; Arnlov, J; Arsenijevic, VSA; Artaman, A; Asad, MM; Asghar, RJ; Assadi, R; Atkins, LS; Badawi, A; Balakrishnan, K; Basu, A; Basu, S; Beardsley, J; Bedi, N; Bekele, T; Bell, ML; Bernabe, E; Beyene, TJ; Bhutta, Z; Bin Abdulhak, A; Blore, JD; Basara, BB; Bose, D; Breitborde, N; Cardenas, R; Castaneda-Orjuela, CA; Castro, RE; Catala-Lopez, F; Cavlin, A; Chang, JC; Che, X; Christophi, CA; Chugh, SS; Cirillo, M; Colquhoun, SM; Cooper, LT; Cooper, C; Leite, ID; Dandona, L; Dandona, R; Davis, A; Dayama, A; Degenhardt, L; De Leo, D; del Pozo-Cruz, B; Deribe, K; Dessalegn, M; deVeber, GA; Dharmaratne, SD; Dilmen, U; Ding, EL; Dorrington, RE; Driscoll, TR; Ermakov, SP; Esteghamati, A; Faraon, EJA; Farzadfar, F; Felicio, MM; Fereshtehnejad, SM; de Lima, GMF; Forouzanfar, MH; Franca, EB; Gaffikin, L; Gambashidze, K; Gankpe, FG; Garcia, AC; Geleijnse, JM; Gibney, KB; Giroud, M; Glaser, EL; Goginashvili, K; Gona, P; Gonzalez-Castell, D; Goto, A; Gouda, HN; Gugnani, HC; Gupta, R; Gupta, R; Hafezi-Nejad, N; Hamadeh, RR; Hammami, M; Hankey, GJ; Harb, HL; Havmoeller, R; Hay, SI; Pi, IBH; Hoek, HW; Hosgood, HD; Hoy, DG; Husseini, A; Idrisov, BT; Innos, K; Inoue, M; Jacobsen, KH; Jahangir, E; Jee, SH; Jensen, PN; Jha, V; Jiang, GH; Jonas, JB; Juel, K; Kabagambe, EK; Kan, HD; Karam, NE; Karch, A; Karema, CK; Kaul, A; Kawakami, N; Kazanjan, K; Kazi, DS; Kemp, AH; Kengne, AP; Kereselidze, M; Khader, YS; Khalifa, SEAH; Khan, EA; Khang, YH; Knibbs, L; Kokubo, Y; Kosen, S; Defo, BK; Kulkarni, C; Kulkarni, VS; Kumar, GA; Kumar, K; Kumar, RB; Kwan, G; Lai, T; Lalloo, R; Lam, H; Lansingh, VC; Larsson, A; Lee, JT; Leigh, J; Leinsalu, M; Leung, R; Li, XH; Li, YC; Li, YM; Liang, J; Liang, XF; Lim, SS; Lin, HH; Lipshultz, SE; Liu, SW; Liu, Y; Lloyd, BK; London, SJ; Lotufo, PA; Ma, JX; Ma, S; Machado, VMP; Mainoo, NK; Majdan, M; Mapoma, CC; Marcenes, W; Marzan, MB; Mason-Jones, AJ; Mehndiratta, MM; Mejia-Rodriguez, F; Memish, ZA; Mendoza, W; Miller, TR; Mills, EJ; Mokdad, AH; Mola, GL; Monasta, L; Monis, JD; Hernandez, JCM; Moore, AR; Moradi-Lakeh, M; Mori, R; Mueller, UO; Mukaigawara, M; Naheed, A; Naidoo, KS; Nand, D; Nangia, V; Nash, D; Nejjari, C; Nelson, RG; Neupane, SP; Newton, CR; Ng, M; Nieuwenhuijsen, MJ; Nisar, MI; Nolte, S; Norheim, OF; Nyakarahuka, L; Oh, IH; Ohkubo, T; Olusanya, BO; Omer, SB; Opio, JN; Orisakwe, OE; Pandian, JD; Papachristou, C; Park, JH; Caicedo, AJP; Patten, SB; Paul, VK; Pavlin, BI; Pearce, N; Pereira, DM; Pesudovs, K; Petzold, M; Poenaru, D; Polanczyk, GV; Polinder, S; Pope, D; Pourmalek, F; Qato, D; Quistberg, DA; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; ur Rahman, S; Raju, M; Rana, SM; Refaat, A; Ronfani, L; Roy, N; Pimienta, TGS; Sahraian, MA; Salomon, JA; Sampson, U; Santos, IS; Sawhney, M; Sayinzoga, F; Schneider, IJC; Schumacher, A; Schwebel, DC; Seedat, S; Sepanlou, SG; Servan-Mori, EE; Shakh-Nazarova, M; Sheikhbahaei, S; Shibuya, K; Shin, HH; Shiue, I; Sigfusdottir, ID; Silberberg, DH; Silva, AP; Singh, JA; Skirbekk, V; Sliwa, K; Soshnikov, SS; Sposato, LA; Sreeramareddy, CT; Stroumpoulis, K; Sturua, L; Sykes, BL; Tabb, KM; Talongwa, RT; Tan, F; Teixeira, CM; Tenkorang, EY; Terkawi, AS; Thorne-Lyman, AL; Tirschwell, DL; Towbin, JA; Tran, BX; Tsilimbaris, M; Uchendu, US; Ukwaja, KN; Undurraga, EA; Uzun, SB; Vallely, AJ; van Gool, CH; Vasankari, TJ; Vavilala, MS; Venketasubramanian, N; Villalpando, S; Violante, FS; Vlassov, VV; Vos, T; Waller, S; Wang, HD; Wang, LH; Wang, XR; Wang, YP; Weichenthal, S; Weiderpass, E; Weintraub, RG; Westerman, R; Wilkinson, JD; Woldeyohannes, SM; Wong, JQ; Wordofa, MA; Xu, GL; Yang, YC; Yano, Y; Yentur, GK; Yip, P; Yonemoto, N; Yoon, SJ; Younis, MZ; Yu, CH; Jin, KY; Zaki, ME; Zhao, Y; Zheng, YF; Zhou, MG; Zhu, J; Zou, XN; Lopez, AD; Naghavi, M; Murray, CJL; Lozano, R				Kassebaum, Nicholas J.; Bertozzi-Villa, Amelia; Coggeshall, Megan S.; Shackelford, Katya A.; Steiner, Caitlyn; Heuton, Kyle R.; Gonzalez-Medina, Diego; Barber, Ryan; Huynh, Chantal; Dicker, Daniel; Templin, Tara; Wolock, Timothy M.; Ozgoren, Ayse Abbasoglu; Abd-Allah, Foad; Abera, Semaw Ferede; Abubakar, Ibrahim; Achoki, Tom; Adelekan, Ademola; Ademi, Zanfina; Adou, Arsene Kouablan; Adsuar, Jose C.; Agardh, Emilie E.; Akena, Dickens; Alasfoor, Deena; Alemu, Zewdie Aderaw; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Al Kahbouri, Mazin J.; Alla, Francois; Allen, Peter J.; AlMazroa, Mohammad A.; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson; Amankwaa, Adansi A.; Amare, Azmeraw T.; Amini, Hassan; Ammar, Walid; Antonio, Carl A. T.; Anwari, Palwasha; Arnlov, Johan; Arsic Arsenijevic, Valentina S.; Artaman, Ali; Asad, Majed Masoud; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Badawi, Alaa; Balakrishnan, Kalpana; Basu, Arindam; Basu, Sanjay; Beardsley, Justin; Bedi, Neeraj; Bekele, Tolesa; Bell, Michelle L.; Bernabe, Eduardo; Beyene, Tariku J.; Bhutta, Zulfiqar; Bin Abdulhak, Aref; Blore, Jed D.; Basara, Berrak Bora; Bose, Dipan; Breitborde, Nicholas; Cardenas, Rosario; Castaneda-Orjuela, Carlos A.; Castro, Ruben Estanislao; Catala-Lopez, Ferran; Cavlin, Alanur; Chang, Jung-Chen; Che, Xuan; Christophi, Costas A.; Chugh, Sumeet S.; Cirillo, Massimo; Colquhoun, Samantha M.; Cooper, Leslie Trumbull; Cooper, Cyrus; Leite, Iuri da Costa; Dandona, Lalit; Dandona, Rakhi; Davis, Adrian; Dayama, Anand; Degenhardt, Louisa; De Leo, Diego; del Pozo-Cruz, Borja; Deribe, Kebede; Dessalegn, Muluken; deVeber, Gabrielle A.; Dharmaratne, Samath D.; Dilmen, Ugur; Ding, Eric L.; Dorrington, Rob E.; Driscoll, Tim R.; Ermakov, Sergei Petrovich; Esteghamati, Alireza; Faraon, Emerito Jose A.; Farzadfar, Farshad; Felicio, Manuela Mendonca; Fereshtehnejad, Seyed-Mohammad; Ferreira de Lima, Graca Maria; Forouzanfar, Mohammad H.; Franca, Elisabeth B.; Gaffikin, Lynne; Gambashidze, Ketevan; Gankpe, Fortune Gbetoho; Garcia, Ana C.; Geleijnse, Johanna M.; Gibney, Katherine B.; Giroud, Maurice; Glaser, Elizabeth L.; Goginashvili, Ketevan; Gona, Philimon; Gonzalez-Castell, Dinorah; Goto, Atsushi; Gouda, Hebe N.; Gugnani, Harish Chander; Gupta, Rahul; Gupta, Rajeev; Hafezi-Nejad, Nima; Hamadeh, Randah Ribhi; Hammami, Mouhanad; Hankey, Graeme J.; Harb, Hilda L.; Havmoeller, Rasmus; Hay, Simon I.; Heredia Pi, Ileana B.; Hoek, Hans W.; Hosgood, H. Dean; Hoy, Damian G.; Husseini, Abdullatif; Idrisov, Bulat T.; Innos, Kaire; Inoue, Manami; Jacobsen, Kathryn H.; Jahangir, Eiman; Jee, Sun Ha; Jensen, Paul N.; Jha, Vivekanand; Jiang, Guohong; Jonas, Jost B.; Juel, Knud; Kabagambe, Edmond Kato; Kan, Haidong; Karam, Nadim E.; Karch, Andre; Karema, Corine Kakizi; Kaul, Anil; Kawakami, Norito; Kazanjan, Konstantin; Kazi, Dhruv S.; Kemp, Andrew H.; Kengne, Andre Pascal; Kereselidze, Maia; Khader, Yousef Saleh; Khalifa, Shams Eldin Ali Hassan; Khan, Ejaz Ahmed; Khang, Young-Ho; Knibbs, Luke; Kokubo, Yoshihiro; Kosen, Soewarta; Defo, Barthelemy Kuate; Kulkarni, Chanda; Kulkarni, Veena S.; Kumar, G. Anil; Kumar, Kaushalendra; Kumar, Ravi B.; Kwan, Gene; Lai, Taavi; Lalloo, Ratilal; Lam, Hilton; Lansingh, Van C.; Larsson, Anders; Lee, Jong-Tae; Leigh, James; Leinsalu, Mall; Leung, Ricky; Li, Xiaohong; Li, Yichong; Li, Yongmei; Liang, Juan; Liang, Xiaofeng; Lim, Stephen S.; Lin, Hsien-Ho; Lipshultz, Steven E.; Liu, Shiwei; Liu, Yang; Lloyd, Belinda K.; London, Stephanie J.; Lotufo, Paulo A.; Ma, Jixiang; Ma, Stefan; Pedro Machado, Vasco Manuel; Mainoo, Nana Kwaku; Majdan, Marek; Mapoma, Christopher Chabila; Marcenes, Wagner; Barrientos Marzan, Melvin; Mason-Jones, Amanda J.; Mehndiratta, Man Mohan; Mejia-Rodriguez, Fabiola; Memish, Ziad A.; Mendoza, Walter; Miller, Ted R.; Mills, Edward J.; Mokdad, Ali H.; Mola, Glen Liddell; Monasta, Lorenzo; de la Cruz Monis, Jonathan; Montanez Hernandez, Julio Cesar; Moore, Ami R.; Moradi-Lakeh, Maziar; Mori, Rintaro; Mueller, Ulrich O.; Mukaigawara, Mitsuru; Naheed, Aliya; Naidoo, Kovin S.; Nand, Devina; Nangia, Vinay; Nash, Denis; Nejjari, Chakib; Nelson, Robert G.; Neupane, Sudan Prasad; Newton, Charles R.; Ng, Marie; Nieuwenhuijsen, Mark J.; Nisar, Muhammad Imran; Nolte, Sandra; Norheim, Ole F.; Nyakarahuka, Luke; Oh, In-Hwan; Ohkubo, Takayoshi; Olusanya, Bolajoko O.; Omer, Saad B.; Opio, John Nelson; Orisakwe, Orish Ebere; Pandian, Jeyaraj D.; Papachristou, Christina; Park, Jae-Hyun; Paternina Caicedo, Angel J.; Patten, Scott B.; Paul, Vinod K.; Pavlin, Boris Igor; Pearce, Neil; Pereira, David M.; Pesudovs, Konrad; Petzold, Max; Poenaru, Dan; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, Dan; Pourmalek, Farshad; Qato, Dima; Quistberg, D. Alex; Rafay, Anwar; Rahimi, Kazem; Rahimi-Movaghar, Vafa; ur Rahman, Sajjad; Raju, Murugesan; Rana, Saleem M.; Refaat, Amany; Ronfani, Luca; Roy, Nobhojit; Sanchez Pimienta, Tania Georgina; Sahraian, Mohammad Ali; Salomon, Joshua A.; Sampson, Uchechukwu; Santos, Itamar S.; Sawhney, Monika; Sayinzoga, Felix; Schneider, Ione J. C.; Schumacher, Austin; Schwebel, David C.; Seedat, Soraya; Sepanlou, Sadaf G.; Servan-Mori, Edson E.; Shakh-Nazarova, Marina; Sheikhbahaei, Sara; Shibuya, Kenji; Shin, Hwashin Hyun; Shiue, Ivy; Sigfusdottir, Inga Dora; Silberberg, Donald H.; Silva, Andrea P.; Singh, Jasvinder A.; Skirbekk, Vegard; Sliwa, Karen; Soshnikov, Sergey S.; Sposato, Luciano A.; Sreeramareddy, Chandrashekhar T.; Stroumpoulis, Konstantinos; Sturua, Lela; Sykes, Bryan L.; Tabb, Karen M.; Talongwa, Roberto Tchio; Tan, Feng; Teixeira, Carolina Maria; Tenkorang, Eric Yeboah; Terkawi, Abdullah Sulieman; Thorne-Lyman, Andrew L.; Tirschwell, David L.; Towbin, Jeffrey A.; Tran, Bach X.; Tsilimbaris, Miltiadis; Uchendu, Uche S.; Ukwaja, Kingsley N.; Undurraga, Eduardo A.; Uzun, Selen Begum; Vallely, Andrew J.; van Gool, Coen H.; Vasankari, Tommi J.; Vavilala, Monica S.; Venketasubramanian, N.; Villalpando, Salvador; Violante, Francesco S.; Vlassov, Vasiliy Victorovich; Vos, Theo; Waller, Stephen; Wang, Haidong; Wang, Linhong; Wang, XiaoRong; Wang, Yanping; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Westerman, Ronny; Wilkinson, James D.; Woldeyohannes, Solomon Meseret; Wong, John Q.; Wordofa, Muluemebet Abera; Xu, Gelin; Yang, Yang C.; Yano, Yuichiro; Yentur, Gokalp Kadri; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa Z.; Yu, Chuanhua; Jin, Kim Yun; Zaki, Maysaa El Sayed; Zhao, Yong; Zheng, Yingfeng; Zhou, Maigeng; Zhu, Jun; Zou, Xiao Nong; Lopez, Alan D.; Naghavi, Mohsen; Murray, Christopher J. L.; Lozano, Rafael			Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							IMMUNODEFICIENCY VIRUS-1 INFECTION; PREGNANCY-RELATED MORTALITY; HIV-INFECTION; ADULT MORTALITY; WOMEN; DEATHS; MORBIDITY; OUTCOMES; HEALTH; IMPACT	Background The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100 000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery. Methods We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basis of a systematic review of the relative risk of dying during pregnancy for HIV-positive women compared with HIV-negative women. We also estimated the fraction of these deaths aggravated by pregnancy on the basis of a systematic review. To estimate the numbers of maternal deaths due to nine different causes, we identified 61 sources from a systematic review and 943 site-years of vital registration data. We also did a systematic review of reports about the timing of maternal death, identifying 142 sources to use in our analysis. We developed estimates for each country for 1990-2013 using Bayesian meta-regression. We estimated 95% uncertainty intervals (UIs) for all values. Findings 292 982 (95% UI 261017-327792) maternal deaths occurred in 2013, compared with 376 034 (343483-407574) in 1990. The global annual rate of change in the MMR was -0.3% (-1.1 to 0.6) from 1990 to 2003, and -2.7% (-3.9 to -1.5) from 2003 to 2013, with evidence of continued acceleration. MMRs reduced consistently in south, east, and southeast Asia between 1990 and 2013, but maternal deaths increased in much of sub-Saharan Africa during the 1990s. 2070 (1290-2866) maternal deaths were related to HIV in 2013, 0.4% (-0.2-0.6) of the global total. MMR was highest in the oldest age groups in both 1990 and 2013. In 2013, most deaths occurred intrapartum or postpartum. Causes varied by region and between 1990 and 2013. We recorded substantial variation in the MMR by country in 2013, from 956.8 (685.1-1262.8) in South Sudan to 2.4 (1.6-3.6) in Iceland. Interpretation Global rates of change suggest that only 16 countries will achieve the MDG 5 target by 2015. Accelerated reductions since the Millennium Declaration in 2000 coincide with increased development assistance for maternal, newborn, and child health. Setting of targets and associated interventions for after 2015 will need careful consideration of regions that are making slow progress, such as west and central Africa.	[Kassebaum, Nicholas J.; Bertozzi-Villa, Amelia; Coggeshall, Megan S.; Shackelford, Katya A.; Steiner, Caitlyn; Heuton, Kyle R.; Gonzalez-Medina, Diego; Barber, Ryan; Huynh, Chantal; Dicker, Daniel; Templin, Tara; Wolock, Timothy M.; Dandona, Lalit; Forouzanfar, Mohammad H.; Lim, Stephen S.; Mokdad, Ali H.; Moradi-Lakeh, Maziar; Ng, Marie; Schumacher, Austin; Vos, Theo; Wang, Haidong; Naghavi, Mohsen; Murray, Christopher J. L.; Lozano, Rafael] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Suite 600, Seattle, WA 98121 USA; [Tirschwell, David L.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Kassebaum, Nicholas J.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Pediat Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Alfonso-Cristancho, Rafael; Jensen, Paul N.; Quistberg, D. Alex; Vavilala, Monica S.] Univ Washington, Seattle, WA 98195 USA; [Ozgoren, Ayse Abbasoglu; Cavlin, Alanur] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Abera, Semaw Ferede] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Tigray, Ethiopia; [Abubakar, Ibrahim] UCL, London, England; [Achoki, Tom] Minist Hlth, Gaborone, Botswana; [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbp, Nigeria; [Colquhoun, Samantha M.] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Ademi, Zanfina; Blore, Jed D.; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Jose C.] Univ Extremadura, Caceres, Spain; [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden; [Akena, Dickens; Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Alasfoor, Deena; Al Kahbouri, Mazin J.] Minist Hlth, Muscat, Oman; [Alemu, Zewdie Aderaw] Debre Markos Univ, Debre Markos, Amhara, Ethiopia; [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Ali, Raghib; Hay, Simon I.; Rahimi, Kazem] Univ Oxford, Oxford, England; [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France; [Allen, Peter J.] Minist Hlth, Belmopan, Cayo, Belize; [AlMazroa, Mohammad A.; Memish, Ziad A.] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Alsharif, Ubai; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany; [Alvarez, Elena] Govt Delegat Natl Plan Drugs, Spanish Observ Drugs, Madrid, Spain; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Alvarez, Elena] Minist Hlth Social Serv & Equal, Madrid, Spain; [Alvis-Guzman, Nelson] Univ Cartagena, Cartagena de Indias, Colombia; [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Amini, Hassan] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Antonio, Carl A. T.; Faraon, Emerito Jose A.] Univ Philippines, Coll Publ Hlth, Manila, Philippines; [Anwari, Palwasha] UN Populat Fund, Kabul, Afghanistan; [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Arsic Arsenijevic, Valentina S.] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Artaman, Ali] Median, Windsor, ON, Canada; [Asad, Majed Masoud] Minist Hlth, Amman, Jordan; [Asghar, Rana J.] Field Epidemiol & Lab Training Program, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Atkins, Lydia S.] Minist Hlth Wellness Human Serv & Gender Relat, Sans Souci, Castries, St Lucia; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India; [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch 1, New Zealand; [Gaffikin, Lynne] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Beardsley, Justin] Univ Oxford, Ho Chi Minh City, Vietnam; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Bekele, Tolesa] Madawalabu Univ, Bale Goba, Oromia, Ethiopia; [Bell, Michelle L.] Yale Univ, New Haven, CT USA; [Bernabe, Eduardo] Kings Coll London, London WC2R 2LS, England; [Beyene, Tariku J.; Deribe, Kebede] Univ Addis Ababa, Debre Zeit, Ethiopia; [Bhutta, Zulfiqar] Aga Khan Univ, Med Ctr, Karachi, Pakistan; [Nisar, Muhammad Imran] Aga Khan Univ, Karachi, Pakistan; [Bin Abdulhak, Aref] Univ Missouri, Kansas City, MO 64110 USA; [Basara, Berrak Bora; Dilmen, Ugur; Yentur, Gokalp Kadri] Gen Directorate Hlth Res, Ankara, Turkey; [Uzun, Selen Begum] Minist Hlth, Ankara, Turkey; [Bose, Dipan] World Bank, Washington, DC 20433 USA; [Breitborde, Nicholas] Univ Arizona, Tucson, AZ USA; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Castro, Ruben Estanislao] Univ Diego Portales, Santiago, Chile; [Lin, Hsien-Ho] Natl Taiwan Univ, Coll Publ Hlth, Taipei 10764, Taiwan; [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan; [Che, Xuan] NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Cirillo, Massimo] Univ Salerno, I-84081 Baronissi, Italy; [Cooper, Leslie Trumbull] Mayo Clin, Rochester, MN USA; [Cooper, Cyrus] Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England; [Leite, Iuri da Costa] Natl Sch Publ Hlth, ENSP Fiocruz, Rio De Janeiro, Brazil; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil; Kumar, Ravi B.] Publ Hlth Fdn India, New Delhi, India; [Davis, Adrian] Publ Hlth England, London, England; [Dayama, Anand] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Liu, Yang; Omer, Saad B.] Emory Univ, Atlanta, GA 30322 USA; [Vallely, Andrew J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ New S Wales, Sydney, NSW, Australia; [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia; [del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand; [Dessalegn, Muluken] Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [deVeber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Ding, Eric L.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Salomon, Joshua A.] Harvard Univ, Boston, MA 02115 USA; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa; [Dorrington, Rob E.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia; [Ermakov, Sergei Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Sahraian, Mohammad Ali] Univ Tehran Med Sci, MS Res Ctr, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Felicio, Manuela Mendonca; Teixeira, Carolina Maria] ARS Norte IP, Dept Saude Publ, Oporto, Portugal; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad; Havmoeller, Rasmus] Karolinska Inst, Stockholm, Sweden; [Pedro Machado, Vasco Manuel] Northern Reg Hlth Adm, Oporto, Portugal; [Ferreira de Lima, Graca Maria] Dept Publ Hlth, Unidade Local Saude Matosinhos, Oporto, Portugal; [Franca, Elisabeth B.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Gambashidze, Ketevan; Kazanjan, Konstantin; Kereselidze, Maia; Shakh-Nazarova, Marina; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth Georgia, Tbilisi, Georgia; [Gankpe, Fortune Gbetoho] Clin Cooperat Parakou, Parakou, Borgou, Benin; [Garcia, Ana C.] Grp Almada Seixal, Unit Primary Hlth Care, Almada, Setubal, Portugal; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gibney, Katherine B.; Lloyd, Belinda K.] Monash Univ, Melbourne, Vic 3004, Australia; [Giroud, Maurice] Univ Hosp Dijon, Dijon, France; [Glaser, Elizabeth L.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Idrisov, Bulat T.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Goginashvili, Ketevan] Minist Labour Hlth & Social Affairs, Tbilisi, Georgia; [Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Gonzalez-Castell, Dinorah; Heredia Pi, Ileana B.; Mejia-Rodriguez, Fabiola; Montanez Hernandez, Julio Cesar; Sanchez Pimienta, Tania Georgina; Servan-Mori, Edson E.; Villalpando, Salvador; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gouda, Hebe N.; Knibbs, Luke] Univ Queensland, Brisbane, Qld, Australia; [Gugnani, Harish Chander] St James Sch Med, Kralendijk, Bonaire, Netherlands; [Gupta, Rahul] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Husseini, Abdullatif] Birzeit Univ, Ramallah, Palestine; [Innos, Kaire; Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jahangir, Eiman] Ochsner Med Ctr, New Orleans, LA USA; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh, India; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [Kabagambe, Edmond Kato; Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA; [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Karam, Nadim E.] Univ Balamand, Beirut, Lebanon; [Karch, Andre] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Karema, Corine Kakizi] Minist Hlth, Malaria & Other Parasit Div, Kigali, Rwanda; [Sayinzoga, Felix] Minist Hlth, Kigali, Rwanda; [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA; [Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kemp, Andrew H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Kengne, Andre Pascal] South African Med Res Council, Cape Town, South Africa; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Al Ramtha, Jordan; [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz Ahmed] Hlth Serv Acad, Islamabad, Pakistan; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kosen, Soewarta] Natl Inst Hlth Res & Dev, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Kulkarni, Chanda] Rajrajeshwari Med Coll & Hosp, Bangalore, Karnataka, India; [Kulkarni, Veena S.] Arkansas State Univ, Jonesboro, AR USA; [Kumar, Kaushalendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Kumar, Ravi B.] Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurgaon, India; [Kwan, Gene] Boston Med Ctr, Boston, MA USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lalloo, Ratilal] Univ Adelaide, ARCPOH, Sch Dent, Adelaide, SA, Australia; [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Lansingh, Van C.] Int Agcy Prevent Blindness & Vis 2020, Weston, FL USA; [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Leung, Ricky] SUNY Albany, Rensselaer, NY USA; [Li, Xiaohong] Natl Ctr Birth Defects Monitoring China, Chengdu, Peoples R China; [Li, Yichong; Liu, Shiwei; Ma, Jixiang; Wang, Linhong; Zhou, Maigeng] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Tan, Feng] Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yongmei] Genentech Inc, San Francisco, CA USA; [Liang, Juan; Wang, Yanping; Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Peoples R China; [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA; [London, Stephanie J.] NIEHS, Res Triangle Pk, NC 27709 USA; [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore; [Mainoo, Nana Kwaku] Xpharmconsult, Kumasi, Ghana; [Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Mapoma, Christopher Chabila] Univ Zambia, Lusaka, Zambia; [Marcenes, Wagner] Univ London, London, England; [Barrientos Marzan, Melvin] Univ East Ramon Magsaysay, Mem Med Ctr, Quezon City, Philippines; [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England; [Mehndiratta, Man Mohan] Janakpuri Super Specialty Hosp, New Delhi, India; [Mendoza, Walter] UN Populat Fund, Lima, Peru; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Mola, Glen Liddell] Univ Papua New Guinea, Port Moresby, Papua N Guinea; [Monasta, Lorenzo; Ronfani, Luca] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [de la Cruz Monis, Jonathan] Bur Int Hlth Cooperat, Manila City, Philippines; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Moradi-Lakeh, Maziar] Univ Med Sci, Dept Community Med, Tehran, Iran; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Mueller, Ulrich O.; Westerman, Ronny] Univ Marburg, Marburg, Germany; [Mukaigawara, Mitsuru] Med & Dent Univ, Tokyo, Japan; [Naheed, Aliya] Int Ctr Diarrhoea Dis Res, Dhaka, Bangladesh; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, South Africa; [Nand, Devina] Minist Hlth Fiji, Suva, Fiji; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Nelson, Robert G.] NIDDK, Phoenix, AZ USA; [Neupane, Sudan Prasad] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway; [Newton, Charles R.] Kenya Med Res Inst Wellcome Trust Programme, Kilifi, Kenya; [Nieuwenhuijsen, Mark J.] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Norheim, Ole F.] Univ Bergen, Bergen, Norway; [Oh, In-Hwan] Kyung Hee Unvers, Seoul, South Korea; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Olusanya, Bolajoko O.] Ctr Healthy Start Initiat, Lagos, Nigeria; [Opio, John Nelson] Lira Dist Local Govt, Lira Municipal Council, Lira, Uganda; [Orisakwe, Orish Ebere] Univ Port Harcourt, Fac Pharm, Toxicol Unit, Port Harcourt, Nigeria; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Park, Jae-Hyun] Sungkyunkwan Univ, Sch Med, Suwon, South Korea; [Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena, Colombia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Paul, Vinod K.] AIIMS, New Delhi, India; [Pavlin, Boris Igor] WHO, Waigani, Papua N Guinea; [Pearce, Neil] London Sch Hyg & Trop Med, London WC1, England; [Pereira, David M.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Braga, Portugal; [Pereira, David M.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA, Australia; [Petzold, Max] Gothenburg Univ, Sahlgrenska Acad, Ctr Appl Biostat, S-41124 Gothenburg, Sweden; [Poenaru, Dan] McMaster Univ, Hamilton, ON, Canada; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Pope, Dan] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA; [Tabb, Karen M.] Univ Illinois, Chicago, IL USA; [Rafay, Anwar] Contech Int, Lahore, Pakistan; [ur Rahman, Sajjad] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MO USA; [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Pakistan; [Refaat, Amany] Walden Univ, Minneapolis, MN USA; [Roy, Nobhojit] Bhaba Atom Res Ctr Hosp, Mumbai, Maharashtra, India; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Seedat, Soraya] Univ Stellenbosch, Cape Town, South Africa; [Shin, Hwashin Hyun; Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland; [Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA; [Silva, Andrea P.] Inst Nacl Epidemiol DrJuan H Jara, Mar Del Plata, Argentina; [Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway; [Soshnikov, Sergey S.] Fed Res Inst Hlth Org, Moscow, Russia; [Soshnikov, Sergey S.] Informat Minist Hlth Russian Federat, Moscow, Russia; [Sposato, Luciano A.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Kajang, Malaysia; [Stroumpoulis, Konstantinos] Hellen Ctr Dis Control & Prevent KEELPNO Greece, Athens, Greece; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc & Sociol, Irvine, CA USA; [Talongwa, Roberto Tchio] Minist Publ Hlth, Yaounde, Cameroon; [Tenkorang, Eric Yeboah] Mem Univ, St John, NF, Canada; [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thorne-Lyman, Andrew L.] Columbia Univ, Earth Inst, New York, NY USA; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Tran, Bach X.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece; [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA; [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakaliki, Nigeria; [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Venketasubramanian, N.] Raffles Hosp, Ctr Neurosci, Singapore, Singapore; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia; [Waller, Stephen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wang, XiaoRong] Shandong Univ, Affiliated Jinan Central Hosp, Jinan 250100, Peoples R China; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Wilkinson, James D.] Univ Miami, Miami, FL USA; [Woldeyohannes, Solomon Meseret] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Manila, Philippines; [Wordofa, Muluemebet Abera] Jimma Univ, Jimma, Ethiopia; [Xu, Gelin] Nanjing Univ, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yang C.] Univ N Carolina, Chapel Hill, NC USA; [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Japan; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Dept Epidemiol & Biostat, Wuhan 430072, Peoples R China; [Jin, Kim Yun] TCM MedicalTk, Nusajaya, Johor Bahru, Malaysia; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Xiao Nong] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Hacettepe University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; University of London; University College London; University of Melbourne; University of Melbourne; Universidad de Extremadura; Makerere University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; University of Oxford; Universite de Lorraine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University System of Georgia; Albany State University; University of Groningen; Bahir Dar University; Kurdistan University of Medical Sciences; University of the Philippines System; University of the Philippines Manila; United Nations Population Fund; Uppsala University; University of Belgrade; Mashhad University Medical Science; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; Stanford University; Stanford University; University of Oxford; Yale University; University of London; King's College London; Addis Ababa University; Aga Khan University; Aga Khan University; University of Missouri System; University of Missouri Kansas City; Ministry of Health - Turkey; The World Bank; University of Arizona; Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Salud (Colombia); University Diego Portales; National Taiwan University; National Taiwan University; National Institutes of Health (NIH) - USA; Cyprus University of Technology; Cedars Sinai Medical Center; University of Salerno; Mayo Clinic; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; Fundacao Oswaldo Cruz; Public Health Foundation of India; Public Health England; Emory University; Emory University; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; Griffith University; University of Auckland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Peradeniya; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Cape Town; University of Cape Town; University of Sydney; University of Sydney; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska Institutet; Universidade Federal de Minas Gerais; National Center for Disease Control & Public Health - Georgia; Wageningen University & Research; Monash University; CHU Dijon Bourgogne; Brandeis University; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; Instituto Nacional de Salud Publica; National Center for Global Health & Medicine - Japan; University of Queensland; University of Queensland; Fortis Escorts Hospital; Arabian Gulf University; University of Western Australia; Parnassia Psychiatric Institute; Yeshiva University; Albert Einstein College of Medicine; Birzeit University; National Institute for Health Development - Estonia; University of Tokyo; University of Tokyo; University of Tokyo; George Mason University; Ochsner Health System; Yonsei University; Yonsei University Health System; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Tianjin Center for Disease Control & Prevention; Ruprecht Karls University Heidelberg; Vanderbilt University; Fudan University; University Balamand; Helmholtz Association; Helmholtz-Center for Infection Research; University of California System; University of California San Francisco; Universidade de Sao Paulo; South African Medical Research Council; Jordan University of Science & Technology; Health Services Academy; Seoul National University (SNU); National Cerebral & Cardiovascular Center - Japan; National Institute of Health Research & Development - Indonesia; Universite de Montreal; Arkansas State University; International Institute for Population Sciences; Public Health Foundation of India; Boston Medical Center; University of Adelaide; Korea University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Roche Holding; Genentech; Sichuan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Ministry of Health-Singapore; University of Trnava; University of Zambia; University of London; UERM Memorial Medical Center; University of York - UK; United Nations Population Fund; Pacific Institute for Research & Evaluation (PIRE); University of Ottawa; University of Papua New Guinea; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; Tehran University of Medical Sciences; National Center for Child Health & Development - Japan; Philipps University Marburg; Tokyo Medical & Dental University (TMDU); International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; Suraj Eye Institute; City University of New York (CUNY) System; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oslo; Kenya Medical Research Institute; Pompeu Fabra University; University of Bergen; Kyung Hee University; Teikyo University; University of Port Harcourt; Sungkyunkwan University (SKKU); Universidad de Cartagena; University of Calgary; All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Universidade do Minho; Flinders University South Australia; University of Gothenburg; McMaster University; Erasmus University Rotterdam; Erasmus MC; University of Liverpool; University of British Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; University of Punjab; Walden University; Bhabha Atomic Research Center (BARC); Marshall University; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; Stellenbosch University; Health Canada; Heriot Watt University; Reykjavik University; University of Pennsylvania; Norwegian Institute of Public Health (NIPH); Ministry of Health of the Russian Federation; Western University (University of Western Ontario); Universiti Tunku Abdul Rahman (UTAR); University of California System; University of California Irvine; Memorial University Newfoundland; University of Virginia; King Fahad Medical City; Columbia University; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Crete; Netherlands National Institute for Public Health & the Environment; UKK Institute; Raffles Hospital; University of Bologna; HSE University (National Research University Higher School of Economics); Uniformed Services University of the Health Sciences - USA; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Miami; University of Gondar; Jimma University; Nanjing University; University of North Carolina; University of North Carolina Chapel Hill; Jichi Medical University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Chongqing Medical University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Kassebaum, NJ (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Suite 600, Seattle, WA 98121 USA.	nickjk@uw.edu	Patten, Scott/B-4434-2011; Bin Abdulhak, Aref/AAK-4348-2020; Beyene, Tariku Jibat/A-6875-2017; Kaul, Anil/B-2075-2016; wang, YA XING/K-9671-2016; Karch, André/D-6973-2017; Khader, Yousef/AAE-9620-2019; Rahimi, Kazem/Q-1279-2015; Soshnikov, Sergey/AAG-9739-2020; Polanczyk, Guilherme V./AAF-6142-2021; Badawi, Alaa/ABC-1300-2021; ABBASOGLU OZGOREN, AYSE/I-8707-2013; Degenhardt, Louisa J/D-4515-2012; Salomon, Joshua/S-1929-2019; Idrisov, Bulat/A-8271-2018; wang, lili/HDL-7210-2022; Juel, Knud/C-8916-2013; Santos, Itamar/M-2208-2019; Hay, Simon Iain/F-8967-2015; Sepanlou, Sadaf G/H-9343-2016; Leung, Ricky/P-3702-2015; Catalá-López, Ferrán/N-6018-2018; Olusanya, Bolajoko O./F-4504-2012; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Sposato, Luciano A/D-7782-2012; Santos, Itamar S/K-7055-2012; wang, xiao/HGB-7081-2022; Geleijnse, Johanna Marianna M/B-5749-2012; Memish, Ziad Ahmed/AEJ-9424-2022; Salomon, Joshua A/D-3898-2009; Liu, Yang/AAA-7224-2019; Bedi, Neeraj/AGR-0606-2022; Castañeda-Orjuela, Carlos/N-2601-2017; Ronfani, Luca/B-6668-2013; Nolte, Sandra/B-7498-2008; Zaki, Maysaa El Sayed/C-1522-2013; Newton, Charles/V-7872-2019; Rana, Saleem M/Y-9791-2018; Nieuwenhuijsen, Mark J/C-3914-2017; Zhou, Maigeng/HCH-7703-2022; Heredia-Pi, Ileana Beatriz/L-4247-2019; Pesudovs, Konrad/T-9403-2019; Amare, Azmeraw T./B-9487-2018; Neupane, Sudan Prasad/C-8056-2011; Singh, Jasvinder/R-6172-2019; Newton, Charles RJC/B-7578-2014; Schwebel, David/GXH-9944-2022; Kengne, Andre Pascal/ABB-3696-2020; Violante, Francesco S/A-6934-2009; Khan, Prof Dr Ejaz/GNP-1245-2022; Marzan, Melvin/AAP-8443-2020; Ding, Eric L./K-1118-2019; Jacobsen, Kathryn H./B-5857-2008; Leinsalu, Mall/I-3768-2018; Norheim, Ole Frithjof/AAC-8771-2020; Mapoma, Christopher Chabila/AAX-3368-2020; Alvis-Guzman, Nelson/D-4913-2013; Weiderpass, Elisabete/AAP-2747-2021; ORISAKWE, ORISH EBERE/X-5852-2019; Zheng, Yingfeng/AAE-2983-2022; Khan, Ejaz A/B-9340-2016; assadi, reza/AAI-1124-2021; Schneider, Ione J.C./J-8762-2013; Naidoo, Kovin Shunmugam/AAF-5914-2020; Pandian, Jeyaraj Durai/AAV-5591-2020; Bose, Dipan/GRS-0467-2022; Lopez, Alan/AAA-2734-2022; Paternina-Caicedo, Angel/N-4496-2015; Pourmalek, Farshad/A-8188-2010; Asghar, Rana Jawad/AAF-7634-2021; Balakrishnan, Kalpana/B-6653-2015; Quistberg, D Alex/P-3538-2019; London, Stephanie/C-3734-2019; Waller, Stephen/AAI-1787-2020; Gona, Philimon/K-1477-2019; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; Adsuar, Jose C/C-6558-2008; Husseini, Abdullatif/E-8377-2015; Deribe, Kebede/I-5422-2019; Papachristou, Christina/AAR-2187-2021; Amini, Heresh/B-3076-2010; Nyakarahuka, Luke/W-8164-2019; Zhao, Yong/Z-3231-2019; Davis, Adrian C/E-6022-2015; Ermakov, Sergey/G-1709-2016; Alsharif, Ubai/AAK-2088-2021; SHIN, HS/AAE-5381-2022; Bin Abdulhak, Aref/AAM-9492-2020; Mason-Jones, Amanda/ABF-1565-2020; Poenaru, Dan/S-2562-2017; Bell, Michelle/Y-4608-2018; Deribe, Kebede/K-7055-2019; Lotufo, Paulo/A-9843-2008; Monasta, Lorenzo/B-1388-2012; Oh, In Hwan/AAI-9070-2020; Hankey, Graeme J/H-4968-2014; Lee, Jong-Tae/AAF-5746-2020; Kan, Haidong/AGU-0328-2022; Antonio, Carl Abelardo/AAP-4280-2020; alla, francois/D-2295-2014; Naohiro, Yonemoto/Y-3761-2019; Bernabe, Eduardo/R-3441-2017; Woldeyohannes, Solomon Meseret/E-5783-2012; Kemp, Andrew Haddon/C-7984-2012; Terkawi, Abdullah Suleiman/AAC-1113-2019; assadi, reza/AAT-6629-2020; Zaki, Maysaa El Sayed/H-3049-2019; wang, lin/HHM-2225-2022; Jahangir, Eiman/P-1053-2015; Villalpando, Salvador/AAS-3874-2021; Bedi, Neeraj/H-2838-2019; Castro, Ruben E/J-1948-2015; Mokdad, Ali H./AAD-1232-2022; A, Naheed/AHB-2940-2022; Rahimi-Movaghar, Vafa/L-6339-2019; Mukaigawara, Mitsuru/L-2144-2016; Alvarez, Elena/S-1068-2019; Refaat, Amany/AAA-8470-2021; Undurraga, Eduardo/I-3739-2014; Weiderpass, Elisabete/M-4029-2016; Lalloo, Ratilal/O-5624-2014; Li, Yichong/A-3559-2019; Rahimi, Kazem/AAA-4250-2022; Soshnikov, Sergey/R-7352-2016; Moradi-Lakeh, Maziar/ABC-9793-2021; A, Naheed/AHB-2941-2022; Pereira, David/M-9286-2013; Alsharif, Ubai/C-6527-2017; Zheng, Yingfeng/CAE-9225-2022; wang, lin/GSE-3040-2022; Nyakarahuka, Luke/AGH-2432-2022; Ärnlöv, Johan/AAF-2746-2019; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Soshnikov, Sergey/AAV-8566-2020; CT, Sreeramareddy/I-1203-2019; Nash, Denis/AFI-7485-2022; Hamadeh, Randah R./AAE-9720-2020; Knibbs, Luke/C-7865-2012; Towbin, Jeffrey A./J-5595-2019; Majdan, Marek/K-5017-2012; Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Ukwaja, Kingsley N./A-7794-2013; Vlassov, Vasiliy/B-4036-2014; Kuate Defo, Barthelemy/I-4818-2017; Refaat, Amany/K-5419-2016; Cirillo, Massimo/G-5480-2018; Lansingh, Van/C-8672-2018	Patten, Scott/0000-0001-9871-4041; Beyene, Tariku Jibat/0000-0002-7474-1966; wang, YA XING/0000-0003-2749-7793; Karch, André/0000-0003-3014-8543; Khader, Yousef/0000-0002-7830-6857; Rahimi, Kazem/0000-0002-4807-4610; Soshnikov, Sergey/0000-0002-6983-7066; Polanczyk, Guilherme V./0000-0003-2311-3289; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; Degenhardt, Louisa J/0000-0002-8513-2218; Salomon, Joshua/0000-0003-3929-5515; Santos, Itamar/0000-0003-3212-8466; Hay, Simon Iain/0000-0002-0611-7272; Sepanlou, Sadaf G/0000-0002-3669-5129; Leung, Ricky/0000-0002-2852-6771; Catalá-López, Ferrán/0000-0002-3833-9312; Olusanya, Bolajoko O./0000-0002-3826-0583; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Sposato, Luciano A/0000-0001-6425-9343; Santos, Itamar S/0000-0003-3212-8466; wang, xiao/0000-0002-4088-3341; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Memish, Ziad Ahmed/0000-0002-5099-0714; Salomon, Joshua A/0000-0003-3929-5515; Liu, Yang/0000-0001-5477-2186; Bedi, Neeraj/0000-0003-4709-8423; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Ronfani, Luca/0000-0001-5710-3914; Nolte, Sandra/0000-0001-6185-9423; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Newton, Charles/0000-0002-6999-5507; Rana, Saleem M/0000-0001-6479-9235; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Pesudovs, Konrad/0000-0002-6322-9369; Amare, Azmeraw T./0000-0002-7940-0335; Singh, Jasvinder/0000-0003-3485-0006; Newton, Charles RJC/0000-0002-6999-5507; Violante, Francesco S/0000-0003-4084-2782; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Marzan, Melvin/0000-0003-2696-7335; Ding, Eric L./0000-0002-5881-8097; Jacobsen, Kathryn H./0000-0002-4198-6246; Leinsalu, Mall/0000-0003-4453-4760; Norheim, Ole Frithjof/0000-0002-5748-5956; Mapoma, Christopher Chabila/0000-0001-9233-5462; Alvis-Guzman, Nelson/0000-0001-9458-864X; Weiderpass, Elisabete/0000-0003-2237-0128; ORISAKWE, ORISH EBERE/0000-0002-5806-9858; Khan, Ejaz A/0000-0002-7072-8035; Schneider, Ione J.C./0000-0001-6339-7832; Paternina-Caicedo, Angel/0000-0002-6332-5174; Pourmalek, Farshad/0000-0002-2134-0771; Balakrishnan, Kalpana/0000-0002-5905-1801; Quistberg, D Alex/0000-0001-9730-2686; London, Stephanie/0000-0003-4911-5290; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; Adsuar, Jose C/0000-0001-7203-3168; Husseini, Abdullatif/0000-0001-8767-5956; Deribe, Kebede/0000-0002-8526-6996; Amini, Heresh/0000-0002-4825-1322; Nyakarahuka, Luke/0000-0002-2944-9157; Zhao, Yong/0000-0001-9290-109X; Davis, Adrian C/0000-0001-7134-7528; Ermakov, Sergey/0000-0003-1072-1162; Alsharif, Ubai/0000-0002-4024-3950; SHIN, HS/0000-0002-7263-6257; Bin Abdulhak, Aref/0000-0001-9988-8609; Mason-Jones, Amanda/0000-0002-4292-3183; Poenaru, Dan/0000-0002-6267-6140; Bell, Michelle/0000-0002-3965-1359; Lotufo, Paulo/0000-0002-4856-8450; Monasta, Lorenzo/0000-0001-7774-548X; Oh, In Hwan/0000-0002-5450-9887; Hankey, Graeme J/0000-0002-6044-7328; Lee, Jong-Tae/0000-0002-8510-3054; Antonio, Carl Abelardo/0000-0001-7476-0553; Bernabe, Eduardo/0000-0002-1858-3713; Kemp, Andrew Haddon/0000-0003-1146-3791; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Jahangir, Eiman/0000-0001-6944-5321; Villalpando, Salvador/0000-0001-6429-3816; Bedi, Neeraj/0000-0003-4709-8423; Castro, Ruben E/0000-0002-7289-9081; Mokdad, Ali H./0000-0002-4994-3339; A, Naheed/0000-0002-6016-5603; Mukaigawara, Mitsuru/0000-0001-6530-2083; Alvarez, Elena/0000-0002-9679-2721; Undurraga, Eduardo/0000-0002-4425-1253; Weiderpass, Elisabete/0000-0003-2237-0128; Lalloo, Ratilal/0000-0001-5822-1269; Li, Yichong/0000-0003-3842-475X; Soshnikov, Sergey/0000-0002-6983-7066; Moradi-Lakeh, Maziar/0000-0001-7381-5305; A, Naheed/0000-0002-6016-5603; Pereira, David/0000-0003-0384-7592; Alsharif, Ubai/0000-0002-4024-3950; Zheng, Yingfeng/0000-0002-0914-7864; Nyakarahuka, Luke/0000-0002-2944-9157; Ärnlöv, Johan/0000-0002-6933-4637; CT, Sreeramareddy/0000-0002-5693-7631; Hamadeh, Randah R./0000-0002-4205-1354; Towbin, Jeffrey A./0000-0002-6585-714X; Majdan, Marek/0000-0001-8037-742X; Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; Ukwaja, Kingsley N./0000-0002-1974-8735; Liu, Zhi-Hong/0000-0001-6093-0726; Servan-Mori, Edson/0000-0001-9820-8325; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Khang, Young-Ho/0000-0002-9585-8266; Ademi, Zanfina/0000-0002-0625-3522; Vlassov, Vasiliy/0000-0001-5203-549X; Gibney, Katherine/0000-0001-5851-5339; Neupane, Sudan Prasad/0000-0002-7389-4178; /0000-0002-9584-0576; Kuate Defo, Barthelemy/0000-0002-6589-0564; Abubakar, Ibrahim/0000-0002-0370-1430; Miller, Ted/0000-0002-0958-2639; Li, Xiaohong/0000-0003-0336-7302; Tabb Dina, Karen/0000-0002-4722-9502; van Gool, Coen H/0000-0001-7170-0563; Refaat, Amany/0000-0002-0501-6146; Seedat, Soraya/0000-0002-5118-786X; Wordofa, Muluemebet Abera/0000-0001-9232-822X; Goto, Atsushi/0000-0003-0669-654X; Farzadfar, Farshad/0000-0001-8288-4046; Xu, Gelin/0000-0002-6194-0341; LIN, HSIEN-HO/0000-0002-7481-6016; Shibuya, Kenji/0000-0003-2528-7530; Shiue, Ivy/0000-0003-1788-3009; Ohkubo, Takayoshi/0000-0002-3283-8196; Nisar, Muhammad Imran/0000-0002-2378-4720; Tenkorang, Eric/0000-0001-6127-3799; Cavlin, Alanur/0000-0001-9714-9984; Juel, Knud/0000-0002-4134-1173; Achoki, Tom/0000-0001-6309-8904; Qato, Dima/0000-0001-5411-6998; Kwan, Gene/0000-0002-0929-6800; Idrisov, Bulat/0000-0002-1971-2572; Sahraian, Mohammad Ali/0000-0002-3224-8807; Colquhoun, Samantha/0000-0002-6750-1147; Mori, Rintaro/0000-0001-7656-6156; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Gouda, Hebe/0000-0002-5709-4509; Assadi, Reza/0000-0002-5016-2994; Glaser, Elizabeth/0000-0002-1918-057X; Cirillo, Massimo/0000-0002-6409-3504; Pope, Daniel/0000-0003-2694-5478; Woldeyohannes, Solomon/0000-0003-2431-2730; Roy, Nobhojit/0000-0003-2022-7416; Tirschwell, David/0000-0002-8059-2901; Abd-Allah, Foad/0000-0001-8308-5756; Kengne, Andre Pascal/0000-0002-5183-131X; Knibbs, Luke/0000-0002-0399-2370; alla, francois/0000-0002-5793-7190; Lansingh, Van/0000-0002-0090-4195; CHANG, JUNG-CHEN/0000-0001-8651-2602; FARAON, EMERITO JOSE A./0000-0001-6157-5930; Vallely, Andrew/0000-0003-1558-4822; Hoek, Hans/0000-0001-6353-5465; Yoon, Seok-Jun/0000-0003-3297-0071; del Pozo Cruz, Borja/0000-0002-9728-1317; Innos, Kaire/0000-0003-0120-2213; Dandona, Rakhi/0000-0003-0926-788X; Cooper, Leslie/0000-0003-1002-3313; , Borja/0000-0003-3944-2212; Che, Xuan/0000-0001-7981-6456; Jha, Vivekanand/0000-0002-8015-9470; Al Asfoor, Deena/0000-0002-7973-1935; Nash, Denis/0000-0002-3280-5386; Pandian, Jeyaraj/0000-0003-0028-1968; WILKINSON, JAMES/0000-0003-1945-5622; Pearce, Neil/0000-0002-9938-7852; Esteghamati, Alireza/0000-0001-5114-3982	Amgen; GlaxoSmithKline; Alliance for Better Bone Health; Merck Sharp and Dohme; Eli Lilly; Pfizer; Novartis; Servier; Medtronic; Roche; CSL; Meiji; Otsuka; LAP Consulting; Fujitsu Software Technologies; Japan Productivity Center; Occupational Health Foundation; Japan Housing Finance Agency; Aishin-Seiki; Japan Dental Association; Sekisui Chemicals; Junpukai Health Care Center; Osaka Chamber of Commerce and Industry; Igaku-Shoin; Taisha-kan; Nanko-do; Nanzan-do; PHP Publication; Japanese Ministry of Education, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Softbank; Japan Management Association; National Council for Scientific and Technological Development; Sdo Paulo Research Foundation; University of Sdo Paulo; Shire; Editora Manole; Takeda; Savient; Regeneron; Allergan; Medical Research Council [MC_UP_A620_1014, U1475000001, G1100684, MC_U147585824, MC_UU_12011/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, CDF-2013-06-012, NF-SI-0513-10085] Funding Source: researchfish; MRC [G1100684, MR/L003120/1] Funding Source: UKRI	Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); Alliance for Better Bone Health; Merck Sharp and Dohme(Merck & Company); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Novartis(Novartis); Servier(Servier); Medtronic(Medtronic); Roche(Roche Holding); CSL; Meiji; Otsuka(Otsuka Pharmaceutical); LAP Consulting; Fujitsu Software Technologies; Japan Productivity Center; Occupational Health Foundation; Japan Housing Finance Agency; Aishin-Seiki; Japan Dental Association; Sekisui Chemicals; Junpukai Health Care Center(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Osaka Chamber of Commerce and Industry; Igaku-Shoin; Taisha-kan; Nanko-do; Nanzan-do; PHP Publication; Japanese Ministry of Education, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Softbank; Japan Management Association; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sdo Paulo Research Foundation; University of Sdo Paulo; Shire; Editora Manole; Takeda(Takeda Pharmaceutical Company Ltd); Savient; Regeneron(Regeneron); Allergan(AbbVieAllergan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cyrus Cooper has received consultancy fees, lecture fees, and honoraria from Amgen, GlaxoSmithKline, Alliance for Better Bone Health, Merck Sharp and Dohme, Eli Lilly, Pfizer, Novartis, Servier, Medtronic, and Roche. Katherine B Gibney received the National Health and Medical Research Council Gustav Nossal scholarship sponsored by CSL in 2012; this award is peer-reviewed through the standard National Health and Medical Research Countil peer-review process, and CSL does not play any part in selection of the awardee. Norito Kawakami has received fees from Meiji, Otsuka, LAP Consulting, Fujitsu Software Technologies, Japan Productivity Center, Occupational Health Foundation, Japan Housing Finance Agency, Aishin-Seiki, and the Japan Dental Association; consultancy fees from Sekisui Chemicals, Junpukai Health Care Center, and Osaka Chamber of Commerce and Industry; and royalties from Igaku-Shoin, Taisha-kan, Nanko-do, Nanzan-do, PHP Publication, and Fujitsu Software Technologies. Norito Kawakami has also received research grants from the Japanese Ministry of Education, Science, and Technology; the Japanese Ministry of Health, Labor and Welfare; Fujitsu Software Technologies; Softbank; and Japan Management Association. Guilherme V Polanczyk has received grants or research support from the National Council for Scientific and Technological Development, the Sdo Paulo Research Foundation, and the University of Sdo Paulo; has served as a paid consultant to Shire; has served on the speakers' bureau of Shire; and has received royalties from Editora Manole. Jasvinder A Singh has received research grants from Takeda and Savient; has received consultant fees from Savient, Takeda, Regeneron, and Allergan; is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; is a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and is a member of the Veterans Affairs Rheumatology Field Advisory Committee. The other authors declare no competing interests.	Acosta CD, 2012, BJOG-INT J OBSTET GY, V119, P474, DOI 10.1111/j.1471-0528.2011.03239.x; [Anonymous], 2004, WHY MOTH DIE 2000 20; Asnani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026281; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brar SS, 2007, AM J CARDIOL, V100, P302, DOI 10.1016/j.amjcard.2007.02.092; Bustreo F, 2012, INT J GYNECOL OBSTET, V119, pS6, DOI 10.1016/j.ijgo.2012.03.008; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Colbourn T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004150; Coley JL, 2001, BRIT J OBSTET GYNAEC, V108, P1125, DOI 10.1016/S0306-5456(01)00269-8; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Conroy AL, 2012, EXPERT REV ANTI-INFE, V10, P1331, DOI [10.1586/eri.12.123, 10.1586/ERI.12.123]; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; de Groot MR, 2003, INT J GYNECOL OBSTET, V81, P9, DOI 10.1016/S0020-7292(02)00399-5; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Gilbert WM, 2007, J REPROD MED, V52, P1046; Gissler M, 2005, EUR J PUBLIC HEALTH, V15, P459, DOI 10.1093/eurpub/cki042; Goland S, 2009, J CARD FAIL, V15, P645, DOI 10.1016/j.cardfail.2009.03.008; Helleringer S, 2013, TROP MED INT HEALTH, V18, P27, DOI 10.1111/tmi.12012; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hounton S, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-1; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Kourtis AP, 2006, AIDS, V20, P1823, DOI 10.1097/01.aids.0000244201.11006.1c; KUMAR RM, 1995, INT J GYNECOL OBSTET, V49, P137, DOI 10.1016/0020-7292(95)02356-H; Lawson GW, 2013, BIRTH-ISS PERINAT C, V40, P96, DOI 10.1111/birt.12041; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Leone T, 2014, POPUL SPACE PLACE, V20, P581, DOI 10.1002/psp.1802; LEPAGE P, 1991, AIDS, V5, P295, DOI 10.1097/00002030-199103000-00008; Lionel J, 2008, TROP DOCT, V38, P144, DOI 10.1258/td.2007.070081; Louis J, 2007, OBSTET GYNECOL, V110, P385, DOI 10.1097/01.AOG.0000275263.81272.fc; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maiques-Montesinos V, 1999, ACTA OBSTET GYN SCAN, V78, P789, DOI 10.1034/j.1600-0412.1999.780909.x; Maman AFOB, 2005, TROP DOCT, V35, P220, DOI 10.1258/004947505774938666; Mangham LJ, 2010, HEALTH POLICY PLANN, V25, P85, DOI 10.1093/heapol/czp066; Matthews LT, 2013, AIDS, V27, pS105, DOI 10.1097/QAD.0000000000000040; McDermott JM, 1996, AM J TROP MED HYG  S, V55, P66; MMIRO F, 1993, PEDIATR AIDS HIV INF, V4, P67; Morgan J, 2013, OBSTET GYN CLIN N AM, V40, P69, DOI 10.1016/j.ogc.2012.11.007; Murray CJL, 2013, LANCET UNPUB; Naghavi M, 2013, LANCET UNPUB; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Nathoo Kj, 2004, Cent Afr J Med, V50, P1; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; Nuwagaba-Biribonwoha H, 2006, AIDS CARE, V18, P614, DOI 10.1080/09540120500359298; Rahimy MC, 2000, BLOOD, V96, P1685, DOI 10.1182/blood.V96.5.1685.h8001685_1685_1689; Romano Mattea, 2010, J Prenat Med, V4, P22; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; RYDER RW, 1994, AIDS, V8, P667, DOI 10.1097/00002030-199405000-00014; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; SHAHIDULLAH M, 1995, STUD FAMILY PLANN, V26, P101, DOI 10.2307/2137935; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; TEMMERMAN M, 1994, OBSTET GYNECOL, V83, P495, DOI 10.1097/00006250-199404000-00002; UN Development Group, 2003, IND MON MILL DEV GOA; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Westreich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058117; Wilkinson H, 2011, BJOG-INT J OBSTET GY, V118, P1402, DOI 10.1111/j.1471-0528.2011.03097.x; World Health Organization, 2004, INT STAT CLASS DIS R, V2; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yusuf HR, 2000, LANCET, V355, P1220, DOI 10.1016/S0140-6736(00)02088-2; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X; Zvandasara P, 2006, JAIDS-J ACQ IMM DEF, V43, P107, DOI 10.1097/01.qai.0000229015.77569.c7	74	778	799	8	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					980	1004		10.1016/S0140-6736(14)60696-6	http://dx.doi.org/10.1016/S0140-6736(14)60696-6			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	24797575	Green Submitted, Green Accepted			2022-12-28	WOS:000341679700031
J	Libri, V; Yandim, C; Athanasopoulos, S; Loyse, N; Natisvili, T; Law, PP; Chan, PK; Mohammad, T; Mauri, M; Tam, KT; Leiper, J; Piper, S; Ramesh, A; Parkinson, MH; Huson, L; Giunti, P; Festenstein, R				Libri, Vincenzo; Yandim, Cihangir; Athanasopoulos, Stavros; Loyse, Naomi; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Mohammad, Tariq; Mauri, Marta; Tam, Kin Tung; Leiper, James; Piper, Sophie; Ramesh, Aravind; Parkinson, Michael H.; Huson, Les; Giunti, Paola; Festenstein, Richard			Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIAL; MOUSE MODEL; HISTONE H3; INHIBITION; FRATAXIN; PHARMACOKINETICS; PROTEIN; METHYLTRANSFERASE; HETEROCHROMATIN	Background Friedreich's ataxia is a progressive degenerative disorder caused by deficiency of the frataxin protein. Expanded GAA repeats within intron 1 of the frataxin (FXN) gene lead to its heterochromatinisation and transcriptional silencing. Preclinical studies have shown that the histone deacetylase inhibitor nicotinamide (vitamin B3) can remodel the pathological heterochromatin and upregulate expression of FXN. We aimed to assess the epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia. Methods In this exploratory, open-label, dose-escalation study in the UK, male and female patients (aged 18 years or older) with Friedreich's ataxia were given single doses (phase 1) and repeated daily doses of 2-8 g oral nicotinamide for 5 days (phase 2) and 8 weeks (phase 3). Doses were gradually escalated during phases 1 and 2, with individual maximum tolerated doses used in phase 3. The primary outcome was the upregulation of frataxin expression. We also assessed the safety and tolerability of nicotinamide, used chromatin immunoprecipitation to investigate changes in chromatin structure at the FXN gene locus, and assessed the effect of nicotinamide treatment on clinical scales for ataxia. This study is registered with ClinicalTrials.gov, number NCT01589809. Findings Nicotinamide was generally well tolerated; the main adverse event was nausea, which in most cases was mild, dose-related, and resolved spontaneously or after dose reduction, use of antinausea drugs, or both. Phase 1 showed a dose-response relation for proportional change in frataxin protein concentration from baseline to 8 h post-dose, which increased with increasing dose (p = 0.0004). Bayesian analysis predicted that 3.8 g would result in a 1 5-times increase and 7.5 g in a doubling of frataxin protein concentration. Phases 2 and 3 showed that daily dosing at 3 5-6 g resulted in a sustained and significant (p < 0.0001) upregulation of frataxin expression, which was accompanied by a reduction in heterochromatin modifications at the FXN locus. Clinical measures showed no significant changes. Interpretation Nicotinamide was associated with a sustained improvement in frataxin concentrations towards those seen in asymptomatic carriers during 8 weeks of daily dosing. Further investigation of the long-term clinical benefits of nicotinamide and its ability to ameliorate frataxin deficiency in Friedreich's ataxia is warranted.	[Libri, Vincenzo] UCL, Leonard Wolfson Expt Neurol Ctr, London, England; [Parkinson, Michael H.; Giunti, Paola] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Athanasopoulos, Stavros; Loyse, Naomi; Mohammad, Tariq; Huson, Les] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, Natl Inst Hlth Res Wellcome Trust, Imperial Clin Res Facil, London W12 0NN, England; [Yandim, Cihangir; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Festenstein, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Gene Control Mech & Dis Grp, London W12 0NN, England; [Yandim, Cihangir; Natisvili, Theona; Law, Pui Pik; Chan, Ping Kei; Festenstein, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England; [Leiper, James; Piper, Sophie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Nitr Oxide Signalling Grp, London W12 0NN, England; [Mauri, Marta] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tam, Kin Tung] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Ramesh, Aravind] Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand	University of London; University College London; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hong Kong; Christchurch Hospital New Zealand	Festenstein, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, Gene Control Mech & Dis Grp, London W12 0NN, England.	r.festenstein@imperial.ac.uk	YANDIM, Cihangir/AAA-2250-2021; Giunti, Paola/E-5526-2012	YANDIM, Cihangir/0000-0002-2050-6186; Giunti, Paola/0000-0003-3508-4788; Law, Pui Pik/0000-0001-8924-0462; Mauri, Marta/0000-0003-0098-3900; Ramesh, Aravind/0000-0001-8302-7097; Leiper, James/0000-0003-4656-519X	Ataxia UK; Ataxia Ireland; Association Suisse de l'Ataxie de Friedreich; Associazione Italiana per le Sindromi Atassiche; UK National Institute for Health Research; European Friedreich's Ataxia Consortium for Translational Studies; Imperial Biomedical Research Centre; MRC [MC_EX_G0801765, G116/182, MC_U120097118, MC_U120081321] Funding Source: UKRI; Medical Research Council [MC_U120097118, MC_EX_G0801765, G116/182, MC_U120081321] Funding Source: researchfish; Ataxia UK [7003] Funding Source: researchfish	Ataxia UK; Ataxia Ireland; Association Suisse de l'Ataxie de Friedreich; Associazione Italiana per le Sindromi Atassiche(Fondazione AIRC per la ricerca sul cancro); UK National Institute for Health Research(National Institute for Health Research (NIHR)); European Friedreich's Ataxia Consortium for Translational Studies; Imperial Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Ataxia UK	Ataxia UK, Ataxia Ireland, Association Suisse de l'Ataxie de Friedreich, Associazione Italiana per le Sindromi Atassiche, UK National Institute for Health Research, European Friedreich's Ataxia Consortium for Translational Studies, and Imperial Biomedical Research Centre.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BEAL MF, 1994, ANN NEUROL, V36, P882, DOI 10.1002/ana.410360613; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Festenstein R, 2006, NAT CHEM BIOL, V2, P512, DOI 10.1038/nchembio1006-512; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; HORSMAN MR, 1993, RADIOTHER ONCOL, V27, P131, DOI 10.1016/0167-8140(93)90133-S; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Koeppen AH, 2013, J NEUROCHEM, V126, P4, DOI 10.1111/jnc.12218; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Lynch DR, 2005, MOVEMENT DISORD, V20, P777, DOI 10.1002/mds.20449; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; Mariotti C, 2012, MOVEMENT DISORD, V27, P446, DOI 10.1002/mds.24066; Meier T, 2012, J NEUROL, V259, P284, DOI 10.1007/s00415-011-6174-y; Ntzoufras I., 2009, BAYESIAN MODELING US; Oja H, 2010, MULTIVARIATE NONPARA; Perlman SL, 2012, J CHILD NEUROL, V27, P1217, DOI 10.1177/0883073812453872; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rufini A, 2011, HUM MOL GENET, V20, P1253, DOI 10.1093/hmg/ddq566; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schmitz-Hubsch T, 2008, NEUROLOGY, V71, P486, DOI 10.1212/01.wnl.0000324863.76290.19; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SPECTOR R, 1979, J NEUROCHEM, V33, P291, DOI 10.1111/j.1471-4159.1979.tb11731.x; STRATFORD MRL, 1994, CANCER CHEMOTH PHARM, V34, P399, DOI 10.1007/s002800050161; Stratford MRL, 1996, BRIT J CANCER, V74, P16, DOI 10.1038/bjc.1996.309; Subramony SH, 2005, NEUROLOGY, V64, P1261, DOI 10.1212/01.WNL.0000156802.15466.79; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Yandim C, 2013, J NEUROCHEM, V126, P21, DOI 10.1111/jnc.12254; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998	45	91	94	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					504	513		10.1016/S0140-6736(14)60382-2	http://dx.doi.org/10.1016/S0140-6736(14)60382-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24794816	hybrid, Green Accepted			2022-12-28	WOS:000340198300029
J	Maianti, JP; McFedries, A; Foda, ZH; Kleiner, RE; Du, XQ; Leissring, MA; Tang, WJ; Charron, MJ; Seeliger, MA; Saghatelian, A; Liu, DR				Maianti, Juan Pablo; McFedries, Amanda; Foda, Zachariah H.; Kleiner, Ralph E.; Du, Xiu Quan; Leissring, Malcolm A.; Tang, Wei-Jen; Charron, Maureen J.; Seeliger, Markus A.; Saghatelian, Alan; Liu, David R.			Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HIGH-FAT DIET; GLUCOSE-TOLERANCE; RISK LOCI; DEGRADATION; AMYLIN; MICE; MACROCYCLES; RECOGNITION; THERAPIES	Despite decades of speculation that inhibiting endogenous insulin degradation might treat type-2 diabetes(1,2), and the identification of IDE (insulin-degrading enzyme) as a diabetes susceptibility gene(3,4), the relationship between the activity of the zinc metalloprotein IDE and glucose homeostasis remains unclear. Although Ide(-/-) mice have elevated insulin levels, they exhibit impaired, rather than improved, glucose tolerance that may arise from compensatory insulin signalling dysfunction(5,6). IDE inhibitors that are active in vivo are therefore needed to elucidate IDE's physiological roles and to determine its potential to serve as a target for the treatment of diabetes. Here we report the discovery of a physiologically active IDE inhibitor identified from a DNA-templated macrocycle library. An X-ray structure of the macrocycle bound to IDE reveals that it engages a binding pocket away from the catalytic site, which explains its remarkable selectivity. Treatment of lean and obese mice with this inhibitor shows that IDE regulates the abundance and signalling of glucagon and amylin, in addition to that of insulin. Under physiological conditions that augment insulin and amylin levels, such as oral glucose administration, acute IDE inhibition leads to substantially improved glucose tolerance and slower gastric emptying. These findings demonstrate the feasibility of modulating IDE activity as a new therapeutic strategy to treat type-2 diabetes and expand our understanding of the roles of IDE in glucose and hormone regulation.	[Maianti, Juan Pablo; McFedries, Amanda; Kleiner, Ralph E.; Saghatelian, Alan; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Foda, Zachariah H.; Seeliger, Markus A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Du, Xiu Quan; Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Leissring, Malcolm A.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Irvine; University of Chicago; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	saghatelian@chemistry.harvard.edu; drliu@fas.harvard.edu	LEISSRING, MALCOLM/AAW-5361-2021; Seeliger, Markus A/D-6409-2013; Liu, David R./HCH-3132-2022	LEISSRING, MALCOLM/0000-0001-7185-4255; Tang, Wei-Jen/0000-0002-8267-8995; Seeliger, Markus/0000-0003-0990-1756	NIH/NIGMS [R01 GM065865, R00 GM080097, R01 GM81539, T32 GM008444, F30 CA174152, DP2 OD002374]; Howard Hughes Medical Institute; Diabetes and Cancer Centers of Albert Einstein College of Medicine; American Diabetes Association [7-11-CD-06]; Burroughs Wellcome Fund CABS; Searle Scholars Program; Fonds de Recherche en Sante du Quebec (FRSQ); Alfred Bader Fund; NATIONAL CANCER INSTITUTE [F30CA174152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM065865, P41GM111244, R01GM081539, R00GM080097, T32GM008444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002374] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Diabetes and Cancer Centers of Albert Einstein College of Medicine; American Diabetes Association(American Diabetes Association); Burroughs Wellcome Fund CABS; Searle Scholars Program; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Alfred Bader Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH/NIGMS (R01 GM065865 (D.R.L.), R00 GM080097 (M.A.S.), R01 GM81539 (W.-J.T.), T32 GM008444 (Z.H.F.), F30 CA174152 (Z.H.F.), DP2 OD002374 (A.S.)), Howard Hughes Medical Institute (D.R.L.), Diabetes and Cancer Centers of Albert Einstein College of Medicine (M.J.C.), American Diabetes Association no. 7-11-CD-06 (M.A.L.), Burroughs Wellcome Fund CABS (A.S.), and the Searle Scholars Program (A.S.). The Fonds de Recherche en Sante du Quebec (FRSQ) and the Alfred Bader Fund supported J.P.M. We thank C. Russ and H. Spurling (Broad Institute) and C. Daly (FAS Center for Systems Biology) for DNA sequencing assistance. We are grateful to S. Johnston and C. Mosher (Broad Institute) for 6bK stability measurements. W. Nolte provided mouse IDE, L. McCord purified CF-IDE and Y.-G. Kim performed CGRP cleavage assays. We are grateful to A. Badran, E. Homan, A.M. Lone and M. Leidl (Harvard University) for experimental assistance. We thank B. Kahn and N. Gray for discussions.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Ahren B, 2008, J ENDOCRINOL, V197, P181, DOI 10.1677/JOE-07-0460; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Gedulin BR, 2006, REGUL PEPTIDES, V137, P121, DOI 10.1016/j.regpep.2006.06.004; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Kim YG, 2012, P NATL ACAD SCI USA, V109, P8523, DOI 10.1073/pnas.1203195109; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003; Riddle MC, 2006, DIABETES CARE, V29, P435, DOI 10.2337/diacare.29.02.06.dc05-1267; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Young Andrew, 2005, Adv Pharmacol, V52, P193, DOI 10.1016/S1054-3589(05)52010-6; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	28	165	177	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					94	U474		10.1038/nature13297	http://dx.doi.org/10.1038/nature13297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24847884	Green Accepted, Green Published			2022-12-28	WOS:000338199400043
J	Gauvreau, GM; O'Byrne, PM; Boulet, LP; Wang, Y; Cockcroft, D; Bigler, J; FitzGerald, JM; Boedigheimer, M; Davis, BE; Dias, C; Gorski, KS; Smith, L; Bautista, E; Comeau, MR; Leigh, R; Parnes, JR				Gauvreau, Gail M.; O'Byrne, Paul M.; Boulet, Louis-Philippe; Wang, Ying; Cockcroft, Donald; Bigler, Jeannette; FitzGerald, J. Mark; Boedigheimer, Michael; Davis, Beth E.; Dias, Clapton; Gorski, Kevin S.; Smith, Lynn; Bautista, Edgar; Comeau, Michael R.; Leigh, Richard; Parnes, Jane R.			Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; INDUCED AIRWAY RESPONSES; HUMAN EPITHELIAL-CELLS; INFLAMMATION; SPUTUM; REPRODUCIBILITY; RESPONSIVENESS; MEPOLIZUMAB; EXPRESSION; CHEMOKINES	BACKGROUND Thymic stromal lymphopoietin (TSLP) is an epithelial-cell-derived cytokine that may be important in initiating allergic inflammation. AMG 157 is a human anti-TSLP monoclonal immunoglobulin G2 lambda that binds human TSLP and prevents receptor interaction. METHODS In this double-blind, placebo-controlled study, we randomly assigned 31 patients with mild allergic asthma to receive three monthly doses of AMG 157 (700 mg) or placebo intravenously. We conducted allergen challenges on days 42 and 84 to evaluate the effect of AMG 157 in reducing the maximum percentage decrease in the forced expiratory volume in 1 second (FEV1). We also measured the fraction of nitric oxide in exhaled air, blood and sputum eosinophils, and airway hyperresponsiveness. The primary end point was the late asthmatic response, as measured 3 to 7 hours after the allergen challenge. RESULTS AMG 157 attenuated most measures of allergen-induced early and late asthmatic responses. The maximum percentage decrease in the FEV1 during the late response was 34.0% smaller in the AMG-157 group than in the placebo group on day 42 (P=0.09) and 45.9% smaller on day 84 (P=0.02). In addition, patients receiving AMG 157 had significant decreases in levels of blood and sputum eosinophils before and after the allergen challenge and in the fraction of exhaled nitric oxide. There were 15 adverse events in the AMG-157 group, as compared with 12 in the placebo group; there were no serious adverse events. CONCLUSIONS Treatment with AMG 157 reduced allergen-induced bronchoconstriction and indexes of airway inflammation before and after allergen challenge. These findings are consistent with a key role for TSLP in allergen-induced airway responses and persistent airway inflammation in patients with allergic asthma. Whether anti-TSLP therapeutics will have clinical value cannot be determined from these data. (Funded by Amgen; ClinicalTrials.gov number, NCT01405963.)	[Gauvreau, Gail M.; O'Byrne, Paul M.] McMaster Univ, Dept Med, Firestone Inst Resp Hlth, Hamilton, ON L8N 3Z5, Canada; [Boulet, Louis-Philippe] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Cockcroft, Donald; Davis, Beth E.] Univ Saskatchewan, Div Respirol Crit Care & Sleep Med, Saskatoon, SK, Canada; [FitzGerald, J. Mark] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Leigh, Richard] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Wang, Ying; Boedigheimer, Michael; Dias, Clapton; Gorski, Kevin S.; Smith, Lynn; Bautista, Edgar; Parnes, Jane R.] Amgen Inc, Thousand Oaks, CA USA; [Bigler, Jeannette; Comeau, Michael R.] Amgen Inc, Seattle, WA USA	McMaster University; Laval University; University of Saskatchewan; University of British Columbia; University of Calgary; Amgen; Amgen	O'Byrne, PM (corresponding author), McMaster Univ, Dept Med, HSC 3W10,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	obyrnep@mcmaster.ca		O'Byrne, Paul/0000-0003-0979-281X	Amgen; AllerGen Network of Centers of Excellence	Amgen(Amgen); AllerGen Network of Centers of Excellence	Supported by Amgen. The AllerGen Network of Centers of Excellence provided administrative funding for the study centers.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL401, DOI 10.1152/ajplung.00027.2009; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; Bunyavanich Supinda, 2011, Clin Mol Allergy, V9, P1, DOI 10.1186/1476-7961-9-1; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corrigan CJ, 2009, ALLERGY, V64, P1014, DOI 10.1111/j.1398-9995.2009.01947.x; Dahlen B, 2009, EUR RESPIR J, V33, P747, DOI 10.1183/09031936.00095508; Davis BE, 2009, EUR RESPIR J, V33, P1302, DOI 10.1183/09031936.00169008; Diamant Z, 2013, J ALLERGY CLIN IMMUN, V132, P1045, DOI 10.1016/j.jaci.2013.08.023; Ferreira MA, 2013, J ALLERGY CLIN IMMUN; Gauvreau GM, 2014, CLIN EXP ALLERGY, V44, P29, DOI 10.1111/cea.12235; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Gauvreau GM, 1999, AM J RESP CRIT CARE, V160, P640, DOI 10.1164/ajrccm.160.2.9809130; Gauvreau GM, 1999, J ALLERGY CLIN IMMUN, V104, P66, DOI 10.1016/S0091-6749(99)70115-6; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Gavala ML, 2013, CURR ALLERGY ASTHM R, V13, P298, DOI 10.1007/s11882-013-0344-1; Green R, 2002, BRIT MED J, V324, P1131; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Haldar P, 2011, NEW ENGL J MED, V364, P588, DOI DOI 10.1056/NEJMX110005; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; INMAN MD, 1995, J ALLERGY CLIN IMMUN, V95, P1191, DOI 10.1016/S0091-6749(95)70075-7; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nolte H, 2013, RESP MED, V107, P656, DOI 10.1016/j.rmed.2013.02.010; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; Parameswaran K, 2004, J ALLERGY CLIN IMMUN, V114, P73, DOI 10.1016/j.jaci.2004.03.054; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	42	530	557	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2102	2110		10.1056/NEJMoa1402895	http://dx.doi.org/10.1056/NEJMoa1402895			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24846652	Bronze			2022-12-28	WOS:000336434000008
J	Rees, M				Rees, Martin			A Longitude Prize for the twenty-first century	NATURE			English	Editorial Material												longitude.prize@nesta.org.uk							0	8	8	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					401	401		10.1038/509401a	http://dx.doi.org/10.1038/509401a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH4VE	24848027	Bronze			2022-12-28	WOS:000336126000004
J	Saponaro, M; Kantidakis, T; Mitter, R; Kelly, GP; Heron, M; Williams, H; Soding, J; Stewart, A; Svejstrup, JQ				Saponaro, Marco; Kantidakis, Theodoros; Mitter, Richard; Kelly, Gavin P.; Heron, Mark; Williams, Hannah; Soeding, Johannes; Stewart, Aengus; Svejstrup, Jesper Q.			RECQL5 Controls Transcript Elongation and Suppresses Genome Instability Associated with Transcription Stress	CELL			English	Article							RNA-POLYMERASE-II; COMMON FRAGILE SITES; HUMAN GENES; INITIATION; REPLICATION; HELICASE; MECHANISMS; CONSEQUENCES; PROMOTERS; ALIGNMENT	RECQL5 is the solemember of theRECQfamily of helicases associated with RNA polymerase II ( RNAPII). We now show that RECQL5 is a general elongation factor that is important for preserving genome stability during transcription. Depletion or overexpression of RECQL5 results in corresponding shifts in the genome- wide RNAPII density profile. Elongation is particularly affected, with RECQL5 depletion causing a striking increase in the average rate, concurrent with increased stalling, pausing, arrest, and/ or backtracking ( transcription stress). RECQL5 therefore controls the movement of RNAPII across genes. Loss of RECQL5 also results in the loss or gain of genomic regions, with the breakpoints of lost regions located in genes and common fragile sites. The chromosomal breakpoints overlap with areas of elevated transcription stress, suggesting thatRECQL5 suppresses such stress and its detrimental effects, and thereby prevents genome instability in the transcribed region of genes.	[Saponaro, Marco; Kantidakis, Theodoros; Williams, Hannah; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Mitter, Richard; Kelly, Gavin P.; Stewart, Aengus] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Heron, Mark; Williams, Hannah] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Heron, Mark; Williams, Hannah] Univ Munich, CIPSM, D-81377 Munich, Germany	Cancer Research UK; Cancer Research UK; University of Munich; University of Munich	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	Jesper.Svejstrup@cancer.org.uk	Söding, Johannes/A-3341-2013; Kantidakis, Theo/Q-8031-2016; Saponaro, Marco/M-1854-2015; Kelly, Gavin/ABG-2715-2021	Söding, Johannes/0000-0001-9642-8244; Kantidakis, Theo/0000-0002-3515-5235; Saponaro, Marco/0000-0002-9302-2553; Kelly, Gavin/0000-0001-7219-560X; Kantidakis, Theodoros/0000-0002-6901-422X; Stewart, Aengus/0000-0001-5182-653X; Williams, Hannah/0000-0003-1828-9845; Svejstrup, Jesper/0000-0003-4964-6147; Mitter, Richard/0000-0002-1279-3760	Association for International Cancer Research; European Research Council; Cancer Research UK; Cancer Research UK [11567] Funding Source: researchfish; Worldwide Cancer Research [09-0730] Funding Source: researchfish	Association for International Cancer Research; European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by grants from Association for International Cancer Research, the European Research Council, and Cancer Research UK (to J.Q.S.). We thank Nick Matthews and staff in the Advanced Sequencing Facility for their contribution; the Cell Services facility for assistance with cell lines; and members of the Svejstrup laboratory for comments on the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Aygun O, 2009, J BIOL CHEM, V284, P23197, DOI 10.1074/jbc.M109.015750; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Fungtammasan A, 2012, GENOME RES, V22, P993, DOI 10.1101/gr.134395.111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Izumikawa K, 2008, BIOCHEM J, V413, P505, DOI 10.1042/BJ20071392; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, MOL CELL BIOL, V31, P2090, DOI 10.1128/MCB.01137-10; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Park P, 2008, CANCER INVEST, V26, P923, DOI 10.1080/07357900801993432; Popuri V, 2012, DNA REPAIR, V11, P624, DOI 10.1016/j.dnarep.2012.05.001; Ramamoorthy M., 2012, MOL BIOL CELL, V23, P4273; Ramamoorthy M, 2013, CARCINOGENESIS, V34, P2218, DOI 10.1093/carcin/bgt183; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	117	119	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1037	1049		10.1016/j.cell.2014.03.048	http://dx.doi.org/10.1016/j.cell.2014.03.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24836610	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000336437200008
J	Merwick, A; Werring, D				Merwick, Aine; Werring, David			Posterior circulation ischaemic stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BASILAR ARTERY-OCCLUSION; HEALTH-CARE PROFESSIONALS; MINOR STROKE; CEREBELLAR INFARCTION; INTRAVENOUS THROMBOLYSIS; ATTACK; STENOSIS; REGISTRY; DISEASE; PROGNOSIS		[Merwick, Aine] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Werring, David] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Stroke Res Grp, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Werring, D (corresponding author), Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Stroke Res Grp, Queen Sq, London WC1N 3BG, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019; Merwick, Aine/L-9754-2013	Werring, David/0000-0003-2074-1861; Merwick, Aine/0000-0001-7533-0117	National Institute for Health Research [11/129/16] Funding Source: researchfish; British Heart Foundation Funding Source: Medline; Department of Health [11/129/16] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Department of Health		Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 1975, Stroke, V6, P564; Bash S, 2005, AM J NEURORADIOL, V26, P1012; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Caplan L, 2000, STROKE, V31, P2011, DOI 10.1161/01.STR.31.8.2011; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Compter A, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-65; Cotter PE, 2013, NEUROLOGY, V80, P1546, DOI 10.1212/WNL.0b013e31828f1828; Dewey HM, 2003, CEREBROVASC DIS, V15, P133, DOI 10.1159/000067142; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Edlow JA, 2008, LANCET NEUROL, V7, P951, DOI 10.1016/S1474-4422(08)70216-3; Flossmann E, 2003, BRAIN, V126, P1940, DOI 10.1093/brain/awg197; Flossmann E, 2008, STROKE, V39, P2457, DOI 10.1161/STROKEAHA.107.511428; Forster A, 2011, CEREBROVASC DIS, V32, P349, DOI 10.1159/000330346; Gulli G, 2012, J NEUROL NEUROSUR PS, V83, P228, DOI 10.1136/jnnp.2010.222091; Gulli G, 2013, STROKE, V44, P598, DOI 10.1161/STROKEAHA.112.669929; Gulli G, 2009, STROKE, V40, P2732, DOI 10.1161/STROKEAHA.109.553859; HACKE W, 1988, STROKE, V19, P1216, DOI 10.1161/01.STR.19.10.1216; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; HORNIG CR, 1994, STROKE, V25, P372, DOI 10.1161/01.STR.25.2.372; HORWITZ NH, 1983, SURG NEUROL, V20, P13, DOI 10.1016/0090-3019(83)90099-X; Intercollegiate Stroke Working Party, 2012, NAT CIIN GUID STROK; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Kuruvilla A, 2011, J STROKE CEREBROVASC, V20, P523, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.005; Levy EI, 2009, STROKE, V40, P3552, DOI 10.1161/STROKEAHA.109.561274; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; Lindsberg PJ, 2004, JAMA-J AM MED ASSOC, V292, P1862, DOI 10.1001/jama.292.15.1862; Lou M, 2010, ANN NY ACAD SCI, V1184, P121, DOI 10.1111/j.1749-6632.2009.05114.x; Lutsep Helmi L, 2008, J Stroke Cerebrovasc Dis, V17, P55, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.003; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Marquardt L, 2009, BRAIN, V132, P982, DOI 10.1093/brain/awp026; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Merwick A, 2013, STROKE, V44, P2814, DOI 10.1161/STROKEAHA.113.001576; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Moreau F, 2013, STROKE, V44, P671, DOI 10.1161/STROKEAHA.111.680033; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Paul NLM, 2013, LANCET NEUROL, V12, P65, DOI 10.1016/S1474-4422(12)70299-5; Sarraj A, 2013, INT J STROKE; Savitz SI, 2005, NEW ENGL J MED, V352, P2618, DOI 10.1056/NEJMra041544; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Searls DE, 2012, ARCH NEUROL-CHICAGO, V69, P346, DOI 10.1001/archneurol.2011.2083; Sheehan OC, 2009, STROKE, V40, P3449, DOI 10.1161/STROKEAHA.109.557074; St George's University of London, VERT ART ISCH STENT; Strbian D, 2013, ANN NEUROL, V73, P688, DOI 10.1002/ana.23904; Tao WD, 2012, STROKE, V43, P2060, DOI 10.1161/STROKEAHA.112.652420; van Campe G, 2003, J NEUROL NEUROSUR PS, V74, P1621, DOI 10.1136/jnnp.74.12.1621; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	53	91	102	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g3175	10.1136/bmj.g3175	http://dx.doi.org/10.1136/bmj.g3175			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24842277	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000336428800004
J	Joughin, I; Smith, BE; Medley, B				Joughin, Ian; Smith, Benjamin E.; Medley, Brooke			Marine Ice Sheet Collapse Potentially Under Way for the Thwaites Glacier Basin, West Antarctica	SCIENCE			English	Article							PINE ISLAND; SHELF; SATELLITE	Resting atop a deep marine basin, the West Antarctic Ice Sheet has long been considered prone to instability. Using a numerical model, we investigated the sensitivity of Thwaites Glacier to ocean melt and whether its unstable retreat is already under way. Our model reproduces observed losses when forced with ocean melt comparable to estimates. Simulated losses are moderate (<0.25 mm per year at sea level) over the 21st century but generally increase thereafter. Except possibly for the lowest-melt scenario, the simulations indicate that early-stage collapse has begun. Less certain is the time scale, with the onset of rapid (>1 mm per year of sea-level rise) collapse in the different simulations within the range of 200 to 900 years.	[Joughin, Ian; Smith, Benjamin E.; Medley, Brooke] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Joughin, I (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.		Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X	NSF [ANT-0424589, ANT-0631973]; NASA [NNX09AE47G]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	Comments by M. Maki, D. Shapero, and four anonymous reviewers improved the manuscript. NSF supported I.J. and B.M.'s contribution (grants ANT-0424589 and ANT-0631973), and B.E.S. was supported by NASA (grant NNX09AE47G). We acknowledge NASA's Operation IceBridge, which provided much of the data used to constrain the model. The data used to constrain the model are archived at the University of Washington Library (http://dx.doi.org/10.6069/H5CC0XMK).	Borstad C. P., 2013, CRYOSPHERE DISCUSS, V7, P3567; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Gagliardini O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043334; Genthon C, 2009, ANN GLACIOL, V50, P55, DOI 10.3189/172756409787769681; Holt JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025561; HUGHES TJ, 1981, J GLACIOL, V27, P518, DOI 10.3189/S002214300001159X; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Joughin I, 2009, J GLACIOL, V55, P245, DOI 10.3189/002214309788608705; Larour E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021693; MACAYEAL DR, 1989, J GEOPHYS RES-SOLID, V94, P4071, DOI 10.1029/JB094iB04p04071; Medley B., 2014, CRYOSPHERE DISCUSS, V8, P953, DOI DOI 10.5194/TCD-8-953-2014; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; Parizek BR, 2013, J GEOPHYS RES-EARTH, V118, P638, DOI 10.1002/jgrf.20044; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033365; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Tinto KJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049026; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	32	519	530	5	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					735	738		10.1126/science.1249055	http://dx.doi.org/10.1126/science.1249055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24821948				2022-12-28	WOS:000335912900038
J	Christensen, TR				Christensen, Torben R.			Climate science: Understand Arctic methane variability	NATURE			English	Editorial Material									[Christensen, Torben R.] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22100 Lund, Sweden; [Christensen, Torben R.] Aarhus Univ, Arctic Res Ctr, DK-8000 Aarhus C, Denmark	Lund University; Aarhus University	Christensen, TR (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22100 Lund, Sweden.			Christensen, Torben R./0000-0002-4917-148X				Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; EHHALT DH, 1974, TELLUS, V26, P58, DOI 10.1111/j.2153-3490.1974.tb01952.x; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Mastepanov M, 2013, BIOGEOSCIENCES, V10, P5139, DOI 10.5194/bg-10-5139-2013; McGuire AD, 2012, BIOGEOSCIENCES, V9, P3185, DOI 10.5194/bg-9-3185-2012; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Shakhova N, 2014, NAT GEOSCI, V7, P64, DOI [10.1038/NGEO2007, 10.1038/ngeo2007]; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036	9	18	19	0	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					279	281		10.1038/509279a	http://dx.doi.org/10.1038/509279a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24834515	Bronze, Green Published			2022-12-28	WOS:000336121200012
J	Feast, MW; Menzies, JW; Matsunaga, N; Whitelock, PA				Feast, Michael W.; Menzies, John W.; Matsunaga, Noriyuki; Whitelock, Patricia A.			Cepheid variables in the flared outer disk of our galaxy	NATURE			English	Article							GRAVITATIONAL LENSING EXPERIMENT.; OGLE-III CATALOG; PERIOD-LUMINOSITY; MILKY-WAY; CLASSICAL CEPHEIDS; DARK-MATTER; STARS; EXTINCTION; KINEMATICS; LIGHT	Flaring and warping of the disk of the Milky Way have been inferred from observations of atomic hydrogen(1,2) but stars associated with flaring have not hitherto been reported. In the area beyond the Galactic centre the stars are largely hidden from view by dust, and the kinematic distances of the gas cannot be estimated. Thirty-two possible Cepheid stars (young pulsating variable stars) in the direction of the Galactic bulge were recently identified(3). With their well-calibrated period-luminosity relationships, Cepheid stars are useful distance indicators(4). When observations of these stars are made in two colours, so that their distance and reddening can be determined simultaneously, the problems of dust obscuration are minimized. Here we report that five of the candidates are classical Cepheid stars. These five stars are distributed from approximately one to two kiloparsecs above and below the plane of the Galaxy, at radial distances of about 13 to 22 kiloparsecs from the centre. The presence of these relatively young (less than 130 million years old) stars so far from the Galactic plane is puzzling, unless they are in the flared outer disk. If so, they may be associated with the outer molecular arm(5).	[Feast, Michael W.; Whitelock, Patricia A.] Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Rondebosch, South Africa; [Feast, Michael W.; Menzies, John W.; Whitelock, Patricia A.] S African Astron Observ, ZA-7935 Observatory, South Africa; [Matsunaga, Noriyuki] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	University of Cape Town; National Research Foundation - South Africa; South African Astronomical Observatory; University of Tokyo	Feast, MW (corresponding author), Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Rondebosch, South Africa.	mwf@ast.uct.ac.za	Whitelock, Patricia/AAJ-6959-2021	Whitelock, Patricia/0000-0002-4678-4432; Feast, Michael/0000-0002-8908-1630	South African National Research Foundation	South African National Research Foundation(National Research Foundation - South Africa)	The observations reported in this Letter were obtained with the Japanese-South African IRSF at Sutherland and the SALT. M. W. F., J.W.M. and P. A. W. gratefully acknowledge research grants from the South African National Research Foundation.	Benedict GF, 2007, ASTRON J, V133, P1810, DOI 10.1086/511980; Bono G, 2005, ASTROPHYS J, V621, P966, DOI 10.1086/427744; Brunthaler A, 2011, ASTRON NACHR, V332, P461, DOI 10.1002/asna.201111560; CALDWELL JAR, 1985, MON NOT R ASTRON SOC, V212, P879, DOI 10.1093/mnras/212.4.879; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Carraro G, 2010, ASTROPHYS J, V718, P683, DOI 10.1088/0004-637X/718/2/683; Dame TM, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L24; Feast M. W., 2013, PLANETS STARS STELLA, V5, P829; FEAST MW, 1967, MON NOT R ASTRON SOC, V136, P141, DOI 10.1093/mnras/136.2.141; Fernie J. D., 1995, INFORM B VARIABLE ST, V4148; Frinchaboy PM, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/74; Groenewegen MAT, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220446; Haschke R., 2013, IAU S, V298, P415; Ibata RA, 1997, ASTRON J, V113, P634, DOI 10.1086/118283; Ibata RA, 2003, MON NOT R ASTRON SOC, V340, pL21, DOI 10.1046/j.1365-8711.2003.06545.x; Inno L, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/84; Johnson CI, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/108; Kalberla PMW, 2007, ASTRON ASTROPHYS, V469, P511, DOI 10.1051/0004-6361:20066362; KERR FJ, 1965, GALACTIC STRUCT, P167; LANEY CD, 1993, MON NOT R ASTRON SOC, V260, P408, DOI 10.1093/mnras/260.2.408; Levine ES, 2006, ASTROPHYS J, V643, P881, DOI 10.1086/503091; Lopez-Corredoira M., 2012, COMMENTS MONOCEROS A; Marconi M, 2013, MON NOT R ASTRON SOC, V428, P2185, DOI 10.1093/mnras/sts197; Matsunaga N, 2011, NATURE, V477, P188, DOI 10.1038/nature10359; Matsunaga N, 2011, MON NOT R ASTRON SOC, V413, P223, DOI 10.1111/j.1365-2966.2010.18126.x; Nagayama T, 2003, PROC SPIE, V4841, P459, DOI 10.1117/12.460770; Nataf DM, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/88; Nishiyama S, 2006, ASTROPHYS J, V638, P839, DOI 10.1086/499038; OLLING RP, 1995, ASTRON J, V110, P591, DOI 10.1086/117545; Pont F, 1997, ASTRON ASTROPHYS, V318, P416; Purcell CW, 2011, NATURE, V477, P301, DOI 10.1038/nature10417; Rich R.M., 2013, PLANETS STARS STELLA, V5, P271, DOI DOI 10.1007/978-94-007-5612-0_6; Sandage A, 2004, ASTRON ASTROPHYS, V424, P43, DOI 10.1051/0004-6361:20040222; Siegel MH, 2007, ASTROPHYS J, V667, pL57, DOI 10.1086/522003; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Sofue Y., 2013, PLANETS STARS STELLA, V5, P985; Soszynski I, 2008, ACTA ASTRONOM, V58, P163; Soszynski I, 2011, ACTA ASTRONOM, V61, P285; Soszynski I, 2008, ACTA ASTRONOM, V58, P293; Yanny B, 2003, ASTROPHYS J, V588, P824, DOI 10.1086/374220; Yong D, 2006, ASTRON J, V131, P2256, DOI 10.1086/500538; Zwitter T, 2004, ASTRON ASTROPHYS, V417, P1055, DOI 10.1051/0004-6361:20034324	42	54	54	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					342	+		10.1038/nature13246	http://dx.doi.org/10.1038/nature13246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828192	Green Submitted			2022-12-28	WOS:000336121200034
J	Northwood, V				Northwood, Victoria			The Art of Medicine Bethlem: a Museum of the Mind	LANCET			English	Editorial Material									Bethlem Royal & Maudsley Hosp, Beckenham BR3 3BX, Kent, England	South London & Maudsley NHS Trust	Northwood, V (corresponding author), Bethlem Royal & Maudsley Hosp, Beckenham BR3 3BX, Kent, England.	Victoria.Northwood@slam.nhs.uk							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1628	1629		10.1016/S0140-6736(14)60779-0	http://dx.doi.org/10.1016/S0140-6736(14)60779-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG8LV	24822259	Bronze			2022-12-28	WOS:000335670800013
J	Haynes, BF; Verkoczy, L				Haynes, Barton F.; Verkoczy, Laurent			Host Controls of HIV Neutralizing Antibodies	SCIENCE			English	Editorial Material							AUTOREACTIVITY; TOLERANCE; AFFINITY; BROAD; 4E10; 2F5		[Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Dept Med, Durham, NC 27710 USA.	barton.haynes@duke.edu			Intramural NIH HHS [Z01 AI000645] Funding Source: Medline; NIAID NIH HHS [UM1 AI100645, UM1-AI00645, R01-AI87202, R01 AI087202] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087202, UM1AI100645, Z01AI000645] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977	15	56	58	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					588	589		10.1126/science.1254990	http://dx.doi.org/10.1126/science.1254990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812389	Green Accepted			2022-12-28	WOS:000335537400028
J	Silk, J; Chluba, J				Silk, Joseph; Chluba, Jens			Next Steps for Cosmology	SCIENCE			English	Editorial Material							SPECTRAL DISTORTIONS; WAVES		[Silk, Joseph] Inst Astrophys, F-75014 Paris, France; [Silk, Joseph; Chluba, Jens] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University	Silk, J (corresponding author), Inst Astrophys, F-75014 Paris, France.	silk@iap.fr; jchluba@pha.jhu.edu		silk, joe/0000-0002-1566-8148; Chluba, Jens/0000-0003-3725-6096				Andre P, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/02/006; Bennett C., 1998, ASTROPHYS J, V508, p123F; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Chluba J, 2012, MON NOT R ASTRON SOC, V419, P1294, DOI 10.1111/j.1365-2966.2011.19786.x; HU W, 1993, PHYS REV D, V48, P485, DOI 10.1103/PhysRevD.48.485; Kamionkowski M, 1998, PHYS REV D, V57, P685, DOI 10.1103/PhysRevD.57.685; Seljak U, 1997, PHYS REV LETT, V78, P2054, DOI 10.1103/PhysRevLett.78.2054; Smirnov A. V., 2012, P SPIE, V8442; Sunyaev R., 1970, J ASTROPHYS SPACE SC, V4, P301; Sunyaev RA, 2009, ASTRON NACHR, V330, P657, DOI 10.1002/asna.200911237	10	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					586	588		10.1126/science.1252724	http://dx.doi.org/10.1126/science.1252724			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812388				2022-12-28	WOS:000335537400027
J	Aggarwal, A				Aggarwal, Anju			National standards of care quality would help India enable health coverage for all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									ACCESS Hlth Int, Hyderabad, Andhra Pradesh, India		Aggarwal, A (corresponding author), ACCESS Hlth Int, Hyderabad, Andhra Pradesh, India.	anju.aggarwal@accessh.org						Chatterjee P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2703; D'Silva J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2479; Mohanan M, 2014, B WORLD HEALTH ORGAN, V92, P187, DOI 10.2471/BLT.13.124644; Sachan D, 2014, LANCET, V383, P1281, DOI 10.1016/S0140-6736(14)60454-2	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2014	348								g3056	10.1136/bmj.g3056	http://dx.doi.org/10.1136/bmj.g3056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SI	24789548				2022-12-28	WOS:000335478400010
J	Ronan, N; Barrett, G				Ronan, Natalie; Barrett, George			PICTURE QUIZ A 68 year old woman with deteriorating hearing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHWANNOMAS; HISTORY; ADULTS		[Ronan, Natalie; Barrett, George] Royal Cornwall Hosp, Ear Nose & Throat Dept, Truro TR1 3LJ, England	Royal Cornwall Hospital	Ronan, N (corresponding author), Royal Cornwall Hosp, Ear Nose & Throat Dept, Truro TR1 3LJ, England.	natalieronan@doctors.net.uk						Arlinger S, 2003, INT J AUDIOL, V42, pS17; Christensen K, 2001, J AM GERIATR SOC, V49, P1512, DOI 10.1046/j.1532-5415.2001.4911245.x; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1991, ACTA OTO-LARYNGOL, V111, P240, DOI 10.3109/00016489109137382; Gopinath B, 2009, ARCH INTERN MED, V169, P415, DOI 10.1001/archinternmed.2008.597; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; McMahon CM, 2008, EAR HEARING, V29, P578, DOI 10.1097/AUD.0b013e31817349d6; Propp JM, 2006, NEURO-ONCOLOGY, V8, P1, DOI 10.1215/S1522851704001097; Shaikh JA, 2011, LARYNGOSCOPE, V121, P2280, DOI 10.1002/lary.21963; Van Abel KM, 2013, LARYNGOSCOPE, V123, P1957, DOI 10.1002/lary.23928	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2014	348								g2984	10.1136/bmj.g2984	http://dx.doi.org/10.1136/bmj.g2984			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SI	24789276				2022-12-28	WOS:000335478400004
J	Dickson, KE; Simen-Kapeu, A; Kinney, MV; Huicho, L; Vesel, L; Lackritz, E; Johnson, JD; von Xylander, S; Rafique, N; Sylla, M; Mwansambo, C; Daelmans, B; Lawn, JE				Dickson, Kim E.; Simen-Kapeu, Aline; Kinney, Mary V.; Huicho, Luis; Vesel, Linda; Lackritz, Eve; Johnson, Joseph de Graft; von Xylander, Severin; Rafique, Nuzhat; Sylla, Mariame; Mwansambo, Charles; Daelmans, Bernadette; Lawn, Joy E.		Lancet Every Newborn Study Grp	Every Newborn: health-systems bottlenecks and strategies to accelerate scale-up in countries	LANCET			English	Article							LOW-RESOURCE SETTINGS; LOW-INCOME COUNTRIES; MIDDLE-INCOME; NEONATAL SURVIVAL; GLOBAL HEALTH; CHILD HEALTH; CARE; SERVICES; COVERAGE; MORTALITY	Universal coverage of essential interventions would reduce neonatal deaths by an estimated 71%, benefit women and children after the first month, and reduce stillbirths. However, the packages with the greatest effect (care around birth, care of small and ill newborn babies), have low and inequitable coverage and are the most sensitive markers of health system function. In eight of the 13 countries with the most neonatal deaths (55% worldwide), we undertook a systematic assessment of bottlenecks to essential maternal and newborn health care, involving more than 600 experts. Of 2465 bottlenecks identified, common constraints were found in all high-burden countries, notably regarding the health workforce, financing, and service delivery. However, bottlenecks for specific interventions might differ across similar health systems. For example, the implementation of kangaroo mother care was noted as challenging in the four Asian country workshops, but was regarded as a feasible aspect of preterm care by respondents in the four African countries. If all high-burden countries achieved the neonatal mortality rates of their region's fastest progressing countries, then the mortality goal of ten or fewer per 1000 livebirths by 2035 recommended in this Series and the Every Newborn Action Plan would be exceeded. We therefore examined fast progressing countries to identify strategies to reduce neonatal mortality. We identified several key factors: (1) workforce planning to increase numbers and upgrade specific skills for care at birth and of small and ill newborn babies, task sharing, incentives for rural health workers; (2) financial protection measures, such as expansion of health insurance, conditional cash transfers, and performance-based financing; and (3) dynamic leadership including innovation and community empowerment. Adapting from the 2005 Lancet Series on neonatal survival and drawing on this Every Newborn Series, we propose a country-led, data-driven process to sharpen national health plans, seize opportunities to address the quality gap for care at birth and care of small and ill newborn babies, and systematically scale up care to reach every mother and newborn baby, particularly the poorest.	[Dickson, Kim E.; Simen-Kapeu, Aline] UNICEF, Programmes Div, New York, NY 10017 USA; [Kinney, Mary V.; Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Huicho, Luis] Univ Nacl Mayor San Marcos, Peruana Cayetano Heredia, Lima 14, Peru; [Huicho, Luis] Inst Nacl Salud Nino, Lima, Peru; [Lackritz, Eve] Global Alliance Preventing Prematur & Stillbirths, Seattle, WA USA; [Johnson, Joseph de Graft] MCHIP, Washington, DC USA; [von Xylander, Severin; Daelmans, Bernadette] WHO, Maternal Child & Adolescent Hlth Dept, CH-1211 Geneva, Switzerland; [Rafique, Nuzhat] UNICEF, Reg Off South Asia, Kathmandu, Nepal; [Sylla, Mariame] UNICEF, West & Cent Africa Reg Off, Dakar, Senegal; [Mwansambo, Charles] Minist Hlth, Lilongwe, Malawi; [Lawn, Joy E.] London Sch Hyg & Trop Med, Ctr Maternal Reprod & Child Hlth, London WC1, England	UNICEF; Save the Children; Universidad Nacional Mayor de San Marcos; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Dickson, KE (corresponding author), UNICEF, Programmes Div, New York, NY 10017 USA.	kdickson@unicef.org	Huicho, Luis/AAD-7353-2019; Kinney, Mary V/M-6952-2013; Lawn, Joy/ABE-6382-2020	Kinney, Mary V/0000-0002-2903-0161; Lawn, Joy/0000-0002-4573-1443; Lackritz, Eve/0000-0002-5397-7291; McDougall, Lori/0000-0002-1885-5344; Huicho, Luis/0000-0002-5272-5885	USAID; Bill & Melinda Gates Foundation	USAID(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This Series was undertaken in association with the Every Newborn Action Plan. Work for this paper was funded through a grant from USAID to UNICEF, and from the Bill & Melinda Gates Foundation to the US Fund for UNICEF. The Children's Investment Fund Foundation funded the epidemiological analysis through the London School of Hygiene and Tropical Medicine. This work would not have been possible without the country technical working groups and country workshop organisers and participants who did the bottleneck analyses. We thank Elsie Akwara and Christabel Nyange for data entry and literature searches and Shefali Oza, Hannah Blencowe, and Marek Lalli for epidemiological and coverage data analyses.	Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Alves D, 2004, ECON HUM BIOL, V2, P391, DOI 10.1016/j.ehb.2004.10.004; [Anonymous], LEV TRENDS CHILD MOR; Attygalle D, 2011, J COLL COMMUNITY PHY, V6, P2; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Ban Ki-moon., 2010, GLOBAL STRATEGY WOME; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bergh AM., 2007, RETROSPECTIVE EVALUA; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Bryce J, 2012, COUNTDOWN 2015 MATER; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Bucagu M, 2012, REPROD HEALTH MATTER, V20, P50, DOI 10.1016/S0968-8080(12)39611-0; Buchan J, 2013, B WORLD HEALTH ORGAN, V91, P834, DOI 10.2471/BLT.13.119008; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Child Trends, 2013, FAM LIF DIFF CENTR S; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Cometto G, 2011, B WORLD HEALTH ORGAN, V91, P881; Commission on Information and Accountability, 2011, KEEP PROM MEAS RES C; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; DFID Management Sciences for Health, 2010, EV MAL EM HUM RES PR; Engmann C, 2013, LANCET, V382, pE26, DOI 10.1016/S0140-6736(13)62293-X; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gabrysch S, 2009, B WORLD HEALTH ORGAN, V87, P724, DOI 10.2471/BLT.08.057794; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gill CJ, 2013, LANCET, V381, P1487, DOI 10.1016/S0140-6736(13)60314-1; INEI, 2013, SER NAC; Instituto Nacional de Estadistica e Informatica, ENC DEM SAL FAM; Instituto Nacional de Estadistica e Informatica, ENC DEM SAL FAM 2012; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jehan K, 2012, REPROD HEALTH MATTER, V20, P142, DOI 10.1016/S0968-8080(12)39609-2; Karki YB, 2013, 17 IUSSP INT POP C B; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P299, DOI 10.1016/j.ijgo.2005.12.005; Kc A, 2011, J Nepal Health Res Counc, V9, P107; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Lagarde M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009094; Lawn JE, 2012, BORN TOO SOON GLOBAL, P60; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Lipato T, 2012, EVALUATION KANGAROO; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; McNay K, 2004, BUCKING TREND SRI LA; Meng QY, 2011, HEALTH POLICY PLANN, V26, P93, DOI 10.1093/heapol/czq038; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Ministerio de Desarrollo e Inclusion Social (MIDIS), PROGR NAC AP DIR MAS; Ministerio de Economia y Finanzas, PROGR ART NUTR; Ministerio de Economia y Finanzas, 2014, PROGR ESTR SAL MAT N; Ministerio de Salud del Peru, PROYECC SEG INT SAL; Ministerio de Salud del Peru, REF SECT SAL; Ministerio de Salud del Peru, SEG INT SAL PROYECC; Ministerio de Salud del Peru, AS UN SAL; Moran AC, 2012, HEALTH POLICY PLANN, V27, P29, DOI 10.1093/heapol/czs046; Pan American Health Organization, AT INT ENF PREV INF; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS21; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pradhan Y V, 2011, J Nepal Health Res Counc, V9, P119; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Requejo J., 2013, ACCOUNTABILITY MATER; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Sama M, 2008, GOVERNING HLTH SYSTE, V1st; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Smith SL, GLOB PUBLIC IN PRESS; Smith SL, 2011, SOC SCI MED, V72, P568, DOI 10.1016/j.socscimed.2010.11.022; Sousa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074772; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; The World Bank, 2011, PER REC PROGR AAA PH; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; UNFPA, 2011, STAT WORLDS MIDW REP; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF WHO, 2013, EV NEWB TOOLK; United Nations, 2012, UN COMM LIF SAV COMM; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Venancio SI, 2012, J EPIDEMIOL COMMUN H, V66, P914, DOI 10.1136/jech-2011-200332; Wall Stephen N, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS39, DOI 10.1097/INF.0b013e31829ff801; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; WHO, ESS INT COMM GUID RE; WHO, 2013, GLOB HLTH ATL HLTH W; WHO, 2007, EV BUS STRENGTH HLTH; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; World Health Organization, 2013, NAT HLTH ACC; World Health Organization, 2012, OPT HLTH WORK ROL MA; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zimba E, 2012, HEALTH POLICY PLANN, V27, P88, DOI 10.1093/heapol/czs043	100	184	185	2	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					438	454		10.1016/S0140-6736(14)60582-1	http://dx.doi.org/10.1016/S0140-6736(14)60582-1			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24853600				2022-12-28	WOS:000340195800027
J	Vermeire, S; O'Byrne, S; Keir, M; Williams, M; Lu, TT; Mansfield, JC; Lamb, CA; Feagan, BG; Panes, J; Salas, A; Baumgart, DC; Schreiber, S; Dotan, I; Sandborn, WJ; Tew, GW; Luca, D; Tang, MT; Diehl, L; Eastham-Anderson, J; De Hertogh, G; Perrier, C; Egen, JG; Kirby, JA; van Assche, G; Rutgeerts, P				Vermeire, Severine; O'Byrne, Sharon; Keir, Mary; Williams, Marna; Lu, Timothy T.; Mansfield, John C.; Lamb, Christopher A.; Feagan, Brian G.; Panes, Julian; Salas, Azucena; Baumgart, Daniel C.; Schreiber, Stefan; Dotan, Iris; Sandborn, William J.; Tew, Gaik W.; Luca, Diana; Tang, Meina T.; Diehl, Lauri; Eastham-Anderson, Jeffrey; De Hertogh, Gert; Perrier, Clementine; Egen, Jackson G.; Kirby, John A.; van Assche, Gert; Rutgeerts, Paul			Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial	LANCET			English	Article							MAINTENANCE THERAPY; CELLS; EXPRESSION; CD103; INFLIXIMAB; ADHESION; RECEPTOR; DISEASE	Background Etrolizumab is a humanised monoclonal antibody that selectively binds the beta 7 subunit of the heterodimeric integrins alpha 4 beta 7 and alpha E beta 7. We aimed to assess etrolizumab in patients with moderately-to-severely active ulcerative colitis. Methods In this double-blind, placebo-controlled, randomised, phase 2 study, patients with moderately-to-severely active ulcerative colitis who had not responded to conventional therapy were recruited from 40 referral centres in 11 countries. Eligible patients (aged 18-75 years; Mayo Clinic Score [MCS] of 5 of higher [or >= 6 in USA]; and disease extending 25 cm or more from anal verge) were randomised (1: 1: 1) to one of two dose levels of subcutaneous etrolizumab (100 mg at weeks 0, 4, and 8, with placebo at week 2; or 420 mg loading dose [LD] at week 0 followed by 300 mg at weeks 2, 4, and 8), or matching placebo. The primary endpoint was clinical remission at week 10, defined as MCS of 2 or less (with no individual subscore of >1), analysed in the modified intention-to-treat population (mITT; all randomly assigned patients who had received at least one dose of study drug, had at least one post-baseline disease-activity assessment, and had a centrally read screening endoscopic subscore of >= 2). This study is registered with ClinicalTrials.gov, number NCT01336465. Findings Between Sept 2, 2011, and July 11, 2012, 124 patients were randomly assigned, of whom five had a endoscopic subscore of 0 or 1 and were excluded from the mITT population, leaving 39 patients in the etrolizumab 100 mg group, 39 in the etrolizumab 300 mg plus LD group, and 41 in the placebo group for the primary analyses. No patients in the placebo group had clinical remission at week 10, compared with eight (21% [95% CI 7-36]) patients in the etrolizumab 100 mg group (p= 0 . 0040) and four (10% [0.2-24]) patients in the 300 mg plus LD group (p= 0 . 048). Adverse events occurred in 25 (61%) of 41 patients in the etrolizumab 100 mg group (five [12%] of which were regarded as serious), 19 (48%) of 40 patients in the etrolizumab 300 mg plus LD group (two [5%] serious), and 31 (72%) of 43 patients in the placebo group (five [12%] serious). Interpretation Etrolizumab was more likely to lead to clinical remission at week 10 than was placebo. Therefore, blockade of both alpha 4 beta 7 and alpha E beta 7 might provide a unique therapeutic approach for the treatment of ulcerative colitis, and phase 3 studies have been planned. Copyright (C) Vermeire et al. Open Access article distributed under the terms of CC BY-NC-ND.	[Vermeire, Severine; De Hertogh, Gert; Perrier, Clementine; van Assche, Gert; Rutgeerts, Paul] Univ Leuven, Leuven, Belgium; [O'Byrne, Sharon; Keir, Mary; Williams, Marna; Lu, Timothy T.; Tew, Gaik W.; Luca, Diana; Tang, Meina T.; Diehl, Lauri; Eastham-Anderson, Jeffrey; Egen, Jackson G.] Genentech Inc, Res & Early Dev, San Francisco, CA 94080 USA; [Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Mansfield, John C.; Lamb, Christopher A.; Kirby, John A.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Feagan, Brian G.] Univ Western Ontario, London, ON, Canada; [van Assche, Gert] Univ Toronto, Toronto, ON, Canada; [Panes, Julian; Salas, Azucena] Hosp Clin Barcelona, Barcelona, Spain; [Baumgart, Daniel C.] Humboldt Univ, Charite Med Sch, D-10099 Berlin, Germany; [Schreiber, Stefan] Univ Kiel, Kiel, Germany; [Dotan, Iris] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel; [Dotan, Iris] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	KU Leuven; Roche Holding; Genentech; University of California System; University of California San Diego; Newcastle University - UK; Western University (University of Western Ontario); University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Vermeire, S (corresponding author), Univ Hosp Leuven, Dept Gastroenterol, B-3000 Leuven, Belgium.	severine.vermeire@uzleuven.be	Baumgart, Daniel C./AAU-2930-2021; Sandborn, William/ABE-8342-2020; Salas, Azucena/AAN-7035-2020; Feagan, Brian G/M-4283-2015; Lamb, Christopher/GPS-9148-2022; Feagan, Brian/G-3292-2011; Panes, Julian/H-5991-2015	Baumgart, Daniel C./0000-0003-2146-507X; Lamb, Christopher/0000-0002-7271-4956; Salas, Azucena/0000-0003-4572-2907; Egen, Jackson/0000-0003-2053-0837; Vermeire, Severine/0000-0001-9942-3019; Kirby, John/0000-0003-2543-4131; Panes, Julian/0000-0002-4971-6902	Genentech, a member of the Roche group; Genentech; Wellcome Trust [093885/Z/10/Z]; Charlotte Kenreigh of Excel Scientific Solutions	Genentech, a member of the Roche group; Genentech(Roche HoldingGenentech); Wellcome Trust(Wellcome TrustEuropean Commission); Charlotte Kenreigh of Excel Scientific Solutions	This study was funded by Genentech, a member of the Roche group. Medical writing support for this manuscript was provided by Charlotte Kenreigh of Excel Scientific Solutions and funded by Genentech. CAL was supported by a grant from the Wellcome Trust (093885/Z/10/Z). We thank Xiahoui Wei, Franklin Fuh, Carrie Looney, Rich Erickson, and Yehong Wang for their contributions to this study and the analyses.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Banz A, 2003, EUR J IMMUNOL, V33, P2419, DOI 10.1002/eji.200324205; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; CEPEK KL, 1993, J IMMUNOL, V150, P3459; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Feagan BG, 2005, NEW ENGL J MED, V353, P2400; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Ludviksson BR, 1999, J IMMUNOL; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schon MP, 1999, J IMMUNOL, V162, P6641; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Vermeire S, 2011, GUT, V60, P1068, DOI 10.1136/gut.2010.226548; Wei X, 2012, CLIN PHARMACOL THER, V91, pS80	29	314	328	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					309	318		10.1016/S0140-6736(14)60661-9	http://dx.doi.org/10.1016/S0140-6736(14)60661-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24814090	Green Published, hybrid			2022-12-28	WOS:000339722400028
J	Sasaki, E; Zhang, X; Sun, HG; Lu, MYJ; Liu, TL; Ou, A; Li, JY; Chen, YH; Ealick, SE; Liu, HW				Sasaki, Eita; Zhang, Xuan; Sun, He G.; Lu, Mei-Yeh Jade; Liu, Tsung-lin; Ou, Albert; Li, Jeng-yi; Chen, Yu-hsiang; Ealick, Steven E.; Liu, Hung-wen			Co-opting sulphur-carrier proteins from primary metabolic pathways for 2-thiosugar biosynthesis	NATURE			English	Article							MOLYBDENUM COFACTOR; SUGAR BIOSYNTHESIS; CRYSTAL-STRUCTURE; THIOLATION; MECHANISM; SEQUENCE; GENES; MOCS3	Sulphur is an essential element for life and is ubiquitous in living systems(1,2). Yet how the sulphur atom is incorporated into many sulphur-containing secondary metabolites is poorly understood. For bond formation between carbon and sulphur in primary metabolites, the major ionic sulphur sources are the persulphide and thiocarboxylate groups on sulphur-carrier (donor) proteins(3,4). Each group is post-translationally generated through the action of a specific activating enzyme. In all reported bacterial cases, the gene encoding the enzyme that catalyses the carbon-sulphur bond formation reaction and that encoding the cognate sulphur-carrier protein exist in the same gene cluster(5). To study the production of the 2-thiosugar moiety in BE-7585A, an antibiotic from Amycolatopsis orientalis, we identified a putative 2-thioglucose synthase, BexX, whose protein sequence and mode of action seem similar to those of ThiG, the enzyme that catalyses thiazole formation in thiamine biosynthesis(6,7). However, no gene encoding a sulphur-carrier protein could be located in the BE-7585A cluster. Subsequent genome sequencing uncovered a few genes encoding sulphur-carrier proteins that are probably involved in the biosynthesis of primary metabolites but only one activating enzyme gene in the A. orientalis genome. Further experiments showed that this activating enzyme can adenylate each of these sulphur carrier proteins and probably also catalyses the subsequent thiolation, through its rhodanese domain. A proper combination of these sulphur-delivery systems is effective for BexX-catalysed2-thioglucose production. The ability of BexX to selectively distinguish sulphur-carrier proteins is given a structural basis using X-ray crystallography. This study is, to our knowledge, the first complete characterization of thiosugar formation in nature and also demonstrates the receptor promiscuity of the A. orientalis sulphur-delivery system. Our results also show that co-opting the sulphur-delivery machinery of primary metabolism for the biosynthesis of sulphur-containing natural products is probably a general strategy found in nature.	[Sasaki, Eita; Liu, Hung-wen] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Zhang, Xuan; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Sun, He G.; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Lu, Mei-Yeh Jade; Li, Jeng-yi; Chen, Yu-hsiang] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lu, Mei-Yeh Jade; Liu, Tsung-lin; Ou, Albert] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Tsung-lin] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan	University of Texas System; University of Texas Austin; Cornell University; University of Texas System; University of Texas Austin; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University	Liu, HW (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Sasaki, Eita/T-7408-2019	Lu, Mei-Yeh Jade/0000-0002-4053-4889	Academia Sinica; National Institutes of Health (NIH) [GM035906, DK67081]; Welch Foundation [F-1511]; National Institute of General Medical Sciences, NIH [GM103403]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R37GM035906, R01GM035906, P41GM103485] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.-H. Wong and R. Chen, as well as Academia Sinica for funding, for the whole-genome draft sequencing; and the staff at the Analytical Instrumentation Facility of the College of Pharmacy (University of Texas), the Advanced Photon Source (APS) Northeastern Collaborative Access Team (NE-CAT) beamlines and the Cornell High Energy Synchrotron Source (CHESS) beamlines (Cornell University) for their assistance in data collection. We also thank D. Kim for assistance with the early biochemical experiments, C. Kinsland for providing the cysO/pTYB1 clone, Y. Zhang for help with the structure determination of BexX-CysO and L. Kinsland for help in preparing the manuscript. This work was supported in part by grants from the National Institutes of Health (NIH) (GM035906 to H.-W.L. and DK67081 to S. E. E.) and the Welch Foundation (F-1511 to H.-W.L.). The X-ray crystallography work was conducted at the APS NE-CAT beamlines, which are supported by award GM103403 from the National Institute of General Medical Sciences, NIH. Use of the APS is	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braunshausen A, 2011, J AM CHEM SOC, V133, P1757, DOI 10.1021/ja109378e; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chowdhury MM, 2012, J BIOL CHEM, V287, P17297, DOI 10.1074/jbc.M112.351429; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kinsland C, 1998, PROTEIN SCI, V7, P1839, DOI 10.1002/pro.5560070821; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lin CI, 2013, CHEM SOC REV, V42, P4377, DOI 10.1039/c2cs35438a; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Parry R. J., 1999, COMPREHENSIVE NATURA, V1, P825; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sasaki E, 2010, J AM CHEM SOC, V132, P15544, DOI 10.1021/ja108061c; Sasaki E, 2010, J AM CHEM SOC, V132, P7405, DOI 10.1021/ja1014037; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Settembre EC, 2004, BIOCHEMISTRY-US, V43, P11647, DOI 10.1021/bi0488911; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V24, P324, DOI 10.1016/0006-3002(57)90201-9; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Voss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028170	45	41	42	4	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					427	+		10.1038/nature13256	http://dx.doi.org/10.1038/nature13256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814342	Green Accepted			2022-12-28	WOS:000337350200041
J	Kadri, SS; O'Grady, NP				Kadri, Sameer S.; O'Grady, Naomi P.			Review: Short and long courses of antibiotics do not differ for mortality in ventilator-associated pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kadri, Sameer S.; O'Grady, Naomi P.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kadri, SS (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.		Kadri, Sameer/Q-9081-2019					Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Magill SS, 2013, CLIN INFECT DIS, V57, P1742, DOI 10.1093/cid/cit577	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC3	10.7326/0003-4819-160-10-201405200-02003	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842437				2022-12-28	WOS:000337347100002
J	Shinohara, H; Behar, M; Inoue, K; Hiroshima, M; Yasuda, T; Nagashima, T; Kimura, S; Sanjo, H; Maeda, S; Yumoto, N; Ki, S; Akira, S; Sako, Y; Hoffmann, A; Kurosaki, T; Okada-Hatakeyama, M				Shinohara, Hisaaki; Behar, Marcelo; Inoue, Kentaro; Hiroshima, Michio; Yasuda, Tomoharu; Nagashima, Takeshi; Kimura, Shuhei; Sanjo, Hideki; Maeda, Shiori; Yumoto, Noriko; Ki, Sewon; Akira, Shizuo; Sako, Yasushi; Hoffmann, Alexander; Kurosaki, Tomohiro; Okada-Hatakeyama, Mariko			Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-kappa B Activation	SCIENCE			English	Article							T-CELL-ACTIVATION; INDUCED PHOSPHORYLATION; BCL10; BETA; FATE	A switchlike response in nuclear factor-kappa B (NF-kappa B) activity implies the existence of a threshold in the NF-kappa B signaling module. We show that the CARD-containing MAGUK protein 1 (CARMA1, also called CARD11)-TAK1 (MAP3K7)-inhibitor of NF-kappa B (I kappa B) kinase-beta (IKK beta) module is a switch mechanism for NF-kappa B activation in B cell receptor (BCR) signaling. Experimental and mathematical modeling analyses showed that IKK activity is regulated by positive feedback from IKK beta to TAK1, generating a steep dose response to BCR stimulation. Mutation of the scaffolding protein CARMA1 at serine-578, an IKK beta target, abrogated not only late TAK1 activity, but also the switchlike activation of NF-kappa B in single cells, suggesting that phosphorylation of this residue accounts for the feedback.	[Shinohara, Hisaaki; Inoue, Kentaro; Nagashima, Takeshi; Yumoto, Noriko; Ki, Sewon; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QC Bio, Los Angeles, CA 90025 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA; [Hiroshima, Michio] RIKEN Quantitat Biol Ctr QBiC, Lab Cell Signaling Dynam, Suita, Osaka 5650874, Japan; [Hiroshima, Michio; Sako, Yasushi] RIKEN, Cellular Informat Lab, Wako, Saitama 3510198, Japan; [Yasuda, Tomoharu; Sanjo, Hideki; Maeda, Shiori; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kimura, Shuhei] Tottori Univ, Grad Sch Engn, Tottori 6808552, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan	RIKEN; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN; RIKEN; RIKEN; Tottori University; Osaka University; Osaka University	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucla.edu; kurosaki@rcai.riken.jp; marikoh@rcai.riken.jp	Akira, Shizuo/C-3134-2009; Yasuda, Tomoharu/J-5102-2019; Kurosaki, Tomohiro/D-1306-2009; Shinohara, Hisaaki/E-3969-2010; Inoue, Kentaro/P-4920-2016; Sako, Yasushi/B-3253-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Shinohara, Hisaaki/0000-0002-6331-2138; Inoue, Kentaro/0000-0002-7447-5856; Sako, Yasushi/0000-0002-5707-5455; Yasuda, Tomoharu/0000-0001-9997-6852	RIKEN RCAI project for Interdisciplinary Research; Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science; Cancer Research Institute; NIH [5R01CA141722]; NATIONAL CANCER INSTITUTE [R01CA141722] Funding Source: NIH RePORTER	RIKEN RCAI project for Interdisciplinary Research; Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Takemori, M. Nomura, S. Magi, A. Imamoto, and P.D. Burrows for advice and review of the manuscript and M. Reth for providing mb1-Cre mice. The study is supported by a RIKEN RCAI project for Interdisciplinary Research to H. S., and in part by Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan and the Aihara Innovative Mathematical Modelling Project, FIRST program, Japan Society for the Promotion of Science, to M.O.-H. M. B. was funded by a Postdoctoral Research Fellowship from the Cancer Research Institute and NIH grant 5R01CA141722 to A. H. The microarray data are deposited at Gene Expression Omnibus under accession number GSE41176. The authors declare no competing financial interests. H. S. designed the research; H. S., T.Y., S. M., N.Y., and S. K. performed the experiments; M. B., K. I., and S. K. performed computational analysis; H. S., M. H, and Y.S. performed single-cell imaging analysis; T.N. analyzed the microarray data; H. S. and S. A. provided essential reagents; H. S., M. B., K. I., and M.O.-H. analyzed the data; H. S., M. B., K. I., A. H., and M.O.-H. wrote the paper; and A. H., T. K., and M.O-H. conceived the study and provided overall direction.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Ninfa Alexander J, 2004, Sci STKE, V2004, ppe20, DOI 10.1126/stke.2322004pe20; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Zeng H, 2007, MOL CELL BIOL, V27, P5235, DOI 10.1128/MCB.01645-06	21	63	64	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					760	764		10.1126/science.1250020	http://dx.doi.org/10.1126/science.1250020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833394				2022-12-28	WOS:000335912900045
J	Zaumseil, J				Zaumseil, Jana			Electronic Control of Circularly Polarized Light Emission	SCIENCE			English	Editorial Material							EMITTING TRANSISTORS; DIODES		Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Zaumseil, J (corresponding author), Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.	jana.zaumseil@fau.de	Zaumseil, Jana/C-1731-2018	Zaumseil, Jana/0000-0002-2048-217X				Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Jo S, 2014, NANO LETT, V14, P2019, DOI 10.1021/nl500171v; Kim SH, 2013, ADV MATER, V25, P1822, DOI 10.1002/adma.201202790; Muccini M, 2012, LASER PHOTONICS REV, V6, P258, DOI 10.1002/lpor.201100008; Murawski C, 2013, ADV MATER, V25, P6801, DOI 10.1002/adma.201301603; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Zhang YJ, 2013, NANO LETT, V13, P3023, DOI 10.1021/nl400902v	11	19	19	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					702	703		10.1126/science.1254496	http://dx.doi.org/10.1126/science.1254496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833380				2022-12-28	WOS:000335912900025
J	Clayton, JA; Collins, FS				Clayton, Janine A.; Collins, Francis S.			NIH to balance sex in cell and animal studies	NATURE			English	Editorial Material							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS		[Clayton, Janine A.] US Natl Inst Hlth, Off Res Womens Hlth, Bethesda, MD 20892 USA; [Collins, Francis S.] US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Clayton, JA (corresponding author), US Natl Inst Hlth, Off Res Womens Hlth, Bethesda, MD 20892 USA.	janine.clayton@nih.gov						Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Du S, 2014, P NATL ACAD SCI USA, V111, P2806, DOI 10.1073/pnas.1307091111; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Fox HC, 2014, NEUROPSYCHOPHARMACOL, V39, P1527, DOI 10.1038/npp.2014.1; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Voskuhl RR, 2001, NEUROSCIENTIST, V7, P258, DOI 10.1177/107385840100700310; Wisdom AJ, 2013, J NEUROSCI RES, V91, P901, DOI 10.1002/jnr.23219; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	15	1013	1019	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					282	283		10.1038/509282a	http://dx.doi.org/10.1038/509282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24834516	Green Published, Bronze			2022-12-28	WOS:000336121200013
J	Wood, JL				Wood, John L.			ORGANIC CHEMISTRY Collaborative synthesis	NATURE			English	Editorial Material							METABOLITES		Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA	Baylor University	Wood, JL (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.	john_l_wood@baylor.edu						BOND RF, 1979, J CHEM SOC PERK T 1, P1751, DOI 10.1039/p19790001751; Finefield JM, 2012, J NAT PROD, V75, P812, DOI 10.1021/np200954v; Mercado-Marin EV, 2014, NATURE, V509, P318, DOI 10.1038/nature13273; Pimenta EF, 2010, J NAT PROD, V73, P1821, DOI 10.1021/np100470h; PORTER AEA, 1970, J CHEM SOC CHEM COMM, P1103, DOI 10.1039/c2970001103a; ZHANG XJ, 1993, J AM CHEM SOC, V115, P8867, DOI 10.1021/ja00072a061	6	2	2	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					293	294		10.1038/509293a	http://dx.doi.org/10.1038/509293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828184				2022-12-28	WOS:000336121200023
J	Spoms, O; Bullmore, ET				Spoms, Olaf; Bullmore, Edward T.			From Connections to Function: The Mouse Brain Connectome Atlas	CELL			English	Editorial Material							NETWORKS	Mapping synaptic connections and projections is crucial for understanding brain dynamics and function. In a recent issue of Nature, Oh et al. present a wiring diagram of the whole mouse brain, where standardized labeling, tracing, and imaging of axonal connections reveal new details in the network organization of neuronal connectivity.	[Spoms, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Dept Psychiat, Cambridge CB2 0SZ, England; [Bullmore, Edward T.] GlaxoSmithKline, ImmunoPsychiat, Alternat Discovery & Dev, Stevenage SG1 2NY, Herts, England	Indiana University System; Indiana University Bloomington; University of Cambridge; GlaxoSmithKline	Spoms, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; Bullmore, Ed/C-1706-2012	Sporns, Olaf/0000-0001-7265-4036; Bullmore, Ed/0000-0002-8955-8283	Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G1000183B, G0001354B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	10	16	16	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					773	775		10.1016/j.cell.2014.04.023	http://dx.doi.org/10.1016/j.cell.2014.04.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813604	Bronze			2022-12-28	WOS:000335765500006
J	Li, SS; Flint, A; Pai, JK; Forman, JP; Hu, FB; Willett, WC; Rexrode, KM; Mukamal, KJ; Rimm, EB				Li, Shanshan; Flint, Alan; Pai, Jennifer K.; Forman, John P.; Hu, Frank B.; Willett, Walter C.; Rexrode, Kathryn M.; Mukamal, Kenneth J.; Rimm, Eric B.			Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TOTAL-ENERGY-INTAKE; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; REINFARCTION TRIAL; EUROPEAN-SOCIETY; FOOD; REPRODUCIBILITY; VALIDITY; RISK	Objective To evaluate the associations of dietary fiber after myocardial infarction (MI) and changes in dietary fiber intake from before to after MI with all cause and cardiovascular mortality. Design Prospective cohort study. Setting Two large prospective cohort studies of US women and men with repeated dietary measurements: the Nurses' Health Study and the Health Professionals Follow-Up Study. Participants 2258 women and 1840 men who were free of cardiovascular disease, stroke, or cancer at enrollment, survived a first MI during follow-up, were free of stroke at the time of initial onset of MI, and provided food frequency questionnaires pre-MI and at least one post-MI. Main outcome measures Associations of dietary fiber post-MI and changes from before to after MI with all cause and cardiovascular mortality using Cox proportional hazards models, adjusting for drug use, medical history, and lifestyle factors. Results Higher post-MI fiber intake was significantly associated with lower all cause mortality (comparing extreme fifths, pooled hazard ratio 0.75, 95% confidence interval 0.58 to 0.97). Greater intake of cereal fiber was more strongly associated with all cause mortality (pooled hazard ratio 0.73, 0.58 to 0.91) than were other sources of dietary fiber. Increased fiber intake from before to after MI was significantly associated with lower all cause mortality (pooled hazard ratio 0.69, 0.55 to 0.87). Conclusions In this prospective study of patients who survived MI, a greater intake of dietary fiber after MI, especially cereal fiber, was inversely associated with all cause mortality. In addition, increasing consumption of fiber from before to after MI was significantly associated with lower all cause and cardiovascular mortality.	[Li, Shanshan; Hu, Frank B.; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Flint, Alan; Hu, Frank B.; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Dept Nutr, Boston, MA 02115 USA; [Pai, Jennifer K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Forman, John P.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Prevent Med, Boston, MA 02115 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Brookline, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Li, SS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	shl607@mail.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Mukamal, Kenneth/GVR-7978-2022; Li, Shanshan/N-2593-2019	Li, Shanshan/0000-0001-6268-125X	National Institute of Health [AA11181, HL35464, HL34594, HL60712, CA55075, CA87969, CA055075]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594, R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute of Health grants AA11181, HL35464, HL34594, HL60712, CA55075, CA87969, and CA055075. The funders play no role in the study design, data collection, analysis and interpretation, the writing of the manuscript, and the decision to submit the article for publication.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Bonnet J, 2008, CLIN THER, V30, P2298, DOI 10.1016/j.clinthera.2008.12.023; Burr ML, 2007, P NUTR SOC, V66, P9, DOI 10.1017/S0029665107005241; BURR ML, 1989, LANCET, V2, P757; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dandona P, 2010, EXP MOL MED, V42, P245, DOI 10.3858/emm.2010.42.4.033; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Estruch R, 2009, J EPIDEMIOL COMMUN H, V63, P582, DOI 10.1136/jech.2008.082214; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Ha MA, 2000, EUR J CLIN NUTR, V54, P861, DOI 10.1038/sj.ejcn.1601109; Hall AS, 2009, EUR J CARDIOV PREV R, V16, P712, DOI 10.1097/HJR.0b013e3283316ce8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Ioannidis JP, 2014, BMJ-BRIT MED J, V348, pg2659; Johnson C, 2008, AM J CARDIOL, V102, P1312, DOI 10.1016/j.amjcard.2008.07.023; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Liu SM, 2002, J AM COLL CARDIOL, V39, P49, DOI 10.1016/S0735-1097(01)01695-3; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mead A, 2006, J HUM NUTR DIET, V19, P401, DOI 10.1111/j.1365-277X.2006.00726.x; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Ness AR, 2002, EUR J CLIN NUTR, V56, P512, DOI 10.1038/sj.ejcn.1601342; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; Satija A, 2012, CURR ATHEROSCLER REP, V14, P505, DOI 10.1007/s11883-012-0275-7; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; Skinner JS, 2007, BRIT MED J, V334, P1112, DOI 10.1136/bmj.39204.531586.AD; United States Department of Agriculture, 2014, DIET GUID AM 2010; Wellenius GA, 2008, AM HEART J, V156, P483, DOI 10.1016/j.ahj.2008.04.009; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; Wong JMW, 2012, J AOAC INT, V95, P24, DOI 10.5740/jaoacint.SGE_Wong	47	22	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2659	10.1136/bmj.g2659	http://dx.doi.org/10.1136/bmj.g2659			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24782515	Green Published, hybrid			2022-12-28	WOS:000335475500004
J	Gates, M; Binagwaho, A				Gates, Melinda; Binagwaho, Agnes			Newborn health: a revolution in waiting	LANCET			English	Editorial Material									[Gates, Melinda] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda	Bill & Melinda Gates Foundation	Gates, M (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	katie.harris@gatesfoundation.org						[Anonymous], 2010, MAT HLTH INV LIF HLT; [Anonymous], 2013, MILL DEV GOALS REP 2; Bhutta ZA, 2014, LANCET; Child Info, 2013, PROGR MILL DEV GOAL; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Lawn JE, 2014, LANCET; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mason E, 2014, LANCET; Save the Children, 2014, END NEWB DEATHS ENS; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tinker A, 2002, HLTH MOTHERS HLTH NE; USAID, 2011, DHS COMP REPORTS; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2014, EV NEWB ACT PLAN END; You D, 2013, LEVELS TRENDS CHILD	16	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E23	E25		10.1016/S0140-6736(14)60810-2	http://dx.doi.org/10.1016/S0140-6736(14)60810-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853597				2022-12-28	WOS:000338921500002
J	Wilkinson, ST; D'Souza, DC				Wilkinson, Samuel T.; D'Souza, Deepak Cyril			Problems With the Medicalization of Marijuana	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Wilkinson, Samuel T.; D'Souza, Deepak Cyril] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [D'Souza, Deepak Cyril] Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, New Haven, CT 06519 USA; [D'Souza, Deepak Cyril] VA Connecticut Healthcare Syst, Schizophrenia & Neuropharmacol Res Grp, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	D'Souza, DC (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Psychiat Serv 116A,VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA.	deepak.dsouza@yale.edu	Wilkinson, Samuel/GQP-1952-2022		NIMH NIH HHS [R25 MH071584, L30 MH111000] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH071584] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Budney AJ, 2006, CURR OPIN PSYCHIATR, V19, P233, DOI 10.1097/01.yco.0000218592.00689.e5; Callaghan RC, 2013, CANCER CAUSE CONTROL, V24, P1811, DOI 10.1007/s10552-013-0259-0; Castle D, 2012, MARIJUANA MADNESS; Cooper ZD, 2013, NEUROPSYCHOPHARMACOL, V38, P1984, DOI 10.1038/npp.2013.97; Kleber HD, 2012, AM J PSYCHIAT, V169, P564, DOI 10.1176/appi.ajp.2012.12030373; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Verweij PE, 2000, JAMA-J AM MED ASSOC, V284, P2875, DOI 10.1001/jama.284.22.2875	10	33	36	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2377	2378		10.1001/jama.2014.6175	http://dx.doi.org/10.1001/jama.2014.6175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9XV	24845238	Green Accepted			2022-12-28	WOS:000337301500014
J	Heusch, G; Libby, P; Gersh, B; Yellon, D; Bohm, M; Lopaschuk, G; Opie, L				Heusch, Gerd; Libby, Peter; Gersh, Bernard; Yellon, Derek; Boehm, Michael; Lopaschuk, Gary; Opie, Lionel			Cardiovascular remodelling in coronary artery disease and heart failure	LANCET			English	Review							ELEVATION MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR HYPERTROPHY; RANDOMIZED CONTROLLED-TRIAL; RENAL SYMPATHETIC DENERVATION; SMOOTH-MUSCLE CELLS; FAILING HUMAN HEART; MYOSIN HEAVY-CHAIN; REPERFUSION INJURY; FATTY-ACID; NO-REFLOW	Remodelling is a response of the myocardium and vasculature to a range of potentially noxious haemodynamic, metabolic, and inflammatory stimuli. Remodelling is initially functional, compensatory, and adaptive but, when sustained, progresses to structural changes that become self-perpetuating and pathogenic. Remodelling involves responses not only of the cardiomyocytes, endothelium, and vascular smooth muscle cells, but also of interstitial cells and matrix. In this Review we characterise the remodelling processes in atherosclerosis, vascular and myocardial ischaemia-reperfusion injury, and heart failure, and we draw attention to potential avenues for innovative therapeutic approaches, including conditioning and metabolic strategies.	[Heusch, Gerd] Univ Klinikum Essen, Inst Pathophysiol, Essen, Germany; [Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Gersh, Bernard] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Gersh, Bernard] Mayo Clin, Coll Med, Rochester, MN USA; [Yellon, Derek] UCL, Hatter Cardiovasc Inst, London, England; [Boehm, Michael] Univ Klinikum Saarlandes, Innere Med Klin 3, Homburg, Germany; [Lopaschuk, Gary] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Opie, Lionel] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, Western Cape, South Africa	University of Duisburg Essen; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic; Mayo Clinic; University of London; University College London; Universitatsklinikum des Saarlandes; University of Alberta; University of Cape Town	Opie, L (corresponding author), Univ Cape Town, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, Western Cape, South Africa.	lionel.opie@uct.ac.za	Heusch, Gerd/ABE-6675-2020; Böhm, Michael/C-3638-2011; Libby, Peter/AAY-6404-2021; Yellon, Derek M/ABD-5110-2021	Libby, Peter/0000-0002-1502-502X; Yellon, Derek/0000-0001-7791-9320	US National Heart, Lung, and Blood Institute [R01 HL080472]; German Research Foundation [He 1320/18-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080472] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/015/26411] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish; Rosetrees Trust [M274] Funding Source: researchfish	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	Karen Sliwa, Director of the Hatter Institute for Cardiovascular Research in Africa, invited all the authors of the Review to Cape Town for this commemorative event on May 3, 2013, which she generously supported. This Review integrates the contributions of the authors of the paper to celebrate the 80th birthday of Lionel Opie. Excellent presentations on topics not covered in this Seminar were by Kieran Clarke (Oxford), Thomas Gaziano (Harvard), Sandrine Lecour, Bongani Mayosi (Chair), Karen Sliwa, and Peter Zilla. Sylvia Dennis ensured smooth organisation. This work was supported in part by a grant from the US National Heart, Lung, and Blood Institute (R01 HL080472 to PL) and the German Research Foundation (He 1320/18-1 to GH).	Abozguia K, 2010, CIRCULATION, V122, P1562, DOI 10.1161/CIRCULATIONAHA.109.934059; Ahokas RA, 2003, CIRC RES, V93, pE124, DOI 10.1161/01.RES.0000102404.81461.25; Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BERSIN RM, 1994, J AM COLL CARDIOL, V23, P1617, DOI 10.1016/0735-1097(94)90665-3; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; BOHM M, 1990, CIRCULATION, V82, P1249, DOI 10.1161/01.CIR.82.4.1249; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Bouhidel O, 2008, AM J PHYSIOL-HEART C, V295, pH1580, DOI 10.1152/ajpheart.00379.2008; Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; CANTY JM, 1985, CIRCULATION, V71, P370, DOI 10.1161/01.CIR.71.2.370; Castellano M, 1997, HYPERTENSION, V29, P715, DOI 10.1161/01.HYP.29.3.715; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; CONWAY MA, 1991, LANCET, V338, P973, DOI 10.1016/0140-6736(91)91838-L; Davies WR, 2013, CIRC-CARDIOVASC INTE, V6, P246, DOI 10.1161/CIRCINTERVENTIONS.112.000184; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; Desmet W, 2011, EUR HEART J, V32, P867, DOI 10.1093/eurheartj/ehq492; DiNicolantonio JJ, 2013, AM J CARDIOL, V111, P765, DOI 10.1016/j.amjcard.2012.11.031; Dorge H, 2000, AM J PHYSIOL-HEART C, V279, pH2587, DOI 10.1152/ajpheart.2000.279.6.H2587; Duncker DJ, 2008, MED BIOL ENG COMPUT, V46, P485, DOI 10.1007/s11517-008-0315-1; Elsasser A, 2004, J AM COLL CARDIOL, V43, P2191, DOI 10.1016/j.jacc.2004.02.053; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; FALK E, 1985, CIRCULATION, V71, P699, DOI 10.1161/01.CIR.71.4.699; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Fearon WF, 2013, CIRCULATION, V127, P2436, DOI 10.1161/CIRCULATIONAHA.112.000298; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Funada J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007533; Gao DF, 2011, HEART, V97, P278, DOI 10.1136/hrt.2010.208751; Gimbrone MA, 2013, CARDIOVASC PATHOL, V22, P9, DOI 10.1016/j.carpath.2012.06.006; Guazzi M, 2010, NAT REV CARDIOL, V7, P648, DOI 10.1038/nrcardio.2010.144; Hahn JY, 2013, CIRCULATION, V128, P1889, DOI 10.1161/CIRCULATIONAHA.113.001690; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heusch G, 2005, AM J PHYSIOL-HEART C, V288, pH984, DOI 10.1152/ajpheart.01109.2004; HEUSCH G, 1987, CIRCULATION, V75, P482, DOI 10.1161/01.CIR.75.2.482; Heusch G, 2001, CIRCULATION, V103, P2876, DOI 10.1161/01.CIR.103.24.2876; Heusch G, 2000, CIRCULATION, V101, P689, DOI 10.1161/01.CIR.101.6.689; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; KADAR A, 1985, PATHOL RES PRACT, V180, P342; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Kleinbongard P, 2013, AM J PHYSIOL-HEART C, V305, pH1222, DOI 10.1152/ajpheart.00358.2013; Kleinbongard P, 2011, CIRC RES, V108, P344, DOI 10.1161/CIRCRESAHA.110.235713; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Knoll R, 2011, EUR J HEART FAIL, V13, P811, DOI 10.1093/eurjhf/hfr071; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lee L, 2005, CIRCULATION, V112, P3280, DOI 10.1161/CIRCULATIONAHA.105.551457; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Lerman A, 2007, EUR HEART J, V28, P788, DOI 10.1093/eurheartj/ehl501; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mewton N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0383-8; Mewton N, 2010, J AM COLL CARDIOL, V55, P1200, DOI 10.1016/j.jacc.2009.10.052; MILLS I, 1994, AM J PHYSIOL, V266, pH447, DOI 10.1152/ajpheart.1994.266.2.H447; Mori J, 2012, CIRC-HEART FAIL, V5, P493, DOI 10.1161/CIRCHEARTFAILURE.112.966705; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NASCIMBEN L, 1995, CIRCULATION, V91, P1824, DOI 10.1161/01.CIR.91.6.1824; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Neef S, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0360-2; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Ohtani T, 2012, EUR HEART J, V33, P1742, DOI 10.1093/eurheartj/ehs135; Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Opie LH, 2004, LANCET, V364, P1733, DOI 10.1016/S0140-6736(04)17412-6; Opie LH, 2009, J AM COLL CARDIOL, V54, P1637, DOI 10.1016/j.jacc.2009.07.024; Ovize M, 2013, CIRC RES, V113, P439, DOI 10.1161/CIRCRESAHA.113.300764; Pandya K, 2009, EUR J HEART FAIL, V11, P648, DOI 10.1093/eurjhf/hfp073; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rezkalla SH, 2004, NAT CLIN PRACT CARD, V1, P96, DOI 10.1038/ncpcardio0047; Robbers LFHJ, 2013, EUR HEART J, V34, P2346, DOI 10.1093/eurheartj/eht100; ROBERTS CS, 1984, AM J CARDIOL, V54, P407, DOI 10.1016/0002-9149(84)90206-6; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Sivaraman V, 2010, J CELL MOL MED, V14, P1740, DOI 10.1111/j.1582-4934.2009.00796.x; Skyschally A, 2007, CIRC RES, V100, P140, DOI 10.1161/01.RES.0000255031.15793.86; Skyschally A, 2013, EUR HEART J, V34, P3314, DOI 10.1093/eurheartj/ehs434; Sloth AD, 2014, EUR HEART J, V35, P168, DOI 10.1093/eurheartj/eht369; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Sorajja P, 2005, EUR HEART J, V26, P667, DOI 10.1093/eurheartj/ehi167; Sorop O, 2008, CIRC RES, V102, P795, DOI 10.1161/CIRCRESAHA.108.172528; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Tardif JC, 2011, EUR HEART J, V32, P2507, DOI 10.1093/eurheartj/ehr311; Taylor M, 2001, J NUCL MED, V42, P55; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Thibault H, 2008, CIRCULATION, V117, P1037, DOI 10.1161/CIRCULATIONAHA.107.729780; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wagner C, 2008, J CARDIOVASC PHARM, V52, P430, DOI 10.1097/FJC.0b013e31818c12a7; Wallhaus TR, 2001, CIRCULATION, V103, P2441; Williams KJ, 2005, ARTERIOSCL THROM VAS, V25, P1536, DOI 10.1161/01.ATV.0000174795.62387.d3; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; ZARINS CK, 1982, SURGERY, V92, P1086; Zhang C., 2011, COMPR PHYSIOL, P521; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhu PL, 2000, CIRCULATION, V101, P1165, DOI 10.1161/01.CIR.101.10.1165; Zile MR, 2011, CIRC-HEART FAIL, V4, P246, DOI 10.1161/CIRCHEARTFAILURE.110.958199	130	488	524	7	170	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1933	1943		10.1016/S0140-6736(14)60107-0	http://dx.doi.org/10.1016/S0140-6736(14)60107-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24831770	Green Accepted			2022-12-28	WOS:000336847800034
J	Kiuchi, T; Koga, H; Kawamoto, M; Shoji, K; Sakai, H; Arai, Y; Ishihara, G; Kawaoka, S; Sugano, S; Shimada, T; Suzuki, Y; Suzuki, MG; Katsuma, S				Kiuchi, Takashi; Koga, Hikaru; Kawamoto, Munetaka; Shoji, Keisuke; Sakai, Hiroki; Arai, Yuji; Ishihara, Genki; Kawaoka, Shinpei; Sugano, Sumio; Shimada, Toru; Suzuki, Yutaka; Suzuki, Masataka G.; Katsuma, Susumu			A single female-specific piRNA is the primary determiner of sex in the silkworm	NATURE			English	Article							W-CHROMOSOME; BOMBYX-MORI; RNA; EXPRESSION; SYSTEM; GENE; IDENTIFICATION; TRANSLOCATION; AMPLIFICATION; TRANSPOSONS	The silkworm Bombyx mori uses a WZ sex determination system that is analogous to the one found in birds and some reptiles. In this system, males have two Z sex chromosomes, whereas females have Z and W sex chromosomes. The silkworm W chromosome has a dominant role in female determination(1,2), suggesting the existence of a dominant feminizing gene in this chromosome. However, the W chromosomeis almost fully occupied by transposable element sequences(3-5), and no functional protein-coding gene has been identified so far. Female-enriched PIWI-interacting RNAs (piRNAs) are the only known transcripts that are produced from the sex-determining region of the W chromosome(6), but the function(s) of these piRNAs are unknown. Here we show that a W-chromosome-derived, female-specific piRNA is the feminizing factor of B. mori. This piRNA is produced from a piRNA precursor which we named Fem. Fem sequences were arranged in tandem in the sex-determining region of the W chromosome. Inhibition of Fem-derived piRNA-mediated signalling in female embryos led to the production of the male-specific splice variants of B. mori doublesex (Bmdsx), a gene which acts at the downstream end of the sex differentiation cascade(7,8). A target gene of Fem-derived piRNA was identified on the Z chromosome of B. mori. This gene, which we named Masc, encoded a CCCH-type zinc finger protein. We show that the silencing of Masc messenger RNA by Fem piRNA is required for the production of female-specific isoforms of Bmdsx in female embryos, and that Masc protein controls both dosage compensation and masculinization in male embryos. Our study characterizes a single small RNA that is responsible for primary sex determination in the WZ sex determination system.	[Kiuchi, Takashi; Koga, Hikaru; Kawamoto, Munetaka; Shoji, Keisuke; Arai, Yuji; Ishihara, Genki; Kawaoka, Shinpei; Shimada, Toru; Katsuma, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Sakai, Hiroki; Suzuki, Masataka G.] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Katsuma, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Kiuchi, Takashi/AAG-4913-2020; Shimada, Toru/A-2033-2011; Sakai, Hiroki/O-1028-2019; Shimada, Toru/AAZ-2703-2021	Kiuchi, Takashi/0000-0003-3616-1650; Shimada, Toru/0000-0002-5791-0000; Sakai, Hiroki/0000-0001-6128-7680; Shimada, Toru/0000-0002-5791-0000; Shoji, Keisuke/0000-0003-0183-654X; Kawamoto, Munetaka/0000-0003-3554-8407	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry;  [22115502];  [22128004]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; ; 	We thank S. G. Kamita for critical reading of the manuscript; Y. Tomari for critical reading of the manuscript and technical suggestions. This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to Su.K. and Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 22115502 and 22128004) to Su.K. and T.S.	Abe H, 2008, GENETICA, V133, P269, DOI 10.1007/s10709-007-9210-1; Abe H, 1998, GENES GENET SYST, V73, P243, DOI 10.1266/ggs.73.243; Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Abe H, 2005, INSECT MOL BIOL, V14, P339, DOI 10.1111/j.1365-2583.2005.00565.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Fujii T, 2006, GENETICA, V127, P253, DOI 10.1007/s10709-005-4147-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-119; Hasimoto H., 1933, JPN J GENET, V8, P245; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; Kawaoka S, 2008, BIOCHEM BIOPH RES CO, V367, P755, DOI 10.1016/j.bbrc.2008.01.013; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Ohbayashi F, 2001, COMP BIOCHEM PHYS B, V128, P145, DOI 10.1016/S1096-4959(00)00304-3; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Sakai H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00235; Sakudoh T, 2011, GENETICS, V187, P965, DOI 10.1534/genetics.110.124982; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shoji K, 2013, GENE, V527, P649, DOI 10.1016/j.gene.2013.06.071; Sugimoto TN, 2012, BIOL LETTERS, V8, P412, DOI 10.1098/rsbl.2011.1114; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; TAZIMA Y, 1944, B SERIC EXP STA JPN, V12, P109; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469	37	289	312	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					633	+		10.1038/nature13315	http://dx.doi.org/10.1038/nature13315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24828047				2022-12-28	WOS:000336457100051
J	Eldridge, JJ				Eldridge, John J.			Windy stars that go with a bang	NATURE			English	Editorial Material							PROGENITOR; SUPERNOVAE		Univ Auckland, Dept Phys, Auckland, New Zealand	University of Auckland	Eldridge, JJ (corresponding author), Univ Auckland, Dept Phys, Private Bag 92019, Auckland, New Zealand.	j.eldridge@auckland.ac.nz		Eldridge, Jan/0000-0002-1722-6343				Benvenuto OG, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/74; Crowther PA, 2007, ANNU REV ASTRON ASTR, V45, P177, DOI 10.1146/annurev.astro.45.051806.110615; Eldridge JJ, 2013, MON NOT R ASTRON SOC, V436, P774, DOI 10.1093/mnras/stt1612; Fremling C., 2014, PREPRINT; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; Gal-Yam A, 2014, NATURE, V509, P471, DOI 10.1038/nature13304; Kochanek CS, 2008, ASTROPHYS J, V684, P1336, DOI 10.1086/590053; Li WD, 2007, ASTROPHYS J, V661, P1013, DOI 10.1086/516747; Maund JR, 2004, NATURE, V427, P129, DOI 10.1038/nature02161; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737	10	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					431	432		10.1038/509431a	http://dx.doi.org/10.1038/509431a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848055				2022-12-28	WOS:000336126000024
J	Rickard, JA; O'Donnell, JA; Evans, JM; Lalaoui, N; Poh, AR; Rogers, T; Vince, JE; Lawlor, KE; Ninnis, RL; Anderton, H; Hall, C; Spall, SK; Phesse, TJ; Abud, HE; Cengia, LH; Corbin, J; Mifsud, S; Di Rago, L; Metcalf, D; Ernst, M; Dewson, G; Roberts, AW; Alexander, WS; Murphy, JM; Ekert, PG; Masters, SL; Vaux, DL; Croker, BA; Gerlic, M; Silke, J				Rickard, James A.; O'Donnell, Joanne A.; Evans, Joseph M.; Lalaoui, Najoua; Poh, Ashleigh R.; Rogers, TeWhiti; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Abud, Helen E.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John			RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis	CELL			English	Article							TUMOR-NECROSIS-FACTOR; MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH; TNF; NECROPTOSIS; CASPASE-8; ACTIVATION; INDUCTION; APOPTOSIS	Upon ligand binding, RIPK1 is recruited to tumor necrosis factor receptor superfamily (TNFRSF) and Toll-like receptor (TLR) complexes promoting prosurvival and inflammatory signaling. RIPK1 also directly regulates caspase-8-mediated apoptosis or, if caspase-8 activity is blocked, RIPK3-MLKL-dependent necroptosis. We show that C57BL/6 Ripk1(-/-) mice die at birth of systemic inflammation that was not transferable by the hematopoietic compartment. However, Ripk1(-/-) progenitors failed to engraft lethally irradiated hosts properly. Blocking TNF reversed this defect in emergency hematopoiesis but, surprisingly, Tnfr1 deficiency did not prevent inflammation in Ripk1(-/-) neonates. Deletion of Ripk3 or Mlkl, but not Casp8, prevented extracellular release of the necroptotic DAMP, IL-33, and reduced Myd88-dependent inflammation. Reduced inflammation in the Ripk1(-/-) Ripk3(-/-), Ripk1(-/-)Mlkl(-/-), and Ripk1(-/-)Myd88(-/-) mice prevented neonatal lethality, but only Ripk1(-/-)Ripk3(-/-)Casp8(-/-) mice survived past weaning. These results reveal a key function for RIPK1 in inhibiting necroptosis and, thereby, a role in limiting, not only promoting, inflammation.	[Rickard, James A.; O'Donnell, Joanne A.; Evans, Joseph M.; Lalaoui, Najoua; Poh, Ashleigh R.; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Rickard, James A.; O'Donnell, Joanne A.; Lalaoui, Najoua; Poh, Ashleigh R.; Vince, James E.; Lawlor, Kate E.; Ninnis, Robert L.; Anderton, Holly; Hall, Cathrine; Spall, Sukhdeep K.; Phesse, Toby J.; Cengia, Louise H.; Corbin, Jason; Mifsud, Sandra; Di Rago, Ladina; Metcalf, Donald; Ernst, Matthias; Dewson, Grant; Roberts, Andrew W.; Alexander, Warren S.; Murphy, James M.; Ekert, Paul G.; Masters, Seth L.; Vaux, David L.; Croker, Ben A.; Gerlic, Motti; Silke, John] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Evans, Joseph M.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Rogers, TeWhiti] Univ Melbourne, Dept Pathol, Parkville, Vic 3050, Australia; [Abud, Helen E.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Roberts, Andrew W.] Univ Melbourne, Fac Med, Parkville, Vic 3050, Australia; [Croker, Ben A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Gerlic, Motti] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; University of Melbourne; Monash University; University of Melbourne; Harvard University; Boston Children's Hospital; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Gerlic, M (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	mgerlic@post.tau.ac.il; j.silke@latrobe.edu.au	Silke, John/B-7622-2008; Gerlic, Motti/U-3484-2017; Ekert, Paul/Q-1842-2015; O'Donnell, Joanne/HHZ-2106-2022; Ernst, Matthias/D-5111-2012; Masters, Seth L/N-2886-2013; Roberts, Andrew W./C-6736-2012; Vaux, David L/C-7249-2013; gerlic, Motti/I-5492-2019; Lalaoui, Najoua/C-1410-2014; Murphy, James/B-4863-2017; dewson, grant/C-7646-2013; Mifsud, Sandra/AAM-6041-2021	Silke, John/0000-0002-7611-5774; Gerlic, Motti/0000-0001-9518-1833; Ekert, Paul/0000-0002-2976-8617; Ernst, Matthias/0000-0002-6399-1177; Masters, Seth L/0000-0003-4763-576X; Roberts, Andrew W./0000-0002-7341-5720; Vaux, David L/0000-0003-2703-1651; gerlic, Motti/0000-0001-9518-1833; Lalaoui, Najoua/0000-0002-0165-3324; Murphy, James/0000-0003-0195-3949; dewson, grant/0000-0003-4251-8898; Lawlor, Kate/0000-0003-0471-6842; Mifsud, Sandra/0000-0002-1010-292X; Abud, Helen/0000-0003-3792-4023; Phesse, Toby/0000-0001-9568-4916; Poh, Ashleigh/0000-0001-8375-4753; O'Donnell, Joanne/0000-0002-8434-1050; Croker, Ben/0000-0002-0885-3599; Anderton, Holly/0000-0003-3913-9686	NHMRC [1016647, 461221, 1016701, 1025594, 1046984, 1046010, 1025239, 637367, 1008131, 1057905]; Australian Research Council Fellowship; APA scholarship; Dora Lush Scholarship; La Trobe University Postgraduate Research Scholarship; VESKI innovation fellowship; ARC Fellowship; Cancer Council Victoria Carden Fellowship; NHMRC fellowships [541901, 1058344, 637309]; Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support; NHMRC IRIISS grant [361646]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); APA scholarship; Dora Lush Scholarship; La Trobe University Postgraduate Research Scholarship; VESKI innovation fellowship; ARC Fellowship(Australian Research Council); Cancer Council Victoria Carden Fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support; NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia)	We thank staff in the WEHI Bioservices facility, Vishva Dixit for Ripk3<SUP>-/-</SUP> mice, Michelle Kelliher for Ripk1<SUP>-/-</SUP> mice, Heinrich Korner for Tnf<SUP>-/-</SUP> and Tnfr1<SUP>-/-</SUP> mice, Stephen Hedrick for Casp8<SUP>fl/fl</SUP> mice, and Anne Voss for helpful discussions. This work was supported by NHMRC grants (1016647, 461221, 1016701, 1025594, 1046984, 1046010, 1025239, 637367, 1008131, and 1057905), an Australian Research Council Fellowship (B.A.C.), an APA scholarship (J.A.R.), a Dora Lush Scholarship (J.A.O.), a La Trobe University Postgraduate Research Scholarship (J.M. E.), a VESKI innovation fellowship (S.L.M.), ARC Fellowship (J.M. M.), Cancer Council Victoria Carden Fellowship (D.M.), and NHMRC fellowships to J.S., W.S.A., and A.W.R. (541901, 1058344, and 637309) with additional support from the Australian Cancer Research Fund, Victorian State Government Operational Infrastructure Support, and an NHMRC IRIISS grant (361646).	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pearl-Yafe M, 2010, STEM CELLS, V28, P1270, DOI 10.1002/stem.448; Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Weill D, 1996, J INTERF CYTOK RES, V16, P395, DOI 10.1089/jir.1996.16.395; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	46	408	417	9	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1175	1188		10.1016/j.cell.2014.04.019	http://dx.doi.org/10.1016/j.cell.2014.04.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24813849	Bronze			2022-12-28	WOS:000336437200018
J	Bloomfield, HE				Bloomfield, Hanna E.			High-dose oral multivitamins and minerals after MI did not reduce CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; PHYSICIANS HEALTH; PREVENTION; MEN		[Bloomfield, Hanna E.] VA Med Ctr, Minneapolis, MN 55417 USA; [Bloomfield, Hanna E.] Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), VA Med Ctr, Minneapolis, MN 55417 USA.			bloomfield, hanna/0000-0002-0756-7064				Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC4	10.7326/0003-4819-160-10-201405200-02004	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842438				2022-12-28	WOS:000337347100003
J	Fletcher, SW				Fletcher, Suzanne W.			Annual mammography screening did not reduce long-term breast cancer mortality in women 40 to 59 years of age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BENEFITS; HARMS		Harvard Univ, Sch Med, Boston, MA 02163 USA	Harvard University; Harvard Medical School	Fletcher, SW (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.							Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, V5th; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	3	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC7	10.7326/0003-4819-160-10-201405200-02007	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842441				2022-12-28	WOS:000337347100006
J	Plummer, NR; Thorp, T; Sultan, S				Plummer, Nicholas R.; Thorp, Thomas; Sultan, Sulaiman			PICTURE QUIZ Sudden onset double vision	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERNUCLEAR OPHTHALMOPLEGIA; STROKE PATIENTS; THROMBOEMBOLISM; PREVENTION; BRAIN		[Plummer, Nicholas R.; Thorp, Thomas; Sultan, Sulaiman] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Acute Stroke Unit, Preston PR2 9HT, Lancs, England	Royal Preston Hospital	Plummer, NR (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Acute Stroke Unit, Preston PR2 9HT, Lancs, England.	nickplummer@cantab.net	Plummer, Nicholas Russell/D-9213-2014	Plummer, Nicholas Russell/0000-0002-1239-9253				ATLAS SW, 1987, AM J NEURORADIOL, V8, P243; Bolanos I, 2004, ACTA NEUROL SCAND, V110, P161, DOI 10.1111/j.1600-0404.2004.00278.x; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Jones SA, 2006, AGE AGEING, V35, P560, DOI 10.1093/ageing/afl074; Keane JR, 2005, ARCH NEUROL-CHICAGO, V62, P714, DOI 10.1001/archneur.62.5.714; Kim JS, 2004, NEUROLOGY, V62, P1491, DOI 10.1212/01.WNL.0000123093.37069.6D; MCBRIDE R, 1994, LANCET, V343, P687; Obuchowska Iwona, 2009, Klin Oczna, V111, P165; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g3286	10.1136/bmj.g3286	http://dx.doi.org/10.1136/bmj.g3286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24840913				2022-12-28	WOS:000336428800018
J	Anantharaman, K; Duhaime, MB; Breier, JA; Wendt, KA; Toner, BM; Dick, GJ				Anantharaman, Karthik; Duhaime, Melissa B.; Breier, John A.; Wendt, Kathleen A.; Toner, Brandy M.; Dick, Gregory J.			Sulfur Oxidation Genes in Diverse Deep-Sea Viruses	SCIENCE			English	Article							MARINE VIRUSES; PHOTOSYNTHESIS GENES; HYDROTHERMAL PLUME; GENOME SEQUENCE; BACTERIA; LINEAGES; HYDROGEN; WATERS	Viruses are the most abundant biological entities in the oceans and a pervasive cause of mortality of microorganisms that drive biogeochemical cycles. Although the ecological and evolutionary effects of viruses on marine phototrophs are well recognized, little is known about their impact on ubiquitous marine lithotrophs. Here, we report 18 genome sequences of double-stranded DNA viruses that putatively infect widespread sulfur-oxidizing bacteria. Fifteen of these viral genomes contain auxiliary metabolic genes for the alpha and gamma subunits of reverse dissimilatory sulfite reductase (rdsr). This enzyme oxidizes elemental sulfur, which is abundant in the hydrothermal plumes studied here. Our findings implicate viruses as a key agent in the sulfur cycle and as a reservoir of genetic diversity for bacterial enzymes that underpin chemosynthesis in the deep oceans.	[Anantharaman, Karthik; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Duhaime, Melissa B.; Dick, Gregory J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Breier, John A.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Wendt, Kathleen A.; Toner, Brandy M.] Univ Minnesota Twin Cities, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Dick, Gregory J.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Woods Hole Oceanographic Institution; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Dick, GJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	gdick@umich.edu	Toner, Brandy/N-7911-2016	Toner, Brandy/0000-0002-3681-3455; Duhaime, Melissa/0000-0001-7884-5087; Breier, John/0000-0002-3591-5548	Gordon and Betty Moore Foundation [GBMF2609]; NSF [OCE1038006, OCE1038055, OCE1037991, OCE1029242]; University of Michigan Rackham Graduate School Faculty Research Fellowship Program; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; National Center for Biotechnology Information (BioProject) [PRJNA234377]; Directorate For Geosciences [1029242, 1038006] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); University of Michigan Rackham Graduate School Faculty Research Fellowship Program; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Biotechnology Information (BioProject); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project is funded in part by the Gordon and Betty Moore Foundation (grant GBMF2609) and the NSF (grants OCE1038006, OCE1038055, OCE1037991, and OCE1029242). We thank the University of Michigan Rackham Graduate School Faculty Research Fellowship Program for their support and M. Li and S. Jain for their assistance. DNA sequencing was conducted at the University of Michigan DNA Sequencing Core. We acknowledge the captain and crew of R/V Thomas G. Thompson, Chief Scientist A.-L. Reysenbach, and J. Sylvan for sampling and logistical support. For assistance with synchrotron measurements at BL10.3.2, we thank K. J. Edwards, J. V. Sorensen, M. A. Marcus, and S. C. Fakra. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. The nucleotide sequences are available from DOE JGI-IMG/MER (Taxon Object IDs: Kilo Moana, 3300001680; ABE, 3300001681; Mariner, 3300001678; Tahi Moana, 3300001679; Tui Malila, 3300001676; Guaymas, 3300001683) and the National Center for Biotechnology Information (BioProject: PRJNA234377). We declare no competing financial interests.	Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Breier JA, 2012, GEOCHIM COSMOCHIM AC, V88, P216, DOI 10.1016/j.gca.2012.04.003; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Lesniewski RA, 2012, ISME J, V6, P2257, DOI 10.1038/ismej.2012.63; Li M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4192; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Marshall KT, 2013, ISME J, V7, P452, DOI 10.1038/ismej.2012.78; McCollom TM, 2000, DEEP-SEA RES PT I, V47, P85, DOI 10.1016/S0967-0637(99)00048-5; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309	28	141	146	6	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					757	760		10.1126/science.1252229	http://dx.doi.org/10.1126/science.1252229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24789974	Green Submitted			2022-12-28	WOS:000335912900044
J	Henrich, J				Henrich, Joseph			Rice, Psychology, and Innovation	SCIENCE			English	Editorial Material							EUROPE; CHINA		[Henrich, Joseph] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1N5, Canada; [Henrich, Joseph] Univ British Columbia, Dept Econ, Vancouver, BC V6T 1N5, Canada	University of British Columbia; University of British Columbia	Henrich, J (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1N5, Canada.	henrich@psych.ubc.ca						Clark G, 2007, PRINC ECON HIST W WO; Gorodnichenko Y, 2011, P NATL ACAD SCI USA, V108, P21316, DOI 10.1073/pnas.1101933108; Greif A, 2010, AM ECON REV, V100, P135, DOI 10.1257/aer.100.2.135; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; Mokyr Joel, 1990, LEVER RICHES; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850	7	28	28	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					593	594		10.1126/science.1253815	http://dx.doi.org/10.1126/science.1253815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6OD	24812392				2022-12-28	WOS:000335537400031
J	Handa, IT; Aerts, R; Berendse, F; Berg, MP; Bruder, A; Butenschoen, O; Chauvet, E; Gessner, MO; Jabiol, J; Makkonen, M; McKie, BG; Malmqvist, B; Peeters, ETHM; Scheu, S; Schmid, B; van Ruijven, J; Vos, VCA; Hattenschwiler, S				Handa, I. Tanya; Aerts, Rien; Berendse, Frank; Berg, Matty P.; Bruder, Andreas; Butenschoen, Olaf; Chauvet, Eric; Gessner, Mark O.; Jabiol, Jeremy; Makkonen, Marika; McKie, Brendan G.; Malmqvist, Bjoern; Peeters, Edwin T. H. M.; Scheu, Stefan; Schmid, Bernhard; van Ruijven, Jasper; Vos, Veronique C. A.; Haettenschwiler, Stephan			Consequences of biodiversity loss for litter decomposition across biomes	NATURE			English	Article							SPECIES FUNCTIONAL DIVERSITY; LEAF-LITTER; ECOSYSTEMS; PATTERNS; SERVICES; CLIMATE; TRAITS	The decomposition of dead organic matter is a major determinant of carbon and nutrient cycling in ecosystems, and of carbon fluxes between the biosphere and the atmosphere(1-3). Decomposition is driven by a vast diversity of organisms that are structured in complex food webs(2,4). Identifying the mechanisms underlying the effects of biodiversity on decomposition is critical(4-6) given the rapid loss of species worldwide and the effects of this loss on human well-being(7-9). Yet despite comprehensive syntheses of studies on how biodiversity affects litter decomposition(4-6,10), key questions remain, including when, where and how biodiversity has a role and whether general patterns and mechanisms occur across ecosystems and different functional types of organism(4,9-12). Here, in field experiments across five terrestrial and aquatic locations, ranging from the subarctic to the tropics, we show that reducing the functional diversity of decomposer organisms and plant litter types slowed the cycling of litter carbon and nitrogen. Moreover, we found evidence of nitrogen transfer from the litter of nitrogen-fixing plants to that of rapidly decomposing plants, but not between other plant functional types, highlighting that specific interactions in litter mixtures control carbon and nitrogen cycling during decomposition. The emergence of this general mechanism and the coherence of patterns across contrasting terrestrial and aquatic ecosystems suggest that biodiversity loss has consistent consequences for litter decomposition and the cycling of major elements on broad spatial scales.	[Handa, I. Tanya; Haettenschwiler, Stephan] CNRS, CEFE, F-34293 Montpellier, France; [Handa, I. Tanya] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Aerts, Rien; Berg, Matty P.; Makkonen, Marika] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Berendse, Frank; van Ruijven, Jasper; Vos, Veronique C. A.] Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Bruder, Andreas; Gessner, Mark O.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Bruder, Andreas; Gessner, Mark O.] ETH, Inst Integrat Biol IBZ, CH-8092 Zurich, Switzerland; [Butenschoen, Olaf; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Chauvet, Eric; Jabiol, Jeremy] Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonctionnelle & Environm, F-31062 Toulouse, France; [Chauvet, Eric; Jabiol, Jeremy] CNRS, EcoLab, F-31062 Toulouse, France; [Gessner, Mark O.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-16775 Stechlin, Germany; [Gessner, Mark O.] TU Berlin, Berlin Inst Technol, Dept Ecol, D-10587 Berlin, Germany; [Makkonen, Marika] Finnish Environm Inst, Climate Change Programme, Helsinki 00251, Finland; [McKie, Brendan G.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [McKie, Brendan G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Peeters, Edwin T. H. M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AA Wageningen, Netherlands; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Quebec; University of Quebec Montreal; Vrije Universiteit Amsterdam; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Technical University of Berlin; Finnish Environment Institute; Umea University; Swedish University of Agricultural Sciences; Wageningen University & Research; University of Zurich; University of Zurich	Hattenschwiler, S (corresponding author), CNRS, CEFE, 1919 Route Mende, F-34293 Montpellier, France.	stephan.hattenschwiler@cefe.cnrs.fr	van Ruijven, Jasper/D-9848-2011; Bruder, Andreas/AFC-9051-2022; van Ruijven, Jasper/ABE-7791-2020; Chauvet, Eric/F-7644-2011; Schmid, Bernhard/C-8625-2009; Scheu, Stefan/H-7049-2015	Bruder, Andreas/0000-0002-4591-491X; van Ruijven, Jasper/0000-0003-0003-2363; Chauvet, Eric/0000-0001-8676-392X; Schmid, Bernhard/0000-0002-8430-3214; Butenschoen, Olaf/0000-0003-1866-9805; McKie, Brendan/0000-0002-1796-9497; Berg, Matty P./0000-0001-8442-8503; Peeters, Edwin T.H.M./0000-0003-2541-1829; Jabiol, Jeremy/0000-0003-4279-2379; Aerts, Rien/0000-0001-6694-0669	European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY	European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY	We thank A. Lecerf and P. Garcia-Palacios for comments on the manuscript. We are grateful to numerous technicians in Montpellier (France) for building field microcosms, in Dubendorf (Switzerland) for water chemical analyses, and in Dubendorf and Gottingen (Germany) for grinding litter samples. We also thank M. Schindler for assistance, B. Buatois, R. Leclerc, P. Schevin and L. Sonie for analyses performed at the Plate-Forme d'Analyses Chimiques en Ecologie, LabEx CeMEB (France), G. Larocque for help with R code and our many colleagues at the field sites and research institutes for their support in various ways. This study is part of the BioCycle research project funded by the European Science Foundation (ESF) as part of its EUROCORES programme EuroDIVERSITY. BioCycle has been endorsed by DIVERSITAS as contributing towards their scientific research priorities in biodiversity science.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Finzi AC, 1998, FOREST ECOL MANAG, V105, P129, DOI 10.1016/S0378-1127(97)00277-6; Frainer A, 2014, J ANIM ECOL, V83, P460, DOI 10.1111/1365-2656.12142; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Lepori F, 2009, OIKOS, V118, P471, DOI 10.1111/j.1600-0706.2008.16989.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Lummer D, 2012, OIKOS, V121, P1649, DOI 10.1111/j.1600-0706.2011.20073.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; May RM, 2011, CR BIOL, V334, P346, DOI 10.1016/j.crvi.2010.12.002; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nijboer R., 1999, 455 IBN; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Swan CM, 2006, OECOLOGIA, V149, P107, DOI 10.1007/s00442-006-0436-x; Vitousek PM, 2000, ECOLOGY, V81, P2366, DOI 10.1890/0012-9658(2000)081[2366:HNFIDL]2.0.CO;2; Vos VCA, 2011, OIKOS, V120, P1092, DOI 10.1111/j.1600-0706.2010.18650.x; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534	35	440	477	68	987	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					218	+		10.1038/nature13247	http://dx.doi.org/10.1038/nature13247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805346	Green Accepted			2022-12-28	WOS:000335454300037
J	Naqvi, N; Li, M; Calvert, JW; Tejada, T; Lambert, JP; Wu, JX; Kesteven, SH; Holman, SR; Matsuda, T; Lovelock, JD; Howard, WW; Iismaa, SE; Chan, AY; Crawford, BH; Wagner, MB; Martin, DIK; Lefer, DJ; Graham, RM; Husain, A				Naqvi, Nawazish; Li, Ming; Calvert, John W.; Tejada, Thor; Lambert, Jonathan P.; Wu, Jianxin; Kesteven, Scott H.; Holman, Sara R.; Matsuda, Torahiro; Lovelock, Joshua D.; Howard, Wesley W.; Iismaa, Siiri E.; Chan, Andrea Y.; Crawford, Brian H.; Wagner, Mary B.; Martin, David I. K.; Lefer, David J.; Graham, Robert M.; Husain, Ahsan			A Proliferative Burst during Preadolescence Establishes the Final Cardiomyocyte Number	CELL			English	Article							GROWTH-FACTOR-I; THYROID-HORMONE; TRANSGENIC MICE; MYOCYTE PROLIFERATION; HEART REGENERATION; CARDIAC-FUNCTION; DNA-SYNTHESIS; HYPERTROPHY; OVEREXPRESSION; CONTRACTILITY	It is widely believed that perinatal cardiomyocyte terminal differentiation blocks cytokinesis, thereby causing binucleation and limiting regenerative repair after injury. This suggests that heart growth should occur entirely by cardiomyocyte hypertrophy during preadolescence when, in mice, cardiac mass increases many-fold over a few weeks. Here, we show that a thyroid hormone surge activates the IGF-1/IGF-1-R/Akt pathway on postnatal day 15 and initiates a brief but intense proliferative burst of predominantly binuclear cardiomyocytes. This proliferation increases cardiomyocyte numbers by similar to 40%, causing a major disparity between heart and cardiomyocyte growth. Also, the response to cardiac injury at postnatal day 15 is intermediate between that observed at postnatal days 2 and 21, further suggesting persistence of cardiomyocyte proliferative capacity beyond the perinatal period. If replicated in humans, this may allow novel regenerative therapies for heart diseases.	[Naqvi, Nawazish; Tejada, Thor; Matsuda, Torahiro; Lovelock, Joshua D.; Howard, Wesley W.; Husain, Ahsan] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Li, Ming; Wu, Jianxin; Kesteven, Scott H.; Holman, Sara R.; Iismaa, Siiri E.; Chan, Andrea Y.; Graham, Robert M.] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Calvert, John W.; Lambert, Jonathan P.; Lefer, David J.] Emory Univ, Sch Med, Carlyle Fraser Heart Ctr, Div Cardiothorac Surg,Dept Surg, Atlanta, GA 30308 USA; [Crawford, Brian H.; Wagner, Mary B.] Childrens Healthcare Atlanta, Ctr Cardiovasc Biol, Atlanta, GA 30322 USA; [Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Iismaa, Siiri E.; Graham, Robert M.] Univ New S Wales, Kensington, NSW 2033, Australia	Emory University; Victor Chang Cardiac Research Institute; Emory University; Children's Healthcare of Atlanta (CHOA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of New South Wales Sydney	Graham, RM (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia.	b.graham@victorchang.edu.au; ahusai2@emory.edu	Lambert, Jonathan P/P-1766-2018; Iismaa, Siiri/C-9300-2013; Calvert, John W/F-4497-2014; Husain, Ahsan/J-6861-2012; Kesteven, Scott/I-8008-2015	Lambert, Jonathan P/0000-0001-7048-6841; Iismaa, Siiri/0000-0003-2409-7356; Calvert, John W/0000-0001-6858-6042; Husain, Ahsan/0000-0003-3426-3469; Lefer, David/0000-0003-2293-7278; Li, Ming/0000-0002-7699-4502	Division of Cardiology, Department of Medicine, Emory University; Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH [HL079040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079040, T32HL007745, P20HL113452, R01HL098481, R01HL088488] Funding Source: NIH RePORTER	Division of Cardiology, Department of Medicine, Emory University; Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Cardiology, Department of Medicine, Emory University; the Carlyle Fraser Heart Center, Emory University Hospital Midtown; NIH grants to A.H. (HL079040), J.W.C. (HL098481), M.B.W. (HL088488), and T.T. (T32HL007745); a John and Mary Brock Translational Research Fund grant (to A. H.); a Regenerative Engineering and Medicine (REM) center at Emory and Georgia Tech grant (to A.H. and N.N.); an Emory and Children's Center for Cardiovascular Biology pilot grant (to A. H., N.N., and M.B.W.); an American Heart Association Scientist Development grant (to N.N.); National Health and Medical Research Council of Australia grants (to R.M. G, S.E.I., and M.L.); a Heart Foundation of Australia grant (to R.M. G., M.L., and S.E.I.); an R.T. Hall Estate grant (to R.M.G., M.L., and S.E.I.); and an Australian Research Council Stem Cells Australia, Special Initiative in Stem Cell Science grant (to R.M.G.). We thank Michael P. Feneley for help with interpretation of the cardiac hemodynamic data, and Alexa Mattheyses at the Integrated Cellular Imaging Core, Emory University, for advice and training in 3D-SIM microscopy.	Bizzozero G, 1894, BMJ, Vi, P728; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chowdhury D, 2001, J THORAC CARDIOV SUR, V122, P1023, DOI 10.1067/mtc.2001.116192; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dai WD, 2011, CIRC-CARDIOVASC INTE, V4, P311, DOI 10.1161/CIRCINTERVENTIONS.111.964049; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; KRISS JP, 1962, CANCER RES, V22, P254; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; MIRSKY I, 1973, BIOPHYS J, V13, P1141, DOI 10.1016/S0006-3495(73)86051-5; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Pantos C, 2007, MOL CELL BIOCHEM, V297, P65, DOI 10.1007/s11010-006-9323-3; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Saiki Y, 1997, SURGERY, V122, P412, DOI 10.1016/S0039-6060(97)90034-9; Schiros CG, 2013, AM J CARDIOL, V111, P1067, DOI 10.1016/j.amjcard.2012.12.027; Sedmera D, 2003, J MOL CELL CARDIOL, V35, P301, DOI 10.1016/S0022-2828(03)00011-7; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097	36	184	190	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					795	807		10.1016/j.cell.2014.03.035	http://dx.doi.org/10.1016/j.cell.2014.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813607	Green Accepted, Bronze			2022-12-28	WOS:000335765500009
J	Baron, RJ; Johnson, D				Baron, Richard J.; Johnson, David			The American Board of Internal Medicine: Evolving Professional Self-regulation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIAN AUTONOMY; CERTIFICATION; MAINTENANCE		[Baron, Richard J.] Amer Board Internal Med, Philadelphia, PA 19106 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	American Board of Internal Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Baron, RJ (corresponding author), Amer Board Internal Med, 510 Walnut St, Philadelphia, PA 19106 USA.	rbaron@abim.org						[Anonymous], 2012, 2012 ABMS CERT STAT, P22; Drazen JM, 2010, NEW ENGL J MED, V362, P946, DOI 10.1056/NEJMe1000174; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P367, DOI 10.1001/jama.2012.19; Iglehart JK, 2012, NEW ENGL J MED, V367, P2543, DOI 10.1056/NEJMhpr1211043; Kempen PM, 2013, J COMMUNITY HOSP INT, V3, DOI 10.3402/jchimp.v3i1.20326; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; Lipner RS, 2013, J CONTIN EDUC HEALTH, V33, pS20, DOI 10.1002/chp.21203; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; Reinertsen JL, 2003, ANN INTERN MED, V138, P992, DOI 10.7326/0003-4819-138-12-200306170-00011	9	15	15	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					221	U95		10.7326/M13-2478	http://dx.doi.org/10.7326/M13-2478			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	24821363				2022-12-28	WOS:000340486000008
J	Miething, C; Scuoppo, C; Bosbach, B; Appelmann, I; Nakitandwe, J; Ma, J; Wu, G; Lintault, L; Auer, M; Premsrirut, PK; Teruya-Feldstein, J; Hicks, J; Benveniste, H; Speicher, MR; Downing, JR; Lowe, SW				Miething, Cornelius; Scuoppo, Claudio; Bosbach, Benedikt; Appelmann, Iris; Nakitandwe, Joy; Ma, Jing; Wu, Gang; Lintault, Laura; Auer, Martina; Premsrirut, Prem K.; Teruya-Feldstein, Julie; Hicks, James; Benveniste, Helene; Speicher, Michael R.; Downing, James R.; Lowe, Scott W.			PTEN action in leukaemia dictated by the tissue microenvironment	NATURE			English	Article							CCR9 CHEMOKINE RECEPTOR; CELL; GENE; THYMOCYTES; EXPRESSION; PI3K; SET; DIFFERENTIATION; ANTAGONIST; INHIBITORS	PTEN encodes a lipid phosphatase that is underexpressed in many cancers owing to deletions, mutations or gene silencing(1-3). PTEN dephosphorylates phosphatidylinositol (3,4,5)-triphosphate, thereby opposing the activity of class I phosphatidylinositol 3-kinases that mediate growth-and survival-factor signalling through phosphatidylinositol 3-kinase effectors such as AKT and mTOR(2). To determine whether continued PTEN inactivation is required to maintain malignancy, here we generate anRNA interference-based transgenic mouse model that allows tetracycline-dependent regulation of PTEN in a time-and tissue-specific manner. Postnatal Pten knockdown in the haematopoietic compartment produced highly disseminated T-cell acute lymphoblastic leukaemia. Notably, reactivation of PTEN mainly reduced T-cell leukaemia dissemination but had little effect on tumour load in haematopoietic organs. Leukaemia infiltration into the intestine was dependent on CCR9G-protein-coupled receptor signalling, which was amplified by PTEN loss. Our results suggest that in the absence of PTEN, G-protein-coupled receptors may have an unanticipated role in driving tumour growth and invasion in an unsupportive environment. They further reveal that the role of PTEN loss in tumour maintenance is not invariant and can be influenced by the tissue microenvironment, thereby producing a form of intratumoral heterogeneity that is independent of cancer genotype.	[Miething, Cornelius; Bosbach, Benedikt; Appelmann, Iris; Teruya-Feldstein, Julie; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Miething, Cornelius; Scuoppo, Claudio; Appelmann, Iris; Lintault, Laura; Premsrirut, Prem K.; Hicks, James; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Nakitandwe, Joy; Ma, Jing; Wu, Gang; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lintault, Laura; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA; [Auer, Martina; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Benveniste, Helene] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; St Jude Children's Research Hospital; Howard Hughes Medical Institute; Medical University of Graz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	lowes@mskcc.org	Miething, Cornelius/F-9498-2014; Speicher, Michael R/B-5362-2013; Wu, Gang/M-8012-2014; Downing, James R./N-8102-2018	Miething, Cornelius/0000-0003-4699-3805; Speicher, Michael R/0000-0003-0105-955X; Wu, Gang/0000-0002-1678-5864; 	DFG [Mi1210/1-1]; Deutsche Krebshilfe (DKH) [109902]; Angel Foundation; National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research; Don Monti Foundation; Geoffrey Beene Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA045508, U01CA105388, P01CA013106, P01CA087497, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016282] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (DKH)(Deutsche Krebshilfe); Angel Foundation; National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research; Don Monti Foundation; Geoffrey Beene Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Cappellani, D. Grace, J. Simon and M. Taylor for technical assistance, S.-Y. Kim for performing tetraploid embryo complementation, J. Cheng for RNA-seq analysis, M. Riggs for CGH array analysis, M. Lupu and C. Le for MRI imaging, V. Longo and P. Zanzonico for PET analysis, J. Pichardo for data management, L. Lopez and A. Giri for tissue microarray construction, M. Saborowski for help with IHC staining, A. Rosello-Diez and M. Asher for expertise in antibody staining characterization and C. Sherr for constructive comments and editorial advice. We thank J. Jaen, M. Penfold and M. Walters from ChemoCentryx for providing the CCR9 small molecule inhibitor. C. M. was supported by a fellowship from the DFG (Mi1210/1-1). I.A. received support by a fellowship from the Deutsche Krebshilfe (DKH no. 109902). C. S. was supported by the Angel Foundation with a Curt Engelhorn fellowship. This work was also supported by a program project grant from the National Cancer Institute, a Leukemia and Lymphoma Society Specialized Center of Research, and philanthropic funds from the Don Monti Foundation. S. W. L. is supported by the Geoffrey Beene Foundation and is an investigator at the Howard Hughes Medical Institute.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BERGER RL, 1994, J AM STAT ASSOC, V89, P1012, DOI 10.2307/2290928; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Campbell DJ, 2002, J CLIN INVEST, V110, P1079, DOI 10.1172/JCI200216946; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Eksteen B, 2010, IDRUGS, V13, P472; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kim WI, 2007, EXP HEMATOL, V35, P1231, DOI 10.1016/j.exphem.2007.04.012; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lakshmi B, 2006, P NATL ACAD SCI USA, V103, P11234, DOI 10.1073/pnas.0602984103; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stambolic V, 2000, CANCER RES, V60, P3605; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tubo NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050498; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	49	39	39	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					402	+		10.1038/nature13239	http://dx.doi.org/10.1038/nature13239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24805236	Green Accepted			2022-12-28	WOS:000337350200036
J	Larson, MH; Mooney, RA; Peters, JM; Windgassen, T; Nayak, D; Gross, CA; Block, SM; Greenleaf, WJ; Landick, R; Weissman, JS				Larson, Matthew H.; Mooney, Rachel A.; Peters, Jason M.; Windgassen, Tricia; Nayak, Dhananjaya; Gross, Carol A.; Block, Steven M.; Greenleaf, William J.; Landick, Robert; Weissman, Jonathan S.			A pause sequence enriched at translation start sites drives transcription dynamics in vivo	SCIENCE			English	Article							BACTERIAL RNA-POLYMERASE; STRUCTURAL BASIS; ELONGATION; MECHANISM; TERMINATION	Transcription by RNA polymerase (RNAP) is interrupted by pauses that play diverse regulatory roles. Although individual pauses have been studied in vitro, the determinants of pauses in vivo and their distribution throughout the bacterial genome remain unknown. Using nascent transcript sequencing, we identified a 16-nucleotide consensus pause sequence in Escherichia coli that accounts for known regulatory pause sites as well as similar to 20,000 new in vivo pause sites. In vitro single-molecule and ensemble analyses demonstrate that these pauses result from RNAP-nucleic acid interactions that inhibit next-nucleotide addition. The consensus sequence also leads to pausing by RNAPs from diverse lineages and is enriched at translation start sites in both E. coli and Bacillus subtilis. Our results thus reveal a conserved mechanism unifying known and newly identified pause events.	[Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Calif Inst Quantitat Biosci, Ctr RNA Syst Biol,Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Mooney, Rachel A.; Windgassen, Tricia; Nayak, Dhananjaya; Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Peters, Jason M.; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Block, Steven M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94025 USA; [Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA; [Greenleaf, William J.] Stanford Univ, Dept Genet, Stanford, CA 94025 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94025 USA.	wjg@stanford.edu; landick@biochem.wisc.edu; weissman@cmp.ucsf.edu	Nayak, Dhananjaya/B-2802-2015; Larson, Matthew/C-8289-2014	Nayak, Dhananjaya/0000-0003-0529-9411; Larson, Matthew/0000-0002-6778-2604; Weissman, Jonathan/0000-0003-2445-670X; Windgassen, Tricia/0000-0003-0165-7525	Center for RNA Systems Biology; Howard Hughes Medical Institute; Ruth L. Kirschstein National Research Service Award; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100611, P50GM102706, R01GM102790, R37GM057035, F32GM108222] Funding Source: NIH RePORTER	Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Brandman, V. Chu, D. Larson, G. Li, C. McLean, and E. Simmons for critical reading of the manuscript and J. Lund and E. Chow for assistance with sequencing. This research was supported by the Center for RNA Systems Biology (J.S.W.), the Howard Hughes Medical Institute (J.S.W.), a Ruth L. Kirschstein National Research Service Award (M.H.L., J.M.P.), and grants from the NIH to C. A. G., S. M. B., W. J. G., and R. L. All data are deposited in Gene Expression Omnibus (accession number GSE56720). Jonathan Weissman and Stirling Churchman have submitted a patent on the NET-seq technology.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Greenleaf WJ, 2006, SCIENCE, V313, P801, DOI 10.1126/science.1130105; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LANDICK R, 1987, P NATL ACAD SCI USA, V84, P1507, DOI 10.1073/pnas.84.6.1507; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Starmer J, 2006, PLOS COMPUT BIOL, V2, P454, DOI 10.1371/journal.pcbi.0020057; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020	19	193	193	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1042	1047		10.1126/science.1251871	http://dx.doi.org/10.1126/science.1251871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24789973	Green Accepted			2022-12-28	WOS:000336495800049
J	McEvoy, CT; Schilling, D; Clay, N; Jackson, K; Go, MD; Spitale, P; Bunten, C; Leiva, M; Gonzales, D; Hollister-Smith, J; Durand, M; Frei, B; Buist, AS; Peters, D; Morris, CD; Spindel, ER				McEvoy, Cindy T.; Schilling, Diane; Clay, Nakia; Jackson, Keith; Go, Mitzi D.; Spitale, Patricia; Bunten, Carol; Leiva, Maria; Gonzales, David; Hollister-Smith, Julie; Durand, Manuel; Frei, Balz; Buist, A. Sonia; Peters, Dawn; Morris, Cynthia D.; Spindel, Eliot R.			Vitamin C Supplementation for Pregnant Smoking Women and Pulmonary Function in Their Newborn Infants A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG-FUNCTION; PRENATAL NICOTINE; RESPIRATORY-FUNCTION; MATERNAL SMOKING; PRETERM INFANTS; AIRWAY FUNCTION; EXPOSURE; RISK; METAANALYSIS; ASSOCIATION	IMPORTANCE Maternal smoking during pregnancy adversely affects offspring lung development, with lifelong decreases in pulmonary function and increased asthma risk. In a primate model, vitamin C blocked some of the in-utero effects of nicotine on lung development and offspring pulmonary function. OBJECTIVE To determine if newborns of pregnant smokers randomized to receive daily vitamin C would have improved results of pulmonary function tests (PFTs) and decreased wheezing compared with those randomized to placebo. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind trial conducted in 3 sites in the Pacific Northwest between March 2007 and January 2011. One hundred fifty-nine newborns of randomized pregnant smokers (76 vitamin C treated and 83 placebo treated) and 76 newborns of pregnant nonsmokers were studied with newborn PFTs. Follow-up assessment including wheezing was assessed through age 1 year, and PFTs were performed at age 1 year. INTERVENTIONS Pregnant women were randomized to receive vitamin C (500 mg/d) (n = 89) or placebo (n = 90). MAIN OUTCOMES AND MEASURES The primary outcomewas measurement of newborn pulmonary function (ratio of the time to peak tidal expiratory flow to expiratory time [TPTEF: TE] and passive respiratory compliance per kilogram [Crs/kg]) within 72 hours of age. Secondary outcomes included incidence of wheezing through age 1 year and PFT results at age 1 year. A subgroup of pregnant smokers and nonsmokers had genotyping performed. RESULTS Newborns of women randomized to vitamin C (n = 76), compared with those randomized to placebo (n = 83), had improved pulmonary function as measured by TPTEF: TE (0.383 vs 0.345 [adjusted 95% CI for difference, 0.011-0.062]; P =.006) and Crs/kg (1.32 vs 1.20 mL/cm H2O/kg [95% CI, 0.02-0.20]; P =.01). Offspring of women randomized to vitamin C had significantly decreased wheezing through age 1 year (15/70 [21%] vs 31/77 [40%]; relative risk, 0.56 [95% CI, 0.33-0.95]; P =.03). There were no significant differences in the 1-year PFT results between the vitamin C and placebo groups. The effect of maternal smoking on newborn lung function was associated with maternal genotype for the a5 nicotinic receptor (rs16969968) (P <.001 for interaction). CONCLUSIONS AND RELEVANCE Supplemental vitamin C taken by pregnant smokers improved newborn PFT results and decreased wheezing through 1 year in the offspring. Vitamin C in pregnant smokers may be an inexpensive and simple approach to decrease the effects of smoking in pregnancy on newborn pulmonary function and respiratory morbidities.	[McEvoy, Cindy T.; Schilling, Diane; Clay, Nakia; Go, Mitzi D.; Gonzales, David; Buist, A. Sonia; Peters, Dawn; Morris, Cynthia D.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Jackson, Keith; Spitale, Patricia] PeaceHlth Southwest Med Ctr, Vancouver, WA USA; [Bunten, Carol] Vancouver Clin, Vancouver, WA USA; [Leiva, Maria] Providence Maternal Care Clin, Portland, OR USA; [Hollister-Smith, Julie; Spindel, Eliot R.] Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Durand, Manuel] Univ So Calif, Keck Sch Med, LAC USC Med Ctr, Los Angeles, CA 90033 USA; [Frei, Balz] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Los Angeles County+USC Medical Center; University of Southern California; Oregon State University	McEvoy, CT (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 707 SW Gaines St, Portland, OR 97239 USA.	mcevoyc@ohsu.edu		Gonzales, David/0000-0002-4323-198X; McEvoy, Cindy/0000-0001-8501-8813; Go, Mitzi Donabel Ang/0000-0001-7098-3223	National Heart, Lung, and Blood Institute (NHLBI) [K23 HL080231]; ODS; NHLBI [HL087710, HL105447, UL1 RR024140 01, P51 OD011092]; Medical Research Foundation of Oregon; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL080231, R01HL087710, R01HL105447] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ODS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Foundation of Oregon; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Heart, Lung, and Blood Institute (NHLBI) grant K23 HL080231 with co-funding from ODS; NHLBI grant HL087710; NHLBI grant HL105447; UL1 RR024140 01; P51 OD011092; Medical Research Foundation of Oregon.	American College of Obstetricians and Gynecologists, 2013, OBSTET GYNECOL, V116, P1241; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Filion KB, 2011, BJOG-INT J OBSTET GY, V118, P1422, DOI 10.1111/j.1471-0528.2011.03065.x; Frei B, 2004, J NUTR, V134, p3196S, DOI 10.1093/jn/134.11.3196S; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hayatbakhsh MR, 2009, THORAX, V64, P810, DOI 10.1136/thx.2009.116301; Hoo AF, 1998, AM J RESP CRIT CARE, V158, P700, DOI 10.1164/ajrccm.158.3.9711057; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Leermakers ETM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034584; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; MARTINEZ FD, 1991, AM REV RESPIR DIS, V143, P312, DOI 10.1164/ajrccm/143.2.312; McEvoy C, 2008, PEDIATRICS, V121, pE1032, DOI 10.1542/peds.2007-2608; McEvoy C, 2013, J PEDIATR-US, V162, P464, DOI 10.1016/j.jpeds.2012.09.042; McEvoy C, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.038; Omenaas E, 2003, RESP MED, V97, P134, DOI 10.1053/rmed.2003.1439; Proskocil BJ, 2005, AM J RESP CRIT CARE, V171, P1032, DOI 10.1164/rccm.200408-1029OC; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Romieu I, 2002, AM J RESP CRIT CARE, V166, P703, DOI 10.1164/rccm.2112074; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Sarginson JE, 2011, AM J MED GENET B, V156B, P275, DOI 10.1002/ajmg.b.31155; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Sekhon HS, 2002, AM J RESP CELL MOL, V26, P31, DOI 10.1165/ajrcmb.26.1.4170; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stoddard J, 1997, AM J PUBLIC HEALTH, V87, P205, DOI 10.2105/AJPH.87.2.205; TAGER IB, 1995, AM J RESP CRIT CARE, V152, P977, DOI 10.1164/ajrccm.152.3.7663813; Nguyen TTD, 2013, PEDIATR PULM, V48, P370, DOI 10.1002/ppul.22656; Tong Van T., 2009, Morbidity and Mortality Weekly Report, V58, P1; Tyrrell J, 2012, HUM MOL GENET, V21, P5344, DOI 10.1093/hmg/dds372; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Weiss ST, 1996, AM J RESP CRIT CARE, V154, pS208, DOI 10.1164/ajrccm/154.6_Pt_2.S208; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC	43	128	134	2	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2074	2082		10.1001/jama.2014.5217	http://dx.doi.org/10.1001/jama.2014.5217			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24838476	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000336392400023
J	Allen, PJ; Gonen, M; Brennan, MF; Bucknor, AA; Robinson, LM; Pappas, MM; Carlucci, KE; D'Angelica, MI; DeMatteo, RP; Kingham, TP; Fong, Y; Jarnagin, WR				Allen, Peter J.; Goenen, Mithat; Brennan, Murray F.; Bucknor, Adjoa A.; Robinson, Lindsay M.; Pappas, Marisa M.; Carlucci, Kate E.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Fong, Yuman; Jarnagin, William R.			Pasireotide for Postoperative Pancreatic Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PLACEBO-CONTROLLED TRIAL; SINGLE-INSTITUTION; PANCREATICODUODENECTOMY; SOMATOSTATIN; COMPLICATIONS; OCTREOTIDE; SOM230; PANCREATICOJEJUNOSTOMY; METAANALYSIS	BACKGROUND Postoperative pancreatic fistula is a major contributor to complications and death associated with pancreatic resection. Pasireotide, a somatostatin analogue that has a longer half-life than octreotide and a broader binding profile, decreases pancreatic exocrine secretions and may prevent postoperative pancreatic fistula. METHODS We conducted a single-center, randomized, double-blind trial of perioperative subcutaneous pasireotide in patients undergoing either pancreaticoduodenectomy or distal pancreatectomy. We randomly assigned 300 patients to receive 900 mu g of subcutaneous pasireotide (152 patients) or placebo (148 patients) twice daily beginning preoperatively on the morning of the operation and continuing for 7 days (14 doses). Randomization was stratified according to the type of resection and whether the pancreatic duct was dilated at the site of transection. The primary end point was the development of pancreatic fistula, leak, or abscess of grade 3 or higher (i.e., requiring drainage). RESULTS The primary end point occurred in 45 of the 300 patients (15%). The rate of grade 3 or higher postoperative pancreatic fistula, leak, or abscess was significantly lower among patients who received pasireotide than among patients who received placebo (9% vs. 21%; relative risk, 0.44; 95% confidence interval [CI], 0.24 to 0.78; P = 0.006). This finding was consistent among 220 patients who underwent pancreaticoduodenectomy (10% vs. 21%; relative risk, 0.49; 95% CI, 0.25 to 0.95) and 80 patients who underwent distal pancreatectomy (7% vs. 23%; relative risk, 0.32; 95% CI, 0.10 to 0.99), as well as among 136 patients with a dilated pancreatic duct (2% vs. 15%; relative risk, 0.11; 95% CI, 0.02 to 0.60) and 164 patients with a nondilated pancreatic duct (15% vs. 27%; relative risk, 0.55; 95% CI, 0.29 to 1.01). CONCLUSIONS Perioperative treatment with pasireotide decreased the rate of clinically significant postoperative pancreatic fistula, leak, or abscess.	[Allen, Peter J.; Brennan, Murray F.; Bucknor, Adjoa A.; Robinson, Lindsay M.; Pappas, Marisa M.; Carlucci, Kate E.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Fong, Yuman; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Div Hepatopancreatobiliary Surg, New York, NY 10065 USA; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Allen, PJ (corresponding author), Mem Sloan Kettering Canc Ctr, HPB Serv, C896,1275 York Ave, New York, NY 10065 USA.	allenp@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Kingham, T Peter/0000-0002-3359-3186; Brennan, Murray/0000-0003-2358-4371	Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Novartis Pharmaceuticals.	Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211; Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Butturini G, 2008, J HEPATO-BILIARY-PAN, V15, P247, DOI 10.1007/s00534-007-1301-y; Chou FF, 1996, EUR J SURG, V162, P477; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu Q, 2011, RADIAT RES, V175, P728, DOI 10.1667/RR2507.1; Fu Q, 2009, RADIAT RES, V171, P698, DOI 10.1667/RR1685.1; Grobmyer SR, 2007, J AM COLL SURGEONS, V204, P356, DOI 10.1016/j.jamcollsurg.2006.11.017; Knaebel HP, 2005, BRIT J SURG, V92, P539, DOI 10.1002/bjs.5000; Koti RS, 2010, HPB, V12, P155, DOI 10.1111/j.1477-2574.2010.00157.x; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Li-Ling J, 2001, BRIT J SURG, V88, P190, DOI 10.1046/j.1365-2168.2001.01659.x; Lowy AM, 1997, ANN SURG, V226, P632, DOI 10.1097/00000658-199711000-00008; Sarr MG, 2003, J AM COLL SURGEONS, V196, P556, DOI 10.1016/S1072-7515(03)00104-2; Stojadinovic A, 2003, J AM COLL SURGEONS, V196, P954, DOI 10.1016/S1072-7515(03)00010-3; Tran K, 2002, ANN SURG, V236, P422, DOI 10.1097/00000658-200210000-00004; Vin Y, 2008, J AM COLL SURGEONS, V207, P490, DOI 10.1016/j.jamcollsurg.2008.05.003; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; YEO CJ, 1995, ANN SURG, V222, P580; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014	21	245	255	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					2014	2022		10.1056/NEJMoa1313688	http://dx.doi.org/10.1056/NEJMoa1313688			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24849084	Bronze			2022-12-28	WOS:000336125500009
J	Rutter, PD; Donaldson, LJ				Rutter, Paul D.; Donaldson, Liam J.			Mandatory polio vaccination for travellers: protecting global public health	LANCET			English	Editorial Material									[Rutter, Paul D.; Donaldson, Liam J.] St Marys Hosp, Independent Monitoring Board, Global Polio Eradicat Initiat, London W2 1NY, England	Imperial College London	Rutter, PD (corresponding author), St Marys Hosp, Independent Monitoring Board, Global Polio Eradicat Initiat, QEQM Bldg, London W2 1NY, England.	imb-prutter@polioeradication.org						[Anonymous], 2013, Wkly Epidemiol Rec, V88, P153; Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P366; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P253; Global Polio Eradication Initiative, 2013, STAT REP SEPT 2013; Global Polio Eradication Initiative, 2014, DAT MON POL CAS COUN; Independent Monitoring Board of the Global Polio Eradication Initiative, 2012, 6 IND MON BOARD GLOB; Independent Monitoring Board of the Global Polio Eradication Initiative, 2011, 1 IND MON BOARD GLOB; Independent Monitoring Board of the Global Polio Eradication Initiative, 2013, 8 IND MON BOARD GLOB; WHO, 2013, IHR EM COMM MIDDL E; *WHO, 1988, WHA4128 WHO; WHO, 2014, INT TRAV HLTH POL; World Health Organization, 2014, WHO STAT M INT HLTH; World Health Organization (WHO), 2011, STAND TERM PAND A H1; World Health Orhanisation, 2009, IHR EM COMM INFL PAN	15	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1695	1697		10.1016/S0140-6736(14)60756-X	http://dx.doi.org/10.1016/S0140-6736(14)60756-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6UO	24814089	Green Published, Bronze			2022-12-28	WOS:000336267300004
J	Kim, JS; Greene, MJ; Zlateski, A; Lee, K; Richardson, M; Turaga, SC; Purcaro, M; Balkam, M; Robinson, A; Behabadi, BF; Campos, M; Denk, W; Seung, HS				Kim, Jinseop S.; Greene, Matthew J.; Zlateski, Aleksandar; Lee, Kisuk; Richardson, Mark; Turaga, Srinivas C.; Purcaro, Michael; Balkam, Matthew; Robinson, Amy; Behabadi, Bardia F.; Campos, Michael; Denk, Winfried; Seung, H. Sebastian		EyeWirers	Space-time wiring specificity supports direction selectivity in the retina	NATURE			English	Article							BIPOLAR CELLS; DENDRITES; MECHANISM; CIRCUIT; MODELS; MAP	How does the mammalian retina detect motion? This classic problem in visual neuroscience has remained unsolved for 50 years. In search of clues, here we reconstruct Off-type starburst amacrine cells (SACs) and bipolar cells (BCs) in serial electron microscopic images with help from EyeWire, an online community of 'citizen neuroscientists'. On the basis of quantitative analyses of contact area and branch depth in the retina, we find evidence that one BC type prefers to wire with a SAC dendrite near the SAC soma, whereas another BC type prefers to wire far from the soma. The near type is known to lag the far type in time of visual response. A mathematical model shows how such 'space-time wiring specificity' could endow SAC dendrites with receptive fields that are oriented in space-time and therefore respond selectively to stimuli that move in the outward direction from the soma.	[Kim, Jinseop S.; Greene, Matthew J.; Lee, Kisuk; Richardson, Mark; Turaga, Srinivas C.; Purcaro, Michael; Balkam, Matthew; Robinson, Amy; Seung, H. Sebastian] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zlateski, Aleksandar] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Behabadi, Bardia F.; Campos, Michael] Qualcomm Res, San Diego, CA 92121 USA; [Denk, Winfried] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Qualcomm; Max Planck Society	Seung, HS (corresponding author), Princeton Neurosci Inst, Princeton, NJ 08544 USA.	sseung@princeton.edu		Kim, Jinseop/0000-0001-7045-6140; Purcaro, Michael/0000-0002-4735-4215	Gatsby Charitable Foundation; Howard Hughes Medical Institute; Human Frontier Science Program; National Institutes of Health; Samsung Scholarship; AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholarship(Samsung); AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was made possible by funding from the Gatsby Charitable Foundation, the Howard Hughes Medical Institute, the Human Frontier Science Program, an anonymous donor, and the National Institutes of Health. K. L. was supported by a Samsung Scholarship. Support from the AWS Research Grants Program gave EyeWire global reach through Amazon Cloudfront. We thank K. Briggman for providing the e2198 data set. J. Mutch created the CNS framework on which CNPKG is based. D. Jia, R. Shearer, and B. Warne assisted in early stages of software development, and W. Silversmith with recent modifications. R. Prentki, L. Trawinski, M. Sorek, A. Ostojic, C. David, R. Avery, S. Temple, A. Bost, M. Greenstein and M. Evans worked in the laboratory to reconstruct neurons, and the first six also served as GrimReaper and hosted EyeWire competitions. Additional reconstructions were provided by R. Han, M. Gavrin, G. Lu, A. Ortiz and D. Udvary. All were trained by R. Prentki, who also created training videos for EyeWirers. We are grateful to A. Norton for 3D renderings, and to E. Almeida for EyeWire graphics. We acknowledge discussions with T. Baden, M. Berry, B. Borghuis, A. Borst, E. J. Chichilnisky, D. Chklovskii, D. Clark, J. Demb, T. Euler, M. Helmstaedter, A. Huberman, S. Lee, R. Masland, J. Sanes and Z. Zhou.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berry MJ, 1998, J NEUROSCI, V18, P2200; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Ciresan DC., 2012, P 25 INT C NEURAL IN, P2843; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Mutch J, 2010, MITCSAILTR2010013CBC; Park SJH, 2014, J NEUROSCI, V34, P3976, DOI 10.1523/JNEUROSCI.5017-13.2014; Reichardt W, 1961, SENS COMMUN, P303; Snyder J.P, 1987, MAP PROJECTIONS WORK, V1395; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Surowiecki J., 2005, WISDOM CROWDS; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; Turaga S., 2009, ADV NEURAL INFORM PR, P1865; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711	46	267	271	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					331	+		10.1038/nature13240	http://dx.doi.org/10.1038/nature13240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805243	Green Accepted			2022-12-28	WOS:000336121200032
J	Minteer, B				Minteer, Ben			Is it right to reverse extinction?	NATURE			English	Editorial Material									Arizona State Univ, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Minteer, B (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	ben.minteer@asu.edu							0	15	16	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					261	261		10.1038/509261a	http://dx.doi.org/10.1038/509261a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH4TM	24828156	Bronze			2022-12-28	WOS:000336121200004
J	Berger, D				Berger, David			PERSONAL VIEW Corruption ruins the doctor-patient relationship in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Broome Hosp, Broome, WA 6725, Australia		Berger, D (corresponding author), Broome Hosp, Robinson Rd, Broome, WA 6725, Australia.	daveberger@gmail.com						[Anonymous], 2010, HINDU; [Anonymous], 2013, IBN LIVE        0404; [Anonymous], 2012, TIMES INDIA; Centre to ask MCI to speed up medical college inspection, 2012, DECCAN HERALD   1102; Congress BJP, 2014, EC TIMES        0301; Dutta N, 2012, HEALTHSITE      0818; Dutta N, 2014, HEALTHSITE      0304; Jilani A. Z., 2009, INTERNET J 3 WORLD M, V8	8	44	44	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g3169	10.1136/bmj.g3169	http://dx.doi.org/10.1136/bmj.g3169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812115	Green Published, Bronze			2022-12-28	WOS:000335819700019
J	Giorgetti, L; Galupa, R; Nora, EP; Piolot, T; Lam, F; Dekker, J; Tiana, G; Heard, E				Giorgetti, Luca; Galupa, Rafael; Nora, Elphege P.; Piolot, Tristan; Lam, France; Dekker, Job; Tiana, Guido; Heard, Edith			Predictive Polymer Modeling Reveals Coupled Fluctuations in Chromosome Conformation and Transcription	CELL			English	Article							GENE-EXPRESSION; CHROMATIN INTERACTIONS; NUCLEAR-ORGANIZATION; DROSOPHILA GENOME; INACTIVATION; ARCHITECTURE; DOMAINS; LOCUS; ACTIVATOR; PROTEIN	A new level of chromosome organization, topologically associating domains (TADs), was recently uncovered by chromosome conformation capture (3C) techniques. To explore TAD structure and function, we developed a polymer model that can extract the full repertoire of chromatin conformations within TADs from population-based 3C data. This model predicts actual physical distances and to what extent chromosomal contacts vary between cells. It also identifies interactions within single TADs that stabilize boundaries between TADs and allows us to identify and genetically validate key structural elements within TADs. Combining the model's predictions with high-resolution DNA FISH and quantitative RNA FISH for TADs within the X-inactivation center (Xic), we dissect the relationship between transcription and spatial proximity to cis-regulatory elements. We demonstrate that contacts between potential regulatory elements occur in the context of fluctuating structures rather than stable loops and propose that such fluctuations may contribute to asymmetric expression in the Xic during X inactivation.	[Giorgetti, Luca; Galupa, Rafael; Nora, Elphege P.; Piolot, Tristan; Lam, France; Heard, Edith] Inst Curie, F-75248 Paris 05, France; [Giorgetti, Luca; Galupa, Rafael; Piolot, Tristan; Lam, France; Heard, Edith] CNRS, UMR3215, F-75248 Paris 05, France; [Giorgetti, Luca; Galupa, Rafael; Piolot, Tristan; Lam, France; Heard, Edith] INSERM, U934, F-75248 Paris 05, France; [Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Tiana, Guido] Univ Milan, Dipartimento Fis, I-20133 Milan, Italy; [Tiana, Guido] Ist Nazl Fis Nucl, I-20133 Milan, Italy; [Heard, Edith] Coll France, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Massachusetts System; University of Massachusetts Worcester; University of Milan; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; PSL Research University Paris; College de France	Tiana, G (corresponding author), Univ Milan, Dipartimento Fis, Via Celoria 16, I-20133 Milan, Italy.	guido.tiana@unimi.it; edith.heard@curie.fr	Heard, Edith/D-7197-2017; Nora, Elphège/AAW-9646-2021; Tiana, Guido/E-2123-2015	Heard, Edith/0000-0001-8052-7117; Nora, Elphège/0000-0002-8347-4396; Tiana, Guido/0000-0001-9868-1809; Galupa, Rafael/0000-0001-7319-043X	EMBO Fellowship [ALTF 1559-2011]; Ligue Nationale contre le cancer; Fondation pour la Recherche Medical, Labex DEEP [ANR-11-LBX-0044]; EpiGeneSys FP7 257082 Network of Excellence; ERC Advanced Investigator award [250367]; EU [259743]; National Human Genome Research Institute [R01HG003143]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	EMBO Fellowship(European Molecular Biology Organization (EMBO)); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medical, Labex DEEP; EpiGeneSys FP7 257082 Network of Excellence; ERC Advanced Investigator award; EU(European Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all members of the Heard team for helpful discussions and Edda Schulz and John Sedat for critical reading of the manuscript. L.G. was supported by an EMBO Fellowship (ALTF 1559-2011); work in the lab of E.H. is supported by the ''Ligue Nationale contre le cancer,'' the Fondation pour la Recherche Medical, Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-0001-02 PSL), the EpiGeneSys FP7 257082 Network of Excellence, ERC Advanced Investigator award 250367, and EU FP7 MODHEP EU grant 259743 (EH). Work in the lab of J.D. is supported by National Human Genome Research Institute (R01HG003143). Cell sorting was performed by S. Grondin in the flow cytometry platform of the Institut Curie.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Bau D, 2011, CHROMOSOME RES, V19, P25, DOI 10.1007/s10577-010-9167-2; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hu Ming, 2013, Quant Biol, V1, P156; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Krijger PHL, 2013, CURR OPIN GENET DEV, V23, P191, DOI 10.1016/j.gde.2012.12.010; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Norgaard AB, 2008, BIOPHYS J, V94, P182, DOI 10.1529/biophysj.107.108241; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	35	291	294	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					950	963		10.1016/j.cell.2014.03.025	http://dx.doi.org/10.1016/j.cell.2014.03.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813616	Green Accepted, Bronze			2022-12-28	WOS:000335765500021
J	Vogelsberger, M; Genel, S; Springel, V; Torrey, P; Sijacki, D; Xu, D; Snyder, G; Bird, S; Nelson, D; Hernquist, L				Vogelsberger, M.; Genel, S.; Springel, V.; Torrey, P.; Sijacki, D.; Xu, D.; Snyder, G.; Bird, S.; Nelson, D.; Hernquist, L.			Properties of galaxies reproduced by a hydrodynamic simulation	NATURE			English	Article							MOVING-MESH COSMOLOGY; COLD DARK-MATTER; LY-ALPHA SYSTEMS; STAR-FORMATION; POWER SPECTRUM; RADIAL-DISTRIBUTION; SCALING RELATIONS; MASSIVE GALAXIES; DWARF GALAXIES; LOCAL UNIVERSE	Previous simulations of the growth of cosmic structures have broadly reproduced the 'cosmic web' of galaxies that we see in the Universe, but failed to create a mixed population of elliptical and spiral galaxies, because of numerical inaccuracies and incomplete physical models. Moreover, they were unable to track the small-scale evolution of gas and stars to the present epoch within a representative portion of the Universe. Here we report a simulation that starts 12 million years after the Big Bang, and traces 13 billion years of cosmic evolution with 12 billion resolution elements in a cube of 106.5 megaparsecs a side. It yields a reasonable population of ellipticals and spirals, reproduces the observed distribution of galaxies in clusters and characteristics of hydrogen on large scales, and at the same time matches the 'metal' and hydrogen content of galaxies on small scales.	[Vogelsberger, M.] MIT, Dept Phys, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Genel, S.; Torrey, P.; Nelson, D.; Hernquist, L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Springel, V.; Xu, D.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Springel, V.] Heidelberg Univ, Zentrum Astron, ARI, D-69120 Heidelberg, Germany; [Sijacki, D.] Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Sijacki, D.] Inst Astron, Cambridge CB3 0HA, England; [Snyder, G.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Bird, S.] Inst Adv Study, Princeton, NJ 08540 USA	Massachusetts Institute of Technology (MIT); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; University of Cambridge; University of Cambridge; Space Telescope Science Institute; Institute for Advanced Study - USA	Vogelsberger, M (corresponding author), MIT, Dept Phys, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA.	mvogelsb@mit.edu	Nelson, Dylan/ABD-5217-2021; Bird, Simeon/ABH-5012-2020	Nelson, Dylan/0000-0001-8421-5890; Bird, Simeon/0000-0001-5803-5490; Springel, Volker/0000-0001-5976-4599; Torrey, Paul/0000-0002-5653-0786; Genel, Shy/0000-0002-3185-1540	DFG Research Centre SFB-881; European Research Council [ERC-StG EXAGAL-308037]; HST [HST-AR-12856.01-A]; NASA from the Space Telescope Science Institute [12856, NAS 5-26555]; NASA [NNX12AC67G]; NSF [AST-1312095, AST-0907969]; Alexander von Humboldt Foundation; GCS [pr85je]; NASA Office of Space Science [NNX13AC07G];  [9,352];  [9,425];  [9,488];  [9,575];  [9,793];  [9,978];  [10,086];  [10,189];  [10,258];  [10,340];  [10,530];  [11,359];  [11,563];  [12,060];  [12,061];  [12,062];  [12,099];  [12,177]; STFC [ST/L000725/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [0907969] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/L000725/1] Funding Source: researchfish	DFG Research Centre SFB-881(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); HST; NASA from the Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); GCS; NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	V. S. acknowledges support from the DFG Research Centre SFB-881 'The Milky Way System' through project A1, and from the European Research Council under ERC-StG EXAGAL-308037. G. S. acknowledges support from the HST grants programme, no. HST-AR-12856.01-A. Support for program no. 12856 was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. L. H. acknowledges support from NASA grant NNX12AC67G and NSF grant AST-1312095. D. X. acknowledges support from the Alexander von Humboldt Foundation. S. B. was supported by NSF grant AST-0907969. The Illustris simulation was run on the CURIE supercomputer at CEA/France as part of PRACE project RA0844, and the SuperMUC computer at the Leibniz Computing Centre, Germany, as part of GCS-project pr85je. Further simulations were run on the Harvard Odyssey and CfA/ITC clusters, the Ranger and Stampede supercomputers at the Texas Advanced Computing Center through XSEDE, and the Kraken supercomputer at Oak Rridge National Laboratory through XSEDE. Figure 1b is based on observations made with the NASA/ESA Hubble Space Telescope. These data were obtained from the Mikulski Archive for Space Telescopes (MAST) at the Space Telescope Science Institute (STScI). These observations were associated with programs 9,352, 9,425, 9,488, 9,575, 9,793, 9,978, 10,086, 10,189, 10,258, 10,340, 10,530, 11,359, 11,563, 12,060, 12,061, 12,062, 12,099 and 12,177, and compiled for the Hubble eXtreme Deep Field data release version 1.0 (http://archive.stsci.edu/prepds/xdf/). Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321529; Altay G, 2013, MON NOT R ASTRON SOC, V436, P2689, DOI 10.1093/mnras/stt1765; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Boylan-Kolchin M, 2011, MON NOT R ASTRON SOC, V415, pL40, DOI 10.1111/j.1745-3933.2011.01074.x; Bregman JN, 2007, ANNU REV ASTRON ASTR, V45, P221, DOI 10.1146/annurev.astro.45.051806.110619; Brook CB, 2012, MON NOT R ASTRON SOC, V424, P1275, DOI 10.1111/j.1365-2966.2012.21306.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Budzynski JM, 2012, MON NOT R ASTRON SOC, V423, P104, DOI 10.1111/j.1365-2966.2012.20663.x; Cen RY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/121; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cortese L, 2011, MON NOT R ASTRON SOC, V415, P1797, DOI 10.1111/j.1365-2966.2011.18822.x; Dave R, 2007, MON NOT R ASTRON SOC, V374, P427, DOI 10.1111/j.1365-2966.2006.11177.x; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Dolag K, 2009, MON NOT R ASTRON SOC, V399, P497, DOI 10.1111/j.1365-2966.2009.15034.x; Ferland GJ, 1998, PUBL ASTRON SOC PAC, V110, P761, DOI 10.1086/316190; Fumagalli M, 2011, MON NOT R ASTRON SOC, V418, P1796, DOI 10.1111/j.1365-2966.2011.19599.x; Gallazzi A, 2005, MON NOT R ASTRON SOC, V362, P41, DOI 10.1111/j.1365-2966.2005.09321.x; Gallazzi A, 2008, MON NOT R ASTRON SOC, V383, P1439, DOI 10.1111/j.1365-2966.2007.12632.x; Genel S, 2013, MON NOT R ASTRON SOC, V435, P1426, DOI 10.1093/mnras/stt1383; Giguere CAF, 2009, ASTROPHYS J, V703, P1416, DOI 10.1088/0004-637X/703/2/1416; Hansen SM, 2009, ASTROPHYS J, V699, P1333, DOI 10.1088/0004-637X/699/2/1333; Hansen SM, 2005, ASTROPHYS J, V633, P122, DOI 10.1086/444554; Hernquist L, 1996, ASTROPHYS J, V457, pL51, DOI 10.1086/309899; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Hopkins P. F., 2013, PREPRINT; Huang S, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/113; Huterer D, 2005, ASTROPART PHYS, V23, P369, DOI 10.1016/j.astropartphys.2005.02.006; Illingworth GD, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/6; KATZ N, 1992, ASTROPHYS J, V391, P502, DOI 10.1086/171366; KENNICUTT RC, 1989, ASTROPHYS J, V344, P685, DOI 10.1086/167834; Keres D, 2012, MON NOT R ASTRON SOC, V425, P2027, DOI 10.1111/j.1365-2966.2012.21548.x; Laureijs R., 2009, PREPRINT; Lewis A, 2011, ASTROPHYSICS SOURCE; Libeskind NI, 2007, MON NOT R ASTRON SOC, V374, P16, DOI 10.1111/j.1365-2966.2006.11205.x; Lupton R, 2004, PUBL ASTRON SOC PAC, V116, P133, DOI 10.1086/382245; Marinacci F, 2014, MON NOT R ASTRON SOC, V437, P1750, DOI 10.1093/mnras/stt2003; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Moustakas J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/50; Nagai D, 2005, ASTROPHYS J, V618, P557, DOI 10.1086/426016; Navarro JF, 2000, ASTROPHYS J, V538, P477, DOI 10.1086/309175; Noterdaeme P, 2009, ASTRON ASTROPHYS, V505, P1087, DOI 10.1051/0004-6361/200912768; Pontzen A, 2008, MON NOT R ASTRON SOC, V390, P1349, DOI 10.1111/j.1365-2966.2008.13782.x; Prochaska JX, 2010, ASTROPHYS J, V718, P392, DOI 10.1088/0004-637X/718/1/392; Quilis V, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/2/L19; Rafelski M, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/89; Saro A, 2006, MON NOT R ASTRON SOC, V373, P397, DOI 10.1111/j.1365-2966.2006.11046.x; Scannapieco C, 2012, MON NOT R ASTRON SOC, V423, P1726, DOI 10.1111/j.1365-2966.2012.20993.x; Schaye J, 2010, MON NOT R ASTRON SOC, V402, P1536, DOI 10.1111/j.1365-2966.2009.16029.x; Seager S, 1999, ASTROPHYS J, V523, pL1, DOI 10.1086/312250; Seager S., 2011, ASTROPHYSICS SOURCE; Seljak U, 1996, ASTROPHYS J, V469, P437, DOI 10.1086/177793; Sijacki D, 2007, MON NOT R ASTRON SOC, V380, P877, DOI 10.1111/j.1365-2966.2007.12153.x; Sijacki D, 2012, MON NOT R ASTRON SOC, V424, P2999, DOI 10.1111/j.1365-2966.2012.21466.x; Spergel D., 2013, PREPRINT; Springel V, 2003, MON NOT R ASTRON SOC, V339, P289, DOI 10.1046/j.1365-8711.2003.06206.x; Springel V, 2001, MON NOT R ASTRON SOC, V328, P726, DOI 10.1046/j.1365-8711.2001.04912.x; Springel V, 2010, MON NOT R ASTRON SOC, V401, P791, DOI 10.1111/j.1365-2966.2009.15715.x; Tal T, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/31; Torrey P, 2012, MON NOT R ASTRON SOC, V427, P2224, DOI 10.1111/j.1365-2966.2012.22082.x; van Daalen MP, 2011, MON NOT R ASTRON SOC, V415, P3649, DOI 10.1111/j.1365-2966.2011.18981.x; Vogelsberger M, 2013, MON NOT R ASTRON SOC, V436, P3031, DOI 10.1093/mnras/stt1789; Vogelsberger M, 2012, MON NOT R ASTRON SOC, V425, P3024, DOI 10.1111/j.1365-2966.2012.21590.x; Weinmann SM, 2012, MON NOT R ASTRON SOC, V426, P2797, DOI 10.1111/j.1365-2966.2012.21931.x; White SDM, 1996, LES HOUCH S, V60, P349; Wiersma RPC, 2011, MON NOT R ASTRON SOC, V415, P353, DOI 10.1111/j.1365-2966.2011.18709.x; Woo J, 2008, MON NOT R ASTRON SOC, V390, P1453, DOI 10.1111/j.1365-2966.2008.13770.x; XU GH, 1995, ASTROPHYS J SUPPL S, V98, P355, DOI 10.1086/192166; Zafar T, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321154; Zahid HJ, 2014, ASTROPHYS SPACE SCI, V349, P873, DOI 10.1007/s10509-013-1666-0; ZELDOVICH YB, 1970, ASTRON ASTROPHYS, V5, P84	75	810	812	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					177	+		10.1038/nature13316	http://dx.doi.org/10.1038/nature13316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805343	Green Submitted			2022-12-28	WOS:000335454300029
J	Lahrouchi, N; Bosscha, MI; Moll, AC				Lahrouchi, Najim; Bosscha, Machteld I.; Moll, Annette C.			A Child With a White Pupil	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RETINOBLASTOMA; SURVIVAL; RISK; CHEMOTHERAPY		[Lahrouchi, Najim; Bosscha, Machteld I.; Moll, Annette C.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Lahrouchi, N (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	najim_lahrouchi@hotmail.com	Bosscha, Machteld/T-2808-2019	Lahrouchi, Najim/0000-0003-1753-452X				Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Canturk S, 2010, BRIT J OPHTHALMOL, V94, P1432, DOI 10.1136/bjo.2009.168062; HOWARD GM, 1965, AM J OPHTHALMOL, V60, P618, DOI 10.1016/0002-9394(65)92249-X; Kaliki S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1422, DOI 10.1001/archophthalmol.2011.289; Leiderman Yannek I, 2007, Semin Ophthalmol, V22, P247, DOI 10.1080/08820530701745165; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; Moll AC, 1997, BRIT J OPHTHALMOL, V81, P559, DOI 10.1136/bjo.81.7.559; Shields CL, 2013, OPHTHALMOLOGY, V120, P311, DOI 10.1016/j.ophtha.2012.07.067; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; SHIELDS CL, 1993, BRIT J OPHTHALMOL, V77, P544, DOI 10.1136/bjo.77.9.544	10	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1799	1800		10.1001/jama.2013.286248	http://dx.doi.org/10.1001/jama.2013.286248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794374				2022-12-28	WOS:000335382300026
J	Pollock, AM; Roderick, P				Pollock, Allyson M.; Roderick, Peter			Trust in the time of markets: protecting patient information	LANCET			English	Editorial Material									[Pollock, Allyson M.; Roderick, Peter] Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England	University of London	Pollock, AM (corresponding author), Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				[Anonymous], 2014, MEM UND US DEP HLTH; Department of Health, 2013, INFORMATION TO SHARE; Donnelly L., 2014, DAILY TELEGRAPH; European Commission, 2014, PROGRESS ON EU DATA; Health and Social Care Information Centre, 2014, REGISTER OF STAGE ON; Health and Social Care Information Centre, 2014, HSCIC AGREES IMPROVE; National Health Service England, 2005, THE HEALTH AND SOCIA; National Health Service England and Wales, 2002, THE HEALTH SERVICE C; NHS England, 2013, THE HEALTH AND SOCIA; NHS England, 2014, NHS ENGLAND ACTS IN; NHS Health Research Authority, 2013, APPLICATION NO 0003; Pollock A, 2012, LANCET, V379, P999, DOI 10.1016/S0140-6736(12)60246-3; Pollock AM, 2014, PROTECTING CONFI DEN; UK Parliament, BILL DOCUMENTS CARE	14	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1523	1524		10.1016/S0140-6736(14)60727-3	http://dx.doi.org/10.1016/S0140-6736(14)60727-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG5YO	24792842				2022-12-28	WOS:000335495400004
J	Garcia, RA; Cabeza, M; Rahbek, C; Araujo, MB				Garcia, Raquel A.; Cabeza, Mar; Rahbek, Carsten; Araujo, Miguel B.			Multiple Dimensions of Climate Change and Their Implications for Biodiversity	SCIENCE			English	Review							LATE-QUATERNARY VEGETATION; RANGE SHIFTS; CHANGE IMPACTS; RESPONSES; CONSERVATION; DYNAMICS; EVENTS; POPULATION; DIVERSITY; NICHE	The 21st century is projected to witness unprecedented climatic changes, with greater warming often reported for high latitudes. Yet, climate change can be measured in a variety of ways, reflecting distinct dimensions of change with unequal spatial patterns across the world. Polar climates are projected to not only warm, but also to shrink in area. By contrast, today's hot and arid climates are expected to expand worldwide and to reach climate states with no current analog. Although rarely appreciated in combination, these multiple dimensions of change convey complementary information. We review existing climate change metrics and discuss how they relate to threats and opportunities for biodiversity. Interpreting climate change metrics is particularly useful for unknown or poorly described species, which represent most of Earth's biodiversity.	[Garcia, Raquel A.; Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biogeog & Global Change, Madrid 28006, Spain; [Garcia, Raquel A.; Rahbek, Carsten; Araujo, Miguel B.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Garcia, Raquel A.; Araujo, Miguel B.] Univ Evora, Res Network Biodivers & Evolutionary Biol InBIO, Res Ctr Biodivers & Genet Resources CIBIO, P-7000 Evora, Portugal; [Garcia, Raquel A.; Cabeza, Mar] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, FIN-00014 Helsinki, Finland; [Rahbek, Carsten; Araujo, Miguel B.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Copenhagen; University of Evora; University of Helsinki; Imperial College London	Garcia, RA (corresponding author), CSIC, Natl Museum Nat Sci, Dept Biogeog & Global Change, Calle Jose Gutierrez Abascal 2, Madrid 28006, Spain.	raquel.ag@gmail.com; miguel.araujo@imperial.ac.uk	Araújo, Miguel B/B-6117-2008; Rahbek, Carsten/L-1129-2013; Cabeza, Mar/ABC-4297-2020	Araújo, Miguel B/0000-0002-5107-7265; Rahbek, Carsten/0000-0003-4585-0300; Cabeza, Mar/0000-0002-7410-7631	Foundation for Science and Technology (FCT) [SFRH/BD/65615/2009]; Integrated Program of ICDT Call [1/SAESCTN/ALENT-07-0224-FEDER-00175]; Academy of Finland [257686]; Danish National Research Foundation; Imperial College London's Grand Challenges in Ecosystems and Environment initiative;  [FCT PTDC/AAC-AMB/98163/2008]	Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Integrated Program of ICDT Call; Academy of Finland(Academy of Finland); Danish National Research Foundation(Danmarks Grundforskningsfond); Imperial College London's Grand Challenges in Ecosystems and Environment initiative; 	We thank H. Prasad for assisting with baseline climate data handling and B. Sandel for sharing the R script for the spatial gradient of climate change. We are grateful to three anonymous reviewers for constructive comments on our manuscript. R. A. G. is funded through a Foundation for Science and Technology (FCT) Ph.D. studentship (SFRH/BD/65615/2009), M. B. A. through the FCT PTDC/AAC-AMB/98163/2008 project and the Integrated Program of IC&DT Call No 1/SAESCTN/ALENT-07-0224-FEDER-00175, and M. C. through the Academy of Finland (grant 257686). C. R., R. A. G., and M. B. A. thank the Danish National Research Foundation for support to the Center for Macroecology, Evolution and Climate, and C. R. and M. B. A. also thank the Imperial College London's Grand Challenges in Ecosystems and Environment initiative for support of their research.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Altwegg R, 2012, P ROY SOC B-BIOL SCI, V279, P1485, DOI 10.1098/rspb.2011.1897; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Bergmann J, 2010, PLANT ECOL, V207, P191, DOI 10.1007/s11258-009-9664-6; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chamaille-Jammes S, 2006, GLOBAL CHANGE BIOL, V12, P392, DOI 10.1111/j.1365-2486.2005.01088.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Convey P, 2003, ANTARCT RES SER, V79, P145; Convey P, 2006, PLANT ECOL, V182, P1, DOI 10.1007/s11258-005-9022-2; Dalsgaard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025891; Davis M.B., 1986, COMMUNITY ECOL, P269; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Durance I, 2010, J N AM BENTHOL SOC, V29, P1367, DOI 10.1899/09-159.1; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Felton A, 2009, BIODIVERS CONSERV, V18, P2243, DOI 10.1007/s10531-009-9652-0; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Fraedrich K, 2001, CLIMATIC CHANGE, V50, P405, DOI 10.1023/A:1010699428863; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Gouveia SF, 2013, ECOGRAPHY, V36, P104, DOI 10.1111/j.1600-0587.2012.07553.x; Graham RW, 1996, SCIENCE, V272, P1601; Gray ST, 2006, ECOLOGY, V87, P1124, DOI 10.1890/0012-9658(2006)87[1124:ROMCVI]2.0.CO;2; Hargrove WW, 2004, ENVIRON MANAGE, V34, pS39, DOI 10.1007/s00267-003-1084-0; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Iwamura T, 2013, GLOBAL ENVIRON CHANG, V23, P1277, DOI 10.1016/j.gloenvcha.2013.07.016; Iwamura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015103; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Morley RJ, 2011, S-P B ENVIRON SCI, P1; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Ohlemuller R, 2006, GLOBAL ECOL BIOGEOGR, V15, P395, DOI 10.1111/j.1466-822X.2006.00245.x; Ordonez A, 2013, CLIMATIC CHANGE, V119, P659, DOI 10.1007/s10584-013-0752-1; Ordonez A, 2013, ECOL LETT, V16, P773, DOI 10.1111/ele.12110; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Overpeck J, 2003, GLO CH IGBP, P81; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Peterson DL, 1997, GLOBAL ECOL BIOGEOGR, V6, P7, DOI 10.2307/2997523; Pitelka LF, 1997, AM SCI, V85, P464; Post, 2013, ECOLOGY CLIMATE CHAN; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; Thomas CD, 2008, EMBO REP, V9, pS28, DOI 10.1038/embor.2008.42; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; WHITTAKER R H, 1975, P385; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Willis KJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0491; Willis KJ, 2011, ANNU REV ECOL EVOL S, V42, P267, DOI 10.1146/annurev-ecolsys-102209-144704; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Wright SJ, 2009, CONSERV BIOL, V23, P1418, DOI 10.1111/j.1523-1739.2009.01337.x; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	119	390	400	55	922	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					486	+	1247579	10.1126/science.1247579	http://dx.doi.org/10.1126/science.1247579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786084				2022-12-28	WOS:000335157700033
J	Lee, T; Cai, LX; Lelyveld, VS; Hai, A; Jasanoff, A				Lee, Taekwan; Cai, Lili X.; Lelyveld, Victor S.; Hai, Aviad; Jasanoff, Alan			Molecular-Level Functional Magnetic Resonance Imaging of Dopaminergic Signaling	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; RAT-BRAIN; DIRECTED EVOLUTION; SHELL; SUBTERRITORIES; TRANSPORTER	We demonstrate a technique for mapping brain activity that combines molecular specificity and spatial coverage using a neurotransmitter sensor detectable by magnetic resonance imaging (MRI). This molecular functional MRI (fMRI) method yielded time-resolved volumetric measurements of dopamine release evoked by reward-related lateral hypothalamic brain stimulation of rats injected with the neurotransmitter sensor. Peak dopamine concentrations and release rates were observed in the anterior nucleus accumbens core. Substantial dopamine transients were also present in more caudal areas. Dopamine-release amplitudes correlated with the rostrocaudal stimulation coordinate, suggesting participation of hypothalamic circuitry in modulating dopamine responses. This work provides a foundation for development and application of quantitative molecular fMRI techniques targeted toward numerous components of neural physiology.	[Lee, Taekwan; Cai, Lili X.; Lelyveld, Victor S.; Hai, Aviad; Jasanoff, Alan] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Jasanoff, Alan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Jasanoff, Alan] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jasanoff, A (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jasanoff@mit.edu		Cai, Lili/0000-0003-3260-2367; /0000-0002-3890-0288	NIH [R01-DA02899, R01-NS076462, DP2-OD002114]; Defense Advanced Research Projects Agency [W911NF-10-0059]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076462] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01-DA02899, R01-NS076462 and DP2-OD002114, and Defense Advanced Research Projects Agency grant W911NF-10-0059 to A.J. We thank G. Westmeyer for technical guidance and A. Graybiel for comments on the manuscript. We also thank C. Blaha, A. Graybiel, M. Howe, T. Rogers, and T. Schneider for assistance with electrochemistry; E. Brustad and F. Arnold for collaboration on sensor development; and A. Liang and S. Lippard for help with stopped-flow measurements. U.S. patent application 12/675,256 pertains to BM3h-9D7.	Addy NA, 2010, J NEUROPHYSIOL, V104, P922, DOI 10.1152/jn.00413.2010; Brustad EM, 2012, J MOL BIOL, V422, P245, DOI 10.1016/j.jmb.2012.05.029; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; FREED C, 1995, J COMP NEUROL, V359, P340, DOI 10.1002/cne.903590211; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jasanoff A, 2007, CURR OPIN NEUROBIOL, V17, P593, DOI 10.1016/j.conb.2007.11.002; Jones SR, 1996, SYNAPSE, V23, P224, DOI 10.1002/(SICI)1098-2396(199607)23:3<224::AID-SYN12>3.3.CO;2-6; MAY LJ, 1988, J NEUROCHEM, V51, P1060, DOI 10.1111/j.1471-4159.1988.tb03069.x; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; Park J, 2010, NEUROSCIENCE, V169, P132, DOI 10.1016/j.neuroscience.2010.04.076; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Saddoris Michael P, 2013, Front Biosci (Elite Ed), V5, P273; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x	20	91	93	8	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					533	535		10.1126/science.1249380	http://dx.doi.org/10.1126/science.1249380			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786083				2022-12-28	WOS:000335157700047
J	van Wijk, RM; van Vlimmeren, LA; Groothuis-Oudshoorn, CGM; Van der Ploeg, CPB; IJzerman, MJ; Boere-Boonekamp, MM				van Wijk, Renske M.; van Vlimmeren, Leo A.; Groothuis-Oudshoorn, Catharina G. M.; Van der Ploeg, Catharina P. B.; IJzerman, Maarten J.; Boere-Boonekamp, Magda M.			Helmet therapy in infants with positional skull deformation: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRONE SLEEPING POSITION; DEATH-SYNDROME; CHILDREN; DEFORMITIES; PREVALENCE; VALIDATION; MANAGEMENT; INCREASE; AGE	Objective To determine the effectiveness of helmet therapy for positional skull deformation compared with the natural course of the condition in infants aged 5-6 months. Design Pragmatic, single blinded, randomised controlled trial (HEADS, HElmet therapy Assessment in Deformed Skulls) nested in a prospective cohort study. Setting 29 paediatric physiotherapy practices; helmet therapy was administered at four specialised centres. Participants 84 infants aged 5 to 6 months with moderate to severe skull deformation, who were born after 36 weeks of gestation and had no muscular torticollis, craniosynostosis, or dysmorphic features. Participants were randomly assigned to helmet therapy (n=42) or to natural course of the condition (n=42) according to a randomisation plan with blocks of eight. Interventions Six months of helmet therapy compared with the natural course of skull deformation. In both trial arms parents were asked to avoid any (additional) treatment for the skull deformation. Main outcome measures The primary outcome was change in skull shape from baseline to 24 months of age assessed using plagiocephalometry (anthropometric measurement instrument). Change scores for plagiocephaly (oblique diameter difference index) and brachycephaly (cranioproportional index) were each included in an analysis of covariance, using baseline values as the covariate. Secondary outcomes were ear deviation, facial asymmetry, occipital lift, and motor development in the infant, quality of life (infant and parent measures), and parental satisfaction and anxiety. Baseline measurements were performed in infants aged between 5 and 6 months, with follow-up measurements at 8, 12, and 24 months. Primary outcome assessment at 24 months was blinded. Results The change score for both plagiocephaly and brachycephaly was equal between the helmet therapy and natural course groups, with a mean difference of -0.2 (95% confidence interval -1.6 to 1.2, P=0.80) and 0.2 (-1.7 to 2.2, P=0.81), respectively. Full recovery was achieved in 10 of 39 (26%) participants in the helmet therapy group and 9 of 40 (23%) participants in the natural course group (odds ratio 1.2, 95% confidence interval 0.4 to 3.3, P=0.74). All parents reported one or more side effects. Conclusions Based on the equal effectiveness of helmet therapy and skull deformation following its natural course, high prevalence of side effects, and high costs associated with helmet therapy, we discourage the use of a helmet as a standard treatment for healthy infants with moderate to severe skull deformation.	[van Wijk, Renske M.; Groothuis-Oudshoorn, Catharina G. M.; IJzerman, Maarten J.; Boere-Boonekamp, Magda M.] Univ Twente, Inst Innovat & Governance Studies, Dept Hlth Technol & Serv Res, NL-7522 NB Enschede, Netherlands; [van Vlimmeren, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil Paediat Phys Therapy, Nijmegen, Netherlands; [van Vlimmeren, Leo A.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Van der Ploeg, Catharina P. B.] TNO Child Hlth, Leiden, Netherlands	University of Twente; Radboud University Nijmegen; Radboud University Nijmegen; Netherlands Organization Applied Science Research	van Wijk, RM (corresponding author), Univ Twente, POB 217, NL-7500 AE Enschede, Netherlands.	r.m.vanwijk@utwente.nl	IJzerman, Maarten/AAB-6894-2020; van Vlimmeren, L.A./L-4722-2015; IJzerman, Maarten J/Q-8963-2016; van Vlimmeren, Leo/E-9956-2018	IJzerman, Maarten/0000-0001-5788-5805; IJzerman, Maarten J/0000-0001-5788-5805; van Vlimmeren, Leo/0000-0002-3511-3393; Groothuis-Oudshoorn, Catharina/0000-0002-4875-5379				[Anonymous], 1980, HANDLEIDING BIJ ZELF; Argenta L, 2004, J CRANIOFAC SURG, V15, P368, DOI 10.1097/00001665-200405000-00004; Argenta LC, 1996, J CRANIOFAC SURG, V7, P5, DOI 10.1097/00001665-199601000-00005; Bayley N, 2006, MANUAL BAYLEY SCALES; Bialocerkowski AE, 2005, DEV MED CHILD NEUROL, V47, P563, DOI 10.1017/S0012162205001118; Boere-Boonekamp MM, 2001, PEDIATRICS, V107, P339, DOI 10.1542/peds.107.2.339; Cabrera-Martos I, 2013, CHILD NERV SYST, V29, P1893, DOI 10.1007/s00381-013-2120-x; CLARREN SK, 1981, J PEDIATR-US, V98, P92, DOI 10.1016/S0022-3476(81)80549-5; Collett B, 2005, J DEV BEHAV PEDIATR, V26, P379, DOI 10.1097/00004703-200510000-00008; Collett BR, 2013, PEDIATRICS, V131, pE109, DOI 10.1542/peds.2012-1779; DEJONGE GA, 1989, BRIT MED J, V298, P722, DOI 10.1136/bmj.298.6675.722; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; Feijen M, 2012, J CRANIOFAC SURG, V23, P998, DOI 10.1097/SCS.0b013e31824e642e; Flannery ABK, 2012, J PEDIATR HEALTH CAR, V26, P320, DOI 10.1016/j.pedhc.2011.10.002; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Goh JL, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.7.FOCUS13260; HARTH SC, 1990, BRIT MED J, V300, P1372, DOI 10.1136/bmj.300.6736.1372; Hutchison BL, 2011, ARCH DIS CHILD, V96, P85, DOI 10.1136/adc.2010.190934; Hutchison BL, 2009, ACTA PAEDIATR, V98, P1494, DOI 10.1111/j.1651-2227.2009.01356.x; Hutchison BL, 2005, CLEFT PALATE-CRAN J, V42, P539, DOI 10.1597/04-059r.1; Hutchison BL, 2004, PEDIATRICS, V114, P970, DOI 10.1542/peds.2003-0668-F; Kane AA, 1996, PEDIATRICS, V97, P877; KATTWINKEL J, 1992, PEDIATRICS, V89, P1120; Katzel EB, 2010, PLAST RECONSTR SURG, V126, p19e; Kennedy E, 2009, PHYS OCCUP THER PEDI, V29, P222, DOI 10.1080/01942630903011016; Kluba S, 2014, J CRANIOMAX IN PRESS; Kluba S, 2011, PLAST RECONSTR SURG, V128, P492, DOI 10.1097/PRS.0b013e31821b62d6; Kordestani RK, 2006, PLAST RECONSTR SURG, V117, P207, DOI 10.1097/01.prs.0000185604.15606.e5; Landgraf JM, 2013, QUAL LIFE RES, V22, P635, DOI 10.1007/s11136-012-0177-8; Lipira AB, 2010, PEDIATRICS, V126, pE936, DOI 10.1542/peds.2009-1249; Loveday BPT, 2001, J CRANIOFAC SURG, V12, P308, DOI 10.1097/00001665-200107000-00003; Meyer-Marcotty P, 2014, J CRANIO MAXILL SURG, V42, P1010, DOI 10.1016/j.jcms.2014.01.026; Mindell JA, 2006, SLEEP, V29, P1263; Mulliken JB, 1999, PLAST RECONSTR SURG, V103, P371, DOI 10.1097/00006534-199902000-00003; Nederlands Centrum Jeugdgezondheid, 2012, JGZ RICHTL PREV SIGN; Nuysink J, 2013, J PEDIATR-US, V163, P658, DOI 10.1016/j.jpeds.2013.04.015; Persing J, 2003, PEDIATRICS, V112, P199, DOI 10.1542/peds.112.1.199; PIPER MC, 1992, CAN J PUBLIC HEALTH, V83, pS46; Robinson S, 2009, J NEUROSURG-PEDIATR, V3, P284, DOI 10.3171/2009.1.PEDS08330; Rovers MM, 2001, J CLIN EPIDEMIOL, V54, P789, DOI 10.1016/S0895-4356(01)00340-7; Statistics Netherlands, 2013, POP SEX AG OR GEN; Steinbok P, 2007, CHILD NERV SYST, V23, P1275, DOI 10.1007/s00381-007-0373-y; Suarez-Almazor ME, 2001, MED DECIS MAKING, V21, P113, DOI 10.1177/02729890122062361; Turk AE, 1996, J CRANIOFAC SURG, V7, P12, DOI 10.1097/00001665-199601000-00006; van Adrichem LNA, 2008, J CRANIOFAC SURG, V19, P15, DOI 10.1097/scs0b013e31815c93cb; Van der Ploeg CBP, 2013, COST ASSESSMENT HELM; van Vlimmeren LA, 2006, EUR J PEDIATR, V165, P149, DOI 10.1007/s00431-005-0011-1; van Vlimmeren LA, 2008, ARCH PEDIAT ADOL MED, V162, P712, DOI 10.1001/archpedi.162.8.712; van Vlimmeren LA, 2007, PEDIATRICS, V119, pE408, DOI 10.1542/peds.2006-2012; van Wijk RM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-108; Vles JSH, 2000, J CRANIOFAC SURG, V11, P572, DOI 10.1097/00001665-200011060-00010; Wilbrand JF, 2012, J CRANIO MAXILL SURG, V40, P341, DOI 10.1016/j.jcms.2011.05.007; Xia JJ, 2008, ARCH PEDIAT ADOL MED, V162, P719, DOI 10.1001/archpedi.162.8.719	53	74	76	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2014	348								g2741	10.1136/bmj.g2741	http://dx.doi.org/10.1136/bmj.g2741			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SI	24784879	Green Published, hybrid			2022-12-28	WOS:000335478400001
J	Lynch, DR; Fischbeck, KH				Lynch, David R.; Fischbeck, Kenneth H.			Nicotinamide in Friedreich's ataxia: useful or not?	LANCET			English	Editorial Material							HISTONE DEACETYLASE INHIBITORS		[Lynch, David R.] Childrens Hosp Philadelphia, Div Neurol & Pediat, Philadelphia, PA 19104 USA; [Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Div Neurol & Pediat, Philadelphia, PA 19104 USA.	lynchd@mail.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003037] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS003037-08] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Libri V, 2014, LANCET; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Soragni E, 2012, J CHILD NEUROL, V27, P1164, DOI 10.1177/0883073812448533; US National Library of Medicine, MEDLINEPLUS NIAC NIA	8	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					474	475		10.1016/S0140-6736(14)60573-0	http://dx.doi.org/10.1016/S0140-6736(14)60573-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24794818	Green Accepted			2022-12-28	WOS:000340198300006
J	Antos, JR				Antos, Joseph R.			Health Care Reform after the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Antos, JR (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA.							Antos JR, 2012, NEW ENGL J MED, V367, P954, DOI 10.1056/NEJMsb1207996; Capretta JC, 2012, NATL AFFAIRS, V11, P3; Capretta JC, 2010, NATL AFFAIRS, V4, P110	3	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2259	2261		10.1056/NEJMp1404298	http://dx.doi.org/10.1056/NEJMp1404298			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7BB	24805986				2022-12-28	WOS:000337033700004
J	Simon, AC; Zhou, JC; Perera, RL; van Deursen, F; Evrin, C; Ivanova, ME; Kilkenny, ML; Renault, L; Kjaer, S; Matak-Vinkovic, D; Labib, K; Costa, A; Pellegrini, L				Simon, Aline C.; Zhou, Jin C.; Perera, Rajika L.; van Deursen, Frederick; Evrin, Cecile; Ivanova, Marina E.; Kilkenny, Mairi L.; Renault, Ludovic; Kjaer, Svend; Matak-Vinkovic, Dijana; Labib, Karim; Costa, Alessandro; Pellegrini, Luca			A Ctf4 trimer couples the CMG helicase to DNA polymerase alpha in the eukaryotic replisome	NATURE			English	Article							SISTER-CHROMATID COHESION; MCM2-7 HELICASE; REPLICATION; COMPLEX; PROGRESSION; PROTEIN; GINS; STOICHIOMETRY; METABOLISM; ACTIVATION	Efficient duplication of the genome requires the concerted action of helicase and DNA polymerases at replication forks(1) to avoid stalling of the replication machinery and consequent genomic instability(2-4). In eukaryotes, the physical coupling between helicase and DNA polymerases remains poorly understood. Here we define the molecular mechanism by which the yeast Ctf4 protein links the Cdc45-MCM-GINS(CMG) DNA helicase to DNA polymerase alpha (Pol alpha) within the replisome. We use X-ray crystallography and electron microscopy to show that Ctf4 self-associates in a constitutive disk-shaped trimer. Trimerization depends on a beta-propeller domain in the carboxy-terminal half of the protein, which is fused to a helical extension that protrudes from one face of the trimeric disk. Critically, Pol alpha and the CMG helicase share a common mechanism of interaction with Ctf4. We show that the amino-terminal tails of the catalytic subunit of Pol alpha and the Sld5 subunit of GINS contain a conserved Ctf4-binding motif that docks onto the exposed helical extension of a Ctf4 protomer within the trimer. Accordingly, we demonstrate that one Ctf4 trimer can support binding of up to three partner proteins, including the simultaneous association with both Pol a and GINS. Our findings indicate that Ctf4 can couple two molecules of Pol alpha to one CMG helicase within the replisome, providing a new model for lagging-strand synthesis in eukaryotes that resembles the emerging model for the simpler replisome of Escherichia coli(5-8). The ability of Ctf4 to act as a platform for multivalent interactions illustrates a mechanism for the concurrent recruitment of factors that act together at the fork.	[Simon, Aline C.; Perera, Rajika L.; Ivanova, Marina E.; Kilkenny, Mairi L.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Zhou, Jin C.; Renault, Ludovic; Costa, Alessandro] Canc Res UK London Res Inst, Clare Hall Labs, London EN6 3LD, England; [van Deursen, Frederick] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England; [Evrin, Cecile; Labib, Karim] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Kjaer, Svend] Canc Res UK London Res Inst, London WC2A 3LY, England; [Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; Cancer Research UK; Cancer Research UK; University of Manchester; University of Dundee; Cancer Research UK; University of Cambridge	Pellegrini, L (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	alessandro.costa@cancer.org.uk; lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Kjaer, Susanne/0000-0002-8347-1398; Perera, Rajika/0000-0002-4932-8168; Zhou, Jin Chuan/0000-0001-5716-5170; Renault, Ludovic/0000-0001-6464-8808	Gates Cambridge PhD program; CRUK; MRC; Wellcome Trust SRF award in basic biomedical science; MRC [MC_UU_12016/13] Funding Source: UKRI; Cancer Research UK [15852] Funding Source: researchfish; Medical Research Council [MC_UU_12016/13] Funding Source: researchfish; Wellcome Trust [102943/Z/13/Z] Funding Source: researchfish	Gates Cambridge PhD program; CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust SRF award in basic biomedical science; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank L. Collinson and R. Carzaniga (LRI) for EM access; D. Frith and B. Snijder (LRI) for mass spectrometry work; J. Maman for help with SEC-MALS; and P. Zegerman and J. Gannon for comments on the manuscript. This work was supported by the Gates Cambridge PhD program (A. C. S.), CRUK (A. C. and K. L.), MRC (K. L.) and a Wellcome Trust SRF award in basic biomedical science (L.P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DePamphilis M. L., 2011, GENOME DUPLICATION; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Gosnell JA, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-13; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	44	134	134	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					293	+		10.1038/nature13234	http://dx.doi.org/10.1038/nature13234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805245	Green Accepted			2022-12-28	WOS:000337032400055
J	Pearse, RM; Harrison, DA; MacDonald, N; Gillies, MA; Blunt, M; Ackland, G; Grocott, MPW; Ahern, A; Griggs, K; Scott, R; Hinds, C; Rowan, K				Pearse, Rupert M.; Harrison, David A.; MacDonald, Neil; Gillies, Michael A.; Blunt, Mark; Ackland, Gareth; Grocott, Michael P. W.; Ahern, Aoife; Griggs, Kathryn; Scott, Rachael; Hinds, Charles; Rowan, Kathryn		OPTIMISE Study Grp	Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery A Randomized Clinical Trial and Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RISK SURGICAL-PATIENTS; ARTERIAL PULSE PRESSURE; HOSPITAL STAY; ESOPHAGEAL DOPPLER; HYDROXYETHYL STARCH; FLUID MANAGEMENT; OXYGEN DELIVERY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE OPTIMIZATION; MICROVASCULAR FLOW	IMPORTANCE Small trials suggest that postoperative outcomes may be improved by the use of cardiac output monitoring to guide administration of intravenous fluid and inotropic drugs as part of a hemodynamic therapy algorithm. OBJECTIVE To evaluate the clinical effectiveness of a perioperative, cardiac output-guided hemodynamic therapy algorithm. DESIGN, SETTING, AND PARTICIPANTS OPTIMISE was a pragmatic, multicenter, randomized, observer-blinded trial of 734 high-risk patients aged 50 years or older undergoing major gastrointestinal surgery at 17 acute care hospitals in the United Kingdom. An updated systematic review and meta-analysis were also conducted including randomized trials published from 1966 to February 2014. INTERVENTIONS Patients were randomly assigned to a cardiac output-guided hemodynamic therapy algorithm for intravenous fluid and inotrope (dopexamine) infusion during and 6 hours following surgery (n=368) or to usual care (n=366). MAIN OUTCOMES AND MEASURES The primary outcome was a composite of predefined 30-day moderate or major complications and mortality. Secondary outcomes were morbidity on day 7; infection, critical care-free days, and all-cause mortality at 30 days; all-cause mortality at 180 days; and length of hospital stay. RESULTS Baseline patient characteristics, clinical care, and volumes of intravenous fluid were similar between groups. Care was nonadherent to the allocated treatment for less than 10% of patients in each group. The primary outcome occurred in 36.6% of intervention and 43.4% of usual care participants (relative risk [RR], 0.84 [95% CI, 0.71-1.011; absolute risk reduction, 6.8% [95% CI, -0.3% to 13.9%]; P = .07). There was no significant difference between groups for any secondary outcomes. Five intervention patients (1.4%) experienced cardiovascular serious adverse events within 24 hours compared with none in the usual care group. Findings of the meta-analysis of 38 trials, including data from this study, suggest that the intervention is associated with fewer complications (intervention, 488/1548 [31.5%] vs control, 614/1476 [41.6%]; RR, 0.77 [95% CI, 0.71-0.831) and a nonsignificant reduction in hospital, 28-day, or 30-day mortality (intervention, 159/3215 deaths [4.9%] vs control, 206/3160 deaths [6.5%]; RR, 0.82 [95% CI, 0.67-1.01]) and mortality at longest follow-up (intervention, 267/3215 deaths [8.3%] vs control, 327/3160 deaths [10.3%]; RR, 0.86 [95% CI, 0.74-1.00]). CONCLUSIONS AND RELEVANCE In a randomized trial of high-risk patients undergoing major gastrointestinal surgery, use of a cardiac output-guided hemodynamic therapy algorithm compared with usual care did not reduce a composite outcome of complications and 30-day mortality. However, inclusion of these data in an updated meta-analysis indicates that the intervention was associated with a reduction in complication rates. Copyright 2014 American Medical Association. All rights reserved.	[Pearse, Rupert M.; MacDonald, Neil; Ahern, Aoife; Hinds, Charles] Queen Mary Univ London, London, England; [Harrison, David A.; Griggs, Kathryn; Scott, Rachael; Rowan, Kathryn] Intens Care Natl Audit & Res Ctr, London, England; [Harrison, David A.; Griggs, Kathryn; Scott, Rachael; Rowan, Kathryn] Univ Edinburgh, Crit Care Unit, Edinburgh, Midlothian, Scotland; [Blunt, Mark] Queen Elizabeth Hosp, Crit Care Unit, Kings Lynn, England; [Ackland, Gareth] UCL, London, England; [Grocott, Michael P. W.] Univ Southampton, Integrat Physiol & Crit Illness Grp, Southampton, England	University of London; Queen Mary University London; Intensive Care National Audit & Research Centre; University of Edinburgh; University of London; University College London; University of Southampton	Pearse, RM (corresponding author), Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England.	r.pearse@qmul.ac.uk	Lobo, Dileep/AAC-6207-2020; Grocott, Michael/C-4394-2008; Pearse, Rupert/H-5426-2011; Kirk-Bayley, Justin/A-1608-2013; Howell, Simon/T-4233-2019; Harrison, David A/O-4355-2018; Evley, Rachel S/I-3464-2013; Ackland, Graeme J/H-2215-2015; Moppett, Iain/B-1756-2008; Coats, Timothy/AAW-1254-2021	Lobo, Dileep/0000-0003-1187-5796; Grocott, Michael/0000-0002-9484-7581; Pearse, Rupert/0000-0002-4373-5934; Kirk-Bayley, Justin/0000-0001-9493-045X; Harrison, David A/0000-0002-9002-9098; Evley, Rachel S/0000-0003-4454-5523; Ackland, Graeme J/0000-0002-1205-7675; Moppett, Iain/0000-0003-3750-6067; Coats, Timothy/0000-0003-2736-2784; Howell, Simon/0000-0001-8467-1466; Rowan, Kathryn/0000-0001-8217-5602; Kunst, Gudrun/0000-0002-9789-1334; Dark, Paul/0000-0003-3309-0164; ACKLAND, GARETH/0000-0003-0565-5164	UK National Institute for Health Research; Academy of Medical Sciences (AMS) [AMS-CSF3-Ackland] Funding Source: researchfish; National Institute for Health Research [RP_2014-04-022, CS/08/08/17] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial was funded through a UK National Institute for Health Research Clinician Scientist Award held by Dr Pearse. Cardiac output monitoring equipment was provided on loan without charge by LiDCO Ltd. Dopexamine was supplied at a small discount by Cephalon Inc and through additional, non-grant-funded provision of staff time and resources from the Intensive Care National Audit and Research Centre.	Agency for Healthcare Research and Quality, 2007, ES DOPPL ULTR BAS CA; Bangash MN, 2013, CRIT CARE, V17, DOI 10.1186/cc12585; BERLAUK JF, 1991, ANN SURG, V214, P289, DOI 10.1097/00000658-199109000-00011; Brandstrup B, 2012, BRIT J ANAESTH, V109, P191, DOI 10.1093/bja/aes163; Cannesson M, 2011, CRIT CARE, V15, DOI 10.1186/cc10364; Cecconi M, 2011, CRIT CARE, V15, DOI 10.1186/cc10246; Challand C, 2012, BRIT J ANAESTH, V108, P53, DOI 10.1093/bja/aer273; Conway DH, 2002, ANAESTHESIA, V57, P845, DOI 10.1046/j.1365-2044.2002.02708.x; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Deans KJ, 2007, CRIT CARE MED, V35, P1509, DOI 10.1097/01.CCM.0000266584.40715.A6; Donati A, 2007, CHEST, V132, P1817, DOI 10.1378/chest.07-0621; Eddleston J, 2009, LEVELS CRITICAL CARE; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Goepfert MS, 2013, ANESTHESIOLOGY, V119, P824, DOI 10.1097/ALN.0b013e31829bd770; Grocott MPW, 2007, J CLIN EPIDEMIOL, V60, P919, DOI 10.1016/j.jclinepi.2006.12.003; Grocott MPW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004082.pub5; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Jerez Gomez Coronado V, 2001, MED INTENSIVA, V25, P297; Jhanji S, 2010, CRIT CARE, V14, DOI 10.1186/cc9220; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Kuper M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3016; Lobo SMA, 2000, CRIT CARE MED, V28, P3396, DOI 10.1097/00003246-200010000-00003; MacDonald N, 2011, CRIT CARE, V15, DOI 10.1186/cc10011; Marquez J, 2008, CRIT CARE MED, V36, P3001, DOI 10.1097/CCM.0b013e31818b31f0; Mayer J, 2010, CRIT CARE, V14, DOI 10.1186/cc8875; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; MYTHEN MG, 1995, ARCH SURG-CHICAGO, V130, P423; National Institute for Health and Clinical Excellence, 2011, CARDIOQ ODM OES DOPP; Noblett SE, 2006, BRIT J SURG, V93, P1069, DOI 10.1002/bjs.5454; Pearse R, 2005, CRIT CARE, V9, pR687, DOI 10.1186/cc3887; Pearse Rupert M, 2007, BMC Cardiovasc Disord, V7, P10, DOI 10.1186/1471-2261-7-10; Pearse RM, 2008, CRIT CARE MED, V36, P1323, DOI 10.1097/CCM.0b013e31816a091b; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Salzwedel C, 2013, CRIT CARE, V17, DOI 10.1186/cc12885; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Sinclair S, 1997, BMJ-BRIT MED J, V315, P909; Smetkin AA, 2009, ACTA ANAESTH SCAND, V53, P505, DOI 10.1111/j.1399-6576.2008.01855.x; Ueno S, 1998, SURGERY, V123, P278, DOI 10.1016/S0039-6060(98)70180-1; Wakeling HG, 2005, BRIT J ANAESTH, V95, P634, DOI 10.1093/bja/aei223; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wilson J, 1999, BRIT MED J, V318, P1099, DOI 10.1136/bmj.318.7191.1099	43	520	540	4	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2181	2190		10.1001/jama.2014.5305	http://dx.doi.org/10.1001/jama.2014.5305			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24842135				2022-12-28	WOS:000336668400019
J	Dillon, CP; Weinlich, R; Rodriguez, DA; Cripps, JG; Quarato, G; Gurung, P; Verbist, KC; Brewer, TL; Llambi, F; Gong, YN; Janke, LJ; Kelliher, MA; Kanneganti, TD; Green, DR				Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Janke, Laura J.; Kelliher, Michelle A.; Kanneganti, Thirumala-Devi; Green, Douglas R.			RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3	CELL			English	Article							DEATH DOMAIN KINASE; NECROSIS-FACTOR RECEPTOR; KAPPA-B ACTIVATION; PROGRAMMED NECROSIS; CELL-DEATH; TNF; UBIQUITINATION; SURVIVAL; INDUCE; FADD	Receptor-interacting protein kinase (RIPK)-1 is involved in RIPK3-dependent and -independent signaling pathways leading to cell death and/or inflammation. Genetic ablation of ripk1 causes postnatal lethality, which was not prevented by deletion of ripk3, caspase-8, or fadd. However, animals that lack RIPK1, RIPK3, and either caspase-8 or FADD survived weaning and matured normally. RIPK1 functions in vitro to limit caspase-8-dependent, TNFR-induced apoptosis, and animals lacking RIPK1, RIPK3, and TNFR1 survive to adulthood. The role of RIPK3 in promoting lethality in ripk1(-/-) mice suggests that RIPK3 activation is inhibited by RIPK1 postbirth. Whereas TNFR-induced RIPK3-dependent necroptosis requires RIPK1, cells lacking RIPK1 were sensitized to necroptosis triggered by poly I: C or interferons. Disruption of TLR (TRIF) or type I interferon (IFNAR) signaling delayed lethality in ripk1(-/-)tnfr1(-/-) mice. These results clarify the complex roles for RIPK1 in postnatal life and provide insights into the regulation of FADD-caspase-8 and RIPK3-MLKL signaling by RIPK1.	[Dillon, Christopher P.; Weinlich, Ricardo; Rodriguez, Diego A.; Cripps, James G.; Quarato, Giovanni; Gurung, Prajwal; Verbist, Katherine C.; Brewer, Taylor L.; Llambi, Fabien; Gong, Yi-Nan; Kanneganti, Thirumala-Devi; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale, Memphis, TN 38105 USA.	douglas.green@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Weinlich, Ricardo/AAW-3154-2020; Dillon, Christopher/P-4457-2014; Janke, Laura/N-8121-2018; Kanneganti, Thirumala-Devi/M-9435-2018; Green, Douglas R/N-8083-2018; Weinlich, Ricardo/S-7495-2016; Quarato, Giovanni/F-8272-2016	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Weinlich, Ricardo/0000-0001-6822-7330; Dillon, Christopher/0000-0002-9458-0266; Janke, Laura/0000-0002-9871-6239; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Green, Douglas R/0000-0002-7332-1417; Quarato, Giovanni/0000-0003-1167-3422; Rodriguez, Diego/0000-0003-4771-0221; Verbist, Katherine/0000-0002-3511-5639; Gurung, Prajwal/0000-0002-7451-9433	U.S. National Institutes of Health [AI44828, CA169291]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075118, R01AI044828, R37AI044828] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Mao Yang, Patrick Fitzgerald, and Maggie Barr for extensive technical assistance. The work was supported by grants from the U.S. National Institutes of Health (AI44828 and CA169291 to D.R.G.) and the American Lebanese Syrian Associated Charities.	Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Khan N, 2014, CURR OPIN IMMUNOL, V26, P76, DOI 10.1016/j.coi.2013.10.017; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	55	376	382	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1189	1202		10.1016/j.cell.2014.04.018	http://dx.doi.org/10.1016/j.cell.2014.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24813850	Green Accepted, Bronze			2022-12-28	WOS:000336437200019
J	Barnett, ML; Linder, JA				Barnett, Michael L.; Linder, Jeffrey A.			Antibiotic Prescribing for Adults With Acute Bronchitis in the United States, 1996-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Barnett, Michael L.; Linder, Jeffrey A.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Linder, JA (corresponding author), Brigham & Womens Hosp, 1620 Tremont St, Boston, MA 02120 USA.	jlinder@partners.org	Linder, Jeffrey/AAF-3424-2021; Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Linder, Jeffrey/0000-0003-2217-184X; Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609	AHRQ HHS [R18 HS018419] Funding Source: Medline; NIAID NIH HHS [R21 AI097759] Funding Source: Medline; NIA NIH HHS [RC4 AG039115] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039115] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Centers for Disease Control and Prevention, GET SMART KNOW ANT W; Centers for Disease Control and Prevention Division of Health Care Statistics National Center for Health Statistics, NAT HLTH CAR SURV; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; National Committee for Quality Assurance, HEDIS 2012 MEAS; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008	6	100	103	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2020	2022		10.1001/jama.2013.286141	http://dx.doi.org/10.1001/jama.2013.286141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846041	Green Accepted, Bronze			2022-12-28	WOS:000336122800026
J	McEvoy, JP; Byerly, M; Hamer, RM; Dominik, R; Swartz, MS; Rosenheck, RA; Ray, N; Lamberti, JS; Buckley, PF; Wilkins, TM; Stroup, TS				McEvoy, Joseph P.; Byerly, Matthew; Hamer, Robert M.; Dominik, Rosalie; Swartz, Marvin S.; Rosenheck, Robert A.; Ray, Neepa; Lamberti, J. Steven; Buckley, Peter F.; Wilkins, Tania M.; Stroup, T. Scott			Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL ANTIPSYCHOTICS; 2ND-GENERATION; FLUPHENAZINE; RISPERIDONE; RELAPSE; DRUGS; COST; RISK	IMPORTANCE Long-acting injectable antipsychotics are used to reduce medication nonadherence and relapse in schizophrenia-spectrum disorders. The relative effectiveness of long-acting injectable versions of second-generation and older antipsychotics has not been assessed. OBJECTIVE To compare the effectiveness of the second-generation long-acting injectable antipsychotic paliperidone palmitate with the older long-acting injectable antipsychotic haloperidol decanoate. DESIGN, SETTING, AND PARTICIPANTS Multisite, double-blind, randomized clinical trial conducted from March 2011 to July 2013 at 22 US clinical research sites. Randomized patients (n = 311) were adults diagnosed with schizophrenia or schizoaffective disorder who were clinically assessed to be at risk of relapse and likely to benefit from a long-acting injectable antipsychotic. INTERVENTIONS Intramuscular injections of haloperidol decanoate 25 to 200 mg or paliperidone palmitate 39 to 234 mg every month for as long as 24 months. MAIN OUTCOME MEASURES Efficacy failure, defined as a psychiatric hospitalization, a need for crisis stabilization, a substantial increase in frequency of outpatient visits, a clinician's decision that oral antipsychotic could not be discontinued within 8 weeks after starting the long-acting injectable antipsychotics, or a clinician's decision to discontinue the assigned long-acting injectable due to inadequate therapeutic benefit. Key secondary outcomes were common adverse effects of antipsychotic medications. RESULTS There was no statistically significant difference in the rate of efficacy failure for paliperidone palmitate compared with haloperidol decanoate (adjusted hazard ratio, 0.98; 95% CI, 0.65-1.47). The number of participants who experienced efficacy failure was 49 (33.8%) in the paliperidone palmitate group and 47 (32.4%) in the haloperidol decanoate group. On average, participants in the paliperidone palmitate group gained weight and those in the haloperidol decanoate group lost weight; after 6 months, the least-squares mean weight change for those taking paliperidone palmitate was increased by 2.17 kg (95% CI, 1.25-3.09) and was decreased for those taking haloperidol decanoate (-0.96 kg; 95% CI, -1.88 to -0.04). Patients taking paliperidone palmitate had significantly higher maximum mean levels of serum prolactin (men, 34.56 mu g/L [95% CI, 29.75-39.37] vs 15.41 mu g/L [95% CI, 10.73-20.08]; P<.001, and for women, 75.19 [95% CI, 63.03-87.36] vs 26.84 [95% CI, 13.29-40.40]; P<.001). Patients taking haloperidol decanoate had significantly larger increases in global ratings of akathisia (0.73 [95% CI, 0.59-0.87] vs 0.45 [95% CI, 0.31-0.59]; P=.006). CONCLUSIONS AND RELEVANCE In adults with schizophrenia or schizoaffective disorder, use of paliperidone palmitate vs haloperidol decanoate did not result in a statistically significant difference in efficacy failure, but was associated with more weight gain and greater increases in serum prolactin, whereas haloperidol decanoate was associated with more akathisia. However, the CIs do not rule out the possibility of a clinically meaningful advantage with paliperidone palmitate.	[McEvoy, Joseph P.; Buckley, Peter F.] Georgia Regents Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Byerly, Matthew] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA; [Hamer, Robert M.; Dominik, Rosalie; Ray, Neepa; Wilkins, Tania M.] Univ N Carolina, Dept Biostat, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Swartz, Marvin S.] Duke Univ, Dept Psychiat, Div Social & Community Psychiat, Durham, NC 27706 USA; [Rosenheck, Robert A.] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Rosenheck, Robert A.] Northeast Program Evaluat Ctr, West Haven, CT USA; [Lamberti, J. Steven] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [Stroup, T. Scott] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA; [Stroup, T. Scott] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Yale University; University of Rochester; Columbia University; New York State Psychiatry Institute	Stroup, TS (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Room 2703,Box 100,1051 Riverside Dr, New York, NY 10032 USA.	stroups@nyspi.columbia.edu	Stroup, Thomas/AAB-7780-2019; Stroup, Thomas S/F-9188-2014	Stroup, Thomas/0000-0002-3123-0672; Stroup, Thomas S/0000-0002-3123-0672	NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081107] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by grants from NIMH to Drs McEvoy and Stroup.	Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Buckley PF, 2012, 52 NEW CLIN DRUG EV; Citrome L, 2010, INT J CLIN PRACT, V64, P216, DOI 10.1111/j.1742-1241.2009.02240.x; Citrome LL, 2004, DRUG TODAY, V40, P445, DOI 10.1358/dot.2004.40.5.850492; Csernansky JG, 2002, NEW ENGL J MED, V346, P16, DOI 10.1056/NEJMoa002028; Goff DC, 2005, SCHIZOPHR RES, V80, P45, DOI 10.1016/j.schres.2005.08.010; HOGARTY GE, 1988, ARCH GEN PSYCHIAT, V45, P797; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; KANE JM, 1983, ARCH GEN PSYCHIAT, V40, P893; Kishimoto T, 2013, J CLIN PSYCHIAT, V74, P957, DOI 10.4088/JCP.13r08440; Leucht C, 2011, SCHIZOPHR RES, V127, P83, DOI 10.1016/j.schres.2010.11.020; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MARDER SR, 1987, ARCH GEN PSYCHIAT, V44, P518; Moore TA, 2007, J CLIN PSYCHIAT, V68, P1751, DOI 10.4088/JCP.v68n1115; Newcomer JW, 2005, CNS DRUGS, V19, P1; OQUIGLEY J, 1989, BIOMETRICS, V45, P135, DOI 10.2307/2532040; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Rosenheck R, 2014, J NERV MENT DIS, V202, P18, DOI 10.1097/NMD.0000000000000065; Rosenheck RA, 2011, NEW ENGL J MED, V364, P842, DOI 10.1056/NEJMoa1005987; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486	21	104	106	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1978	1986		10.1001/jama.2014.4310	http://dx.doi.org/10.1001/jama.2014.4310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846035	Bronze, Green Accepted			2022-12-28	WOS:000336122800020
J	Setoguchi, S; Stevenson, LW; Stewart, GC; Bhatt, DL; Epstein, AE; Desai, M; Williams, LA; Chen, CY				Setoguchi, Soko; Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.; Epstein, Andrew E.; Desai, Manisha; Williams, Lauren A.; Chen, Chih-Ying			Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; OCCUPATIONAL EPIDEMIOLOGY; MYOCARDIAL-INFARCTION; MORTALITY; THERAPY; DISEASE; DEATH; HOSPITALIZATION; COLLABORATION; POPULATION	Objective To assess the potential contribution of unmeasured general health status to patient selection in assessments of the clinical effectiveness of implantable cardioverter-defibrillator (ICD) therapy. Design Retrospective cohort study. Setting Linked data from an ICD registry, heart failure registry, and Medicare claims data for ICDs implanted in 2005 through 2009. Participants 29 426 patients admitted to hospital with heart failure aged 66 years or older and eligible for ICD therapy for primary prevention. Main outcome measures Non-traumatic hip fracture, admission to a skilled nursing facility, and 30 day mortality-outcomes unlikely to be improved by ICD therapy. Results Compared with 17 853 patients without ICD therapy, 11 573 patients with ICD therapy were younger and had lower ejection fraction and more cardiac admissions to hospital but fewer non-cardiac admissions to hospital and comorbid conditions. Patients with ICD therapy had greater freedom from unrelated events after adjusting for age and sex: hip fracture (hazard ratio 0.77, 95% confidence interval 0.64 to 0.92), skilled nursing facility admission (0.53, 0.50 to 0.55), and 30 day mortality (0.12, 0.10 to 0.15). Conclusions Lower risks of measured outcomes likely reflect unmeasured differences in comorbidity and frailty. The findings highlight potential pitfalls of observational comparative effectiveness research and support physician consideration of general health status in selecting patients for ICD therapy.	[Setoguchi, Soko; Williams, Lauren A.; Chen, Chih-Ying] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Setoguchi, Soko; Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.; Williams, Lauren A.; Chen, Chih-Ying] Harvard Univ, Sch Med, Boston, MA USA; [Setoguchi, Soko] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC 27715 USA; [Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Epstein, Andrew E.] Univ Penn, Cardiovasc Div, Electrophysiol Sect, Philadelphia, PA 19104 USA; [Desai, Manisha] Stanford Univ, Sch Med, Quantitat Sci Unit, Palo Alto, CA 94304 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Stanford University	Setoguchi, S (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	soko@post.harvard.edu			Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program [HHSA29020050016I]; Centers for Medicare & Medicaid Services, US Department of Health and Human Services [HHSM500201000001I]; Agency for Healthcare Research and Quality [K02HS017731]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017731] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Medicare & Medicaid Services, US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under contract No HHSA29020050016I, task order 3, from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program; and contract No HHSM500201000001I, task orders 2 and 6, from the Centers for Medicare & Medicaid Services, US Department of Health and Human Services. SS was supported by midcareer development award K02HS017731 from the Agency for Healthcare Research and Quality.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bavry AA, 2006, J CLIN EPIDEMIOL, V59, P763, DOI 10.1016/j.jclinepi.2005.12.015; Cacciatore F, 2005, EUR J CLIN INVEST, V35, P723, DOI 10.1111/j.1365-2362.2005.01572.x; Centers for Medicare & Medicaid Services, 2013, NAT COV DET NCD IMPL; Chan PS, 2006, ARCH INTERN MED, V166, P2228, DOI 10.1001/archinte.166.20.2228; CHECKOWAY H, 1990, ARCH ENVIRON HEALTH, V45, P95, DOI 10.1080/00039896.1990.9935932; Fonarow GC, 2011, AM HEART J, V161, P1024, DOI 10.1016/j.ahj.2011.01.027; FOX AJ, 1976, BRIT J PREV SOC MED, V30, P225; Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675; Friedmann E, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.009; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; HALLSTROM AP, 1991, STAT MED, V10, P1621, DOI 10.1002/sim.4780101013; HEMMINKI E, 1993, J CLIN EPIDEMIOL, V46, P211, DOI 10.1016/0895-4356(93)90068-C; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Knol MJ, 2010, J CLIN EPIDEMIOL, V63, P728, DOI 10.1016/j.jclinepi.2009.08.028; Konstam V, 1996, AM J CARDIOL, V78, P890, DOI 10.1016/S0002-9149(96)00463-8; Lee DS, 2007, J AM COLL CARDIOL, V49, P2408, DOI 10.1016/j.jacc.2007.02.058; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Little R.J.A., 2002, STAT ANAL MISSING DA; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehta PA, 2008, EUR J HEART FAIL, V10, P1108, DOI 10.1016/j.ejheart.2008.09.004; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Murberg TA, 2004, INT J PSYCHIAT MED, V34, P207, DOI 10.2190/GKJ2-P8BD-V59X-MJNQ; Piccini JP, 2008, CIRCULATION, V118, P926, DOI 10.1161/CIRCULATIONAHA.108.773838; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Ray WA, 2002, INJ PREV, V8, P276, DOI 10.1136/ip.8.4.276; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; ROBINS J, 1989, STAT MED, V8, P679, DOI 10.1002/sim.4780080608; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Setoguchi S, 2014, CIRC CARDIOVASC QUAL; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Setoguchi S, 2009, CAN MED ASSOC J, V180, P611, DOI 10.1503/cmaj.080769; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Smith SC, 2008, HEART RHYTHM, V5, P934, DOI 10.1016/j.hrthm.2008.04.015; Stevenson LW, 2008, J AM COLL CARDIOL, V52, P1702, DOI 10.1016/j.jacc.2008.08.028; Stewart GC, 2010, J CARD FAIL, V16, P106, DOI 10.1016/j.cardfail.2009.09.003; Tung P, 2013, NAT REV CARDIOL, V10, P135, DOI 10.1038/nrcardio.2012.201	44	27	27	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g2866	10.1136/bmj.g2866	http://dx.doi.org/10.1136/bmj.g2866			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812112	Green Published, hybrid			2022-12-28	WOS:000335819700002
J	Peltier, A; Goutman, SA; Callaghan, BC				Peltier, Amanda; Goutman, Stephen A.; Callaghan, Brian C.			Painful diabetic neuropathy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALPHA-LIPOIC ACID; QUALITY-OF-LIFE; PERIPHERAL NEUROPATHY; NATURAL-HISTORY; SKIN BIOPSY; PHARMACOLOGICAL-TREATMENT; SENSORY NEUROPATHY; METABOLIC SYNDROME; DOUBLE-BLIND; RISK-FACTORS	Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat this condition. Diagnostic tests in this field are evolving rapidly. These include the use of skin biopsies to measure small unmyelinated fibers, as well as even newer techniques that can measure both small unmyelinated fibers and large myelinated fibers in the same biopsy. The main treatments for painful diabetic neuropathy remain management of the underlying diabetes and drugs for the relief of pain. However, emerging evidence points to major differences between type 1 and type 2 diabetes, including the ability of glycemic control to prevent neuropathy. Enhanced glucose control is much more effective at preventing neuropathy in patients with type 2 diabetes than in those with type 1 disease. This dichotomy emphasizes the need to study the pathophysiologic differences between the two types of diabetes, because different treatments may be needed for each condition. The impact of the metabolic syndrome on neuropathy in patients with type 2 diabetes may account for the difference between the two types of diabetes and requires further study. Finally, neuropathic pain is under-recognized and undertreated despite an ever evolving list of effective drugs. Evidence exists to support several drugs, but the optimal sequence and combination of these drugs are still to be determined.	[Peltier, Amanda] Vanderbilt Univ, Dept Neurol, Nashville, TN 37235 USA; [Goutman, Stephen A.; Callaghan, Brian C.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan	Callaghan, BC (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	bcallagh@med.umich.edu		Peltier, Amanda/0000-0003-1097-7715; Goutman, Stephen/0000-0001-8780-6637	Impeto Medical	Impeto Medical	AP and SG have none. BCC received research support from Impeto Medical.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Afilalo M, 2013, PAIN PHYSICIAN, V16, P27; Agrawal Y, 2010, OTOL NEUROTOL, V31, P1445, DOI 10.1097/MAO.0b013e3181f2f035; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arezzo JC, 2002, INT REV NEUROBIOL, V50, P229; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Azad N, 1999, J DIABETES COMPLICAT, V13, P307, DOI 10.1016/S1056-8727(99)00062-8; Benbow SJ, 1998, QJM-INT J MED, V91, P733, DOI 10.1093/qjmed/91.11.733; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bonadonna RC, 2006, DIABETES CARE, V29, P2701, DOI 10.2337/dc06-0942; Bosi E, 2013, DIABETOLOGIA, V56, P467, DOI 10.1007/s00125-012-2795-7; Boyd Amanda, 2011, J Diabetes Sci Technol, V5, P714; Boyko EJ, 2006, DIABETES CARE, V29, P1202, DOI 10.2337/dc05-2031; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007543.pub2; Callaghan B, 2013, ANN NEUROL, V74, P397, DOI 10.1002/ana.23986; Callaghan BC, 2012, CURR OPIN NEUROL, V25, P536, DOI 10.1097/WCO.0b013e328357a797; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Centers for Disease Control and Prevention, 2011, 2011 NAT DIAB FACT S; Chattopadhyay M, 2008, J NEUROSCI, V28, P6652, DOI 10.1523/JNEUROSCI.5530-07.2008; Chaudhry V, 2008, COCHRANE DB SYST REV, V3; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x; DELLON AL, 1992, PLAST RECONSTR SURG, V89, P689, DOI 10.1097/00006534-199204000-00018; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dunnigan SK, 2013, DIABETES CARE, V36, P3684, DOI 10.2337/dc13-0746; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Dyck PJ, 1997, NEUROLOGY, V49, P229, DOI 10.1212/WNL.49.1.229; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Dyck PJB, 1999, NEUROLOGY, V53, P2113, DOI 10.1212/WNL.53.9.2113; Eisenberg E, 2001, NEUROLOGY, V57, P505, DOI 10.1212/WNL.57.3.505; Eisenberg E, 2007, DRUGS, V67, P1265, DOI 10.2165/00003495-200767090-00003; England JD, 2005, ARCH PHYS MED REHAB, V86, P167, DOI 10.1016/j.apmr.2004.09.011; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Freeman R, 2003, NEUROLOGY, V60, P465, DOI 10.1212/WNL.60.3.465; Galloway C, 2013, CYTOKINE, V63, P1, DOI 10.1016/j.cyto.2013.04.009; Gibbons CH, 2008, NEUROLOGY, V70, P2299, DOI 10.1212/01.wnl.0000314646.49565.c0; Gibbons CH, 2013, J PERIPHER NERV SYST, V18, P153, DOI 10.1111/jns5.12021; Gibbons CH, 2010, ANN NEUROL, V67, P534, DOI 10.1002/ana.21952; Gill D., 2011, COCHRANE DB SYST REV, V10; Gossrau G, 2011, PAIN MED, V12, P953, DOI 10.1111/j.1526-4637.2011.01140.x; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Han TT, 2012, EUR J ENDOCRINOL, V167, P465, DOI 10.1530/EJE-12-0555; Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Holland NR, 1998, ANN NEUROL, V44, P47, DOI 10.1002/ana.410440111; Illigens BMW, 2013, AUTON NEUROSCI-BASIC, V177, P286, DOI 10.1016/j.autneu.2013.06.006; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2009, IDF DIAB ATL SEC IDF; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Katz JS, 2001, MUSCLE NERVE, V24, P794, DOI 10.1002/mus.1071; Kelkar P, 2003, J NEUROL NEUROSUR PS, V74, P803, DOI 10.1136/jnnp.74.6.803; Kennedy WR, 1996, SEMIN NEUROL, V16, P163, DOI 10.1055/s-2008-1040972; KIKTA DG, 1982, ANN NEUROL, V11, P80, DOI 10.1002/ana.410110114; Kluding PM, 2012, J DIABETES COMPLICAT, V26, P424, DOI 10.1016/j.jdiacomp.2012.05.007; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Linn T, 1996, METABOLISM, V45, P1508, DOI 10.1016/S0026-0495(96)90180-8; Low PA, 1997, MUSCLE NERVE, V20, P1561, DOI 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; Margolis DJ, 2011, INCIDENCE DIABETIC F; MARTIN MM, 1953, BRAIN, V76, P594, DOI 10.1093/brain/76.4.594; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; Myers MI, 2013, MUSCLE NERVE, V47, P1, DOI 10.1002/mus.23510; Myers MI, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0323-2; Ohnari Keiko, 2007, Brain and Nerve (Tokyo), V59, P1247; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; Pergolizzi JV, 2013, PAIN PRACT, V13, P239, DOI 10.1111/j.1533-2500.2012.00578.x; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Pop-Busui R, 2010, CURR DIABETES REP, V10, P276, DOI 10.1007/s11892-010-0120-8; Powers AC, 2012, HARRISONS PRINCIPLES; Provitera V, 2007, MUSCLE NERVE, V35, P767, DOI 10.1002/mus.20771; Raskin P, 2004, NEUROLOGY, V63, P865, DOI 10.1212/01.WNL.0000137341.89781.14; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Sands ML, 1997, DIABETES CARE, V20, P322, DOI 10.2337/diacare.20.3.322; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Sills GJ, 2006, CURR OPIN PHARMACOL, V6, P108, DOI 10.1016/j.coph.2005.11.003; Singleton JR, 2008, J PERIPHER NERV SYST, V13, P218, DOI 10.1111/j.1529-8027.2008.00180.x; Singleton JR, 2001, MUSCLE NERVE, V24, P1225, DOI 10.1002/mus.1136; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; Smith SC, 2012, DIABETES RES CLIN PR, V96, P261, DOI 10.1016/j.diabres.2011.11.013; Spallone V, 2012, CLIN J PAIN, V28, P726, DOI 10.1097/AJP.0b013e318243075c; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2011, DIABETES METAB RES R; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Thomsen NOB, 2009, J HAND SURG-AM, V34A, P1177, DOI 10.1016/j.jhsa.2009.04.006; Thrainsdottir S, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2008.01118.x; Tovi J, 1998, ACTA NEUROL SCAND, V98, P346; Valdivia JMV, 2013, ANN PLAS SURG, V70, P675, DOI 10.1097/SAP.0b013e3182764fb0; Vallianou Natalia, 2009, Rev Diabet Stud, V6, P230, DOI 10.1900/RDS.2009.6.230; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; van Steenbergen-Weijenburg KM, 2011, DIABETIC MED, V28, P86, DOI 10.1111/j.1464-5491.2010.03125.x; Vickrey BG, 2000, NEUROREHAB NEURAL RE, V14, P93, DOI 10.1177/154596830001400202; Vincent AM, 2013, HAND CLINIC, V115, P591, DOI 10.1016/B978-0-444-52902-2.00034-5; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Webster Lynn R, 2012, J Pain Res, V5, P7, DOI 10.2147/JPR.S25272; Wiffen PJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008314.pub3; Williams LH, 2010, AM J MED, V123, P748, DOI 10.1016/j.amjmed.2010.01.023; Young BA, 2010, GEN HOSP PSYCHIAT, V32, P119, DOI 10.1016/j.genhosppsych.2009.11.018; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557; Zhou MK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007963.pub2; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216; Ziegler D, 2011, DIABETES CARE, V34, P2054, DOI 10.2337/dc11-0503; Zur E, 2014, CLIN J PAIN, V30, P73, DOI 10.1097/AJP.0b013e318285d1ba	117	119	131	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2014	348								g1799	10.1136/bmj.g1799	http://dx.doi.org/10.1136/bmj.g1799			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OG	24803311				2022-12-28	WOS:000335819000001
J	Sifre, D; Gardes, E; Massuyeau, M; Hashim, L; Hier-Majumder, S; Gaillard, F				Sifre, David; Gardes, Emmanuel; Massuyeau, Malcolm; Hashim, Leila; Hier-Majumder, Saswata; Gaillard, Fabrice			Electrical conductivity during incipient melting in the oceanic low-velocity zone	NATURE			English	Article							MANTLE; CARBON; LITHOSPHERE; EXTRACTION; BOUNDARY; ROCKS; WATER; 14-DEGREES-N; CONSTRAINTS; OLIVINE	The low-viscosity layer in the upper mantle, the asthenosphere, is a requirement for plate tectonics(1). The seismic low velocities and the high electrical conductivities of the asthenosphere are attributed either to subsolidus, water-related defects in olivine minerals(2-4) or to a few volume per cent of partial melt(5-8), but these two interpretations have two shortcomings. First, the amount of water stored in olivine is not expected to be higher than 50 parts per million owing to partitioning with other mantle phases(9) (including pargasite amphibole at moderate temperatures(10)) and partial melting at high temperatures(9). Second, elevated melt volume fractions are impeded by the temperatures prevailing in the asthenosphere, which are too low, and by the melt mobility, which is high and can lead to gravitational segregation(11,12). Here we determine the electrical conductivity of carbon-dioxide-rich and water-rich melts, typically produced at the onset of mantle melting. Electrical conductivity increases modestly with moderate amounts of water and carbon dioxide, but it increases drastically once the carbon dioxide content exceeds six weight per cent in the melt. Incipient melts, long-expected to prevail in the asthenosphere(10,13-15), can therefore produce high electrical conductivities there. Taking into account variable degrees of depletion of the mantle in water and carbon dioxide, and their effect on the petrology of incipient melting, we calculated conductivity profiles across the asthenosphere for various tectonic plate ages. Several electrical discontinuities are predicted and match geophysical observations in a consistent petrological and geochemical framework. In moderately aged plates (more than five million years old), incipient melts probably trigger both the seismic low velocities and the high electrical conductivities in the upper part of the asthenosphere, whereas in young plates(4), where seamount volcanism occurs(6), a higher degree of melting is expected.	[Sifre, David; Gardes, Emmanuel; Massuyeau, Malcolm; Hashim, Leila; Hier-Majumder, Saswata; Gaillard, Fabrice] Univ Orleans, ISTO, UMR 7327, F-45071 Orleans, France; [Sifre, David; Gardes, Emmanuel; Massuyeau, Malcolm; Hashim, Leila; Hier-Majumder, Saswata; Gaillard, Fabrice] CNRS, ISTO, UMR 7327, F-45071 Orleans, France; [Sifre, David; Gardes, Emmanuel; Massuyeau, Malcolm; Hashim, Leila; Hier-Majumder, Saswata; Gaillard, Fabrice] Bur Rech Geol & Minieres, ISTO, UMR 7327, F-45060 Orleans, France; [Gardes, Emmanuel] Univ Caen Basse Normandie, CNRS, Ctr Rech Ions Mat & Photon,UMR 6252, Commissariat Energie Atom,Ecole Natl Super Ingeni, F-14070 Caen, France; [Hier-Majumder, Saswata] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Hier-Majumder, Saswata] Univ Maryland, Ctr Sci Computat & Appl Math Modeling, College Pk, MD 20742 USA; [Hier-Majumder, Saswata] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England	Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of London; Royal Holloway University London	Gaillard, F (corresponding author), Univ Orleans, ISTO, UMR 7327, F-45071 Orleans, France.	fabrice.gaillard@cnrs-orleans.fr	Gaillard, Fabrice/H-1308-2012; Hier-Majumder, Saswata/C-3917-2009; Hier-Majumder, Saswata/Q-7365-2019	Gaillard, Fabrice/0000-0001-8079-0476; Hier-Majumder, Saswata/0000-0002-2629-1729; Hier-Majumder, Saswata/0000-0002-2629-1729; Gaillard, Fabrice/0000-0002-4443-8253; Massuyeau, Malcolm/0000-0003-1401-7738	European Research Council (ERC) [279790]; French agency for research (ANR) [2010 BLAN62101]; US NSF [EAR1215800]; University of Orleans; Directorate For Geosciences [1215800] Funding Source: National Science Foundation	European Research Council (ERC)(European Research Council (ERC)); French agency for research (ANR)(French National Research Agency (ANR)); US NSF(National Science Foundation (NSF)); University of Orleans; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work, part of the ElectroLith project, benefited from funding by the European Research Council (ERC project #279790) and the French agency for research (ANR project #2010 BLAN62101). S. H.-M. acknowledges support from the US NSF grant EAR1215800 and a grant from the University of Orleans. We thank David H. Green for comments.	[Anonymous], [No title captured], DOI DOI 10.1130/2005.2388(13); Caricchi L, 2011, EARTH PLANET SC LETT, V302, P81, DOI 10.1016/j.epsl.2010.11.041; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; Dasgupta R, 2013, REV MINERAL GEOCHEM, V75, P183, DOI 10.2138/rmg.2013.75.7; Dasgupta R, 2013, NATURE, V493, P211, DOI 10.1038/nature11731; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Faul UH, 2001, NATURE, V410, P920, DOI 10.1038/35073556; Fischer KM, 2010, ANNU REV EARTH PL SC, V38, P551, DOI 10.1146/annurev-earth-040809-152438; Gaillard F, 2004, EARTH PLANET SC LETT, V218, P215, DOI 10.1016/S0012-821X(03)00639-3; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Garapic G, 2013, GEOCHEM GEOPHY GEOSY, V14, P556, DOI 10.1029/2012GC004547; Glover PWJ, 2000, EARTH PLANET SC LETT, V180, P369, DOI 10.1016/S0012-821X(00)00168-0; Green D.H., 2005, GSA AM SPEC PAPER, V388, P217; Green DH, 2010, NATURE, V467, P448, DOI 10.1038/nature09369; GREEN DH, 1976, TECTONOPHYSICS, V32, P61, DOI 10.1016/0040-1951(76)90086-X; Guillot B, 2011, GEOCHIM COSMOCHIM AC, V75, P1829, DOI 10.1016/j.gca.2011.01.004; Hammouda T, 2000, GEOLOGY, V28, P283, DOI 10.1130/0091-7613(2000)28<283:UMIBCM>2.0.CO;2; Hashim L, 2013, EARTH PLANET SC LETT, V373, P20, DOI 10.1016/j.epsl.2013.04.026; Hier-Majumder S, 2006, EARTH PLANET SC LETT, V248, P735, DOI 10.1016/j.epsl.2006.06.015; Hier-Majumder S, 2011, EARTH PLANET SC LETT, V308, P334, DOI 10.1016/j.epsl.2011.05.055; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hoink T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003698; Iacono-Marziano G, 2012, GEOCHIM COSMOCHIM AC, V97, P1, DOI 10.1016/j.gca.2012.08.035; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; Jones AG, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004055; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Katz RF, 2012, EARTH PLANET SC LETT, V335, P226, DOI 10.1016/j.epsl.2012.04.042; Keppler H, 2003, NATURE, V424, P414, DOI 10.1038/nature01828; LANGE RL, 1990, REV MINERAL, V24, P25; Liu Q, 2003, CONTRIB MINERAL PETR, V146, P370, DOI 10.1007/s00410-003-0505-7; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; MINARIK WG, 1995, EARTH PLANET SC LETT, V133, P423, DOI 10.1016/0012-821X(95)00085-Q; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; O'Reilly SY, 2010, LITHOS, V120, P1, DOI 10.1016/j.lithos.2010.03.016; Partzsch GM, 2000, TECTONOPHYSICS, V317, P189, DOI 10.1016/S0040-1951(99)00320-0; Pommier A, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005269; Pommier A, 2010, AM MINERAL, V95, P284, DOI 10.2138/am.2010.3314; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; Stagno V, 2013, NATURE, V493, P84, DOI 10.1038/nature11679; Takei Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005850; ten Grotenhuis SM, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003462; TYBURCZY JA, 1983, J GEOPHYS RES, V88, P2413, DOI 10.1029/JB088iB03p02413; Utada H, 2014, PHYS EARTH PLANET IN, V227, P41, DOI 10.1016/j.pepi.2013.12.004; WALLACE ME, 1988, NATURE, V335, P343, DOI 10.1038/335343a0; Yoshino T, 2012, PHYS EARTH PLANET IN, V194, P1, DOI 10.1016/j.pepi.2012.01.005; Yoshino T, 2010, EARTH PLANET SC LETT, V295, P593, DOI 10.1016/j.epsl.2010.04.050	55	143	151	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					81	+		10.1038/nature13245	http://dx.doi.org/10.1038/nature13245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784219	Green Submitted, Green Accepted			2022-12-28	WOS:000335199100043
J	Myles, PR; Leonardi-Bee, J				Myles, Puja R.; Leonardi-Bee, Jo		PRIDE Res Consortium Investigators	NEWS STORY ON TAMIFLU STUDY Authors' reply to Mark Jones's second critique of the study by Muthuri and colleagues reported in The BMJ	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Myles, Puja R.; Leonardi-Bee, Jo; PRIDE Res Consortium Investigators] Univ Nottingham, City Hosp, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Myles, PR (corresponding author), Univ Nottingham, City Hosp, Nottingham NG5 1PB, England.	puja.myles@nottingham.ac.uk		Leonardi-Bee, Jo/0000-0003-0893-6068; Myles, Puja/0000-0002-8976-890X				Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Jones M, 2014, BMJ-BRIT MED J, V348, pg3001; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Kmietowicz Zosia, 2014, BMJ, V348, pg2228, DOI 10.1136/bmj.g2228; Muthuri SG, 2014, LANCET RESP MED; Myles PR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2990	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2014	348								g3004	10.1136/bmj.g3004	http://dx.doi.org/10.1136/bmj.g3004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RZ	24788389				2022-12-28	WOS:000335477500005
J	McCarthy, D; Schoen, C; Radley, D				McCarthy, Douglas; Schoen, Cathy; Radley, David			State Health System Performance A Scorecard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McCarthy, Douglas; Schoen, Cathy] Commonwealth Fund, New York, NY 10021 USA; [Radley, David] Inst Healthcare Improvement, Cambridge, MA USA	Commonwealth Fund; Institute for Healthcare Improvement	McCarthy, D (corresponding author), Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA.	dm@cmwf.org	McCarthy, Douglas/GSJ-0784-2022	McCarthy, Douglas/0000-0002-3295-3522				Chokshi DA, JAMA FORUM YOUNG ADU; Davis K, 1978, HEALTH AND THE WAR O; Jones DK, 2014, JAMA-J AM MED ASSOC, V311, P1965, DOI 10.1001/jama.2014.3700; Radley D, 2014, AIMING HIGHER A SCOR; The Commonwealth Fund, MINNESOTA COMPREHENS; The Commonwealth Fund, MEDICAID EXPANSION	6	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					131	132		10.1001/jama.2014.5374	http://dx.doi.org/10.1001/jama.2014.5374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	24788783				2022-12-28	WOS:000338511200016
J	Hovestadt, V; Jones, DTW; Picelli, S; Wang, W; Kool, M; Northcott, PA; Sultan, M; Stachurski, K; Ryzhova, M; Warnatz, HJ; Ralser, M; Brun, S; Bunt, J; Jager, N; Kleinheinz, K; Erkek, S; Weber, UD; Bartholomae, CC; von Kalle, C; Lawerenz, C; Eils, J; Koster, J; Versteeg, R; Milde, T; Witt, O; Schmidt, S; Wolf, S; Pietsch, T; Rutkowski, S; Scheurlen, W; Taylor, MD; Brors, B; Felsberg, J; Reifenberger, G; Borkhardt, A; Lehrach, H; Wechsler-Reya, RJ; Eils, R; Yaspo, ML; Landgraf, P; Korshunov, A; Zapatka, M; Radlwimmer, B; Pfister, SM; Lichter, P				Hovestadt, Volker; Jones, David T. W.; Picelli, Simone; Wang, Wei; Kool, Marcel; Northcott, Paul A.; Sultan, Marc; Stachurski, Katharina; Ryzhova, Marina; Warnatz, Hans-Joerg; Ralser, Meryem; Brun, Sonja; Bunt, Jens; Jaeger, Natalie; Kleinheinz, Kortine; Erkek, Scrap; Weber, Ursula D.; Bartholomae, Cynthia C.; von Kalle, Christof; Lawerenz, Chris; Eils, Jurgen; Koster, Jan; Versteeg, Rogier; Milde, Till; Witt, Olaf; Schmidt, Sabine; Wolf, Stephan; Pietsch, Torsten; Rutkowski, Stefan; Scheurlen, Wolfram; Taylor, Michael D.; Brors, Benedikt; Felsberg, Joerg; Reifenberger, Guido; Borkhardt, Arndt; Lehrach, Hans; Wechsler-Reya, Robert J.; Eils, Roland; Yaspo, Marie-Laure; Landgraf, Pablo; Korshunov, Andrey; Zapatka, Marc; Radlwimmer, Bernhard; Pfister, Stefan M.; Lichter, Peter			Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing	NATURE			English	Article							CANCER GENOME; GENE; DIFFERENTIATION; HYPERMETHYLATION; IDENTIFICATION; SUPPRESSOR; METHYLOME; ULTRAFAST; ALIGNMENT; MUTATION	Epigenetic alterations, that is, disruption of DNA methylation and chromatin architecture, are now acknowledged as a universal feature of tumorigenesis(1). Medulloblastoma, a clinically challenging, malignant childhood brain tumour, is no exception. Despite much progress from recent genomics studies, with recurrent changes identified in each of the four distinct tumour subgroups(WNT-pathway-activated, SHH-pathway-activated, and the less-well-characterized Group 3 and Group 4)(2-4), many cases still lack an obvious genetic driver. Here we present whole-genome bisulphite-sequencing data from thirty-four human and five murine tumours plus eight human and three murine normal controls, augmented with matched whole-genome, RNA and chromatin immunoprecipitation sequencing data. This comprehensive data set allowed us to decipher several features underlying the interplay between the genome, epigenome and transcriptome, and its effects on medulloblastoma pathophysiology. Most notable were highly prevalent regions of hypomethylation correlating with increased gene expression, extending tens of kilobases downstream of transcription start sites. Focal regions of low methylation linked to transcription-factor-binding sites shed light on differential transcriptional networks between subgroups, whereas increased methylation due to re-normalization of repressed chromatin in DNA methylation valleys was positively correlated with gene expression. Large, partially methylated domains affecting up to one-third of the genome showed increased mutation rates and gene silencing in a subgroup-specific fashion. Epigenetic alterations also affected novel medulloblastoma candidate genes (for example, LIN28B), resulting in alternative promoter usage and/or differential messenger RNA/microRNA expression. Analysis of mouse medulloblastoma and precursor-cell methylation demonstrated a somatic origin for many alterations. Our data provide insights into the epigenetic regulation of transcription and genome organization in medulloblastoma pathogenesis, which are probably also of importance in a wider developmental and disease context.	[Hovestadt, Volker; Picelli, Simone; Wang, Wei; Kleinheinz, Kortine; Weber, Ursula D.; Zapatka, Marc; Radlwimmer, Bernhard; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Erkek, Scrap; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Sultan, Marc; Warnatz, Hans-Joerg; Ralser, Meryem; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stachurski, Katharina; Borkhardt, Arndt; Landgraf, Pablo] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Brun, Sonja; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Designated Canc Ctr, NCI, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Bunt, Jens] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Bunt, Jens; Koster, Jan; Versteeg, Rogier] Univ Amsterdam, AMC, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Jaeger, Natalie; Kleinheinz, Kortine; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Erkek, Scrap] EMBL, D-69117 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Lawerenz, Chris; Eils, Jurgen] German Canc Res Ctr, Data Management Facil, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, D-69120 Heidelberg, Germany; [Schmidt, Sabine; Wolf, Stephan] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Pietsch, Torsten] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; [Rutkowski, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Felsberg, Joerg; Reifenberger, Guido] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, IPMB, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany; [Eils, Roland; Lichter, Peter] Heidelberg Ctr Personalised Oncol DKFZ HIPO, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Heinrich Heine University Dusseldorf; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hovestadt, V (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Northcott, Paul A/N-4022-2018; Versteeg, Rogier/AAQ-1765-2020; Zapatka, Marc/G-9896-2013; Jones, David TW/G-9588-2013; Milde, Till/AAR-4528-2021; Ryzhova, Marina/G-4178-2014; Bunt, Jens/C-4775-2014; Pfister, Stefan M/F-6860-2013; Hovestadt, Volker/ABG-2076-2021; Erkek, Serap/AAV-5549-2020; Brors, Benedikt/E-5620-2013; Milde, Till/L-7755-2015; Kool, Marcel/H-2541-2013; Eils, Roland/B-6121-2009; Koster, Jan/C-5934-2008; Radlwimmer, Bernhard F/I-3229-2013; Reifenberger, Guido/AAE-3599-2019; Jones, David T. W./Z-1963-2019	Northcott, Paul A/0000-0002-1220-5252; Zapatka, Marc/0000-0001-8287-5967; Jones, David TW/0000-0002-2036-5141; Milde, Till/0000-0002-7267-1052; Ryzhova, Marina/0000-0001-7206-6365; Bunt, Jens/0000-0003-0397-2019; Pfister, Stefan M/0000-0002-5447-5322; Hovestadt, Volker/0000-0002-3480-6649; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Koster, Jan/0000-0002-0890-7585; Radlwimmer, Bernhard F/0000-0002-4553-7800; Warnatz, Hans-Jorg/0000-0002-0327-9209; Korshunov, Andrey/0000-0002-5257-3623; Jaeger, Natalie/0000-0002-9589-7580; Kleinheinz, Kortine/0000-0002-1859-2281; Erkek, Serap/0000-0003-4439-5203; Versteeg, Rogier/0000-0001-7172-0388; Taylor, Michael/0000-0001-7009-3466; Picelli, Simone/0000-0002-1747-614X	German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A]; German Federal Ministry of Education and Research (MedSys) [0315416C]; German Federal Ministry of Education and Research (NGFNplus) [01GS0883]; DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundations KWF [2010-4713]; KIKA; German Research Foundation (DFG) [LA2983/2-1]	German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (MedSys)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (NGFNplus)(Federal Ministry of Education & Research (BMBF)); DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundations KWF; KIKA; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank the members of the ICGC PedBrain Tumor Project, the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility, the European Molecular Biology Laboratory (EMBL) Genomics Core Facility, M. Schick, R. Fischer, M. Bewerunge-Hudler, M. Knopf, R. Kabbe, A. Benner, R. Volckman and P. van Sluis for technical support and helpful discussion. Active Motif, Inc. is acknowledged for ChIP and library preparation. We also thank C. Plass for critical reading of the manuscript. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C and NGFN<SUP>plus</SUP> #01GS0883). Additional support came from the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Dutch Cancer Foundations KWF (2010-4713) and KIKA (M.Ko.), and the German Research Foundation (DFG; grant LA2983/2-1 to P.La.).	[Anonymous], 2010, R LANG ENV STAT COMP; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Bunt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026058; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Manoranjan B, 2013, STEM CELLS, V31, P1266, DOI 10.1002/stem.1401; Milde T, 2012, J NEURO-ONCOL, V110, P335, DOI 10.1007/s11060-012-0978-1; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	288	291	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					537	+		10.1038/nature13268	http://dx.doi.org/10.1038/nature13268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847876	Green Published			2022-12-28	WOS:000337806300047
J	Schauder, CM; Wu, XD; Saheki, Y; Narayanaswamy, P; Torta, F; Wenk, MR; De Camilli, P; Reinisch, KM				Schauder, Curtis M.; Wu, Xudong; Saheki, Yasunori; Narayanaswamy, Pradeep; Torta, Federico; Wenk, Markus R.; De Camilli, Pietro; Reinisch, Karin M.			Structure of a lipid-bound extended synaptotagmin indicates a role in lipid transfer	NATURE			English	Article							CONTACT SITES; CRYSTAL-STRUCTURE; PROTEINS; ER; REVEALS; DOMAINS	Growing evidence suggests that close appositions between the endoplasmic reticulum(ER) and other membranes, including appositions with the plasma membrane (PM), mediate exchange of lipids between these bilayers. The mechanisms of such exchange, which allows lipid transfer independently of vesicular transport, remain poorly understood. The presence of a synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain, a proposed lipid-binding module, in several proteins localized at membrane contact sites has raised the possibility that such domains may be implicated in lipid transport(1,2). SMP-containing proteins include components of the ERMES complex, an ER-mitochondrial tether(3), and the extended synaptotagmins (known as tricalbins in yeast), which are ER-PM tethers(4-6). Here we present at 2.44 angstrom resolution the crystal structure of a fragment of human extended synaptotagmin 2 (E-SYT2), including an SMP domain and two adjacent C2 domains. The SMP domain has a beta-barrel structure like protein modules in the tubular-lipid-binding (TULIP) superfamily. It dimerizes to form an approximately 90-angstrom-long cylinder traversed by a channel lined entirely with hydrophobic residues, with the two C2A-C2B fragments forming arched structures flexibly linked to the SMP domain. Importantly, structural analysis complemented by mass spectrometry revealed the presence of glycerophospholipids in the E-SYT2 SMP channel, indicating a direct role for E-SYTs in lipid transport. These findings provide strong evidence for a role of SMP-domain-containing proteins in the control of lipid transfer at membrane contact sites and have broad implications beyond the field of ER-to-PM appositions.	[Schauder, Curtis M.; Wu, Xudong; Saheki, Yasunori; De Camilli, Pietro; Reinisch, Karin M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Saheki, Yasunori; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Saheki, Yasunori; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Narayanaswamy, Pradeep] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; National University of Singapore; National University of Singapore	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	pietro.decamilli@yale.edu; karin.reinisch@yale.edu	Wenk, Markus Rene/D-1441-2014; Saheki, Yasunori/D-5430-2016	Saheki, Yasunori/0000-0002-1229-6668; Torta, Federico/0000-0001-7545-7484	National Institutes of Health [GM080616, R37NS36251, DK082700]; National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council [BMRC-SERC Diag-034]; National Science Foundation Graduate Research Fellowship [DGE-1122492]; Uehara Memorial Foundation; Japanese Society for Promotion of Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore via the Life Sciences Institute (LSI); Biochemical Research Council; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to the staff at NE-CAT beamline 24ID-C at the Advanced Photon Source for assistance with data collection. We thank H. Shen and N. Kumar for discussion. This work was supported by the National Institutes of Health (GM080616 to K.M.R., R37NS36251 and DK082700 to P.D.C.). M.R.W. and F.T. are funded by grants from the National University of Singapore via the Life Sciences Institute (LSI) and the Biochemical Research Council (BMRC-SERC Diag-034). C.M.S. is recipient of an National Science Foundation Graduate Research Fellowship (DGE-1122492). Y.S. was supported by the Uehara Memorial Foundation and the Japanese Society for Promotion of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopec KO, 2011, BIOCHEM SOC T, V39, P1033, DOI 10.1042/BST0391033; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Xu JJ, 2014, STRUCTURE, V22, P269, DOI 10.1016/j.str.2013.11.011; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	30	201	206	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					552	+		10.1038/nature13269	http://dx.doi.org/10.1038/nature13269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847877	Green Accepted			2022-12-28	WOS:000337806300050
J	Rau, IG; Baumann, S; Rusponi, S; Donati, F; Stepanow, S; Gragnaniello, L; Dreiser, J; Piamonteze, C; Nolting, F; Gangopadhyay, S; Albertini, OR; Macfarlane, RM; Lutz, CP; Jones, BA; Gambardella, P; Heinrich, AJ; Brune, H				Rau, Ileana G.; Baumann, Susanne; Rusponi, Stefano; Donati, Fabio; Stepanow, Sebastian; Gragnaniello, Luca; Dreiser, Jan; Piamonteze, Cinthia; Nolting, Frithjof; Gangopadhyay, Shruba; Albertini, Oliver R.; Macfarlane, Roger M.; Lutz, Christopher P.; Jones, Barbara A.; Gambardella, Pietro; Heinrich, Andreas J.; Brune, Harald			Reaching the magnetic anisotropy limit of a 3d metal atom	SCIENCE			English	Article							RAY CIRCULAR-DICHROISM; PERPENDICULAR-ANISOTROPY; SPECTROSCOPY; ABSORPTION; RESOLUTION; SURFACE; MOMENT	Designing systems with large magnetic anisotropy is critical to realize nanoscopic magnets. Thus far, the magnetic anisotropy energy per atom in single-molecule magnets and ferromagnetic films remains typically one to two orders of magnitude below the theoretical limit imposed by the atomic spin-orbit interaction. We realized the maximum magnetic anisotropy for a 3d transition metal atom by coordinating a single Co atom to the O site of an MgO(100) surface. Scanning tunneling spectroscopy reveals a record-high zero-field splitting of 58 millielectron volts as well as slow relaxation of the Co atom's magnetization. This striking behavior originates from the dominating axial ligand field at the O adsorption site, which leads to out-of-plane uniaxial anisotropy while preserving the gas-phase orbital moment of Co, as observed with x-ray magnetic circular dichroism.	[Rau, Ileana G.; Baumann, Susanne; Gangopadhyay, Shruba; Albertini, Oliver R.; Macfarlane, Roger M.; Lutz, Christopher P.; Jones, Barbara A.; Heinrich, Andreas J.] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Baumann, Susanne] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Rusponi, Stefano; Donati, Fabio; Gragnaniello, Luca; Dreiser, Jan; Brune, Harald] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, Stn 3, CH-1015 Lausanne, Switzerland; [Stepanow, Sebastian; Gambardella, Pietro] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Dreiser, Jan; Piamonteze, Cinthia; Nolting, Frithjof] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Albertini, Oliver R.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA	International Business Machines (IBM); University of Basel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Georgetown University	Gambardella, P (corresponding author), ETH, Dept Mat, Honggerbergring 64, CH-8093 Zurich, Switzerland.	pietro.gambardella@mat.ethz.ch; andreash@us.ibm.com; harald.brune@epfl.ch	Nolting, Frithjof/ABD-7373-2021; Brune, Harald/E-7284-2017; Dreiser, Jan/W-6261-2018; Donati, Fabio/M-9306-2016; Nolting, Frithjof/J-4820-2017; Donati, Fabio/AAV-9856-2021; Gambardella, Pietro/B-1880-2009; gangopadhyay, shruba/M-2079-2015; Piamonteze, Cinthia/E-9740-2016	Nolting, Frithjof/0000-0002-5679-5370; Brune, Harald/0000-0003-4459-3111; Dreiser, Jan/0000-0001-7480-1271; Donati, Fabio/0000-0002-3932-2889; Nolting, Frithjof/0000-0002-5679-5370; Donati, Fabio/0000-0002-3932-2889; Gambardella, Pietro/0000-0003-0031-9217; Piamonteze, Cinthia/0000-0002-8416-9668; Stepanow, Sebastian/0000-0002-4090-6574; Rusponi, Stefano/0000-0002-8494-5532; Baumann, Susanne/0000-0002-3821-494X	Swiss Competence Centre for Materials Science and Technology (CCMX); Ambizione grant of the Swiss National Science Foundation; Office of Naval Research; National Science Foundation [DMR-1006605, 1066293]; Division Of Materials Research [1006605] Funding Source: National Science Foundation	Swiss Competence Centre for Materials Science and Technology (CCMX); Ambizione grant of the Swiss National Science Foundation; Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	S. S. and P. G. acknowledge support from the Swiss Competence Centre for Materials Science and Technology (CCMX). J.D. acknowledges funding by an Ambizione grant of the Swiss National Science Foundation. I. G. R., S. B., C. P. L., and A.J.H. thank B. Melior for expert technical assistance. C. P. L and A.J.H. thank the Office of Naval Research for financial support. S. G., O.R.A., and B.A.J. thank the National Energy Research Scientific Computing Center (NERSC) for computational resources. O.R.A. was supported by the National Science Foundation under grant DMR-1006605. B.A.J. thanks the Aspen Center for Physics and National Science Foundation grant 1066293 for hospitality while doing the calculations which appear in this paper. We thank A. Cavallin for helping in developing the Igor code used to analyze the XAS spectra. I. G. R., S. B., R. M. M., C. P. L., and A.J.H. performed the STM experiments and data analysis. S. G., O.R.A., and B.A.J. carried out the DFT calculations. S. R., F. D., L. G., S. B., J.D., C. P., and F.N. carried out the XMCD experiments. F. D., S. R., S. S., and P. G. analyzed the XMCD data. S. S. wrote the multiplet calculation code and performed the simulations. All authors discussed the results and participated in writing the manuscript. A.J.H., P. G., and H. B. initiated and directed this research. The authors declare that they have no competing financial interests.	Baumann S, 2014, ACS NANO, V8, P1739, DOI 10.1021/nn4061034; BLUME M, 1962, PROC R SOC LON SER-A, V270, P127, DOI 10.1098/rspa.1962.0207; BRUNO P, 1989, PHYS REV B, V39, P865, DOI 10.1103/PhysRevB.39.865; Bryan AM, 2012, INORG CHEM, V51, P3366, DOI 10.1021/ic2012414; CARCIA PF, 1988, J APPL PHYS, V63, P5066, DOI 10.1063/1.340404; CARRA P, 1993, PHYS REV LETT, V70, P694, DOI 10.1103/PhysRevLett.70.694; Cubukcu M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863407; de Groot F, 2001, CHEM REV, V101, P1779, DOI 10.1021/cr9900681; DEGROOT FMF, 1993, J PHYS-CONDENS MAT, V5, P2277, DOI 10.1088/0953-8984/5/14/023; Donati F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.236801; ERIKSSON O, 1990, PHYS REV B, V42, P2707, DOI 10.1103/PhysRevB.42.2707; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; Gajek M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694270; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Gambardella P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047202; Gambardella P, 2002, NATURE, V416, P301, DOI 10.1038/416301a; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gauyacq JP, 2012, PROG SURF SCI, V87, P63, DOI 10.1016/j.progsurf.2012.05.003; Giraud R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057203; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; Ikeda Shoji, 2012, SPIN, V2, DOI 10.1142/S2010324712400036; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/NMAT2804, 10.1038/nmat2804]; Jesche A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4333; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Khizroev S., 2004, PERPENDICULAR MAGNET; Klatyk J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207202; Lehnert A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.104430; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; LOWDIN PO, 1955, PHYS REV, V97, P1474, DOI 10.1103/PhysRev.97.1474; Manchon A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2969711; McGarvey B., 1966, ELECT SPIN RESONANCE, V3; MEIKLEJOHN WH, 1986, P IEEE, V74, P1570, DOI 10.1109/PROC.1986.13669; Miyamachi T, 2013, NATURE, V503, P242, DOI 10.1038/nature12759; Monso S, 2002, APPL PHYS LETT, V80, P4157, DOI 10.1063/1.1483122; Neyman KM, 2004, APPL PHYS A-MATER, V78, P823, DOI [10.1007/s00339-033-2437-5, 10.1007/s00339-003-2437-5]; Rinehart JD, 2011, CHEM SCI, V2, P2078, DOI 10.1039/c1sc00513h; Schintke S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.276801; Sun JZ, 2000, PHYS REV B, V62, P570, DOI 10.1103/PhysRevB.62.570; THOLE BT, 1992, PHYS REV LETT, V68, P1943, DOI 10.1103/PhysRevLett.68.1943; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; van Vleck J., 1966, THEORY ELECT MAGNETI; WELLER D, 1995, PHYS REV LETT, V75, P3752, DOI 10.1103/PhysRevLett.75.3752; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; Yang HX, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054401; Zadrozny JM, 2013, NAT CHEM, V5, P577, DOI [10.1038/NCHEM.1630, 10.1038/nchem.1630]	46	268	270	12	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					988	992		10.1126/science.1252841	http://dx.doi.org/10.1126/science.1252841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24812206				2022-12-28	WOS:000336495800035
J	Lundgren, P				Lundgren, Paul			EARTH SCIENCE Fertile fields for seismicity	NATURE			English	Editorial Material							SAN-ANDREAS FAULT; SIERRA-NEVADA; ROCK UPLIFT; CALIFORNIA		CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Lundgren, P (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	paul.r.lundgren@jpl.nasa.gov						Amos CB, 2014, NATURE, V509, P483, DOI 10.1038/nature13275; Bettinelli P, 2008, EARTH PLANET SC LETT, V266, P332, DOI 10.1016/j.epsl.2007.11.021; Blewitt G, 2013, J GEODYN, V72, P11, DOI 10.1016/j.jog.2013.08.004; Fu YN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008925; Heki K, 2003, EARTH PLANET SC LETT, V207, P159, DOI 10.1016/S0012-821X(02)01148-2; Luttrell K, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004752; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Saleeby J, 2013, GEOSPHERE, V9, P394, DOI 10.1130/GES00816.1; SAVAGE JC, 1978, J GEOPHYS RES, V83, P3369, DOI 10.1029/JB083iB07p03369; SIEH KE, 1984, GEOL SOC AM BULL, V95, P883, DOI 10.1130/0016-7606(1984)95<883:HAOTSA>2.0.CO;2; SMALL EE, 1995, SCIENCE, V270, P277, DOI 10.1126/science.270.5234.277; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; van der Woerd J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003559	13	0	0	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					436	437		10.1038/nature13338	http://dx.doi.org/10.1038/nature13338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828039				2022-12-28	WOS:000336126000028
J	McGee, S				McGee, Steven			Bedside Teaching Rounds Reconsidered	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CASE PRESENTATIONS; PERCEPTIONS		[McGee, Steven] Dept Vet Affairs Med Ctr, Gen Med Serv, Seattle, WA 98108 USA; [McGee, Steven] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McGee, S (corresponding author), Dept Vet Affairs Med Ctr, Gen Med Serv, Seattle, WA 98108 USA.	steven.mcgee@va.gov						Crumlish CM, 2009, J HOSP MED, V4, P304, DOI 10.1002/jhm.540; Cushing H, 1925, THE LIFE OF SIR WILL; Dhaliwal G, 2013, JAMA-J AM MED ASSOC, V310, P2247, DOI 10.1001/jama.2013.282322; Gonzalo JD, 2009, TEACH LEARN MED, V21, P105, DOI 10.1080/10401330902791156; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; Osler W, 1951, AEQUANIMITAS WITH OT; Rogers HD, 2003, ACAD MED, V78, P945, DOI 10.1097/00001888-200309000-00023; SIMONS RJ, 1989, NEW ENGL J MED, V321, P1273, DOI 10.1056/NEJM198911023211821	8	26	28	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1971	1972		10.1001/jama.2013.286201	http://dx.doi.org/10.1001/jama.2013.286201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846031				2022-12-28	WOS:000336122800016
J	Lau, YC; Lip, GYH				Lau, Yee C.; Lip, Gregory Y. H.			Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lau, Yee C.; Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Birmingham	Lau, YC (corresponding author), Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.			Lau, Yee Cheng/0000-0001-7094-8970				Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC5	10.7326/0003-4819-160-10-201405200-02005	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842439				2022-12-28	WOS:000337347100004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Doctors and patients confuse cervical screening with diagnostic tests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, DORSET ECHO     0409; [Anonymous], NHS CERV SCREEN PROG; [Anonymous], 2013, MIRROR          0307; NHS, 2010, CLIN PRACT GUID ASS; *NICE, 2005, REF GUID SUSP CANC; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Scottish Executive, 2007, SCOTT REF GUID SUSP; Stoppard M., 2013, MIRROR          0527; Templeton SK, 2014, SUNDAY TIMES	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3334	10.1136/bmj.g3334	http://dx.doi.org/10.1136/bmj.g3334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846386				2022-12-28	WOS:000336429100004
J	Wong, FL; Bhatia, S; Landier, W; Francisco, L; Leisenring, W; Hudson, MM; Armstrong, GT; Mertens, A; Stovall, M; Robison, LL; Lyman, GH; Lipshultz, SE; Armenian, SH				Wong, F. Lennie; Bhatia, Smita; Landier, Wendy; Francisco, Liton; Leisenring, Wendy; Hudson, Melissa M.; Armstrong, Gregory T.; Mertens, Ann; Stovall, Marilyn; Robison, Leslie L.; Lyman, Gary H.; Lipshultz, Steven E.; Armenian, Saro H.			Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							VENTRICULAR EJECTION FRACTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; DOXORUBICIN THERAPY; ADULT SURVIVORS; 5-YEAR SURVIVORS; CARDIAC EVENTS; LATE MORTALITY; ENALAPRIL; ECHOCARDIOGRAPHY; CARDIOMYOPATHY	Background: Childhood cancer survivors treated with anthracyclines are at high risk for asymptomatic left ventricular dysfunction (ALVD), subsequent heart failure, and death. The consensus-based Children's Oncology Group (COG) Long-Term Follow-up Guidelines recommend lifetime echocardiographic screening for ALVD. Objective: To evaluate the efficacy and cost-effectiveness of the COG guidelines and to identify more cost-effective screening strategies. Design: Simulation of life histories using Markov health states. Data Sources: Childhood Cancer Survivor Study; published literature. Target Population: Childhood cancer survivors. Time Horizon: Lifetime. Perspective: Societal. Intervention: Echocardiographic screening followed by angiotensin-converting enzyme (ACE) inhibitor and beta-blocker therapies after ALVD diagnosis. Outcome Measures: Quality-adjusted life-years (QALYs), costs, incremental cost-effectiveness ratios (ICERs) in dollars per QALY, and cumulative incidence of heart failure. Results of Base-Case Analysis: The COG guidelines versus no screening have an ICER of $61 500, extend life expectancy by 6 months and QALYs by 1.6 months, and reduce the cumulative incidence of heart failure by 18% at 30 years after cancer diagnosis. However, less frequent screenings are more cost-effective than the guidelines and maintain 80% of the health benefits. Results of Sensitivity Analysis: The ICER was most sensitive to the magnitude of ALVD treatment efficacy; higher treatment efficacy resulted in lower ICER. Limitation: Lifetime non-heart failure mortality and the cumulative incidence of heart failure more than 20 years after diagnosis were extrapolated; the efficacy of ACE inhibitor and beta-blocker therapy in childhood cancer survivors with ALVD is undetermined (or unknown). Conclusion: The COG guidelines could reduce the risk for heart failure in survivors at less than $100 000/QALY. Less frequent screening achieves most of the benefits and would be more cost-effective than the COG guidelines.	[Wong, F. Lennie] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Emory Univ, Sch Med, Atlanta, GA USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Wayne State Univ, Sch Med, Detroit, MI 48201 USA; Childrens Hosp Michigan, Detroit, MI 48201 USA	City of Hope; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; Emory University; University of Texas System; UTMD Anderson Cancer Center; Wayne State University; Children's Hospital of Michigan	Wong, FL (corresponding author), City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA.	lwong@coh.org	Hudson, Melissa M/N-4441-2018; Robison, Leslie/N-8122-2018; Lyman, Gary H/K-5227-2019; Armstrong, Gregory/N-8096-2018	Hudson, Melissa M/0000-0001-6984-2407; Lyman, Gary H/0000-0002-0823-8086; Leisenring, Wendy/0000-0001-7405-0906	Lance Armstrong Foundation; National Cancer Institute [U24-CA55727, U10-CA098543, 2 K12-CA001727-14]; NATIONAL CANCER INSTITUTE [P30CA033572, U10CA098543, U10CA180886, P30CA016672, K12CA001727, U24CA055727] Funding Source: NIH RePORTER	Lance Armstrong Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part by the Lance Armstrong Foundation (Drs. Wong and Armenian) and grants U24-CA55727 (Dr. Robison), U10-CA098543 (primary investigator Dr. Adamson), and 2 K12-CA001727-14 (primary investigator Dr. Mortimer) from the National Cancer Institute.	Armenian SH, 2011, BLOOD, V118, P6023, DOI 10.1182/blood-2011-06-358226; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Armstrong GT, 2010, J CLIN ONCOL, V28, P1224, DOI 10.1200/JCO.2009.24.4608; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Blanco E, 2012, LEUKEMIA LYMPHOMA, V53, P878, DOI 10.3109/10428194.2011.639018; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Centers for Disease Control and Prevention, 2001, NAT HOSP DISCH SURV; ERBEL R, 1984, EUR HEART J, V5, P477, DOI 10.1093/oxfordjournals.eurheartj.a061694; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; First DataBank, 2010, DRUG PRIC POL; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gimelli A, 2008, INT J CARDIOVAS IMAG, V24, P793, DOI 10.1007/s10554-008-9317-1; Gold MR, 1996, COST EFFECTIVENESS H; Guldner L, 2006, RADIOTHER ONCOL, V81, P47, DOI 10.1016/j.radonc.2006.08.020; Habash-Bseiso DE, 2005, CLIN MED RES, V3, P75, DOI 10.3121/cmr.3.2.75; Healthcare Cost and Utilization Project (HCUP), 2008, OV NAT INP SAMPL; Heidenreich PA, 2004, J AM COLL CARDIOL, V43, P1019, DOI 10.1016/j.jacc.2003.10.043; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kirsch J, 2000, HEALTH ECON, V9, P149, DOI 10.1002/(SICI)1099-1050(200003)9:2<149::AID-HEC501>3.0.CO;2-N; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Lipshultz SE, 2002, J CLIN ONCOL, V20, P4517, DOI 10.1200/JCO.2002.12.102; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; Lipshultz SE, 2013, CIRCULATION, V128, P1927, DOI 10.1161/CIR.0b013e3182a88099; Lucariello RJ, 1997, CLIN CARDIOL, V20, P943, DOI 10.1002/clc.4960201108; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; NAIK MM, 1995, J AM COLL CARDIOL, V25, P937, DOI 10.1016/0735-1097(94)00506-L; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Pein F, 2004, BRIT J CANCER, V91, P37, DOI 10.1038/sj.bjc.6601904; Roberts RA, 2009, EAR HEARING, V30, P369, DOI 10.1097/AUD.0b013e31819f316a; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rovai D, 2008, ACTA CARDIOL, V63, P507, DOI 10.2143/AC.63.4.2033051; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; Stinett AA, 1996, COST EFFECTIVENESS H, P349; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; U.S. Census Bureau, 2011, STAT ABSTR US; U.S. Department of Labor, 2010, NAT COMP SURV; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	47	72	74	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					672	+		10.7326/M13-2498	http://dx.doi.org/10.7326/M13-2498			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842414	Green Accepted			2022-12-28	WOS:000337347100014
J	Bradshaw, A				Bradshaw, Ann			PERSONAL VIEW Relink education with practice to restore compassion to nursing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford OX3 0FL, England	Oxford Brookes University	Bradshaw, A (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Jack Straws Lane, Oxford OX3 0FL, England.	aebradshaw@brookes.ac.uk						Commissioning Board Chief Nursing Officer and DH Chief Nursing Adviser, 2012, COMP PRACT; Dean Erin, 2014, Nurs Stand, V28, P10, DOI 10.7748/ns2014.01.28.21.10.s4; Delamothe T, 2011, BMJ-BRIT MED J, V342, pd3416; General Nursing Council for England and Wales, 1923, SYLL SUBJ EX CERT GE; Jarman B, 2013, LANCET, V382, P573, DOI 10.1016/S0140-6736(13)61726-2; Lloyd-Still A., 1921, NURS TIMES, P498; Nolan P, 2013, NURS ETHICS, V20, P840, DOI 10.1177/0969733013498744a; Nursing and Midwifery Council, 2010, STAND PRER NURS ED; Royal College of Nursing, 2012, REP WILL COMM NURS Q, P6	9	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g3310	10.1136/bmj.g3310	http://dx.doi.org/10.1136/bmj.g3310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24841391				2022-12-28	WOS:000336428800019
J	Lupulescu, AI; Rimer, JD				Lupulescu, Alexandra I.; Rimer, Jeffrey D.			In Situ Imaging of Silicalite-1 Surface Growth Reveals the Mechanism of Crystallization	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; ANGLE X-RAY; CRYSTAL-GROWTH; ELEVATED-TEMPERATURES; CRYO-TEM; NUCLEATION; NANOPARTICLES; SCATTERING; EVOLUTION; DIRECTION	The growth mechanism of silicalite-1 (MFI zeolite) is juxtaposed between classical models that postulate silica molecules as primary growth units and nonclassical pathways based on the aggregation of metastable silica nanoparticle precursors. Although experimental evidence gathered over the past two decades suggests that precursor attachment is the dominant pathway, direct validation of this hypothesis and the relative roles of molecular and precursor species has remained elusive. We present an in situ study of silicalite-1 crystallization at characteristic synthesis conditions. Using time-resolved atomic force microscopy images, we observed silica precursor attachment to crystal surfaces, followed by concomitant structural rearrangement and three-dimensional growth by accretion of silica molecules. We confirm that silicalite-1 growth occurs via the addition of both silica molecules and precursors, bridging classical and nonclassical mechanisms.	[Lupulescu, Alexandra I.; Rimer, Jeffrey D.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA	University of Houston System; University of Houston	Rimer, JD (corresponding author), Univ Houston, Dept Chem & Biomol Engn, 4800 Calhoun Rd, Houston, TX 77204 USA.	jrimer@central.uh.edu			NSF [CAREER-1151098, BRIGE-1032621, MRI-1040446]; American Chemical Society [PRF 52422-DNI5]; Welch Foundation [E-1794]	NSF(National Science Foundation (NSF)); American Chemical Society(American Chemical Society); Welch Foundation(The Welch Foundation)	We acknowledge support from NSF (grants CAREER-1151098 and BRIGE-1032621), the American Chemical Society (grant PRF 52422-DNI5), and the Welch Foundation (grant E-1794). SAXS measurements were performed on an instrument that was purchased with support from NSF (grant MRI-1040446). We are grateful to J. Li and M. Rutgers at Asylum Research for technical assistance.	Aerts A, 2011, PHYS CHEM CHEM PHYS, V13, P4318, DOI 10.1039/c0cp01592j; Anderson MW, 2007, FARADAY DISCUSS, V136, P143, DOI 10.1039/b617782b; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; BURKETT SL, 1995, CHEM MATER, V7, P920, DOI 10.1021/cm00053a017; Cubillas P, 2013, CHEM-EUR J, V19, P8236, DOI 10.1002/chem.201300778; Davis TM, 2006, NAT MATER, V5, P400, DOI 10.1038/nmat1636; de Moor PPEA, 1997, J PHYS CHEM B, V101, P11077, DOI 10.1021/jp9724784; Fedeyko JM, 2004, J PHYS CHEM B, V108, P12271, DOI 10.1021/jp047623+; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Habraken WJEM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2490; Holden MA, 2012, J AM CHEM SOC, V134, P13066, DOI 10.1021/ja303814p; Kirschhock CEA, 1999, J PHYS CHEM B, V103, P11021, DOI 10.1021/jp992272y; Knight CTG, 2006, PHYS CHEM CHEM PHYS, V8, P3099, DOI 10.1039/b606419a; Kumar S, 2007, J PHYS CHEM B, V111, P3398, DOI 10.1021/jp0677445; Kumar S, 2011, MICROPOR MESOPOR MAT, V144, P74, DOI 10.1016/j.micromeso.2011.02.029; Kumar S, 2008, J AM CHEM SOC, V130, P17284, DOI 10.1021/ja8063167; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Lupulescu AI, 2012, ANGEW CHEM INT EDIT, V51, P3345, DOI 10.1002/anie.201107725; Meza LI, 2007, J AM CHEM SOC, V129, P15192, DOI 10.1021/ja0739887; Nikolakis V, 2000, CHEM MATER, V12, P845, DOI 10.1021/cm990653i; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Rimer JD, 2005, J PHYS CHEM B, V109, P12762, DOI 10.1021/jp052045y; Rimer JD, 2007, CHEM MATER, V19, P4189, DOI 10.1021/cm070708d; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; Schoeman BJ, 1998, MICROPOR MESOPOR MAT, V22, P9, DOI 10.1016/S1387-1811(98)00080-8; Van Driessche AES, 2012, SCIENCE, V336, P69, DOI 10.1126/science.1215648; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; Watson JN, 1996, CHEM COMMUN, P2767, DOI 10.1039/cc9960002767; Yau ST, 2001, J AM CHEM SOC, V123, P1080, DOI 10.1021/ja003039c; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	33	246	253	57	647	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					729	732		10.1126/science.1250984	http://dx.doi.org/10.1126/science.1250984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833388				2022-12-28	WOS:000335912900036
J	Rodriguez, I				Rodriguez, Ivan			NEUROBIOLOGY To care or not to care	NATURE			English	Editorial Material							SEXUAL-BEHAVIOR; MOUSE; SYSTEM		Univ Geneva, Dept Genet & Evolut, CH-1205 Geneva, Switzerland	University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dept Genet & Evolut, CH-1205 Geneva, Switzerland.	ivan.rodriguez@unige.ch		rodriguez, ivan/0000-0002-6468-0565				BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Ferrero DM, 2013, NATURE, V502, P368, DOI 10.1038/nature12579; Ferris CF, 1999, BRAIN RES, V832, P1, DOI 10.1016/S0006-8993(99)01432-8; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; PERRIGO G, 1992, CHRONOBIOL INT, V9, P421, DOI 10.3109/07420529209064554; Pusey A. E., 1994, INFANTICIDE PARENTAL, P277; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307	9	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					294	296		10.1038/509294a	http://dx.doi.org/10.1038/509294a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH4TM	24828185				2022-12-28	WOS:000336121200024
J	Marin, JR; Weaver, MD; Yealy, DM; Mannix, RC				Marin, Jennifer R.; Weaver, Matthew D.; Yealy, Donald M.; Mannix, Rebekah C.			Trends in Visits for Traumatic Brain Injury to Emergency Departments in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Marin, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Weaver, Matthew D.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15224 USA; [Mannix, Rebekah C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School	Marin, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, 4401 Penn Ave,AOB Ste 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu	Mannix, Rebekah/AAD-8702-2020	Marin, Jennifer/0000-0003-3090-664X; Mannix, Rebekah/0000-0003-3608-2792	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER; NHLBI NIH HHS [K12HL109068] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], INJURY PREVENTION AN; [Anonymous], NATIONWIDE EMERGENCY; Faul M., TRAUMATIC BRAIN INJU; Langlois JA, 2004, TRAUMATIC BRAIN INJU; National Conference of State Legislatures, TRAUMATIC BRAIN INJU; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	6	153	155	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1917	1919		10.1001/jama.2014.3979	http://dx.doi.org/10.1001/jama.2014.3979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825648	Bronze			2022-12-28	WOS:000335798100025
J	Robinson, JG; Nedergaard, BS; Rogers, WJ; Fialkow, J; Neutel, JM; Ramstad, D; Somaratne, R; Legg, JC; Nelson, P; Scott, R; Wasserman, SM; Weiss, R				Robinson, Jennifer G.; Nedergaard, Bettina S.; Rogers, William J.; Fialkow, Jonathan; Neutel, Joel M.; Ramstad, David; Somaratne, Ransi; Legg, Jason C.; Nelson, Patric; Scott, Rob; Wasserman, Scott M.; Weiss, Robert		LAPLACE-2 Investigators	Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SUBTILISIN/KEXIN TYPE 9; MONOCLONAL-ANTIBODY; AMG 145; EFFICACY; SAFETY; REDUCTION; TOLERABILITY; ATORVASTATIN; SIMVASTATIN	IMPORTANCE In phase 2 studies, evolocumab, a fully human monoclonal antibody to PCSK9, reduced LDL-C levels in patients receiving statin therapy. OBJECTIVE To evaluate the efficacy and tolerability of evolocumab when used in combination with a moderate-vs high-intensity statin. DESIGN, SETTING, AND PATIENTS Phase 3, 12-week, randomized, double-blind, placebo-and ezetimibe-controlled study conducted between January and December of 2013 in patients with primary hypercholesterolemia and mixed dyslipidemia at 198 sites in 17 countries. INTERVENTIONS Patients (n = 2067) were randomized to 1 of 24 treatment groups in 2 steps. Patients were initially randomized to a daily, moderate-intensity (atorvastatin [10 mg], simvastatin [40mg], or rosuvastatin [5 mg]) or high-intensity (atorvastatin [80 mg], rosuvastatin [40mg]) statin. After a 4-week lipid-stabilization period, patients (n = 1899) were randomized to compare evolocumab (140 mg every 2 weeks or 420mg monthly) with placebo (every 2 weeks or monthly) or ezetimibe (10 mg or placebo daily; atorvastatin patients only) when added to statin therapies. MAIN OUTCOMES AND MEASURES Percent change from baseline in low-density lipoprotein cholesterol (LDL-C) level at the mean of weeks 10 and 12 and at week 12. RESULTS Evolocumab reduced LDL-C levels by 66%(95% CI, 58% to 73%) to 75%(95% CI, 65% to 84%) (every 2weeks) and by 63%(95% CI, 54% to 71%) to 75%(95% CI, 67% to 83%) (monthly) vs placebo at the mean of weeks 10 and 12 in the moderate-and high-intensity statin-treated groups; the LDL-C reductions at week 12 were comparable. For moderate-intensity statin groups, evolocumab every 2weeks reduced LDL-C from a baseline mean of 115 to 124mg/ dL to an on-treatment mean of 39 to 49mg/dL; monthly evolocumab reduced LDL-C from a baseline mean of 123 to 126mg/dL to an on-treatment mean of 43 to 48mg/dL. For highintensity statin groups, evolocumab every 2weeks reduced LDL-C from a baseline mean of 89 to 94mg/dL to an on-treatment mean of 35 to 38mg/dL; monthly evolocumab reduced LDL-C from a baseline mean of 89 to 94mg/dL to an on-treatment mean of 33 to 35mg/dL. Adverse events were reported in 36%, 40%, and 39% of evolocumab-, ezetimibe-, and placebo-treated patients, respectively. The most common adverse events in evolocumab-treated patients were back pain, arthralgia, headache, muscle spasms, and pain in extremity (all < 2%). CONCLUSIONS AND RELEVANCE In this 12-week trial conducted among patients with primary hypercholesterolemia and mixed dyslipidemia, evolocumab added to moderate-or high-intensity statin therapy resulted in additional LDL-C lowering. Further studies are needed to evaluate the longer-term clinical outcomes and safety of this approach for LDL-C lowering.	[Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [Robinson, Jennifer G.] Univ Iowa, Dept Med, Coll Publ Hlth, Iowa City, IA 52242 USA; [Nedergaard, Bettina S.] Ctr Clin & Basic Res, Aalborg, Denmark; [Rogers, William J.] Univ Alabama Birmingham, Med Ctr, Div Cardiovasc Dis, Birmingham, AL USA; [Fialkow, Jonathan] Florida Int Univ, Dept Med, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Neutel, Joel M.] Orange Cty Res Ctr, Tustin, CA USA; [Ramstad, David] Hampton Rd Ctr Clin Res, Suffolk, VA USA; [Somaratne, Ransi; Legg, Jason C.; Nelson, Patric; Scott, Rob; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Weiss, Robert] Maine Res Associates, Auburn, AL USA	University of Iowa; University of Iowa; Center Clinical & Basic Research; University of Alabama System; University of Alabama Birmingham; State University System of Florida; Florida International University; Amgen	Robinson, JG (corresponding author), Univ Iowa, Dept Epidemiol, Prevent Intervent Ctr, Coll Publ Hlth, 145 N Riverside Dr,S455 CPBH, Iowa City, IA 52242 USA.	jennifer-g-robinson@uiowa.edu	Ceska, Richard/A-1840-2017; Shvarts, Yury Григорьевич/AAB-4929-2022; Pintus, Paolo/AAQ-7789-2021; Václavík, Jan/D-4535-2015; , Jennifer/AAD-8336-2019; Passaro, Angelina/P-3401-2015	Ceska, Richard/0000-0002-2541-5179; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Pintus, Paolo/0000-0002-8666-8399; Passaro, Angelina/0000-0001-8462-7000; HASSANIN, HANA/0000-0002-1492-3653; Scott, Robert/0000-0001-8266-1061	Amarin; Amgen; AstraZeneca; Daiichi-Sankyo; Esperion; Genentech/Hoffman La Roche; Glaxo-Smith Kline; Merck; Regeneron/Sanofi; Zinfandel/Takeda; Sanofi; Pfizer; Regeneron; Genentech; Hoffman-Laroche; Eli Lilly; Bristol-Myers Squibb; Novartis; GlaxoSmithKline; Takeda; Arete Therapeutics; Akros; Forest Research Institute; Lilly; Shire-Novartis; Aventis; NovoNordisk	Amarin; Amgen(Amgen); AstraZeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Esperion; Genentech/Hoffman La Roche; Glaxo-Smith Kline(GlaxoSmithKline); Merck(Merck & Company); Regeneron/Sanofi(Regeneron); Zinfandel/Takeda; Sanofi; Pfizer(Pfizer); Regeneron(Regeneron); Genentech(Roche HoldingGenentech); Hoffman-Laroche; Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Takeda(Takeda Pharmaceutical Company Ltd); Arete Therapeutics; Akros; Forest Research Institute; Lilly(Eli Lilly); Shire-Novartis; Aventis(Sanofi-Aventis); NovoNordisk(Novo Nordisk)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Robinson reported that her institution has received research grants from Amarin, Amgen, AstraZeneca, Daiichi-Sankyo, Esperion, Genentech/Hoffman La Roche, Glaxo-Smith Kline, Merck, Regeneron/Sanofi, and Zinfandel/Takeda; and reported serving as a consultant for Amgen, Hoffman LaRoche, Pfizer, and Sanofi. DrWeiss reported serving as a principal investigator for studies sponsored by Amgen, Sanofi, and Pfizer and receiving research grants during the past year from Amgen, Sanofi, Regeneron, Pfizer, Genentech, Hoffman-Laroche, Eli Lilly, and Merck. Dr Fialkow reported serving as principal investigator for studies sponsored by Amgen and serving on speakers bureaus for Pfizer, Bristol Myers Squibb, and Amarin Pharmaceuticals. Dr Nedergaard reported serving as principal investigator for studies sponsored by Amgen. Dr Neutel reported serving as principal investigator for multiple clinical trials and serving on speakers bureaus for multiple companies. Dr Ramstad reported serving as principal investigator for studies sponsored by Amgen, Pfizer, Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Takeda, Daiichi-Sankyo, Arete Therapeutics, Akros, Forest Research Institute, Lilly, Shire-Novartis, Hoffman-LaRoche, Aventis, and NovoNordisk. Dr Rogers reported serving as principal investigator for studies sponsored by Amgen and Sanofi. Drs Somaratne, Legg, Scott, and Wasserman and Mr Nelson, all Amgen employees, reported owning Amgen stock/stock options.; Baron (Capitol Interventional Cardiology, Carmichael, California); Robert Bear (Cardiovascular Consultants, Glendale, Arizona); Barry Bertolet (Cardiology Associates of North Mississippi, Tupelo); Ravi Bhagwat (Cardiology Associates of Northwest Indiana LLC, Hammond); Nancy Coburn (Advanced Clinical Research, Carmichael, California); Lisa Connery (Lynn Institute of Norman, Norman, Oklahoma); Ira Dauber (South Denver Cardiology Associates, Littleton, Colorado); Mathew Davis (Rochester Clinical Research Inc, Rochester, NY); Charles Diederich (Banksville Medical, Pittsburgh, Pennsylvania); Gregory Eaton (Mid Ohio Heart Clinic Inc, Mansfield); Jonathan Fialkow (Cardiovascular Research Center of South Florida, Miami); Gary Fishbein (Dayton Heart Center, Dayton, Ohio); William French (Harbor UCLA Medical Center, Torrance, California); Ira Friedlander (Aultman Cardiology Clinical Trials, Canton, Ohio); Debra Fuchs-Ertman (InterMed PA, Portland, Maine); Daniel Ginsberg (MultiCare Health System Research Institute, Tacoma, Washington); Michaelk Hagan (Montana Health Research Institute, Billings); Elie Hage-Korban (Kore Cardiovascular Research, Jackson, Tennessee); Stephen Halpern (Radiant Research-Santa Rosa, Santa Rosa, California); David Henderson (Cardiology Research Associates, Daytona Beach, Florida); Patricia Houser (Amherst Family Practice, Winchester, Virgina); Hassan Ibrahim (North Ohio Research Ltd, Sandusky); William Jennings (Radiant Research Inc, San Antonio, Texas); Alan Kivitz (Altoona Center for Clinical Research, Duncansville, Pennsylvania); Lisa Kozlowski (Buffalo Cardiology and Pulmonary Associates, Williamsville, New York); Irving Loh (Westlake Medical Research, Thousand Oaks, California); Michael Malone (Charlotte Heart Group Research Center, Port Charlotte, Florida); Brock McConnehey (Northwest Clinical Trials Inc, Boise, Idaho); Kevin McCullum (York Hospital, York, Pennsylvania); Michael Miller (University of Maryland Medical Center, Baltimore); Mark Napoli (Clinical Trials of America Inc, Monroe, Louisiana); Joel Neutel (Orange County Research Center, Tustin, California); Drew Purdy (Black Hills Cardiovascular Research, Rapid City, South Dakota); Mansoor Qureshi (Michigan Heart, Ypsilanti); David Ramstad (Hampton Roads Center for Clinical Research, Suffolk, Virginia); Tooraj Raoof (T Joseph Raoof MD Inc Encino Research Center, Encino, California); Alan Reichman (Clinical Trial Network, Houston, Texas); Kenneth Rich (Research Across America Apex Acquisition LLC, Santa Ana, California); Jennifer Robinson (University of Iowa Hospital and Clinics, Iowa City); William Rogers (University of Alabama at Birmingham Medical Center); Jorge Salazar (Health First Physicians Inc, Melbourne, Florida); Emanuel Shaoulian (Pacific Coast Cardiology and Research, Newport Beach, California); J. Christopher Stringer (Central New York Clinical Research, Manlius, New York); Gregory Tarleton (Clinical Trials of America Inc, Winston-Salem, North Carolina); Martin Throne (Radiant Research Atlanta, Atlanta, Georgia); Cheryle Webb (Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio); Robert Weiss (Maine Research Associates, Auburn); Alan Wiseman (Eastern Maine Medical Center, Bangor).	Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Civeira Oterman F, EUR HEART J, DOI [10.1093/eurheartj/eht307.P681, DOI 10.1093/EURHEARTJ/EHT307.P681]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Germano G, 2012, EUR HEART J, V33, P137; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Grundy SM, 2013, J CLIN LIPIDOL, V7, P561, DOI 10.1016/j.jacl.2013.10.001; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hsia J, 2011, J AM COLL CARDIOL, V57, P1666, DOI 10.1016/j.jacc.2010.09.082; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Robinson JG, 2006, AM J CARDIOL, V98, P1405, DOI 10.1016/j.amjcard.2006.06.039; Robinson JG, 2014, CLIN CARDIOL, V37, P195, DOI 10.1002/clc.22252; Santos RD, 2012, ATHEROSCLEROSIS, V224, P150, DOI 10.1016/j.atherosclerosis.2012.06.052; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Wiens BL, 2003, PHARM STAT, V2, P211, DOI 10.1002/pst.64	23	366	393	4	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1870	1882		10.1001/jama.2014.4030	http://dx.doi.org/10.1001/jama.2014.4030			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825642				2022-12-28	WOS:000335798100019
J	Akers, KG; Martinez-Canabal, A; Restivo, L; Yiu, AP; De Cristofaro, A; Hsiang, HL; Wheeler, AL; Guskjolen, A; Niibori, Y; Shoji, H; Ohira, K; Richards, BA; Miyakawa, T; Josselyn, SA; Frankland, PW				Akers, Katherine G.; Martinez-Canabal, Alonso; Restivo, Leonardo; Yiu, Adelaide P.; De Cristofaro, Antonietta; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Guskjolen, Axel; Niibori, Yosuke; Shoji, Hirotaka; Ohira, Koji; Richards, Blake A.; Miyakawa, Tsuyoshi; Josselyn, Sheena A.; Frankland, Paul W.			Hippocampal Neurogenesis Regulates Forgetting During Adulthood and Infancy	SCIENCE			English	Article							DENTATE GYRUS; RAT HIPPOCAMPUS; GRANULE CELLS; NEURONS BORN; MEMORY; FEAR; PROLIFERATION; STIMULATION; HYPOTHESIS; ONTOGENY	Throughout life, new neurons are continuously added to the dentate gyrus. As this continuous addition remodels hippocampal circuits, computational models predict that neurogenesis leads to degradation or forgetting of established memories. Consistent with this, increasing neurogenesis after the formation of a memory was sufficient to induce forgetting in adult mice. By contrast, during infancy, when hippocampal neurogenesis levels are high and freshly generated memories tend to be rapidly forgotten (infantile amnesia), decreasing neurogenesis after memory formation mitigated forgetting. In precocial species, including guinea pigs and degus, most granule cells are generated prenatally. Consistent with reduced levels of postnatal hippocampal neurogenesis, infant guinea pigs and degus did not exhibit forgetting. However, increasing neurogenesis after memory formation induced infantile amnesia in these species.	[Akers, Katherine G.; Martinez-Canabal, Alonso; Restivo, Leonardo; Yiu, Adelaide P.; De Cristofaro, Antonietta; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Guskjolen, Axel; Niibori, Yosuke; Richards, Blake A.; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Martinez-Canabal, Alonso; Hsiang, Hwa-Lin (Liz); Wheeler, Anne L.; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Guskjolen, Axel; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Shoji, Hirotaka; Ohira, Koji; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3GM, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Fujita Health University; University of Toronto	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca; paul.frankland@sickkids.ca	Martinez-canabal, Alonso/AAJ-9239-2021; Miyakawa, Tsuyoshi/A-7741-2008; Akers, Katherine G./A-4537-2013; Martinez-Canabal, Alonso/N-5288-2019; Wheeler, Anne/V-1215-2019; Martinez-Canabal, Alonso/K-8734-2018	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Akers, Katherine G./0000-0002-4578-6575; Martinez-Canabal, Alonso/0000-0001-6638-5618; Wheeler, Anne/0000-0002-1103-0526; Richards, Blake/0000-0001-9662-2151; Ohira, Koji/0000-0003-0170-8652; Restivo, Leonardo/0000-0002-3709-5504	Brain Canada; Canadian Institutes of Health Research (CIHR) [MOP86762, MOP74650]; Centre for Brain and Behavior at the Hospital for Sick Children; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI); CIHR; El Consejo Nacional de Ciencia y Tecnologia; Donald and Doris Milne Alzheimer's Disease Fellowship; Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada	Brain Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre for Brain and Behavior at the Hospital for Sick Children; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST); Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI); CIHR(Canadian Institutes of Health Research (CIHR)); El Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Donald and Doris Milne Alzheimer's Disease Fellowship; Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from Brain Canada to P. W. F., the Canadian Institutes of Health Research (CIHR) to P. W. F. (MOP86762) and S.A.J. (MOP74650), the Centre for Brain and Behavior at the Hospital for Sick Children to P. W. F. and S.A.J., and the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (JST-CREST) and Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (KAKENHI) to T. M. K. G. A. and H.-L. H. (CIHR), A. M.-C. (El Consejo Nacional de Ciencia y Tecnologia), A.P.Y. (Donald and Doris Milne Alzheimer's Disease Fellowship), A. L. W. (Ontario Mental Health Foundation), and A. G. and B. A. R. (Natural Sciences and Engineering Research Council of Canada) were supported by fellowships. Data are archived in the Dryad repository (doi: 10.5061/dryad.s7q3c).	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Acsady L, 1998, J NEUROSCI, V18, P3386; Akers KG, 2012, LEARN MEMORY, V19, P598, DOI 10.1101/lm.027581.112; Campbell B. A., 1984, COMP PERSPECTIVES DE, P23; CAMPBELL BA, 1972, PSYCHOL REV, V79, P215, DOI 10.1037/h0032690; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; Freud S., 1905, BASIC WRITINGS S FRE, P30; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guidi S, 2005, HIPPOCAMPUS, V15, P285, DOI 10.1002/hipo.20050; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2012, LEARN MEMORY, V19, P423, DOI 10.1101/lm.021311.110; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maekawa M, 2009, NEUROSCI RES, V63, P259, DOI 10.1016/j.neures.2008.12.006; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGonigal R, 2012, HIPPOCAMPUS, V22, P1242, DOI 10.1002/hipo.20998; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Niibori Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2261; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richards BA, 2013, HIPPOCAMPUS, V23, P207, DOI 10.1002/hipo.22089; Rubin DC, 2000, MEMORY, V8, P265, DOI 10.1080/096582100406810; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; Weisz VI, 2012, COGNITION, V125, P13, DOI 10.1016/j.cognition.2012.07.002; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	428	439	8	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					598	602		10.1126/science.1248903	http://dx.doi.org/10.1126/science.1248903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812394				2022-12-28	WOS:000335537400035
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED How the UK drug regulator became the herbalists' marketeer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cameron M, 2013, COCHRANE DATABASE SY, V5; Ernst E, 1998, ARCH SURG-CHICAGO, V133, P1187, DOI 10.1001/archsurg.133.11.1187; Gagnier JJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004504; Medicines and Healthcare Products Regulatory Agency, 2011, REG YOUR PROD TRAD H; Medicines and Healthcare Products Regulatory Agency, 2013, LIST PROD GRANT TRAD; Medicines and Healthcare Products Regulatory Agency, 2011, HERB MED REG LIC HER; PITTLER MH, 2004, COCHRANE DB SYST REV, V1; Tacklind J, 2012, COCHRANE DB SYST REV, V12	8	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2014	348								g3194	10.1136/bmj.g3194	http://dx.doi.org/10.1136/bmj.g3194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OT	24816732				2022-12-28	WOS:000335820400005
J	Thomas, EJ; Classen, DC				Thomas, Eric J.; Classen, David C.			Patient Safety: Let's Measure What Matters	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ADVERSE EVENTS; TRENDS; UTAH		[Thomas, Eric J.] Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX 77030 USA; Univ Utah, Sch Med, Salt Lake City, UT 84149 USA	University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah	Thomas, EJ (corresponding author), Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, 6410 Fannin St,UTPB 1100, Houston, TX 77030 USA.	eric.thomas@uth.tmc.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Institute of Medicine, 2011, HLTH IT PAT SAF BUIL; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Levinson DR., 2010, OEI060900090 DEP HLT; Meyer GS, 2012, BMJ QUAL SAF, V21, P964, DOI 10.1136/bmjqs-2012-001081; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991	10	12	12	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					642	U212		10.7326/M13-2528	http://dx.doi.org/10.7326/M13-2528			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI0GO	24798525				2022-12-28	WOS:000336524400007
J	Ort, DR; Long, SP				Ort, Donald R.; Long, Stephen P.			Limits on Yields in the Corn Belt	SCIENCE			English	Editorial Material									[Ort, Donald R.] Univ Illinois, USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA; [Ort, Donald R.; Long, Stephen P.] Univ Illinois, Dept Plant Biol & Crop Sci, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ort, DR (corresponding author), Univ Illinois, USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA.	d-ort@igb.illinois.edu	Long, Stephen/AAA-1741-2019; Long, Stephen P/A-2488-2008	Long, Stephen/0000-0002-8501-7164; Long, Stephen P/0000-0002-8501-7164				Alexandratos N., 2012, WORLD AGRICULTURE TO; [Anonymous], 2012, THE 2012 STATISTICAL; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Drewry DT, 2014, GLOBAL CHANGE BIOL, V20, P1955, DOI 10.1111/gcb.12567; Food and Agriculture Organization of the United Nations (FAO), 2013, FAO STATISTICAL DATA; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108	8	97	100	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					483	484		10.1126/science.1253884	http://dx.doi.org/10.1126/science.1253884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786071				2022-12-28	WOS:000335157700032
J	May, M				May, Mike			Antibiotics	NATURE			English	Editorial Material																			0	3	3	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S1	S1		10.1038/509S1a	http://dx.doi.org/10.1038/509S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784421	Bronze			2022-12-28	WOS:000335199100001
J	Merson, MH				Merson, Michael H.			University Engagement in Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA	Duke University	Merson, MH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA.							Frenk J, 2014, LANCET, V383, P94, DOI 10.1016/S0140-6736(13)62561-1; Hill DR, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.11-0571; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kerry VB, 2013, J GLOB HLTH, V3; Richards-Kortum R, 2012, SCIENCE, V336, P430, DOI 10.1126/science.1213947	5	53	53	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1676	1678		10.1056/NEJMp1401124	http://dx.doi.org/10.1056/NEJMp1401124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4QM	24785204				2022-12-28	WOS:000335405200004
J	Jack, A				Jack, Andrew			Tamiflu: "a nice little earner"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Biocryst Pharmaceuticals, 2013, ANN REPORT; Freemantle N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2371; Jack A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3811; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Love J., 2005, FINANCIAL TIMES; Murthuri SG, 2014, LANCET; United States Government Accountability Office, 2011, INFL PAND LESS H1N1	7	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2524	10.1136/bmj.g2524	http://dx.doi.org/10.1136/bmj.g2524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811410				2022-12-28	WOS:000334348700016
J	Berkley, S; Dybul, M; Godal, T; Lake, A				Berkley, Seth; Dybul, Mark; Godal, Tore; Lake, Anthony			Integration and innovation to advance newborn survival	LANCET			English	Editorial Material									[Berkley, Seth] GAVI Alliance, CH-1202 Geneva, Switzerland; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Godal, Tore] Norwegian Minist Foreign Affairs, Oslo, Norway; [Lake, Anthony] UNICEF, New York, NY USA	UNICEF	Berkley, S (corresponding author), GAVI Alliance, CH-1202 Geneva, Switzerland.	sberkley@gavialliance.org						Bhutta ZA, 2014, LANCET; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Gertler P, REWARDING P IN PRESS; Lawn JE, 2014, LANCET; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Mason E, 2014, LANCET; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Nair H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S30; Save the Children, 2014, END NEWB DEATHS ENS; WHO, 2014, MAT NEON TET MNT EL; You D, 2013, LEVELS TRENDS CHILD	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					E22	E23		10.1016/S0140-6736(14)60691-7	http://dx.doi.org/10.1016/S0140-6736(14)60691-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	24853595				2022-12-28	WOS:000338921500001
J	Aaron, HJ				Aaron, Henry J.			Here to Stay - Beyond the Rough Launch of the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2257	2259		10.1056/NEJMp1404194	http://dx.doi.org/10.1056/NEJMp1404194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7BB	24805987				2022-12-28	WOS:000337033700003
J	Deuker, MM; McMahon, M				Deuker, Marian M.; McMahon, Martin			CANCER BIOLOGY Enzyme meets a surprise target	NATURE			English	Editorial Material							SIGNAL-TRANSDUCTION; KINASE KINASES; RAS ONCOGENES; TUMOR-GROWTH; LUNG-CANCER; C-RAF; EXPRESSION; MEKK2; CELLS		[Deuker, Marian M.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Deuker, Marian M.; McMahon, Martin] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Deuker, MM (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	mcmahon@cc.ucsf.edu			NCI NIH HHS [R01 CA131261, R01 CA176839] Funding Source: Medline; NIGMS NIH HHS [T32 GM064337] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA131261, R01CA176839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2013, J BIOMOL SCREEN, V18, P388, DOI 10.1177/1087057112466430; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	20	5	5	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					225	226		10.1038/nature13343	http://dx.doi.org/10.1038/nature13343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24847879	Green Accepted			2022-12-28	WOS:000337032400040
J	Peters, AJ; Chen, SX; Komiyama, T				Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki			Emergence of reproducible spatiotemporal activity during motor learning	NATURE			English	Article							INTRACORTICAL MICROSTIMULATION; LAMINAR ORGANIZATION; NEURAL ACTIVITY; BEHAVING MICE; IN-VIVO; CORTEX; REPRESENTATIONS; MOVEMENT; NEURONS; INFORMATION	The motor cortex is capable of reliably driving complex movements(1,2) yet exhibits considerable plasticity during motor learning(3-10). These observations suggest that the fundamental relationship between motor cortex activity and movement may not be fixed but is instead shaped by learning; however, to what extent and how motor learning shapes this relationship are not fully understood. Here we addressed this issue by using in vivo two-photon calcium imaging(11) to monitor the activity of the same population of hundreds of layer 2/3 neurons while mice learned a forelimb lever-press task over two weeks. Excitatory and inhibitory neurons were identified by transgenic labelling(12,13). Inhibitory neuron activity was relatively stable and balanced local excitatory neuron activity on a movement-by-movement basis, whereas excitatory neuron activity showed higher dynamism during the initial phase of learning. The dynamics of excitatory neurons during the initial phase involved the expansion of the movement-related population which explored various activity patterns even during similar movements. This was followed by a refinement into a smaller population exhibiting reproducible spatiotemporal sequences of activity. This pattern of activity associated with the learned movement was unique to expert animals and not observed during similar movements made during the naive phase, and the relationship between neuronal activity and individual movements became more consistent with learning. These changes in population activity coincided with a transient increase in dendritic spine turnover in these neurons. Our results indicate that a novel and reproducible activity-movement relationship develops as a result of motor learning, and we speculate that synaptic plasticity within the motor cortex underlies the emergence of reproducible spatiotemporal activity patterns for learned movements. These results underscore the profound influence of learning on the way that the cortex produces movements.	[Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki] Univ Calif San Diego, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Peters, Andrew J.; Chen, Simon X.; Komiyama, Takaki] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Komiyama, Takaki] Univ Calif San Diego, PRESTO, JST, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), Univ Calif San Diego, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	tkomiyama@ucsd.edu		Peters, Andrew/0000-0001-9351-1456; Komiyama, Takaki/0000-0001-9609-4600; Chen, Simon/0000-0002-7595-7443	Japan Science and Technology Agency (PRESTO); Pew Charitable Trusts; Alfred P. Sloan Foundation; David & Lucile Packard Foundation; Human Frontier Science Program; New York Stem Cell Foundation; Neuroplasticity of Aging Training Grant [AG000216]	Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Pew Charitable Trusts; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); New York Stem Cell Foundation; Neuroplasticity of Aging Training Grant	We thank A. Kim and S. Kalina for technical assistance; L. L. Looger, J. Akerboom, D. S. Kim and the GENIE Project at Janelia Farm for making GCaMP available; E. Kyubwa and J. Keller for help with task development; A. D. Lien and M. Caudill for help with two-photon guided recordings; and M. Long, R. Malinow, G. Murphy, M. Scanziani and members of the Komiyama laboratory for comments and discussions. This work was supported by grants from Japan Science and Technology Agency (PRESTO), Pew Charitable Trusts, Alfred P. Sloan Foundation, David & Lucile Packard Foundation, Human Frontier Science Program and New York Stem Cell Foundation to T. K. A. J. P. is supported by the Neuroplasticity of Aging Training Grant (AG000216). S. X. C. is a Human Frontier Science Program postdoctoral fellow. T. K. is a NYSCF-Robertson Investigator.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arduin PJ, 2013, J NEUROSCI, V33, P8308, DOI 10.1523/JNEUROSCI.2744-12.2013; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Chestek CA, 2007, J NEUROSCI, V27, P10742, DOI 10.1523/JNEUROSCI.0959-07.2007; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graziano M.S.A., 2009, INTELLIGENT MOVEMENT; Harrison TC, 2012, NEURON, V74, P397, DOI 10.1016/j.neuron.2012.02.028; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Nudo RJ, 1996, J NEUROSCI, V16, P785; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	39	252	253	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					263	+		10.1038/nature13235	http://dx.doi.org/10.1038/nature13235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24805237				2022-12-28	WOS:000337032400049
J	Zeuzem, S; Dusheiko, GM; Salupere, R; Mangia, A; Flisiak, R; Hyland, RH; Illeperuma, A; Svarovskaia, E; Brainard, DM; Symonds, WT; Subramanian, M; McHutchison, JG; Weiland, O; Reesink, HW; Ferenci, P; Hezode, C; Esteban, R				Zeuzem, Stefan; Dusheiko, Geoffrey M.; Salupere, Riina; Mangia, Alessandra; Flisiak, Robert; Hyland, Robert H.; Illeperuma, Ari; Svarovskaia, Evguenia; Brainard, Diana M.; Symonds, William T.; Subramanian, Mani; McHutchison, John G.; Weiland, Ola; Reesink, Hendrik W.; Ferenci, Peter; Hezode, Christophe; Esteban, Rafael		VALENCE Investigators	Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HEPATITIS-C; THERAPIES	BACKGROUND In clinical trials, treatment with a combination of the nucleotide polymerase inhibitor sofosbuvir and the antiviral drug ribavirin was associated with high response rates among patients with hepatitis C virus (HCV) genotype 2 infection, with lower response rates among patients with HCV genotype 3 infection. METHODS We conducted a study involving patients with HCV genotype 2 or 3 infection, some of whom had undergone previous treatment with an interferon-based regimen. We randomly assigned 91 patients with HCV genotype 2 infection and 328 with HCV genotype 3 infection, in a 4: 1 ratio, to receive sofosbuvir-ribavirin or placebo for 12 weeks. On the basis of emerging data from phase 3 trials indicating that patients with HCV genotype 3 infection had higher response rates when they were treated for 16 weeks, as compared with 12 weeks, the study was unblinded, treatment for all patients with genotype 3 infection was extended to 24 weeks, the placebo group was terminated, and the goals of the study were redefined to be descriptive and not include hypothesis testing. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Of the 419 patients who were enrolled and treated, 21% had cirrhosis and 58% had received previous interferon-based treatment. The criterion for a sustained virologic response was met in 68 of 73 patients (93%; 95% confidence interval [CI], 85 to 98) with HCV genotype 2 infection who were treated for 12 weeks and in 213 of 250 patients (85%; 95% CI, 80 to 89) with HCV genotype 3 infection who were treated for 24 weeks. Among patients with HCV genotype 3 infection, response rates were 91% and 68% among those without and those with cirrhosis, respectively. The most common adverse events were headache, fatigue, and pruritus. CONCLUSIONS Therapy with sofosbuvir-ribavirin for 12 weeks in patients with HCV genotype 2 infection and for 24 weeks in patients with HCV genotype 3 infection resulted in high rates of sustained virologic response.	[Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, D-60590 Frankfurt, Germany; [Dusheiko, Geoffrey M.] Royal Free Hosp, London, England; [Dusheiko, Geoffrey M.] UCL, Sch Med, London WC1E 6BT, England; [Salupere, Riina] Tartu Univ Hosp, Tartu, Estonia; [Mangia, Alessandra] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Flisiak, Robert] Med Univ Bialystok, Bialystok, Poland; [Hyland, Robert H.; Illeperuma, Ari; Svarovskaia, Evguenia; Brainard, Diana M.; Symonds, William T.; Subramanian, Mani; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Weiland, Ola] Karolinska Inst, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Reesink, Hendrik W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Ferenci, Peter] Med Univ Vienna, Vienna, Austria; [Hezode, Christophe] Univ Paris Est, Hop Henri Mondor, AP HP, INSERM,U955, Creteil, France; [Esteban, Rafael] Hosp Univ Val dHebron, Barcelona, Spain	Goethe University Frankfurt; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School; IRCCS Casa Sollievo Della Sofferenza; Medical University of Bialystok; Gilead Sciences; Karolinska Institutet; Karolinska University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Vienna; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Zeuzem, S (corresponding author), Goethe Univ Frankfurt, Med Ctr, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	Wiesch, Julian Schulze zur/AAT-8452-2021; Hezode, Christophe/U-4659-2018; Romero-Gomez, Manuel/L-8030-2014; Mathurin, Philippe/A-9121-2018; Mangia, A/AAL-5357-2020; Zeuzem, Stefan/AAE-7435-2019; Andreone, Pietro/K-8050-2016; Flisiak, Robert/S-5356-2018	Romero-Gomez, Manuel/0000-0001-8494-8947; Mathurin, Philippe/0000-0003-3447-2025; Mangia, A/0000-0002-2600-3555; Andreone, Pietro/0000-0002-4794-9809; van Hoek, Bart/0000-0001-6527-764X; Crespo, Javier/0000-0001-8248-0172; Jablkowski, Maciej/0000-0002-3661-6777; Flisiak, Robert/0000-0003-3394-1635; esteban, rafael/0000-0001-5280-392X; Ryder, Stephen David/0000-0001-9649-4444; Norrgren, Hans/0000-0001-5780-530X; Albert, TRAN/0000-0003-0003-5361; Weiland, Ola/0000-0002-6934-9724; Ustianowski, Andrew/0000-0002-6134-7855	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Supported by Gilead Sciences.	Alberti A, 2004, J HEPATOL, V40, P1032, DOI 10.1016/j.jhep.2004.04.008; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Fried MW, 2011, J HEPATOL, V55, P69, DOI 10.1016/j.jhep.2010.10.032; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goossens N, 2013, HEPATOLOGY; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kanwal F, 2014, HEPATOLOGY; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Tapper EB, 2013, J VIRAL HEPATITIS, V20, P669, DOI 10.1111/jvh.12168; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Wartelle-Bladou C, 2012, J VIRAL HEPATITIS, V19, P525, DOI 10.1111/j.1365-2893.2012.01634.x	16	635	660	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1993	2001		10.1056/NEJMoa1316145	http://dx.doi.org/10.1056/NEJMoa1316145			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24795201	Green Submitted, Green Published			2022-12-28	WOS:000336125500007
J	Marcucci, M				Marcucci, Maura			In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS(2) and CHA(2)DS(2)-VASc	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Milan, Milan, Italy	University of Milan	Marcucci, M (corresponding author), Univ Milan, Milan, Italy.							Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC13	10.7326/0003-4819-160-10-201405200-02013	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842435				2022-12-28	WOS:000337347100012
J	Idzko, M; Ferrari, D; Eltzschig, HK				Idzko, Marco; Ferrari, Davide; Eltzschig, Holger K.			Nucleotide signalling during inflammation	NATURE			English	Review							REGULATORY T-CELLS; EXTRACELLULAR ADENOSINE-TRIPHOSPHATE; P2 PURINERGIC RECEPTORS; FIND-ME SIGNAL; AIRWAY INFLAMMATION; HUMAN EOSINOPHILS; ATP RELEASE; INCREASED SUSCEPTIBILITY; INTESTINAL INFLAMMATION; P2Y(6) RECEPTORS	Inflammatory conditions are associated with the extracellular release of nucleotides, particularly ATP. In the extracellular compartment, ATP predominantly functions as a signalling molecule through the activation of purinergic P2 receptors. Metabotropic P2Y receptors are G-protein-coupled, whereas ionotropic P2X receptors are ATP-gated ion channels. Here we discuss how signalling events through P2 receptors alter the outcomes of inflammatory or infectious diseases. Recent studies implicate a role for P2X/P2Ysignalling in mounting appropriate inflammatory responses critical for host defence against invading pathogens or tumours. Conversely, P2X/P2Ysignalling can promote chronic inflammation during ischaemia and reperfusion injury, inflammatory bowel disease or acute and chronic diseases of the lungs. Although nucleotide signalling has been used clinically in patients before, research indicates an expanding field of opportunities for specifically targeting individual P2 receptors for the treatment of inflammatory or infectious diseases.	[Idzko, Marco] Univ Freiburg, Freiburg Univ Med Ctr, Dept Pneumol, D-79106 Freiburg, Germany; [Ferrari, Davide] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Organ Protect Program, Sch Med, Aurora, CO 80045 USA	University of Freiburg; University of Ferrara; University of Colorado System; University of Colorado Anschutz Medical Campus	Idzko, M (corresponding author), Univ Freiburg, Freiburg Univ Med Ctr, Dept Pneumol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.idzko@uniklinik-freiburg.de	Ferrari, Davide/F-5644-2015	Ferrari, Davide/0000-0002-5727-9204	Deutsche Forschungsgemeinschaft [ID7/3-1 ID7/4-1]; Boehringer-Ingelheim Foundation; National Institutes of Health [R01-DK097075, R01-HL0921, R01-DK083385, R01-HL098294, POIHL114457-01]; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075, R01DK083385] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer-Ingelheim Foundation(Boehringer Ingelheim); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge S. A. Eltzschig for help with artwork during manuscript preparation. The present research is supported by Deutsche Forschungsgemeinschaft grant ID7/3-1 ID7/4-1 and a grant by the Boehringer-Ingelheim Foundation to I. D., as well as National Institutes of Health grants R01-DK097075, R01-HL0921, R01-DK083385, R01-HL098294, POIHL114457-01 and a grant by the Crohn's and Colitis Foundation of America to H.K.E.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567; Ben Addi A, 2010, J IMMUNOL, V185, P5900, DOI 10.4049/jimmunol.0901799; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Bunyavanich S, 2012, CLIN EXP ALLERGY, V42, P229, DOI 10.1111/j.1365-2222.2011.03874.x; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Coutinho-Silva R, 2005, IMMUNOBIOLOGY, V209, P661, DOI 10.1016/j.imbio.2004.09.007; Coutinho-Silva R, 2012, MICROBES INFECT, V14, P1271, DOI 10.1016/j.micinf.2012.05.009; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Davis SD, 2013, NEW ENGL J MED, V368, P2026, DOI 10.1056/NEJMe1303487; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Deterding RR, 2007, AM J RESP CRIT CARE, V176, P362, DOI 10.1164/rccm.200608-1238OC; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Fredholm B, 2010, ACTA PHYSIOL, V199, P91, DOI 10.1111/j.1748-1716.2010.02113.x; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Geary C, 2005, AM J PHYSIOL-LUNG C, V289, pL890, DOI 10.1152/ajplung.00428.2004; Gendaszewska-Darmach E, 2011, PURINERG SIGNAL, V7, P193, DOI 10.1007/s11302-011-9233-z; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Grbic DM, 2012, INFLAMM BOWEL DIS, V18, P1456, DOI 10.1002/ibd.21931; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; Horckmans M, 2012, AM J PHYSIOL-HEART C, V303, pH835, DOI 10.1152/ajpheart.00256.2012; Idzko M, 2004, J CELL PHYSIOL, V201, P286, DOI 10.1002/jcp.20070; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Inoue Y, 2008, SHOCK, V30, P173, DOI 10.1097/SHK.0b013e318160dad4; Jacobson KA, 2012, PURINERG SIGNAL, V8, P419, DOI 10.1007/s11302-012-9294-7; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kellerman D, 2008, PULM PHARMACOL THER, V21, P600, DOI 10.1016/j.pupt.2007.12.003; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Killeen ME, 2013, J IMMUNOL, V190, P4324, DOI 10.4049/jimmunol.1202045; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Kobayashi T, 2010, J IMMUNOL, V184, P6350, DOI 10.4049/jimmunol.0902673; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Li D, 2012, ARTERIOSCL THROM VAS, V32, pE81, DOI 10.1161/ATVBAHA.111.239095; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Manthei DM, 2012, J ALLERGY CLIN IMMUN, V130, P496, DOI 10.1016/j.jaci.2012.05.040; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Muhlestein JB, 2010, THROMB HAEMOSTASIS, V103, P71, DOI 10.1160/TH09-03-0177; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Neves JS, 2010, J ALLERGY CLIN IMMUN, V125, P477, DOI 10.1016/j.jaci.2009.11.029; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Ratjen F, 2012, J CYST FIBROS, V11, P539, DOI 10.1016/j.jcf.2012.05.003; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Soulet C, 2004, J THROMB HAEMOST, V2, P135, DOI 10.1111/j.1538-7836.2004.00556.x; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Yashiro K, 2009, TRANSPLANTATION, V87, P660, DOI 10.1097/TP.0b013e318196305a; Zhang J., 2012, NATURE IN PRESS; Zhang K, 2014, NATURE; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	116	592	611	7	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					310	317		10.1038/nature13085	http://dx.doi.org/10.1038/nature13085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828189	Green Accepted			2022-12-28	WOS:000336121200029
J	Yeh, S; Forooghian, F; Suhler, EB				Yeh, Steven; Forooghian, Farzin; Suhler, Eric B.			Implications of the Pacific Ocular Inflammation Uveitis Epidemiology Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; DISEASE	IMPORTANCE Uveitis is responsible for a significant proportion of legal blindness in the United States. Currently, there are few population-based reports characterizing the epidemiology of uveitis. OBJECTIVE To ascertain the incidence and prevalence of uveitis in a Hawaiian population and compare these estimates with those from prior population-based studies. DESIGN Retrospective, population-based cohort study conducted from January 1, 2006, to December 31, 2007. SETTING Kaiser Permanente Hawaii, a multispecialty managed care organization serving approximately 15% of the general Hawaiian population with locations throughout the Hawaiian islands. PARTICIPANTS All patients enrolled in the Kaiser Permanente Hawaii health plan during the study (N = 217 061). MAIN OUTCOMES AND MEASURES Clinical diagnosis of uveitis, either incident or prevalent, during the study determined by an initial search of the electronic medical record database of Kaiser Permanente Hawaii for uveitis-associated International Classification of Diseases, Ninth Revision diagnosis codes and subsequently confirmed through individual record review by a uveitis specialist. RESULTS Of 217 061 eligible patients, 872 were identified using International Classification of Diseases, Ninth Revision codes and 224 cases of uveitis were confirmed. The overall uveitis incidence ratewas 24.9 cases per 100 000 person-years. The annual prevalence rates for 2006 and 2007 were 57.5 and 58.0per 100 000 persons, respectively. No difference in incidence rate was found by sex (P = .63), but female patients had a higher prevalence (P = .008). Incidence and prevalence increased with older age (P < .001 for incidence and prevalence). Pacific Islanders had a lower prevalence rate than non-Pacific Islanders (2006: P = .09,2007: P = .04), while white individuals had a higher prevalence rate than nonwhite individuals (2006: P = .07, 2007: P = .01). CONCLUSIONS AND RELEVANCE The incidence and prevalence of uveitis in this population were much lower than in the Northern California Epidemiology ofUveitis Study, but similar to the Northwest Veterans Affairs Study. The results of this study highlight incidence and prevalence estimates in a new population and provide novel comparisons by race. These differences by race raise questions regarding the effects of genetic and environmental influences on the pathophysiology of uveitis.	[Yeh, Steven] Emory Univ, Sch Med, Emory Eye Ctr, Atlanta, GA 30322 USA; [Forooghian, Farzin] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Suhler, Eric B.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Suhler, Eric B.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA	Emory University; University of British Columbia; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Yeh, S (corresponding author), Emory Univ, Sch Med, Emory Eye Ctr, 1365B Clifton Rd NE, Atlanta, GA 30322 USA.	steven.yeh@emory.edu						Acharya NR, 2013, JAMA OPHTHALMOL, V131, P1405, DOI 10.1001/jamaophthalmol.2013.4237; Fang J, 2014, AM J OPHTHALMOL, V157, P488, DOI 10.1016/j.ajo.2013.10.010; Feng JB, 2010, RHEUMATOL INT, V30, P1017, DOI 10.1007/s00296-009-1087-0; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Lin P, 2010, OPHTHALMOLOGY, V117, P585, DOI 10.1016/j.ophtha.2009.08.011; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; OLLIER WER, 1995, BRIT MED BULL, V51, P267, DOI 10.1093/oxfordjournals.bmb.a072960; Reeves SW, 2006, OPHTHALMOLOGY, V113, P302, DOI 10.1016/j.ophtha.2005.10.008; Suhler EB, 2008, AM J OPHTHALMOL, V146, P890, DOI 10.1016/j.ajo.2008.09.014; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Thorne JE, 2008, AM J OPHTHALMOL, V145, P841, DOI 10.1016/j.ajo.2007.12.032	11	8	8	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1912	+		10.1001/jama.2014.2294	http://dx.doi.org/10.1001/jama.2014.2294			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825646				2022-12-28	WOS:000335798100023
J	Lopez-Mosqueda, J; Dikic, I				Lopez-Mosqueda, Jaime; Dikic, Ivan			Deciphering Functions of Branched Ubiquitin Chains	CELL			English	Editorial Material							MECHANISM; COMPLEX; E2S	The anaphase-promoting complex/cyclosome targets proteins for degradation by catalyzing homotypic ubiquitin chains of different linkage types. In this issue of Cell, Meyer and Rape diversify the degradation signals by demonstrating that the APC/C and its cognate E2 conjugating enzymes enhance the rate of substrate degradation by decorating them with branched Lys11 and Lys48 ubiquitin chains.	[Lopez-Mosqueda, Jaime; Dikic, Ivan] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	dikic@biochem2.uni-frankfurt.de	Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035	10	11	11	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					767	769		10.1016/j.cell.2014.04.026	http://dx.doi.org/10.1016/j.cell.2014.04.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813601	Bronze			2022-12-28	WOS:000335765500003
J	Wang, L; Zhang, J; Duan, J; Gao, X; Zhu, W; Lu, X; Yang, L; Zhang, J; Li, G; Ci, W; Li, W; Zhou, Q; Aluru, N; Tang, F; He, C; Huang, X; Liu, J				Wang, Lu; Zhang, Jun; Duan, Jialei; Gao, Xinxing; Zhu, Wei; Lu, Xingyu; Yang, Lu; Zhang, Jing; Li, Guoqiang; Ci, Weimin; Li, Wei; Zhou, Qi; Aluru, Neel; Tang, Fuchou; He, Chuan; Huang, Xingxu; Liu, Jiang			Programming and Inheritance of Parental DNA Methylomes in Mammals	CELL			English	Article							METHYLATION; GENOME; 5-HYDROXYMETHYLCYTOSINE; IDENTIFICATION; CELLS; 5-FORMYLCYTOSINE; FERTILIZATION; DEMETHYLATION; CONFLICT; DYNAMICS	The reprogramming of parental methylomes is essential for embryonic development. In mammals, paternal 5-methylcytosines (5mCs) have been proposed to be actively converted to oxidized bases. These paternal oxidized bases and maternal 5mCs are believed to be passively diluted by cell divisions. By generating single-base resolution, allele-specific DNA methylomes from mouse gametes, early embryos, and primordial germ cell (PGC), as well as single-base-resolution maps of oxidized cytosine bases for early embryos, we report the existence of 5hmC and 5fC in both maternal and paternal genomes and find that 5mC or its oxidized derivatives, at the majority of demethylated CpGs, are converted to unmodified cytosines independent of passive dilution from gametes to four-cell embryos. Therefore, we conclude that paternal methylome and at least a significant proportion of maternal methylome go through active demethylation during embryonic development. Additionally, all the known imprinting control regions (ICRs) were classified into germ-line or somatic ICRs.	[Wang, Lu; Duan, Jialei; Zhu, Wei; Zhang, Jing; Li, Guoqiang; Liu, Jiang] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Ci, Weimin] Chinese Acad Sci, Beijing Inst Gen, Lab Dis Genom & Individualized Med, Beijing 100101, Peoples R China; [Wang, Lu; Zhu, Wei; Li, Guoqiang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Jun; Gao, Xinxing; Huang, Xingxu] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Lu, Xingyu; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Lu, Xingyu; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Yang, Lu; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Aluru, Neel] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; University of Chicago; University of Chicago; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Woods Hole Oceanographic Institution	Huang, X (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; liuj@big.ac.cn	Duan, Jialei/F-4539-2011; Li, Guoqiang/K-2850-2016; Zhang, Jing/F-4707-2015; Wang, Lu/I-8245-2018; Ci, Weimin/AAS-5984-2021; Zhu, Wei/HGA-4471-2022	Duan, Jialei/0000-0003-4086-7461; Li, Guoqiang/0000-0001-5303-5707; Zhang, Jing/0000-0001-5903-6487; Wang, Lu/0000-0002-8896-0115; Ci, Weimin/0000-0002-4111-5360; Zhu, Wei/0000-0003-1459-6733; Liu, Jiang/0000-0002-5687-5047; huang, xingxu/0000-0001-8934-1247	973 Program of China [2010CB945101, 2011CB510101]; National Natural Science Foundation of China [91219104, 81171902, 91231112, 31171244, 31200958]; National Institutes of Health [HG006827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER; Directorate For Geosciences [1314642] Funding Source: National Science Foundation	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the 973 Program of China to X.H. (2010CB945101), to J.L. (2011CB510101); from National Natural Science Foundation of China to J.L. (91219104 and 81171902), to W.C. (91231112 and 31171244), to J.Z. (31200958). C.H. is supported by National Institutes of Health (HG006827). We thank the sequencing facility in BIG, CAS.	Collado-Fernandez E, 2012, INT J DEV BIOL, V56, P799, DOI 10.1387/ijdb.120140ec; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iwasa Y, 1998, CURR TOP DEV BIOL, V40, P255, DOI 10.1016/S0070-2153(08)60369-5; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; SURANI MA, 1990, DEVELOPMENT, P89; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Veenstra GJC, 2001, BBA-GENE STRUCT EXPR, V1521, P39, DOI 10.1016/S0167-4781(01)00280-9; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	47	341	367	5	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					979	991		10.1016/j.cell.2014.04.017	http://dx.doi.org/10.1016/j.cell.2014.04.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813617	Green Accepted, Bronze			2022-12-28	WOS:000335765500023
J	El-Sadr, WM; Philip, NM; Justman, J				El-Sadr, Wafaa M.; Philip, Neena M.; Justman, Jessica			Letting HIV Transform Academia - Embracing Implementation Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El-Sadr, Wafaa M.; Philip, Neena M.; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA	Columbia University	El-Sadr, WM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA.		Justman, Jessica/AAA-3572-2020					[Anonymous], 1890, P INST SETH LOW LL D; Hirokazu Yoshikawa, 2013, INVESTING OUR FUTURE; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Wildavsky B., 2010, GREAT BRAIN RACE GLO	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1679	1681		10.1056/NEJMp1314777	http://dx.doi.org/10.1056/NEJMp1314777			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG4QM	24785205	Green Published			2022-12-28	WOS:000335405200005
J	Detmer, DE; Shortliffe, EH				Detmer, Don E.; Shortliffe, Edward H.			Clinical Informatics Prospects for a New Medical Subspecialty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detmer, Don E.] Univ Virginia, Charlottesville, VA USA; [Shortliffe, Edward H.] Arizona State Univ, Phoenix, AZ 85004 USA	University of Virginia; Arizona State University; Arizona State University-Downtown Phoenix	Shortliffe, EH (corresponding author), Arizona State Univ, Coll Hlth Solut, 550 N 3rd St, Phoenix, AZ 85004 USA.	ted@shortliffe.net		Shortliffe, Edward/0000-0001-5201-6176				Gardner RM, 2009, J AM MED INFORM ASSN, V16, P153, DOI 10.1197/jamia.M3045; National Library of Medicine, NLMS U BAS BIOM INF; Safran C, 2009, J AM MED INFORM ASSN, V16, P158, DOI 10.1197/jamia.M3046; Shortliffe EH, 2011, J AM MED INFORM ASSN, V18, P890, DOI 10.1136/amiajnl-2011-000582; Shortliffe EH, 2010, JAMA-J AM MED ASSOC, V304, P1227, DOI 10.1001/jama.2010.1262; Stead WW, 2011, ACAD MED, V86, P429, DOI 10.1097/ACM.0b013e3181f41e8c	6	27	27	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2067	2068		10.1001/jama.2014.3514	http://dx.doi.org/10.1001/jama.2014.3514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24823876				2022-12-28	WOS:000336392400019
J	Sasaki, T; Yamamoto, Y; Koashi, M				Sasaki, Toshihiko; Yamamoto, Yoshihisa; Koashi, Masato			Practical quantum key distribution protocol without monitoring signal disturbance	NATURE			English	Article							SINGLE-PHOTON SOURCE; CRYPTOGRAPHY; SECURITY	Quantum cryptography(1-8) exploits the fundamental laws of quantum mechanics to provide a secure way to exchange private information. Such an exchange requires a common random bit sequence, called a key, to be shared secretly between the sender and the receiver. The basic idea behind quantum key distribution (QKD) has widely been understood as the property that any attempt to distinguish encoded quantum states causes a disturbance in the signal. As a result, implementation of a QKD protocol involves an estimation of the experimental parameters influenced by the eavesdropper's intervention, which is achieved by randomly sampling the signal. If the estimation of many parameters with high precision is required, the portion of the signal that is sacrificed increases, thus decreasing the efficiency of the protocol(9,10). Here we propose a QKD protocol based on an entirely different principle. The sender encodes a bit sequence onto non-orthogonal quantum states and the receiver randomly dictates how a single bit should be calculated from the sequence. The eavesdropper, who is unable to learn the whole of the sequence, cannot guess the bit value correctly. An achievable rate of secure key distribution is calculated by considering complementary choices between quantum measurements of two conjugate observables(11). We found that a practical implementation using a laser pulse train achieves a key rate comparable to a decoy-state QKD protocol(12-14), an often-used technique for lasers. It also has a better tolerance of bit errors and of finite-sized-key effects. We anticipate that this finding will give new insight into how the probabilistic nature of quantum mechanics can be related to secure communication, and will facilitate the simple and efficient use of conventional lasers for QKD.	[Sasaki, Toshihiko; Koashi, Masato] Univ Tokyo, Grad Sch Engn, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Yamamoto, Yoshihisa] Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA; [Yamamoto, Yoshihisa] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan	University of Tokyo; Stanford University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Koashi, M (corresponding author), Univ Tokyo, Grad Sch Engn, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan.	koashi@qi.t.u-tokyo.ac.jp	Yamamoto, Yoshihisa/A-2811-2012; Sasaki, Toshihiko/P-7518-2019	Yamamoto, Yoshihisa/0000-0002-4150-6804; Sasaki, Toshihiko/0000-0003-0745-6791	Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST); MEXT [21102008]; Photon Frontier Network Program (MEXT)	Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon Frontier Network Program (MEXT)	We thank H. Takesue and K. Tamaki for helpful discussions. This work was supported by the Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST), Grant-in-Aid for Scientific Research on Innovative Areas number 21102008 (MEXT), and Photon Frontier Network Program (MEXT).	Bennett C.H., 1984, P IEEE INT C COMP SY, P175, DOI DOI 10.1016/J.TCS.2014.05.025; BENNETT CH, 1992, PHYS REV LETT, V68, P3121, DOI 10.1103/PhysRevLett.68.3121; Bourgoin JP, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023006; Brassard G, 2000, PHYS REV LETT, V85, P1330, DOI 10.1103/PhysRevLett.85.1330; Cai RYQ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045024; Claudon J, 2010, NAT PHOTONICS, V4, P174, DOI 10.1038/nphoton.2009.287x; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Gottesman D, 2004, QUANTUM INF COMPUT, V4, P325; Grosshans F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.057902; Hayashi M., 2013, PREPRINT; Hayashi M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093014; He YM, 2013, NAT NANOTECHNOL, V8, P213, DOI [10.1038/nnano.2012.262, 10.1038/NNANO.2012.262]; HUTTNER B, 1995, PHYS REV A, V51, P1863, DOI 10.1103/PhysRevA.51.1863; Hwang WY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057901; Inoue K, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022317; Koashi M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045018; Lo HK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230504; Mayers D, 2001, J ACM, V48, P351, DOI 10.1145/382780.382781; Nauerth S, 2013, NAT PHOTONICS, V7, P382, DOI [10.1038/nphoton.2013.46, 10.1038/NPHOTON.2013.46]; Pawlowski M, 2009, NATURE, V461, P1101, DOI 10.1038/nature08400; Scarani V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057901; Stucki D, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2126792; Takesue H, 2007, NAT PHOTONICS, V1, P343, DOI 10.1038/nphoton.2007.75; Tamaki K., 2012, PREPRINT; Tomamichel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1631; Wang JY, 2013, NAT PHOTONICS, V7, P387, DOI [10.1038/nphoton.2013.89, 10.1038/NPHOTON.2013.89]; Wang XB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230503; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790	30	225	232	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					475	+		10.1038/nature13303	http://dx.doi.org/10.1038/nature13303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848060				2022-12-28	WOS:000336126000035
J	Taguchi, T; Terada, Y				Taguchi, Takafumi; Terada, Yoshio			Subperiosteal Bone Resorption	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Taguchi, Takafumi; Terada, Yoshio] Kochi Med Sch, Kochi, Japan	Kochi University	Taguchi, T (corresponding author), Kochi Med Sch, Kochi, Japan.	ttagu27k@axel.ocn.ne.jp							0	3	3	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					E32	E32		10.1056/NEJMicm1308814	http://dx.doi.org/10.1056/NEJMicm1308814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24849102				2022-12-28	WOS:000336125500001
J	Cole, TB				Cole, Thomas B.			Astrolabe Muhammad ibn Sa'id as-Sabban	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1946	1947		10.1001/jama.2013.279502	http://dx.doi.org/10.1001/jama.2013.279502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846019				2022-12-28	WOS:000336122800001
J	Wagner, JP; Hiatt, JR				Wagner, Justin P.; Hiatt, Jonathan R.			B-Type Natriuretic Peptide for the Evaluation of Volume Status in Elderly Postoperative Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wagner, Justin P.; Hiatt, Jonathan R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wagner, JP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, 10833 Le Conte Ave 72-235 CHS, Los Angeles, CA 90095 USA.	jwagner@mednet.ucla.edu	Wagner, Justin/ABC-2668-2021					Berri RN, 2012, J AM COLL SURGEONS, V214, P778, DOI 10.1016/j.jamcollsurg.2012.01.046; Dokainish H, 2004, CIRCULATION, V109, P2432, DOI 10.1161/01.CIR.0000127882.58426.7A; Jason P, 2005, CRIT CARE MED, V33, P2094, DOI 10.1097/01.CCM.0000178351.03327.9F; Mandeville JC, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/513480; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Parsonage WA, 2005, AM J CARDIOL, V95, P883, DOI 10.1016/j.amjcard.2004.12.021; Suttie S, 2011, ANN VASC SURG, V25, P248, DOI 10.1016/j.avsg.2010.10.002; Tung RH, 2004, CRIT CARE MED, V32, P1643, DOI 10.1097/01.CCM.0000133694.28370.7F; Watters JM, 2004, ACS SURG PRINCIPLES, P1	9	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					2017	2018		10.1001/jama.2013.7300	http://dx.doi.org/10.1001/jama.2013.7300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846040				2022-12-28	WOS:000336122800025
J	Smith, DA				Smith, Donald A.			Review: Statins are not associated with cognitive impairment or dementia in cognitively intact adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.			Martin, Seth/0000-0002-7021-7622					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC11	10.7326/0003-4819-160-10-201405200-02011	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842433				2022-12-28	WOS:000337347100010
J	Chatters, JC; Kennett, DJ; Asmerom, Y; Kemp, BM; Polyak, V; Blank, AN; Beddows, PA; Reinhardt, E; Arroyo-Cabrales, J; Bolnick, DA; Malhi, RS; Culleton, BJ; Erreguerena, PL; Rissolo, D; Morell-Hart, S; Stafford, TW				Chatters, James C.; Kennett, Douglas J.; Asmerom, Yemane; Kemp, Brian M.; Polyak, Victor; Blank, Alberto Nava; Beddows, Patricia A.; Reinhardt, Eduard; Arroyo-Cabrales, Joaquin; Bolnick, Deborah A.; Malhi, Ripan S.; Culleton, Brendan J.; Luna Erreguerena, Pilar; Rissolo, Dominique; Morell-Hart, Shanti; Stafford, Thomas W., Jr.			Late Pleistocene Human Skeleton and mtDNA Link Paleoamericans and Modern Native Americans	SCIENCE			English	Article							AGE; HISTORY	Because of differences in craniofacial morphology and dentition between the earliest American skeletons and modern Native Americans, separate origins have been postulated for them, despite genetic evidence to the contrary. We describe a near-complete human skeleton with an intact cranium and preserved DNA found with extinct fauna in a submerged cave on Mexico's Yucatan Peninsula. This skeleton dates to between 13,000 and 12,000 calendar years ago and has Paleoamerican craniofacial characteristics and a Beringian-derived mitochondrial DNA (mtDNA) haplogroup (D1). Thus, the differences between Paleoamericans and Native Americans probably resulted from in situ evolution rather than separate ancestry.	[Chatters, James C.] Appl Paleosci, Bothell, WA 98011 USA; [Chatters, James C.] DirectAMS, Bothell, WA 98011 USA; [Kennett, Douglas J.; Culleton, Brendan J.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Kennett, Douglas J.; Culleton, Brendan J.] Penn State Univ, Inst Energy, University Pk, PA 16802 USA; [Kennett, Douglas J.; Culleton, Brendan J.] Penn State Univ, Inst Environm, University Pk, PA 16802 USA; [Asmerom, Yemane; Polyak, Victor] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Blank, Alberto Nava] Bay Area Underwater Explorers, Berkeley, CA USA; [Beddows, Patricia A.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Reinhardt, Eduard] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON L8S 4K1, Canada; [Arroyo-Cabrales, Joaquin] Inst Nacl Antropol & Hist, Colonia Ctr Hist, Mexico City 06060, DF, Mexico; [Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Bolnick, Deborah A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Luna Erreguerena, Pilar] Inst Nacl Antropol & Hist, Subdirecc Arqueol Subacuat, Mexico City 06070, DF, Mexico; [Rissolo, Dominique] Waitt Inst, La Jolla, CA 92038 USA; [Morell-Hart, Shanti] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Stafford, Thomas W., Jr.] Aarhus Univ, Dept Phys & Astron, Ctr AMS 14C, Aarhus, Denmark; [Stafford, Thomas W., Jr.] Nat Hist Museum Denmark, Geol Museum, Ctr GeoGenet, Copenhagen, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of New Mexico; Washington State University; Washington State University; Northwestern University; McMaster University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Aarhus University	Chatters, JC (corresponding author), Appl Paleosci, 10322 NE 190th St, Bothell, WA 98011 USA.	paleosci@gmail.com	Kennett, Douglas J/I-7613-2015; Beddows, Patricia A. A./B-1034-2009; Arroyo-Cabrales, Joaquin/S-8752-2019	Kennett, Douglas J/0000-0001-5133-9010; Beddows, Patricia A. A./0000-0002-5482-5329; Arroyo-Cabrales, Joaquin/0000-0002-9095-489X; Malhi, Ripan/0000-0002-1484-0292; Morell-Hart, Shanti/0000-0003-1866-8714	National Geographic Society; Archaeological Institute of America; Waitt Institute; Instituto Nacional de Antropologia e Historia; NSF; Pennsylvania State University; University of New Mexico; University of Texas at Austin; University of Illinois; Urbana-Champaign; DirectAMS	National Geographic Society(National Geographic Society); Archaeological Institute of America; Waitt Institute; Instituto Nacional de Antropologia e Historia; NSF(National Science Foundation (NSF)); Pennsylvania State University; University of New Mexico; University of Texas at Austin; University of Illinois; Urbana-Champaign; DirectAMS	Data reported here are available in tables S2 to S5 and at GenBank (accession no. KJ710435). Support was provided by the National Geographic Society, the Archaeological Institute of America, the Waitt Institute, the Instituto Nacional de Antropologia e Historia, NSF (Y.A., V.P., and D.K.), Pennsylvania State University, the University of New Mexico, the University of Texas at Austin, the University of Illinois, Urbana-Champaign, and DirectAMS.	Bard E, 2010, SCIENCE, V327, P1235, DOI 10.1126/science.1180557; Chatters J. C., 2010, HUMAN VARIATION AM I, V38, P51; Pierre MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043486; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; GRAHAM RW, 2001, WORLD ELEPHANTS, P707; Haynes G, 2013, QUATERN INT, V285, P89, DOI 10.1016/j.quaint.2010.07.026; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Lahr M. M., 1996, EVOLUTION OF MODERN; Lahr MM, 1997, EVOL ANTHROPOL, V6, P2, DOI 10.1002/(SICI)1520-6505(1997)6:1<2::AID-EVAN2>3.0.CO;2-K; Medina-Elizalde M, 2013, EARTH PLANET SC LETT, V362, P310, DOI 10.1016/j.epsl.2012.12.001; Milne GA, 2013, GLOBAL PLANET CHANGE, V107, P119, DOI 10.1016/j.gloplacha.2013.04.014; Neves WA, 2013, PALEOAMERICAN ODYSSE, P397; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Powell J. F., 2004, THE FIRST AMERICANS; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Raff JA, 2014, NATURE, V506, P162, DOI 10.1038/506162a; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Steele DG, 1999, WHO WERE THE FIRST AMERICANS?, P97; SZABO BJ, 1978, GEOLOGY, V6, P713, DOI 10.1130/0091-7613(1978)6<713:AAMOTL>2.0.CO;2; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308	25	111	119	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					750	754		10.1126/science.1252619	http://dx.doi.org/10.1126/science.1252619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH1WQ	24833392				2022-12-28	WOS:000335912900042
J	Hawkes, N				Hawkes, Nigel			The Better Care Fund: a disaster in waiting?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3345	10.1136/bmj.g3345	http://dx.doi.org/10.1136/bmj.g3345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838350				2022-12-28	WOS:000336158400008
J	Khambati, N				Khambati, Nisreen			India's two finger test after rape violates women and should be eliminated from medical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIOLENCE		Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England	University of Southampton	Khambati, N (corresponding author), Univ Southampton, Fac Med, Bldg 85,Life Sci Bldg,Highfield Campus, Southampton SO17 1BJ, Hants, England.	nk13g09@southampton.ac.uk		Khambati, Nisreen/0000-0003-2693-3266				Agnes F., 2005, EC POLIT WEEKLY, V40, P1859; Baxi P., 2005, VIOLENCE NORMAL TIME, P266; BHAT R, 2004, ANAL PUBLIC EXPENDIT; Centre for Enquiry Into Health and Allied Themes, 2012, EST COMPR HLTH SECT; Friedman A., 2013, JERUSALEM POST; Gill AK, 2013, INT J CRIM JUSTICE S, V8, P166; Human Rights Watch, 2010, DIGN TRIAL 2010; Jain A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f229; Jha M, 2013, J PUNJAB ACAD FORENS, V13, P45; Mascarenhas A., 2014, INDIAN EXPRESS; Mukadam R., 2011, RESPONDING SEXUAL AS; Prasad S, 1999, Violence Against Women, V5, P478, DOI 10.1177/10778019922181338; World Health Organization, 2003, GUID MED LEG CAR VIC; Yee A, 2013, LANCET, V381, P1445, DOI 10.1016/S0140-6736(13)60912-5	14	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3336	10.1136/bmj.g3336	http://dx.doi.org/10.1136/bmj.g3336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838105				2022-12-28	WOS:000336158400005
J	van Berlo, JH; Kanisicak, O; Maillet, M; Vagnozzi, RJ; Karch, J; Lin, SCJ; Middleton, RC; Marban, E; Molkentin, JD				van Berlo, Jop H.; Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Middleton, Ryan C.; Marban, Eduardo; Molkentin, Jeffery D.			c-kit(+) cells minimally contribute cardiomyocytes to the heart	NATURE			English	Article							CARDIAC STEM-CELLS; C-KIT; ADULT; FUSION; REGENERATION; MYOCARDIUM; EXPRESSION; MOUSE; ADOPT	If and how the heart regenerates after an injury event is highly debated. c-kit-expressing cardiac progenitor cells have been reported as the primary source for generation of new myocardium after injury. Here we generated two genetic approaches in mice to examine whether endogenous c-kit(+) cells contribute differentiated cardiomyocytes to the heart during development, with ageing or after injury in adulthood. A complementary DNA encoding either Cre recombinase or a tamoxifen-inducible MerCreMer chimaeric protein was targeted to the Kit locus in mice and then bred with reporter lines to permanently mark cell lineage. Endogenous c-kit(+) cells did produce new cardiomyocytes within the heart, although at a percentage of approximately 0.03 or less, and if a preponderance towards cellular fusion is considered, the percentage falls to below approximately 0.008. By contrast, c-kit(+) cells amply generated cardiac endothelial cells. Thus, endogenous c-kit(+) cells cangenerate cardiomyocytes within the heart, although probably at a functionally insignificant level.	[van Berlo, Jop H.; Kanisicak, Onur; Maillet, Marjorie; Vagnozzi, Ronald J.; Karch, Jason; Lin, Suh-Chin J.; Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [van Berlo, Jop H.] Univ Minnesota, Lillehei Heart Inst, Div Cardiol, Dept Med, Minneapolis, MN 55455 USA; [Middleton, Ryan C.; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Cedars Sinai Medical Center; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org	Marban, Eduardo/GWC-8514-2022; Vagnozzi, Ronald/AAR-6891-2020; Kanisicak, Onur/AAU-4586-2020	Vagnozzi, Ronald/0000-0002-8027-1809; Kanisicak, Onur/0000-0002-8393-4874; Molkentin, Jeffery/0000-0002-3558-6529; van Berlo, Jop/0000-0001-9229-4429	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL112852, P50HL077101, R01HL105924, P01HL108806, P50HL052318, R37HL060562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (to J.H.v.B., E. M. and J.D.M.). J.D.M. is an investigator of the Howard Hughes Medical Institute.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Liu QH, 2009, CIRC RES, V105, P1110, DOI 10.1161/CIRCRESAHA.109.200741; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Mauduit C, 1999, HUM REPROD UPDATE, V5, P535, DOI 10.1093/humupd/5.5.535; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NAGY ARJ, 2000, GENE TARGETING PRACT; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sandlow JI, 1996, J ANDROL, V17, P403; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033407; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093	27	564	581	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					337	+		10.1038/nature13309	http://dx.doi.org/10.1038/nature13309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805242	Green Accepted, Green Published			2022-12-28	WOS:000336121200033
J	Kondo, T; Uehara, T; Ikegami, A; Ikusaka, M				Kondo, Takeshi; Uehara, Takanori; Ikegami, Akiko; Ikusaka, Masatomi			Paroxysmal burning pain caused by erythromelalgia	LANCET			English	Editorial Material									[Kondo, Takeshi; Uehara, Takanori; Ikegami, Akiko; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba 2608677, Japan	Chiba University	Kondo, T (corresponding author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	chiba_u_soshin@mac.com	Kondo, Takeshi/GXG-4271-2022	Kondo, Takeshi/0000-0001-6285-4966				Berlin AL, 2004, J AM ACAD DERMATOL, V50, P456, DOI 10.1016/S0190-9622(03)02121-2; Cohen JS, 2000, J AM ACAD DERMATOL, V43, P841, DOI 10.1067/mjd.2000.109301; Davis MDP, 2006, J AM ACAD DERMATOL, V55, P519, DOI 10.1016/j.jaad.2006.04.067; Nanayakkara PWB, 2007, NETH J MED, V65, P349; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070	5	7	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1692	1692		10.1016/S0140-6736(14)60655-3	http://dx.doi.org/10.1016/S0140-6736(14)60655-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24814455				2022-12-28	WOS:000335670800032
J	Gibson, DG; Venter, JC				Gibson, Daniel G.; Venter, J. Craig			SYNTHETIC BIOLOGY Construction of a yeast chromosome	NATURE			English	Editorial Material							MYCOPLASMA-GENITALIUM GENOME		[Gibson, Daniel G.; Venter, J. Craig] J Craig Venter Inst, La Jolla, CA 92037 USA; [Gibson, Daniel G.; Venter, J. Craig] Synthet Genom, La Jolla, CA USA	J. Craig Venter Institute	Gibson, DG (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	dgibson@jcvi.org						Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Annaluru Narayana, 2012, Methods Mol Biol, V852, P77, DOI 10.1007/978-1-61779-564-0_7; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Glass JI, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.89; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759	10	20	22	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					168	169		10.1038/509168a	http://dx.doi.org/10.1038/509168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805340				2022-12-28	WOS:000335454300024
J	Hsu, YC; Li, LS; Fuchs, E				Hsu, Ya-Chieh; Li, Lishi; Fuchs, Elaine			Transit-Amplifying Cells Orchestrate Stem Cell Activity and Tissue Regeneration	CELL			English	Article							HAIR-FOLLICLE; SONIC-HEDGEHOG; SELF-RENEWAL; NICHE; ORGANIZATION; ACTIVATION; PROGENY; TRANSDUCTION; PRECURSORS; QUIESCENT	Transit-amplifying cells (TACs) are an early intermediate in tissue regeneration. Here, using hair follicles (HFs) as a paradigm, we show that emerging TACs constitute a signaling center that orchestrates tissue growth. Whereas primed stem cells (SCs) generate TACs, quiescent SCs only proliferate after TACs form and begin expressing Sonic Hedgehog (SHH). TAC generation is independent of autocrine SHH, but the TAC pool wanes if they can't produce SHH. We trace this paradox to two direct actions of SHH: promoting quiescent-SC proliferation and regulating dermal factors that stoke TAC expansion. Ingrained within quiescent SCs' special sensitivity to SHH signaling is their high expression of GAS1. Without sufficient input from quiescent SCs, replenishment of primed SCs for the next hair cycle is compromised, delaying regeneration and eventually leading to regeneration failure. Our findings unveil TACs as transient but indispensable integrators of SC niche components and reveal an intriguing interdependency of primed and quiescent SC populations on tissue regeneration.	[Hsu, Ya-Chieh; Li, Lishi; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIH [K99-AR063127]; NIH/NIAMS [R01AR050452]; Empire State Stem Cell (NYSTEM) [N09G074]; NYSDOH [C023046]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR063127, R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Empire State Stem Cell (NYSTEM); NYSDOH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to C-M. Fan for Gas1<SUP>-/-</SUP>, H. Westphal for the Shh<SUP>null</SUP> mice, and many colleagues who donated mice to JAX; S. Mazel, L. Li,S. Semova, and S. Tadesse for sorting (RU FCRC facility, supported by NYSDOH Contract #C023046); RU Comparative Biology Center (AAALAC-accredited) for veterinary care; members of the Fuchs' lab, in particular, M. Kadaja for lentiviral constructs, C-Y. Chang, S-J. Luo, N. Oshimori, B. Keyes, and K. Tumaneng for comments on the manuscript, L. Polak, N. Stokes, D. Oristian A. Aldeguer, and S. Hacker for assistance in mouse research, and J. Racelis for assistance with in situ hybridization. Y-C.H. was a NYSCF-Druckenmiller Postdoctoral Fellow and is now supported by NIH K99-R00 pathway to independence award K99-AR063127. L. L. is a Helen Hay Whitney Postdoctoral Fellow. E. F. is an HHMI Investigator. This work was supported by a grant (to E. F.) from the NIH/NIAMS (R01AR050452) and partially by a grant from Empire State Stem Cell (NYSTEM; N09G074), NYSTEM funds through NYSDOH (Contract C023046; RU FCRC).	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fantauzzo KA, 2011, CELL STEM CELL, V8, P8, DOI 10.1016/j.stem.2010.12.018; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Paladini RD, 2005, J INVEST DERMATOL, V125, P638, DOI 10.1111/j.0022-202X.2005.23867.x; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vied C, 2012, DEV CELL, V23, P836, DOI 10.1016/j.devcel.2012.09.010; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Xiong YQ, 2013, DEV CELL, V25, P169, DOI 10.1016/j.devcel.2013.03.015; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	59	225	229	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					935	949		10.1016/j.cell.2014.02.057	http://dx.doi.org/10.1016/j.cell.2014.02.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813615	Bronze, Green Accepted			2022-12-28	WOS:000335765500020
J	Liu, SP; Lorenzen, ED; Fumagalli, M; Li, B; Harris, K; Xiong, ZJ; Zhou, L; Korneliussen, TS; Somel, M; Babbitt, C; Wray, G; Li, JW; He, WM; Wang, Z; Fu, WJ; Xiang, XY; Morgan, CC; Doherty, A; O'Connell, MJ; McInerney, JO; Born, EW; Dalen, L; Dietz, R; Orlando, L; Sonne, C; Zhang, GJ; Nielsen, R; Willerslev, E; Wang, J				Liu, Shiping; Lorenzen, Eline D.; Fumagalli, Matteo; Li, Bo; Harris, Kelley; Xiong, Zijun; Zhou, Long; Korneliussen, Thorfinn Sand; Somel, Mehmet; Babbitt, Courtney; Wray, Greg; Li, Jianwen; He, Weiming; Wang, Zhuo; Fu, Wenjing; Xiang, Xueyan; Morgan, Claire C.; Doherty, Aoife; O'Connell, Mary J.; McInerney, James O.; Born, Erik W.; Dalen, Love; Dietz, Rune; Orlando, Ludovic; Sonne, Christian; Zhang, Guojie; Nielsen, Rasmus; Willerslev, Eske; Wang, Jun			Population Genomics Reveal Recent Speciation and Rapid Evolutionary Adaptation in Polar Bears	CELL			English	Article							SOUTHERN BEAUFORT SEA; URSUS-MARITIMUS; DILATED CARDIOMYOPATHY; BODY-COMPOSITION; LYST GENE; MUTATION; GREENLAND; PREDATION; ADMIXTURE; SEQUENCE	Polar bears are uniquely adapted to life in the High Arctic and have undergone drastic physiological changes in response to Arctic climates and a hyper-lipid diet of primarily marine mammal prey. We analyzed 89 complete genomes of polar bear and brown bear using population genomic modeling and show that the species diverged only 479-343 thousand years BP. We find that genes on the polar bear lineage have been under stronger positive selection than in brown bears; nine of the top 16 genes under strong positive selection are associated with cardiomyopathy and vascular disease, implying important reorganization of the cardiovascular system. One of the genes showing the strongest evidence of selection, APOB, encodes the primary lipoprotein component of low-density lipoprotein (LDL); functional mutations in APOB may explain how polar bears are able to cope with life-long elevated LDL levels that are associated with high risk of heart disease in humans.	[Liu, Shiping; Li, Bo; Xiong, Zijun; Zhou, Long; Li, Jianwen; He, Weiming; Wang, Zhuo; Fu, Wenjing; Xiang, Xueyan; Zhang, Guojie; Nielsen, Rasmus; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Shiping; He, Weiming] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Lorenzen, Eline D.; Fumagalli, Matteo; Somel, Mehmet; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lorenzen, Eline D.; Korneliussen, Thorfinn Sand; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Harris, Kelley] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Babbitt, Courtney; Wray, Greg] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Babbitt, Courtney; Wray, Greg] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Xiang, Xueyan] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Morgan, Claire C.; O'Connell, Mary J.] Dublin City Univ, Sch Biotechnol, Bioinformat & Mol Evolut Grp, Dublin 9, Ireland; [Doherty, Aoife; McInerney, James O.] Natl Univ Ireland, Dept Biol, Bioinformat & Mol Evolut Unit, Maynooth, Co Kildare, Ireland; [Born, Erik W.] Govt Greenland Representat Denmark, Greenland Inst Nat Resources, DK-1016 Copenhagen K, Denmark; [Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden; [Dietz, Rune; Sonne, Christian] Aarhus Univ, Arctic Res Ctr, Dept Biosci, DK-4000 Roskilde, Denmark; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Willerslev, Eske; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen O, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China	Beijing Genomics Institute (BGI); South China University of Technology; University of California System; University of California Berkeley; University of Copenhagen; University of California System; University of California Berkeley; Duke University; Duke University; Sichuan University; Dublin City University; Maynooth University; Greenland Institute of Natural Resources; Swedish Museum of Natural History; Aarhus University; University of Copenhagen; University of California System; University of California Berkeley; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	rasmus_nielsen@berkeley.edu; ewillerslev@snm.ku.dk; wangj@genomics.org.cn	Zhang, Guojie/B-6188-2014; Mcinerney, James/AAF-7234-2020; Zhang, Guojie/J-7273-2019; McInerney, James/B-5108-2012; Korneliussen, Thorfinn Sand/ABB-7656-2021; Willerslev, Eske/AAA-5686-2019; Dalén, Love/A-6686-2008; Fumagalli, Matteo/H-6448-2019; Korneliussen, Thorfinn Sand/F-6421-2014; Sonne, Christian/I-7532-2013; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/A-9619-2011; Somel, Mehmet/B-1471-2016; Dietz, Rune/F-9154-2015; Wang, Jun/C-8434-2016; Nielsen, Rasmus/D-4405-2009; Wang, Jun/B-9503-2016; Lorenzen, Eline/D-1442-2012	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; McInerney, James/0000-0003-1885-2503; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Dalén, Love/0000-0001-8270-7613; Fumagalli, Matteo/0000-0002-4084-2953; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Sonne, Christian/0000-0001-5723-5263; Orlando, Ludovic/0000-0003-3936-1850; Willerslev, Eske/0000-0002-7081-6748; Dietz, Rune/0000-0001-9652-317X; Somel, Mehmet/0000-0002-3138-1307; Wang, Jun/0000-0002-8540-8931; O'Connell, Mary/0000-0002-1877-1001; Nielsen, Rasmus/0000-0003-0513-6591; Xiong, Zijun/0000-0003-3923-0703; Xiang, Xueyan/0000-0003-1843-0474; LIU, Shiping/0000-0003-0019-619X; Wang, Jun/0000-0002-2113-5874; Lorenzen, Eline/0000-0002-6353-2819; Wang, Zhuo/0000-0002-4069-9501	NIH [2R14003229-07, 5P-50-GM- 081883]; Swedish Research Council; BiodivERsA ERA-NET project Climigrate; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); BiodivERsA ERA-NET project Climigrate; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the subsistence Greenland hunters for their valuable participation in obtaining the polar bear samples used in this study, which were collected through a number of projects funded under the DANCEA (Danish Cooperation for Environment in the Arctic) programme. We thank the University of Alaska Museum of the North for providing the ABC brown bear samples and IIpo Kojola, Katherine Kendall, and John Waller for providing additional samples. We thank Zhaolei Zhang, Yaping Zhang, Fang Li, and Weilin Qiu for help and Xiaoning Wang (South China University of Technology) and the National Gene Bank Project of China and Shenzhen Municipal Government of China (NO. JC201005260191A, CXB201108250096A). E.D.L. was supported by grants from the Danish Council for Independent Research broken vertical bar Natural Sciences (09-069307) and a Marie Curie International Outgoing Fellowship within the European Community 7th Framework Programme (PIOF-GA-2009-253376). M F. and M.S. were supported by EMBO Long-term Postdoctoral Fellowships (ALTF-229-2011 and ALTF-1475-2010) and grant PJ008116 from Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea. K. H. was supported by a National Science Foundation Graduate Research Fellowship and a UC Berkeley Chancellors Fellowship. R. N. was supported by NIH (2R14003229-07). G.A.W. was supported by NIH (5P-50-GM- 081883 to the Duke Center for Systems Biology). C.C.M. and M J.O'C. thank the Irish Research Council for Science, Engineering and Technology (Embark Initiative to CCM (RS2000172) and Science Foundation Ireland Research Frontiers Program (EOB2673). L.D. was supported by grants from the Swedish Research Council and the BiodivERsA ERA-NET project Climigrate.	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cronin MA, 2009, J HERED, V100, P681, DOI 10.1093/jhered/esp061; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Dickson AJ, 2009, NAT GEOSCI, V2, P428, DOI 10.1038/NGEO527; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Fumagalli M., 2014, BIOINFORMATICS; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Gutierrez-Gil B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-56; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hedberg GE, 2011, ZOO BIOL, V30, P550, DOI 10.1002/zoo.20375; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Kunieda T, 1999, MAMM GENOME, V10, P1146, DOI 10.1007/s003359901181; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Ormbostad I., 2012, THESIS NORWEGIAN U S; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Pages M, 2008, MOL PHYLOGENET EVOL, V47, P73, DOI 10.1016/j.ympev.2007.10.019; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Runkel F, 2006, MAMM GENOME, V17, P203, DOI 10.1007/s00335-005-0015-1; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Trantow CM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001008; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GQ, 2012, J HUM GENET, V57, P727, DOI 10.1038/jhg.2012.101; Whitfield AJ, 2004, CLIN CHEM, V50, P1725, DOI 10.1373/clinchem.2004.038026; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758	49	214	216	10	547	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					785	794		10.1016/j.cell.2014.03.054	http://dx.doi.org/10.1016/j.cell.2014.03.054			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813606	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000335765500008
J	Qi, XS; Han, GH				Qi, Xingshun; Han, Guohong			Abdominal-Wall Varices in the Budd-Chiari Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 57-year-old man with a 5-year history of intermittent edema of the legs was admitted to the hospital because of varices in the right abdominal and chest walls. The varices had been gradually increasing in size and number over a period of 18 years. A 57-year-old man with a 5-year history of intermittent edema of the legs was admitted to the hospital because of varices in the right abdominal and chest walls (Panel A). The varices had been gradually increasing in size and number over a period of 18 years. Abnormal results of laboratory tests included a total bilirubin level of 44.0 mol per liter (2.6 mg per deciliter; normal range, 3.4 to 20.5 mol per liter [0.2 to 1.2 mg per deciliter]), a serum albumin level of 28.2 g per liter (normal range, 40 to 55), and a prothrombin time of 17.1 seconds ...	[Qi, Xingshun; Han, Guohong] Xijing Hosp Digest Dis, Xian, Peoples R China		Qi, XS (corresponding author), Xijing Hosp Digest Dis, Xian, Peoples R China.	hangh@fmmu.edu.cn	Qi, Xingshun/M-7063-2013	Qi, Xingshun/0000-0002-9448-6739					0	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1829	1829		10.1056/NEJMicm1308567	http://dx.doi.org/10.1056/NEJMicm1308567			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806162				2022-12-28	WOS:000335997900010
J	Bezerra, JA; Spino, C; Magee, JC; Shneider, BL; Rosenthal, P; Wang, KS; Erlichman, J; Haber, B; Hertel, PM; Karpen, SJ; Kerkar, N; Loomes, KM; Molleston, JP; Murray, KF; Romero, R; Schwarz, KB; Shepherd, R; Suchy, FJ; Turmelle, YP; Whitington, PF; Moore, J; Sherker, AH; Robuck, PR; Sokol, RJ				Bezerra, Jorge A.; Spino, Cathie; Magee, John C.; Shneider, Benjamin L.; Rosenthal, Philip; Wang, Kasper S.; Erlichman, Jessi; Haber, Barbara; Hertel, Paula M.; Karpen, Saul J.; Kerkar, Nanda; Loomes, Kathleen M.; Molleston, Jean P.; Murray, Karen F.; Romero, Rene; Schwarz, Kathleen B.; Shepherd, Ross; Suchy, Frederick J.; Turmelle, Yumirle P.; Whitington, Peter F.; Moore, Jeffrey; Sherker, Averell H.; Robuck, Patricia R.; Sokol, Ronald J.		ChiLDREN	Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants With Biliary Atresia The START Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT STEROID-THERAPY; KASAI PORTOENTEROSTOMY; OUTCOMES; MANAGEMENT; IMPROVE; FLOW	IMPORTANCE Biliary atresia is the most common cause of end-stage liver disease in children. Controversy exists as to whether use of steroids after hepatoportoenterostomy improves clinical outcome. OBJECTIVE To determine whether the addition of high-dose corticosteroids after hepatoportoenterostomy is superior to surgery alone in improving biliary drainage and survival with the native liver. DESIGN, SETTING, AND PATIENTS The multicenter, double-blind Steroids in Biliary Atresia Randomized Trial (START) was conducted in 140 infants (mean age, 2.3 months) between September 2005 and February 2011 in the United States; follow-up ended in January 2013. INTERVENTIONS Participants were randomized to receive intravenous methylprednisolone (4 mg/kg/d for 2 weeks) and oral prednisolone (2 mg/kg/d for 2 weeks) followed by a tapering protocol for 9 weeks (n = 70) or placebo (n = 70) initiated within 72 hours of hepatoportoenterostomy. MAIN OUTCOMES AND MEASURES The primary end point (powered to detect a 25% absolute treatment difference) was the percentage of participants with a serum total bilirubin level of less than 1.5 mg/dL with his/her native liver at 6 months posthepatoportoenterostomy. Secondary outcomes included survival with native liver at 24 months of age and serious adverse events. RESULTS The proportion of participants with improved bile drainage was not statistically significantly improved by steroids at 6 months posthepatoportoenterostomy (58.6%[41/70] of steroids group vs 48.6%[34/70] of placebo group; adjusted relative risk, 1.14 [95% CI, 0.83 to 1.57]; P =.43). The adjusted absolute risk difference was 8.7%(95% CI, -10.4% to 27.7%). Transplant-free survival was 58.7% in the steroids group vs 59.4% in the placebo group (adjusted hazard ratio, 1.0 [95% CI, 0.6 to 1.8]; P = .99) at 24 months of age. The percentage of participants with serious adverse events was 81.4%[57/70] of the steroids group and 80.0%[56/70] of the placebo group (P > .99); however, participants receiving steroids had an earlier time of onset of their first serious adverse event by 30 days posthepatoportoenterostomy (37.2%[95% CI, 26.9% to 50.0%] of steroids group vs 19.0% [95% CI, 11.5% to 30.4%] of placebo group; P = .008). CONCLUSIONS AND RELEVANCE Among infants with biliary atresia who have undergone hepatoportoenterostomy, high-dose steroid therapy following surgery did not result in statistically significant treatment differences in bile drainage at 6 months, although a small clinical benefit could not be excluded. Steroid treatment was associated with earlier onset of serious adverse events in children with biliary atresia.	[Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Spino, Cathie; Magee, John C.; Moore, Jeffrey] Univ Michigan, Ann Arbor, MI 48109 USA; [Shneider, Benjamin L.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Rosenthal, Philip] UCSF Benioff Childrens Hosp, San Francisco, CA USA; [Wang, Kasper S.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Wang, Kasper S.] Univ So Calif, Los Angeles, CA USA; [Erlichman, Jessi; Haber, Barbara; Loomes, Kathleen M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hertel, Paula M.; Shepherd, Ross] Baylor Coll Med, Houston, TX 77030 USA; [Hertel, Paula M.; Shepherd, Ross] Texas Childrens Hosp, Houston, TX 77030 USA; [Karpen, Saul J.; Romero, Rene] Emory Univ, Sch Med, Atlanta, GA USA; [Karpen, Saul J.; Romero, Rene] Childrens Healthcare Atlanta, Atlanta, GA USA; [Kerkar, Nanda] Mt Sinai Sch Med, New York, NY USA; [Molleston, Jean P.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Molleston, Jean P.] Riley Hosp Children, Indianapolis, IN USA; [Murray, Karen F.] Seattle Childrens Hosp, Seattle, WA USA; [Schwarz, Kathleen B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Suchy, Frederick J.; Sokol, Ronald J.] Univ Colorado, Sch Med, Aurora, CO USA; [Suchy, Frederick J.; Sokol, Ronald J.] Childrens Hosp Colorado, Aurora, CO USA; [Turmelle, Yumirle P.] Washington Univ, Sch Med, St Louis, MO USA; [Whitington, Peter F.] Lurie Childrens Hosp Chicago, Chicago, IL USA; [Sherker, Averell H.; Robuck, Patricia R.] NIDDK, NIH, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; Baylor College of Medicine; Emory University; Children's Healthcare of Atlanta (CHOA); Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Washington University (WUSTL); Ann & Robert H. Lurie Children's Hospital of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bezerra, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jorge.bezerra@cchmc.org	Sherker, Averell H/A-2889-2013; Shepherd, Ross W/M-9713-2014	Sherker, Averell H/0000-0003-0409-6938; Shepherd, Ross W/0000-0002-5348-5107; Goodhue, Catherine/0000-0001-8833-9938; bucuvalas, john/0000-0002-6767-8874	National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) [DK62503, TR000424, DK62436, TR000150, DK62497, TR000077, DK62453, TR000154, DK62445, DK62481, TR000003, DK62466, TR000005, DK62500, TR000004, DK62452, TR000448, DK62470, DK84575, TR000423, DK84585, TR000454, DK84536, TR000007, DK62456]; NIDDK; GlaxoSmithKline; Axcan Pharma US Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR001082, UL1TR000424, UL1TR000005, UL1TR000448, UL1TR002529, UL1TR000004, UL1TR000150, UL1TR000130, UL1TR000154, UL1TR000003, UL1TR000423, ZIATR000007, UL1TR001108, UL1TR001079, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062453, U01DK062466, U01DK062481, U01DK084575, U01DK103149, U01DK062500, U01DK062452, P30DK078392, U01DK062503, U01DK062456, U01DK062497, U01DK084585, U01DK084538, U01DK062470, U01DK084536, U01DK103135, U01DK062436, U01DK062445] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); GlaxoSmithKline(GlaxoSmithKline); Axcan Pharma US Inc; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The following National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) grants supported the START study: DK62503 and TR000424 (awarded to Johns Hopkins University School of Medicine), DK62436 and TR000150 (Lurie Children's Hospital of Chicago), DK62497 and TR000077 (Cincinnati Children's Hospital Medical Center), DK62453 and TR000154 (University of Colorado School of Medicine and Children's Hospital Colorado, Aurora), DK62445 (Mount Sinai School of Medicine), DK62481 and TR000003 (Children's Hospital of Philadelphia), DK62466 and TR000005 (Children's Hospital of Pittsburgh of UPMC), DK62500 and TR000004 (UCSF Benioff Children's Hospital), DK62452 and TR000448 (Washington University School of Medicine and St Louis Children's Hospital), DK62470 (Baylor College of Medicine and Texas Children's Hospital, Houston), DK84575 and TR000423 (Seattle Children's Hospital), DK84538 and TR000130 (Children's Hospital Los Angeles and University of Southern California), DK84585, DK62470, and TR000454 (Emory University School of Medicine and Children's Healthcare of Atlanta), DK84536 and TR000007 (Indiana University School of Medicine and Riley Hospital for Children), and DK62456 (University of Michigan data coordinating center). The following companies provided support for the START study, each of which provided formula or medications as part of a cooperative agreement with the NIDDK: GlaxoSmithKline supplied ranitidine; Axcan Pharma US Inc, fat-soluble vitamins and tocopherol polyethylene glycol succinate; Axcan Pharma US Inc, ursodiol until 2009; and Mead Johnson Nutrition, Pregestimil.	[Anonymous], 2012, CATEGORICAL DATA ANA; Chardot C, 2013, J HEPATOL, V58, P1209, DOI 10.1016/j.jhep.2013.01.040; Davenport M, 2004, LANCET, V363, P1354, DOI 10.1016/S0140-6736(04)16045-5; Davenport M, 2007, HEPATOLOGY, V46, P1821, DOI 10.1002/hep.21873; Davenport M, 2013, J HEPATOL, V59, P1054, DOI 10.1016/j.jhep.2013.06.012; Dillon PW, 2001, J PEDIATR SURG, V36, P80, DOI 10.1053/jpsu.2001.20013; Escobar MA, 2006, J PEDIATR SURG, V41, P99, DOI 10.1016/j.jpedsurg.2005.10.072; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Haynes RC, 1980, ADRENOCORTICOTROPIC; KARRER FM, 1985, J PEDIATR SURG, V20, P693, DOI 10.1016/S0022-3468(85)80026-9; Kasai M, 1978, World J Surg, V2, P571; Kobayashi H, 2005, J PEDIATR SURG, V40, P327, DOI 10.1016/j.jpedsurg.2004.10.017; Lampela H, 2012, SCAND J GASTROENTERO, V47, P99, DOI 10.3109/00365521.2011.627446; Lao OB, 2010, AM J SURG, V199, P680, DOI 10.1016/j.amjsurg.2010.01.014; Meyers RL, 2003, J PEDIATR SURG, V38, P406, DOI 10.1053/jpsu.2003.50069; MINER PB, 1979, BIOCHEM PHARMACOL, V28, P1063, DOI 10.1016/0006-2952(79)90304-6; MINER PB, 1980, GASTROENTEROLOGY, V79, P212; Muraji T, 2004, J PEDIATR SURG, V39, P1803, DOI 10.1016/j.jpedsurg.2004.08.019; Muraji T, 1997, J PEDIATR SURG, V32, P1103, DOI 10.1016/S0022-3468(97)90408-5; Ohi R, 2000, Clin Liver Dis, V4, P779, DOI 10.1016/S1089-3261(05)70141-0; Sarkhy A, 2011, CAN J GASTROENTEROL, V25, P440, DOI 10.1155/2011/125610; Schreiber RA, 2010, J PEDIATR GASTR NUTR, V51, P61, DOI 10.1097/MPG.0b013e3181d67e5e; Serinet MO, 2006, HEPATOLOGY, V44, P75, DOI 10.1002/hep.21219; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Shneider BL, 2012, PEDIATRICS, V130, pE607, DOI 10.1542/peds.2011-1423; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Tatekawa Y, 2005, J PEDIATR SURG, V40, P1574, DOI 10.1016/j.jpedsurg.2005.06.017	27	106	120	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1750	1759		10.1001/jama.2014.2623	http://dx.doi.org/10.1001/jama.2014.2623			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794368	Green Accepted, Green Published			2022-12-28	WOS:000335382300020
J	Evans, RL				Evans, Rob L.			GEOPHYSICS Making the Earth move	NATURE			English	Editorial Material							UPPER-MANTLE; ASTHENOSPHERE; LITHOSPHERE; WATER		Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Evans, RL (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	revans@whoi.edu		Evans, Robert/0000-0001-5585-0684				Beghein C, 2014, SCIENCE, V343, P1237, DOI 10.1126/science.1246724; Dasgupta R, 2007, GEOLOGY, V35, P135, DOI 10.1130/G22856A.1; Evans R.L., 2012, MAGNETOTELLURIC METH, P50; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; Olugboji TM, 2013, GEOCHEM GEOPHY GEOSY, V14, P880, DOI 10.1002/ggge.20086; Pommier A, 2011, COMPUT GEOSCI-UK, V37, P1450, DOI 10.1016/j.cageo.2011.01.002; Pommier A., 2013, AGU FALL M SAN FRANC; Sifre D, 2014, NATURE, V509, P81, DOI 10.1038/nature13245; Tackley P. J., 2000, GEOCHEM GEOPHY GEOSY, V1, P1, DOI [10.1029/2000GC000036, DOI 10.1029/2000GC000036, 10.1029/200GC000036, 10.1029/2000GC000043]	14	2	3	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					40	41		10.1038/509040a	http://dx.doi.org/10.1038/509040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784212				2022-12-28	WOS:000335199100034
J	O'Dowd, A				O'Dowd, Adrian			Respiratory Medicine Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2014	348								g2941	10.1136/bmj.g2941	http://dx.doi.org/10.1136/bmj.g2941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SI	24789473				2022-12-28	WOS:000335478400003
J	Chowdhury, R; Sekirnik, R; Brissett, NC; Krojer, T; Ho, CH; Ng, SS; Clifton, IJ; Ge, W; Kershaw, NJ; Fox, GC; Muniz, JRC; Vollmar, M; Phillips, C; Pilka, ES; Kavanagh, KL; von Delft, F; Oppermann, U; McDonough, MA; Doherty, AJ; Schofield, CJ				Chowdhury, Rasheduzzaman; Sekirnik, Rok; Brissett, Nigel C.; Krojer, Tobias; Ho, Chia-hua; Ng, Stanley S.; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; Fox, Gavin C.; Muniz, Joao R. C.; Vollmar, Melanie; Phillips, Claire; Pilka, Ewa S.; Kavanagh, Kathryn L.; von Delft, Frank; Oppermann, Udo; McDonough, Michael A.; Doherty, Aidan J.; Schofield, Christopher J.			Ribosomal oxygenases are structurally conserved from prokaryotes to humans	NATURE			English	Article							TRANSCRIPTION FACTOR OSTERIX; CRYSTAL-STRUCTURE; LYSYL-HYDROXYLATION; SUBSTRATE-BINDING; HISTONE; PROTEIN; 2-OXOGLUTARATE; INSIGHTS; SYSTEM; DOMAIN	2-Oxoglutarate (2OG)-dependent oxygenases have important roles in the regulation of gene expression via demethylation of N-methylated chromatin components(1,2) and in the hydroxylation of transcription factors(3) and splicing factor proteins(4). Recently, 2OG-dependent oxygenases that catalyse hydroxylation of transferRNA(5-7) and ribosomal proteins(8) have been shown to be important in translation relating to cellular growth, T(H)17-cell differentiation and translational accuracy(9-12). The finding that ribosomal oxygenases (ROXs) occur in organisms ranging from prokaryotes to humans(8) raises questions as to their structural and evolutionary relationships. In Escherichia coli, YcfD catalyses arginine hydroxylation in the ribosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleolar protein 66 (NO66) catalyse histidine hydroxylation in the ribosomal proteins RPL27A and RPL8, respectively. The functional assignments of ROXs open therapeutic possibilities via either ROX inhibition or targeting of differentially modified ribosomes. Despite differences in the residue and protein selectivities of prokaryotic and eukaryotic ROXs, comparison of the crystal structures of E. coli YcfD and Rhodothermus marinus YcfD with those of human MINA53 and NO66 reveals highly conserved folds and novel dimerization modes defining a new structural subfamily of 2OG-dependent oxygenases. ROX structures with and without their substrates support their functional assignments as hydroxylases but not demethylases, and reveal how the subfamily has evolved to catalyse the hydroxylation of different residue side chains of ribosomal proteins. Comparison of ROX crystal structures with those of other JmjC-domain-containing hydroxylases, including the hypoxia-inducible factor asparaginyl hydroxylase FIH and histone N-epsilon -methyl lysine demethylases, identifies branch points in 2OG-dependent oxygenase evolution and distinguishes between JmjC-containing hydroxylases and demethylases catalysing modifications of translational and transcriptional machinery. The structures reveal that new protein hydroxylation activities can evolve by changing the coordination position from which the iron-bound substrate-oxidizing species reacts. This coordination flexibility has probably contributed to the evolution of the wide range of reactions catalysed by oxygenases.	[Chowdhury, Rasheduzzaman; Sekirnik, Rok; Ho, Chia-hua; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; McDonough, Michael A.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Chowdhury, Rasheduzzaman; Sekirnik, Rok; Ho, Chia-hua; Clifton, Ian J.; Ge, Wei; Kershaw, Nadia J.; McDonough, Michael A.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Brissett, Nigel C.; Doherty, Aidan J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Krojer, Tobias; Ng, Stanley S.; Muniz, Joao R. C.; Vollmar, Melanie; Phillips, Claire; Pilka, Ewa S.; Kavanagh, Kathryn L.; von Delft, Frank; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Fox, Gavin C.] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Oppermann, Udo] Botnar Res Ctr, NIHR Oxford Biomed Res Unit, Oxford OX3 7LD, England	University of Oxford; University of Oxford; University of Sussex; University of Oxford; SOLEIL Synchrotron; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Mansfield Rd, Oxford OX1 3TA, England.	rasheduzzaman.chowdhury@chem.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; Krojer, Tobias/ABE-3829-2021; McDonough, Michael A/G-2744-2013; McDonough, Michael/N-8913-2019; Muniz, Joao R/B-7782-2016	Chowdhury, Rashed/0000-0002-8058-6149; McDonough, Michael A/0000-0003-4664-6942; McDonough, Michael/0000-0003-4664-6942; Muniz, Joao R/0000-0003-2731-3966; Krojer, Tobias/0000-0003-0661-0814; Vollmar, Melanie/0000-0002-9162-9159; von Delft, Frank/0000-0003-0378-0017; Doherty, Aidan/0000-0002-6370-1109; Kershaw, Nadia/0000-0002-3554-2622; Schofield, Christopher/0000-0002-0290-6565; Brissett, Nigel/0000-0003-3645-6408; Sekirnik, Rok/0000-0001-6008-9500	Biotechnology and Biological Sciences Research Council; Wellcome Trust; European Research Council; Medical Research Council; Oxford NIHR Biomedical Research Unit; Cancer Research UK; Arthritis Research UK; Bayer Healthcare; Rosetree Foundation; Slovenian Academy of Sciences and Arts; Abbvie; Boehringer Ingelheim; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Eli Lilly; Genome Canada; GlaxoSmithKline; Ontario Ministry of Economic Development and Innovation; Janssen; Novartis Research Foundation; Pfizer; Takeda; BBSRC [BB/L004275/1, BB/J003018/1, BB/L009846/1, BB/J018643/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018643/1, BB/J003018/1, BB/L004275/1, BB/L009846/1, BB/C518230/1] Funding Source: researchfish; Cancer Research UK [6947] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford NIHR Biomedical Research Unit; Cancer Research UK(Cancer Research UK); Arthritis Research UK(Versus Arthritis); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Rosetree Foundation(Rosetrees Trust); Slovenian Academy of Sciences and Arts; Abbvie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Eli Lilly(Eli Lilly); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Ontario Ministry of Economic Development and Innovation; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, European Research Council, Medical Research Council, Oxford NIHR Biomedical Research Unit, Cancer Research UK, Arthritis Research UK, Bayer Healthcare, the Rosetree Foundation and the Slovenian Academy of Sciences and Arts (R. S.) for funding. We thank the scientists of beamlines X10SA (Swiss Light Source) and I02, I03, I04, I04-1 (Diamond Light Source) for assistance. The Structural Genomics Consortium is a registered charity (number 1097737) funded by Abbvie, Boehringer Ingelheim, the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Eli Lilly, Genome Canada, GlaxoSmithKline, the Ontario Ministry of Economic Development and Innovation, Janssen, Novartis Research Foundation, Pfizer, Takeda and the Wellcome Trust.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henri J, 2010, J BIOL CHEM, V285, P30767, DOI 10.1074/jbc.M110.106864; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kato M, 2011, NUCLEIC ACIDS RES, V39, P1576, DOI 10.1093/nar/gkq919; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; MILLER R, 1993, SCIENCE, V259, P1430, DOI 10.1126/science.8451639; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tao Y, 2013, J BIOL CHEM, V288, P16430, DOI 10.1074/jbc.M112.446849; Teichmann M, 2012, TRANSCR-AUSTIN, V3, P2, DOI 10.4161/trns.3.1.18917; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Woon ECY, 2012, ANGEW CHEM INT EDIT, V51, P1631, DOI 10.1002/anie.201107833; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	59	75	78	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					422	+		10.1038/nature13263	http://dx.doi.org/10.1038/nature13263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24814345	Green Accepted, Green Submitted			2022-12-28	WOS:000337350200040
J	Hejnol, A				Hejnol, Andreas			EVOLUTIONARY BIOLOGY Excitation over jelly nerves	NATURE			English	Editorial Material							GENOME		Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway	University of Bergen	Hejnol, A (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway.	andreas.hejnol@sars.uib.no	Hejnol, Andreas/C-5577-2012	Hejnol, Andreas/0000-0003-2196-8507				Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Jager M, 2011, J EXP ZOOL PART B, V316B, P171, DOI 10.1002/jez.b.21386; Maxmen A., 2014, NAUTILUS; Maxwell EK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-714; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9	8	4	4	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					38	39		10.1038/nature13340	http://dx.doi.org/10.1038/nature13340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24847878				2022-12-28	WOS:000336768900024
J	Koyano, F; Okatsu, K; Kosako, H; Tamura, Y; Go, E; Kimura, M; Kimura, Y; Tsuchiya, H; Yoshihara, H; Hirokawa, T; Endo, T; Fon, EA; Trempe, JF; Saeki, Y; Tanaka, K; Matsuda, N				Koyano, Fumika; Okatsu, Kei; Kosako, Hidetaka; Tamura, Yasushi; Go, Etsu; Kimura, Mayumi; Kimura, Yoko; Tsuchiya, Hikaru; Yoshihara, Hidehito; Hirokawa, Takatsugu; Endo, Toshiya; Fon, Edward A.; Trempe, Jean-Francois; Saeki, Yasushi; Tanaka, Keiji; Matsuda, Noriyuki			Ubiquitin is phosphorylated by PINK1 to activate parkin	NATURE			English	Article							MITOCHONDRIAL TRANSLOCATION; MECHANISMS; DROSOPHILA-PINK1; RECRUITMENT; DYSFUNCTION; MUTATIONS; DEFECTS; COMPLEX; DOMAIN	PINK1 (PTEN induced putative kinase 1) and PARKIN (also known as PARK2) have been identified as the causal genes responsible for hereditary recessive early-onset Parkinsonism(1,2). PINK1 is a Ser/Thr kinase that specifically accumulates on depolarized mitochondria, whereas parkin is an E3 ubiquitin ligase that catalyses ubiquitin transfer to mitochondrial substrates(3-5). PINK1 acts as an upstream factor for parkin(6,7) and is essential both for the activation of latent E3 parkin activity(8) and for recruiting parkin onto depolarized mitochondria(8-12). Recently, mechanistic insights into mitochondrial quality control mediated by PINK1 and parkin have been revealed(3-5), and PINK1-dependent phosphorylation of parkin has been reported(13-15). However, the requirement of PINK1 for parkin activation was not bypassed by phosphomimetic parkin mutation(15), and how PINK1 accelerates the E3 activity of parkin on damaged mitochondria is still obscure. Here we report that ubiquitin is the genuine substrate of PINK1. PINK1 phosphorylated ubiquitin at Ser 65 both in vitro and in cells, and a Ser 65 phosphopeptide derived from endogenous ubiquitin was only detected in cells in the presence of PINK1 and following a decrease in mitochondrial membrane potential. Unexpectedly, phosphomimetic ubiquitin bypassed PINK1-dependent activation of a phosphomimetic parkin mutant in cells. Furthermore, phosphomimetic ubiquitin accelerates discharge of the thioester conjugate formed by UBCH7 (also known as UBE2L3) and ubiquitin (UBCH7 ubiquitin) in the presence of parkin in vitro, indicating that it acts allosterically. The phosphorylation-dependent interaction between ubiquitin and parkin suggests that phosphorylated ubiquitin unlocks autoinhibition of the catalytic cysteine. Our results show that PINK1-dependent phosphorylation of both parkin and ubiquitin is sufficient for full activation of parkin E3 activity. These findings demonstrate that phosphorylated ubiquitin is a parkin activator.	[Koyano, Fumika; Okatsu, Kei; Go, Etsu; Kimura, Mayumi; Kimura, Yoko; Tsuchiya, Hikaru; Yoshihara, Hidehito; Saeki, Yasushi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Koyano, Fumika; Okatsu, Kei] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kosako, Hidetaka] Univ Tokushima, Div Cell Signaling, Fujii Mem Inst Med Sci, Tokushima 7708503, Japan; [Tamura, Yasushi] Nagoya Univ, Res Ctr Mat Sci, Nagoya, Aichi 4648602, Japan; [Kimura, Yoko] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan; [Endo, Toshiya] Nagoya Univ, Grad Sch Sci, JST CREST Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Kyoto Sangyo Univ, JST CREST Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Fon, Edward A.] McGill Univ, McGill Parkinson Program, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Tokushima University; Nagoya University; Shizuoka University; National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University; Kyoto Sangyo University; McGill University; McGill University; Tokyo Metropolitan Institute of Medical Science	Matsuda, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp; matsuda-nr@igakuken.or.jp	Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Kimura, Yoko/E-6845-2013; Saeki, Yasushi/AAR-8198-2021; Matsuda, Noriyuki/AAI-3156-2020	Tamura, Yasushi/0000-0002-8462-0607; Kimura, Yoko/0000-0002-3054-9753; Saeki, Yasushi/0000-0002-9202-5453; Matsuda, Noriyuki/0000-0001-8199-952X; Okatsu, Kei/0000-0001-8949-3750	JSPS KAKENHI [23687018, 23-6061, 21000012, 24657072, 22227003]; MEXT KAKENHI [24111557, 25112522, 24112008]; Tomizawa Jun-ichi and Keiko Fund; JST CREST; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; McGill University; GRASP from the FRSQ; CIHR; FRSQ; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24657072, 26650042, 26440101, 26000014] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tomizawa Jun-ichi and Keiko Fund; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; McGill University; GRASP from the FRSQ; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 23687018 (to N.M.), 23-6061 (to K.O.), 21000012 (to K. T.), 24657072 and 22227003 (to Y.T. and T.E.); MEXT KAKENHI grant numbers 24111557 and 25112522 (to N.M.), 24112008 (to Y.S.); the Tomizawa Jun-ichi and Keiko Fund (to N.M.); JST CREST (to T. E.); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT (to T. H.); startup funds from McGill University and the GRASP from the FRSQ (to J.-F.T.); an Operating Grant from the CIHR and a Chercheur National Award from the FRSQ (to E. A. F.); and the Takeda Science Foundation (to H. K., K. T. and N.M.). We thank N. Croteau and S. Rasool for technical assistance, T. Ueno for anti-FoF1 antibody, and D. Finley for yeast strain SUB328.	Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P223, DOI 10.1016/j.bbrc.2013.05.080; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	30	933	962	11	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					162	+		10.1038/nature13392	http://dx.doi.org/10.1038/nature13392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24784582				2022-12-28	WOS:000336768900049
J	Hanada, M; Hyakutake, Y; Ishiki, G; Nishimura, J				Hanada, Masanori; Hyakutake, Yoshifumi; Ishiki, Goro; Nishimura, Jun			Holographic description of a quantum black hole on a computer	SCIENCE			English	Article								Black holes have been predicted to radiate particles and eventually evaporate, which has led to the information loss paradox and implies that the fundamental laws of quantum mechanics may be violated. Superstring theory, a consistent theory of quantum gravity, provides a possible solution to the paradox if evaporating black holes can actually be described in terms of standard quantum mechanical systems, as conjectured from the theory. Here, we test this conjecture by calculating the mass of a black hole in the corresponding quantum mechanical system numerically. Our results agree well with the prediction from gravity theory, including the leading quantum gravity correction. Our ability to simulate black holes offers the potential to further explore the yet mysterious nature of quantum gravity through well-established quantum mechanics.	[Hanada, Masanori; Ishiki, Goro] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan; [Hanada, Masanori] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Hanada, Masanori] Stanford Univ, Stanford Inst Theoret Phys, Stanford, CA 94305 USA; [Hyakutake, Yoshifumi] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Nishimura, Jun] High Energy Accelerator Org KEK, Theory Ctr, Tsukuba, Ibaraki 3050801, Japan; [Nishimura, Jun] Grad Univ Adv Studies SOKENDAI, Tsukuba, Ibaraki 3050801, Japan	Kyoto University; Kyoto University; Stanford University; Ibaraki University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan	Hanada, M (corresponding author), Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	hanada@yukawa.kyoto-u.ac.jp	Hyakutake, Yoshifumi/ABE-9642-2021	Hanada, Masanori/0000-0001-5174-2571; Nishimura, Jun/0000-0003-3232-538X	Hakubi Center for Advanced Research, Kyoto University; National Science Foundation [PHYS-1066293]; Ministry of Education, Science, Sports and Culture [25800163, 19740141, 24740140]; Japan Society for the Promotion of Science [20540286, 23244057]; High Performance Computing Infrastructure System Research Project [hp120162]; Grants-in-Aid for Scientific Research [23244057] Funding Source: KAKEN	Hakubi Center for Advanced Research, Kyoto University; National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); High Performance Computing Infrastructure System Research Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank S. Aoki, S. Hartnoll, I. Kanamori, H. Kawai, E. Poppitz, A. Schafer, S. Shenker, L. Susskind, M. Tezuka, A. Ueda, and M. Unsal for discussions and comments. M.H. is supported by the Hakubi Center for Advanced Research, Kyoto University and by the National Science Foundation under grant no. PHYS-1066293. M.H. and Y.H. are partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), 25800163, 2013 (M.H.); 19740141, 2007 (Y.H.); and 24740140, 2012 (Y.H.). The work of J.N. was supported in part by Grant-in-Aid for Scientific Research (nos. 20540286 and 23244057) from the Japan Society for the Promotion of Science. Computations were carried out on PC cluster systems in KEK and the Osaka University Cybermedia Center (the latter being provided by the High Performance Computing Infrastructure System Research Project, project ID: hp120162). All the data obtained in the present work are presented in table S1 of the supplementary materials.	Anagnostopoulos KN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.021601; Ardehali AA, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2013)024; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; BEKENSTEIN JD, 1973, PHYS REV D, V7, P2333, DOI 10.1103/PhysRevD.7.2333; Catterall S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.041502; DEWIT B, 1988, NUCL PHYS B, V305, P545, DOI 10.1016/0550-3213(88)90116-2; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; Hanada M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.161602; Hanada M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)020; Hanada M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.191602; HAWKING SW, 1982, COMMUN MATH PHYS, V87, P395, DOI 10.1007/BF01206031; HAWKING SW, 1976, COMMUN MATH PHYS, V46, P206, DOI 10.1007/BF01608497; HAWKING SW, 1975, COMMUN MATH PHYS, V43, P199, DOI 10.1007/BF02345020; Horowitz G. T., 2004, JHEP, V0402, P008, DOI DOI 10.1088/1126-6708/2004/02/008; Hyakutake Y, 2014, PROG THEOR EXP PHYS, V2014, DOI 10.1093/ptep/ptu028; Ishii N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022001; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Kabat D, 2001, PHYS REV LETT, V86, P1426, DOI 10.1103/PhysRevLett.86.1426; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; Minahan JA, 2012, LETT MATH PHYS, V99, P33, DOI 10.1007/s11005-011-0522-9; Polchinski J, 1995, PHYS REV LETT, V75, P4724, DOI 10.1103/PhysRevLett.75.4724; SUSSKIND L, 1995, J MATH PHYS, V36, P6377, DOI 10.1063/1.531249; Witten E, 1996, NUCL PHYS B, V460, P335, DOI 10.1016/0550-3213(95)00610-9	26	62	62	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					882	885		10.1126/science.1250122	http://dx.doi.org/10.1126/science.1250122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24790030	Green Submitted			2022-12-28	WOS:000336233800042
J	Bintanja, R; Selten, FM				Bintanja, R.; Selten, F. M.			Future increases in Arctic precipitation linked to local evaporation and sea-ice retreat	NATURE			English	Article							CLIMATE; AMPLIFICATION; CYCLE	Precipitation changes projected for the end of the twenty-first century show an increase of more than 50 per cent in the Arctic regions(1,2). This marked increase, which is among the highest globally, has previously been attributed primarily to enhanced poleward moisture transport from lower latitudes(3,4). Here we use state-of-the-art global climate models(5) to show that the projected increases in Arctic precipitation over the twenty-first century, which peak in late autumn and winter, are instead due mainly to strongly intensified local surface evaporation (maximum in winter), and only to a lesser degree due to enhanced moisture inflow from lower latitudes(maximum in late summer and autumn). Moreover, we show that the enhanced surface evaporation results mainly from retreating winter sea ice, signalling an amplified Arctic hydrological cycle. This demonstrates that increases in Arctic precipitation are firmly linked to Arctic warming and sea-ice decline. As a result, the Arctic mean precipitation sensitivity (4.5 per cent increase per degree of temperature warming) is much larger than the global value (1.6 to 1.9 per cent per kelvin). The associated seasonally varying increase in Arctic precipitation is likely to increase river discharge(6-8) and snowfall over ice sheets(9) (thereby affecting global sea level), and could even affect global climate through freshening of the Arctic Ocean and subsequent modulations of the Atlantic meridional overturning circulation(10,11).	[Bintanja, R.; Selten, F. M.] Royal Netherlands Meteorol Inst KNMI, NL-3731 GA De Bilt, Netherlands	Royal Netherlands Meteorological Institute	Bintanja, R (corresponding author), Royal Netherlands Meteorol Inst KNMI, Utrechtseweg 297, NL-3731 GA De Bilt, Netherlands.	bintanja@knmi.nl		Swanton, Charles/0000-0002-4299-3018				Alexeev VA, 2005, CLIM DYNAM, V24, P655, DOI 10.1007/s00382-005-0018-3; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Barry RG, 2000, NATO SCI S PRT 2 ENV, V70, P45; Bengtsson L, 2011, TELLUS A, V63, P907, DOI 10.1111/j.1600-0870.2011.00534.x; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; Bintanja R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01556; Bintanja R, 2012, CLIM DYNAM, V39, P2659, DOI 10.1007/s00382-011-1272-1; Bintanja R, 2011, NAT GEOSCI, V4, P758, DOI [10.1038/ngeo1285, 10.1038/NGEO1285]; Cai M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024481; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Davies FJ, 2014, CLIM DYNAM, V42, P2099, DOI 10.1007/s00382-013-1849-y; Francis JA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000902; Hazeleger W, 2010, B AM METEOROL SOC, V91, P1357, DOI 10.1175/2010BAMS2877.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Holland MM, 2006, J CLIMATE, V19, P6221, DOI 10.1175/JCLI3967.1; Holland MM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI [10.1029/2006JG000354, 10.1029/2006JG000286]; Kattsov VM, 2007, J HYDROMETEOROL, V8, P571, DOI 10.1175/JHM575.1; Kattsov VM, 2000, J CLIMATE, V13, P1362, DOI 10.1175/1520-0442(2000)013<1362:TCTOAP>2.0.CO;2; Kug JS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043673; Kurita N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046064; Liu JP, 2012, P NATL ACAD SCI USA, V109, P4074, DOI 10.1073/pnas.1114910109; Min SK, 2008, SCIENCE, V320, P518, DOI 10.1126/science.1153468; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Screen JA, 2012, CLIM DYNAM, V38, P2243, DOI 10.1007/s00382-011-1105-2; Singarayer JS, 2006, J CLIMATE, V19, P1109, DOI 10.1175/JCLI3649.1; Stephens GL, 2008, J CLIMATE, V21, P6141, DOI 10.1175/2008JCLI2144.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Walsh JE, 1998, J CLIMATE, V11, P72, DOI 10.1175/1520-0442(1998)011<0072:APAEMR>2.0.CO;2; Walsh JE, 2000, NATO SCI S PRT 2 ENV, V70, P21; Zhang XD, 2013, NAT CLIM CHANGE, V3, P47, DOI [10.1038/nclimate1631, 10.1038/NCLIMATE1631]	30	368	372	12	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					479	+		10.1038/nature13259	http://dx.doi.org/10.1038/nature13259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24805239				2022-12-28	WOS:000336126000036
J	Sniderman, AD; Toth, PP; Thanassoulis, G; Pencina, MJ; Furberg, CD				Sniderman, Allan D.; Toth, Peter P.; Thanassoulis, George; Pencina, Michael J.; Furberg, Curt D.			Taking a longer term view of cardiovascular risk: the causal exposure paradigm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; AGE; METAANALYSIS; PREVENTION; GUIDELINES; STATINS; CALCIUM; BURDEN		[Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ H3A 1A1, Canada; [Toth, Peter P.] Univ Illinois, Sch Med, Dept Family & Community Med, Peoria, IL USA; [Thanassoulis, George] CGH Med Ctr, Sterling, IL USA; [Thanassoulis, George] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cardiol Div,Dept Med, Montreal, PQ H3A 1A1, Canada; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Furberg, Curt D.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	McGill University; Royal Victoria Hospital; University of Illinois System; University of Illinois Peoria; McGill University; Royal Victoria Hospital; Duke University; Wake Forest University	Sniderman, AD (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	allansniderman@hotmail.com	Toth, Peter/GMW-6552-2022					Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pencina MJ, 2014, N ENGL J MED; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sniderman AD, 2008, LANCET, V371, P1547, DOI [10.1016/S0140-6736(08)60313-X, 10.1016/s0140-6736(08)60313-x]; Sniderman AD, 2013, MAYO CLIN PROC, V88, P1108, DOI 10.1016/j.mayocp.2013.07.012; Stone NJ, 2013, CIRCULATION	18	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2014	348								g3047	10.1136/bmj.g3047	http://dx.doi.org/10.1136/bmj.g3047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZX	24850828				2022-12-28	WOS:000336429200001
J	Garg, AX; Boudville, N				Garg, Amit X.; Boudville, Neil			Live kidney donation was associated with increased mortality and end-stage renal disease at 15 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Garg, Amit X.] Univ Western Ontario, London, ON, Canada; [Boudville, Neil] Univ Western Australia, Perth, WA 6009, Australia	Western University (University of Western Ontario); University of Western Australia	Garg, AX (corresponding author), Univ Western Ontario, London, ON, Canada.		Boudville, Neil/H-8864-2014	Boudville, Neil/0000-0002-5884-640X				Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Reese PR, 2013, J AM SOC NEPHROL, V24, p71A; Reule S, 2013, AM J KIDNEY DIS, V61, P194, DOI 10.1053/j.ajkd.2012.07.013	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC12	10.7326/0003-4819-160-10-201405200-02012	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842434				2022-12-28	WOS:000337347100011
J	Ragauskas, AJ; Beckham, GT; Biddy, MJ; Chandra, R; Chen, F; Davis, MF; Davison, BH; Dixon, RA; Gilna, P; Keller, M; Langan, P; Naskar, AK; Saddler, JN; Tschaplinski, TJ; Tuskan, GA; Wyman, CE				Ragauskas, Arthur J.; Beckham, Gregg T.; Biddy, Mary J.; Chandra, Richard; Chen, Fang; Davis, Mark F.; Davison, Brian H.; Dixon, Richard A.; Gilna, Paul; Keller, Martin; Langan, Paul; Naskar, Amit K.; Saddler, Jack N.; Tschaplinski, Timothy J.; Tuskan, Gerald A.; Wyman, Charles E.			Lignin Valorization: Improving Lignin Processing in the Biorefinery	SCIENCE			English	Review							CINNAMYL ALCOHOL-DEHYDROGENASE; REFINING CELLULOSIC BIOMASS; CELL-WALL COMPOSITION; IONIC LIQUID; LIGNOCELLULOSIC BIOMASS; CARBON-FIBER; KRAFT LIGNIN; BIOSYNTHESIS PERTURBATIONS; HYDROTHERMAL PRETREATMENT; CARBOHYDRATE COMPLEXES	Research and development activities directed toward commercial production of cellulosic ethanol have created the opportunity to dramatically increase the transformation of lignin to value-added products. Here, we highlight recent advances in this lignin valorization effort. Discovery of genetic variants in native populations of bioenergy crops and direct manipulation of biosynthesis pathways have produced lignin feedstocks with favorable properties for recovery and downstream conversion. Advances in analytical chemistry and computational modeling detail the structure of the modified lignin and direct bioengineering strategies for future targeted properties. Refinement of biomass pretreatment technologies has further facilitated lignin recovery, and this coupled with genetic engineering will enable new uses for this biopolymer, including low-cost carbon fibers, engineered plastics and thermoplastic elastomers, polymeric foams, fungible fuels, and commodity chemicals.	[Ragauskas, Arthur J.] Georgia Inst Technol, Inst Paper Sci & Technol, Sch Chem & Biochem, BioEnergy Sci Ctr, Atlanta, GA 30332 USA; [Beckham, Gregg T.; Biddy, Mary J.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80402 USA; [Beckham, Gregg T.; Biddy, Mary J.] Natl Renewable Energy Lab, Natl Adv Biofuels Consortium, Golden, CO 80402 USA; [Chandra, Richard; Saddler, Jack N.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Chen, Fang; Dixon, Richard A.] Univ N Texas, Dept Biol Sci, BioEnergy Sci Ctr, Denton, TX 76203 USA; [Davis, Mark F.] Natl Renewable Energy Lab, BioEnergy Sci Ctr, Golden, CO 80402 USA; [Davis, Mark F.] Natl Renewable Energy Lab, Natl Adv Biofuels Consortium, Golden, CO 80402 USA; [Davison, Brian H.; Gilna, Paul; Tschaplinski, Timothy J.; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Biosci Div, Oak Ridge, TN 37831 USA; [Keller, Martin] Oak Ridge Natl Lab, Energy & Environm Sci Directorate, Oak Ridge, TN 37831 USA; [Langan, Paul] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Naskar, Amit K.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Wyman, Charles E.] Univ Calif Riverside, BioEnergy Sci Ctr, Ctr Environm Res & Technol, Riverside, CA 92507 USA; [Wyman, Charles E.] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92507 USA	University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of British Columbia; University of North Texas System; University of North Texas Denton; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Riverside; University of California System; University of California Riverside	Ragauskas, AJ (corresponding author), Georgia Inst Technol, Inst Paper Sci & Technol, Sch Chem & Biochem, BioEnergy Sci Ctr, Atlanta, GA 30332 USA.	ragauskas@chemistry.gatech.edu	Ragauskas, Art/J-7486-2016; Tschaplinski, Timothy/D-6382-2018; Langan, Paul/N-5237-2015; Gilna, Paul/I-3608-2016; Davison, Brian/D-7617-2013; Tuskan, Gerald/A-6225-2011; Davis, Mark/F-7341-2017	Ragauskas, Art/0000-0002-3536-554X; Tschaplinski, Timothy/0000-0002-9540-6622; Langan, Paul/0000-0002-0247-3122; Gilna, Paul/0000-0002-6542-0191; Davison, Brian/0000-0002-7408-3609; Tuskan, Gerald/0000-0003-0106-1289; Naskar, Amit/0000-0002-1094-0325; Davis, Mark/0000-0003-4541-9852	U.S. Department of Energy (DOE); Genomic Science Program, Office of Biological and Environmental Research, DOE [FWP ERKP752]; DOE BioEnergy Technologies Office through American Recovery and Reinvestment Act Funds; DOE; BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the DOE Office of Science	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Genomic Science Program, Office of Biological and Environmental Research, DOE; DOE BioEnergy Technologies Office through American Recovery and Reinvestment Act Funds; DOE(United States Department of Energy (DOE)); BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by several agencies, including the Laboratory Directed Research and Development Programs at ORNL and NREL [ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy (DOE); NREL is managed by Alliance for Sustainable Energy, LLC, for DOE]; Genomic Science Program, Office of Biological and Environmental Research, DOE, under FWP ERKP752; National Advanced Biofuels Consortium, which is funded by DOE BioEnergy Technologies Office through American Recovery and Reinvestment Act Funds, and DOE and the BioEnergy Science Center (BESC). BESC is a DOE Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science.	Agarwal U.P., 2010, LIGNIN LIGNANS ADV C, P104, DOI 10.1201/EBK1574444865; Alonso DM, 2012, CHEM SOC REV, V41, P8075, DOI 10.1039/c2cs35188a; Araujo JDP, 2010, CHEM ENG RES DES, V88, P1024, DOI 10.1016/j.cherd.2010.01.021; Archambault-Leger V, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-49; ARGYROPOULOS D, 2013, Patent No. 20130255216; Baker DA, 2013, J APPL POLYM SCI, V130, P713, DOI 10.1002/app.39273; Balakshin M, 2011, PLANTA, V233, P1097, DOI 10.1007/s00425-011-1359-2; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Braun JL, 2005, CARBON, V43, P385, DOI 10.1016/j.carbon.2004.09.027; Brodin I, 2012, HOLZFORSCHUNG, V66, P141, DOI 10.1515/HF.2011.133; Brosse N, 2012, BIOFUEL BIOPROD BIOR, V6, P580, DOI 10.1002/bbb.1353; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chapple C, 2007, NAT BIOTECHNOL, V25, P746, DOI 10.1038/nbt0707-746; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2013, PLANT J, V73, P201, DOI 10.1111/tpj.12012; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Chung HY, 2013, GREEN MATER, V1, P137, DOI 10.1680/gmat.12.00009; Chylla RA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-45; CIEMNIECKI SL, 1988, POLYMER, V29, P1021, DOI 10.1016/0032-3861(88)90010-9; Cox BJ, 2013, BIORESOURCE TECHNOL, V134, P59, DOI 10.1016/j.biortech.2013.01.081; Dale BE, 2012, BIOTECHNOL PROGR, V28, P893, DOI 10.1002/btpr.1575; Das L, 2012, BIOFUELS-UK, V3, P155, DOI 10.4155/bfs.12.5; David K, 2010, ENERG ENVIRON SCI, V3, P1182, DOI 10.1039/b926617h; Davis R., 2013, TP510060223 NREL; DeAngelis F, 2006, CHIM IND MILA, V88, P58; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Du XY, 2013, PLANT J, V74, P328, DOI 10.1111/tpj.12124; El Hage R, 2009, POLYM DEGRAD STABIL, V94, P1632, DOI 10.1016/j.polymdegradstab.2009.07.007; Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x; Faaij APC, 2006, ENERG POLICY, V34, P322, DOI 10.1016/j.enpol.2004.03.026; Foston M, 2013, CARBON, V52, P65, DOI 10.1016/j.carbon.2012.09.006; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; Gallego-Giraldo L, 2011, P NATL ACAD SCI USA, V108, P20814, DOI 10.1073/pnas.1117873108; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Guerra A, 2006, J AGR FOOD CHEM, V54, P5939, DOI 10.1021/jf060722v; Harton SE, 2012, ACS MACRO LETT, V1, P568, DOI 10.1021/mz300045e; Hilburg SL, 2014, POLYMER, V55, P995, DOI 10.1016/j.polymer.2013.12.070; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hirai N, 2009, J POWER SOURCES, V191, P97, DOI 10.1016/j.jpowsour.2008.10.090; Holtman KM, 2003, J AGR FOOD CHEM, V51, P3535, DOI 10.1021/jf0340411; Hu F, 2012, BIOENERG RES, V5, P1043, DOI 10.1007/s12155-012-9208-0; Huang F, 2013, IND ENG CHEM RES, V52, P1743, DOI 10.1021/ie302242h; HUMBIRD D, 2012, NRELTP510047764, P41914; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Hurt RH, 2000, PHYS TODAY, V53, P39, DOI 10.1063/1.883020; Jung S, 2012, ANGEW CHEM INT EDIT, V51, P12005, DOI 10.1002/anie.201205243; Kim JY, 2011, BIORESOURCE TECHNOL, V102, P9020, DOI 10.1016/j.biortech.2011.07.081; Kiyoto S, 2013, PLANTA, V237, P705, DOI 10.1007/s00425-012-1784-x; Kleinert M, 2008, ENERG FUEL, V22, P1371, DOI 10.1021/ef700631w; Lane J., 2014, BIOFUELS DIGEST; Langholtz M, 2014, SAE INT J MATER MANU, V7, P115, DOI 10.4271/2013-01-9092; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Laskar DD, 2013, IND CROP PROD, V50, P391, DOI 10.1016/j.indcrop.2013.08.002; Lawson JW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144209; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Li MY, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-38; Li X, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-27; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Li Y, 2012, J WOOD CHEM TECHNOL, V32, P210, DOI 10.1080/02773813.2011.652795; Lindsey K, 2013, BIOMASS BIOENERG, V56, P29, DOI 10.1016/j.biombioe.2013.04.023; Lora J, 2008, MONOMERS, POLYMERS AND COMPOSITES FROM RENEWABLE RESOURCES, P225, DOI 10.1016/B978-0-08-045316-3.00010-7; Macfarlane AL, 2009, CHEM ENG J, V148, P15, DOI 10.1016/j.cej.2008.07.036; Martinez AT, 2005, INT MICROBIOL, V8, P195; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Molinari HBC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00050; Morreel K, 2010, PLANT PHYSIOL, V153, P1464, DOI 10.1104/pp.110.156489; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Mu W, 2013, BIOENERG RES, V6, P1183, DOI 10.1007/s12155-013-9314-7; National Research Council, 2011, ASS FUEL EC TECHN LI; Nonhebel S, 2005, RENEW SUST ENERG REV, V9, P191, DOI 10.1016/j.rser.2004.02.003; Norberg I, 2013, J APPL POLYM SCI, V128, P3824, DOI 10.1002/app.38588; Nowakowski DJ, 2010, J ANAL APPL PYROL, V88, P53, DOI 10.1016/j.jaap.2010.02.009; Nunes CA, 2011, QUIM NOVA, V34, P279, DOI 10.1590/S0100-40422011000200020; Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270; Patwardhan PR, 2011, CHEMSUSCHEM, V4, P1629, DOI 10.1002/cssc.201100133; Perlack R.D., 2011, US BILLION TON UPDAT; Petridis L, 2011, J AM CHEM SOC, V133, P20277, DOI 10.1021/ja206839u; Pingali SV, 2010, BIOMACROMOLECULES, V11, P2329, DOI 10.1021/bm100455h; Porth I, 2013, NEW PHYTOL, V197, P777, DOI 10.1111/nph.12014; Poursorkhabi V, 2013, BIORESOURCES, V8, P5083; Pu YQ, 2009, BIOENERG RES, V2, P198, DOI 10.1007/s12155-009-9056-8; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rogers LA, 2005, NEW PHYTOL, V168, P123, DOI 10.1111/j.1469-8137.2005.01496.x; Saha BC, 2013, IND CROP PROD, V44, P367, DOI 10.1016/j.indcrop.2012.11.025; Saha D, 2013, ACS APPL MATER INTER, V5, P5868, DOI 10.1021/am401661f; Salanti A, 2012, BIOMACROMOLECULES, V13, P445, DOI 10.1021/bm2014763; Salvachua D, 2011, BIORESOURCE TECHNOL, V102, P7500, DOI 10.1016/j.biortech.2011.05.027; Sannigrahi P, 2013, AQUEOUS PRETREATMENT, P201, DOI DOI 10.1002/9780470975831.CH10; Sannigrahi P, 2011, J BIOBASED MATER BIO, V5, P514, DOI 10.1166/jbmb.2011.1170; Sannigrahi P, 2010, BIOFUEL BIOPROD BIOR, V4, P209, DOI 10.1002/bbb.206; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Shen B, 2002, PLANT J, V29, P371, DOI 10.1046/j.1365-313X.2002.01221.x; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Stewart D, 2008, IND CROP PROD, V27, P202, DOI 10.1016/j.indcrop.2007.07.008; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Sykes R, 2009, METHODS MOL BIOL, V581, P169, DOI 10.1007/978-1-60761-214-8_12; Talmadge MS, 2014, GREEN CHEM, V16, P407, DOI 10.1039/c3gc41951g; TETARD L, 2012, IND BIOTECHNOLOGY, V8, P245, DOI DOI 10.1089/IND.2012.0017; Tobimatsu Y, 2013, PLANT J, V76, P357, DOI 10.1111/tpj.12299; Tobimatsu Y, 2013, PLANT CELL, V25, P2587, DOI 10.1105/tpc.113.113142; Trajano HL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-110; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; *US DOE OFF BIOM P, 2014, BIOM MULT PROGR PLAN, P41914; *US DOE OFF BIOM P, 2014, 30 30 WORKSH WASH DC, P41914; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Wang HM, 2013, ACS CATAL, V3, P1047, DOI 10.1021/cs400069z; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wen JL, 2013, J AGR FOOD CHEM, V61, P635, DOI 10.1021/jf3051939; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Wyman CE, 2003, BIOTECHNOL PROGR, V19, P254, DOI 10.1021/bp025654l; Wyman CE, 2013, AQUEOUS PRETREATMENT, V2013, P239, DOI 10.1002/9780470975831.ch12; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Zeng Yining, 2012, Methods Mol Biol, V908, P49, DOI 10.1007/978-1-61779-956-3_5; Zhang KW, 2012, PLANT CELL, V24, P3135, DOI 10.1105/tpc.112.101287; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1; Zhou CZ, 2011, ANAL CHEM, V83, P7020, DOI 10.1021/ac200903y; Ziebell A, 2010, J BIOL CHEM, V285, P38961, DOI 10.1074/jbc.M110.137315	127	2345	2399	146	2621	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					709	+	1246843	10.1126/science.1246843	http://dx.doi.org/10.1126/science.1246843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833396				2022-12-28	WOS:000335912900030
J	Soria-Carrasco, V; Gompert, Z; Comeault, AA; Farkas, TE; Parchman, TL; Johnston, JS; Buerkle, CA; Feder, JL; Bast, J; Schwander, T; Egan, SP; Crespi, BJ; Nosil, P				Soria-Carrasco, Victor; Gompert, Zachariah; Comeault, Aaron A.; Farkas, Timothy E.; Parchman, Thomas L.; Johnston, J. Spencer; Buerkle, C. Alex; Feder, Jeffrey L.; Bast, Jens; Schwander, Tanja; Egan, Scott P.; Crespi, Bernard J.; Nosil, Patrik			Stick Insect Genomes Reveal Natural Selection's Role in Parallel Speciation	SCIENCE			English	Article							HOST-PLANT ADAPTATION; REPRODUCTIVE ISOLATION; GENE-FLOW; EVOLUTION; DIVERGENCE; ISLANDS	Natural selection can drive the repeated evolution of reproductive isolation, but the genomic basis of parallel speciation remains poorly understood. We analyzed whole-genome divergence between replicate pairs of stick insect populations that are adapted to different host plants and undergoing parallel speciation. We found thousands of modest-sized genomic regions of accentuated divergence between populations, most of which are unique to individual population pairs. We also detected parallel genomic divergence across population pairs involving an excess of coding genes with specific molecular functions. Regions of parallel genomic divergence in nature exhibited exceptional allele frequency changes between hosts in a field transplant experiment. The results advance understanding of biological diversification by providing convergent observational and experimental evidence for selection's role in driving repeatable genomic divergence.	[Soria-Carrasco, Victor; Comeault, Aaron A.; Farkas, Timothy E.; Nosil, Patrik] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Parchman, Thomas L.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Buerkle, C. Alex] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Feder, Jeffrey L.] Univ Notre Dame, Dept Biol, South Bend, IN 46556 USA; [Bast, Jens] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Schwander, Tanja] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Egan, Scott P.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Crespi, Bernard J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of Sheffield; Utah System of Higher Education; Utah State University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Texas A&M University System; Texas A&M University College Station; University of Wyoming; University of Notre Dame; University of Gottingen; University of Lausanne; Rice University; Simon Fraser University	Nosil, P (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	p.nosil@sheffield.ac.uk		Bast, Jens/0000-0003-0017-3860; Soria-Carrasco, Victor/0000-0002-6568-5544; Gompert, Zachariah/0000-0003-2248-2488; Schwander, Tanja/0000-0003-1945-5374; Comeault, Aaron/0000-0003-3954-2416	European Research Council [R/129639]; Utah State University; Wellcome Trust [090532/Z/09/Z]; Medical Research Council Hub grant [G0900747 91070]; NCBI short read archive (BioProject) [PRJNA243533]	European Research Council(European Research Council (ERC)European Commission); Utah State University; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCBI short read archive (BioProject)	The work was funded by the European Research Council (grant R/129639) and Utah State University start-up funds. We thank J. Slate, A. Beckerman, D. Schluter, and two anonymous reviewers for constructive feedback and the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council Hub grant G0900747 91070) for generation of the sequencing data. O. Simakov and A. Kapusta provided scripts for transposable elements annotation. The data reported in this paper are tabulated in the supplementary materials and archived at the following databases. The raw sequencing reads are in the NCBI short read archive (BioProject ID: PRJNA243533), and the whole genome assembly and annotation at http://nosil-lab.group.shef.ac.uk/resources. Additional data and computer source code have been deposited in the Dryad repository, datadryad.org, and are also available from the authors upon request. The authors declare no conflicts of interest.	Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Burke MK, 2012, P ROY SOC B-BIOL SCI, V279, P5029, DOI 10.1098/rspb.2012.0799; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Gompert Z, 2014, ECOL LETT, V17, P369, DOI 10.1111/ele.12238; Hofer T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-107; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Losos JB, 2009, LIZARDS IN AN EVOLUT; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2012, P ROY SOC B-BIOL SCI, V279, P5058, DOI 10.1098/rspb.2012.0813; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; van Ooik T, 2010, ANN ZOOL FENN, V47, P215, DOI 10.5735/086.047.0306; Vincent J, 1990, STRUCTURAL BIOMATERI; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	24	296	302	9	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					738	742		10.1126/science.1252136	http://dx.doi.org/10.1126/science.1252136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833390				2022-12-28	WOS:000335912900039
J	Molina, I; Prat, JGI; Salvador, F; Trevino, B; Sulleiro, E; Serre, N; Pou, D; Roure, S; Cabezos, J; Valerio, L; Blanco-Grau, A; Sanchez-Montalva, A; Vidal, X; Pahissa, A				Molina, Israel; Gomez i Prat, Jordi; Salvador, Fernando; Trevino, Begona; Sulleiro, Elena; Serre, Nuria; Pou, Diana; Roure, Silvia; Cabezos, Juan; Valerio, Lluis; Blanco-Grau, Albert; Sanchez-Montalva, Adrian; Vidal, Xavier; Pahissa, Albert			Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRYPANOSOMA SCHIZOTRYPANUM CRUZI; FOLLOW-UP; SCH 56592; EFFICACY; CHEMOTHERAPY; INFECTION; SAFETY; PHASE	BACKGROUND Current therapeutic options for Chagas' disease are limited to benznidazole and nifurtimox, which have been associated with low cure rates in the chronic stage of the disease and which have considerable toxicity. Posaconazole has shown trypanocidal activity in murine models. METHODS We performed a prospective, randomized clinical trial to assess the efficacy and safety of posaconazole as compared with the efficacy and safety of benznidazole in adults with chronic Trypanosoma cruzi infection. We randomly assigned patients to receive posaconazole at a dose of 400 mg twice daily (high-dose posaconazole), posaconazole at a dose of 100 mg twice daily (low-dose posaconazole), or benznidazole at a dose of 150 mg twice daily; all the study drugs were administered for 60 days. We assessed antiparasitic activity by testing for the presence of T. cruzi DNA, using real-time polymerase-chain-reaction (rt-PCR) assays, during the treatment period and 10 months after the end of treatment. Posaconazole absorption was assessed on day 14. RESULTS The intention-to-treat population included 78 patients. During the treatment period, all the patients tested negative for T. cruzi DNA on rt-PCR assay beyond day 14, except for 2 patients in the low-dose posaconazole group who tested positive on day 60. During the follow-up period, in the intention-to-treat analysis, 92% of the patients receiving low-dose posaconazole and 81% receiving high-dose posaconazole, as compared with 38% receiving benznidazole, tested positive for T. cruzi DNA on rt-PCR assay (P<0.01 for the comparison of the benznidazole group with either posaconazole group); in the per-protocol analysis, 90% of the patients receiving low-dose posaconazole and 80% of those receiving high-dose posaconazole, as compared with 6% receiving benznidazole, tested positive on rt-PCR assay (P<0.001 for the comparison of the benznidazole group with either posaconazole group). In the benznidazole group, treatment was discontinued in 5 patients because of severe cutaneous reactions; in the posaconazole groups, 4 patients had aminotransferase levels that were more than 3 times the upper limit of the normal range, but there were no discontinuations of treatment. CONCLUSIONS Posaconazole showed antitrypanosomal activity in patients with chronic Chagas' disease. However, significantly more patients in the posaconazole groups than in the benznidazole group had treatment failure during follow-up.	[Molina, Israel; Salvador, Fernando; Sanchez-Montalva, Adrian; Pahissa, Albert] Vall dHebron Teaching Hosp, Dept Infect Dis, Barcelona 08035, Spain; [Sulleiro, Elena] Vall dHebron Teaching Hosp, Dept Microbiol, Barcelona 08035, Spain; [Blanco-Grau, Albert] Vall dHebron Teaching Hosp, Drug Monitoring Unit, Clin Lab, Barcelona 08035, Spain; [Vidal, Xavier] Vall dHebron Teaching Hosp, Clin Pharmacol Serv, Barcelona 08035, Spain; [Gomez i Prat, Jordi; Trevino, Begona; Serre, Nuria; Pou, Diana; Cabezos, Juan] Vall dHebron Drassanes, Special Program Infect Dis, Barcelona, Spain; [Molina, Israel; Gomez i Prat, Jordi; Salvador, Fernando; Trevino, Begona; Sulleiro, Elena; Serre, Nuria; Pou, Diana; Cabezos, Juan; Sanchez-Montalva, Adrian; Pahissa, Albert] PROSICS Barcelona, Catalan Inst Hlth, Int Hlth Program, Barcelona, Spain; [Roure, Silvia] Germans Trias & Pujol Teaching Hosp, Dept Internal Med, Infect Dis Unit, Int Hlth Unit Metropolitana Nord, Barcelona, Spain; [Valerio, Lluis] PROSICS Metropolitana Nord, Int Hlth Unit Metropolitana Nord, Barcelona, Spain; [Vidal, Xavier] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, E-08193 Barcelona, Spain; [Vidal, Xavier] WHO Collaborating Ctr Res & Training Pharmacoepid, Fundacio Inst Catala Farmacol, Barcelona, Spain	Autonomous University of Barcelona	Molina, I (corresponding author), Vall dHebron Teaching Hosp, Dept Infect Dis, PROSICS Barcelona, P Vall dHebron 119-129, Barcelona 08035, Spain.	imolina@vhebron.net	Vidal, Xavier/I-5958-2019; Blanco-Grau, Albert/AAB-6069-2019	Vidal, Xavier/0000-0001-6705-4298; Blanco-Grau, Albert/0000-0002-4213-3827; Salvador, Fernando/0000-0002-0546-1354; Sulleiro, Elena/0000-0002-9783-6060; Molina Romero, Israel/0000-0001-6642-7515; Serre Delcor, Nuria/0000-0001-5984-4185	Ministry of Health, Spain	Ministry of Health, Spain	Supported by the Ministry of Health, Spain.	Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Braga MS, 2000, REV INST MED TROP SP, V42, P157; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Chhun S, 2007, J CHROMATOGR B, V852, P223, DOI 10.1016/j.jchromb.2007.01.021; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; Coura JR, 2011, MEM I OSWALDO CRUZ, V106, P641, DOI 10.1590/S0074-02762011000600001; de Castro AM, 2006, PARASITOL RES, V99, P379, DOI 10.1007/s00436-006-0172-5; de Lana M, 2009, MEM I OSWALDO CRUZ, V104, P1139, DOI 10.1590/S0074-02762009000800011; de REZENDE J, 1960, Rev Bras Gastroenterol, V12, P247; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fernandes CD, 2009, MEM I OSWALDO CRUZ, V104, P27, DOI 10.1590/S0074-02762009000100004; Gallerano R R, 2000, Rev Fac Cien Med Univ Nac Cordoba, V57, P135; Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027; Krishna G, 2009, ANTIMICROB AGENTS CH, V53, P958, DOI 10.1128/AAC.01034-08; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Kwon DS, 2007, EXPERT OPIN PHARMACO, V8, P1167, DOI 10.1517/14656566.8.8.1167; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; MALDONADO RA, 1993, ANTIMICROB AGENTS CH, V37, P1353, DOI 10.1128/AAC.37.6.1353; Guedes PMM, 2012, TROP MED INT HEALTH, V17, P1057, DOI 10.1111/j.1365-3156.2012.03025.x; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; R Core Team, 2012, R LANG ENV STAT COMP; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Streiger Mirtha L., 2004, Rev. Soc. Bras. Med. Trop., V37, P365; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13&lt;1387::AID-SIM268&gt;3.0.CO;2-R; Ullmann AJ, 2006, ANTIMICROB AGENTS CH, V50, P658, DOI 10.1128/AAC.50.2.658-666.2006; Urbina JA, 1998, ANTIMICROB AGENTS CH, V42, P1771, DOI 10.1128/AAC.42.7.1771; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Ximenes CA, 1984, REV SOC BRAS MED TRO, V17, P23	35	394	403	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1899	1908		10.1056/NEJMoa1313122	http://dx.doi.org/10.1056/NEJMoa1313122			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UH	24827034				2022-12-28	WOS:000336123600006
J	Longo, DR; Woolf, SH				Longo, Daniel R.; Woolf, Steven H.			Rethinking the Information Priorities of Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Longo, Daniel R.; Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Richmond, VA 23298 USA	Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Ctr Soc & Hlth, 830 E Main St,POB 980159, Richmond, VA 23298 USA.	swoolf@vcu.edu			AHRQ HHS [1R21 HS021902-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS021902] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Agency for Health Care Research and Quality (AHRQ), QUAL IND; Agency for Healthcare Research and Quality, 2019, PUBL REP QUAL IMPR S; Etz R, 2013, N AM PRIM CAR RES GR; Longo DR, 2012, AM AC COMM HEALTHC R; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Milleson M, 2012, WILL AFFORDABLE CARE; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500	8	14	14	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1857	1858		10.1001/jama.2014.3038	http://dx.doi.org/10.1001/jama.2014.3038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24825638				2022-12-28	WOS:000335798100015
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2014 Lifetime Achievement Award 2014: Sir Iain Chalmers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2014	348								g2921	10.1136/bmj.g2921	http://dx.doi.org/10.1136/bmj.g2921			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OT	24817068				2022-12-28	WOS:000335820400001
J	Silver, PA; Way, JC; Arnold, FH; Meyerowitz, JT				Silver, Pamela A.; Way, Jeffrey C.; Arnold, Frances H.; Meyerowitz, Joseph T.			Engineering explored	NATURE			English	Editorial Material							ESCHERICHIA-COLI		[Silver, Pamela A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Silver, Pamela A.; Way, Jeffrey C.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Arnold, Frances H.; Meyerowitz, Joseph T.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Harvard University; Harvard Medical School; California Institute of Technology	Silver, PA (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu; jeff.way@wyss.harvard.edu; frances@cheme.caltech.edu; jmeyerow@caltech.edu		Arnold, Frances H./0000-0002-4027-364X				Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Keasling JD, 2012, P AM PHILOS SOC, V156, P283; Kotula J. W., 2014, P NATL ACAD SCI US; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Trudeau DL, 2013, CURR OPIN CHEM BIOL, V17, P902, DOI 10.1016/j.cbpa.2013.10.007	7	25	26	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					166	167		10.1038/509166a	http://dx.doi.org/10.1038/509166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805338				2022-12-28	WOS:000335454300022
J	Raj, T; Rothamel, K; Mostafavi, S; Ye, C; Lee, MN; Replogle, JM; Feng, T; Lee, M; Asinovski, N; Frohlich, I; Imboywa, S; Von Korff, A; Okada, Y; Patsopoulos, NA; Davis, S; McCabe, C; Paik, HI; Srivastava, GP; Raychaudhuri, S; Hafler, DA; Koller, D; Regev, A; Hacohen, N; Mathis, D; Benoist, C; Stranger, BE; De Jager, PL				Raj, Towfique; Rothamel, Katie; Mostafavi, Sara; Ye, Chun; Lee, Mark N.; Replogle, Joseph M.; Feng, Ting; Lee, Michelle; Asinovski, Natasha; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Okada, Yukinori; Patsopoulos, Nikolaos A.; Davis, Scott; McCabe, Cristin; Paik, Hyun-il; Srivastava, Gyan P.; Raychaudhuri, Soumya; Hafler, David A.; Koller, Daphne; Regev, Aviv; Hacohen, Nir; Mathis, Diane; Benoist, Christophe; Stranger, Barbara E.; De Jager, Philip L.			Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTOME	To extend our understanding of the genetic basis of human immune function and dysfunction, we performed an expression quantitative trait locus (eQTL) study of purified CD4(+) T cells and monocytes, representing adaptive and innate immunity, in a multi-ethnic cohort of 461 healthy individuals. Context-specific cis- and trans-eQTLs were identified, and cross-population mapping allowed, in some cases, putative functional assignment of candidate causal regulatory variants for disease-associated loci. We note an over-representation of T cell-specific eQTLs among susceptibility alleles for autoimmune diseases and of monocyte-specific eQTLs among Alzheimer's and Parkinson's disease variants. This polarization implicates specific immune cell types in these diseases and points to the need to identify the cell-autonomous effects of disease susceptibility variants.	[Raj, Towfique; Replogle, Joseph M.; Lee, Michelle; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; De Jager, Philip L.] Brigham & Womens Hosp, Programin Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [Raj, Towfique; Replogle, Joseph M.; Lee, Michelle; Frohlich, Irene; Imboywa, Selina; Von Korff, Alina; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; De Jager, Philip L.] Brigham & Womens Hosp, Programin Translat NeuroPsychiat Genom, Inst Neurosci, Dept Psychiat, Boston, MA 02115 USA; [Raj, Towfique; Okada, Yukinori; Patsopoulos, Nikolaos A.; Srivastava, Gyan P.; Raychaudhuri, Soumya; De Jager, Philip L.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Raj, Towfique; Lee, Mark N.; Okada, Yukinori; Patsopoulos, Nikolaos A.; Srivastava, Gyan P.; Raychaudhuri, Soumya; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Raj, Towfique; Ye, Chun; Lee, Mark N.; Replogle, Joseph M.; Okada, Yukinori; Patsopoulos, Nikolaos A.; McCabe, Cristin; Srivastava, Gyan P.; Raychaudhuri, Soumya; Hafler, David A.; Regev, Aviv; Hacohen, Nir; De Jager, Philip L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rothamel, Katie; Feng, Ting; Asinovski, Natasha; Davis, Scott; Paik, Hyun-il; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Div Immunol, Microbiol & Immunobiol Immunol, Boston, MA 02115 USA; [Mostafavi, Sara; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Stranger, Barbara E.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Stanford University; Tokyo Medical & Dental University (TMDU); RIKEN; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; University of Chicago; University of Chicago	Benoist, C (corresponding author), Harvard Univ, Sch Med, Div Immunol, Microbiol & Immunobiol Immunol, Boston, MA 02115 USA.	christophe_benoist@hms.harvard.edu; bstranger@medicine.bsd.uchicago.edu; pdejager@partners.org	Raj, Towfique/ABD-7620-2021; Ye, Chun/AAK-4868-2021	Ye, Chun/0000-0001-6560-3783; Stranger, Barbara/0000-0001-9021-7331; Replogle, Joseph/0000-0003-1832-919X; Patsopoulos, Nikolaos/0000-0003-3757-8941; Raychaudhuri, Soumya/0000-0002-1901-8265; Lee, Mark/0000-0002-9576-9589	U.S. National Institute of General Medical Sciences [RC2 GM093080]; NIH [F32 AG043267]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the study participants in the Phenogenetic Project for their contributions. We are grateful to T. Flutre and X. Wen for assistance with running the Bayesian model averaging software. This work was supported by U.S. National Institute of General Medical Sciences grant RC2 GM093080 (C. B.). T. R. is supported by the NIH F32 Fellowship (F32 AG043267). Gene expression data are deposited in the National Center for Biotechnology Information Gene Expression Omnibus under accession no. GSE56035.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	16	320	325	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					519	523		10.1126/science.1249547	http://dx.doi.org/10.1126/science.1249547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786080	Green Submitted, Green Accepted			2022-12-28	WOS:000335157700044
J	Siyushev, P; Stein, G; Wrachtrup, JR; Gerhardt, I				Siyushev, Petr; Stein, Guilherme; Wrachtrup, Joeg; Gerhardt, Ilja			Molecular photons interfaced with alkali atoms	NATURE			English	Article							SINGLE-MOLECULE; CRYSTALLINE SYSTEM; P-TERPHENYL; SPECTROSCOPY; EXCITATION; EMISSION; DIBENZOTERRYLENE; TERRYLENE; VAPOR	Future quantum communication will rely on the integration of single-photon sources, quantum memories and systems with strong single-photon nonlinearities(1). Two key parameters are crucial for the single-photon source: a high photon flux with a very small bandwidth, and a spectral match to other components of the system. Atoms or ions may act as single-photon sources-owing to their narrow-band emission and their intrinsic spectral match to other atomic systems-and can serve as quantum nonlinear elements. Unfortunately, their emission rates are still limited, even for highly efficient cavity designs(2). Single solid-state emitters such as single organic dye molecules are significantly brighter(3) and allow for narrowband photons(4); they have shown potential in a variety of quantum optical experiments(5,6) but have yet to be interfaced with other components such as stationary memory qubits. Here we describe the optical interaction between Fourier-limited photons from a single organic molecule and atomic alkali vapours, which can constitute an efficient quantum memory. Single-photon emission rates reach up to several hundred thousand counts per second and show a high spectral brightness of 30,000 detectable photons per second per megahertz of bandwidth. The molecular emission is robust and we demonstrate perfect tuning to the spectral transitions of the sodium D line and efficient filtering, even for emitters at ambient conditions. In addition, we achieve storage of molecular photons originating from a single dibenzanthanthrene molecule in atomic sodium vapour. Given the large set of molecular emission lines matching to atomic transitions, our results enable the combination of almost ideal single-photon sources with various atomic vapours, such that experiments with giant single photon nonlinearities, mediated, for example, by Rydberg atoms(7,8), become feasible.	[Siyushev, Petr; Stein, Guilherme; Wrachtrup, Joeg; Gerhardt, Ilja] Univ Stuttgart, Inst Phys 3, Stuttgart Res Ctr Photon Engn SCoPE, D-70569 Stuttgart, Germany; [Siyushev, Petr; Stein, Guilherme; Wrachtrup, Joeg; Gerhardt, Ilja] Ctr Integrated Quantum Sci & Technol IQST, D-70569 Stuttgart, Germany; [Wrachtrup, Joeg; Gerhardt, Ilja] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	University of Stuttgart; Max Planck Society	Gerhardt, I (corresponding author), Univ Stuttgart, Inst Phys 3, Stuttgart Res Ctr Photon Engn SCoPE, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	i.gerhardt@fkf.mpg.de		Siyushev, Petr/0000-0002-2463-5006	Max Planck Society; BMBF; EU	Max Planck Society(Max Planck SocietyFoundation CELLEX); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	We thank W. Kiefer for the calculation of the sodium-D<INF>2</INF>-FADOF transmission (Fig. 3). G.S. acknowledges support by J. Pflaum (University of Wurzburg). I.G. acknowledges discussions with R. Low and S. Hofferberth (University of Stuttgart). J.W. acknowledges support by the Max Planck Society (via a Max Planck fellowship), the BMBF (via the projects QuORep and Q.com) and the EU (via the project SIQS and the ERC grant SQUTEC).	Boiron AM, 1996, J CHEM PHYS, V105, P3969, DOI 10.1063/1.472270; Boyd RW, 2002, PROG OPTICS, V43, P497, DOI 10.1016/S0079-6638(02)80030-0; DICK DJ, 1991, OPT LETT, V16, P867, DOI 10.1364/OL.16.000867; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Firstenberg O, 2013, NATURE, V502, P71, DOI 10.1038/nature12512; Gerhardt I, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.011402; Harrell SD, 2009, J OPT SOC AM B, V26, P659, DOI 10.1364/JOSAB.26.000659; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Jelezko F, 1996, J PHYS CHEM-US, V100, P13892, DOI 10.1021/jp960845q; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kiraz A, 2004, APPL PHYS LETT, V85, P920, DOI 10.1063/1.1779351; Kiraz A, 2003, J CHEM PHYS, V118, P10821, DOI 10.1063/1.1582845; Kitson SC, 1998, PHYS REV A, V58, P620, DOI 10.1103/PhysRevA.58.620; KUMMER S, 1994, CHEM PHYS LETT, V229, P309, DOI 10.1016/0009-2614(94)01043-9; Kummer S, 1997, J CHEM PHYS, V107, P7673, DOI 10.1063/1.475107; Lee KG, 2011, NAT PHOTONICS, V5, P166, DOI [10.1038/nphoton.2010.312, 10.1038/NPHOTON.2010.312]; Lettow R, 2007, OPT EXPRESS, V15, P15842, DOI 10.1364/OE.15.015842; Lounis B, 2005, REP PROG PHYS, V68, P1129, DOI 10.1088/0034-4885/68/5/R04; Mais S, 1999, CHEM PHYS, V247, P41, DOI 10.1016/S0301-0104(99)00106-8; Nicolet AAL, 2007, CHEMPHYSCHEM, V8, P1215, DOI 10.1002/cphc.200700091; Nisbet-Jones PBR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103036; Nonn T, 2001, CHEM PHYS LETT, V336, P97, DOI 10.1016/S0009-2614(01)00084-7; ORRIT M, 1992, CHEM PHYS LETT, V196, P595, DOI 10.1016/0009-2614(92)86000-8; Parigi V, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233602; Peloso MP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045007; Petelski T, 2003, EUR PHYS J D, V22, P279, DOI 10.1140/epjd/e2002-00238-4; Pirotta M, 1996, CHEM PHYS LETT, V250, P576, DOI 10.1016/0009-2614(96)00053-X; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Shi Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.240801; Tey MK, 2008, NAT PHYS, V4, P924, DOI 10.1038/nphys1096; WILD UP, 1992, CHEM PHYS LETT, V193, P451, DOI 10.1016/0009-2614(92)85830-4; Wrigge G, 2008, NAT PHYS, V4, P60, DOI 10.1038/nphys812	33	70	71	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					66	+		10.1038/nature13191	http://dx.doi.org/10.1038/nature13191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784217				2022-12-28	WOS:000335199100040
J	Khalifian, S; Brazio, PS; Mohan, R; Shaffer, C; Brandacher, G; Barth, RN; Rodriguez, ED				Khalifian, Saami; Brazio, Philip S.; Mohan, Raja; Shaffer, Cynthia; Brandacher, Gerald; Barth, Rolf N.; Rodriguez, Eduardo D.			Facial transplantation: the first 9 years	LANCET			English	Review							COMPOSITE TISSUE ALLOTRANSPLANTATION; HUMAN FACE TRANSPLANTATION; STEM-CELL INFUSION; OUTCOMES 18 MONTHS; CYTOMEGALOVIRUS-INFECTION; FOLLOW-UP; DOUBLE JAW; HAND; GRAFT; ALLOGRAFT	Since the first facial transplantation in 2005, 28 have been done worldwide with encouraging immunological, functional, psychological, and aesthetic outcomes. Unlike solid organ transplantation, which is potentially life-saving, facial transplantation is life-changing. This difference has generated ethical concerns about the exposure of otherwise young and healthy individuals to the sequelae of lifelong, high-dose, multidrug immunosuppression. Nevertheless, advances in immunomodulatory and immunosuppressive protocols, microsurgical techniques, and computer-aided surgical planning have enabled broader clinical application of this procedure to patients. Although episodes of acute skin rejection continue to pose a serious threat to face transplant recipients, all cases have been controlled with conventional immunosuppressive regimens, and no cases of chronic rejection have been reported.	[Khalifian, Saami; Brazio, Philip S.; Mohan, Raja; Shaffer, Cynthia] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Div Plast & Reconstruct Surg, Baltimore, MD 21201 USA; [Barth, Rolf N.] Univ Maryland, Med Ctr, Div Transplant Surg, Baltimore, MD 21201 USA; [Khalifian, Saami; Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Reconstruct Transplantat Program, Baltimore, MD USA; [Rodriguez, Eduardo D.] NYU, Langone Med Ctr, Inst Reconstruct Plast Surg, Dept Plast Surg, New York, NY 10016 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; New York University; NYU Langone Medical Center	Rodriguez, ED (corresponding author), NYU, Langone Med Ctr, 307 East 33rd St, New York, NY 10016 USA.	eduardo.rodriguez@nyumc.org	Brandacher, Gerald/L-7540-2016; Barth, Rolf/B-2542-2014	Brazio, Philip/0000-0002-0789-6001; Barth, Rolf/0000-0002-6770-5473; Brandacher, Gerald/0000-0001-7790-441X	Paul and Daisy Soros Fellowship	Paul and Daisy Soros Fellowship	SK acknowledges partial support by The Paul and Daisy Soros Fellowship.	Aziz SR, 2000, J ORAL MAXIL SURG, V58, P992, DOI 10.1053/joms.2000.8742; Barret JP, 2011, TRANSPL P, V43, P3533, DOI 10.1016/j.transproceed.2011.10.012; Barret JP, 2013, J PLAST RECONSTR AES, V66, P723, DOI 10.1016/j.bjps.2012.08.046; Barret JP, 2011, ANN SURG, V254, P252, DOI 10.1097/SLA.0b013e318226a607; Barth R, 2013, AM J TRANSPLANT, V13, P203; BenMarzouk-Hidalgo OJ, 2011, ANTIMICROB AGENTS CH, V55, P5949, DOI 10.1128/AAC.05335-11; Blondeel P, 2013, STATE ART FACIAL REC; Bonanno A, 2010, OPHTHAL PLAST RECONS, V26, P18, DOI 10.1097/IOP.0b013e3181b8e646; Breidenbach W, STATE ART FACIAL REC; Brown EN, 2012, PLAST RECONSTR SURG, V130, P815, DOI 10.1097/PRS.0b013e318262f2c9; Canan S, 1999, ANN PLAS SURG, V43, P613, DOI 10.1097/00000637-199912000-00006; Carty MJ, 2013, PLAST RECONSTR SURG, V132, P423, DOI 10.1097/PRS.0b013e318295883d; Cavadas P, 2012, ASRT 3 BIENN M CHIC; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chelmonski A, 2011, TRANSPL P, V43, P2827, DOI 10.1016/j.transproceed.2011.06.031; Coffman KL, 2010, CURR OPIN ORGAN TRAN, V15, P236, DOI 10.1097/MOT.0b013e328337267d; Connor NP, 1998, J COMMUN DISORD, V31, P535, DOI 10.1016/S0021-9924(98)00024-0; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Diaz-Siso JR, 2013, J PLAST RECONSTR AES, V66, P1458, DOI 10.1016/j.bjps.2013.06.046; Dorafshar AH, 2013, PLAST RECONSTR SURG, V131, P241, DOI 10.1097/PRS.0b013e3182789d38; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Errico Michael, 2012, JRSM Short Rep, V3, P74, DOI 10.1258/shorts.2012.011178; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Fisher M, 2012, PLAST RECONSTR SURG, V130, P389, DOI 10.1097/PRS.0b013e3182589e12; Fishman JA, 2007, CLIN TRANSPLANT, V21, P149, DOI 10.1111/j.1399-0012.2006.00618.x; GAMBA A, 1992, HEAD NECK-J SCI SPEC, V14, P218, DOI 10.1002/hed.2880140309; Gillies H., 1957, PRINCIPLES ART PLAST; Gomez-Cia T, 2011, PLAST RECONSTR SURG, V127, P995, DOI 10.1097/PRS.0b013e318200b00b; Gordon CR, 2012, J CRANIOFAC SURG, V23, P81, DOI 10.1097/SCS.0b013e318240ca77; Gordon CR, 2011, PLAST RECONSTR SURG, V128, p465E, DOI 10.1097/PRS.0b013e31822b6949; Gordon CR, 2011, PLAST RECONSTR SURG, V127, P1515, DOI 10.1097/PRS.0b013e318208d03c; Gordon CR, 2009, ANN PLAS SURG, V63, P572, DOI 10.1097/SAP.0b013e3181ba5245; GROSSI P, 1995, TRANSPLANTATION, V59, P847; Guntinas-Lichius O, 2008, NEW ENGL J MED, V358, P2179, DOI 10.1056/NEJMc080003; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Gupta A, 1999, J PHARMACOL TOXICOL, V41, P183, DOI 10.1016/S1056-8719(99)00041-6; Guyomard V, 2009, J PLAST RECONSTR AES, V62, P782, DOI 10.1016/j.bjps.2007.09.054; Haddock NT, 2012, PLAST RECONSTR SURG, V130, P1235, DOI 10.1097/PRS.0b013e31826d16a6; Haekens Christel M, 2011, Plast Surg Nurs, V31, P160, DOI 10.1097/PSN.0b013e318231ad8a; Hautz T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/757310; HO M, 1994, TRANSPL P, V26, P7; Hu KS, 2006, J CRANIOFAC SURG, V17, P1111, DOI 10.1097/01.scs.0000236436.97720.5f; Humar A, 2001, TRANSPLANTATION, V72, P1920, DOI 10.1097/00007890-200112270-00009; Hwang K, 2005, J CRANIOFAC SURG, V16, P647, DOI 10.1097/01.JPS.0000157814.29792.F2; Hwang K, 2008, J CRANIOFAC SURG, V19, P1675, DOI 10.1097/SCS.0b013e31818c0495; Infante-Cossio P, 2013, MED ORAL PATOL ORAL, V18, pE263, DOI 10.4317/medoral.18552; Jacobs JMS, 2013, PLAST RECONSTR SURG, V131, P64, DOI 10.1097/PRS.0b013e3182729ef0; Kanitakis J, 2011, AM J TRANSPLANT, V11, P1338, DOI 10.1111/j.1600-6143.2011.03507.x; Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x; Lantieri L, 2011, AM J TRANSPLANT, V11, P367, DOI 10.1111/j.1600-6143.2010.03406.x; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Littlewood KE, 2008, BEST PRACT RES-CLIN, V22, P585, DOI 10.1016/j.bpa.2008.05.005; Losee JE, 2012, J CRANIOFAC SURG, V23, P260, DOI 10.1097/SCS.0b013e318241b958; Meningaud JP, 2008, PLAST RECONSTR SURG, V122, P1383, DOI 10.1097/PRS.0b013e3181882146; Morelon E, 2013, AM J TRANSPLANT, V13, P202; Morelon E, 2012, TRANSPLANTATION, V93, P855, DOI 10.1097/TP.0b013e31824728b8; Morelon E, 2011, TRANSPL INT, V24, P75; Morris P, 2007, TRANSPLANTATION, V83, P109, DOI 10.1097/01.tp.0000254201.89012.ae; Mundinger GS, 2011, PLAST RECONSTR SURG, V128, P1193, DOI 10.1097/PRS.0b013e318230c5d0; NORDIN M, 1989, ACTA PHYSIOL SCAND, V135, P149, DOI 10.1111/j.1748-1716.1989.tb08562.x; Petruzzo P, 2011, AM J TRANSPLANT, V11, P808, DOI 10.1111/j.1600-6143.2011.03469.x; Petruzzo Palmina, 2011, Clin Transpl, P247; Petruzzo P, 2012, TRANSPLANTATION, V93, P236, DOI 10.1097/TP.0b013e31823d4af6; Petruzzo P, 2010, TRANSPLANTATION, V90, P1590, DOI 10.1097/TP.0b013e3181ff1472; Pomahac B, 2011, AM J TRANSPLANT, V11, P386, DOI 10.1111/j.1600-6143.2010.03368.x; Pomahac B, 2013, STATE ART FACIAL REC; Pomahac B, 2013, PLAST RECONSTR SURG, V131, P1069, DOI 10.1097/PRS.0b013e3182865cd3; Pomahac B, 2012, NEW ENGL J MED, V366, P715, DOI 10.1056/NEJMoa1111432; Pomahac B, 2012, J CRANIOFAC SURG, V23, P265, DOI 10.1097/SCS.0b013e318241b8b8; Press TA, 2013, EMERGENCY FACE TRANS; Rumsey N., 2012, OXFORD HDB PSYCHOL A; Rumsey N., 2012, OXFORD HDB PSYCHOL A; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Shankland WE, 2001, CRANIO, V19, P78, DOI 10.1080/08869634.2001.11746155; Shanmugarajah K, 2012, CURR OPIN OTOLARYNGO, V20, P291, DOI 10.1097/MOO.0b013e3283552cc5; Shanmugarajah K, 2011, INT J SURG, V9, P600, DOI 10.1016/j.ijsu.2011.09.005; Siemionow M, 2012, J CRANIOFAC SURG, V23, P254, DOI 10.1097/SCS.0b013e318241b920; Siemionow M, 2011, PLAST RECONSTR SURG, V128, p707E, DOI 10.1097/PRS.0b013e318230c77b; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P1875, DOI 10.1097/PRS.0b013e31820e90c3; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P652, DOI 10.1097/PRS.0b013e3181fed6fd; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Siemionow MZ, 2010, PLAST RECONSTR SURG, V126, P1232, DOI 10.1097/PRS.0b013e3181ee482d; Siemionow MZ, 2010, PLAST RECONSTR SURG, V125, P111, DOI 10.1097/PRS.0b013e3181c15c4c; Singhal D, 2012, PLAST RECONSTR SURG, V129, p81E, DOI 10.1097/PRS.0b013e31823621db; Svenaeus F, 2012, J MED PHILOS, V37, P139, DOI 10.1093/jmp/jhs011; Tartaglia Alexander, 2005, Work, V25, P57; Torres JJ, 2012, MODERN PATHOL, V25, p135A; Unadkat JV, 2010, AM J TRANSPLANT, V10, P251, DOI 10.1111/j.1600-6143.2009.02941.x; VANDERWOUDEN JC, 1992, J OCCUP ENVIRON MED, V34, P1084, DOI 10.1097/00043764-199211000-00010; Vargas CD, 2009, P NATL ACAD SCI USA, V106, P7197, DOI 10.1073/pnas.0809614106	90	177	180	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2153	2163		10.1016/S0140-6736(13)62632-X	http://dx.doi.org/10.1016/S0140-6736(13)62632-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	24783986	Green Submitted			2022-12-28	WOS:000346354300032
J	Starrs, AM				Starrs, Ann M.			Survival convergence: bringing maternal and newborn health together for 2015 and beyond	LANCET			English	Editorial Material									Family Care Int, New York, NY 10006 USA		Starrs, AM (corresponding author), Family Care Int, New York, NY 10006 USA.	astarrs@familycareintl.org						[Anonymous], 2011, GLOB REV KEY INT REL; [Anonymous], 1996, MOTH BAB PACK IMPL S; Bhutta ZA, 2014, LANCET; Darmstadt GL, 2014, LANCET; Dickson KE, 2014, LANCET; Lawn JE, 2014, LANCET; Mason E, 2014, LANCET; Secretary-General's High-Level Panel of Eminent Persons, 2013, NEW GLOB PARTN ER PO; UNICEF, 2015, COMMITTING CHILD SUR; WHO, 2014, PROV AG 67 WORLD HLT; World Health Organization, 2014, EV NEWB ACT PLAN ED	11	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					211	213		10.1016/S0140-6736(14)60838-2	http://dx.doi.org/10.1016/S0140-6736(14)60838-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	24853594				2022-12-28	WOS:000339384100005
J	Flynn, TM; O'Loughlin, EJ; Mishra, B; DiChristina, TJ; Kemner, KM				Flynn, Theodore M.; O'Loughlin, Edward J.; Mishra, Bhoopesh; DiChristina, Thomas J.; Kemner, Kenneth M.			Sulfur-mediated electron shuttling during bacterial iron reduction	SCIENCE			English	Article							MICROBIAL REDUCTION; SULFATE REDUCTION; AQUIFER; FE(III); LIFE; KINETICS; SULFIDE; GROWTH; REDOX; GENE	Microbial reduction of ferric iron [Fe(III)] is an important biogeochemical process in anoxic aquifers. Depending on groundwater pH, dissimilatory metal-reducing bacteria can also respire alternative electron acceptors to survive, including elemental sulfur (S degrees). To understand the interplay of Fe/S cycling under alkaline conditions, we combined thermodynamic geochemical modeling with bioreactor experiments using Shewanella oneidensis MR-1. Under these conditions, S. oneidensis can enzymatically reduce S degrees but not goethite (alpha-FeOOH). The HS- produced subsequently reduces goethite abiotically. Because of the prevalence of alkaline conditions in many aquifers, Fe(III) reduction may thus proceed via S degrees-mediated electron-shuttling pathways.	[Flynn, Theodore M.; O'Loughlin, Edward J.; Mishra, Bhoopesh; Kemner, Kenneth M.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Flynn, Theodore M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Mishra, Bhoopesh] IIT, Dept Phys, Chicago, IL 60616 USA; [DiChristina, Thomas J.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Illinois Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kemner, KM (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	kemner@anl.gov	Flynn, Theodore/C-1221-2008; O'Loughlin, Edward/C-9565-2013	Flynn, Theodore/0000-0002-1838-8942; O'Loughlin, Edward/0000-0003-1607-9529	Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE [DE-AC02-06CH11357]; NSF-Earth Sciences [EAR-1128799]; DOE-GeoSciences [DE-FG02-94ER14466]; DOE Office of Science, Office of Basic Energy Sciences; Argonne Director's Fellowship; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service [HHSN272200900040C]; NSF (Molecular and Cellular Biosciences) [1021735]; Div Of Molecular and Cellular Bioscience [1021735] Funding Source: National Science Foundation	Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE; NSF-Earth Sciences(National Science Foundation (NSF)); DOE-GeoSciences(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Argonne Director's Fellowship; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service; NSF (Molecular and Cellular Biosciences); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is part of the Subsurface Science Scientific Focus Area at Argonne National Laboratory supported by the Subsurface Biogeochemical Research Program, U.S. Department of Energy (DOE) Office of Science, Office of Biological and Environmental Research, under DOE contract DE-AC02-06CH11357. We appreciate the technical assistance of M. Newville, and A. Lanzirotti. K. Nealson, J. Fredrickson, and K. Haugen provided helpful comments that improved the manuscript. X-ray analyses were conducted at Argonne National Laboratory's Advanced Photon Source (APS), GeoSoilEnviroCARS (Sector 13), supported by NSF-Earth Sciences (EAR-1128799) and DOE-GeoSciences (DE-FG02-94ER14466). Use of the APS was supported by the DOE Office of Science, Office of Basic Energy Sciences. T. F. was supported in part by an Argonne Director's Fellowship and the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Service (contract no. HHSN272200900040C). T. D. was supported by NSF (Molecular and Cellular Biosciences grant no. 1021735). All additional data have been archived in the supplementary materials.	ANDREWS JN, 1994, WATER RESOUR RES, V30, P45, DOI 10.1029/93WR02226; Bethke CM, 2011, AM J SCI, V311, P183, DOI 10.2475/03.2011.01; Bickle MJ, 2009, NAT GEOSCI, V2, P815, DOI 10.1038/ngeo687; Borch T, 2010, ENVIRON SCI TECHNOL, V44, P15, DOI 10.1021/es9026248; Burns JL, 2009, APPL ENVIRON MICROB, V75, P5209, DOI 10.1128/AEM.00888-09; Edwards KJ, 2012, ANNU REV EARTH PL SC, V40, P551, DOI 10.1146/annurev-earth-042711-105500; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Fuller SJ, 2014, APPL ENVIRON MICROB, V80, P128, DOI 10.1128/AEM.02282-13; Haveman SA, 2008, APPL ENVIRON MICROB, V74, P4277, DOI 10.1128/AEM.02901-07; Heimann A, 2010, EARTH PLANET SC LETT, V294, P8, DOI 10.1016/j.epsl.2010.02.015; Hellige K, 2012, GEOCHIM COSMOCHIM AC, V81, P69, DOI 10.1016/j.gca.2011.12.014; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Jin Q, 2007, AM J SCI, V307, P643, DOI 10.2475/04.2007.01; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Kirk MF, 2009, APPL GEOCHEM, V24, P426, DOI 10.1016/j.apgeochem.2008.12.022; Kirk MF, 2004, GEOLOGY, V32, P953, DOI 10.1130/G20842.1; Ledin M, 1996, EARTH-SCI REV, V41, P67, DOI 10.1016/0012-8252(96)00016-5; Lovley D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P635, DOI 10.1007/0-387-30742-7_21; McGrail BP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004169; MCMAHON PB, 1991, NATURE, V349, P233, DOI 10.1038/349233a0; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; Poulton SW, 2004, GEOCHIM COSMOCHIM AC, V68, P3703, DOI 10.1016/j.gca.2004.03.012; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; Wu LL, 2009, GEOCHIM COSMOCHIM AC, V73, P5584, DOI 10.1016/j.gca.2009.06.026	30	130	143	24	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1039	1042		10.1126/science.1252066	http://dx.doi.org/10.1126/science.1252066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24789972	Green Accepted, Green Submitted			2022-12-28	WOS:000336495800048
J	Castro, M; King, TS; Kunselman, SJ; Cabana, MD; Denlinger, L; Holguin, F; Kazani, SD; Moore, WC; Moy, J; Sorkness, CA; Avila, P; Bacharier, LB; Bleecker, E; Boushey, HA; Chmiel, J; Fitzpatrick, AM; Gentile, D; Hundal, M; Israel, E; Kraft, M; Krishnan, JA; LaForce, C; Lazarus, SC; Lemanske, R; Lugogo, N; Martin, RJ; Mauger, DT; Naureckas, E; Peters, SP; Phipatanakul, W; Que, LG; Sheshadri, A; Smith, L; Solway, J; Sullivan-Vedder, L; Sumino, K; Wechsler, ME; Wenzel, S; White, SR; Sutherland, ER				Castro, Mario; King, Tonya S.; Kunselman, Susan J.; Cabana, Michael D.; Denlinger, Loren; Holguin, Fernando; Kazani, Shamsah D.; Moore, Wendy C.; Moy, James; Sorkness, Christine A.; Avila, Pedro; Bacharier, Leonard B.; Bleecker, Eugene; Boushey, Homer A.; Chmiel, James; Fitzpatrick, Anne M.; Gentile, Deborah; Hundal, Mandeep; Israel, Elliot; Kraft, Monica; Krishnan, Jerry A.; LaForce, Craig; Lazarus, Stephen C.; Lemanske, Robert; Lugogo, Njira; Martin, Richard J.; Mauger, David T.; Naureckas, Edward; Peters, Stephen P.; Phipatanakul, Wanda; Que, Loretta G.; Sheshadri, Ajay; Smith, Lewis; Solway, Julian; Sullivan-Vedder, Lisa; Sumino, Kaharu; Wechsler, Michael E.; Wenzel, Sally; White, Steven R.; Sutherland, E. Rand		Natl Heart Lung Blood Inst	Effect of Vitamin D-3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels The VIDA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; LUNG-FUNCTION; RESPONSIVENESS; MONTELUKAST; ASSOCIATION; RELIABILITY; EXPRESSION; CHILDHOOD; INDUCTION	IMPORTANCE In asthma and other diseases, vitamin D insufficiency is associated with adverse outcomes. It is not known if supplementing inhaled corticosteroids with oral vitamin D-3 improves outcomes in patients with asthma and vitamin D insufficiency. OBJECTIVE To evaluate if vitamin D supplementation would improve the clinical efficacy of inhaled corticosteroids in patients with symptomatic asthma and lower vitamin D levels. DESIGN, SETTING, AND PARTICIPANTS The VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma) randomized, double-blind, parallel, placebo-controlled trial studying adult patients with symptomatic asthma and a serum 25-hydroxyvitamin D level of less than 30 ng/mL was conducted across 9 academic US medical centers in the National Heart, Lung, and Blood Institute's AsthmaNet network, with enrollment starting in April 2011 and follow-up complete by January 2014. After a run-in period that included treatment with an inhaled corticosteroid, 408 patients were randomized. INTERVENTIONS Oral vitamin D-3 (100 000 IU once, then 4000 IU/d for 28 weeks; n = 201) or placebo (n = 207) was added to inhaled ciclesonide (320 g/d). If asthma control was achieved after 12 weeks, ciclesonide was tapered to 160 g/d for 8 weeks, then to 80 g/d for 8 weeks if asthma control was maintained. MAIN OUTCOMES AND MEASURES The primary outcomewas time to first asthma treatment failure (a composite outcome of decline in lung function and increases in use of beta-agonists, systemic corticosteroids, and health care). RESULTS Treatment with vitamin D-3 did not alter the rate of first treatment failure during 28 weeks (28%[95% CI, 21%-34%] with vitamin D-3 vs 29% [95% CI, 23%-35%] with placebo; adjusted hazard ratio, 0.9 [95% CI, 0.6-1.3]). Of 14 prespecified secondary outcomes, 9 were analyzed, including asthma exacerbation; of those 9, the only statistically significant outcome was a small difference in the overall dose of ciclesonide required to maintain asthma control (111.3 g/d [95% CI, 102.2-120.4 g/d] in the vitamin D-3 group vs 126.2 g/d [95% CI, 117.2-135.3 g/d] in the placebo group; difference of 14.9 g/d [95% CI, 2.1-27.7 g/d]). CONCLUSIONS AND RELEVANCE Vitamin D-3 did not reduce the rate of first treatment failure or exacerbation in adults with persistent asthma and vitamin D insufficiency. These findings do not support a strategy of therapeutic vitamin D-3 supplementation in patients with symptomatic asthma.	[Castro, Mario; Bacharier, Leonard B.; Sheshadri, Ajay; Sumino, Kaharu] Washington Univ, Sch Med, St Louis, MO USA; [King, Tonya S.; Kunselman, Susan J.; Mauger, David T.] Penn State Univ, Hershey, PA USA; [Cabana, Michael D.; Boushey, Homer A.; Lazarus, Stephen C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Denlinger, Loren; Sorkness, Christine A.; Lemanske, Robert] Univ Wisconsin, Madison, WI 53706 USA; [Holguin, Fernando; Wenzel, Sally] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Kazani, Shamsah D.; Israel, Elliot] Brigham & Womens Hosp, Boston, MA 02115 USA; [Moore, Wendy C.; Bleecker, Eugene; Peters, Stephen P.] Wake Forest Sch Med, Winston Salem, NC USA; [Moy, James] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Avila, Pedro; Smith, Lewis] Northwestern Univ, Chicago, IL 60611 USA; [Chmiel, James] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Fitzpatrick, Anne M.] Emory Univ, Atlanta, GA 30322 USA; [Gentile, Deborah] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Hundal, Mandeep; Kraft, Monica; Lugogo, Njira; Que, Loretta G.] Duke Univ, Sch Med, Durham, NC USA; [Krishnan, Jerry A.] Univ Illinois, Chicago, IL USA; [LaForce, Craig] North Carolina Clin Res, Raleigh, NC USA; [Martin, Richard J.; Wechsler, Michael E.; Sutherland, E. Rand] Natl Jewish Hlth, Denver, CO USA; [Naureckas, Edward; Solway, Julian; White, Steven R.] Univ Chicago, Chicago, IL 60637 USA; [Phipatanakul, Wanda] Boston Childrens Hosp, Boston, MA USA; [Sullivan-Vedder, Lisa] Aurora Sinai Med Ctr, Milwaukee, WI USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Wake Forest University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Emory University; Allegheny General Hospital; Duke University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Jewish Health; University of Chicago; Harvard University; Boston Children's Hospital	King, TS (corresponding author), Penn State Coll Med, Dept Publ Hlth Sci, 90 Hope Dr,Ste 2200-A210, Hershey, PA 17033 USA.	tking@phs.psu.edu	Wechsler, Michael/AAC-5506-2019; Sheshadri, Ajay/AAN-7427-2020; Sumino, Kaharu/AAA-2028-2021	Sheshadri, Ajay/0000-0002-8091-0180; Sumino, Kaharu/0000-0002-6214-2966; Bacharier, Leonard/0000-0003-0432-2704; Smith, Lewis J/0000-0002-4728-1562; Wenzel, Sally/0000-0002-4242-0164; Fitzpatrick, Anne/0000-0002-2933-5926	National Heart, Lung, and Blood Institute [HL098102, U10HL098096, UL1TR000150, UL1TR000430, UL1TR000050, HL098075, UL1TR001082, HL098090, HL098177, UL1TR000439, HL098098, UL1TR000448, HL098107, HL098112, HL098103, UL1TR000454, HL098115]; Sunovion Pharmaceuticals Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR000448, UL1TR001082, UL1TR000454, UL1TR000050, UL1TR000427, UL1TR000150, UL1TR000430, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098177, U10HL098096, U10HL098075, U10HL098102, U10HL098112, U10HL098107, U10HL074225, U10HL098115, U10HL098090, T32HL007317, U10HL098103, U10HL098098] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sunovion Pharmaceuticals Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was conducted with the support of grants HL098102, U10HL098096, UL1TR000150, UL1TR000430, UL1TR000050, HL098075, UL1TR001082, HL098090, HL098177, UL1TR000439, HL098098, UL1TR000448, HL098107, HL098112, HL098103, UL1TR000454, and HL098115 that were awarded by the National Heart, Lung, and Blood Institute. Ciclesonide and levalbuterol were provided without cost by Sunovion Pharmaceuticals Inc.	Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Brehm John M, 2010, J Allergy Clin Immunol, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Cantorna MT, 2006, PROG BIOPHYS MOL BIO, V92, P60, DOI 10.1016/j.pbiomolbio.2006.02.020; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; HYLAND ME, 1995, BRIT J CLIN PSYCHOL, V34, P601, DOI 10.1111/j.2044-8260.1995.tb01494.x; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, pe1; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Song YF, 2007, RESPIROLOGY, V12, P486, DOI 10.1111/j.1440-1843.2007.01099.x; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	30	180	187	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2083	2091		10.1001/jama.2014.5052	http://dx.doi.org/10.1001/jama.2014.5052			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24838406	Bronze, Green Accepted			2022-12-28	WOS:000336392400024
J	Ferenci, P; Bernstein, D; Lalezari, J; Cohen, D; Luo, Y; Cooper, C; Tam, E; Marinho, RT; Tsai, N; Nyberg, A; Box, TD; Younes, Z; Enayati, P; Green, S; Baruch, Y; Bhandari, BR; Caruntu, FA; Sepe, T; Chulanov, V; Janczewska, E; Rizzardini, G; Gervain, J; Planas, R; Moreno, C; Hassanein, T; Xie, WG; King, M; Podsadecki, T; Reddy, KR				Ferenci, Peter; Bernstein, David; Lalezari, Jacob; Cohen, Daniel; Luo, Yan; Cooper, Curtis; Tam, Edward; Marinho, Rui T.; Tsai, Naoky; Nyberg, Anders; Box, Terry D.; Younes, Ziad; Enayati, Pedram; Green, Sinikka; Baruch, Yaacov; Bhandari, Bal Raj; Caruntu, Florin Alexandru; Sepe, Thomas; Chulanov, Vladimir; Janczewska, Ewa; Rizzardini, Giuliano; Gervain, Judit; Planas, Ramon; Moreno, Christophe; Hassanein, Tarek; Xie, Wangang; King, Martin; Podsadecki, Thomas; Reddy, K. Rajender			ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1 HEPATITIS-C; ANTIVIRAL AGENTS; TREATMENT-NAIVE; TELAPREVIR; SOFOSBUVIR; PEGINTERFERON; DACLATASVIR; COMBINATION; INTERFERON; BOCEPREVIR	BACKGROUND The interferon-free regimen of ABT-450 with ritonavir (ABT-450/r), ombitasvir, and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic response in a phase 2 study involving patients with hepatitis C virus (HCV) genotype 1 infection. We conducted two phase 3 trials to examine the efficacy and safety of this regimen in previously untreated patients with HCV genotype 1 infection and no cirrhosis. METHODS We randomly assigned 419 patients with HCV genotype 1b infection (PEARL-III study) and 305 patients with genotype 1a infection (PEARL-IV study) to 12 weeks of ABT-450/r-ombitasvir (at a once-daily dose of 150 mg of ABT-450, 100 mg of ritonavir, and 25 mg of ombitasvir), dasabuvir (250 mg twice daily), and ribavirin administered according to body weight or to matching placebo for ribavirin. The primary efficacy end point was a sustained virologic response (an HCV RNA level of <25 IU per milliliter) 12 weeks after the end of treatment. RESULTS The study regimen resulted in high rates of sustained virologic response among patients with HCV genotype 1b infection (99.5% with ribavirin and 99.0% without ribavirin) and among those with genotype 1a infection (97.0% and 90.2%, respectively). Of patients with genotype 1b infection, 1 had virologic failure, and 2 did not have data available at post-treatment week 12. Among patients with genotype 1a infection, the rate of virologic failure was higher in the ribavirin-free group than in the ribavirin group (7.8% vs. 2.0%). In both studies, decreases in the hemoglobin level were significantly more common in patients receiving ribavirin. Two patients (0.3%) discontinued the study drugs owing to adverse events. The most common adverse events were fatigue, headache, and nausea. CONCLUSIONS Twelve weeks of treatment with ABT-450/r-ombitasvir and dasabuvir without ribavirin was associated with high rates of sustained virologic response among previously untreated patients with HCV genotype 1 infection. Rates of virologic failure were higher without ribavirin than with ribavirin among patients with genotype 1a infection but not among those with genotype 1b infection.	[Ferenci, Peter] Med Univ Vienna, A-1090 Vienna, Austria; [Bernstein, David] Hofstra North Shore LIJ Sch Med, Manhasset, NY USA; [Lalezari, Jacob] Quest Clin Res, San Francisco, CA USA; [Nyberg, Anders] Kaiser Permanente, San Diego, CA USA; [Enayati, Pedram] Calif Liver Inst, Los Angeles, CA USA; [Green, Sinikka] eStudySite, La Mesa, CA USA; [Hassanein, Tarek] So Calif Liver Ctr, Coronado, CA USA; [Hassanein, Tarek] So Calif Res Ctr, Coronado, CA USA; [Cohen, Daniel; Luo, Yan; Xie, Wangang; King, Martin; Podsadecki, Thomas] AbbVie, N Chicago, IL USA; [Cooper, Curtis] Univ Ottawa, Ottawa, ON, Canada; [Tam, Edward] Liver & Intestinal Res Ctr, Vancouver, BC, Canada; [Marinho, Rui T.] Ctr Hosp Lisboa Norte, Med Sch Lisbon, Lisbon, Portugal; [Tsai, Naoky] Queens Med Ctr, Ctr Liver, Honolulu, HI USA; [Box, Terry D.] Clin Res Ctr Amer, Murray, UT USA; [Younes, Ziad] Gastro One, Germantown, TN USA; [Baruch, Yaacov] Rambam Hlth Care Campus, Haifa, Israel; [Bhandari, Bal Raj] Delta Res Partners, Bastrop, LA USA; [Caruntu, Florin Alexandru] Matei Bals Natl Inst Infect Dis, Bucharest, Romania; [Sepe, Thomas] Univ Gastroenterol, Providence, RI USA; [Chulanov, Vladimir] Cent Res Inst Epidemiol, Moscow, Russia; [Janczewska, Ewa] ID Clin, Myslowice, Poland; [Rizzardini, Giuliano] Osped L Sacco, Milan, Italy; [Gervain, Judit] Szent Gyorgy Hosp, Szekesfehervar, Hungary; [Planas, Ramon] Hosp Badalona Germans Trias & Pujol, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Badalona, Spain; [Moreno, Christophe] Univ Libre Bruxelles, Clin Univ Bruxelles Hop Erasme, Brussels, Belgium; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA	Medical University of Vienna; Hofstra University; Northwell Health; Kaiser Permanente; AbbVie; University of Ottawa; Universidade de Lisboa; The Queen's Medical Center; Rambam Health Care Campus; National Institute for Infectious Diseases "Matei Bals"; University of Milan; Luigi Sacco Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Germans Trias i Pujol; Universite Libre de Bruxelles; University of Pennsylvania	Ferenci, P (corresponding author), Med Univ Vienna, Univ Klin Innere Med 3, Klin Abt Gastroenterol & Hepatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	peter.ferenci@meduniwien.ac.at	Janczewska, Ewa/J-7231-2015; Chulanov, Vladimir/AAY-7277-2020; Villa, Erica/A-7576-2012; Rugina, Sorin/U-5168-2019; Cooper, Curtis/M-9320-2019; Chulanov, Vladimir/S-4708-2016; Romero-Gomez, Manuel/L-8030-2014	Janczewska, Ewa/0000-0002-5406-4603; Chulanov, Vladimir/0000-0001-6303-9293; Villa, Erica/0000-0001-6388-7022; Chulanov, Vladimir/0000-0001-6303-9293; Romero-Gomez, Manuel/0000-0001-8494-8947; Caruntu, Florin Alexandru/0000-0001-6103-5336; Aspinall, Richard/0000-0002-5208-8185; TAM, EDWARD/0000-0002-8306-3968; Ryder, Stephen David/0000-0001-9649-4444	AbbVie	AbbVie(AbbVie)	Sponsored by AbbVie.	Chung RT, 2012, NEW ENGL J MED, V366, P273, DOI 10.1056/NEJMe1113272; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson Ira M, 2012, Gastroenterol Hepatol (N Y), V8, P1; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Menon RM, 2009, HEPDART 2009 KOH COA; Pilot-Matias T, 2012, 47 ANN M EUR ASS STU; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sun SCC, 2011, J VIRAL HEPATITIS, V18, P861, DOI 10.1111/j.1365-2893.2010.01396.x; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	26	574	606	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1983	1992		10.1056/NEJMoa1402338	http://dx.doi.org/10.1056/NEJMoa1402338			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UZ	24795200				2022-12-28	WOS:000336125500006
J	Nguyen, LN; Ma, DL; Shui, GH; Wong, PY; Cazenave-Gassiot, A; Zhang, XD; Wenk, MR; Goh, ELK; Silver, DL				Nguyen, Long N.; Ma, Dongliang; Shui, Guanghou; Wong, Peiyan; Cazenave-Gassiot, Amaury; Zhang, Xiaodong; Wenk, Markus R.; Goh, Eyleen L. K.; Silver, David L.			Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid	NATURE			English	Article							CARDIOVASCULAR-DISEASE; BRAIN; DEFICIENCY; MECHANISM	Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is essential for normal brain growth and cognitive function(1-4). Consistent with its importance in the brain, DHA is highly enriched in brain phospholipids(5-7). Despite being an abundant fatty acid in brain phospholipids, DHA cannot be de novo synthesized in brain and must be imported across the blood-brain barrier, but mechanisms for DHA uptake in brain have remained enigmatic. Here we identify a member of the major facilitator superfamily-Mfsd2a (previously an orphan transporter)-as the major transporter for DHA uptake into brain. Mfsd2a is found to be expressed exclusively in endothelium of the blood-brain barrier of micro-vessels. Lipidomic analysis indicates that Mfsd2a-deficient (Mfsd2a-knockout) mice show markedly reduced levels of DHA in brain accompanied by neuronal cell loss in hippocampus and cerebellum, as well as cognitive deficits and severe anxiety, and microcephaly. Unexpectedly, cell-based studies indicate that Mfsd2a transports DHA in the form of lysophosphatidylcholine (LPC), but not unesterified fatty acid, in a sodium-dependent manner. Notably, Mfsd2a transports common plasma LPCs carrying long-chain fatty acids such LPC oleate and LPC palmitate, but not LPCs with less than a 14-carbon acyl chain. Moreover, we determine that the phosphor-zwitterionic headgroup of LPC is critical for transport. Importantly, Mfsd2a-knockout mice have markedly reduced uptake of labelled LPC DHA, and other LPCs, from plasma into brain, demonstrating that Mfsd2a is required for brain uptake of DHA. Our findings reveal an unexpected essential physiological role of plasma-derived LPCs in brain growth and function.	[Nguyen, Long N.; Silver, David L.] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Ma, Dongliang; Wong, Peiyan; Zhang, Xiaodong; Goh, Eyleen L. K.] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Shui, Guanghou; Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Silver, DL (corresponding author), Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	david.silver@duke-nus.edu.sg	Cazenave-Gassiot, Amaury/E-4536-2014; Wenk, Markus Rene/D-1441-2014; Nguyen, Long/AAY-6172-2021	Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Goh, Eyleen/0000-0002-8244-6959; ma, Dongliang/0000-0003-3077-1968; Silver, David/0000-0002-7289-9890; Nguyen, Long N/0000-0002-9857-2239; Wong, Peiyan/0000-0003-3734-2461; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Shui, Guanghou/0000-0002-1621-9643	Singapore Ministry of Health's National Medical Research Council [CBRG/0012/2012]; Singapore National Research Foundation Competitive Research Program [2008-01, 2007-04]; National University of Singapore's Life Sciences Institute; Singapore National Medical Research Council Translational and Clinical Research Program [NMRC/TCR/003-GMS/2008]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); Singapore National Medical Research Council Translational and Clinical Research Program(National Medical Research Council, Singapore)	This work was supported in part by grants from the Singapore Ministry of Health's National Medical Research Council CBRG/0012/2012 (to D. L. S.), the Singapore National Research Foundation Competitive Research Program grants 2008-01 (to E. L. G.) and 2007-04 (to M. R. W.), National University of Singapore's Life Sciences Institute (to M. R. W.), and Singapore National Medical Research Council Translational and Clinical Research Program NMRC/TCR/003-GMS/2008 (to X.Z.). We would like to thank B. Tan (Duke-NUS) for technical assistance with lipid extractions, and S. Ying (Duke-NUS) for assistance with behavioural phenotyping.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Carrie I, 2000, J LIPID RES, V41, P473; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Wong PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051455	19	552	572	6	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					503	+		10.1038/nature13241	http://dx.doi.org/10.1038/nature13241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828044				2022-12-28	WOS:000336126000041
J	Burden, ACF				Burden, A. C. Felix			Review: Ultrasonography screening reduces long-term abdominal aortic aneurysm-related mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REPAIR		Sandwell & West Birmingham Clin Commissioning Grp, Birmingham, W Midlands, England		Burden, ACF (corresponding author), Sandwell & West Birmingham Clin Commissioning Grp, Birmingham, W Midlands, England.		Burden, Felix/AAE-9711-2020	Burden, Andrew/0000-0001-8764-376X				Brady AR, 2002, NEW ENGL J MED, V346, P1445; Earnshaw JJ, 2012, EUR J VASC ENDOVASC, V44, P465, DOI 10.1016/j.ejvs.2012.09.004; Harris R, 2012, ARCH INTERN MED, V172, P1462, DOI 10.1001/archinternmed.2012.4280; Sandiford P, 2011, BRIT J SURG, V98, P645, DOI 10.1002/bjs.7461; Schanzer A, 2011, CIRCULATION, V123, P2848, DOI 10.1161/CIRCULATIONAHA.110.014902	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10							JC6	10.7326/0003-4819-160-10-201405200-02006	http://dx.doi.org/10.7326/0003-4819-160-10-201405200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842440				2022-12-28	WOS:000337347100005
J	Ryan, AM; Mushlin, AI				Ryan, Andrew M.; Mushlin, Alvin I.			The Affordable Care Act's Payment Reforms and the Future of Hospitals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ryan, Andrew M.; Mushlin, Alvin I.] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Ryan, AM (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 East 67th St, New York, NY 10065 USA.	amr2015@med.cornell.edu			AHRQ HHS [K01 HS018546-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018546] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Altman SH, 2006, HEALTH AFFAIR, V25, P11, DOI 10.1377/hlthaff.25.1.11; [Anonymous], 2012, COMMUNICATION; Berenson R.A., 2011, ACCOUNTABLE CARE ORG; Bradford JW, 2011, ACCOUNTING COST US H; Cresswell J., 2013, NY TIMES, pB1; Fuchs VR, 2012, NEW ENGL J MED, V366, P973, DOI 10.1056/NEJMp1200478; Ginsburg P, 1976, HLTH VICTIM CAUSE IN, P293; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; SALKEVER DS, 1976, MILBANK FUND Q, V54, P185, DOI 10.2307/3349587; SLOAN FA, 1981, REV ECON STAT, V63, P479, DOI 10.2307/1935842	10	5	6	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2014	160	10					729	+		10.7326/M13-2033	http://dx.doi.org/10.7326/M13-2033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MJ	24842419				2022-12-28	WOS:000337347100020
J	Chow, WY; Rajan, R; Muller, KH; Reid, DG; Skepper, JN; Wong, WC; Brooks, RA; Green, M; Bihan, D; Farndale, RW; Slatter, DA; Shanahan, CM; Duer, MJ				Chow, W. Ying; Rajan, Rakesh; Muller, Karin H.; Reid, David G.; Skepper, Jeremy N.; Wong, Wai Ching; Brooks, Roger A.; Green, Maggie; Bihan, Dominique; Farndale, Richard W.; Slatter, David A.; Shanahan, Catherine M.; Duer, Melinda J.			NMR Spectroscopy of Native and in Vitro Tissues Implicates PolyADP Ribose in Biomineralization	SCIENCE			English	Article							SOLID-STATE NMR; ORGANIC-MINERAL INTERFACE; POLY(ADP-RIBOSE) POLYMERASE; MAGNETIC-RESONANCE; CHEMICAL-SHIFTS; BONE; C-13; DYNAMICS; SURFACE; DEATH	Nuclear magnetic resonance (NMR) spectroscopy is useful to determine molecular structure in tissues grown in vitro only if their fidelity, relative to native tissue, can be established. Here, we use multidimensional NMR spectra of animal and in vitro model tissues as fingerprints of their respective molecular structures, allowing us to compare the intact tissues at atomic length scales. To obtain spectra from animal tissues, we developed a heavy mouse enriched by about 20% in the NMR-active isotopes carbon-13 and nitrogen-15. The resulting spectra allowed us to refine an in vitro model of developing bone and to probe its detailed structure. The identification of an unexpected molecule, poly(adenosine diphosphate ribose), that may be implicated in calcification of the bone matrix, illustrates the analytical power of this approach.	[Chow, W. Ying; Reid, David G.; Wong, Wai Ching; Duer, Melinda J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Rajan, Rakesh; Brooks, Roger A.] Univ Cambridge, Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 0QQ, England; [Muller, Karin H.; Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Green, Maggie] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SZ, England; [Bihan, Dominique; Farndale, Richard W.; Slatter, David A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Shanahan, Catherine M.] Kings Coll London, British Heart Fdn Ctr Res Excellence, James Black Ctr, Div Cardiovasc, London SE5 9NU, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of London; King's College London	Duer, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjd13@cam.ac.uk	Muller, Karin/W-2453-2019; , Roger/N-7021-2019; Slatter, David/AAV-5771-2020; Chow, Ying/G-9297-2011; Slatter, David/AAW-6938-2021	Chow, Ying/0000-0003-0719-5958; Muller, Karin Helga/0000-0003-4693-8558; Duer, Melinda/0000-0002-9196-5072; Shanahan, Catherine/0000-0002-8352-8171	BBSRC [BB/G021392/1]; BHF [PG/08/011/24416, PG/10/43/28390]; EPSRC; MRC [G0500707]; National Institute of Health Research; Biotechnology and Biological Sciences Research Council [BB/G021392/1] Funding Source: researchfish; British Heart Foundation [RG/09/003/27122, PG/10/43/28390, RG/11/14/29056] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1235152] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors appreciate advice from M. Norman and J. Keeley; technical support from S. Thomas and R. Westwood (Central Biological Services, University of Cambridge); helpful interactions with D. Martel (SAFE, Augy, France); and advice and assistance with AFM from R. Oliver and C. Grover (University of Cambridge). The authors acknowledge funding from BBSRC for D.A.S., D.G.R. (BB/G021392/1), M.J.D., R.R., and R.W.F.; from BHF for D.A.S. and R.W.F. (PG/08/011/24416), K.H.M. (PG/10/43/28390), M.J.D., J.N.S., and C.M.S.; from EPSRC for W.Y.C. and W.C.W.; from MRC for D.B. and R.W.F. (G0500707); and from the National Institute of Health Research for R.A.B.	Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217; Bertazzo S, 2012, NANOSCALE, V4, P2851, DOI 10.1039/c2nr30431g; Bockmann A, 2006, CR CHIM, V9, P381, DOI 10.1016/j.crci.2005.06.008; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dey A, 2010, NAT MATER, V9, P1010, DOI [10.1038/nmat2900, 10.1038/NMAT2900]; Duer MJ, 2008, ARTERIOSCL THROM VAS, V28, P2030, DOI 10.1161/ATVBAHA.108.172387; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hohwy M, 1998, J CHEM PHYS, V108, P2686, DOI 10.1063/1.475661; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; SARKAR SK, 1983, J BIOL CHEM, V258, P9762; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; SPIRO RG, 1969, J BIOL CHEM, V244, P602; TORCHIA DA, 1985, BIOPOLYMERS, V24, P65, DOI 10.1002/bip.360240107; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wise ER, 2007, CHEM MATER, V19, P5055, DOI 10.1021/cm702054c; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; ZIMMERMANN B, 1994, CELL TISSUE RES, V275, P345, DOI 10.1007/BF00319433	26	64	64	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					742	746		10.1126/science.1248167	http://dx.doi.org/10.1126/science.1248167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833391	Green Submitted			2022-12-28	WOS:000335912900040
J	Malyshev, DA; Dhami, K; Lavergne, T; Chen, TJ; Dai, N; Foster, JM; Correa, IR; Romesberg, FE				Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Dai, Nan; Foster, Jeremy M.; Correa, Ivan R., Jr.; Romesberg, Floyd E.			A semi-synthetic organism with an expanded genetic alphabet	NATURE			English	Article							UNNATURAL BASE-PAIR; DNA; NUCLEOTIDE; REPLICATION; TRANSPORT; PROTEINS; EFFICIENT; MUTATION; ATP/ADP	Organisms are defined by the information encoded in their genomes, and since the origin of life this information has been encoded using a two-base-pair genetic alphabet (A-T and G-C). In vitro, the alphabet has been expanded to include several unnatural base pairs (UBPs)(1-3). We have developed a class of UBPs formed between nucleotides bearing hydrophobic nucleobases, exemplified by the pair formed between d5SICS and dNaM (d5SICS-dNaM), which is efficiently PCR-amplified(1) and transcribed(4,5) in vitro, and whose unique mechanism of replication has been characterized(6,7). However, expansion of an organism's genetic alphabet presents new and unprecedented challenges: the unnatural nucleoside triphosphates must be available inside the cell; endogenous polymerases must be able to use the unnatural triphosphates to faithfully replicate DNA containing the UBP within the complex cellular milieu; and finally, the UBP must be stable in the presence of pathways that maintain the integrity of DNA. Here we show that an exogenously expressed algal nucleotide triphosphate transporter efficiently imports the triphosphates of both d5SICS and dNaM (d5SICSTP and dNaMTP) into Escherichia coli, and that the endogenous replication machinery uses them to accurately replicate a plasmid containing d5SICS-dNaM. Neither the presence of the unnatural triphosphates nor the replication of the UBP introduces a notable growth burden. Lastly, we find that the UBP is not efficiently excised by DNA repair pathways. Thus, the resulting bacterium is the first organism to propagate stably an expanded genetic alphabet.	[Malyshev, Denis A.; Dhami, Kirandeep; Lavergne, Thomas; Chen, Tingjian; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Dai, Nan; Foster, Jeremy M.; Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	Scripps Research Institute; New England Biolabs	Romesberg, FE (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	floyd@scripps.edu	Chen, Tingjian/L-2659-2013; LAVERGNE, Thomas G/N-8896-2013; Romesberg, Floyd/M-2821-2017; Dai, Nan/I-5950-2013	Chen, Tingjian/0000-0002-4458-4269; LAVERGNE, Thomas G/0000-0002-0029-0015; Romesberg, Floyd/0000-0001-6317-1315; Correa, Ivan/0000-0002-3169-6878	US National Institutes of Health (NIH) [GM 060005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060005] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Haferkamp and J. Audia for kindly providing the NTT plasmids and helpful discussions, and P. Ordoukhanian for providing access to the Center for Protein and Nucleic Acid Research at TSRI. This work was supported by the US National Institutes of Health (NIH) (GM 060005).	Allen JM, 2011, NUCLEIC ACIDS RES, V39, P7020, DOI 10.1093/nar/gkr157; Alpert A., 2003, ABRF 2003; Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Ast M, 2009, P NATL ACAD SCI USA, V106, P3621, DOI 10.1073/pnas.0808862106; Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Betz K, 2013, J AM CHEM SOC, V135, P18637, DOI 10.1021/ja409609j; Betz K, 2012, NAT CHEM BIOL, V8, P612, DOI [10.1038/NCHEMBIO.966, 10.1038/nchembio.966]; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Haferkamp I, 2012, PLANT BIOLOGY, V14, P675, DOI 10.1111/j.1438-8677.2012.00591.x; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Knab S, 2011, J BACTERIOL, V193, P225, DOI 10.1128/JB.00919-10; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; Lavergne T, 2012, CHEM-EUR J, V18, P1231, DOI 10.1002/chem.201102066; Li LJ, 2014, J AM CHEM SOC, V136, P826, DOI 10.1021/ja408814g; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Malyshev DA, 2009, J AM CHEM SOC, V131, P14620, DOI 10.1021/ja906186f; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; REIJENGA JC, 1986, J CHROMATOGR, V374, P162, DOI 10.1016/S0378-4347(00)83266-1; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Seo YJ, 2011, J AM CHEM SOC, V133, P19878, DOI 10.1021/ja207907d; Seo YJ, 2009, J AM CHEM SOC, V131, P3246, DOI 10.1021/ja807853m; Seo YJ, 2009, J AM CHEM SOC, V131, P5046, DOI 10.1021/ja9006996; TOMIZAWA J, 1979, ANNU REV BIOCHEM, V48, P999, DOI 10.1146/annurev.bi.48.070179.005031; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; Wu YQ, 2002, J AM CHEM SOC, V124, P14626, DOI 10.1021/ja028050m; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	38	358	382	28	434	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					385	+		10.1038/nature13314	http://dx.doi.org/10.1038/nature13314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24805238	Green Accepted			2022-12-28	WOS:000336121200044
J	Mercado-Marin, EV; Garcia-Reynaga, P; Romminger, S; Pimenta, EF; Romney, DK; Lodewyk, MW; Williams, DE; Andersen, RJ; Miller, SJ; Tantillo, DJ; Berlinck, RGS; Sarpong, R				Mercado-Marin, Eduardo V.; Garcia-Reynaga, Pablo; Romminger, Stelamar; Pimenta, Eli F.; Romney, David K.; Lodewyk, Michael W.; Williams, David E.; Andersen, Raymond J.; Miller, Scott J.; Tantillo, Dean J.; Berlinck, Roberto G. S.; Sarpong, Richmond			Total synthesis and isolation of citrinalin and cyclopiamine congeners	NATURE			English	Article							ENANTIOSELECTIVE TOTAL-SYNTHESIS; MARINE-DERIVED FUNGUS; OXIDATION; STEPHACIDIN; METABOLITES; DERIVATIVES; ALKALOIDS; CHEMISTRY; SECONDARY; REVISION	Many natural products that contain basic nitrogen atoms-for example alkaloids like morphine and quinine-have the potential to treat a broad range of human diseases. However, the presence of a nitrogen atom in a target molecule can complicate its chemical synthesis because of the basicity of nitrogen atoms and their susceptibility to oxidation. Obtaining such compounds by chemical synthesis can be further complicated by the presence of multiple nitrogen atoms, but it can be done by the selective introduction and removal of functional groups that mitigate basicity. Here we use such a strategy to complete the chemical syntheses of citrinalin B and cyclopiamine B. The chemical connections that have been realized as a result of these syntheses, in addition to the isolation of both 17-hydroxycitrinalin B and citrinalin C (which contains a bicyclo[2.2.2]diazaoctane structural unit) through carbon-13 feeding studies, support the existence of a common bicyclo[2.2.2]diazaoctane-containing biogenetic precursor to these compounds, as has been proposed previously.	[Mercado-Marin, Eduardo V.; Garcia-Reynaga, Pablo; Sarpong, Richmond] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Romminger, Stelamar; Pimenta, Eli F.; Berlinck, Roberto G. S.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Romney, David K.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Lodewyk, Michael W.; Tantillo, Dean J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Chem & Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada	University of California System; University of California Berkeley; Universidade de Sao Paulo; Yale University; University of California System; University of California Davis; University of British Columbia	Berlinck, RGS (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, CP 780, BR-13560970 Sao Carlos, SP, Brazil.	rgsberlinck@iqsc.usp.br; rsarpong@berkeley.edu	Miller, Scott/N-7761-2017; Berlinck, Roberto G. S./G-4756-2010	Miller, Scott/0000-0001-7817-1318; Berlinck, Roberto G. S./0000-0003-0118-2523; Romney, David/0000-0003-0498-7597; Sarpong, Richmond/0000-0002-0028-6323	US National Institutes of Health (NIH) [NIGMS RO1 086374]; US National Science Foundation (NSF); Brazilian National Council of Technological and Scientific Development (CNPq) [470643/2010-2]; Sao Paulo Research Foundation (FAPESP) [2012/50026-3]; NSEPC; NSF [CHE-0957416, CHE-030089]; NIH [GM096403, S10-RR027172]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096403] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)(National Science Foundation (NSF)); Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSEPC; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.S. and P.G.-R. thank the US National Institutes of Health (NIH; NIGMS RO1 086374) for financial support. R. S. is a Camille Dreyfus Teacher Scholar. E. V. M.-M. acknowledges the US National Science Foundation (NSF) for a graduate fellowship (GRFP). S. R., E. F. P. and R. G. S. B. are grateful to the Brazilian National Council of Technological and Scientific Development (CNPq; grant 470643/2010-2) and the Sao Paulo Research Foundation (FAPESP; grant 2012/50026-3) for funding. D. E. W. and R.J.A. thank NSEPC for funding. M. W. L. and D.J.T. acknowledge support from the NSF (CHE-0957416 and supercomputing resources through a grant from the XSEDE programme: CHE-030089). S.J.M. is grateful to the NIH for support (GM096403). We thank A. DiPasquale for solving the crystal structures of ent-2 center dot HCl, 6, 27 and 36 (supported by NIH Shared Instrumentation Grant S10-RR027172). We would like to thank T. Lebold, R. M. Williams and D. Sherman for discussions.	Bian ZG, 2013, J AM CHEM SOC, V135, P10886, DOI 10.1021/ja405547f; BOND RF, 1979, J CHEM SOC PERK T 1, P1751, DOI 10.1039/p19790001751; BORCH RF, 1968, TETRAHEDRON LETT, P61; DAVIS FA, 1982, J ORG CHEM, V47, P1774, DOI 10.1021/jo00348a039; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Finefield JM, 2012, J NAT PROD, V75, P812, DOI 10.1021/np200954v; GHAFFAR T, 1995, TETRAHEDRON LETT, V36, P8657, DOI 10.1016/0040-4039(95)01785-G; Grotjahn DB, 2004, J AM CHEM SOC, V126, P12232, DOI 10.1021/ja046360u; Grubbs AW, 2007, ANGEW CHEM INT EDIT, V46, P2257, DOI 10.1002/anie.200604377; Guerrero CA, 2011, ORG LETT, V13, P5164, DOI 10.1021/ol2020362; GULLER R, 1994, TETRAHEDRON LETT, V35, P865, DOI 10.1016/S0040-4039(00)75984-3; Herzon SB, 2005, J AM CHEM SOC, V127, P5342, DOI 10.1021/ja0510616; Jewett JC, 2007, ANGEW CHEM INT EDIT, V46, P6502, DOI 10.1002/anie.200701677; JOHNSON CR, 1992, TETRAHEDRON LETT, V33, P917, DOI 10.1016/S0040-4039(00)91575-2; Kishi Y., 1970, TETRAHEDRON LETT, V11, P5127; Kolundzic F, 2011, J AM CHEM SOC, V133, P9104, DOI 10.1021/ja202706g; Kong K, 2013, J AM CHEM SOC, V135, P10890, DOI 10.1021/ja405548b; Kushida N, 2007, J ANTIBIOT, V60, P667, DOI 10.1038/ja.2007.85; Lodewyk MW, 2012, CHEM REV, V112, P1839, DOI 10.1021/cr200106v; Marti C, 2003, EUR J ORG CHEM, V2003, P2209, DOI 10.1002/ejoc.200300050; MILLER DG, 1990, J ORG CHEM, V55, P2924, DOI 10.1021/jo00296a067; Miller KA, 2009, CHEM SOC REV, V38, P3160, DOI 10.1039/b816705m; MORIARTY RM, 1993, J ORG CHEM, V58, P2478, DOI 10.1021/jo00061a022; Movassaghi M, 2008, ORG LETT, V10, P4009, DOI 10.1021/ol8015176; Mugishima T, 2005, J ORG CHEM, V70, P9430, DOI 10.1021/jo051499o; Myers AG, 2003, J AM CHEM SOC, V125, P12080, DOI 10.1021/ja0372006; OHIRA S, 1989, SYNTHETIC COMMUN, V19, P561, DOI 10.1080/00397918908050700; OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Pimenta EF, 2010, J NAT PROD, V73, P1821, DOI 10.1021/np100470h; Stocking EM, 1999, ANGEW CHEM INT EDIT, V38, P786, DOI 10.1002/(SICI)1521-3773(19990315)38:6<786::AID-ANIE786>3.0.CO;2-7; Tsuda M, 2004, ORG LETT, V6, P3087, DOI 10.1021/ol048900y; ZHANG XJ, 1993, J AM CHEM SOC, V115, P8867, DOI 10.1021/ja00072a061	33	111	111	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					318	324		10.1038/nature13273	http://dx.doi.org/10.1038/nature13273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24828190	Green Accepted, Green Submitted			2022-12-28	WOS:000336121200030
J	Watts, G				Watts, Geoff			William Howard Feindel Obituary	LANCET			English	Biographical-Item																		FEINDEL WH, 2013, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1630	1630		10.1016/S0140-6736(14)60780-7	http://dx.doi.org/10.1016/S0140-6736(14)60780-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24822260				2022-12-28	WOS:000335670800014
J	Voss, FK; Ullrich, F; Munch, J; Lazarow, K; Lutter, D; Mah, N; Andrade-Navarro, MA; von Kries, JP; Stauber, T; Jentsch, TJ				Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lazarow, Katina; Lutter, Darius; Mah, Nancy; Andrade-Navarro, Miguel A.; von Kries, Jens P.; Stauber, Tobias; Jentsch, Thomas J.			Identification of LRRC8 Heteromers as an Essential Component of the Volume-Regulated Anion Channel VRAC	SCIENCE			English	Article							CHLORIDE CHANNELS; SEPARATE TAURINE; ACTIVATION; CURRENTS; EFFLUX; FAMILY	Regulation of cell volume is critical for many cellular and organismal functions, yet the molecular identity of a key player, the volume-regulated anion channel VRAC, has remained unknown. A genome-wide small interfering RNA screen in mammalian cells identified LRRC8A as a VRAC component. LRRC8A formed heteromers with other LRRC8 multispan membrane proteins. Genomic disruption of LRRC8A ablated VRAC currents. Cells with disruption of all five LRRC8 genes required LRRC8A cotransfection with other LRRC8 isoforms to reconstitute VRAC currents. The isoform combination determined VRAC inactivation kinetics. Taurine flux and regulatory volume decrease also depended on LRRC8 proteins. Our work shows that VRAC defines a class of anion channels, suggests that VRAC is identical to the volume-sensitive organic osmolyte/anion channel VSOAC, and explains the heterogeneity of native VRAC currents.	[Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lazarow, Katina; Lutter, Darius; von Kries, Jens P.; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lutter, Darius; Mah, Nancy; Andrade-Navarro, Miguel A.; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Voss, Felizia K.; Ullrich, Florian; Muench, Jonas; Lutter, Darius] Free Univ Berlin, Grad Program, Berlin, Germany; [Jentsch, Thomas J.] Charite, D-13353 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stauber, T (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	tstauber@fmp-berlin.de; jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010; Ullrich, Florian/AAA-6043-2019	Stauber, Tobias/0000-0003-0727-6109; Ullrich, Florian/0000-0002-1153-2040; Mah, Nancy/0000-0002-1240-8076; Jentsch, Thomas/0000-0002-3509-2553	European Research Council Advanced Grant [294435]; Deutsche Forschungsgemeinschaft [Exc 257]	European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Neuenschwander for technical advice concerning the assay; H.-P. Rahn for help with fluorescence-activated cell sorting; A. Brockhoff and W. Meyerhof for use of their Fluorometric Image Plate Reader in a pilot experiment; and J. Liebold, N. Kronke, J. Jedamzick, and S. Kleissle for technical assistance. Supported by the European Research Council Advanced Grant (FP/2007-2013) 294435 "Cytovolion" and the Deutsche Forschungsgemeinschaft (Exc 257 "Neurocure") to T.J.J	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fischmeister R, 2005, J PHYSIOL-LONDON, V562, P477, DOI 10.1113/jphysiol.2004.075622; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Hernandez-Carballo CY, 2010, PFLUG ARCH EUR J PHY, V460, P633, DOI 10.1007/s00424-010-0842-0; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; LAMBERT IH, 1994, J MEMBRANE BIOL, V142, P289; Leaney JL, 1997, J PHYSIOL-LONDON, V501, P555, DOI 10.1111/j.1469-7793.1997.555bm.x; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Moser T, 1995, PFLUG ARCH EUR J PHY, V431, P196, DOI 10.1007/BF00410191; NILIUS B, 1994, PFLUG ARCH EUR J PHY, V428, P364, DOI 10.1007/BF00724520; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; Smits G, 2004, MOL IMMUNOL, V41, P561, DOI 10.1016/j.molimm.2004.04.001; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; STRANGE K, 1995, KIDNEY INT, V48, P994, DOI 10.1038/ki.1995.381; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Wang GX, 2004, AM J PHYSIOL-HEART C, V287, pH533, DOI 10.1152/ajpheart.00228.2003	31	380	394	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					634	638		10.1126/science.1252826	http://dx.doi.org/10.1126/science.1252826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24790029	Green Accepted			2022-12-28	WOS:000335537400044
J	Wals, AEJ; Brody, M; Dillon, J; Stevenson, RB				Wals, Arjen E. J.; Brody, Michael; Dillon, Justin; Stevenson, Robert B.			SCIENCE EDUCATION Convergence Between Science and Environmental Education	SCIENCE			English	Editorial Material									[Wals, Arjen E. J.] Wageningen Univ, NL-6708 PB Wageningen, Netherlands; [Brody, Michael] Montana State Univ, Bozeman, MT 59717 USA; [Dillon, Justin] Kings Coll London, London SE1 9NH, England; [Stevenson, Robert B.] James Cook Univ, Cairns, Qld 4870, Australia	Wageningen University & Research; Montana State University System; Montana State University Bozeman; University of London; King's College London; James Cook University	Wals, AEJ (corresponding author), Wageningen Univ, NL-6708 PB Wageningen, Netherlands.	arjen.wals@wur.nl	Dillon, Justin/AAH-5468-2021; Wals, Arjen/J-6773-2015	Wals, Arjen/0000-0003-4735-1126; Stevenson, Bob/0000-0002-7985-5487				Bell AC, 2008, ENVIRON EDUC RES, V14, P77, DOI 10.1080/13504620701843426; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bybee RW, 2010, SCIENCE, V329, P996, DOI 10.1126/science.1194998; Dickinson JL, 2013, TRENDS ECOL EVOL, V28, P561, DOI 10.1016/j.tree.2013.05.011; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Gough A, 2002, INT J SCI EDUC, V24, P1201, DOI 10.1080/09500690210136611; Hargreaves L. G., 2008, EDUC REV, V6, P69; Justin Dillon., 2010, ENGAGING ENV ED LEAR, P219; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; NAAEE, 2013, E STEM; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Ruiz-Gallardo JR, 2013, J ENVIRON EDUC, V44, P252, DOI 10.1080/00958964.2013.786669; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stevenson RB, 2013, INTERNATIONAL HANDBOOK OF RESEARCH ON ENVIRONMENTAL EDUCATION, P1; Tytler R, 2012, RES SCI EDUC, V42, P155, DOI 10.1007/s11165-011-9262-1; Zaradic P. A., 2008, SCI AM, V18, P24	18	179	183	3	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					583	584		10.1126/science.1250515	http://dx.doi.org/10.1126/science.1250515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6OD	24812386				2022-12-28	WOS:000335537400025
J	Batshaw, ML; Groft, SC; Krischer, JP				Batshaw, Mark L.; Groft, Stephen C.; Krischer, Jeffrey P.			Research Into Rare Diseases of Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN		[Batshaw, Mark L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Groft, Stephen C.] NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Krischer, Jeffrey P.] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); State University System of Florida; University of South Florida	Batshaw, ML (corresponding author), Childrens Natl Med Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	mbatshaw@childrensnational.org			NCRR NIH HHS [U54 RR019453] Funding Source: Medline; NICHD NIH HHS [U54 HD061221] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019453] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], ORPHAN PRODUCT DESIG; [Anonymous], RESEARCH CONDITION A; HANLEY WB, 1971, CAN MED ASSOC J, V104, P1089; LeMons C, DRUGS FOR RARE DISEA; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Sun Angela, 2012, Adv Pediatr, V59, P209, DOI 10.1016/j.yapd.2012.04.013; Thorat C, 2012, PEDIATRICS, V129, P516, DOI 10.1542/peds.2011-1798	7	16	17	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1729	1730		10.1001/jama.2013.285873	http://dx.doi.org/10.1001/jama.2013.285873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794360	Green Accepted			2022-12-28	WOS:000335382300012
J	Gaglani, SM; Haynes, MR				Gaglani, Shiv M.; Haynes, M. Ryan			What Can Medical Education Learn From Facebook and Netflix?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gaglani, Shiv M.; Haynes, M. Ryan] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Gaglani, SM (corresponding author), 733 North Broadway,Suite 137, Baltimore, MD 21205 USA.	sgaglani@jhmi.edu						Barzansky B, 2012, JAMA-J AM MED ASSOC, V308, P2257, DOI 10.1001/jama.2012.13425; Hollinderbaumer A, 2013, GMS Z MED AUSBILD, V30, pDoc14; Johanson P., 2011, L ARMSTRONG BIOGRAPH; Kanter SL, 2012, ACAD MED, V87, P679, DOI 10.1097/ACM.0b013e31825a5a2a; Kirschner PA, 2013, EDUC PSYCHOL-US, V48, P169, DOI 10.1080/00461520.2013.804395; Liasion Committee on Medical Education, 2013, LCME CACMS GUID I SE; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; Raikos A, 2014, ANAT SCI EDUC, V7, P12, DOI 10.1002/ase.1361	8	4	4	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					640	U209		10.7326/M13-2286	http://dx.doi.org/10.7326/M13-2286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI0GO	24798524				2022-12-28	WOS:000336524400006
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Who pays this doctor? It's time patients knew	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				House of Commons Health Committee, 2013 ACC HEAR GEN ME; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2014	348								g3039	10.1136/bmj.g3039	http://dx.doi.org/10.1136/bmj.g3039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OG	24801129				2022-12-28	WOS:000335819000003
J	Hyun, I				Hyun, Insoo			Regulate embryos made for research	NATURE			English	Editorial Material									Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	insoo.hyun@case.edu			NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Chung Y.G., 2014, CELL STEM CELL; Dworkin R., 1993, LIFES DOMINION; National Institute of Health, 1994, REP HUM EMBR RES PAN; Nisbet MC, 2004, PUBLIC OPIN QUART, V68, P131, DOI 10.1093/poq/nfh009; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Vogel G, 2014, SCIENCE, V343, P827, DOI 10.1126/science.343.6173.827; Yamada M., 2014, NATURE	8	11	11	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					27	28		10.1038/509027a	http://dx.doi.org/10.1038/509027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784200	Bronze			2022-12-28	WOS:000335199100022
J	Rangaka, MX; Wilkinson, RJ; Boulle, A; Glynn, JR; Fielding, K; van Cutsem, G; Wilkinson, KA; Goliath, R; Mathee, S; Goemaere, E; Maartens, G				Rangaka, Molebogeng X.; Wilkinson, Robert J.; Boulle, Andrew; Glynn, Judith R.; Fielding, Katherine; van Cutsem, Gilles; Wilkinson, Katalin A.; Goliath, Rene; Mathee, Shaheed; Goemaere, Eric; Maartens, Gary			Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial	LANCET			English	Article							HIV-INFECTED PATIENTS; RIO-DE-JANEIRO; LATENT TUBERCULOSIS; TREATMENT PROGRAM; INCOME COUNTRIES; SOUTH-AFRICA; SAMPLE-SIZE; ADULTS; INITIATION; RELEASE	Background Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid preventive therapy on the risk of tuberculosis in people infected with HIV-1 concurrently receiving antiretroviral therapy. Methods For this pragmatic randomised double-blind, placebo-controlled trial in Khayelitsha, South Africa, we randomly assigned (1:1) patients to receive either isoniazid preventive therapy or a placebo for 12 months (could be completed during 15 months). Randomisation was done with random number generator software. Participants, physicians, and pharmacy staff were masked to group assignment. The primary endpoint was time to development of incident tuberculosis (definite, probable, or possible). We excluded tuberculosis at screening by sputum culture. We did a modified intention-to-treat analysis and excluded all patients randomly assigned to groups who withdrew before receiving study drug or whose baseline sputum culture results suggested prevalent tuberculosis. This study is registered with ClinicalTrials.gov, number NCT00463086. Findings 1329 participants were randomly assigned to receive isoniazid preventive therapy (n=662) or placebo (n=667) between Jan 31, 2008, and Sept 31, 2011, and contributed 3227 person-years of follow-up to the analysis. We recorded 95 incident cases of tuberculosis; 37 were in the isoniazid preventive therapy group (2.3 per 100 person-years, 95% CI 1.6-3.1), and 58 in the placebo group (3 6 per 100 person-years, 2.8-4.7; hazard ratio [HR] 0.63, 95% CI 0.41-0.94). Study drug was discontinued because of grade 3 or 4 raised alanine transaminase concentrations in 19 of 662 individuals in the isoniazid preventive therapy group and ten of the 667 individuals in the placebo group (risk ratio 1.9, 95% CI 0.90-4.09). We noted no evidence that the effect of isoniazid preventive therapy was restricted to patients who were positive on tuberculin skin test or interferon gamma release assay (adjusted HR for patients with negative tests 0.43 [0.21-0.86] and 0.43 [0.20-0.96]; for positive tests 0.86 [0.37-2.00] and 0.55 [0.26-1.24], respectively). Interpretation Without a more predictive test or a multivariate algorithm that predicts benefit, isoniazid preventive therapy should be recommended to all patients receiving antiretroviral therapy in moderate or high incidence areas irrespective of tuberculin skin test or interferon gamma release assay status.	[Rangaka, Molebogeng X.; Boulle, Andrew; van Cutsem, Gilles] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Rangaka, Molebogeng X.; Wilkinson, Robert J.; Wilkinson, Katalin A.; Goliath, Rene] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Rangaka, Molebogeng X.; Glynn, Judith R.] London Sch Hyg & Trop Med, London WC1, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England; [van Cutsem, Gilles; Goemaere, Eric] Medecins Sans Frontieres, Cape Town, South Africa; [Mathee, Shaheed] Prov Govt Western Cape, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; MRC National Institute for Medical Research	Rangaka, MX (corresponding author), Univ Cape Town, Sch Hlth Sci, Ctr Infect Dis Res & Epidemiol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	mxrangaka@yahoo.co.uk	Wilkinson, Katalin/AAQ-7713-2021; Wilkinson, Katalin/AAF-6805-2020; Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019; Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008; Rangaka, Molebogeng/E-4116-2015	Wilkinson, Katalin/0000-0002-9796-2040; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062; Fielding, Katherine/0000-0002-6524-3754; RANGAKA, Molebogeng/0000-0001-9594-188X; Wilkinson, Robert/0000-0002-2753-1800	Department of Health of South Africa; Wellcome Trust; Medecins Sans Frontieres; European and Developing Countries Clinical Trials Partnership; Foundation for Innovation and New Diagnostics; European Union; Hasso Plattner (Institute of Infectious Diseases and Molecular Medicine, University of Cape Town); MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MC_U117588499] Funding Source: researchfish; Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish	Department of Health of South Africa; Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres; European and Developing Countries Clinical Trials Partnership; Foundation for Innovation and New Diagnostics; European Union(European Commission); Hasso Plattner (Institute of Infectious Diseases and Molecular Medicine, University of Cape Town); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding Department of Health of South Africa, the Wellcome Trust, Medecins Sans Frontieres, European and Developing Countries Clinical Trials Partnership, Foundation for Innovation and New Diagnostics, the European Union, and Hasso Plattner (Institute of Infectious Diseases and Molecular Medicine, University of Cape Town).	Akolo C., 2010, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD000171.PUB3); [Anonymous], WHO REP 2011 GLOB TU; Boulle A, 2004, 15 INT AIDS C BANGK, P3239; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fisk TL, 2003, AIDS, V17, P1102, DOI 10.1097/00002030-200305020-00027; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Kirenga BJ, 2013, INT J TUBERC LUNG D, V17, P336, DOI 10.5588/ijtld.12.0298; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; LAKATOS E, 1992, STAT MED, V11, P179, DOI 10.1002/sim.4780110205; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Rangaka MX, 2012, EUR RESPIR J, V39, P163, DOI 10.1183/09031936.00058911; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047400; Wen X, 2002, EUR J CLIN PHARMACOL, V57, P799, DOI 10.1007/s00228-001-0396-3; WHO, 2013, GLOB UPD HIV TREATM; WHO Stop TB Department, GUID INT TUB CAS FIN; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	35	184	189	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					682	690		10.1016/S0140-6736(14)60162-8	http://dx.doi.org/10.1016/S0140-6736(14)60162-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	24835842	Green Accepted			2022-12-28	WOS:000341359100026
J	Feldman, AM; DiSesa, VJ				Feldman, Arthur M.; DiSesa, Verdi J.			Transcatheter Aortic Valve Replacement Flattening the Cost Curve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIGH-RISK PATIENTS; STENOSIS		[Feldman, Arthur M.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; [DiSesa, Verdi J.] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Feldman, AM (corresponding author), Temple Univ, Sch Med, Dept Med, 3500 N Broad St,Ste 1150, Philadelphia, PA 19140 USA.	arthur.feldman@tuhs.temple.edu						Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Doble B, 2013, J THORAC CARDIOVASC, V146, pe3; Doble B, 2013, J THORAC CARDIOV SUR, V146, P52, DOI 10.1016/j.jtcvs.2012.06.018; Gurvitch R, 2011, CATHETER CARDIO INTE, V78, P977, DOI 10.1002/ccd.22961; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Simons CT, 2013, CIRC-CARDIOVASC QUAL, V6, P419, DOI 10.1161/CIRCOUTCOMES.113.000280; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	9	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					25	26		10.1001/jama.2014.4606	http://dx.doi.org/10.1001/jama.2014.4606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24798052				2022-12-28	WOS:000338131100013
J	Madiraju, AK; Erion, DM; Rahimi, Y; Zhang, XM; Braddock, DT; Albright, RA; Prigaro, BJ; Wood, JL; Bhanot, S; MacDonald, MJ; Jurczak, MJ; Camporez, JP; Lee, HY; Cline, GW; Samuel, VT; Kibbey, RG; Shulman, GI				Madiraju, Anila K.; Erion, Derek M.; Rahimi, Yasmeen; Zhang, Xian-Man; Braddock, Demetrios T.; Albright, Ronald A.; Prigaro, Brett J.; Wood, John L.; Bhanot, Sanjay; MacDonald, Michael J.; Jurczak, Michael J.; Camporez, Joao-Paulo; Lee, Hui-Young; Cline, Gary W.; Samuel, Varman T.; Kibbey, Richard G.; Shulman, Gerald I.			Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase	NATURE			English	Article							GLYCEROL 3-PHOSPHATE DEHYDROGENASE; ACTIVATED PROTEIN-KINASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; REDOX STATE; HEPATIC GLUCONEOGENESIS; REDUCING EQUIVALENTS; GLUCOSE-HOMEOSTASIS; LIVER; DIET; PHOSPHORYLATION	Metformin is considered to be one of the most effective therapeutics for treating type 2 diabetes because it specifically reduces hepatic gluconeogenesis without increasing insulin secretion, inducing weight gain or posing a risk of hypoglycaemia(1,2). For over half a century, this agent has been prescribed to patients with type 2 diabetes world wide, yet the underlying mechanism by which metformin inhibits hepatic gluconeogenesis remains unknown. Here we show that metformin non-competitively inhibits the redox shuttle enzyme mitochondrial glycerophosphate dehydrogenase, resulting in an altered hepatocellular redox state, reduced conversion of lactate and glycerol to glucose, and decreased hepatic gluconeogenesis. Acute and chronic low-dose metformin treatment effectively reduced endogenous glucose production, while increasing cytosolic redox and decreasing mitochondrial redox states. Antisense oligonucleotide knockdown of hepatic mitochondrial glycerophosphate dehydrogenase in rats resulted in a phenotype akin to chronic metformin treatment, and abrogated metformin-mediated increases in cytosolic redox state, decreases in plasma glucose concentrations, and inhibition of endogenous glucose production. These findings were replicated in whole-body mitochondrial glycerophosphate dehydrogenase knockout mice. These results have significant implications for understanding the mechanism of metformin's blood glucose lowering effects and provide a new therapeutic target for type 2 diabetes.	[Madiraju, Anila K.; Erion, Derek M.; Rahimi, Yasmeen; Zhang, Xian-Man; Jurczak, Michael J.; Camporez, Joao-Paulo; Lee, Hui-Young; Cline, Gary W.; Samuel, Varman T.; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Madiraju, Anila K.; Erion, Derek M.; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Madiraju, Anila K.; Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Braddock, Demetrios T.; Albright, Ronald A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Prigaro, Brett J.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wood, John L.] Baylor Univ, Dept Chem & Biochem, Canc Prevent Res Inst Texas Scholar, Waco, TX 76798 USA; [Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Colorado State University; Baylor University; Isis Pharmaceuticals Inc; University of Wisconsin System; University of Wisconsin Madison; Novo Nordisk Foundation; University of Copenhagen	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019; Camporez, Joao Paulo G/B-9122-2015	Shulman, Gerald I./0000-0003-1529-5668; Lee, Hui-Young/0000-0002-3464-6382; MacDonald, Michael/0000-0002-0201-9245; Jurczak, Michael/0000-0002-6335-6915; Camporez, Joao Paulo/0000-0003-3486-4301	National Institutes of Health [R24 DK-085638, R01 DK-40936, P30 DK-45735, P30 DK-034989, U24 DK-059635, R01 DK-28348, K01 DK-099402, R01 DK-092606]; American Diabetes Association [7-12-BS-092, 1-14-Merck-10]; VA Merit Award [I01-BX000901]; Novo Nordisk Foundation Center for Basic Metabolic Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092606, K01DK099402, U24DK059635, R01DK040936, P30DK034989, P30DK045735, R24DK085638, R01DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); VA Merit Award(US Department of Veterans Affairs); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Dong, M. Kahn, Y. Kosover and J. J. Hsiao for their technical support, and S. Singh and D. Gregg for discussions. This publication was supported by grants from the National Institutes of Health: R24 DK-085638, R01 DK-40936, P30 DK-45735, P30 DK-034989, U24 DK-059635, R01 DK-28348, K01 DK-099402, R01 DK-092606; grants from the American Diabetes Association: 7-12-BS-092, 1-14-Merck-10; a VA Merit Award (I01-BX000901); and by the Novo Nordisk Foundation Center for Basic Metabolic Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or National Institutes of Health.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barbera A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5; BREMER J, 1975, BIOCHIM BIOPHYS ACTA, V376, P387, DOI 10.1016/0005-2728(75)90161-9; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Carmignani M, 2001, J MED CHEM, V44, P2950, DOI 10.1021/jm001017v; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; COLE ES, 1978, J BIOL CHEM, V253, P7952; Colussi T, 2008, BIOCHEMISTRY-US, V47, P965, DOI 10.1021/bi701685u; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; GARRIB A, 1986, J BIOL CHEM, V261, P8042; HARDING JW, 1975, BIOCHEM J, V146, P223, DOI 10.1042/bj1460223; HARDING JW, 1975, BIOCHEM J, V148, P545, DOI 10.1042/bj1480545; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; KREBS HA, 1968, BIOCHEM J, V108, P513, DOI 10.1042/bj1080513; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PROCHAZKA M, 1989, J BIOL CHEM, V264, P4679; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; SUGANO T, 1980, J BIOCHEM-TOKYO, V87, P153, DOI 10.1093/oxfordjournals.jbchem.a132721; WHITE HB, 1969, J BIOL CHEM, V244, P6031; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	33	769	797	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					542	+		10.1038/nature13270	http://dx.doi.org/10.1038/nature13270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24847880	Green Accepted			2022-12-28	WOS:000337806300048
J	Grover, A; Slavin, PL; Willson, P				Grover, Atul; Slavin, Peter L.; Willson, Peters			The Economics of Academic Medical Centers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grover, Atul; Willson, Peters] Assoc Amer Med Coll, Washington, DC 20001 USA; [Slavin, Peter L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Slavin, Peter L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Association of American Medical Colleges; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Grover, A (corresponding author), Assoc Amer Med Coll, Washington, DC 20001 USA.							Anderson GF, 1989, PROVIDING HOSP SERVI, P107; Conroy J, 2013, MEDICARE PATIENT HOS; Dzau VJ, 2013, NEW ENGL J MED, V369, P991, DOI 10.1056/NEJMp1302374; NEWHOUSE JP, 1970, AM ECON REV, V60, P64	4	41	41	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2360	2362		10.1056/NEJMp1403609	http://dx.doi.org/10.1056/NEJMp1403609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0OA	24826948	Bronze			2022-12-28	WOS:000337353000003
J	Detsky, AS; Krumholz, HM				Detsky, Allan S.; Krumholz, Harlan M.			Reducing the Trauma of Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Univ Toronto, Mt Sinai Hosp, Inst Hlth Policy Management & Evaluat, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Krumholz, Harlan M.] Yale Univ, Yale New Haven Hosp, Sect Cardiovasc Med, Sch Med,Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5N 2N8, Canada.	adetsky@mtsinai.on.ca	, Harlan/AAI-2875-2020					Chen C, 2014, JAMA-J AM MED ASSOC, V311, P673, DOI 10.1001/jama.2014.11; Detsky ME, 2008, JAMA-J AM MED ASSOC, V300, P954, DOI 10.1001/jama.300.8.954; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Sinha SK, 2012, JAMA-J AM MED ASSOC, V308, P2573, DOI 10.1001/jama.2012.68313	5	65	65	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2169	2170		10.1001/jama.2014.3695	http://dx.doi.org/10.1001/jama.2014.3695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24788549				2022-12-28	WOS:000336668400013
J	Uesaka, N; Uchigashima, M; Mikuni, T; Nakazawa, T; Nakao, H; Hirai, H; Aiba, A; Watanabe, M; Kano, M				Uesaka, Naofumi; Uchigashima, Motokazu; Mikuni, Takayasu; Nakazawa, Takanobu; Nakao, Harumi; Hirai, Hirokazu; Aiba, Atsu; Watanabe, Masahiko; Kano, Masanobu			Retrograde semaphorin signaling regulates synapse elimination in the developing mouse brain	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; CLIMBING FIBER; CA2+ CHANNEL; INNERVATION; COMPETITION; RECEPTOR; 7A	Neural circuits are shaped by elimination of early-formed redundant synapses during postnatal development. Retrograde signaling from postsynaptic cells regulates synapse elimination. In this work, we identified semaphorins, a family of versatile cell recognition molecules, as retrograde signals for elimination of redundant climbing fiber to Purkinje cell synapses in developing mouse cerebellum. Knockdown of Sema3A, a secreted semaphorin, in Purkinje cells or its receptor in climbing fibers accelerated synapse elimination during postnatal day 8 (P8) to P18. Conversely, knockdown of Sema7A, a membrane-anchored semaphorin, in Purkinje cells or either of its two receptors in climbing fibers impaired synapse elimination after P15. The effect of Sema7A involves signaling by metabotropic glutamate receptor 1, a canonical pathway for climbing fiber synapse elimination. These findings define how semaphorins retrogradely regulate multiple processes of synapse elimination.	[Uesaka, Naofumi; Mikuni, Takayasu; Nakazawa, Takanobu; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Nakao, Harumi; Aiba, Atsu] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrated Med, Lab Anim Resources, Tokyo 1130033, Japan; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 3718511, Japan	University of Tokyo; Hokkaido University; University of Tokyo; Gunma University	Kano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	WATANABE, Masahiko/A-4055-2012; Hirai, Hirokazu/ABP-1143-2022; Uesaka, Naofumi/S-6072-2018; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Uesaka, Naofumi/0000-0002-9744-944X; Watanabe, Masahiko/0000-0001-5037-7138; Mikuni, Takayasu/0000-0002-9769-9369; Aiba, Atsu/0000-0002-8192-0778; Hirai, Hirokazu/0000-0002-0721-4293; NAKAZAWA, Takanobu/0000-0003-4863-1277; Nakao, Harumi/0000-0003-1729-7405; Kano, Masanobu/0000-0002-0725-3292	Funding Program for Next Generation World-Leading Researchers [LS021]; Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Comprehensive Brain Science Network; Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [21220006];  [25000015];  [19100005];  [24220007];  [23650160]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); Comprehensive Brain Science Network; Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Nienhuis for the gifts of the lentiviral backbone vector and the packaging plasmid. A Purkinje cell-tropic viral vector has been patented (19). We also thank K. Kitamura, K. Hashimoto, Y. Sugaya, and M. Mahoney for helpful discussions and K. Matsuyama, M. Sekiguchi, M. Watanabe, S. Tanaka, and A. Koseki for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (21220006 and 25000015 to M. K., 19100005 and 24220007 to M. W., and 23650160 to N.U.), the Funding Program for Next Generation World-Leading Researchers (LS021) to H. H., the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior), Comprehensive Brain Science Network, and the Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H. H. and T. Torashima are inventors on a Japanese and a U.S. patent application for a Purkinje cell-tropic viral vector (the modified L7 promoter sequences that enable robust transgene expression specifically in cerebellar Purkinje cells, PCT/JP2007/055017 filed on 7 March 2007 and US20100146649), which is owned by Japan Science and Technology Agency (19). Materials described here are available from H. H. and A. Nienhuis, subject to a material transfer agreement (MTA) with Gunma University for the modified L7 promoter and an MTA with St. Jude Children's Research Hospital and the George Washington University for the pCL20c MSCV-GFP. Additional data can be found in the supplementary materials.	CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CREPEL F, 1981, DEV BRAIN RES, V1, P59, DOI 10.1016/0165-3806(81)90094-8; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hirai H., 2012, Japanese Patent, Patent No. 4975733; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Uesaka N, 2012, J NEUROSCI, V32, P11657, DOI 10.1523/JNEUROSCI.1097-12.2012; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x	19	77	78	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1020	1023		10.1126/science.1252514	http://dx.doi.org/10.1126/science.1252514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24831527				2022-12-28	WOS:000336495800043
J	van Deursen, JM				van Deursen, Jan M.			The role of senescent cells in ageing	NATURE			English	Review							DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; GENE-EXPRESSION; LIFE-SPAN; CANCER; P53; RAS; HETEROCHROMATIN	Cellular senescence has historically been viewed as an irreversible cell-cycle arrest mechanism that acts to protect against cancer, but recent discoveries have extended its known role to complex biological processes such as development, tissue repair, ageing and age-related disorders. New insights indicate that, unlike a static endpoint, senescence represents a series of progressive and phenotypically diverse cellular states acquired after the initial growth arrest. A deeper understanding of the molecular mechanisms underlying the multi-step progression of senescence and the development and function of acute versus chronic senescent cells may lead to new therapeutic strategies for age-related pathologies and extend healthy lifespan.	[van Deursen, Jan M.] Mayo Clin, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA; [van Deursen, Jan M.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu			Paul Glenn Foundation; National Institutes of Health [R01CA96985, R01CA166347, AG41122-01P2]; NATIONAL CANCER INSTITUTE [R01CA096985, R01CA166347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041122] Funding Source: NIH RePORTER	Paul Glenn Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I thank J. Campisi, J. Kirkland, R. Naylor, B. Childs, D. Baker, R. Urrutia, M. McNiven and R. Bram for helpful discussions and comments on the manuscript. I apologize to those whom I was unable to reference owing to space limitations. This work was supported by grants from the Paul Glenn Foundation and the National Institutes of Health (R01CA96985, R01CA166347 and AG41122-01P2).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2012, NAT CELL BIOL, V14, P649, DOI 10.1038/ncb2519; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; BENZ G, 1991, AM J DERMATOPATH, V13, P538, DOI 10.1097/00000372-199113060-00003; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Faggioli F, 2012, HUM MOL GENET, V21, P5246, DOI 10.1093/hmg/dds375; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; GROVE GL, 1977, J CELL PHYSIOL, V90, P415, DOI 10.1002/jcp.1040900305; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hein N, 2012, SENESCENCE, P171; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kondoh H, 2005, CANCER RES, V65, P177; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2011, DIFFERENTIATION, V81, P222, DOI 10.1016/j.diff.2011.01.001; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Newgard CB, 2013, J CLIN INVEST, V123, P946, DOI 10.1172/JCI68833; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rajagopalan S, 2012, P NATL ACAD SCI USA, V109, P20596, DOI 10.1073/pnas.1208248109; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P1272, DOI 10.1038/ncb1009-1272a; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Romanov VS, 2010, CELL CYCLE, V9, P3945, DOI 10.4161/cc.9.19.13160; Roninson IB, 2003, CANCER RES, V63, P2705; Schmidt S, 2010, CELL CYCLE, V9, P4469, DOI 10.4161/cc.9.22.13684; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2000, CANCER RES, V60, P3689; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wang JR, 2011, CELL CYCLE, V10, P3016, DOI 10.4161/cc.10.17.17543; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	101	1345	1376	38	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					439	446		10.1038/nature13193	http://dx.doi.org/10.1038/nature13193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848057	Green Accepted			2022-12-28	WOS:000336126000029
J	Saio, T; Guan, X; Rossi, P; Economou, A; Kalodimos, CG				Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Economou, Anastassios; Kalodimos, Charalampos G.			Structural Basis for Protein Antiaggregation Activity of the Trigger Factor Chaperone	SCIENCE			English	Article							MALTOSE-BINDING PROTEIN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; NASCENT CHAIN; ALKALINE-PHOSPHATASE; CHEMICAL-EXCHANGE; MEMBRANE-PROTEIN; EXCITED-STATES; NMR	Molecular chaperones prevent aggregation and misfolding of proteins, but scarcity of structural data has impeded an understanding of the recognition and antiaggregation mechanisms. We report the solution structure, dynamics, and energetics of three trigger factor (TF) chaperone molecules in complex with alkaline phosphatase (PhoA) captured in the unfolded state. Our data show that TF uses multiple sites to bind to several regions of the PhoA substrate protein primarily through hydrophobic contacts. Nuclear magnetic resonance (NMR) relaxation experiments show that TF interacts with PhoA in a highly dynamic fashion, but as the number and length of the PhoA regions engaged by TF increase, a more stable complex gradually emerges. Multivalent binding keeps the substrate protein in an extended, unfolded conformation. The results show how molecular chaperones recognize unfolded polypeptides and, by acting as unfoldases and holdases, prevent the aggregation and premature (mis)folding of unfolded proteins.	[Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA; [Saio, Tomohide; Guan, Xiao; Rossi, Paolo; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & chem Biol, Piscataway, NJ 08854 USA; [Economou, Anastassios] Katholieke Univ Leuven, Rega Inst, Lab Mol Bacteriol, Dept Microbiol & Immunol, Minderbroedersstraat 10, B-3000 Leuven, Belgium; [Economou, Anastassios] Univ Crete, Inst Mol Biol & Biotechnol FORTH, POB 1385, GR-71110 Iraklion, NE, Greece; [Economou, Anastassios] Univ Crete, Dept Biol, POB 1385, GR-71110 Iraklion, NE, Greece	Rutgers State University New Brunswick; Rutgers State University New Brunswick; KU Leuven; University of Crete; University of Crete	Kalodimos, CG (corresponding author), Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/Q-9846-2018	Economou, Anastassios/0000-0002-1770-507X; Kalodimos, Charalampos/0000-0001-6354-2796; Guan, Xiao/0000-0001-7180-6536; Saio, Tomohide/0000-0003-3639-7399	NIH [GM073854]; Nonaco (Aristeia-Excellence) [1473]; KUL-Spa; RiMembR; StrepSynth; Japanese Society for the Promotion of Science; American Heart Association [14POST18600039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nonaco (Aristeia-Excellence); KUL-Spa; RiMembR; StrepSynth; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C. G. K. thanks L. E. Kay and B. Bukau for fruitful discussions and comments. We thank M. T. Pai and A. Bhattacharya for contributions during the early phase of the project, S. Patel for the use of a spectrofluorometer, and S. Kim and Y. Xia (University of Minnesota) for their help with setting up NMR experiments. This work is supported by NIH grant GM073854 (C. G. K.), Nonaco (Aristeia-Excellence, #1473), KUL-Spa, RiMembR, and StrepSynth (A. E.). T. S. is the recipient of postdoctoral fellowships from the Japanese Society for the Promotion of Science and the American Heart Association (14POST18600039). We thank Bruker Biospin for the use of the 700-MHz instrument. Coordinates and structural restraints have been deposited with the Protein Data Bank under accession codes 2MLY, 2MLX, and 2MLZ, for TF-PhoA<SUP>a-c</SUP>, TF-PhoA<SUP>d-e</SUP>, and TF-PhoA<SUP>f-g</SUP>, respectively.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dyson HJ, 2005, METHOD ENZYMOL, V394, P299, DOI 10.1016/S0076-6879(05)94011-1; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Hoffmann A, 2009, NAT STRUCT MOL BIOL, V16, P1006, DOI 10.1038/nsmb1009-1006; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horwich AL, 2011, NAT MED, V17, P1211, DOI 10.1038/nm.2468; Hsu STD, 2009, BIOMOL NMR ASSIGN, V3, P17, DOI 10.1007/s12104-008-9130-8; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Novokhatny V, 1997, PROTEIN SCI, V6, P141; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Raffy S, 1998, PROTEIN SCI, V7, P2136, DOI 10.1002/pro.5560071010; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Saul FA, 2003, PROTEIN SCI, V12, P577, DOI 10.1110/ps.0235103; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; Sugase K, 2007, J AM CHEM SOC, V129, P13406, DOI 10.1021/ja0762238; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Tomikiewicz D, 2008, J MOL BIOL, V377, P83, DOI 10.1016/j.jmb.2008.01.014; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Velyvis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043725; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Yao Y, 2008, J BIOMOL NMR, V40, P23, DOI 10.1007/s10858-007-9207-1; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	93	182	186	4	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					597	+	1250494	10.1126/science.1250494	http://dx.doi.org/10.1126/science.1250494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812405	Green Accepted			2022-12-28	WOS:000335537400034
J	Okabe, Y; Medzhitov, R				Okabe, Yasutaka; Medzhitov, Ruslan			Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages	CELL			English	Article							RETINOIC-ACID; VITAMIN-A; DENDRITIC CELLS; MILKY SPOTS; T-CELLS; DIFFERENTIATION; BETA; ACTIVATION; GENERATION; EXPRESSION	Tissue-resident macrophages are highly heterogeneous in terms of their functions and phenotypes as a consequence of adaptation to different tissue environments. Local tissue-derived signals are thought to control functional polarization of resident macrophages; however, the identity of these signals remains largely unknown. It is also unknown whether functional heterogeneity is a result of irreversible lineage-specific differentiation or a consequence of continuous but reversible induction of diverse functional programs. Here, we identified retinoic acid as a signal that induces tissue-specific localization and functional polarization of peritoneal macrophages through the reversible induction of transcription factor GATA6. We further found that GATA6 in macrophages regulates gut IgA production through peritoneal B-1 cells. These results provide insight into the regulation of tissue-resident macrophage functional specialization by tissue-derived signals.	[Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Okabe, Yasutaka/0000-0002-1913-7280	Japan Society for the Promotion of Science (JSPS); Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Blavatnik Family Foundation; NIH [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Blavatnik Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Medzhitov laboratory and the W. M. Keck facility for microarray analysis. Y.O. was supported by the Japan Society for the Promotion of Science (JSPS), Uehara Memorial Foundation, and Kanae Foundation for the Promotion of Medical Science. R. M. lab is supported by The Blavatnik Family Foundation, grants from NIH (AI046688, AI089771, CA157461) and the Howard Hughes Medical Institute.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chang J, 2013, EUR J IMMUNOL, V43, P967, DOI 10.1002/eji.201242772; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fortunel NO, 2000, BLOOD, V96, P2022; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraushaar DC, 2013, INT J BIOL SCI, V9, P1134, DOI 10.7150/ijbs.7998; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Maruya M, 2011, P NATL ACAD SCI USA, V108, P722, DOI 10.1073/pnas.1014697108; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; RATAJCZAK MZ, 1987, CLIN EXP IMMUNOL, V69, P198; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SMITH SM, 1987, J NUTR, V117, P857, DOI 10.1093/jn/117.5.857; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; WIJFFELS JFAM, 1992, RES IMMUNOL, V143, P401, DOI 10.1016/S0923-2494(05)80072-0; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	53	564	581	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					832	844		10.1016/j.cell.2014.04.016	http://dx.doi.org/10.1016/j.cell.2014.04.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24792964	Green Accepted, Bronze			2022-12-28	WOS:000335765500012
J	Palpant, NJ; Murry, CE				Palpant, Nathan J.; Murry, Charles E.			Proliferation at the Heart of Preadolescence	CELL			English	Editorial Material							REGENERATION	Cardiomyocytes, the cells of the heart muscle, lose nearly all of their proliferative capacity after birth, limiting the heart's ability to regenerate. Naqvi et al. now identify a transient burst of cardiomyocyte proliferation during preadolescence, driven by a thyroid hormone surge, with therapeutic implications for congenital and acquired heart diseases.	[Palpant, Nathan J.; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Dept Pathol, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Dept Bioengn, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Dept Med Cardiol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Dept Pathol, Seattle, WA 98109 USA.	murry@uw.edu	Palpant, Nathan/B-1641-2017	Palpant, Nathan/0000-0002-9334-8107				Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chattergoon NN, 2012, FASEB J, V26, P397, DOI 10.1096/fj.10-179895; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Yang X., 2014, J MOL CELL CARDIOL; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322	9	4	4	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					765	767		10.1016/j.cell.2014.04.025	http://dx.doi.org/10.1016/j.cell.2014.04.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813600	Bronze			2022-12-28	WOS:000335765500002
J	Appleby, J				Appleby, John			Health related lifestyles of children: getting better?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						[Anonymous], 2013, BBC NEWS; Buck D., 2012, IMPLICATIONS POLICY; Chief Medical Officer, 2014, ANN REP CHIEF MED OF; Chief Medical Officer, 2013, ANN REP CHIEF MED OF; Hale DR, 2012, J PUBLIC HEALTH-UK, V34, pI11, DOI 10.1093/pubmed/fdr112; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Mcdermott N, 2013, DAILY MAIL      1013; The Health and Social Care Information Centre, 2013, SMOK DRINK DRUG US Y; The Health and Social Care Information Centre LS, NAT CHILD MEAS PROGR	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2014	348								g3025	10.1136/bmj.g3025	http://dx.doi.org/10.1136/bmj.g3025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SN	24792237				2022-12-28	WOS:000335478900002
J	Neshev, D; Kivshar, Y				Neshev, Dragomir; Kivshar, Yuri			Nonlinear Optics Pushed to the Edge	SCIENCE			English	Editorial Material							GENERATION		[Neshev, Dragomir; Kivshar, Yuri] Australian Natl Univ, Nonlinear Phys Ctr, Canberra, ACT 0200, Australia	Australian National University	Neshev, D (corresponding author), Australian Natl Univ, Nonlinear Phys Ctr, GPO Box 4, Canberra, ACT 0200, Australia.	dnn124@physics.anu.edu.au; ysk@internode.on.net	Kivshar, Yuri/ABA-7970-2020; Kivshar, Yuri/AAJ-1901-2020; Neshev, Dragomir N/A-3759-2008	Kivshar, Yuri/0000-0002-3410-812X; Neshev, Dragomir N/0000-0002-4508-8646				Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161403; Li YL, 2013, NANO LETT, V13, P3329, DOI 10.1021/nl401561r; Malard LM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201401; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Saltiel SM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103902; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Yin XB, 2014, SCIENCE, V344, P488, DOI 10.1126/science.1250564; Zeng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01608	11	11	11	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					482	483		10.1126/science.1253531	http://dx.doi.org/10.1126/science.1253531			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786070				2022-12-28	WOS:000335157700031
J	May, M				May, Mike			DRUG DEVELOPMENT Time for teamwork	NATURE			English	Editorial Material																		Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Spellberg B, 2012, APUA CLIN NEWSL, V30, P8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	3	31	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S4	S5		10.1038/509S4a	http://dx.doi.org/10.1038/509S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784427				2022-12-28	WOS:000335199100003
J	Zhang, J; Zhang, KH; Gao, ZG; Paoletta, S; Zhang, DD; Han, GW; Li, TT; Ma, LM; Zhang, WR; Muller, CE; Yang, HY; Jiang, HL; Cherezov, V; Katritch, V; Jacobson, KA; Stevens, RC; Wu, BL; Zhao, Q				Zhang, Jin; Zhang, Kaihua; Gao, Zhan-Guo; Paoletta, Silvia; Zhang, Dandan; Han, Gye Won; Li, Tingting; Ma, Limin; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang			Agonist-bound structure of the human P2Y(12) receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; RESOLUTION CRYSTAL-STRUCTURE; A(2A) ADENOSINE RECEPTOR; MEMBRANE-PROTEINS; IDENTIFICATION; ANTAGONISTS; ACTIVATION; RHODOPSIN; COMPLEX	The P2Y(12) receptor (P2Y(12)R), one of eight members of the P2YR family expressed in humans, is one of the most prominent clinical drug targets for inhibition of platelet aggregation. Although mutagenesis and modelling studies of the P2Y(12)R provided useful insights into ligand binding(1-4), the agonist and antagonist recognition and function at the P2Y(12)R remain poorly understood at the molecular level. Here we report the structures of the human P2Y(12)R in complex with the full agonist 2-methylthio-adenosine-5'-diphosphate (2MeSADP, a close analogue of endogenous agonist ADP) at 2.5 angstrom resolution, and the corresponding ATP derivative 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 angstrom resolution. These structures, together with the structure of the P2Y(12)R with antagonist ethyl 6-(4-((benzylsulfonyl) carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283)(5), reveal striking conformational changes between nucleotide and non-nucleotide ligand complexes in the extracellular regions. Further analysis of these changes provides insight into a distinct ligand binding landscape inthed-group of class AG-protein-coupled receptors (GPCRs). Agonist and non-nucleotide antagonist adopt different orientations in the P2Y(12)R, with only partially overlapped binding pockets. The agonist-bound P2Y(12)R structure answers long-standing questions surrounding P2Y(12)R-agonist recognition, and reveals interactions with several residues that had not been reported to be involved in agonist binding. As a first example, to our knowledge, of a GPCR in which agonist access to the binding pocket requires large-scale rearrangements in the highly malleable extracellular region, the structural and docking studies will therefore provide invaluable insight into the pharmacology and mechanisms of action of agonists and different classes of antagonists for the P2Y(12)R and potentially for other closely related P2YRs.	[Zhang, Jin; Zhang, Kaihua; Zhang, Dandan; Li, Tingting; Ma, Limin; Zhang, Wenru; Wu, Beili; Zhao, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Paoletta, Silvia; Jacobson, Kenneth A.] Natl Inst Diabet & Digest & Kidney Dis, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mueller, Christa E.] Univ Bonn, PharmaCtr Bonn, D-53121 Bonn, Germany; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, IHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute; University of Bonn; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	beiliwu@simm.ac.cn; zhaoq@simm.ac.cn	Müller, Christa Elisabeth/C-7748-2014; Jacobson, Kenneth Alan/A-1530-2009; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Zhang, Kaihua/AAD-7882-2022; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022	Müller, Christa Elisabeth/0000-0002-0013-6624; Jacobson, Kenneth Alan/0000-0001-8104-1493; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Zhang, Kaihua/0000-0003-3734-3624; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB910400, 2012CB518000, 2014CB910400]; National Institutes of Health [R01AI100604, U54 GM094618]; National Science Foundation of China [31370729]; National Science and Technology Major Project [2013ZX09507001, 2012ZX09301001]; National Institutes of Health NIDDK Intramural Research Program; National Natural Science Foundation of China [91313000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031116, ZIADK031126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; National Institutes of Health NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Basic Research Program of China grants 2012CB910400, 2012CB518000 and 2014CB910400 (B. W., Q.Z.), the National Institutes of Health grants R01AI100604 (B. W., Q.Z.) and U54 GM094618 (V. C., V. K., R. C. S.; Target GPCR-87), the National Science Foundation of China grants 31370729 and National Science and Technology Major Project 2013ZX09507001 and 2012ZX09301001 (B. W., Q.Z.), National Institutes of Health NIDDK Intramural Research Program (K.A.J.) and the National Natural Science Foundation of China 91313000 (H.J.). The authors thank S. Nylander, E. Kiselev and S. Moss for scientific feedback on the manuscript, A. Walker for assistance with manuscript preparation and K. Kadyshevskaya for help with figure preparation. The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2013B1049). We thank the beamline staff members of the BL41XU for help with X-ray data collection.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cattaneo M, 2011, BLOOD, V117, P2102, DOI 10.1182/blood-2010-08-263111; Chang H, 2012, J THROMB HAEMOST, V10, P2573, DOI 10.1111/jth.12035; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Daly ME, 2009, BLOOD, V113, P4110, DOI 10.1182/blood-2008-11-190850; Ding ZG, 2006, MOL PHARMACOL, V69, P338, DOI 10.1124/mol.105.014654; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fujioka M, 2012, DRUG DISCOV TODAY, V17, P1133, DOI 10.1016/j.drudis.2012.06.010; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hoffmann K, 2008, BIOCHEM PHARMACOL, V76, P1201, DOI 10.1016/j.bcp.2008.08.029; Ignatovica V, 2012, FEBS J, V279, P180, DOI 10.1111/j.1742-4658.2011.08410.x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kauffenstein G, 2004, J THROMB HAEMOST, V2, P1980, DOI 10.1111/j.1538-7836.2004.00926.x; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schmidt P, 2013, MOL PHARMACOL, V83, P256, DOI 10.1124/mol.112.082198; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Srinivasan S, 2009, J BIOL CHEM, V284, P16108, DOI 10.1074/jbc.M809780200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhao Q, 2012, ACTA PHARMACOL SIN, V33, P324, DOI 10.1038/aps.2011.187; Zhou XE, 2012, ACTA PHARMACOL SIN, V33, P291, DOI 10.1038/aps.2011.171	34	226	240	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					119	122		10.1038/nature13288	http://dx.doi.org/10.1038/nature13288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784220	Green Accepted			2022-12-28	WOS:000335199100051
J	Jefferson, T; Jones, M; Doshi, P; Spencer, EA; Onakpoya, I; Heneghan, CJ				Jefferson, Tom; Jones, Mark; Doshi, Peter; Spencer, Elizabeth A.; Onakpoya, Igho; Heneghan, Carl J.			Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEUROPSYCHIATRIC ADVERSE EVENTS	Objective To describe the potential benefits and harms of oseltamivir by reviewing all clinical study reports (or similar document when no clinical study report exists) of randomised placebo controlled trials and regulatory comments ("regulatory information"). Design Systematic review of regulatory information. Data sources Clinical study reports, trial registries, electronic databases, regulatory archives, and correspondence with manufacturers. Eligibility criteria for selecting studies Randomised placebo controlled trials on adults and children who had confirmed or suspected exposure to natural influenza. Main outcome measures Time to first alleviation of symptoms, influenza outcomes, complications, admissions to hospital, and adverse events in the intention to treat population. Results From the European Medicines Agency and Roche, we obtained clinical study reports for 83 trials. We included 23 trials in stage 1 (reliability and completeness screen) and 20 in stage 2 (formal analysis). In treatment trials on adults, oseltamivir reduced the time to first alleviation of symptoms by 16.8 hours (95% confidence interval 8.4 to 25.1 hours, P<0.001). There was no effect in children with asthma, but there was an effect in otherwise healthy children (mean difference 29 hours, 95% confidence interval 12 to 47 hours, P=0.001). In treatment trials there was no difference in admissions to hospital in adults (risk difference 0.15%, 95% confidence interval -0.91% to 0.78%, P=0.84) and sparse data in children and for prophylaxis. In adult treatment trials, oseltamivir reduced investigator mediated unverified pneumonia (risk difference 1.00%, 0.22% to 1.49%; number needed to treat to benefit (NNTB) 100, 95% confidence interval 67 to 451). The effect was not statistically significant in the five trials that used a more detailed diagnostic form for "pneumonia," and no clinical study reports reported laboratory or diagnostic confirmation of "pneumonia." The effect on unverified pneumonia in children and for prophylaxis was not significant. There was no significant reduction in risk of unverified bronchitis, otitis media, sinusitis, or any complication classified as serious or that led to study withdrawal. 14 of 20 trials prompted participants to self report all secondary illnesses to an investigator. Oseltamivir in the treatment of adults increased the risk of nausea (risk difference 3.66%, 0.90% to 7.39%; number needed to treat to harm (NNTH) 28, 95% confidence interval 14 to 112) and vomiting (4.56%, 2.39% to 7.58%; 22, 14 to 42). In treatment of children, oseltamivir induced vomiting (5.34%, 1.75% to 10.29%; 19, 10 to 57). In prophylaxis trials, oseltamivir reduced symptomatic influenza in participants by 55% (3.05%, 1.83% to 3.88%; NNTB 33, 26 to 55) and households (13.6%, 9.52% to 15.47%; NNTB 7, 6 to 11) based on one study, but there was no significant effect on asymptomatic influenza and no evidence of a reduction in transmission. In prophylaxis studies, oseltamivir increased the risk of psychiatric adverse events during the combined "on-treatment" and "off-treatment" periods (risk difference 1.06%, 0.07% to 2.76%; NNTH 94, 36 to 1538) and there was a dose-response effect on psychiatric events in two "pivotal" treatment trials of oseltamivir, at 75 mg (standard dose) and 150 mg (high dose) twice daily (P=0.038). In prophylaxis studies, oseltamivir increased the risk of headaches on-treatment (risk difference 3.15%, 0.88% to 5.78%; NNTH 32, 18 to 115), renal events with treatment (0.67%, -0.01% to 2.93%), and nausea while receiving treatment (4.15%, 0.86% to 9.51%; NNTH 25, 11 to 116). Conclusions In prophylactic studies oseltamivir reduces the proportion of symptomatic influenza. In treatment studies it also modestly reduces the time to first alleviation of symptoms, but it causes nausea and vomiting and increases the risk of headaches and renal and psychiatric syndromes. The evidence of clinically significant effects on complications and viral transmission is limited because of rarity of such events and problems with study design. The trade-off between benefits and harms should be borne in mind when making decisions to use oseltamivir for treatment, prophylaxis, or stockpiling.	[Jefferson, Tom] Cochrane Acute Resp Infect Grp, I-00187 Rome, Italy; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Doshi, Peter] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Spencer, Elizabeth A.; Onakpoya, Igho; Heneghan, Carl J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Queensland; University System of Maryland; University of Maryland Baltimore; University of Oxford	Jefferson, T (corresponding author), Cochrane Acute Resp Infect Grp, Via Puglie 23, I-00187 Rome, Italy.	jefferson.tom@gmail.com	; Jones, Mark/I-2720-2016	Spencer, Elizabeth/0000-0002-9079-8006; Jones, Mark/0000-0001-6858-9710	NIHR Health Technology Assessment programme; National Institute for Health Research [10/80/01] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment programme and will be published in full in the Health Technology Assessment journal series (more details are available at www.nets.nihr.ac.uk/projects/hta/108001). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The study sponsor had no role in study design; the collection, analysis, and interpretation of data; the writing of the article; and the decision to submit the article for publication. All the authors have no ties to the manufacturer or the sponsor (apart from those disclosed) and had access to all parts of the deidentified clinical study reports from the oseltamivir trial programme.	[Anonymous], 2009, INVESTIGATORS GUIDE; Donaldson L, 2006, J ROY SOC MED, V99, P222, DOI 10.1258/jrsm.99.5.222; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; European Medicines Agency, 2010, EUROPEAN MEDICINES A; F Hoffmann-La Roche, 2013, ROCHE GLOBAL POLICY; Food and Drug Administration, 2000, MEDICAL REVIEW PART; Food and Drug Administration, 2000, DRUG APPROVAL PACKAG; Godlee F, 2012, BMJ-BRIT MED J, V345, pe7304; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Jefferson T, 2011, BMJ-BRIT MED J, V342, pc7258; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Jones M, 2012, DRUG SAFETY, V35, P1187, DOI 10.2165/11641690-000000000-00000; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, pb3172; Toovey S, 2012, DRUG SAFETY, V35, P1188; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; US Department of Health and Human Services, 2005, HHS PANDEMIC INFLUEN; World Health Organization, 2013, WHO MODEL LIST OF ES; World Health Organization, 2007, WHO INTERIM PROTOCOL	20	229	245	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2545	10.1136/bmj.g2545	http://dx.doi.org/10.1136/bmj.g2545			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811411	Green Published, hybrid			2022-12-28	WOS:000334348700012
J	Richeldi, L; du Bois, RM; Raghu, G; Azuma, A; Brown, KK; Costabel, U; Cottin, V; Flaherty, KR; Hansell, DM; Inoue, Y; Kim, DS; Kolb, M; Nicholson, AG; Noble, PW; Selman, M; Taniguchi, H; Brun, M; Le Maulf, F; Girard, M; Stowasser, S; Schlenker-Herceg, R; Disse, B; Collard, HR				Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K.; Costabel, Ulrich; Cottin, Vincent; Flaherty, Kevin R.; Hansell, David M.; Inoue, Yoshikazu; Kim, Dong Soon; Kolb, Martin; Nicholson, Andrew G.; Noble, Paul W.; Selman, Moises; Taniguchi, Hiroyuki; Brun, Michele; Le Maulf, Florence; Girard, Mannaig; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Disse, Bernd; Collard, Harold R.		INPULSIS Trial Investigators	Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; RESPIRATORY QUESTIONNAIRE; INTERSTITIAL PNEUMONIA; ACUTE EXACERBATION	BACKGROUND Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. METHODS We conducted two replicate 52-week, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis. The primary end point was the annual rate of decline in forced vital capacity (FVC). Key secondary end points were the time to the first acute exacerbation and the change from baseline in the total score on the St. George's Respiratory Questionnaire, both assessed over a 52-week period. RESULTS A total of 1066 patients were randomly assigned in a 3: 2 ratio to receive nintedanib or placebo. The adjusted annual rate of change in FVC was -114.7 ml with nintedanib versus -239.9 ml with placebo (difference, 125.3 ml; 95% confidence interval [CI], 77.7 to 172.8; P<0.001) in INPULSIS-1 and -113.6 ml with nintedanib versus -207.3 ml with placebo (difference, 93.7 ml; 95% CI, 44.8 to 142.7; P<0.001) in INPULSIS-2. In INPULSIS-1, there was no significant difference between the nintedanib and placebo groups in the time to the first acute exacerbation (hazard ratio with nintedanib, 1.15; 95% CI, 0.54 to 2.42; P=0.67); in INPULSIS-2, there was a significant benefit with nintedanib versus placebo (hazard ratio, 0.38; 95% CI, 0.19 to 0.77; P=0.005). The most frequent adverse event in the nintedanib groups was diarrhea, with rates of 61.5% and 18.6% in the nintedanib and placebo groups, respectively, in INPULSIS-1 and 63.2% and 18.3% in the two groups, respectively, in INPULSIS-2. CONCLUSIONS In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of disease progression; nintedanib was frequently associated with diarrhea, which led to discontinuation of the study medication in less than 5% of patients. (Funded by Boehringer Ingelheim; INPULSIS-1 and INPULSIS-2 ClinicalTrials.gov numbers, NCT01335464 and NCT01335477.)	[Richeldi, Luca] Univ Southampton, Natl Inst Hlth Res, Southampton Resp Bio Med Res Unit, Southampton SO9 5NH, Hants, England; [Richeldi, Luca] Univ Southampton, Southampton SO9 5NH, Hants, England; [du Bois, Roland M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Hansell, David M.; Nicholson, Andrew G.] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Hansell, David M.; Nicholson, Andrew G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Raghu, Ganesh] Univ Washington, Seattle, WA 98195 USA; [Azuma, Arata] Nippon Med Sch, Tokyo 113, Japan; [Inoue, Yoshikazu] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Taniguchi, Hiroyuki] Tosei Gen Hosp, Seto, Aichi, Japan; [Brown, Kevin K.] Natl Jewish Hlth, Denver, CO USA; [Costabel, Ulrich] Univ Duisburg Essen, Univ Hosp, Ruhrlandklin, Essen, Germany; [Stowasser, Susanne; Disse, Bernd] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Cottin, Vincent] Univ Lyon, Louis Pradel Hosp, Lyon, France; [Brun, Michele; Le Maulf, Florence; Girard, Mannaig] Boehringer Ingelheim GmbH & Co KG, Reims, France; [Flaherty, Kevin R.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Kim, Dong Soon] Univ Ulsan, Asan Med Ctr, Seoul, South Korea; [Kolb, Martin] McMaster Univ, Hamilton, ON, Canada; [Noble, Paul W.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Selman, Moises] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Schlenker-Herceg, Rozsa] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Collard, Harold R.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Southampton; University of Southampton; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of Washington; University of Washington Seattle; Nippon Medical School; Tosei General Hospital; National Jewish Health; University of Duisburg Essen; Boehringer Ingelheim; CHU Lyon; Boehringer Ingelheim; University of Michigan System; University of Michigan; University of Ulsan; McMaster University; Cedars Sinai Medical Center; Boehringer Ingelheim; University of California System; University of California San Francisco	Richeldi, L (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Mailpoint 813,LE75 E Level,South Acad Block, Southampton SO16 6YD, Hants, England.	l.richeldi@soton.ac.uk	Richeldi, Luca/ABF-2486-2020; Kayacan, Oya/AAQ-1674-2020; Brown, Kevin/ABF-2544-2020; Alfageme, Inmaculada/K-2092-2014; Setoguchi, Yasuhiro/AAE-1448-2021; Richeldi, Luca/B-6243-2019; Ohkouchi, Shinya/AEV-0334-2022; Inoue, Yoshikazu/ABE-9772-2020; Poletti, Venerino/K-8821-2016	Richeldi, Luca/0000-0001-8594-1448; Kayacan, Oya/0000-0001-5842-4226; Alfageme, Inmaculada/0000-0002-5106-1669; Setoguchi, Yasuhiro/0000-0002-0892-6364; Ohkouchi, Shinya/0000-0002-4658-6487; chanez, pascal/0000-0003-4059-0917; Wijsenbeek, Marlies/0000-0002-4527-6962; Morell Brotad, Ferran/0000-0002-7206-4543; Ozkan, Serir/0000-0001-5460-8300; Azuma, Arata/0000-0003-0506-9966; Poletti, Venerino/0000-0002-8634-2284	Boehringer Ingelheim; National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit at the University Hospital Southampton NHS Foundation Trust; NIHR Respiratory Disease Bio-medical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London; InterMune; MedImmune; Roche; Takeda; Biogen Idec; Sanofi-Aventis; ImmuneWorks; Shionogi; Gilead; FibroGen; Promedior; Actelion; Centocor; Sanofi-Genzyme; Altitude Pharma; Amgen; Biogen-Stromedix; Celgene; Moerae; Matrix; Novartis; Pfizer; Veracyte; Galecto; Genentech; Bayer; GlaxoSmithKline; Ikaria; Vertex; Forest; Excel; France Foundation; Bristol-Myers Squibb; Moerae Matrix; Roche-Genentech; Olympus; AstraZeneca; Chugai; Asahi Kasei Pharma; Abbott; Eli Lilly; Eisai; Kyorin; Meiji Seika Pharma; Ono Pharmaceutical; Philips Respironics; Taiho Pharmaceutical; Terumo; Teijin Pharma; Fukuda Denshi; Mesoblast; National Institute for Health Research [NF-SI-0512-10157] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit at the University Hospital Southampton NHS Foundation Trust; NIHR Respiratory Disease Bio-medical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London(General Electric); InterMune; MedImmune(AstraZenecaMedimmune); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Biogen Idec(Biogen); Sanofi-Aventis(Sanofi-Aventis); ImmuneWorks; Shionogi; Gilead(Gilead Sciences); FibroGen; Promedior; Actelion; Centocor; Sanofi-Genzyme(Sanofi-AventisGenzyme Corporation); Altitude Pharma; Amgen(Amgen); Biogen-Stromedix; Celgene(Bristol-Myers SquibbCelgene Corporation); Moerae; Matrix; Novartis(Novartis); Pfizer(Pfizer); Veracyte; Galecto; Genentech(Roche HoldingGenentech); Bayer(Bayer AG); GlaxoSmithKline(GlaxoSmithKline); Ikaria; Vertex(Vertex Pharmaceuticals); Forest; Excel; France Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Moerae Matrix; Roche-Genentech(Roche HoldingGenentech); Olympus; AstraZeneca(AstraZeneca); Chugai; Asahi Kasei Pharma; Abbott(Abbott Laboratories); Eli Lilly(Eli Lilly); Eisai(Eisai Co Ltd); Kyorin; Meiji Seika Pharma; Ono Pharmaceutical; Philips Respironics; Taiho Pharmaceutical; Terumo; Teijin Pharma; Fukuda Denshi; Mesoblast; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by Boehringer Ingelheim and by grants from the National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit at the University Hospital Southampton NHS Foundation Trust (to Dr. Richeldi) and from the NIHR Respiratory Disease Bio-medical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London (to Drs. Hansell and Nicholson).; Dr. Richeldi reports receiving fees for serving on advisory boards from InterMune, MedImmune, Roche, and Takeda, consulting fees from Biogen Idec, Sanofi-Aventis, and ImmuneWorks, lecture fees from Shionogi, and grant support from InterMune. Dr. du Bois reports receiving consulting fees from InterMune. Dr. Raghu reports receiving consulting fees from Boehringer Ingelheim, Biogen Idec, Gilead, FibroGen, and Promedior. Dr. Azuma reports receiving fees for serving on advisory boards from Shionogi and Takeda and for serving on steering committees from InterMune. Dr. Brown reports receiving fees for serving on an advisory board from MedImmune, fees for serving on steering committees for Actelion, Centocor, Gilead, and Sanofi-Genzyme, consulting fees from Actelion, Altitude Pharma, Amgen, Biogen-Stromedix, Celgene, Centocor, FibroGen, Genentech, GeNO, Genoa Pharma, Gilead, Mesoblast, Moerae Matrix, Novartis, Pfizer, Promedior, Sanofi-Genzyme, Veracyte, and Galecto, and grant support from Actelion, Amgen, Genentech, Gilead, and Sanofi-Genzyme. Dr. Costabel reports receiving fees for serving on advisory boards and steering committees from InterMune, consulting fees from Gilead, Centocor, Roche, and Bayer, lecture fees from InterMune and Bayer, and grant support through his institution from InterMune, Gilead, Centocor, and Sanofi-Aventis. Dr. Cottin reports receiving fees for serving on advisory boards and for consulting from Bayer, Gilead, GlaxoSmithKline, InterMune, and Roche, fees for serving on an advisory board and contributing to educational material from Boehringer Ingelheim, lecture fees from Actelion, Boehringer Ingelheim, and InterMune, and travel support from Actelion, GlaxoSmithKline, and InterMune. Dr. Flaherty reports receiving consulting fees from FibroGen, Genentech, Gilead, Ikaria, ImmuneWorks, MedImmune, Novartis, Takeda, Vertex, Veracyte, Roche, and InterMune, lecture fees from GlaxoSmithKline, Forest, Excel, and the France Foundation, and grant support from ImmuneWorks, InterMune, and Bristol-Myers Squibb. Dr. Kolb reports receiving consulting fees from InterMune and grant support from InterMune and GlaxoSmithKline. Dr. Nicholson reports receiving lecture fees from InterMune. Dr. Noble reports receiving consulting fees from InterMune, Moerae Matrix, Bristol-Myers Squibb, Roche-Genentech, and Takeda. Dr. Taniguchi reports receiving fees for serving on advisory boards from Shionogi, Olympus, AstraZeneca and Chugai and lecture fees from AstraZeneca, Asahi Kasei Pharma, Abbott, Bayer, Eli Lilly, Eisai, GlaxoSmithKline, Kyorin, Novartis, Meiji Seika Pharma, Ono Pharmaceutical, Philips Respironics, Pfizer, Taiho Pharmaceutical, Terumo, Teijin Pharma, and Fukuda Denshi. Drs. Brun, Le Maulf, Girard, Stowasser, Schlenker-Herceg, and Disse report being employees of Boehringer Ingelheim. Dr. Collard reports receiving consulting fees through his institution from Bayer, FibroGen, Gilead, InterMune, Mesoblast, Moerae Matrix, Pfizer, Promedior, and Takeda and grant support through his institution from Genentech. No other potential conflict of interest relevant to this article was reported.	Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-73; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223	20	2463	2556	18	246	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2071	2082		10.1056/NEJMoa1402584	http://dx.doi.org/10.1056/NEJMoa1402584			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24836310	Green Published			2022-12-28	WOS:000336434000005
J	Briggs, DEG				Briggs, Derek E. G.			Adolf Seilacher (1925-2014) OBITUARY	NATURE			English	Biographical-Item									[Briggs, Derek E. G.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, New Haven, CT USA	Yale University; Yale University	Briggs, DEG (corresponding author), Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA.	derek.briggs@yale.edu						SEILACHER A, PUBLICATION LIST	1	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					428	428		10.1038/509428a	http://dx.doi.org/10.1038/509428a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848054	Bronze			2022-12-28	WOS:000336126000022
J	Matsuda, R				Matsuda, Ryotaro			MATERIALS CHEMISTRY Selectivity from flexibility	NATURE			English	Editorial Material							POROUS COORDINATION POLYMERS; FRAMEWORK; SORPTION; CRYSTALS		Kyoto Univ, Inst Integrated Cell Mat Sci, Nishikyo Ku, Kyoto 6158530, Japan	Kyoto University	Matsuda, R (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Nishikyo Ku, Kyoto 6158530, Japan.	rmatsuda@icems.kyoto-u.ac.jp	Matsuda, Ryotaro/AGA-6072-2022	Matsuda, Ryotaro/0000-0002-7665-6212				Cussen EJ, 2002, J AM CHEM SOC, V124, P9574, DOI 10.1021/ja0262737; Halder GJ, 2005, J AM CHEM SOC, V127, P7891, DOI 10.1021/ja042420k; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitagawa S, 2007, COORDIN CHEM REV, V251, P2490, DOI 10.1016/j.ccr.2007.07.009; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Li D, 2001, CHEM PHYS LETT, V335, P50, DOI 10.1016/S0009-2614(00)01419-6; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Matsuda R, 2004, J AM CHEM SOC, V126, P14063, DOI 10.1021/ja046925m; Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Serre C, 2002, J AM CHEM SOC, V124, P13519, DOI 10.1021/ja0276974; Warren JE, 2014, ANGEW CHEM INT EDIT, V53, P4592, DOI 10.1002/anie.201307656; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	14	33	33	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					434	435		10.1038/509434a	http://dx.doi.org/10.1038/509434a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24848056				2022-12-28	WOS:000336126000026
J	Varshavsky, A				Varshavsky, Alexander			Discovery of the Biology of the Ubiquitin System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							END RULE PATHWAY; PROTEIN; DEGRADATION; PROTEOLYSIS		[Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu			NIDDK NIH HHS [R01 DK039520] Funding Source: Medline; NIGMS NIH HHS [R01 GM031530] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; VARSHAVSKY A, 2006, CANDID SCI, V6, P311; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306	10	10	10	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1969	1970		10.1001/jama.2014.5549	http://dx.doi.org/10.1001/jama.2014.5549			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24846030				2022-12-28	WOS:000336122800015
J	Manzoli, L; Flacco, ME; D'Addario, M; Capasso, L; De Vito, C; Marzuillo, C; Villari, P; Ioannidis, JPA				Manzoli, Lamberto; Flacco, Maria Elena; D'Addario, Maddalena; Capasso, Lorenzo; De Vito, Corrado; Marzuillo, Carolina; Villari, Paolo; Ioannidis, John P. A.			Non-publication and delayed publication of randomized trials on vaccines: survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CROSS-SECTIONAL ANALYSIS; OUTCOME REPORTING BIAS; BIOMEDICAL-RESEARCH; CLINICAL-RESEARCH; RETROSPECTIVE COHORT; INCREASING VALUE; HEALTH-RESEARCH; ADVERSE EVENTS; REDUCING WASTE; COMPLETENESS	Objective To evaluate the extent of non-publication or delayed publication of registered randomized trials on vaccines, and to investigate potential determinants of delay to publication. Design Survey. Data sources Trials registry websites, Scopus, PubMed, Google. Study selection Randomized controlled trials evaluating the safety or the efficacy or immunogenicity of human papillomavirus (HPV), pandemic A/H1N1 2009 influenza, and meningococcal, pneumococcal, and rotavirus vaccines that were registered in ClinicalTrials.gov, Current Controlled Trials, WHO International Clinical Trials Registry Platform, Clinical Study Register, or Indian, Australian-New Zealand, and Chinese trial registries in 2006-12. Electronic databases were searched up to February 2014 to identify published manuscripts containing trial results. These were reviewed and classified as positive, mixed, or negative. We also reviewed the results available in ClinicalTrials.gov. Main outcome measures Publication status of trial results and time from completion to publication in peer reviewed journals. Data synthesis Cox proportional hazards regression was used to evaluate potential predictors of publication delay. Results We analysed 384 trials (85% sponsored by industry). Of 355 trials (404 758 participants) that were completed, 176 (n = 151 379) had been published in peer reviewed journals. Another 42 trials (total sample 62 765) remained unpublished but reported results in ClinicalTrials.gov. The proportion of trials published 12, 24, 36, and 48 months after completion was 12%, 29%, 53%, and 73%, respectively. Including results posted in ClinicalTrials.gov, 48 months after study completion results were available for 82% of the trials and 90% of the participants. Delay to publication between non-industry and industry sponsored trials did not differ, but non-industry sponsored trials were 4.42-fold (P = 0.008) more likely to report negative or mixed findings. Negative results were reported by only 2% of the published trials. Conclusions Most vaccine trials are published eventually or the results posted in ClinicalTrials.gov, but delays to publication of several years are common. Actions should focus on the timely dissemination of data from vaccine trials to the public.	[Manzoli, Lamberto; Flacco, Maria Elena; Capasso, Lorenzo] Univ G dAnnunzio, Dept Med & Aging Sci, I-66013 Chieti, Italy; [Manzoli, Lamberto; Capasso, Lorenzo] CeSI Biotech, Chieti, Italy; [Flacco, Maria Elena] Local Hlth Unit Pescara, Pescara, Italy; [D'Addario, Maddalena] Univ Bern, Div Clin Epidemiol & Biostat, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [D'Addario, Maddalena] Univ Bern, Div Int & Environm Hlth, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [De Vito, Corrado; Marzuillo, Carolina; Villari, Paolo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	G d'Annunzio University of Chieti-Pescara; University of Bern; University of Bern; Sapienza University Rome; Stanford University; Stanford University	Manzoli, L (corresponding author), Univ G dAnnunzio, Dept Med & Aging Sci, Via Vestini 5, I-66013 Chieti, Italy.	lmanzoli@post.harvard.edu	Capasso, Lorenzo/F-2389-2017; Manzoli, Lamberto/K-1895-2018; Flacco, Maria Elena/E-3306-2017; Ioannidis, John P. A./G-9836-2011	Capasso, Lorenzo/0000-0002-9902-8577; Manzoli, Lamberto/0000-0002-8129-9344; Flacco, Maria Elena/0000-0003-1404-4314; DE VITO, CORRADO/0000-0002-7846-672X; villari, paolo/0000-0002-3139-0668; MARZUILLO, CAROLINA/0000-0002-7299-5727				Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Galsworthy MJ, 2012, LANCET, V380, P971, DOI 10.1016/S0140-6736(12)61528-1; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028346; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Leung GM, 2010, PLOS MED, V7; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Manzoli L, 2009, LANCET INFECT DIS, V9, P482, DOI 10.1016/S1473-3099(09)70153-7; Patsopoulos Nikolaos A, 2009, Open Med, V3, pe62; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schulz K.F., 2010, BMJ-BRIT MED J, V340, pe332; Scott P, 2012, PEDIATR INFECT DIS J, V31, P1286, DOI 10.1097/INF.0b013e31827032bb; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; Sibbald B, 1998, BRIT MED J, V316, P201; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Strech D, 2012, J CLIN EPIDEMIOL, V65, P276, DOI 10.1016/j.jclinepi.2011.07.002; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Turner S, 2013, BMJ OPEN, V3; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Verstraeten T, 2008, VACCINE, V26, P6630, DOI 10.1016/j.vaccine.2008.09.049; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; World Medical Association, 2013, DECL HELS ETH PRINC; Wu JA, 2010, J INFECT DIS, V202, P675, DOI 10.1086/655226; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	46	62	62	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2014	348								g3058	10.1136/bmj.g3058	http://dx.doi.org/10.1136/bmj.g3058			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5HF	24838102	Green Published, hybrid			2022-12-28	WOS:000336158400001
J	McKnight, K; Hoang, HD; Prasain, JK; Brown, N; Vibbert, J; Hollister, KA; Moore, R; Ragains, JR; Reese, J; Miller, MA				McKnight, Katherine; Hoang, Hieu D.; Prasain, Jeevan K.; Brown, Naoko; Vibbert, Jack; Hollister, Kyle A.; Moore, Ray; Ragains, Justin R.; Reese, Jeff; Miller, Michael A.			Neurosensory Perception of Environmental Cues Modulates Sperm Motility Critical for Fertilization	SCIENCE			English	Article							PROSTAGLANDINS; CHANNEL	Environmental exposures affect gamete function and fertility, but the mechanisms are poorly understood. Here, we show that pheromones sensed by ciliated neurons in the Caenorhabditis elegans nose alter the lipid microenvironment within the oviduct, thereby affecting sperm motility. In favorable environments, pheromone-responsive sensory neurons secrete a transforming growth factor-beta ligand called DAF-7, which acts as a neuroendocrine factor that stimulates prostaglandin-endoperoxide synthase [cyclooxygenase (Cox)]-independent prostaglandin synthesis in the ovary. Oocytes secrete F-class prostaglandins that guide sperm toward them. These prostaglandins are also synthesized in Cox knockout mice, raising the possibility that similar mechanisms exist in other animals. Our data indicate that environmental cues perceived by the female nervous system affect sperm function.	[McKnight, Katherine] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Birmingham, AL 35294 USA; [Hoang, Hieu D.; Vibbert, Jack; Miller, Michael A.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Prasain, Jeevan K.; Moore, Ray] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Brown, Naoko; Reese, Jeff] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Hollister, Kyle A.; Ragains, Justin R.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Reese, Jeff] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Louisiana State University System; Louisiana State University; Vanderbilt University	Miller, MA (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	mamiller@uab.edu		Reese, Jeff/0000-0001-8751-6146; Hoang, Hieu/0000-0002-5893-7651; Miller, Michael/0000-0003-4872-7121	NIH [GM085105, HL096967, HL109199]; University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program; UAB Skin Disease Research Center [P30 AR050948]; UAB-University of California San Diego O'Brien Acute Kidney Injury Center [P30 DK079337]; UAB Lung Health Center [HL114439, HL110950]; UAB Center for Free Radical Biology; National Center for Research Resources Shared Instrumentation grant [S10 RR19261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110950, R01HL109199, R01HL096967, R01HL114439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085105] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program; UAB Skin Disease Research Center; UAB-University of California San Diego O'Brien Acute Kidney Injury Center; UAB Lung Health Center; UAB Center for Free Radical Biology; National Center for Research Resources Shared Instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Ashrafi, R. Butcher, J. Parant, I. Kadisha, and T. van Groen for reagents or technical assistance and the NIH-supported Caenorhabditis Genetics Center (P40 OD010440) for strains. This work was supported by NIH grants (GM085105 to M. A. M.; HL096967 and HL109199 to J. R.) and the University of Alabama at Birmingham (UAB) Reproductive Endocrinology and Infertility Fellowship Program. The UAB Targeted Metabolomics and Proteomics Laboratory has been supported by the UAB Skin Disease Research Center (P30 AR050948), UAB-University of California San Diego O'Brien Acute Kidney Injury Center (P30 DK079337), UAB Lung Health Center (HL114439 and HL110950), UAB Center for Free Radical Biology, and a National Center for Research Resources Shared Instrumentation grant (S10 RR19261). All data are provided in the main paper and supplementary materials. We declare no conflicts of interest.	Cariboni A, 2007, TRENDS NEUROSCI, V30, P638, DOI 10.1016/j.tins.2007.09.002; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Edmonds JW, 2011, DEV BIOL, V359, P47, DOI 10.1016/j.ydbio.2011.08.014; Edmonds JW, 2010, DEV CELL, V19, P858, DOI 10.1016/j.devcel.2010.11.005; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Hoang HD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003271; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Ludewig A. H., 2013, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.155.1, DOI 10.1895/WORMBOOK.1.155.1]; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Prasain JK, 2013, JOVE-J VIS EXP, DOI 10.3791/50447; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	20	32	33	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					754	757		10.1126/science.1250598	http://dx.doi.org/10.1126/science.1250598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833393	Green Accepted			2022-12-28	WOS:000335912900043
J	Roland, M; Campbell, S				Roland, Martin; Campbell, Stephen			Successes and Failures of Pay for Performance in the United Kingdom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY-OF-CARE; FOR-PERFORMANCE; ADVANCED ACCESS; HEALTH-CARE; UK QUALITY; LONGITUDINAL ANALYSIS; FINANCIAL INCENTIVES; PATIENT SURVEY; INDICATORS; GUIDELINES		[Roland, Martin] Univ Cambridge, Cambridge, England; [Campbell, Stephen] Univ Manchester, Manchester, Lancs, England	University of Cambridge; University of Manchester	Roland, M (corresponding author), Univ Cambridge, Cambridge, England.			Roland, Martin/0000-0002-8533-3060; Campbell, Stephen/0000-0002-2328-4136				Asprey A, 2013, BRIT J GEN PRACT, V63, pE200, DOI 10.3399/bjgp13X664252; Box Graham, 2009, Qual Prim Care, V17, P291; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-57; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Campbell S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567117; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Campbell SM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-85; Campbell SM, 2010, MED J AUSTRALIA, V193, P408, DOI 10.5694/j.1326-5377.2010.tb03971.x; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Checkland K, 2008, SOCIOL HEALTH ILL, V30, P788, DOI 10.1111/j.1467-9566.2008.01081.x; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Dudley RA, 2005, JAMA-J AM MED ASSOC, V294, P1821, DOI 10.1001/jama.294.14.1821; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Gravelle H, 2010, ECON J, V120, pF129, DOI 10.1111/j.1468-0297.2009.02340.x; Grimshaw JM, 2001, MED CARE, V39, pII2; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; HOWIE JGR, 1995, BRIT J GEN PRACT, V45, P121; Lester H, 2013, BRIT J GEN PRACT, V63, pE408, DOI 10.3399/bjgp13X668203; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; Lester HE, 2011, BMJ QUAL SAF, V20, P1057, DOI 10.1136/bmjqs.2010.048371; Leydon GM, 2011, BRIT J GEN PRACT, V61, P117, DOI 10.3399/bjgp11X556236; Maisey S, 2008, J HEALTH SERV RES PO, V13, P133, DOI 10.1258/jhsrp.2008.007118; McGregor W, 2008, BRIT J GEN PRACT, V58, P711, DOI 10.3399/bjgp08X342183; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; NHS Employers, CHANG QOF 2014 15; Pope C, 2008, J HEALTH SERV RES PO, V13, P33, DOI 10.1258/jhsrp.2007.007039; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2012, ANN INTERN MED, V157, P912, DOI 10.7326/0003-4819-157-12-201212180-00014; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5982; Roland M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3851; Salisbury C, 2007, BRIT J GEN PRACT, V57, P615; Salisbury C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4224; Smith P., 1995, INT J PUBLIC ADMIN, V18, P277, DOI DOI 10.1080/01900699508525011; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247	38	79	79	3	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1944	1949		10.1056/NEJMhpr1316051	http://dx.doi.org/10.1056/NEJMhpr1316051			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UH	24827040				2022-12-28	WOS:000336123600012
J	Shetty, P				Shetty, Priya			Carl Hart: advocate for rational drug policy	LANCET			English	Biographical-Item																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2014	383	9929					1627	1627		10.1016/S0140-6736(14)60778-9	http://dx.doi.org/10.1016/S0140-6736(14)60778-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG8LV	24814448				2022-12-28	WOS:000335670800012
J	Mindell, JA				Mindell, Joseph A.			A SWELL Channel Indeed	SCIENCE			English	Editorial Material									NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826	4	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					585	586		10.1126/science.1254591	http://dx.doi.org/10.1126/science.1254591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24812387				2022-12-28	WOS:000335537400026
J	Asch, DA; Terwiesch, C; Mahoney, KB; Rosin, R				Asch, David A.; Terwiesch, Christian; Mahoney, Kevin B.; Rosin, Roy			Insourcing Health Care Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Rather than seek solutions to health care's problems in facile recommendations from management gurus with experience in unrelated industries, we'd do better to find a solution process to use from within. And the process for high-impact innovation can in fact be learned. Many health care professionals find it irritating when management gurus recommend solving health care's problems with approaches they would copy and paste from unrelated industries a former chief executive of a manufacturing company claims that the same simple lessons that enabled him to transform his own industry can improve value in health care, or a business-school professor offers an eight-point leadership plan that she's translated into health care as easily as if she'd translated it into French. Many people who work in health care value outside perspectives and are open to new approaches and yet bristle at facile ...	[Asch, David A.] Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Asch, David A.; Terwiesch, Christian; Mahoney, Kevin B.; Rosin, Roy] Univ Penn, Ctr Hlth Care Innovat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Terwiesch, Christian] Univ Penn, Mack Inst Innovat Management, Wharton Sch, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X				Design Council, 2007, 11 LESS MAN DES 11 G	1	31	31	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1775	1777		10.1056/NEJMp1401135	http://dx.doi.org/10.1056/NEJMp1401135			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH3CD	24806157	Green Published			2022-12-28	WOS:000335997900003
J	Bintcliffe, O; Maskell, N				Bintcliffe, Oliver; Maskell, Nick			Spontaneous pneumothorax	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SECONDARY SPONTANEOUS PNEUMOTHORAX; RECURRENT SPONTANEOUS PNEUMOTHORAX; PERSISTENT AIR-LEAK; COMPUTED-TOMOGRAPHY; CONTROLLED-TRIAL; MANAGEMENT; DRAINAGE; ASPIRATION; THERAPY; TETRACYCLINE		[Bintcliffe, Oliver; Maskell, Nick] Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol BS10 5NB, Avon, England	University of Bristol	Maskell, N (corresponding author), Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol BS10 5NB, Avon, England.	nick.maskell@bristol.ac.uk		maskell, nick/0000-0002-1276-6500				Ahmedzai S, 2011, THORAX, V66, P1, DOI 10.1136/thoraxjnl-2011-200295; Alifano M, 2003, CHEST, V124, P1004, DOI 10.1378/chest.124.3.1004; ALMIND M, 1989, THORAX, V44, P627, DOI 10.1136/thx.44.8.627; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; BENSE L, 1993, CHEST, V103, P433, DOI 10.1378/chest.103.2.433; Brims FJH, 2013, THORAX, V68, P664, DOI 10.1136/thoraxjnl-2012-202875; Cao GQ, 2012, ANN THORAC SURG, V93, P1652, DOI 10.1016/j.athoracsur.2012.01.093; Chee CBE, 1998, RESP MED, V92, P757, DOI 10.1016/S0954-6111(98)90008-7; Chen CH, 2012, AM J EMERG MED, V30, P45, DOI 10.1016/j.ajem.2010.09.014; Chen JS, 2013, LANCET, V381, P1277, DOI 10.1016/S0140-6736(12)62170-9; Feldman A L, 1993, J Subst Abuse, V5, P183, DOI 10.1016/0899-3289(93)90061-F; Foroulis CN, 2012, SURG ENDOSC, V26, P607, DOI 10.1007/s00464-011-1734-x; Guo YB, 2005, RESPIROLOGY, V10, P378, DOI 10.1111/j.1440-1843.2005.00715.x; Gupta D, 2000, THORAX, V55, P666, DOI 10.1136/thorax.55.8.666; Ho KK, 2011, AM J EMERG MED, V29, P1152, DOI 10.1016/j.ajem.2010.05.017; Kelly AM, 2006, EMERG MED J, V23, P780, DOI 10.1136/emj.2006.037143; LIGHT RW, 1990, JAMA-J AM MED ASSOC, V264, P2224, DOI 10.1001/jama.264.17.2224; LIPPERT HL, 1991, EUR RESPIR J, V4, P324; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; NORTHFIELD TC, 1971, BMJ-BRIT MED J, V4, P86, DOI 10.1136/bmj.4.5779.86; Parlak M, 2012, RESP MED, V106, P1600, DOI 10.1016/j.rmed.2012.08.005; Perrin K., 2013, RANDOMISED CONTROLLE; Sadikot RT, 1997, THORAX, V52, P805, DOI 10.1136/thx.52.9.805; SCHOENENBERGER RA, 1991, ARCH SURG-CHICAGO, V126, P764; Smit HJM, 1998, RESP MED, V92, P1132, DOI 10.1016/S0954-6111(98)90407-3; SO SY, 1982, THORAX, V37, P46, DOI 10.1136/thx.37.1.46; Travaline JM, 2009, CHEST, V136, P355, DOI 10.1378/chest.08-2389; Wakai A, 2007, COCHRANE DB SYST REV; WITHERS JN, 1964, AM J SURG, V108, P772, DOI 10.1016/0002-9610(64)90030-3	30	27	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2014	348								g2928	10.1136/bmj.g2928	http://dx.doi.org/10.1136/bmj.g2928			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OM	24812003				2022-12-28	WOS:000335819700003
J	Collins, JJ				Collins, James J.			How best to build a cell	NATURE			English	Editorial Material									Boston Univ, Boston, MA 02215 USA	Boston University	Collins, JJ (corresponding author), Boston Univ, Boston, MA 02215 USA.								0	20	20	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					155	157						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24812682				2022-12-28	WOS:000335454300012
J	Georgescauld, F; Popova, K; Gupta, AJ; Bracher, A; Engen, JR; Hayer-Hartl, M; Hartl, FU				Georgescauld, Florian; Popova, Kristina; Gupta, Amit J.; Bracher, Andreas; Engen, John R.; Hayer-Hartl, Manajit; Hartl, F. Ulrich			GroEL/ES Chaperonin Modulates the Mechanism and Accelerates the Rate of TIM-Barrel Domain Folding	CELL			English	Article							MASS-SPECTROMETRY; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI; IN-VIVO; E. COLI; PROTEIN; CONFINEMENT; RESOLUTION; KINETICS; MODEL	The GroEL/ES chaperonin system functions as a protein folding cage. Many obligate substrates of GroEL share the (beta alpha)(8) TIM-barrel fold, but how the chaperonin promotes folding of these proteins is not known. Here, we analyzed the folding of DapA at peptide resolution using hydrogen/deuterium exchange and mass spectrometry. During spontaneous folding, all elements of the DapA TIM barrel acquire structure simultaneously in a process associated with a long search time. In contrast, GroEL/ES accelerates folding more than 30-fold by catalyzing segmental structure formation in the TIM barrel. Segmental structure formation is also observed during the fast spontaneous folding of a structural homolog of DapA from a bacterium that lacks GroEL/ES. Thus, chaperonin independence correlates with folding properties otherwise enforced by protein confinement in the GroEL/ES cage. We suggest that folding catalysis by GroEL/ES is required by a set of proteins to reach native state at a biologically relevant time scale, avoiding aggregation or degradation.	[Georgescauld, Florian; Popova, Kristina; Gupta, Amit J.; Bracher, Andreas; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Engen, John R.] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA; [Hartl, F. Ulrich] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany	Max Planck Society; Northeastern University; University of Munich	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Georgescauld, Florian/AAH-7125-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Gupta, Amit Jean/0000-0002-6045-2848; Popova, Kristina/0000-0002-3957-2060; Engen, John R./0000-0002-6918-9476; Georgescauld, Florian/0000-0003-0530-1884	Munich Center for Integrated Protein Science (CiPSM); NIH [R01 GM101135]; Waters Corporation; La Fondation pour la Recherche Medicale [FRM SPE20071211473];  [06/2012-06/2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135] Funding Source: NIH RePORTER	Munich Center for Integrated Protein Science (CiPSM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corporation; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Moroder and H.J. Musiol for the synthesis of beta-semialdehyde. Expert technical assistance by N. Wischnewski and A. R. Lange is acknowledged, as is assistance with the H/DX experiments from T.E. Wales, R.E. Iacob, and R. Korner. We thank the MPIB crystallization facility and the personnel at beamline X10SA of SLS Villigen, Switzerland for their assistance. We gratefully acknowledge the financial support from the Munich Center for Integrated Protein Science (CiPSM). J.R.E. was on sabbatical at the Department of Cellular Biochemistry, Max Planck Institute of Biochemistry from 06/2012-06/2013 and was partially supported during this time by NIH R01 GM101135 and a research collaboration with the Waters Corporation. F.G. was supported by a postdoctoral fellowship from La Fondation pour la Recherche Medicale (code FRM SPE20071211473).	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; Bicout DJ, 2000, PROTEIN SCI, V9, P452; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; England JL, 2008, BIOPHYS J, V95, P3391, DOI [10.1529/biophysj.108.131037, 10.1529/biophysj.l08.131037]; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Groebke K, 1996, P NATL ACAD SCI USA, V93, P4025, DOI 10.1073/pnas.93.9.4025; Hayer-Hartl M, 2006, BIOCHEMISTRY-US, V45, P13356, DOI 10.1021/bi061597j; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002537; ROBINSON CV, 1994, NATURE, V372, P646, DOI 10.1038/372646a0; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Schmid F X, 1986, Methods Enzymol, V131, P70; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; Sirur A, 2013, BIOPHYS J, V104, P1098, DOI 10.1016/j.bpj.2013.01.034; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WOODWARD CK, 1979, ANNU REV BIOPHYS BIO, V8, P99, DOI 10.1146/annurev.bb.08.060179.000531; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	51	86	90	2	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					922	934		10.1016/j.cell.2014.03.038	http://dx.doi.org/10.1016/j.cell.2014.03.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813614	Green Accepted, Bronze			2022-12-28	WOS:000335765500019
J	Kalaitzidis, D; Scadden, DT				Kalaitzidis, Demetrios; Scadden, David T.			Tic-TACs: Refreshing Hair Growth	CELL			English	Editorial Material							STEM-CELL; REGENERATION; NICHE	Although stem cells are subject to niche control, evidence is emerging that they also contribute to generating the niche through their offspring. Using the hair follicle as a model, Hsu at al. demonstrate that the transient-amplifying cells, downstream of stem cells and well-known cell producers, signal back to stem cells to maintain long-term regenerative capacity.	[Kalaitzidis, Demetrios; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Kalaitzidis, Demetrios; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Kalaitzidis, Demetrios; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Kalaitzidis, D (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	dkalaitzidis@partners.org; david_scadden@harvard.edu			NHLBI NIH HHS [U01 HL100402] Funding Source: Medline; NIBIB NIH HHS [R01 EB014703] Funding Source: Medline; NIDDK NIH HHS [K01 DK092300] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092300] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Morgan BA, 1998, DEV BIOL, V201, P1, DOI 10.1006/dbio.1998.8969; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Solanas G, 2013, NAT REV MOL CELL BIO, V14, P737, DOI 10.1038/nrm3675; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	9	3	3	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					769	770		10.1016/j.cell.2014.04.014	http://dx.doi.org/10.1016/j.cell.2014.04.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813602	Green Accepted, Bronze			2022-12-28	WOS:000335765500004
J	McLaren, JR				McLaren, Jennie R.			ECOLOGY Diversity in the afterlife	NATURE			English	Editorial Material							BIODIVERSITY LOSS; DECOMPOSITION; ECOSYSTEMS		Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso	McLaren, JR (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	jrmclaren@utep.edu	McLaren, Jennie/U-9130-2019	McLaren, Jennie/0000-0003-2004-4783				Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479	9	1	2	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					173	174		10.1038/509173a	http://dx.doi.org/10.1038/509173a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24805342				2022-12-28	WOS:000335454300027
J	Meyer, HJ; Rape, M				Meyer, Hermann-Josef; Rape, Michael			Enhanced Protein Degradation by Branched Ubiquitin Chains	CELL			English	Article							MULTIUBIQUITIN CHAIN; ENZYMES; E2S	Posttranslational modification of cell-cycle regulators with ubiquitin chains is essential for eukaryotic cell division. Such chains can be connected through seven lysine residues or the amino terminus of ubiquitin, thereby allowing the assembly of eight homogenous and multiple mixed or branched conjugates. Although functions of homogenous chain types have been described, physiological roles of branched structures are unknown. Here, we report that the anaphase-promoting complex (APC/C) efficiently synthesizes branched conjugates that contain multiple blocks of K11-linked chains. Compared to homogenous chains, the branched conjugates assembled by the APC/C strongly enhance substrate recognition by the proteasome, thereby driving degradation of cell-cycle regulators during early mitosis. Our work, therefore, identifies an enzyme and substrates for modification with branched ubiquitin chains and points to an important role of these conjugates in providing an improved signal for proteasomal degradation.	[Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Meyer, Hermann-Josef; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Gabriel Hayes. We thank Xianfang Donna Xia for early contributions and Rebecca Heald for fluorescently tagged HeLa cells. We are grateful to Julia Schaletzky and members of the M.R. lab for comments on the manuscript and encouraging discussions. This work was funded by grants from the NIH (to M.R.). M.R. is an investigator of the Howard Hughes Medical Institute.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8	27	293	307	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					910	921		10.1016/j.cell.2014.03.037	http://dx.doi.org/10.1016/j.cell.2014.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24813613	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000335765500018
J	Insel, TR				Insel, Thomas R.			Mental Disorders in Childhood Shifting the Focus From Behavioral Symptoms to Neurodevelopmental Trajectories	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOSIS		NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, NIH, NIMH Room 8129,6001 Execut Blvd, Bethesda, MD 20892 USA.	insel@mail.nih.gov						BrainSpan, BRAINSPAN ATL DEV HU; Brent BK, 2013, CHILD ADOL PSYCH CL, V22, P689, DOI 10.1016/j.chc.2013.06.003; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Stafford MR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f185; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447	10	61	62	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2014	311	17					1727	1728		10.1001/jama.2014.1193	http://dx.doi.org/10.1001/jama.2014.1193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4IG	24794359				2022-12-28	WOS:000335382300011
J	Chambers, J				Chambers, John			Forming Terrestrial Planets	SCIENCE			English	Editorial Material							LOW-MASS; MARS; EARTH		Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Chambers, J (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	jchambers@carnegiescience.edu		Chambers, John/0000-0001-9046-2265				Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Allegre CJ, 2008, EARTH PLANET SC LETT, V267, P386, DOI 10.1016/j.epsl.2007.11.056; Dauphas N, 2011, NATURE, V473, P489, DOI 10.1038/nature10077; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; Hansen BMS, 2009, ASTROPHYS J, V703, P1131, DOI 10.1088/0004-637X/703/1/1131; Jin LP, 2008, ASTROPHYS J LETT, V674, pL105, DOI 10.1086/529375; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Wetherill G. W., 1977, PROTOSTARS PLANETS, P565	12	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					478	479		10.1126/science.1252257	http://dx.doi.org/10.1126/science.1252257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786067				2022-12-28	WOS:000335157700028
J	Fukino, T; Joo, H; Hisada, Y; Obana, M; Yamagishi, H; Hikima, T; Takata, M; Fujita, N; Aida, T				Fukino, Takahiro; Joo, Hyunho; Hisada, Yuki; Obana, Maiko; Yamagishi, Hiroshi; Hikima, Takaaki; Takata, Masaki; Fujita, Norifumi; Aida, Takuzo			Manipulation of Discrete Nanostructures by Selective Modulation of Noncovalent Forces	SCIENCE			English	Article							COMPLEXES; MICELLES; NANOTUBES; POLYMERS; DESIGN; LIGAND; GROWTH	Covalent organic synthesis commonly uses the strategy of selective bond cleavage and formation. If a similar approach can be applied stepwisely to noncovalent synthesis, more exotic or challenging nanostructures might become achievable. Here, we report that ferrocene-based tetratopic pyridyl ligands, which can dynamically change their geometry by means of thermal rotation of their cyclopentadienyl rings in solution, assemble with AgBF4 into discrete metal-organic nanotubes with large and uniform diameters. The nanotubes can be cut into metal-organic nanorings through selective attenuation of the inter-nanoring interaction via ferrocene oxidation. The resultant nanorings can be transferred onto inorganic substrates electrostatically or allowed to reassemble to form the original nanotube by the reductive neutralization of their oxidized ferrocene units.	[Fukino, Takahiro; Joo, Hyunho; Hisada, Yuki; Obana, Maiko; Yamagishi, Hiroshi; Fujita, Norifumi; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Hikima, Takaaki; Takata, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795198, Japan; [Aida, Takuzo] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN; RIKEN	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	aida@macro.t.u-tokyo.ac.jp	Yamagishi, Hiroshi/AAD-2313-2022; Takata, Masaki/M-1525-2014; Aida, Takuzo/I-9117-2012		Japan Society for the Promotion of Science [23.9024];  [25000005];  [21108012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	T.F. thanks the Japan Society for the Promotion of Science Young Scientist Fellowship (23.9024). We acknowledge Grant-in-Aid for Specially Promoted Research on "Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy" (25000005) and for Scientific Research on Innovative Areas "Coordination Programming" (21108012). The synchrotron x-ray diffraction experiments were performed at the BL45XU in the SPring-8 with the approval of the RIKEN SPring-8 Center (proposal 20130079).	ABEL EW, 1991, J ORGANOMET CHEM, V403, P195, DOI 10.1016/0022-328X(91)83100-I; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Braga D, 2002, CHEM COMMUN, P1080, DOI 10.1039/b200344a; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Chen CY, 2007, INORG CHIM ACTA, V360, P21, DOI 10.1016/j.ica.2006.06.013; de Jeu W. H., 1980, PHYSICAL PROPERTIES, P24; Eisele DM, 2012, NAT CHEM, V4, P655, DOI [10.1038/NCHEM.1380, 10.1038/nchem.1380]; Erhardt R, 2001, MACROMOLECULES, V34, P1069, DOI 10.1021/ma000670p; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Jin W, 2005, P NATL ACAD SCI USA, V102, P10801, DOI 10.1073/pnas.0500852102; Khlobystov AN, 2001, COORDIN CHEM REV, V222, P155, DOI 10.1016/S0010-8545(01)00370-8; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Liu TB, 2011, SCIENCE, V331, P1590, DOI 10.1126/science.1201121; Muller A, 1999, NATURE, V397, P48, DOI 10.1038/16215; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Muraoka T, 2003, J AM CHEM SOC, V125, P5612, DOI 10.1021/ja034994f; OSTER G, 1952, ACTA CRYSTALLOGR, V5, P272, DOI 10.1107/S0365110X5200071X; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; SCHUMANN H, 1995, J ORGANOMET CHEM, V487, P245, DOI 10.1016/0022-328X(94)05098-V; Shin S, 2013, J AM CHEM SOC, V135, P2156, DOI 10.1021/ja400160j; Shklyarevskiy IO, 2005, LANGMUIR, V21, P2108, DOI 10.1021/la047166o; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Tarabout C, 2011, P NATL ACAD SCI USA, V108, P7679, DOI 10.1073/pnas.1017343108; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	29	118	118	7	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					499	504		10.1126/science.1252120	http://dx.doi.org/10.1126/science.1252120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786075				2022-12-28	WOS:000335157700038
J	Hundt, PM; Jiang, B; van Reijzen, ME; Guo, H; Beck, RD				Hundt, P. Morten; Jiang, Bin; van Reijzen, Maarten E.; Guo, Hua; Beck, Rainer D.			Vibrationally Promoted Dissociation of Water on Ni(111)	SCIENCE			English	Article							CHEMICALLY ACCURATE SIMULATION; TOTAL-ENERGY CALCULATIONS; BOND-SELECTED REACTION; WAVE BASIS-SET; FUNDAMENTAL-ASPECTS; SOLID-SURFACES; CHEMISORPTION; METHANE; STATE; MODE	Water dissociation on transition-metal catalysts is an important step in steam reforming and the water-gas shift reaction. To probe the effect of translational and vibrational activation on this important heterogeneous reaction, we performed state-resolved gas/surface reactivity measurements for the dissociative chemisorption of D2O on Ni(111), using molecular beam techniques. The reaction occurs via a direct pathway, because both the translational and vibrational energies promote the dissociation. The experimentally measured initial sticking probabilities were used to calibrate a first-principles potential energy surface based on density functional theory. Quantum dynamical calculations on the scaled potential energy surface reproduced the experimental results semiquantitatively. The larger increase of the dissociation probability by vibrational excitation than by translation per unit of energy is consistent with a late barrier along the O-D stretch reaction coordinate.	[Hundt, P. Morten; van Reijzen, Maarten E.; Beck, Rainer D.] Ecole Polytech Fed Lausanne, Lab Chim Phys Mol, CH-1015 Lausanne, Switzerland; [Jiang, Bin; Guo, Hua] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of New Mexico	Guo, H (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	hguo@unm.edu; rainer.beck@epfl.ch	Hundt, Morten/P-2420-2015; Guo, H./J-2685-2014; Beck, Rainer D/A-4422-2012; jiang, bin/F-2391-2014	Guo, H./0000-0001-9901-053X; Beck, Rainer D/0000-0002-8152-8290; jiang, bin/0000-0003-2696-5436	Swiss National Science Foundation [146487/1]; Ecole Polytechnique Federale de Lausanne; U.S. NSF [CHE-0910828]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; U.S. NSF(National Science Foundation (NSF))	P.M.H., M.v.R., and R.D.B. gratefully acknowledge financial support from the Swiss National Science Foundation (grant no. 146487/1) and the Ecole Polytechnique Federale de Lausanne. B.J. and H.G. thank the U.S. NSF (grant no. CHE-0910828) for support. The experiments were done by the Lausanne group, and the theory was developed by the Albuquerque group.	Beck RD, 2003, SCIENCE, V302, P98, DOI 10.1126/science.1088996; Bowman JM, 2011, PHYS CHEM CHEM PHYS, V13, P8094, DOI 10.1039/c0cp02722g; BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2194, DOI 10.1021/j100112a021; Bukoski A, 2003, J CHEM PHYS, V118, P843, DOI 10.1063/1.1525803; Chadwick H, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861054; Chen L, 2012, FARADAY DISCUSS, V157, P285, DOI 10.1039/c2fd20007d; Diaz C, 2009, SCIENCE, V326, P832, DOI 10.1126/science.1178722; Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413; Han DW, 2013, J PHYS CHEM A, V117, P8651, DOI 10.1021/jp402987w; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; HSIAO MC, 1991, J PHYS CHEM-US, V95, P8263, DOI 10.1021/j100174a046; Hundt PM, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4742914; Jackson B, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3634073; Jiang B, 2013, J AM CHEM SOC, V135, P15251, DOI 10.1021/ja408422y; Jiang B, 2013, CHEM SCI, V4, P3249, DOI 10.1039/c3sc51040a; Jiang B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4810007; Jiang B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4776770; Jiang B, 2013, CHEM SCI, V4, P503, DOI 10.1039/c2sc21393a; Jiang B, 2012, P NATL ACAD SCI USA, V109, P10224, DOI 10.1073/pnas.1203895109; Juurlink LBF, 2009, PROG SURF SCI, V84, P69, DOI 10.1016/j.progsurf.2009.01.001; Juurlink LBF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208303; Killelea DR, 2008, SCIENCE, V319, P790, DOI 10.1126/science.1152819; Killelea DR, 2013, PHYS CHEM CHEM PHYS, V15, P20545, DOI 10.1039/c3cp53765j; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kroes GJ, 2008, SCIENCE, V321, P794, DOI 10.1126/science.1157717; Kroes GJ, 2012, PHYS CHEM CHEM PHYS, V14, P14966, DOI 10.1039/c2cp42471a; Luntz AC, 2000, J CHEM PHYS, V113, P6901, DOI 10.1063/1.1311280; Maroni P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246104; Mondal A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4749246; Nattino F, 2014, J PHYS CHEM LETT, V5, P1294, DOI 10.1021/jz500233n; Nave S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.233408; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; Schmid MP, 2003, REV SCI INSTRUM, V74, P4110, DOI 10.1063/1.1599064; Seenivasan H, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4827641; Sementa L, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4776224; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; SINHA A, 1992, J CHEM PHYS, V96, P372, DOI 10.1063/1.462473; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X; Tiwari AK, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357415; UKRAINTSEV VA, 1994, J CHEM PHYS, V101, P1564, DOI 10.1063/1.468476; Yoder BL, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3665136; Yoder BL, 2010, SCIENCE, V329, P553, DOI 10.1126/science.1191751; Zhang DH, 2000, SCIENCE, V290, P961, DOI 10.1126/science.290.5493.961	45	147	149	7	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					504	507		10.1126/science.1251277	http://dx.doi.org/10.1126/science.1251277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786076	Green Submitted, Green Published			2022-12-28	WOS:000335157700039
J	Cannon, B				Cannon, Bill			MICROBIOLOGY Resistance fighters	NATURE			English	Editorial Material							ANTIBIOTIC-RESISTANCE											Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Dantas G, 2014, AM SCI, V102, P42, DOI 10.1511/2014.106.42; David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014	8	10	10	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S6	S8		10.1038/509S6a	http://dx.doi.org/10.1038/509S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784428	Bronze			2022-12-28	WOS:000335199100004
J	McCartney, M				McCartney, Margaret			Withdraw Saatchi's quackery bill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, MED INN BILL WILL IT; National Institute for Health Research, MYST SHOPP REP; Warlow C, 2005, CLIN MED, V5, P33, DOI 10.7861/clinmedicine.5-1-33	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2014	348								g2974	10.1136/bmj.g2974	http://dx.doi.org/10.1136/bmj.g2974			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5RF	24780239				2022-12-28	WOS:000335475500023
J	Belluz, J				Belluz, Julia			Tug of war for antiviral drugs data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Belluz, J (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jbelluz@gmail.com						Doshi P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1615; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106	4	1	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2227	10.1136/bmj.g2227	http://dx.doi.org/10.1136/bmj.g2227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24811408				2022-12-28	WOS:000334348700017
J	Swaminathan, S				Swaminathan, Soumya			Preventive treatment for tuberculosis in people with HIV	LANCET			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; THERAPY; INFECTION		Natl Inst Res TB, Madras 600031, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Swaminathan, S (corresponding author), Natl Inst Res TB, Madras 600031, Tamil Nadu, India.	soumyas@nirt.res.in						Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI [10.1056/NEJMoa1214289, 10.1056/NEJMc1402073]; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hofmeyr A, 2007, TUBERCULOSIS, V87, P459, DOI 10.1016/j.tube.2007.05.013; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Mills HL, 2011, J R SOC INTERFACE, V8, P1510, DOI 10.1098/rsif.2011.0160; Rangaka MX, 2014, LANCET; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Swaminathan S, 2008, INT J TUBERC LUNG D, V12, P168; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; WHO, 2008, WHO 3 IS M REP INT C	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					644	646		10.1016/S0140-6736(14)60268-3	http://dx.doi.org/10.1016/S0140-6736(14)60268-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5CJ	24835843	Green Accepted			2022-12-28	WOS:000341359100009
J	Albert, JS; Yerges-Armstrong, LM; Horenstein, RB; Pollin, TI; Sreenivasan, UT; Chai, S; Blaner, WS; Snitker, S; O'Connell, JR; Gong, DW; Breyer, RJ; Ryan, AS; McLenithan, JC; Shuldiner, AR; Sztalryd, C; Damcott, CM				Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Blaner, William S.; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; Breyer, Richard J., III; Ryan, Alice S.; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.			Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; PPAR-GAMMA; PARTIAL LIPODYSTROPHY; DEFICIENT MICE; TISSUE; DISEASE; EXPRESSION; RESISTANCE; LIPOLYSIS	BACKGROUND Lipolysis regulates energy homeostasis through the hydrolysis of intracellular triglycerides and the release of fatty acids for use as energy substrates or lipid mediators in cellular processes. Genes encoding proteins that regulate energy homeostasis through lipolysis are thus likely to play an important role in determining susceptibility to metabolic disorders. METHODS We sequenced 12 lipolytic-pathway genes in Old Order Amish participants whose fasting serum triglyceride levels were at the extremes of the distribution and identified a novel 19-bp frameshift deletion in exon 9 of LIPE, encoding hormone-sensitive lipase (HSL), a key enzyme for lipolysis. We genotyped the deletion in DNA from 2738 Amish participants and performed association analyses to determine the effects of the deletion on metabolic traits. We also obtained biopsy specimens of abdominal subcutaneous adipose tissue from 2 study participants who were homozygous for the deletion (DD genotype), 10 who were heterozygous (ID genotype), and 7 who were noncarriers (II genotype) for assessment of adipose histologic characteristics, lipolysis, enzyme activity, cytokine release, and messenger RNA (mRNA) and protein levels. RESULTS Carriers of the mutation had dyslipidemia, hepatic steatosis, systemic insulin resistance, and diabetes. In adipose tissue from study participants with the DD genotype, the mutation resulted in the absence of HSL protein, small adipocytes, impaired lipolysis, insulin resistance, and inflammation. Transcription factors responsive to peroxisome-proliferator-activated receptor gamma (PPAR-gamma) and downstream target genes were down-regulated in adipose tissue from participants with the DD genotype, altering the regulation of pathways influencing adipogenesis, insulin sensitivity, and lipid metabolism. CONCLUSIONS These findings indicate the physiological significance of HSL in adipocyte function and the regulation of systemic lipid and glucose homeostasis and underscore the severe metabolic consequences of impaired lipolysis.	[Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Albert, Jessica S.; Yerges-Armstrong, Laura M.; Horenstein, Richard B.; Pollin, Toni I.; Sreenivasan, Urmila T.; Chai, Sumbul; Snitker, Soren; O'Connell, Jeffrey R.; Gong, Da-Wei; McLenithan, John C.; Shuldiner, Alan R.; Sztalryd, Carole; Damcott, Coleen M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Gong, Da-Wei; Ryan, Alice S.; Shuldiner, Alan R.; Sztalryd, Carole] Baltimore VA Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA; [Breyer, Richard J., III] Baltimore VA Med Ctr, Dept Radiol & Nucl Med, Baltimore, MD USA; [Ryan, Alice S.] Baltimore VA Med Ctr, Vet Affairs VA Res Serv, Dept Med, Div Gerontol & Geriatr Med, Baltimore, MD USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Columbia University	Damcott, CM (corresponding author), Univ Maryland, Sch Med, 660 W Redwood St,Rm 592, Baltimore, MD 21201 USA.	cdamcott@medicine.umaryland.edu	Sreenivasan, Urmila/AAV-6154-2020	Shuldiner, Alan/0000-0001-9921-4305	National Institutes of Health [R01DK075017, R01DK74828, U01HL072515, R01DK54261, U01HL84756, U01GM074518, R01HL104193, R01HL088119]; American Heart Association [11PRE7610008]; University of Maryland Multidisciplinary Clinical Research Career Development Program [NIH K12RR023250]; Mid-Atlantic Nutrition and Obesity Research Center [NIH P30DK072488]; Baltimore Diabetes Research Center [NIH P60DK079637]; American Diabetes Association; U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive) [2007-35205-17883]; Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center; VA Research Career Scientist Award; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088119, R01HL104193, U01HL072515, U01HL084756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075017, R01DK054261, R01DK074828, P30DK079637, P60DK079637, R01DK068437, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Maryland Multidisciplinary Clinical Research Career Development Program; Mid-Atlantic Nutrition and Obesity Research Center; Baltimore Diabetes Research Center; American Diabetes Association(American Diabetes Association); U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive); Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center; VA Research Career Scientist Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (R01DK075017, R01DK74828, U01HL072515, R01DK54261, U01HL84756, U01GM074518, R01HL104193, and R01HL088119), the American Heart Association (11PRE7610008, to Dr. Albert), the University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH K12RR023250, to Dr. Damcott), the Mid-Atlantic Nutrition and Obesity Research Center (NIH P30DK072488), the Baltimore Diabetes Research Center (NIH P60DK079637), the American Diabetes Association, the U.S. Department of Agriculture National Institute of Food and Agriculture (National Research Initiative Competitive Grant 2007-35205-17883), and the Geriatric Research Education and Clinical Center, Baltimore Veterans Affairs (VA) Medical Center, and by a VA Research Career Scientist Award (to Dr. Ryan).	BEILER K, 1988, FISHER FAMILY HIST D; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gray SL, 2005, BIOCHEM SOC T, V33, P1053, DOI 10.1042/BST0331053; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Haemmerle G, 2003, CURR OPIN LIPIDOL, V14, P289, DOI 10.1097/00041433-200306000-00009; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shen WJ, 2011, BBA-MOL CELL BIOL L, V1811, P9, DOI 10.1016/j.bbalip.2010.10.001; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	24	121	123	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2307	2315		10.1056/NEJMoa1315496	http://dx.doi.org/10.1056/NEJMoa1315496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24848981	Green Accepted			2022-12-28	WOS:000337033700010
J	Martins, VC; Busch, K; Juraeva, D; Blum, C; Ludwig, C; Rasche, V; Lasitschka, F; Mastitsky, SE; Brors, B; Hielscher, T; Fehling, HJ; Rodewald, HR				Martins, Vera C.; Busch, Katrin; Juraeva, Dilafruz; Blum, Carmen; Ludwig, Carolin; Rasche, Volker; Lasitschka, Felix; Mastitsky, Sergey E.; Brors, Benedikt; Hielscher, Thomas; Fehling, Hans Joerg; Rodewald, Hans-Reimer			Cell competition is a tumour suppressor mechanism in the thymus	NATURE			English	Article							MOLECULAR PATHOGENESIS; HEMATOPOIETIC STEM; NOTCH1 MUTATIONS; C-KIT; MICE; EXPRESSION; EXPANSION; LEUKEMIA; ACTIVATION; THYMOCYTES	Cell competitionis an emerging principle underlying selection for cellular fitness during development and disease. Competition may be relevant for cancer, but an experimental link between defects in competition and tumorigenesis is elusive. In the thymus, T lymphocytes develop from precursors that are constantly replaced by bone-marrow-derived progenitors. Here we show that in mice this turnover is regulated by natural cell competition between 'young' bone-marrow-derived and 'old' thymus-resident progenitors that, although genetically identical, execute differential gene expression programs. Disruption of cell competition leads to progenitor self-renewal, upregulation of Hmga1, transformation, and T-cell acute lymphoblastic leukaemia (T-ALL) resembling the human disease in pathology, genomic lesions, leukaemia-associated transcripts, and activating mutations in Notch1. Hence, cell competition is a tumour suppressor mechanism in the thymus. Failure to select fit progenitors through cell competition may explain leukaemia in X-linked severe combined immune deficiency patients who showed thymus-autonomous T-cell development after therapy with gene-corrected autologous progenitors.	[Martins, Vera C.; Busch, Katrin; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Martins, Vera C.; Blum, Carmen; Ludwig, Carolin; Fehling, Hans Joerg] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Juraeva, Dilafruz; Mastitsky, Sergey E.; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Rasche, Volker] Univ Ulm, Core Facil Small Anim MRI, D-89081 Ulm, Germany; [Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de	Martins, Vera/M-1356-2015; Martins, Vera C./AAF-5238-2020; Rasche, Volker/P-6523-2016; Brors, Benedikt/E-5620-2013	Martins, Vera/0000-0001-8717-9709; Martins, Vera C./0000-0001-8717-9709; Rasche, Volker/0000-0001-8844-3583; Brors, Benedikt/0000-0001-5940-3101; Mastitsky, Sergey/0000-0002-1068-4579	ERC Advanced Grant [233074]; DFG-SFB938-project L; Helmholtz PCCC Alliance	ERC Advanced Grant(Estonian Research Council); DFG-SFB938-project L; Helmholtz PCCC Alliance	We thank A. Tietz and T. Arnsperger for technical assistance, T. Ashworth and J. Aster, M. Nussenzweig and P. Fink for materials and mice, the animal facilities for mouse husbandry, S. Henze, O. Heil and E. Korpelainen for expression array experiments and support on Chipster. We thank B. Edgar, L. Johnston, T. Boehm, A. Rudensky, R. Medzhitov, M. Muckenthaler, A. Kulodzik, T. Sanda, T. Look, P. Lichter, T. Feyerabend and I. Rode for help and discussions. H.-R.R. was supported by ERC Advanced Grant No. 233074, DFG-SFB938-project L, and the Helmholtz PCCC Alliance.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Baker NE, 2011, CURR BIOL, V21, pR11, DOI 10.1016/j.cub.2010.11.030; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cavazzana-Calvo M, 2011, BLOOD, V117, P4420, DOI 10.1182/blood-2010-09-255679; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Di Cello F, 2013, LEUKEMIA LYMPHOMA, V54, P1762, DOI 10.3109/10428194.2013.764422; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FREY JR, 1992, J EXP MED, V175, P1067, DOI 10.1084/jem.175.4.1067; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Porter CC, 2011, LEUKEMIA, V25, P891, DOI 10.1038/leu.2011.22; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; Tsuji H, 2009, MUTAT RES-FUND MOL M, V660, P22, DOI 10.1016/j.mrfmmm.2008.10.002; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	45	154	158	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					465	+		10.1038/nature13317	http://dx.doi.org/10.1038/nature13317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24828041				2022-12-28	WOS:000336126000033
J	Ford, AC; Moayyedi, P				Ford, Alexander C.; Moayyedi, Paul			UNCERTAINTIES PAGE Whom should we "test and treat" for Helicobacter pylori?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; ERADICATION THERAPY; GASTRIC-CANCER; METAANALYSIS; DYSPEPSIA; RISK; INFECTION; COMMUNITY; DISEASE; GERD		[Ford, Alexander C.] Leeds Gen Infirm, Leeds Gastroenterol Inst, Leeds, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Moayyedi, Paul] McMaster Univ, Med Ctr, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	Leeds General Infirmary; University of Leeds; University of Leeds; McMaster University	Moayyedi, P (corresponding author), McMaster Univ, Med Ctr, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.	moayyep@mcmaster.ca	Ford, Alexander/K-5491-2012; Moayyedi, Paul/M-6178-2014	Ford, Alexander/0000-0001-6371-4359; Moayyedi, Paul/0000-0002-3616-9292				Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Ford AC, 2005, AM J EPIDEMIOL, V162, P454, DOI 10.1093/aje/kwi218; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Graham DY, 2011, HELICOBACTER, V16, P343, DOI 10.1111/j.1523-5378.2011.00891.x; Harvey RF, 2010, ALIMENT PHARM THER, V32, P394, DOI 10.1111/j.1365-2036.2010.04363.x; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, INT AGENCY RES CANC, V61, P177; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Lane JA, 2006, BMJ-BRIT MED J, V332, P199, DOI 10.1136/bmj.38702.662546.55; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Moayyedi P, 2000, LANCET, V355, P1665, DOI 10.1016/S0140-6736(00)02236-4; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Moayyedi P, 2011, ARCH INTERN MED, V171, P1936, DOI 10.1001/archinternmed.2011.541; Plummer M, 2013, AM J GASTROENTEROL, V108, P216, DOI 10.1038/ajg.2012.409; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Saad AM, 2012, SCAND J GASTROENTERO, V47, P129, DOI 10.3109/00365521.2011.648955; Sonnenberg A, 2013, AM J GASTROENTEROL, V108, P208, DOI 10.1038/ajg.2012.407; Videlock EJ, 2012, ALIMENT PHARM THER, V35, P1355, DOI 10.1111/j.1365-2036.2012.05104.x; Wang Q, 2013, HELICOBACTER, V18, P41, DOI 10.1111/hel.12012; Xie TT, 2013, EUR J GASTROEN HEPAT, V25, P1195, DOI 10.1097/MEG.0b013e328363e2c7; Yaghoobi M, 2010, AM J GASTROENTEROL, V105, P1007, DOI 10.1038/ajg.2009.734; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	28	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2014	348								g3320	10.1136/bmj.g3320	http://dx.doi.org/10.1136/bmj.g3320			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZW	24846521				2022-12-28	WOS:000336429100003
J	Gupta, A; Stacey, S; Amissah-Arthur, KN				Gupta, Anjali; Stacey, Simon; Amissah-Arthur, Kwesi N.			10-MINUTE CONSULTATION Eyelid lumps and lesions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gupta, Anjali; Amissah-Arthur, Kwesi N.] Birmingham & Midland Eye Ctr, Birmingham B18 7QH, W Midlands, England; [Stacey, Simon] Westrop Surg, Swindon SN6 7DN, Wilts, England		Gupta, A (corresponding author), Birmingham & Midland Eye Ctr, Dudley Rd, Birmingham B18 7QH, W Midlands, England.	anjaligupta@doctors.org.uk		Amissah-Arthur, Kwesi Nyan/0000-0003-2018-2043					0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2014	348								g3029	10.1136/bmj.g3029	http://dx.doi.org/10.1136/bmj.g3029			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8ZV	24842942				2022-12-28	WOS:000336428800002
J	Jones, AM; Xuan, YH; Xu, M; Wang, RS; Ho, CH; Lalonde, S; You, CH; Sardi, MI; Parsa, SA; Smith-Valle, E; Su, TY; Frazer, KA; Pilot, G; Pratelli, R; Grossmann, G; Acharya, BR; Hu, HC; Engineer, C; Villiers, F; Ju, CL; Takeda, K; Su, Z; Dong, QF; Assmann, SM; Chen, J; Kwak, JM; Schroeder, JI; Albert, R; Rhee, SY; Frommer, WB				Jones, Alexander M.; Xuan, Yuanhu; Xu, Meng; Wang, Rui-Sheng; Ho, Cheng-Hsun; Lalonde, Sylvie; You, Chang Hun; Sardi, Maria I.; Parsa, Saman A.; Smith-Valle, Erika; Su, Tianying; Frazer, Keith A.; Pilot, Guillaume; Pratelli, Rejane; Grossmann, Guido; Acharya, Biswa R.; Hu, Heng-Cheng; Engineer, Cawas; Villiers, Florent; Ju, Chuanli; Takeda, Kouji; Su, Zhao; Dong, Qunfeng; Assmann, Sarah M.; Chen, Jin; Kwak, June M.; Schroeder, Julian I.; Albert, Reka; Rhee, Seung Y.; Frommer, Wolf B.			Border Control-A Membrane-Linked Interactome of Arabidopsis	SCIENCE			English	Article							ABSCISIC-ACID; PROTEIN-KINASE; ENDOCYTOSIS; NETWORK; VERSION; MAP	Cellular membranes act as signaling platforms and control solute transport. Membrane receptors, transporters, and enzymes communicate with intracellular processes through protein-protein interactions. Using a split-ubiquitin yeast two-hybrid screen that covers a test-space of 6.4 x 10(6) pairs, we identified 12,102 membrane/signaling protein interactions from Arabidopsis. Besides confirmation of expected interactions such as heterotrimeric G protein subunit interactions and aquaporin oligomerization, >99% of the interactions were previously unknown. Interactions were confirmed at a rate of 32% in orthogonal in planta split-green flourescent protein interaction assays, which was statistically indistinguishable from the confirmation rate for known interactions collected from literature (38%). Regulatory associations in membrane protein trafficking, turnover, and phosphorylation include regulation of potassium channel activity through abscisic acid signaling, transporter activity by a WNK kinase, and a brassinolide receptor kinase by trafficking-related proteins. These examples underscore the utility of the membrane/signaling protein interaction network for gene discovery and hypothesis generation in plants and other organisms.	[Jones, Alexander M.; Xuan, Yuanhu; Xu, Meng; Ho, Cheng-Hsun; Lalonde, Sylvie; You, Chang Hun; Sardi, Maria I.; Parsa, Saman A.; Smith-Valle, Erika; Su, Tianying; Frazer, Keith A.; Pilot, Guillaume; Pratelli, Rejane; Grossmann, Guido; Chen, Jin; Rhee, Seung Y.; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Wang, Rui-Sheng; Albert, Reka] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Pilot, Guillaume; Pratelli, Rejane] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Acharya, Biswa R.; Su, Zhao; Assmann, Sarah M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hu, Heng-Cheng; Villiers, Florent; Ju, Chuanli; Takeda, Kouji; Kwak, June M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Engineer, Cawas; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Chen, Jin] Michigan State Univ, US DOE, Plant Res Lab, E Lansing, MI 48824 USA; [Chen, Jin] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Kwak, June M.] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Ctr Plant Aging Res, Inst Basic Sci, Taegu 711873, South Korea	Carnegie Institution for Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton; Michigan State University; United States Department of Energy (DOE); Michigan State University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS)	Rhee, SY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	srhee@carnegiescience.edu; wfrommer@stanford.edu	Frommer, Wolf B/A-8256-2008; Grossmann, Guido/GQA-5985-2022; Grossmann, Guido/D-3537-2014; Albert, Reka/E-2195-2011; Kwak, June M/G-8332-2011; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Grossmann, Guido/0000-0001-7529-9244; Grossmann, Guido/0000-0001-7529-9244; Albert, Reka/0000-0002-9485-0828; Kwak, June M/0000-0001-6948-5155; Frommer, Wolf B/0000-0001-6465-0115; Chen, Jin/0000-0001-6721-3199; Wang, Ruisheng/0000-0003-4920-4357; , Yuanhu/0000-0002-4704-8090; Ho, Cheng-Hsun/0000-0002-0895-1914; Schroeder, Julian/0000-0002-3283-5972; Jones, Alexander/0000-0002-3662-2915; Pilot, Guillaume/0000-0001-7520-1059	National Science Foundation (NSF) Arabidopsis grant [MCB-0618402, MCB-1052348];  [NSF-MCB-1021677];  [NSF-MCB-0918220];  [NSF-MCB-1121612]; Div Of Molecular and Cellular Bioscience [1052348, 1414339, 1121612] Funding Source: National Science Foundation	National Science Foundation (NSF) Arabidopsis grant(National Science Foundation (NSF)); ; ; ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank W. Monsell (Pennsylvania State University) and Y. S. Han (University of Maryland) for technical assistance and K. Revanna and V. Desu (University of North Texas) for assistance with the MIND web portal development. This work was made possible by a National Science Foundation (NSF) Arabidopsis 2010 grant (MCB-0618402) to W.B.F., S.M.A., R.A., J.M.K., S.Y.R., and J.I.S. and NSF Arabidopsis 2010 grant (MCB-1052348) to W.B.F. and S.Y.R., with partial support from NSF-MCB-1021677 (W.B.F.), NSF-MCB-0918220 (J.I.S.) and NSF-MCB-1121612 (S.M.A. and R.A.). Because of the large number of constructs, we are not able to distribute individual clones. We make split-ubiquitin system vectors and an Arabidopsis ORF collection available through the Arabidopsis Biological Resource Center (https://abrc.osu.edu) and split-GFP assay vectors available through AddGene (www.addgene.org). Instructions for acquiring other materials as well as a materials transfer agreement governing plasmids are provided online at www.associomics.org. Additional materials are included in the suplementary materials. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Andersson ER, 2012, CELL MOL LIFE SCI, V69, P1755, DOI 10.1007/s00018-011-0877-1; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bienert GP, 2012, BIOCHEM J, V445, P101, DOI 10.1042/BJ20111704; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Contento AL, 2012, J CELL SCI, V125, P3511, DOI 10.1242/jcs.093559; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Ho CH, 2014, ELIFE, V3, DOI 10.7554/eLife.01917; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schulze Waltraud X, 2003, BMC Biochem, V4, P3, DOI 10.1186/1471-2091-4-3; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Song L, 2009, CELL RES, V19, P864, DOI 10.1038/cr.2009.66; Sterken R, 2009, PLANT CELL, V21, P2987, DOI 10.1105/tpc.109.067017; Takahashi D., 2014, BIOSCI REP; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Van Zeebroeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024275; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	42	149	150	3	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2014	344	6185					711	716		10.1126/science.1251358	http://dx.doi.org/10.1126/science.1251358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH1WQ	24833385				2022-12-28	WOS:000335912900032
J	Hudson, ZM; Manners, I				Hudson, Zachary M.; Manners, Ian			Assembly and Disassembly of Ferrocene-Based Nanotubes	SCIENCE			English	Editorial Material							MICELLES		[Hudson, Zachary M.; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Hudson, ZM (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	ian.manners@bristol.ac.uk	Hudson, Zachary/I-8452-2012	Hudson, Zachary/0000-0002-8033-4136; Manners, Ian/0000-0002-3794-967X				Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Fielding LA, 2013, CHEM SCI, V4, P2081, DOI 10.1039/c3sc50305d; Fukino T, 2014, SCIENCE, V344, P499, DOI 10.1126/science.1252120; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Kastler M, 2005, J AM CHEM SOC, V127, P4286, DOI 10.1021/ja0430696; Li CS, 1997, J AM CHEM SOC, V119, P1609, DOI 10.1021/ja9600284; Ma YJ, 2006, NAT MATER, V5, P724, DOI 10.1038/nmat1716; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Whittell GR, 2011, NAT MATER, V10, P176, DOI 10.1038/nmat2966; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340; Zhu JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3297	12	11	11	1	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					481	482		10.1126/science.1254140	http://dx.doi.org/10.1126/science.1254140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24786069				2022-12-28	WOS:000335157700030
J	Hede, K				Hede, Karyn			AN INFECTIOUS ARMS RACE	NATURE			English	Editorial Material													Hede, Karyn/AGR-8461-2022	Hede, Karyn/0000-0003-2815-0636					0	80	85	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S2	S3		10.1038/509S2a	http://dx.doi.org/10.1038/509S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784426	Bronze			2022-12-28	WOS:000335199100002
J	Shapiro, ED				Shapiro, Eugene D.			Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONFIRMED ERYTHEMA MIGRANS; BORRELIA-BURGDORFERI; HEMATOGENOUS DISSEMINATION; IMMUNOGLOBULIN-M; SEROLOGIC TESTS; NORTH-AMERICA; DOUBLE-BLIND; TICK BITES; DOXYCYCLINE; DURATION	A 32-year-old pregnant woman from southeastern Connecticut presents to her physician in July at 26 weeks' gestation because of a skin lesion. She reports she has had fatigue, arthralgia, and headache for 2 days and a rash in her left axilla for 1 day. She lives in a wooded area and works in her garden frequently. Six weeks earlier, she had removed a small tick that was attached behind her right knee. On physical examination, she is afebrile. She has an erythematous, oval macular lesion, 7 to 8 cm in diameter, in her left axilla, with enhanced central erythema; no other abnormalities are needed. How should her case be managed?	[Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Invest Med, New Haven, CT USA; [Shapiro, Eugene D.] Yale Univ, Dept Pediat, Sch Publ Hlth, New Haven, CT 06520 USA; [Shapiro, Eugene D.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Shapiro, Eugene D.] Yale Univ, Sch Publ Hlth, Dept Invest Med, New Haven, CT USA; [Shapiro, Eugene D.] Grad Sch Arts & Sci, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Shapiro, ED (corresponding author), Yale Dept Pediat, POB 208064,333 Cedar St, New Haven, CT 06520 USA.	eugene.shapiro@yale.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, KL2TR000140] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000142, KL2 TR000140] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Baker PJ, 2010, FASEB J, V24, P4175, DOI 10.1096/fj.10-167247; Branda JA, 2013, ANN INTERN MED, V159, P61, DOI 10.7326/0003-4819-159-1-201307020-00009; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Centers for Disease Control and Prevention, LYM DIS DAT; Cooper JD, 2004, PEDIATR INFECT DIS J, V23, P1105, DOI 10.1097/01.inf.0000145411.57449.f3; Dattwyler RJ, 1997, NEW ENGL J MED, V337, P289, DOI 10.1056/NEJM199707313370501; Ei Khoury M.Y., 2013, EXPERT REV ANTI-INFE, V11, P983; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; GERBER MA, 1994, PEDIATR NEUROL, V11, P41, DOI 10.1016/0887-8994(94)90088-4; Halperin JJ, 2008, NEUROLOGY, V70, P1223; Halperin JJ, 2008, NEUROLOGY, V70, P986, DOI 10.1212/01.WNL.0000291407.40667.69; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hatcher S, 2008, BRIT MED J, V336, P1124, DOI 10.1136/bmj.39554.592014.BE; Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397; Hilton E, 1997, J CLIN MICROBIOL, V35, P774, DOI 10.1128/JCM.35.3.774-776.1997; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lantos PM, 2011, EXPERT REV ANTI-INFE, V9, P787, DOI [10.1586/eri.11.63, 10.1586/ERI.11.63]; LEY C, 1995, AM J EPIDEMIOL, V142, pS39, DOI 10.1093/aje/142.Supplement_9.S39; Liveris D, 2012, DIAGN MICR INFEC DIS, V73, P243, DOI 10.1016/j.diagmicrobio.2012.03.026; Ljostad U, 2008, LANCET NEUROL, V7, P675, DOI 10.1016/S1474-4422(08)70150-9; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; PIESMAN J, 1991, J INFECT DIS, V163, P895, DOI 10.1093/infdis/163.4.895; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Seltzer EG, 1996, PEDIATR INFECT DIS J, V15, P762, DOI 10.1097/00006454-199609000-00003; Shapiro ED, 2001, NEW ENGL J MED, V345, P133, DOI 10.1056/NEJM200107123450210; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; STROBINO BA, 1993, AM J OBSTET GYNECOL, V169, P367, DOI 10.1016/0002-9378(93)90088-Z; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Walker DH, 1996, JAMA-J AM MED ASSOC, V275, P463, DOI 10.1001/jama.275.6.463; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wormser GP, 2007, CLIN INFECT DIS, V45, P941, DOI 10.1086/522848; Wormser GP, 2008, CLIN VACCINE IMMUNOL, V15, P1519, DOI 10.1128/CVI.00109-08; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Wormser GP, 2005, ANN INTERN MED, V142, P751, DOI 10.7326/0003-4819-142-9-200505030-00011; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Wormser GP, 2005, CLIN INFECT DIS, V41, P958, DOI 10.1086/432935; Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5	49	123	127	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1724	1731		10.1056/NEJMcp1314325	http://dx.doi.org/10.1056/NEJMcp1314325			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	25119621	Green Accepted			2022-12-28	WOS:000335405200010
J	Goncalves, BP; Huang, CY; Morrison, R; Holte, S; Kabyemela, E; Prevots, DR; Fried, M; Duffy, PE				Goncalves, Bronner P.; Huang, Chiung-Yu; Morrison, Robert; Holte, Sarah; Kabyemela, Edward; Prevots, D. Rebecca; Fried, Michal; Duffy, Patrick E.			Parasite Burden and Severity of Malaria in Tanzanian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SICKLE-CELL GENE; RURAL AREA; AFRICAN CHILDREN; MORBIDITY; MORTALITY; TRANSMISSION; TRIAL; EXPOSURE; VACCINES	BackgroundSevere Plasmodium falciparum malaria is a major cause of death in children. The contribution of the parasite burden to the pathogenesis of severe malaria has been controversial. MethodsWe documented P. falciparum infection and disease in Tanzanian children followed from birth for an average of 2 years and for as long as 4 years. ResultsOf the 882 children in our study, 102 had severe malaria, but only 3 had more than two episodes. More than half of first episodes of severe malaria occurred after a second infection. Although parasite levels were higher on average when children had severe rather than mild disease, most children (67 of 102) had high-density infection (>2500 parasites per 200 white cells) with only mild symptoms before severe malaria, after severe malaria, or both. The incidence of severe malaria decreased considerably after infancy, whereas the incidence of high-density infection was similar among all age groups. Infections before and after episodes of severe malaria were associated with similar parasite densities. Nonuse of bed nets, placental malaria at the time of a woman's second or subsequent delivery, high-transmission season, and absence of the sickle cell trait increased severe-malaria risk and parasite density during infections. ConclusionsResistance to severe malaria was not acquired after one or two mild infections. Although the parasite burden was higher on average during episodes of severe malaria, a high parasite burden was often insufficient to cause severe malaria even in children who later were susceptible. The diverging rates of severe disease and high-density infection after infancy, as well as the similar parasite burdens before and after severe malaria, indicate that naturally acquired resistance to severe malaria is not explained by improved control of parasite density. (Funded by the National Institute of Allergy and Infectious Diseases and others.) The pathogenesis of severe malaria due to Plasmodium falciparum remains controversial. In this study conducted over several years and involving 882 Tanzanian children, parasite burden was insufficient to explain the development of severe illness. Although almost 600,000 African children die each year from malaria,(1) most infections in children are mild.(2),(3) Fundamental questions about the pathogenesis of malaria remain unresolved, such as the relative contributions of parasite burden and host inflammation to severe disease.(4) In areas where transmission is stable, severe malaria is unlikely to occur after 5 years of age, presumably as a result of immunity,(5) and mathematical models suggest that protection against noncerebral severe malaria develops after one or two infections.(6) The mechanism of protective immunity is unclear; it might, for example, involve the reduction of parasite density or the blocking of ...	[Goncalves, Bronner P.; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Goncalves, Bronner P.; Prevots, D. Rebecca] NIAID, Lab Clin Infect Dis, Epidemiol Unit, NIH, Rockville, MD 20852 USA; [Huang, Chiung-Yu] NIAID, Biostat Res Branch, NIH, Rockville, MD 20852 USA; [Morrison, Robert; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Kabyemela, Edward; Fried, Michal; Duffy, Patrick E.] Muheza Designated Dist Hosp, Offspring Malaria Studies Project, Muheza, Tanzania	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Center for Infectious Disease Research; Fred Hutchinson Cancer Center	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 111,5640 Fishers Lane, Rockville, MD 20852 USA.	patrick.duffy@nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID extramural program [R01AI52059]; Fogarty International Center of the NIH [D43 TW005509]; Foundation for the NIH through the Grand Challenges in Global Health Initiative - Bill and Melinda Gates Foundation [1364]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001178, ZIAAI001134] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID extramural program; Fogarty International Center of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Foundation for the NIH through the Grand Challenges in Global Health Initiative - Bill and Melinda Gates Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and by grants from the NIAID extramural program (R01AI52059), the Fogarty International Center (D43 TW005509) of the NIH, and the Foundation for the NIH through the Grand Challenges in Global Health Initiative, which is funded by the Bill and Melinda Gates Foundation (1364).	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; [Anonymous], 2012, WORLD MALARIA REPORT; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Casals-Pascual C, 2006, CURR MOL MED, V6, P155, DOI 10.2174/156652406776055159; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; ERUNKULU OA, 1992, CLIN EXP IMMUNOL, V89, P296, DOI 10.1111/j.1365-2249.1992.tb06948.x; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; NELSON W, 1988, J QUAL TECHNOL, V20, P24, DOI 10.1080/00224065.1988.11979080; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; PROCACCI PG, 1991, T ROY SOC TROP MED H, V85, P181, DOI 10.1016/0035-9203(91)90013-O; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; SALUM FM, 1994, ACTA TROP, V58, P29, DOI 10.1016/0001-706X(94)90119-8; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P212, DOI 10.1016/0035-9203(88)90414-2; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Warimwe GM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003247; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WEATHERALL DJ, 1982, BRIT MED BULL, V38, P147, DOI 10.1093/oxfordjournals.bmb.a071751; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	40	95	95	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2014	370	19					1799	1808		10.1056/NEJMoa1303944	http://dx.doi.org/10.1056/NEJMoa1303944			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH3CD	24806160	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:000335997900008
J	Gammon, K				Gammon, Katharine			DRUG DISCOVERY Leaving no stone unturned	NATURE			English	Editorial Material																		Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Scholl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033637; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Zlitni S, 2013, NAT CHEM BIOL, V9, P796, DOI [10.1038/nchembio.1361, 10.1038/NCHEMBIO.1361]	9	15	15	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S10	S12		10.1038/509S10a	http://dx.doi.org/10.1038/509S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784422	Bronze			2022-12-28	WOS:000335199100006
